<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>ASHPOfficial</title>
    <atom:link href="https://feed.podbean.com/ashpofficial/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://www.ashp.org/Professional-Development/ASHP-Podcasts</link>
    <description><![CDATA[<p><span>ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.</span></p>]]></description>
    <pubDate>Fri, 12 Jun 2026 17:10:07 -0400</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2025 All rights reserved.</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>ASHPOfficial is the premier podcast of ASHP and the collective voice of our 60,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.</itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
<itunes:category text="Science" />
    <itunes:owner>
        <itunes:name>American Society of Health-System Pharmacists©</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/6070738/ASHPOfficial_Final_Artwork.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/6070738/ASHPOfficial_Final_Artwork.jpg</url>
        <title>ASHPOfficial</title>
        <link>https://www.ashp.org/Professional-Development/ASHP-Podcasts</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Rolling the Dice with Biosafety: Pharmacy Best Practices for the Safe Handling and Management of Live Therapeutics</title>
        <itunes:title>Rolling the Dice with Biosafety: Pharmacy Best Practices for the Safe Handling and Management of Live Therapeutics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/rolling-the-dice-with-biosafety-pharmacy-best-practices-for-the-safe-handling-and-management-of-live-therapeutics/</link>
                    <comments>https://ashpofficial.podbean.com/e/rolling-the-dice-with-biosafety-pharmacy-best-practices-for-the-safe-handling-and-management-of-live-therapeutics/#comments</comments>        <pubDate>Fri, 12 Jun 2026 17:10:07 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/21d902f6-b6e1-3a35-b6fc-2981fc632f9e</guid>
                                    <description><![CDATA[<p>The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cju5rc54dab97q7f/2_ASHPOfficial_-_Rolling_the_Dice_with_Biosafety_Pharmacy_Best_Practices_for_the_Safe_Handling_and_Management_of_Live_Therapeutics_-_Mix_Revised81ims.mp3" length="21961850" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1372</itunes:duration>
                <itunes:episode>1532</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics/Clinical Conversations: SCPP: Outpatient Pharmacy Continuous Glucose Monitoring Service: A Pilot Program</title>
        <itunes:title>Hot Topics/Clinical Conversations: SCPP: Outpatient Pharmacy Continuous Glucose Monitoring Service: A Pilot Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsclinical-conversations-scpp-outpatient-pharmacy-continuous-glucose-monitoring-service-a-pilot-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsclinical-conversations-scpp-outpatient-pharmacy-continuous-glucose-monitoring-service-a-pilot-program/#comments</comments>        <pubDate>Thu, 11 Jun 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5da274eb-c507-3e8b-87f7-92ba19463d45</guid>
                                    <description><![CDATA[<p>This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vum52mv3pjjcppbd/Outpatient_Pharmacy_Continuous_Glucose_Monitoring_Service_A_Pilot_mixdownb4tuo.mp3" length="29427956" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1217</itunes:duration>
                <itunes:episode>1522</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: Practice Transformation: Making eGFR the Standard for CKD Dosing</title>
        <itunes:title>Clinical Conversations: SCSS: Practice Transformation: Making eGFR the Standard for CKD Dosing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-practice-transformation-making-egfr-the-standard-for-ckd-dosing/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-practice-transformation-making-egfr-the-standard-for-ckd-dosing/#comments</comments>        <pubDate>Tue, 09 Jun 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5f39cc60-eb0b-339e-b275-33403abd8624</guid>
                                    <description><![CDATA[<p>This episode discusses the urgency for pharmacists to transition from using Cockcroft-Gault eCrCL to non-race based estimated glomerular filtration rate (eGFR) to improve medication-related decision-making in persons with reduced kidney function.  Listeners will learn how to transition from C-G eCrCL to eGFR adjusted for body surface area to improve medication effectiveness and safety in persons with chronic kidney disease.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the urgency for pharmacists to transition from using Cockcroft-Gault eCrCL to non-race based estimated glomerular filtration rate (eGFR) to improve medication-related decision-making in persons with reduced kidney function.  Listeners will learn how to transition from C-G eCrCL to eGFR adjusted for body surface area to improve medication effectiveness and safety in persons with chronic kidney disease.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ib48inns9bepbjix/ASHPOfficial_-_Practice_Transformation_-_Making_eGFR_the_Standard_for_CKD_Dosing_-_Mix6wzs7.mp3" length="32160419" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the urgency for pharmacists to transition from using Cockcroft-Gault eCrCL to non-race based estimated glomerular filtration rate (eGFR) to improve medication-related decision-making in persons with reduced kidney function.  Listeners will learn how to transition from C-G eCrCL to eGFR adjusted for body surface area to improve medication effectiveness and safety in persons with chronic kidney disease.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2010</itunes:duration>
                <itunes:episode>1525</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Caring for Yourself While Caring for Patients: Micro Strategies for Wellness</title>
        <itunes:title>Pharmacy Leadership: Caring for Yourself While Caring for Patients: Micro Strategies for Wellness</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-caring-for-yourself-while-caring-for-patients-micro-strategies-for-wellness/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-caring-for-yourself-while-caring-for-patients-micro-strategies-for-wellness/#comments</comments>        <pubDate>Mon, 08 Jun 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/61762c8b-4258-305e-be0e-52cbdfb5ebec</guid>
                                    <description><![CDATA[<p>Two wellness experts discuss ways that we can take care of our own well-being. They will share insights into how events in our workday interfere with wellness and what we can do to maintain and re-establish wellness. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Two wellness experts discuss ways that we can take care of our own well-being. They will share insights into how events in our workday interfere with wellness and what we can do to maintain and re-establish wellness. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hn5jic75txfh8xbn/Caring_for_Yourself_While_Caring_for_Patients_Mixdown_06012026be8d7.mp3" length="45907061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two wellness experts discuss ways that we can take care of our own well-being. They will share insights into how events in our workday interfere with wellness and what we can do to maintain and re-establish wellness. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1434</itunes:duration>
                <itunes:episode>1531</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Muscle Loss (CE)</title>
        <itunes:title>Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Muscle Loss (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonists-and-muscle-loss-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonists-and-muscle-loss-ce/#comments</comments>        <pubDate>Sat, 06 Jun 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fa35fec4-fd4c-34ac-80b2-c8ffbd6438d0</guid>
                                    <description><![CDATA[<p>This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hff4sj852j3n76m5/ASHPOfficial_GLP_1_Receptor_Antagonists_and_Muscle_Loss_CE_mix_1_9m87v.mp3" length="20574908" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1285</itunes:duration>
                <itunes:episode>1524</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Interdisciplinary Collaboration to Reduce Low-Value Alert Noise in the Electronic Health Record</title>
        <itunes:title>Informatics Bytes: Interdisciplinary Collaboration to Reduce Low-Value Alert Noise in the Electronic Health Record</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-interdisciplinary-collaboration-to-reduce-low-value-alert-noise-in-the-electronic-health-record/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-interdisciplinary-collaboration-to-reduce-low-value-alert-noise-in-the-electronic-health-record/#comments</comments>        <pubDate>Wed, 03 Jun 2026 15:52:26 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bda39634-1cca-3024-b518-7b08384dab58</guid>
                                    <description><![CDATA[<p>This podcast explores how an interdisciplinary team of pharmacists, nurses, and providers redesigned frequently ignored and interruptive allergy review alerts within the electronic health record (EHR). By leveraging data from the EHR and incorporating frontline feedback, the team implemented changes to reduce noise and maintain patient safety. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores how an interdisciplinary team of pharmacists, nurses, and providers redesigned frequently ignored and interruptive allergy review alerts within the electronic health record (EHR). By leveraging data from the EHR and incorporating frontline feedback, the team implemented changes to reduce noise and maintain patient safety. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zg6cyn3juf8fcgr4/Interdisciplinary_Collaboration_to_Reduce_Low-Value_Alert_Noise_in_the_Electronic_Health_Record_mixdown94b6e.mp3" length="44884252" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores how an interdisciplinary team of pharmacists, nurses, and providers redesigned frequently ignored and interruptive allergy review alerts within the electronic health record (EHR). By leveraging data from the EHR and incorporating frontline feedback, the team implemented changes to reduce noise and maintain patient safety. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1862</itunes:duration>
                <itunes:episode>1530</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: Filtering the Latest: Staying Current With Kidney Care</title>
        <itunes:title>Clinical Conversations: SCSS: Filtering the Latest: Staying Current With Kidney Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-filtering-the-latest-a-discussion-of-staying-current-with-kidney-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-filtering-the-latest-a-discussion-of-staying-current-with-kidney-care/#comments</comments>        <pubDate>Wed, 03 Jun 2026 15:50:27 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4739e409-47f4-34cd-ae34-9d0ad90c361f</guid>
                                    <description><![CDATA[<p class="xmsonormal">Through practical discussions, expert insights, and real-world strategies, participants discuss best practices for keeping up-to-date and translating new information through practical discussions, expert insights, and real-world strategies. This podcast is designed to support pharmacists navigating rapidly evolving cardio-kidney-metabolic care. </p>
<p class="xmsonormal"> The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">Through practical discussions, expert insights, and real-world strategies, participants discuss best practices for keeping up-to-date and translating new information through practical discussions, expert insights, and real-world strategies. This podcast is designed to support pharmacists navigating rapidly evolving cardio-kidney-metabolic care. </p>
<p class="xmsonormal"> <em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7mv69rs8eq9z223h/ASHPOfficial_-_Filtering_the_Latest_-_A_Discussion_of_Staying_Current_with_Kidney_Care_-_Mixatkzd.mp3" length="49277435" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Through practical discussions, expert insights, and real-world strategies, participants discuss best practices for keeping up-to-date and translating new information through practical discussions, expert insights, and real-world strategies. This podcast is designed to support pharmacists navigating rapidly evolving cardio-kidney-metabolic care. 
 The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3079</itunes:duration>
                <itunes:episode>1529</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: The New Practitioner Playbook: Legislative Edition</title>
        <itunes:title>Advocating for Impact: The New Practitioner Playbook: Legislative Edition</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-the-new-practitioner-playbook-legislative-edition/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-the-new-practitioner-playbook-legislative-edition/#comments</comments>        <pubDate>Wed, 03 Jun 2026 14:46:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/76a99a8c-3dc8-312c-9986-6daa60d7d5c3</guid>
                                    <description><![CDATA[<p>This podcast breaks down key legislative updates and explores what they mean for new practitioners. Listeners will gain practical insight into how these changes impact day-to-day practice across care settings, along with actionable ways to apply new policies in their own roles. The episode also highlights opportunities for advocacy and engagement, empowering early-career professionals to get involved and help shape the future of the profession.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast breaks down key legislative updates and explores what they mean for new practitioners. Listeners will gain practical insight into how these changes impact day-to-day practice across care settings, along with actionable ways to apply new policies in their own roles. The episode also highlights opportunities for advocacy and engagement, empowering early-career professionals to get involved and help shape the future of the profession.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ef3p4zrr924e58t9/The_new_Practitioner_playbook_edit_mixdown9i5xo.mp3" length="37929036" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast breaks down key legislative updates and explores what they mean for new practitioners. Listeners will gain practical insight into how these changes impact day-to-day practice across care settings, along with actionable ways to apply new policies in their own roles. The episode also highlights opportunities for advocacy and engagement, empowering early-career professionals to get involved and help shape the future of the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1579</itunes:duration>
                <itunes:episode>1528</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Insights and Connections: A Real Conversation About 340B</title>
        <itunes:title>Insights and Connections: A Real Conversation About 340B</itunes:title>
        <link>https://ashpofficial.podbean.com/e/insights-and-connections-a-real-conversation-about-340b/</link>
                    <comments>https://ashpofficial.podbean.com/e/insights-and-connections-a-real-conversation-about-340b/#comments</comments>        <pubDate>Tue, 02 Jun 2026 10:10:26 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/13b29a75-c1d6-3aec-b2a3-d4e8b646dcfe</guid>
                                    <description><![CDATA[<p>What does the future hold for the 340B Drug Pricing Program? In this episode, ASHP Executive Vice President and CEO Sam Calabrese sits down with ASHP Chief Advocacy Officer and Vice President of Government Relations Tom Kraus to discuss what health-system pharmacy professionals are hearing on the ground, the real-world value the 340B program brings to patients and communities, and ASHP’s latest efforts to safeguard the program. Tune in for an inside look at the challenges, opportunities, and advocacy shaping the road ahead.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>What does the future hold for the 340B Drug Pricing Program? In this episode, ASHP Executive Vice President and CEO Sam Calabrese sits down with ASHP Chief Advocacy Officer and Vice President of Government Relations Tom Kraus to discuss what health-system pharmacy professionals are hearing on the ground, the real-world value the 340B program brings to patients and communities, and ASHP’s latest efforts to safeguard the program. Tune in for an inside look at the challenges, opportunities, and advocacy shaping the road ahead.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kfpq45sdz2ss9es7/A_Real_Conversation_About_340B_mix_MASTER9653x.mp3" length="38249695" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What does the future hold for the 340B Drug Pricing Program? In this episode, ASHP Executive Vice President and CEO Sam Calabrese sits down with ASHP Chief Advocacy Officer and Vice President of Government Relations Tom Kraus to discuss what health-system pharmacy professionals are hearing on the ground, the real-world value the 340B program brings to patients and communities, and ASHP’s latest efforts to safeguard the program. Tune in for an inside look at the challenges, opportunities, and advocacy shaping the road ahead.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1585</itunes:duration>
                <itunes:episode>1527</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): T-Cell-Engaging Bispecific Antibodies in Cancer: What the Non-Oncology Pharmacist Needs to Know about Acute Toxicities (CE)</title>
        <itunes:title>Clinical Conversations (CE): T-Cell-Engaging Bispecific Antibodies in Cancer: What the Non-Oncology Pharmacist Needs to Know about Acute Toxicities (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-t-cell-engaging-bispecific-antibodies-in-cancer-what-the-non-oncology-pharmacist-needs-to-know-about-acute-toxicities-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-t-cell-engaging-bispecific-antibodies-in-cancer-what-the-non-oncology-pharmacist-needs-to-know-about-acute-toxicities-ce/#comments</comments>        <pubDate>Sat, 30 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8abe2714-dd9d-30f7-aa7e-15ba6056227e</guid>
                                    <description><![CDATA[<p>T-cell-engaging bispecific antibodies represent a major therapeutic and scientific advancement in the treatment of several types of cancer. However, they carry a risk of some unique acute toxicities, such as cytokine release syndrome and neurologic toxicity. This podcast reviews this emerging drug class and strategies for recognition and management of their unique adverse events.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>T-cell-engaging bispecific antibodies represent a major therapeutic and scientific advancement in the treatment of several types of cancer. However, they carry a risk of some unique acute toxicities, such as cytokine release syndrome and neurologic toxicity. This podcast reviews this emerging drug class and strategies for recognition and management of their unique adverse events.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tb5c4ntcfgaq6zta/BiTE-Sized_Breakthroughs_Clinical_Data_and_Practice_Approaches_for_New_Indications_for_Advanced_Therapies_mixdown8o4c6.mp3" length="23859200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[T-cell-engaging bispecific antibodies represent a major therapeutic and scientific advancement in the treatment of several types of cancer. However, they carry a risk of some unique acute toxicities, such as cytokine release syndrome and neurologic toxicity. This podcast reviews this emerging drug class and strategies for recognition and management of their unique adverse events.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1491</itunes:duration>
                <itunes:episode>1521</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Innovating PGY2 Residency Training Through a Virtual Precepting Model</title>
        <itunes:title>Educator Essentials: Innovating PGY2 Residency Training Through a Virtual Precepting Model</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-innovating-pgy2-residency-training-through-a-virtual-precepting-model/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-innovating-pgy2-residency-training-through-a-virtual-precepting-model/#comments</comments>        <pubDate>Fri, 29 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/09d7999b-f0c2-358c-9917-f80dd35b0dc8</guid>
                                    <description><![CDATA[<p>This episode explores the development of an innovative telehealth‑focused, virtual postgraduate year 2 ambulatory care residency program within the VA, highlighting how it expands access to specialized training, leverages a virtual precepting model, and prepares pharmacists for emerging virtual care roles. Speakers share insights and lessons learned from designing a virtual residency model, including strategies for overcoming implementation challenges and supporting resident success. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode explores the development of an innovative telehealth‑focused, virtual postgraduate year 2 ambulatory care residency program within the VA, highlighting how it expands access to specialized training, leverages a virtual precepting model, and prepares pharmacists for emerging virtual care roles. Speakers share insights and lessons learned from designing a virtual residency model, including strategies for overcoming implementation challenges and supporting resident success. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sf9iicexida5rr28/ASHPOfficial_-_Innovating_PGY2_Residency_Training_Through_a_Virtual_Precepting_Model_-_Mix8advb.mp3" length="27587597" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode explores the development of an innovative telehealth‑focused, virtual postgraduate year 2 ambulatory care residency program within the VA, highlighting how it expands access to specialized training, leverages a virtual precepting model, and prepares pharmacists for emerging virtual care roles. Speakers share insights and lessons learned from designing a virtual residency model, including strategies for overcoming implementation challenges and supporting resident success. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1724</itunes:duration>
                <itunes:episode>1526</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy Practice: BiTE-Sized Breakthroughs: Clinical Data and Practice Approaches for New Indications for Advanced Therapies</title>
        <itunes:title>Hot Topics in Pharmacy Practice: BiTE-Sized Breakthroughs: Clinical Data and Practice Approaches for New Indications for Advanced Therapies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-bite-sized-breakthroughs-clinical-data-and-practice-approaches-for-new-indications-for-advanced-therapies/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-bite-sized-breakthroughs-clinical-data-and-practice-approaches-for-new-indications-for-advanced-therapies/#comments</comments>        <pubDate>Thu, 28 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a39bbf1a-5555-301c-8568-d612a312db75</guid>
                                    <description><![CDATA[<p>BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8xvnahuej3xswcsg/BiTE-Sized_Breakthroughs_Clinical_Data_and_Practice_Approaches_for_New_Indications_for_Advanced_Therapies_mixdown_1_6ncly.mp3" length="36766117" type="audio/mpeg"/>
        <itunes:summary><![CDATA[BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1524</itunes:duration>
                <itunes:episode>1523</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Research that Moves Pharmacy Forward: Conversations with the 2025 ASHP Foundation Literature Awardees</title>
        <itunes:title>Research in Pharmacy Practice: Research that Moves Pharmacy Forward: Conversations with the 2025 ASHP Foundation Literature Awardees</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-research-that-moves-pharmacy-forward-conversations-with-the-2025-ashp-foundation-literature-awardees/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-research-that-moves-pharmacy-forward-conversations-with-the-2025-ashp-foundation-literature-awardees/#comments</comments>        <pubDate>Thu, 28 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5c2115f6-4459-3889-a017-d3e01186567e</guid>
                                    <description><![CDATA[<p>Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m6xr5jhsubx5rhvw/ASHPOfficial_-_2025_Lit_Awards_ASC_Podcast_-_Mix7xzu2.mp3" length="16629671" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1039</itunes:duration>
                <itunes:episode>1520</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Echoes to Outcomes: Developing a System for Tracking and Responding to Electronic Health Record User Feedback</title>
        <itunes:title>Informatics Bytes: Echoes to Outcomes: Developing a System for Tracking and Responding to Electronic Health Record User Feedback</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-echoes-to-outcomes-developing-a-system-for-tracking-and-responding-to-electronic-health-record-user-feedback/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-echoes-to-outcomes-developing-a-system-for-tracking-and-responding-to-electronic-health-record-user-feedback/#comments</comments>        <pubDate>Wed, 27 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0cb802ba-397d-343a-9165-86a6e0a83f24</guid>
                                    <description><![CDATA[<p>This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process.  Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process.  Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zt2nchn49cw5s77q/Echoes_to_Outcomes_Developing_a_System_for_Tracking_and_Responding_to_Electronic_Health_Record_User_Feedback_mixdown9i89r.mp3" length="44476852" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process.  Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1845</itunes:duration>
                <itunes:episode>1518</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series: Anastasiya Shor, PharmD, BCPS</title>
        <itunes:title>We're Your Pharmacist Podcast Series: Anastasiya Shor, PharmD, BCPS</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-anastasiya-shor-pharmd-bcps/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-anastasiya-shor-pharmd-bcps/#comments</comments>        <pubDate>Tue, 26 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b9c94d6-e8b6-3cca-b45b-78beaff20b17</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q9qs8jdhd9r5xwcf/We_re_Your_Pharmacist_Anastasiya_Shor_with_Ashley_Boedecker_Mixdown_04072026bbhbb.mp3" length="21126766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>660</itunes:duration>
                <itunes:episode>1519</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: From Evidence to Action: Using Antivirals to Treat High-Risk Hospitalized Patients With COVID-19</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: From Evidence to Action: Using Antivirals to Treat High-Risk Hospitalized Patients With COVID-19</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-from-evidence-to-action-using-antivirals-to-treat-high-risk-hospitalized-patients-with-covid-19/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-from-evidence-to-action-using-antivirals-to-treat-high-risk-hospitalized-patients-with-covid-19/#comments</comments>        <pubDate>Tue, 19 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c97862b3-a3b2-3ea4-81aa-53aac093707e</guid>
                                    <description><![CDATA[<p>COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.</p>
<p>Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.</p>
<p>Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ycwm2s4rm3hcuey4/ADV_From_Evidence_to_Action_Using_Antivirals_to_Treat_High-Risk_Hospitalized_Patients_With_COVID-19_mixdown6gy76.mp3" length="32508990" type="audio/mpeg"/>
        <itunes:summary><![CDATA[COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.
Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1352</itunes:duration>
                <itunes:episode>1513</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)</title>
        <itunes:title>Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonist-s-role-in-mental-health-and-substance-use-disorders-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonist-s-role-in-mental-health-and-substance-use-disorders-ce/#comments</comments>        <pubDate>Sat, 16 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/34020cad-45c9-3001-a295-121928f11ec4</guid>
                                    <description><![CDATA[<p>This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dpbda599j9cjmhg5/ASHPOfficial_-_GLP-1_Receptor_Agonist_s_Role_in_Mental_Health_and_Substance_Use_Disorders_-_Mix7bvsc.mp3" length="14105987" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>881</itunes:duration>
                <itunes:episode>1480</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Shaping the Future of Pharmacy Education</title>
        <itunes:title>Technician Insights: Shaping the Future of Pharmacy Education</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-shaping-the-future-of-pharmacy-education/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-shaping-the-future-of-pharmacy-education/#comments</comments>        <pubDate>Fri, 15 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4d39a6f9-a133-399e-9ef2-af26ce79f374</guid>
                                    <description><![CDATA[<p class="elementtoproof" style="background: white;">This episode explores the unique perspectives of pharmacy technician educators and their role in shaping the next generation of technicians. Listeners will gain insights into effective teaching strategies, current challenges in technician education, and innovative approaches to competency development. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="elementtoproof" style="background: white;">This episode explores the unique perspectives of pharmacy technician educators and their role in shaping the next generation of technicians. Listeners will gain insights into effective teaching strategies, current challenges in technician education, and innovative approaches to competency development. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q22gc6iy3a4u8xkk/ASHPOfficial_-_Technician_Insights_-_Shaping_the_Future_of_Pharmacy_Education_-_Mixbaqux.mp3" length="31090814" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode explores the unique perspectives of pharmacy technician educators and their role in shaping the next generation of technicians. Listeners will gain insights into effective teaching strategies, current challenges in technician education, and innovative approaches to competency development. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1943</itunes:duration>
                <itunes:episode>1505</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>AJHP Voices: Proceedings of the ASHP Autoverification Work Group: Findings and Guidance</title>
        <itunes:title>AJHP Voices: Proceedings of the ASHP Autoverification Work Group: Findings and Guidance</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-proceedings-of-the-ashp-autoverification-work-group-findings-and-guidance/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-proceedings-of-the-ashp-autoverification-work-group-findings-and-guidance/#comments</comments>        <pubDate>Thu, 14 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b3240bdb-01b7-3376-81f8-4244361f11e1</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Ben Anderson and Dr. Mike Ganio discuss the AJHP ASHP Report "Proceedings of the ASHP Autoverification Work Group: Findings and Guidance” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Ben Anderson and Dr. Mike Ganio discuss the AJHP ASHP Report "Proceedings of the ASHP Autoverification Work Group: Findings and Guidance” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ihwpj5ti8u4m466y/ASHP_Autoverification_Work_Group_Edited77ego.mp3" length="78969721" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Ben Anderson and Dr. Mike Ganio discuss the AJHP ASHP Report "Proceedings of the ASHP Autoverification Work Group: Findings and Guidance” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2467</itunes:duration>
                <itunes:episode>1512</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: DKA</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: DKA</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-dka/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-dka/#comments</comments>        <pubDate>Tue, 12 May 2026 16:31:55 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2044c1df-0288-3493-bf1d-d62b0d548d46</guid>
                                    <description><![CDATA[<p>This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6gwcc8tppajpmxuq/REPS_DKA_mixdown_1_62dar.mp3" length="76226024" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3167</itunes:duration>
                <itunes:episode>1517</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Doses and Dollars: The Latest on New Drug Pricing Models</title>
        <itunes:title>Advocating for Impact: Doses and Dollars: The Latest on New Drug Pricing Models</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-doses-and-dollars-the-latest-on-new-drug-pricing-models/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-doses-and-dollars-the-latest-on-new-drug-pricing-models/#comments</comments>        <pubDate>Tue, 12 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/583552d6-f4ef-3b73-b23a-b9bb1895e0d3</guid>
                                    <description><![CDATA[<p>This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xxpfqd9494hduxsq/Doses_and_Dollars_The_Latest_on_New_Drug_Pricing_Models_mixdownbd5wf.mp3" length="26111975" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1080</itunes:duration>
                <itunes:episode>1514</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SCSS DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Martha Roberts</title>
        <itunes:title>Pharmacy Leadership: SCSS DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Martha Roberts</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadershipscssdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-clinical-specialists-and-scientists-martharoberts/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadershipscssdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-clinical-specialists-and-scientists-martharoberts/#comments</comments>        <pubDate>Mon, 11 May 2026 18:33:01 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6e5771ae-9923-3071-962b-1e47c702ac25</guid>
                                    <description><![CDATA[<p style="background: white;">In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="background: white;">In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p25ss37w7yivypb5/Section_of_Clinical_Specialists_and_Scientists_Distinguished_Service_Award_mixdownbptld.mp3" length="19541077" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>806</itunes:duration>
                <itunes:episode>1516</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Status Epilepticus</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Status Epilepticus</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-status-epilepticus/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-status-epilepticus/#comments</comments>        <pubDate>Fri, 08 May 2026 17:24:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c55fdfa1-c77e-3a43-bc42-87985d5d4fc7</guid>
                                    <description><![CDATA[<p>This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pmbs9hmunw5fm8mk/Recorded_Pharmacist_Series_REPS_Status_Epilepticus_mixdown_2_7rr65.mp3" length="46723887" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1938</itunes:duration>
                <itunes:episode>1515</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology Darren Ferer</title>
        <itunes:title>A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology Darren Ferer</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology-darren-ferer/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology-darren-ferer/#comments</comments>        <pubDate>Fri, 08 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/952daa8e-cbac-3d10-bb73-a66dd58d3635</guid>
                                    <description><![CDATA[<p>In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zerf4dtbzkkqiujb/Section_of_Pharmacy_Informatics_and_Technology_Distinguished_Service_Award_mixdownb30c6.mp3" length="26902574" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1113</itunes:duration>
                <itunes:episode>1510</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Insights &amp; Connections: Shaping Pharmacy’s Future</title>
        <itunes:title>Insights &amp; Connections: Shaping Pharmacy’s Future</itunes:title>
        <link>https://ashpofficial.podbean.com/e/insights-connections-shaping-pharmacy-s-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/insights-connections-shaping-pharmacy-s-future/#comments</comments>        <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d0792cf4-9a00-334c-8684-7bddddcc6e4f</guid>
                                    <description><![CDATA[<p>Insights &amp; Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.</p>
<p>Through conversations with ASHP Executive Vice President &amp; CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Insights &amp; Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.</p>
<p>Through conversations with ASHP Executive Vice President &amp; CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d6bh5pq72xpmhx74/Final_main_Updated_CEO_Blog_Podcast_with_Sam_V_Calabrese_and_Melanie_A_Dodd_mixdown96b7m.mp3" length="40844725" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Insights &amp; Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.
Through conversations with ASHP Executive Vice President &amp; CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1693</itunes:duration>
                <itunes:episode>1511</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Vaccine Preventable Diseases: Measles Revisited (CE)</title>
        <itunes:title>Clinical Conversations: CE: Vaccine Preventable Diseases: Measles Revisited (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-measles-revisited-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-measles-revisited-ce/#comments</comments>        <pubDate>Sat, 02 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a73388e2-233f-3bb4-b496-54c7be1c9719</guid>
                                    <description><![CDATA[<p>There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vfqrftdeh6mzw2ud/Part_1_Vaccine_Preventable_Diseases_Measles_Revisited_mixdown9ttiq.mp3" length="43365423" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1799</itunes:duration>
                <itunes:episode>1509</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Bringing Pharmacy Careers to Life: Insights from the University of Rhode Island's College of Pharmacy SSHP</title>
        <itunes:title>Student Perspectives: Bringing Pharmacy Careers to Life: Insights from the University of Rhode Island's College of Pharmacy SSHP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-bringing-pharmacy-careers-to-life-insights-from-the-university-of-rhode-islands-college-of-pharmacy-sshp/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-bringing-pharmacy-careers-to-life-insights-from-the-university-of-rhode-islands-college-of-pharmacy-sshp/#comments</comments>        <pubDate>Fri, 01 May 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9f3650f9-a0bb-3e5d-841e-9e4cb65ef3f8</guid>
                                    <description><![CDATA[<p>This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5tter48h8df2ggzb/Bringing_Pharmacy_Careers_to_Life_Insights_from_the_University_of_Rhode_Island_s_College_of_Pharmacy_SSHP_mixdown768lz.mp3" length="32521666" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1347</itunes:duration>
                <itunes:episode>1504</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Sourcing the Vaccine Resources</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Sourcing the Vaccine Resources</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-sourcing-the-vaccine-resources/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-sourcing-the-vaccine-resources/#comments</comments>        <pubDate>Wed, 29 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ba1d0418-fd5f-3fce-b038-4a7bac88404a</guid>
                                    <description><![CDATA[<p>Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ej823py7acgba4vp/ADV_Sourcing_the_Vaccine_Resources_mixdownadibr.mp3" length="26520441" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1103</itunes:duration>
                <itunes:episode>1465</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Controlled Conversations: Fighting Diversion with Compliance</title>
        <itunes:title>Technician Insights: Controlled Conversations: Fighting Diversion with Compliance</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-controlled-conversations-fighting-diversion-with-compliance/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-controlled-conversations-fighting-diversion-with-compliance/#comments</comments>        <pubDate>Tue, 28 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d6127f6d-1335-3386-952e-c3f3e8e57a59</guid>
                                    <description><![CDATA[<p>In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yt7xgktzfxsysr5s/2_Tech_Insights_Controlled_Conversations_Fighting_Diversion_with_Compliance_mixdown8ig9u.mp3" length="34188179" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1416</itunes:duration>
                <itunes:episode>1503</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Todd Lemke</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Todd Lemke</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-todd-lemke/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-todd-lemke/#comments</comments>        <pubDate>Fri, 24 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c6022057-c0fe-31d7-a420-3e45f68fdef1</guid>
                                    <description><![CDATA[<p>Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mezgh3iyt5gw8kcm/2_Section_of_Inpatient_Care_Practitioners_Distinguished_Service_Award_mixdown7h67a.mp3" length="20911374" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>863</itunes:duration>
                <itunes:episode>1501</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: All In: Playing the Advocacy Game Across the Spectrum of Pharmacy Practice</title>
        <itunes:title>Advocating for Impact: All In: Playing the Advocacy Game Across the Spectrum of Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-all-in-playing-the-advocacy-game-across-the-spectrum-of-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-all-in-playing-the-advocacy-game-across-the-spectrum-of-pharmacy-practice/#comments</comments>        <pubDate>Thu, 23 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fef06f83-1928-331d-9fce-d822de5d699b</guid>
                                    <description><![CDATA[<p>Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6kx7p2nniwm95qj5/All_In_Playing_the_Advoacy_Game_Across_the_Spectrum_of_Pharmacy_Practice_mixdown6mdn0.mp3" length="33203183" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1376</itunes:duration>
                <itunes:episode>1498</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Access Granted: Unlocking the Benefits of COVID-19 Antiviral Therapies</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Access Granted: Unlocking the Benefits of COVID-19 Antiviral Therapies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-access-granted-unlocking-the-benefits-of-covid-19-antiviral-therapies/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-access-granted-unlocking-the-benefits-of-covid-19-antiviral-therapies/#comments</comments>        <pubDate>Wed, 22 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3f1bcdf4-611a-362f-8631-e98d8470826b</guid>
                                    <description><![CDATA[<p>COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.</p>
<p>Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.</p>
<p>Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9x272h5atx2kurbn/ADV_Access_Granted_Unlocking_the_Benefits_of_COVID-19_Antiviral_Therapies_mixdown6jdmo.mp3" length="25459660" type="audio/mpeg"/>
        <itunes:summary><![CDATA[COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.
Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                <itunes:episode>1502</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP/Pharmacy Futures (#4): Quiet Cracking, Loud Consequences: How Might We Foster Resilient Leadership in Our Workforce – Pharmacy Futures Speaker Series Podcast 2026</title>
        <itunes:title>Live with ASHP/Pharmacy Futures (#4): Quiet Cracking, Loud Consequences: How Might We Foster Resilient Leadership in Our Workforce – Pharmacy Futures Speaker Series Podcast 2026</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashppharmacy-futures-4quiet-cracking-loud-consequences-how-might-wefoster-resilient-leadership-in-ourworkforce%e2%80%93-pharmacy-futuresspeak/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashppharmacy-futures-4quiet-cracking-loud-consequences-how-might-wefoster-resilient-leadership-in-ourworkforce%e2%80%93-pharmacy-futuresspeak/#comments</comments>        <pubDate>Wed, 22 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9ed9f640-4353-3719-86ea-420024f1c084</guid>
                                    <description><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Michael Wolcott to discuss how today’s pharmacy teams are navigating disruptions to resilience, from burnout and compassion fatigue to less visible challenges like “quiet cracking.” This episode explores how these dynamics show up across individuals, teams, and organizations offering a preview of the insights and strategies attendees can expect to learn in this session.</p>
<p>Listen in for a glimpse of what’s ahead, then register to join us at Pharmacy Futures and be part of the full experience.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Michael Wolcott to discuss how today’s pharmacy teams are navigating disruptions to resilience, from burnout and compassion fatigue to less visible challenges like “quiet cracking.” This episode explores how these dynamics show up across individuals, teams, and organizations offering a preview of the insights and strategies attendees can expect to learn in this session.</p>
<p>Listen in for a glimpse of what’s ahead, then register to join us at Pharmacy Futures and be part of the full experience.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z3mj74486yx5qjrc/Pharmacy_Futures_2026_Michael_Wolcott_and_Hannah_Post_Mixdown_041620268x26h.mp3" length="14012566" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Michael Wolcott to discuss how today’s pharmacy teams are navigating disruptions to resilience, from burnout and compassion fatigue to less visible challenges like “quiet cracking.” This episode explores how these dynamics show up across individuals, teams, and organizations offering a preview of the insights and strategies attendees can expect to learn in this session.
Listen in for a glimpse of what’s ahead, then register to join us at Pharmacy Futures and be part of the full experience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>437</itunes:duration>
                <itunes:episode>1500</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy/Pharmacy Leadership PALRC: Unpacking Your PAL Toolkit</title>
        <itunes:title>Hot Topics in Pharmacy/Pharmacy Leadership PALRC: Unpacking Your PAL Toolkit</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacypharmacy-leadership-palrc-unpacking-your-pal-toolkit/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacypharmacy-leadership-palrc-unpacking-your-pal-toolkit/#comments</comments>        <pubDate>Tue, 21 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fb1a6c2a-39f2-3241-8ff0-f26c7d97a937</guid>
                                    <description><![CDATA[<p>What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/whi9npktt59s6zh2/ASHPOfficial_-_Unpacking_Your_PAL_Toolkit_-_Mix9s4c4.mp3" length="44209217" type="audio/mpeg"/>
        <itunes:summary><![CDATA[What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2763</itunes:duration>
                <itunes:episode>1490</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Moving the Needle in Infectious Diseases: A Discussion with Pharmacist Researchers</title>
        <itunes:title>Research in Pharmacy Practice: Moving the Needle in Infectious Diseases: A Discussion with Pharmacist Researchers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-moving-the-needle-in-infectious-diseases-a-discussion-with-pharmacist-researchers/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-moving-the-needle-in-infectious-diseases-a-discussion-with-pharmacist-researchers/#comments</comments>        <pubDate>Mon, 20 Apr 2026 10:59:39 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/14753db4-c836-33cc-9040-6b24ebc61ba7</guid>
                                    <description><![CDATA[<p>ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cdnkgpjureqh25m9/Moving_the_Needle_in_Infectious_Diseases_A_Discussion_with_Pharmacist_Researchers_mixdown71zlg.mp3" length="31083242" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1287</itunes:duration>
                <itunes:episode>1499</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: GLP Practice Insights: A Pharmacists Primer for MASLD MASH (CE)</title>
        <itunes:title>Clinical Conversations: CE: GLP Practice Insights: A Pharmacists Primer for MASLD MASH (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-a-pharmacists-primer-for-masld-mash-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-a-pharmacists-primer-for-masld-mash-ce/#comments</comments>        <pubDate>Sat, 18 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cd16759e-47c1-3270-85e4-061daf7783db</guid>
                                    <description><![CDATA[<p>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sddyzx5yn24bswxr/GLP_Practice_Insights_A_Pharmacists_Primer_for_MASLD_MASH_CE_mixdown6wko8.mp3" length="32378496" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1340</itunes:duration>
                <itunes:episode>1481</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL DSA Awardee: A Conversation with Distinguished Service Awardee for the Section Pharmacy Practice Leaders Rick Couldry</title>
        <itunes:title>Pharmacy Leadership: SPPL DSA Awardee: A Conversation with Distinguished Service Awardee for the Section Pharmacy Practice Leaders Rick Couldry</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-pharmacy-practice-leaders-rick-couldry/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-pharmacy-practice-leaders-rick-couldry/#comments</comments>        <pubDate>Thu, 16 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dbcb4164-5670-3960-a4b0-b4d0c6055eaa</guid>
                                    <description><![CDATA[<p>This episode features Section of Pharmacy Practice Leaders Immediate Past Chair Kat Miller and 2025 Distinguished Service Awardee Rick Couldry discussing what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features Section of Pharmacy Practice Leaders Immediate Past Chair Kat Miller and 2025 Distinguished Service Awardee Rick Couldry discussing what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/adv2df5xywyqr39t/Section_of_Pharmacy_Practice_Leaders_Distinguished_Service_Award_mixdownbrzgy.mp3" length="22228101" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features Section of Pharmacy Practice Leaders Immediate Past Chair Kat Miller and 2025 Distinguished Service Awardee Rick Couldry discussing what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>918</itunes:duration>
                <itunes:episode>1497</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series: Exploring Hospital and Health-System Pharmacy Careers</title>
        <itunes:title>We're Your Pharmacist Podcast Series: Exploring Hospital and Health-System Pharmacy Careers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-exploring-hospital-and-health-system-pharmacy-careers/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-exploring-hospital-and-health-system-pharmacy-careers/#comments</comments>        <pubDate>Wed, 15 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e8eaa9f-3016-35da-8208-2fc795049307</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features, Justin Moore, Lucas Shultz, and Elizabeth Wade. They share what inspired them to pursue a career in pharmacy and offer insights into the role of a hospital and health-system pharmacist.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features, Justin Moore, Lucas Shultz, and Elizabeth Wade. They share what inspired them to pursue a career in pharmacy and offer insights into the role of a hospital and health-system pharmacist.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bu36rruk935gswr9/ASHP_-_We_re_Your_Pharmacist_-_HOSA_-_Mix8fdot.mp3" length="46784864" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features, Justin Moore, Lucas Shultz, and Elizabeth Wade. They share what inspired them to pursue a career in pharmacy and offer insights into the role of a hospital and health-system pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1949</itunes:duration>
                <itunes:episode>1492</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners Jamie Cavanaugh</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners Jamie Cavanaugh</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-ambulatory-care-practitioners-jamie-cavanaugh/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-ambulatory-care-practitioners-jamie-cavanaugh/#comments</comments>        <pubDate>Tue, 14 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4ce44a5d-8948-350a-98e3-593a72d6a207</guid>
                                    <description><![CDATA[<p>Sara Panella sits down with the Section of Ambulatory Care Practitioners Distinguished Service Awardee Jamie Cavanaugh to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sara Panella sits down with the Section of Ambulatory Care Practitioners Distinguished Service Awardee Jamie Cavanaugh to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dgxf5xwxyd6ct7gu/Section_of_Ambulatory_Care_Practitioners_Distinguished_Service_Award_mixdownafid5.mp3" length="16487022" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sara Panella sits down with the Section of Ambulatory Care Practitioners Distinguished Service Awardee Jamie Cavanaugh to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>678</itunes:duration>
                <itunes:episode>1488</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Approach to the Poisoned Patient</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Approach to the Poisoned Patient</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-approach-to-the-poisoned-patient/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-approach-to-the-poisoned-patient/#comments</comments>        <pubDate>Sat, 11 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/89db82f8-7b80-3bd5-ae49-7c691a8e660c</guid>
                                    <description><![CDATA[<p>This episode will focus on how pharmacists in the emergency medicine environment should identify and evaluate patients exposed to poisons. This presentation will cover the basics of exposure management to common poisons and medications to better prepare the pharmacist for quick initiation of therapy.  CE for this episode expires 2 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will focus on how pharmacists in the emergency medicine environment should identify and evaluate patients exposed to poisons. This presentation will cover the basics of exposure management to common poisons and medications to better prepare the pharmacist for quick initiation of therapy.  CE for this episode expires 2 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fqw8jphyvuh4vy2m/Recorded_Pharmacist_Series_REPS_Approach_to_the_Poisoned_Patient_mixdown7d1dq.mp3" length="47253119" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will focus on how pharmacists in the emergency medicine environment should identify and evaluate patients exposed to poisons. This presentation will cover the basics of exposure management to common poisons and medications to better prepare the pharmacist for quick initiation of therapy.  CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1960</itunes:duration>
                <itunes:episode>1483</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practices 2025: Transforming Value-Based Deep Vein Thrombosis Care Through a Pharmacist-Led Clinic</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practices 2025: Transforming Value-Based Deep Vein Thrombosis Care Through a Pharmacist-Led Clinic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practices-2025-transforming-value-based-deep-thrombosis-care-through-a-pharmacist-led-clinic/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practices-2025-transforming-value-based-deep-thrombosis-care-through-a-pharmacist-led-clinic/#comments</comments>        <pubDate>Fri, 10 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ecf99534-007d-34a3-ae17-546e0dc9ede9</guid>
                                    <description><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at Cone Health recognized for a program focusing on a pharmacist-led deep vein thrombosis clinic (DVT). The episode highlights how the DVT clinic was built, including how pharmacists centralized outpatient care through the inclusion of imagining, diagnosis, treatment, and dispensing at one location.    </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at Cone Health recognized for a program focusing on a pharmacist-led deep vein thrombosis clinic (DVT). The episode highlights how the DVT clinic was built, including how pharmacists centralized outpatient care through the inclusion of imagining, diagnosis, treatment, and dispensing at one location.    </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3am4aw6h7x845uw8/ASHP_Best_Practices_2025_Transforming_Value-Based_Deep_Thrombosis_Care_Through_a_Pharmacist-Led_Clinic_mixdown82343.mp3" length="27876305" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features the 2025 ASHP Best Practice Award winning team at Cone Health recognized for a program focusing on a pharmacist-led deep vein thrombosis clinic (DVT). The episode highlights how the DVT clinic was built, including how pharmacists centralized outpatient care through the inclusion of imagining, diagnosis, treatment, and dispensing at one location.    
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1153</itunes:duration>
                <itunes:episode>1494</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practices 2025: Expanding Pharmacist Prescriptive Authority to Advance Oral Chemotherapy Management</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practices 2025: Expanding Pharmacist Prescriptive Authority to Advance Oral Chemotherapy Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practices-2025-expanding-pharmacist-prescriptive-authority-to-advance-oral-chemotherapy-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practices-2025-expanding-pharmacist-prescriptive-authority-to-advance-oral-chemotherapy-management/#comments</comments>        <pubDate>Wed, 08 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/943191e7-2dc3-3d40-8eff-3d5adbc98247</guid>
                                    <description><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at the Fred Hutchinson Cancer Center who is recognized for a program focusing on pharmacist prescriptive authority and optimizing care through identifying and prescribing oral chemotherapy for patients.   The initiative exemplifies ASHP’s new strategic plan and its patient care pillar, advancing innovative pharmacy practices that expand access, improve outcomes, and elevate the role of pharmacists as integral members of the healthcare team. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at the Fred Hutchinson Cancer Center who is recognized for a program focusing on pharmacist prescriptive authority and optimizing care through identifying and prescribing oral chemotherapy for patients.   The initiative exemplifies ASHP’s new strategic plan and its patient care pillar, advancing innovative pharmacy practices that expand access, improve outcomes, and elevate the role of pharmacists as integral members of the healthcare team. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vuyazbi5npiv4yrb/_ASHP_Best_Practices_2025_Expanding_Pharmacist_Prescriptive_Authority_to_Advance_Oral_Chemotherapy_Management_mixdownbc9w9.mp3" length="20283838" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features the 2025 ASHP Best Practice Award winning team at the Fred Hutchinson Cancer Center who is recognized for a program focusing on pharmacist prescriptive authority and optimizing care through identifying and prescribing oral chemotherapy for patients.   The initiative exemplifies ASHP’s new strategic plan and its patient care pillar, advancing innovative pharmacy practices that expand access, improve outcomes, and elevate the role of pharmacists as integral members of the healthcare team. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>837</itunes:duration>
                <itunes:episode>1493</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Foundation Residency Award: Excellence in Pharmacy Resident Training and Mentoring</title>
        <itunes:title>ASHP Foundation Residency Award: Excellence in Pharmacy Resident Training and Mentoring</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-foundation-residency-award-excellence-in-pharmacy-resident-training-and-mentoring-1775506352/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-foundation-residency-award-excellence-in-pharmacy-resident-training-and-mentoring-1775506352/#comments</comments>        <pubDate>Mon, 06 Apr 2026 16:12:32 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/14b4669e-2cb4-3329-969c-abd789ec31ca</guid>
                                    <description><![CDATA[<p>Hear from the 2025 ASHP Foundation Pharmacy Residency Excellence Awardees as they discuss their best practices and career highlights. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hear from the 2025 ASHP Foundation Pharmacy Residency Excellence Awardees as they discuss their best practices and career highlights. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5ng9svqm4wcejtwg/ASHPOfficial_-_Excellence_in_Pharmacy_Resident_Training_and_Mentoring_-_Revised_1_8seq4.mp3" length="38422925" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hear from the 2025 ASHP Foundation Pharmacy Residency Excellence Awardees as they discuss their best practices and career highlights. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2401</itunes:duration>
                <itunes:episode>1495</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Leveling Up Professional Skills: Insights from the SDSU College of Pharmacy SSHP</title>
        <itunes:title>Student Perspectives: Leveling Up Professional Skills: Insights from the SDSU College of Pharmacy SSHP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-leveling-up-professional-skills-insights-from-the-sdsu-college-of-pharmacy-sshp/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-leveling-up-professional-skills-insights-from-the-sdsu-college-of-pharmacy-sshp/#comments</comments>        <pubDate>Fri, 03 Apr 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5325643b-8984-3e94-97ac-629d49098638</guid>
                                    <description><![CDATA[<p>This episode spotlights the South Dakota State University College of Pharmacy SSHP Professionalism MiniSeries, a collection of student-driven events designed to help pharmacy students strengthen their professional identity and prepare for postgraduate training.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode spotlights the South Dakota State University College of Pharmacy SSHP Professionalism MiniSeries, a collection of student-driven events designed to help pharmacy students strengthen their professional identity and prepare for postgraduate training.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yriyzve6qkzqmgi4/Leveling_Up_Professional_Skills_Insights_from_the_SDSU_College_of_Pharmacy_SSHP_mixdown72mev.mp3" length="19534651" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode spotlights the South Dakota State University College of Pharmacy SSHP Professionalism MiniSeries, a collection of student-driven events designed to help pharmacy students strengthen their professional identity and prepare for postgraduate training.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>805</itunes:duration>
                <itunes:episode>1484</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Lauren Ashton</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Lauren Ashton</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-lauren-ashton/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-lauren-ashton/#comments</comments>        <pubDate>Tue, 31 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/22535a80-eeff-3201-a6c6-bd4d9ac8448a</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Lauren Ashton, a doctor of pharmacy student at Northeast Ohio Medical University. She shares what inspired her to pursue a career in pharmacy and offers insights into the experiences of a pharmacy student. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Lauren Ashton, a doctor of pharmacy student at Northeast Ohio Medical University. She shares what inspired her to pursue a career in pharmacy and offers insights into the experiences of a pharmacy student. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dggf5vxbwx68nvvy/We_re_Your_Pharmacist_Podcast_with_Lauren_Ashton_Mixdown_0325202689mmd.mp3" length="13154186" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Lauren Ashton, a doctor of pharmacy student at Northeast Ohio Medical University. She shares what inspired her to pursue a career in pharmacy and offers insights into the experiences of a pharmacy student. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
 ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>411</itunes:duration>
                <itunes:episode>1487</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: The 340B Drug Pricing Program: Understanding Federal and State Legislative Reform Efforts</title>
        <itunes:title>Advocating for Impact: The 340B Drug Pricing Program: Understanding Federal and State Legislative Reform Efforts</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-the-340b-drug-pricing-program-understanding-federal-and-state-legislative-reform-efforts/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-the-340b-drug-pricing-program-understanding-federal-and-state-legislative-reform-efforts/#comments</comments>        <pubDate>Tue, 31 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/483d824e-74f4-3243-a618-82bf56897d8b</guid>
                                    <description><![CDATA[<p>This episode dicusses the role of the 340B Drug Pricing Program in public health infrastructure, state and federal legislative reform of the program, the advocacy role of health systems and pharmacy teams, and the differing views shared by health systems and pharmaceutical manufacturers regarding 340B legislative reform.  Listeners will learn the background and purpose of the 340B program, ongoing efforts to reform the program at the state and federal levels, and what actions are commonly undertaken to influence  reform and the differing views held by 340B stakeholders. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode dicusses the role of the 340B Drug Pricing Program in public health infrastructure, state and federal legislative reform of the program, the advocacy role of health systems and pharmacy teams, and the differing views shared by health systems and pharmaceutical manufacturers regarding 340B legislative reform.  Listeners will learn the background and purpose of the 340B program, ongoing efforts to reform the program at the state and federal levels, and what actions are commonly undertaken to influence  reform and the differing views held by 340B stakeholders. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ddfzuzct65cnkzkt/ASHPOfficial_-_340B_Developments_Impacting_Pharmacy_and_Health_System_Practice_-_Critical_State_and_Federal_Policy_Considerations_-_Mix8dftt.mp3" length="26354945" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode dicusses the role of the 340B Drug Pricing Program in public health infrastructure, state and federal legislative reform of the program, the advocacy role of health systems and pharmacy teams, and the differing views shared by health systems and pharmaceutical manufacturers regarding 340B legislative reform.  Listeners will learn the background and purpose of the 340B program, ongoing efforts to reform the program at the state and federal levels, and what actions are commonly undertaken to influence  reform and the differing views held by 340B stakeholders. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1647</itunes:duration>
                <itunes:episode>1486</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: Pharmacy Futures and Preceptors 2026 (#2): Physical Examination Essentials: A Workshop for Contemporary Pharmacy Practice – Pharmacy Futures Speaker Series Podcast 2026</title>
        <itunes:title>Live with ASHP: Pharmacy Futures and Preceptors 2026 (#2): Physical Examination Essentials: A Workshop for Contemporary Pharmacy Practice – Pharmacy Futures Speaker Series Podcast 2026</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashppharmacyfutures-and-preceptors-20262-physical-examinationessentialsa-workshop-for-contemporarypharmacy-practice-%e2%80%93pharmacy-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashppharmacyfutures-and-preceptors-20262-physical-examinationessentialsa-workshop-for-contemporarypharmacy-practice-%e2%80%93pharmacy-future/#comments</comments>        <pubDate>Mon, 30 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/05286ce5-a51b-31da-a8e2-01ff6700ad3f</guid>
                                    <description><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Joe Anderson to discuss the updated physical exam interactive workshop for pharmacists with a focus on blood pressure, test and treat diagnostics, the Medicare annual wellness exam, and specific techniques for assessing heart failure and volume overload.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Joe Anderson to discuss the updated physical exam interactive workshop for pharmacists with a focus on blood pressure, test and treat diagnostics, the Medicare annual wellness exam, and specific techniques for assessing heart failure and volume overload.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5aaqyce7xqxpiymq/Pharmacy_Futures_2026_Joe_Anderson_with_Cynthia_Von_Heeringen_Mixdown_031120266vxz0.mp3" length="22102881" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Joe Anderson to discuss the updated physical exam interactive workshop for pharmacists with a focus on blood pressure, test and treat diagnostics, the Medicare annual wellness exam, and specific techniques for assessing heart failure and volume overload.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>690</itunes:duration>
                <itunes:episode>1482</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 8</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 8</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-8/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-8/#comments</comments>        <pubDate>Sat, 28 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/35689102-0573-304a-af06-917e3db7c09c</guid>
                                    <description><![CDATA[<p>Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system.  This episode will review organizational considerations and strategies around these novel therapies including complexities and structures of supply chain operations, financial models and impacts, clinical operations needs and planning, and interdisciplinary alignment and collaboration. CE for this episode expires 3 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system.  This episode will review organizational considerations and strategies around these novel therapies including complexities and structures of supply chain operations, financial models and impacts, clinical operations needs and planning, and interdisciplinary alignment and collaboration. CE for this episode expires 3 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tem48hne9b8r4zhz/Recorded_Pharmacist_Series_REPS_Cell_and_Gene_Therapies_Part_8_mixdownb8ma3.mp3" length="67346841" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system.  This episode will review organizational considerations and strategies around these novel therapies including complexities and structures of supply chain operations, financial models and impacts, clinical operations needs and planning, and interdisciplinary alignment and collaboration. CE for this episode expires 3 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2798</itunes:duration>
                <itunes:episode>1475</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: Pharmacy Futures and Preceptors 2026  (#1): Return of the Efficiency: AI Strikes Back in Precepting – Pharmacy Futures Speaker Series Podcast 2026</title>
        <itunes:title>Live with ASHP: Pharmacy Futures and Preceptors 2026  (#1): Return of the Efficiency: AI Strikes Back in Precepting – Pharmacy Futures Speaker Series Podcast 2026</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashppharmacyfutures-and-preceptors-20261return-ofthe-efficiencyai-strikes-back-inprecepting%e2%80%93-pharmacy-futuresspeaker-seriespodcast-20/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashppharmacyfutures-and-preceptors-20261return-ofthe-efficiencyai-strikes-back-inprecepting%e2%80%93-pharmacy-futuresspeaker-seriespodcast-20/#comments</comments>        <pubDate>Thu, 26 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d45127f2-2ec1-39f5-8da1-566e200304d5</guid>
                                    <description><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, Megan Adelman, PharmD, BCPS, BCGP, family medicine clinical specialist at the Cleveland Clinic Akron General, discusses opportunities and strategies to incorporate AI tools into the precepting workflow. These practical ideas can be implemented by attendees right away and immediately impact administrative efficiencies, allowing more valuable time with students and residents for in-depth discussions and learning.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, Megan Adelman, PharmD, BCPS, BCGP, family medicine clinical specialist at the Cleveland Clinic Akron General, discusses opportunities and strategies to incorporate AI tools into the precepting workflow. These practical ideas can be implemented by attendees right away and immediately impact administrative efficiencies, allowing more valuable time with students and residents for in-depth discussions and learning.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5qt5b2gpj8ae8ark/Pharmacy_Futures_Speaker_Series_with_Megan_Adelman_and_Cynthia_Von_Heeringen9eqg5.mp3" length="14017576" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, Megan Adelman, PharmD, BCPS, BCGP, family medicine clinical specialist at the Cleveland Clinic Akron General, discusses opportunities and strategies to incorporate AI tools into the precepting workflow. These practical ideas can be implemented by attendees right away and immediately impact administrative efficiencies, allowing more valuable time with students and residents for in-depth discussions and learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>438</itunes:duration>
                <itunes:episode>1471</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-Being and Resilience in Pharmacy Practice *CPEL*: Critical Communication to Bridge the Well-Being Gap Between New Practitioners, Pharmacy Management and Pharmacy Leadership</title>
        <itunes:title>Well-Being and Resilience in Pharmacy Practice *CPEL*: Critical Communication to Bridge the Well-Being Gap Between New Practitioners, Pharmacy Management and Pharmacy Leadership</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeingandresiliencein-pharmacy-practice-cpelcritical-communication-tobridge-the-well-being-gap-betweennew-practitioners-pharmacy-management-and-ph/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeingandresiliencein-pharmacy-practice-cpelcritical-communication-tobridge-the-well-being-gap-betweennew-practitioners-pharmacy-management-and-ph/#comments</comments>        <pubDate>Wed, 25 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/de2ad38f-f2c7-37cb-b226-52a42ece2dd1</guid>
                                    <description><![CDATA[<p>Well-being, burnout, and resilience have been hot topics within the healthcare community. These topics are particularly relevant to new practitioners, especially in the age after the COVID-19 pandemic. This podcast aims to investigate potential well-being gaps they may face and how to address them with their manager and in their department. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Well-being, burnout, and resilience have been hot topics within the healthcare community. These topics are particularly relevant to new practitioners, especially in the age after the COVID-19 pandemic. This podcast aims to investigate potential well-being gaps they may face and how to address them with their manager and in their department. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rti4n7z5vzemnrrp/ASHPOfficial_Critical_Communication_to_Bridge_the_Well_Being_Gap_Between_New_Practitioners_and_Pharmacy_Management_and_Pharmacy_Leadership_mix61znl.mp3" length="28263971" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Well-being, burnout, and resilience have been hot topics within the healthcare community. These topics are particularly relevant to new practitioners, especially in the age after the COVID-19 pandemic. This podcast aims to investigate potential well-being gaps they may face and how to address them with their manager and in their department. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1766</itunes:duration>
                <itunes:episode>1478</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Pneu Types of Pneumococcal Serotypes</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Pneu Types of Pneumococcal Serotypes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-pneu-types-of-pneumococcal-serotypes/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-pneu-types-of-pneumococcal-serotypes/#comments</comments>        <pubDate>Mon, 23 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a12b2f5c-ae57-37b4-92e9-c43a9fc1aa0e</guid>
                                    <description><![CDATA[<p>Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sjp36kzeipeici27/_ADV_Pneu_Types_of_Pneumococcal_Serotypes_mixdown8fmx2.mp3" length="30545536" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1270</itunes:duration>
                <itunes:episode>1466</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: GLP Practice Insights: Periprocedural Management of GLP-1 Receptor Agonists (CE)</title>
        <itunes:title>Clinical Conversations: CE: GLP Practice Insights: Periprocedural Management of GLP-1 Receptor Agonists (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-periprocedural-management-of-glp-1-receptor-agonists-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-periprocedural-management-of-glp-1-receptor-agonists-ce/#comments</comments>        <pubDate>Sat, 21 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e86821d-9d0b-3633-9c79-a6335109e179</guid>
                                    <description><![CDATA[<p>This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yjy6vk75zdbdmg9x/GLP_Practice_Insights_Periprocedural_Management_of_GLP-1_Receptors_CE_mixdowna8mca.mp3" length="35180187" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1457</itunes:duration>
                <itunes:episode>1479</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Inside CIDP Treatment: What Pharmacists Need to Know</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Inside CIDP Treatment: What Pharmacists Need to Know</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-inside-cidp-treatment-what-pharmacists-need-to-know/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-inside-cidp-treatment-what-pharmacists-need-to-know/#comments</comments>        <pubDate>Tue, 17 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/64dcc869-d57a-3638-a399-cfaf15a06b91</guid>
                                    <description><![CDATA[<p>Learn from experts in the field of CIDP.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field of CIDP.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pchac5inz8ugrfrx/ASHPOfficial_-_ADV_-_Inside_CIDP_Treatment_What_Pharmacists_Need_to_Know_-_Revised74wt5.mp3" length="30325619" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field of CIDP.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1895</itunes:duration>
                <itunes:episode>1477</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: Cell and Gene Therapies Part 7</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: Cell and Gene Therapies Part 7</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-7/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-7/#comments</comments>        <pubDate>Sat, 14 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fe8dbc5f-a305-3c1b-bb4b-e7234d24d270</guid>
                                    <description><![CDATA[<p>This episode will overview important supportive care topics for cell-based therapies, primarily targeted for practitioners that have less exposure to these therapies but are now being introduced to their use. Specific topics will include tumor lysis syndrome and chemotherapy induced nausea and vomiting, anti-infective prophylaxis, cytokine release syndrome, and immune effector cell-associated neurotoxicity syndrome. CE for this episode expires 2 years after the date it was originally published.</p>
<p> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will overview important supportive care topics for cell-based therapies, primarily targeted for practitioners that have less exposure to these therapies but are now being introduced to their use. Specific topics will include tumor lysis syndrome and chemotherapy induced nausea and vomiting, anti-infective prophylaxis, cytokine release syndrome, and immune effector cell-associated neurotoxicity syndrome. CE for this episode expires 2 years after the date it was originally published.</p>
<p> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/774pk3b8hn683d5v/Recorded_Pharmacist_Series_REPS_Cell_and_Gene_Therapies_Part_7_mixdown9udix.mp3" length="52001895" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will overview important supportive care topics for cell-based therapies, primarily targeted for practitioners that have less exposure to these therapies but are now being introduced to their use. Specific topics will include tumor lysis syndrome and chemotherapy induced nausea and vomiting, anti-infective prophylaxis, cytokine release syndrome, and immune effector cell-associated neurotoxicity syndrome. CE for this episode expires 2 years after the date it was originally published.
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2158</itunes:duration>
                <itunes:episode>1474</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients</title>
        <itunes:title>AJHP Voices: Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-establishing-a-cyp3a5-genotype%e2%80%93guided-tacrolimus-dosing-protocol-in-adult-kidney-transplant-recipients/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-establishing-a-cyp3a5-genotype%e2%80%93guided-tacrolimus-dosing-protocol-in-adult-kidney-transplant-recipients/#comments</comments>        <pubDate>Fri, 13 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a96669df-1f5a-343d-86ec-145d0d768eca</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Amy Pasternak and Dr. Jamie Park discuss the AJHP Descriptive Report "Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Amy Pasternak and Dr. Jamie Park discuss the AJHP Descriptive Report "Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a7fvqser8jpn6rdp/CYP3A5_genotype_guided_tacrolimus_dosing_protocolamdst.mp3" length="53100586" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Amy Pasternak and Dr. Jamie Park discuss the AJHP Descriptive Report "Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1659</itunes:duration>
                <itunes:episode>1473</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Student Perspectives: Leadership in Medication Use and Safety</title>
        <itunes:title>Student Perspectives: Leadership in Medication Use and Safety</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-leadership-in-medication-use-and-safety/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-leadership-in-medication-use-and-safety/#comments</comments>        <pubDate>Thu, 12 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2b4f90da-8111-37f0-85ec-0dfb9211b9f3</guid>
                                    <description><![CDATA[<p>Join us for an inspiring session where we explore how the pharmacist's role in medication safety is evolving. Speakers will share how ASHP's Practice Advancement Initiative 2030 is being integrated into practice, artificial intelligence use in advancing medication safety, and tips for student pharmacists on how to get involved in medication safety.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for an inspiring session where we explore how the pharmacist's role in medication safety is evolving. Speakers will share how ASHP's Practice Advancement Initiative 2030 is being integrated into practice, artificial intelligence use in advancing medication safety, and tips for student pharmacists on how to get involved in medication safety.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jcinx3g26c3da9kd/ASHPOfficial_-_Leadership_in_Medication_Use_and_Safety_-_Mixa688j.mp3" length="35234126" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for an inspiring session where we explore how the pharmacist's role in medication safety is evolving. Speakers will share how ASHP's Practice Advancement Initiative 2030 is being integrated into practice, artificial intelligence use in advancing medication safety, and tips for student pharmacists on how to get involved in medication safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2202</itunes:duration>
                <itunes:episode>1472</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Scaling Up Obesity Care: Pharmacists, CPAs, and Clinic Success (CE)</title>
        <itunes:title>Clinical Conversations: CE: Scaling Up Obesity Care: Pharmacists, CPAs, and Clinic Success (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-scaling-up-obesity-care-pharmacists-cpas-and-clinic-success-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-scaling-up-obesity-care-pharmacists-cpas-and-clinic-success-ce/#comments</comments>        <pubDate>Wed, 11 Mar 2026 14:00:47 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d9e532bb-267a-3a8a-ba77-076a5e768f9f</guid>
                                    <description><![CDATA[<p>This podcast discusses how pharmacists are expanding their roles in obesity management through collaborative practice agreements (CPAs) and innovative clinic workflows. Guests share their experiences launching and sustaining weight management services, highlighting operational considerations and billing strategies. Listeners will gain practical insights into establishing pharmacist-led obesity care models and supporting patients in achieving long-term success.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast discusses how pharmacists are expanding their roles in obesity management through collaborative practice agreements (CPAs) and innovative clinic workflows. Guests share their experiences launching and sustaining weight management services, highlighting operational considerations and billing strategies. Listeners will gain practical insights into establishing pharmacist-led obesity care models and supporting patients in achieving long-term success.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2fg8c7dpipbjpjqx/Part_3_Scaling_Up_Obesity_Care_Pharmacists_CPAs_and_Clinic_Success_CE_mixdown7zpvn.mp3" length="43505022" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast discusses how pharmacists are expanding their roles in obesity management through collaborative practice agreements (CPAs) and innovative clinic workflows. Guests share their experiences launching and sustaining weight management services, highlighting operational considerations and billing strategies. Listeners will gain practical insights into establishing pharmacist-led obesity care models and supporting patients in achieving long-term success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1804</itunes:duration>
                <itunes:episode>1476</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resiliency in Practice: Cognitive Load and Burnout: Uncovering the Connection</title>
        <itunes:title>Wellbeing and Resiliency in Practice: Cognitive Load and Burnout: Uncovering the Connection</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-cognitive-load-and-burnout-uncovering-the-connection/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-cognitive-load-and-burnout-uncovering-the-connection/#comments</comments>        <pubDate>Wed, 11 Mar 2026 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a627d9b2-6f57-348a-b09d-ebe2c9324357</guid>
                                    <description><![CDATA[<p>This episode will explore the concept of cognitive load, which describes the mental effort required to process information and directly impacts cognitive function. In the workforce, cognitive overload has been linked with occupational burnout. Addressing cognitive overload in the workplace is an available strategy to help manage occupational burnout. Listeners will learn about cognitive load theory, its linkage to occupational burnout, and strategies that may reduce cognitive load.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will explore the concept of cognitive load, which describes the mental effort required to process information and directly impacts cognitive function. In the workforce, cognitive overload has been linked with occupational burnout. Addressing cognitive overload in the workplace is an available strategy to help manage occupational burnout. Listeners will learn about cognitive load theory, its linkage to occupational burnout, and strategies that may reduce cognitive load.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gzsw3c7yjfnh7nhf/Cognitive_Load_and_Burnout_Uncovering_the_Connection_mixdown9fhll.mp3" length="29686136" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will explore the concept of cognitive load, which describes the mental effort required to process information and directly impacts cognitive function. In the workforce, cognitive overload has been linked with occupational burnout. Addressing cognitive overload in the workplace is an available strategy to help manage occupational burnout. Listeners will learn about cognitive load theory, its linkage to occupational burnout, and strategies that may reduce cognitive load.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1228</itunes:duration>
                <itunes:episode>1469</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: The Pharmacist's Role in Transforming Nephrology Care</title>
        <itunes:title>Clinical Conversations: SCSS: The Pharmacist's Role in Transforming Nephrology Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-the-pharmacists-role-in-transforming-nephrology-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-the-pharmacists-role-in-transforming-nephrology-care/#comments</comments>        <pubDate>Fri, 06 Mar 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d5df561e-f880-3896-a3ce-77cad5a88127</guid>
                                    <description><![CDATA[<p>This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v3ffbgtxiqe9qzbz/3_The_Pharmacist_s_Role_in_Transforming_Nephrology_Care_mixdown9y1fc.mp3" length="40582639" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1682</itunes:duration>
                <itunes:episode>1468</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: NPF: A Conversation with the 2025 New Practitioners Forum Distinguished Service Awardee: Justin Moore</title>
        <itunes:title>Pharmacy Leadership: NPF: A Conversation with the 2025 New Practitioners Forum Distinguished Service Awardee: Justin Moore</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-the-2025-new-practitioners-forum-distinguished-service-awardee-justin-moore/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-the-2025-new-practitioners-forum-distinguished-service-awardee-justin-moore/#comments</comments>        <pubDate>Thu, 05 Mar 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a1be90d2-2c12-35ba-ac90-af6d3069cc93</guid>
                                    <description><![CDATA[<p>In this episode, Luna Shi, chair of the New Practitioners Forum Executive Committee (NPF), sits down with the 2025 NPF Distinguished Service Awardee, Justin Moore, to discuss his leadership within the forum and ASHP and its impact on his professional journey. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Luna Shi, chair of the New Practitioners Forum Executive Committee (NPF), sits down with the 2025 NPF Distinguished Service Awardee, Justin Moore, to discuss his leadership within the forum and ASHP and its impact on his professional journey. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/675chs5zhyfncc7x/2_A_Conversation_with_the_2025_New_Practitioners_Forum_Distinguished_Service_Awardee_Justin_Moore_mixdown88mpy.mp3" length="32185903" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Luna Shi, chair of the New Practitioners Forum Executive Committee (NPF), sits down with the 2025 NPF Distinguished Service Awardee, Justin Moore, to discuss his leadership within the forum and ASHP and its impact on his professional journey. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1333</itunes:duration>
                <itunes:episode>1470</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Between the Doses: The Science, Schedules, and Shared Decision Making for Pediatric Immunization Updates (CE)</title>
        <itunes:title>Clinical Conversations (CE): Between the Doses: The Science, Schedules, and Shared Decision Making for Pediatric Immunization Updates (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-between-the-doses-the-science-schedules-and-shared-decision-making-for-pediatric-immunization-updates-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-between-the-doses-the-science-schedules-and-shared-decision-making-for-pediatric-immunization-updates-ce/#comments</comments>        <pubDate>Mon, 02 Mar 2026 12:41:17 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6f023a6a-378c-3f0c-ac26-b83d4cd745cd</guid>
                                    <description><![CDATA[<p>This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vj7yurq6bvn9nbub/Between_the_Doses_The_Science_Schedules_and_Shared_Decision_Making_for_Pediatric_Immunizations_Updates_mixdownb7bv5.mp3" length="25082958" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1037</itunes:duration>
                <itunes:episode>1467</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review</title>
        <itunes:title>AJHP Voices: Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-utilization-rate-and-predictors-of-sodium-glucose-cotransporter-2-inhibitor-use-in-patients-with-heart-failure-a-continuing-review/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-utilization-rate-and-predictors-of-sodium-glucose-cotransporter-2-inhibitor-use-in-patients-with-heart-failure-a-continuing-review/#comments</comments>        <pubDate>Mon, 02 Mar 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1547394d-33ac-3e37-bd74-da336e246548</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qg9vb3379cy3cxnd/Utilization_rate_and_predictors_FINALagei5.mp3" length="50791811" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1587</itunes:duration>
                <itunes:episode>1463</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 6</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 6</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-6/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-6/#comments</comments>        <pubDate>Sat, 28 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a59b6da4-2fe4-30c8-883c-b25f150db19a</guid>
                                    <description><![CDATA[<p>This activity will discuss clinical and safety strategies for implementation that will translate to better care for patients and a safer handling environment for providers, patients, and caregivers. Additional details and discussion about collection, processing to final dose product, dose storage/preparation/administration, and safe handling may provide more insight and considerations applicable for pharmacy practice.  CE for this episode expires 2 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This activity will discuss clinical and safety strategies for implementation that will translate to better care for patients and a safer handling environment for providers, patients, and caregivers. Additional details and discussion about collection, processing to final dose product, dose storage/preparation/administration, and safe handling may provide more insight and considerations applicable for pharmacy practice.  CE for this episode expires 2 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fqgpj2g87wm6tskz/Recorded_Pharmacist_Series_REPS_CREPS_Cell_and_Gene_Therapies_Part_6_mixdown_1_66idr.mp3" length="39976659" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This activity will discuss clinical and safety strategies for implementation that will translate to better care for patients and a safer handling environment for providers, patients, and caregivers. Additional details and discussion about collection, processing to final dose product, dose storage/preparation/administration, and safe handling may provide more insight and considerations applicable for pharmacy practice.  CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1657</itunes:duration>
                <itunes:episode>1462</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Best Practices 2025: Pharmacist-Led Scale Implementation Facilitation of Panel-Based Pharmacogenomic Testing</title>
        <itunes:title>ASHP Best Practices 2025: Pharmacist-Led Scale Implementation Facilitation of Panel-Based Pharmacogenomic Testing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-best-practices-2025-pharmacist-led-scale-implementation-facilitation-of-panel-based-pharmacogenomic-testing/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-best-practices-2025-pharmacist-led-scale-implementation-facilitation-of-panel-based-pharmacogenomic-testing/#comments</comments>        <pubDate>Fri, 27 Feb 2026 11:35:39 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/620579d5-0452-3f7e-b130-0c145bd66405</guid>
                                    <description><![CDATA[<p class="xxxelementtoproof" style="background: white;">This episode features the 2025 ASHP Best Practice Award winning team at the Veterans Administration (VA), recognized for a program focusing on pharmacist-led pharmacogenomics testing. Listeners will learn how the VA started and expanded the program including how they trained pharmacists, implemented the program, and expanded access to patient care.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxelementtoproof" style="background: white;">This episode features the 2025 ASHP Best Practice Award winning team at the Veterans Administration (VA), recognized for a program focusing on pharmacist-led pharmacogenomics testing. Listeners will learn how the VA started and expanded the program including how they trained pharmacists, implemented the program, and expanded access to patient care.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/t4y6vywvmcnv4k23/ASHP_Best_Practices_2025_Pharmacist-led_scale_implementation_facilitation_of_panel-based_pharmacogenomic_testing_mixdown9ropi.mp3" length="15546224" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features the 2025 ASHP Best Practice Award winning team at the Veterans Administration (VA), recognized for a program focusing on pharmacist-led pharmacogenomics testing. Listeners will learn how the VA started and expanded the program including how they trained pharmacists, implemented the program, and expanded access to patient care.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>640</itunes:duration>
                <itunes:episode>1464</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Under Pressure: The Pharmacist’s Role in Pulmonary Arterial Hypertension (CE)</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Under Pressure: The Pharmacist’s Role in Pulmonary Arterial Hypertension (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-under-pressure-the-pharmacist-s-role-in-pulmonary-arterial-hypertension-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-under-pressure-the-pharmacist-s-role-in-pulmonary-arterial-hypertension-ce/#comments</comments>        <pubDate>Tue, 24 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/20117ced-7f48-3246-9c30-36fec6b8e600</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on PAH. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on PAH. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ma6s7xfdtyfa5gsz/ASHPOfficial_-_ADV_Under_Pressure_The_Pharmacist_s_Role_in_Pulmonary_Arterial_Hypertension_-_Mix6qcqr.mp3" length="49380886" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on PAH. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2057</itunes:duration>
                <itunes:episode>1459</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Scaling Up Obesity Care: Cost, Coverage, and Impact on Patients Getting Pharmacotherapy (CE)</title>
        <itunes:title>Clinical Conversations: CE: Scaling Up Obesity Care: Cost, Coverage, and Impact on Patients Getting Pharmacotherapy (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-scaling-up-obesity-care-cost-coverage-and-impact-on-patients-getting-pharmacotherapy-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-scaling-up-obesity-care-cost-coverage-and-impact-on-patients-getting-pharmacotherapy-ce/#comments</comments>        <pubDate>Sat, 21 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c21be4f7-91cf-3377-b106-ef89f484013d</guid>
                                    <description><![CDATA[<p>This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist’s role in helping patients overcome financial obstacles and sustain access to effective obesity treatments.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist’s role in helping patients overcome financial obstacles and sustain access to effective obesity treatments.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yschw4skajivp4yy/Scaling_Up_Obesity_Care_Cost_Coverage_and_Impact_on_Patients_Getting_Pharmacotherapy_CE_mixdown79ytk.mp3" length="30950513" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist’s role in helping patients overcome financial obstacles and sustain access to effective obesity treatments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                <itunes:episode>1457</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Community Pharmacy Practitioners Melissa Ortega</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Community Pharmacy Practitioners Melissa Ortega</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-community-pharmacy-practitioners-melissa-ortega/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-community-pharmacy-practitioners-melissa-ortega/#comments</comments>        <pubDate>Tue, 17 Feb 2026 10:09:57 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b536121-04d8-3731-95e4-d29b7cdafa86</guid>
                                    <description><![CDATA[<p>Immediate-Past Chair of the Section of Community Pharmacy Practitioners Courtney Isom sits down with the Section of Community Pharmacy Practitioners Distinguished Service Awardee Melissa Ortega to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Immediate-Past Chair of the Section of Community Pharmacy Practitioners Courtney Isom sits down with the Section of Community Pharmacy Practitioners Distinguished Service Awardee Melissa Ortega to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4b89m6acfpqv9szn/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Community_Pharmacy_Practitioners_Melissa_Ortega_mixdown9up5u.mp3" length="24374400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Immediate-Past Chair of the Section of Community Pharmacy Practitioners Courtney Isom sits down with the Section of Community Pharmacy Practitioners Distinguished Service Awardee Melissa Ortega to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1007</itunes:duration>
                <itunes:episode>1461</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 5</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Cell and Gene Therapies Part 5</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-5/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-cell-and-gene-therapies-part-5/#comments</comments>        <pubDate>Sat, 14 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/78ad4e30-e6ed-373a-a541-2ea6ae0957a8</guid>
                                    <description><![CDATA[<p>This episode will cover the background of cellular-based gene therapies from basic cell biology to genetic targets currently used in treatment. Experts will review the mechanisms for modifying cellular genetic material and the common viral vector platforms used in ex-vivo cellular therapy production. An overview of the steps and processes for cellular therapy preparation, manufacturing, handling and administration will be provided. Additionally, this presentation will discuss novel cellular therapy agents currently approved for use and the highly anticipated cellular therapies currently under investigation. CE for this episode expires 2 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will cover the background of cellular-based gene therapies from basic cell biology to genetic targets currently used in treatment. Experts will review the mechanisms for modifying cellular genetic material and the common viral vector platforms used in ex-vivo cellular therapy production. An overview of the steps and processes for cellular therapy preparation, manufacturing, handling and administration will be provided. Additionally, this presentation will discuss novel cellular therapy agents currently approved for use and the highly anticipated cellular therapies currently under investigation. CE for this episode expires 2 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4xesi2dy735h964e/Repurposed_REPS_Cell_and_Gene_Therapies_Part_5_mixdownaxy7a.mp3" length="46179185" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will cover the background of cellular-based gene therapies from basic cell biology to genetic targets currently used in treatment. Experts will review the mechanisms for modifying cellular genetic material and the common viral vector platforms used in ex-vivo cellular therapy production. An overview of the steps and processes for cellular therapy preparation, manufacturing, handling and administration will be provided. Additionally, this presentation will discuss novel cellular therapy agents currently approved for use and the highly anticipated cellular therapies currently under investigation. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1916</itunes:duration>
                <itunes:episode>1460</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: GLP Practice Insights: Periprocedural Management of GLP-1 Receptor Agonists (CE)</title>
        <itunes:title>Clinical Conversations: GLP Practice Insights: Periprocedural Management of GLP-1 Receptor Agonists (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonists-and-muscle-loss-ce-1769636630/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-glp-practice-insights-glp-1-receptor-agonists-and-muscle-loss-ce-1769636630/#comments</comments>        <pubDate>Sat, 07 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c2fb4405-5ffe-30d7-b2d5-3e8956aac12a</guid>
                                    <description><![CDATA[<p>This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zadky7wzqvdrhm94/ASHPOfficial_GLP_Practice_Insights_GLP_1_Receptor_Antagonists_and_Muscle_Loss_CE_mix_1_7u68p.mp3" length="23052305" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1440</itunes:duration>
                <itunes:episode>1455</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: The Painful Plug for Patient-centered Pain Care</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: The Painful Plug for Patient-centered Pain Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-painful-plug-for-patient-centered-pain-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-painful-plug-for-patient-centered-pain-care/#comments</comments>        <pubDate>Thu, 05 Feb 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a570222f-7266-3bd2-ac28-2d040bb5256c</guid>
                                    <description><![CDATA[<p>Learn from experts in the field of Opioid REMS including appropriate treatment for pain management including opioids, non-opioid analgesics, and non-pharmacological therapies.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field of Opioid REMS including appropriate treatment for pain management including opioids, non-opioid analgesics, and non-pharmacological therapies.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bg3vihhxk8ji4jw8/ADV_The_Painful_Plug_for_Patient-centered_Pain_Care_mixdown8w83u.mp3" length="44245792" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field of Opioid REMS including appropriate treatment for pain management including opioids, non-opioid analgesics, and non-pharmacological therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1841</itunes:duration>
                <itunes:episode>1458</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: REPS: Cell and Gene Therapies Part 4</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: REPS: Cell and Gene Therapies Part 4</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-reps-cell-and-gene-therapies-part-4/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-reps-cell-and-gene-therapies-part-4/#comments</comments>        <pubDate>Sat, 31 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7c4a9dc6-ebcc-3935-8082-81f43398e5b4</guid>
                                    <description><![CDATA[<p>This episode will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed. CE for this episode expires 2 years after the date it was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed. CE for this episode expires 2 years after the date it was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4t3vssa4dzrkakph/Recorded_Pharmacist_Series_REPS_Cell_and_Gene_Therapies_Part_4_mixdownbhj9t.mp3" length="45254901" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1877</itunes:duration>
                <itunes:episode>1448</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Scaling Up Obesity Care: Conversations about Adolescent Obesity and Treatment (CE)</title>
        <itunes:title>Scaling Up Obesity Care: Conversations about Adolescent Obesity and Treatment (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/scaling-up-obesity-care-conversations-about-adolescent-obesity-and-treatment-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/scaling-up-obesity-care-conversations-about-adolescent-obesity-and-treatment-ce/#comments</comments>        <pubDate>Sat, 31 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1165a1fa-5a29-3239-bc67-3659144ba111</guid>
                                    <description><![CDATA[<p>This episode addresses the growing challenge of adolescent obesity, which now affects over 22% of US teens. The discussion highlights Food and Drug Administration-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode addresses the growing challenge of adolescent obesity, which now affects over 22% of US teens. The discussion highlights Food and Drug Administration-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/szaipfu7erys5b3i/ASHPOfficial_Scaling_Up_Obesity_Care_Conversations_about_Adolescent_Obesity_and_Treatment_mix9ku53.mp3" length="44354333" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode addresses the growing challenge of adolescent obesity, which now affects over 22% of US teens. The discussion highlights Food and Drug Administration-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2772</itunes:duration>
                <itunes:episode>1444</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Dr. John Wood, MD, MBA, FAAFP, and Dr. James Kelly, MD</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Dr. John Wood, MD, MBA, FAAFP, and Dr. James Kelly, MD</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-dr-john-wood-md-mba-faafp-and-dr-james-kelly-md/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-dr-john-wood-md-mba-faafp-and-dr-james-kelly-md/#comments</comments>        <pubDate>Fri, 30 Jan 2026 11:37:27 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f2eb60c4-8dc0-366a-879c-ea53d8746b20</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features John Wood, Executive Medical Director, Primary Care and Population Health, Penn Medicine Lancaster General Health, and James Kelly, Regional Medical Director and Primary Care Provider, Penn Medicine Lancaster General Health, as they share their perspectives on the vital role pharmacists play in supporting patients. They discuss how pharmacists enhance care, improve outcomes, and strengthen the physician–pharmacist partnership. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features John Wood, Executive Medical Director, Primary Care and Population Health, Penn Medicine Lancaster General Health, and James Kelly, Regional Medical Director and Primary Care Provider, Penn Medicine Lancaster General Health, as they share their perspectives on the vital role pharmacists play in supporting patients. They discuss how pharmacists enhance care, improve outcomes, and strengthen the physician–pharmacist partnership. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2abew9esz2jxuk6f/We_re_Your_Pharmacist_Drs_James_Kelly_and_John_Wood_Mixdown_01232026atpj7.mp3" length="54208631" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features John Wood, Executive Medical Director, Primary Care and Population Health, Penn Medicine Lancaster General Health, and James Kelly, Regional Medical Director and Primary Care Provider, Penn Medicine Lancaster General Health, as they share their perspectives on the vital role pharmacists play in supporting patients. They discuss how pharmacists enhance care, improve outcomes, and strengthen the physician–pharmacist partnership. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1694</itunes:duration>
                <itunes:episode>1456</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: Fast Facts for Ambulatory Care Billing: 2026 Physician Fee Schedule Update</title>
        <itunes:title>Hot Topics in Pharmacy: Fast Facts for Ambulatory Care Billing: 2026 Physician Fee Schedule Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-fast-facts-for-ambulatory-care-billing-2026-physician-fee-schedule-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-fast-facts-for-ambulatory-care-billing-2026-physician-fee-schedule-update/#comments</comments>        <pubDate>Wed, 28 Jan 2026 11:17:14 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f7ed66d1-59a8-3d05-a0e4-c82cd81a429c</guid>
                                    <description><![CDATA[<p>Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xpvnaip6skj8ks96/ASHPOfficial_-_Fast_Facts_for_Ambulatory_Care_Billing_-_2026_Physician_Fee_Schedule_Update_-_Mix_2_6jzjo.mp3" length="46162620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1923</itunes:duration>
                <itunes:episode>1454</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Best Practices 2025: Elevating Outcomes and Pharmacoequity — An Enterprise Comprehensive Ambulatory Care Pharmacy Program Embracing Standardization, Digitalization, and Reduction of Health Disparities</title>
        <itunes:title>Best Practices 2025: Elevating Outcomes and Pharmacoequity — An Enterprise Comprehensive Ambulatory Care Pharmacy Program Embracing Standardization, Digitalization, and Reduction of Health Disparities</itunes:title>
        <link>https://ashpofficial.podbean.com/e/bestpractices2025elevatingoutcomesand-pharmacoequity-%e2%80%94an-enterprisecomprehensive-ambulatorycarepharmacy-program-embracing-standardization-d/</link>
                    <comments>https://ashpofficial.podbean.com/e/bestpractices2025elevatingoutcomesand-pharmacoequity-%e2%80%94an-enterprisecomprehensive-ambulatorycarepharmacy-program-embracing-standardization-d/#comments</comments>        <pubDate>Tue, 27 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cec942b7-721a-3fe8-803d-315c7cfa7b4f</guid>
                                    <description><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mdkh9fvxr2mey8gv/ASHP_Best_Practices_2025_Elevating_Outcomes_and_Pharmacoequity_mixdown7psx4.mp3" length="15626418" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>643</itunes:duration>
                <itunes:episode>1452</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: 2026 Pharmacy Forecast Report</title>
        <itunes:title>AJHP Voices: 2026 Pharmacy Forecast Report</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-2026-pharmacy-forecast-report/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-2026-pharmacy-forecast-report/#comments</comments>        <pubDate>Fri, 23 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/35e3d9fd-b6e2-3f99-8d14-07f6a52cdb1e</guid>
                                    <description><![CDATA[<p>In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7mun98mt5n8jhjyd/2026_Pharmacy_Forecast_Report_FINAL8szy2.mp3" length="51963316" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1623</itunes:duration>
                <itunes:episode>1449</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>How CMS, the IRA, and Manufacturers Are Shaping Drug Prices</title>
        <itunes:title>How CMS, the IRA, and Manufacturers Are Shaping Drug Prices</itunes:title>
        <link>https://ashpofficial.podbean.com/e/how-cms-the-ira-and-manufacturers-are-shaping-drug-prices/</link>
                    <comments>https://ashpofficial.podbean.com/e/how-cms-the-ira-and-manufacturers-are-shaping-drug-prices/#comments</comments>        <pubDate>Thu, 22 Jan 2026 11:18:33 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/624640e9-abb0-391a-979a-e7884aea8d61</guid>
                                    <description><![CDATA[<p>This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rxbzwra7xe4p3t5v/2_Negotiating_Fairness_How_CMS_the_IRA_and_Manufacturers_Are_Shaping_Drug_Prices_20251124T113405410361_mixdown79qno.mp3" length="27482280" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1137</itunes:duration>
                <itunes:episode>1450</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Dose of Leadership: From Technician Bench to Leadership Bench</title>
        <itunes:title>Technician Insights: Dose of Leadership: From Technician Bench to Leadership Bench</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-dose-of-leadership-from-technician-bench-to-leadership-bench/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-dose-of-leadership-from-technician-bench-to-leadership-bench/#comments</comments>        <pubDate>Thu, 22 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b804ba7-5b7b-3844-ac5d-98916615a5a1</guid>
                                    <description><![CDATA[<p>This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tctx5rwgtab4jdy3/Dose_of_Leadership_From_Technician_Bench_to_Leadership_Bench_mixdownad6wo.mp3" length="18572746" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>766</itunes:duration>
                <itunes:episode>1443</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Live with ASHP: Hot Take From a Hot Body</title>
        <itunes:title>Live with ASHP: Hot Take From a Hot Body</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-hot-take-from-a-hot-body/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-hot-take-from-a-hot-body/#comments</comments>        <pubDate>Thu, 22 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/671bbb79-3750-3399-9fd9-d2d59edf7fa0</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xrsqksmtwbpa7aeg/Hot_Take_from_a_Hot_Body_Megan_M_mixdown6adzp.mp3" length="10547492" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>431</itunes:duration>
                <itunes:episode>1439</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: Spotlight on Science: The Weight Debate — Best Practices for High-Risk Medication Dosing Controversies in Extreme Weight Patients</title>
        <itunes:title>Live with ASHP: Spotlight on Science: The Weight Debate — Best Practices for High-Risk Medication Dosing Controversies in Extreme Weight Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashpspotlighton-science-the-weight-debate%e2%80%94-best-practices-for-high-risk-medication-dosingcontroversies-in-extremeweight-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashpspotlighton-science-the-weight-debate%e2%80%94-best-practices-for-high-risk-medication-dosingcontroversies-in-extremeweight-patients/#comments</comments>        <pubDate>Tue, 20 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c3a7cd77-5f25-3208-aa15-6737170447e6</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jyib943mtxts36nt/Spotlight_on_Science_The_Weight_Debate_-_Best_Practices_for_High-Risk_Medication_Dosing_Controversies_in_Extreme_Weight_Patients_mixdown89sjf.mp3" length="12640288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>519</itunes:duration>
                <itunes:episode>1447</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Theme issue on emergency medicine pharmacy practice</title>
        <itunes:title>AJHP Voices: Theme issue on emergency medicine pharmacy practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-theme-issue-on-emergency-medicine-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-theme-issue-on-emergency-medicine-pharmacy-practice/#comments</comments>        <pubDate>Fri, 16 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b0a3ec7e-c91a-3dc2-a5ec-e3d40ec7b478</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5dgd8jxpjebct42t/EM_Theme_Issue7yp44.mp3" length="63422021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1981</itunes:duration>
                <itunes:episode>1445</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Live with ASHP: Anticoagulation Management and Stewardship in Complex Patients: A Case-Based Exploration of Solutions</title>
        <itunes:title>Live with ASHP: Anticoagulation Management and Stewardship in Complex Patients: A Case-Based Exploration of Solutions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-anticoagulation-management-and-stewardship-in-complex-patients-a-case-based-exploration-of-solutions/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-anticoagulation-management-and-stewardship-in-complex-patients-a-case-based-exploration-of-solutions/#comments</comments>        <pubDate>Thu, 15 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b8e0bfc-e9c4-368f-a37c-5c4f90c50894</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4s9dviyvw3b3yuzr/ASHPOfficial_Anticoagulation_Management_and_Stewardship_in_Complex_Patients_A_Case_Based_Exploration_of_Solutions_mix8t2gp.mp3" length="30287255" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1892</itunes:duration>
                <itunes:episode>1446</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: What Happens in Vegas... Stays MSSA-Free? Ceftriaxone vs. Cefazolin for MSSA Management</title>
        <itunes:title>Live with ASHP: What Happens in Vegas... Stays MSSA-Free? Ceftriaxone vs. Cefazolin for MSSA Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-what-happens-in-vegas-stays-mssa-free-ceftriaxone-vs-cefazolin-for-mssa-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-what-happens-in-vegas-stays-mssa-free-ceftriaxone-vs-cefazolin-for-mssa-management/#comments</comments>        <pubDate>Wed, 14 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/aa3d080e-7654-3ec1-9173-9460d91feb3c</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kt9fqxh7tszuqhgg/Post-MCM_Podcast_Series_What_Happens_in_Vegas_Stays_MSSA-Free_Ceftriaxone_vs_Cefazolin_for_MSSA_Management_Nguyen_mixdown_1_7zn3a.mp3" length="17912491" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>738</itunes:duration>
                <itunes:episode>1438</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resiliency in Practice: Safe to Speak: How to Foster Psychological Safety to Promote Effective Teamwork</title>
        <itunes:title>Wellbeing and Resiliency in Practice: Safe to Speak: How to Foster Psychological Safety to Promote Effective Teamwork</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-safe-to-speak-how-to-foster-psychological-safety-to-promote-effective-teamwork/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-safe-to-speak-how-to-foster-psychological-safety-to-promote-effective-teamwork/#comments</comments>        <pubDate>Tue, 13 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c550a554-e74b-3114-909e-80d24eb630bf</guid>
                                    <description><![CDATA[<p>This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2hqxarv3cmm9q7nz/ASHPOfficial_-_Well-Being_and_Resilience_-_Psychological_Safety_MIX82qss.mp3" length="51584168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1289</itunes:duration>
                <itunes:episode>1441</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: CE: Recorded Pharmacist Series: Trauma</title>
        <itunes:title>Clinical Conversations: CE: Recorded Pharmacist Series: Trauma</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-trauma/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-trauma/#comments</comments>        <pubDate>Sat, 10 Jan 2026 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/02e3c1bf-895c-31f2-aa87-8ff5eb667696</guid>
                                    <description><![CDATA[<p>The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists’ role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists’ role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tsrh7mn4ac5gu35f/Recorded_Pharmacist_Series_REPS_Trauma_mixdownaxjlc.mp3" length="47264721" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists’ role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1961</itunes:duration>
                <itunes:episode>1437</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Guidelines Spotlight: Evaluating Off-Label Medication Use in Hospitals</title>
        <itunes:title>ASHP Guidelines Spotlight: Evaluating Off-Label Medication Use in Hospitals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-guidelines-spotlight-evaluating-off-label-medication-use-in-hospitals/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-guidelines-spotlight-evaluating-off-label-medication-use-in-hospitals/#comments</comments>        <pubDate>Fri, 09 Jan 2026 16:17:06 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bcbfcac7-f878-3b79-aac2-eca943c41ee6</guid>
                                    <description><![CDATA[<p>This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&amp;T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&amp;T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hmmkrubgggcssiem/ASHPOfficial_ASHP_Guidelines_Spotlight_Evaluating_Off_Label_Medication_Use_in_Hospitals_rev161f0m.mp3" length="45110354" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&amp;T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2819</itunes:duration>
                <itunes:episode>1442</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: Bridging the Gap: Prescribing and Optimizing Medications for Opioid Use Disorder Across the Spectrum of Care From Primary to Acute Care</title>
        <itunes:title>Live with ASHP: Bridging the Gap: Prescribing and Optimizing Medications for Opioid Use Disorder Across the Spectrum of Care From Primary to Acute Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-bridging-the-gap-prescribing-and-optimizing-medications-for-opioid-use-disorder-across-the-spectrum-of-care-from-primary-to-acute-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-bridging-the-gap-prescribing-and-optimizing-medications-for-opioid-use-disorder-across-the-spectrum-of-care-from-primary-to-acute-care/#comments</comments>        <pubDate>Thu, 08 Jan 2026 15:47:01 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/176115fc-19ca-38e1-ad87-dced50d05e06</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mjrff3dwd9mzdjjh/Bridging_the_Gap_Prescribing_and_Optimizing_Medications_for_Opioid_Use_Disorder_Across_the_Spectrum_of_Care_From_Primary_to_Acute_Care_mixdown6tknj.mp3" length="20616163" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>851</itunes:duration>
                <itunes:episode>1440</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: Myasthenic Crisis</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: Myasthenic Crisis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-myasthenic-crisis/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-myasthenic-crisis/#comments</comments>        <pubDate>Sat, 20 Dec 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/690ed6ad-f181-3dea-b120-791c31695e4d</guid>
                                    <description><![CDATA[<p>Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jmwtrz7582xmkaxj/2_Recorded_Pharmacist_Series_Myasthenic_Crisis_mixdown67zce.mp3" length="41482407" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1720</itunes:duration>
                <itunes:episode>1427</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Jennifer Slaughter, PharmD, PhD, BCACP, and her patient Debbie</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Jennifer Slaughter, PharmD, PhD, BCACP, and her patient Debbie</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-jennifer-slaughter-pharmd-phd-bcacp-and-her-patient-debbie/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-jennifer-slaughter-pharmd-phd-bcacp-and-her-patient-debbie/#comments</comments>        <pubDate>Thu, 18 Dec 2025 14:20:38 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7c579239-41a5-3cd8-a635-4b792e86a207</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xvn8bdx3ks6fd9n7/We_re_Your_Pharmacist_Jen_Slaughter_Debbie_Heinreich_Revised_Mixdown_12102025ams27.mp3" length="37979571" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1186</itunes:duration>
                <itunes:episode>1436</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Live With ASHP (Post MCM Series): Stacking the Deck: Population Health Workflow and Metrics</title>
        <itunes:title>Live With ASHP (Post MCM Series): Stacking the Deck: Population Health Workflow and Metrics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/stacking-the-deck-population-health-workflow-and-metrics/</link>
                    <comments>https://ashpofficial.podbean.com/e/stacking-the-deck-population-health-workflow-and-metrics/#comments</comments>        <pubDate>Wed, 17 Dec 2025 15:33:49 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e148ca3b-6fee-35e4-a693-d4885a4d0f2a</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9cxqhaeg6w6xmr9j/Stacking_the_Deck_Population_Health_Workflows_Metrics_mixdown9a7ql.mp3" length="12366759" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>507</itunes:duration>
                <itunes:episode>1434</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live With ASHP (Post MCM Series): There's a Lot on the Table: Playing Your Best Hand for Residency Interviews</title>
        <itunes:title>Live With ASHP (Post MCM Series): There's a Lot on the Table: Playing Your Best Hand for Residency Interviews</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-post-mcm-series-theres-a-lot-on-the-table-playing-your-best-hand-for-residency-interviews/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-post-mcm-series-theres-a-lot-on-the-table-playing-your-best-hand-for-residency-interviews/#comments</comments>        <pubDate>Wed, 17 Dec 2025 13:43:35 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/187c9473-1a7b-35c2-9729-fd5b1c7f0563</guid>
                                    <description><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9izzny99f6eabmup/ASHPOfficial_There_s_a_Lot_on_the_Table_Playing_Your_Best_Hand_for_Residency_Interviews_mix9o7zg.mp3" length="8658534" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>353</itunes:duration>
                <itunes:episode>1435</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A Conversation with Jaclyn Moreno</title>
        <itunes:title>Live from Midyear: A Conversation with Jaclyn Moreno</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-jaclyn-moreno/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-jaclyn-moreno/#comments</comments>        <pubDate>Tue, 16 Dec 2025 11:34:58 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2aafefad-f62a-3f1a-8429-46c0ff593b9b</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/b4nu3i4dsk6hbdgf/Student_experiences_at_the_Midyear_Jaclyn_Moreno_Christina_Madison_mixdownbkg46.mp3" length="37515935" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1555</itunes:duration>
                <itunes:episode>1433</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP: The ABCs of CSPs</title>
        <itunes:title>Live with ASHP: The ABCs of CSPs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-the-abcs-of-csps/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-the-abcs-of-csps/#comments</comments>        <pubDate>Mon, 15 Dec 2025 16:25:22 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3f024766-9079-390b-b3d6-44be4d9e3eaa</guid>
                                    <description><![CDATA[<p>A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/idjkr224fu3v5m6w/The_ABCs_of_CSPs_mixdown8t8cd.mp3" length="12220142" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting &amp; Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>501</itunes:duration>
                <itunes:episode>1432</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: An advocacy roadmap to recognition and payment for pharmacist patient-care services</title>
        <itunes:title>AJHP Voices: An advocacy roadmap to recognition and payment for pharmacist patient-care services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-an-advocacy-roadmap-to-recognition-and-payment-for-pharmacist-patient-care-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-an-advocacy-roadmap-to-recognition-and-payment-for-pharmacist-patient-care-services/#comments</comments>        <pubDate>Mon, 15 Dec 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3467ca16-3e3f-358c-86b1-ca195d0c4e0f</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mc5642ejjm8c8394/An_advocacy_roadmap_to_recognition_and_paymenta0bx6.mp3" length="62419186" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1950</itunes:duration>
                <itunes:episode>1431</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: Anaphylaxis</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: Anaphylaxis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-anaphylaxis/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-anaphylaxis/#comments</comments>        <pubDate>Sat, 13 Dec 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a7e6fcb3-3883-3264-a930-7d3506b5aa6f</guid>
                                    <description><![CDATA[<p>Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hcrr3ki32ekywuec/Recorded_Pharmacist_Series_Anaphylaxis_mixdown8ptib.mp3" length="34979200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1449</itunes:duration>
                <itunes:episode>1426</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Deanna Jo Laughlin</title>
        <itunes:title>Live from Midyear: A conversation with Deanna Jo Laughlin</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-deanna-jo-laughlin/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-deanna-jo-laughlin/#comments</comments>        <pubDate>Wed, 10 Dec 2025 11:45:34 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5fac2edf-6fc1-37a8-a08a-f7104626fe82</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fn979wk8s4hgzse5/Student_experiences_at_the_Midyear_Deanna_Jo_Laughlin_Christina_Madison_mixdown82thk.mp3" length="22928524" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>947</itunes:duration>
                <itunes:episode>1430</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Allison Given</title>
        <itunes:title>Live from Midyear: A conversation with Allison Given</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-allison-given/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-allison-given/#comments</comments>        <pubDate>Wed, 10 Dec 2025 10:50:56 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8f50f381-c9e0-3559-b532-a2df4266322c</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! </p>
<p> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! </p>
<p> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/irqh64hkszg48mkh/Student_experiences_at_the_Midyear_Allison_Given_Alfred_Awuah_mixdownb2k1x.mp3" length="9266101" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting &amp; Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! 
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>378</itunes:duration>
                <itunes:episode>1429</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics  in Pharmacy: Breaking Down ASHP's New Statement on the Pharmacist's Role in Substance Use Disorder</title>
        <itunes:title>Hot Topics  in Pharmacy: Breaking Down ASHP's New Statement on the Pharmacist's Role in Substance Use Disorder</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-breaking-down-ashps-new-statement-on-the-pharmacists-role-in-substance-use-disorder/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-breaking-down-ashps-new-statement-on-the-pharmacists-role-in-substance-use-disorder/#comments</comments>        <pubDate>Thu, 04 Dec 2025 19:11:14 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7d94d01c-7dd2-3503-a47e-4a41e7213406</guid>
                                    <description><![CDATA[<p>Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i7dsxdvqbapzhqnk/Breaking_Down_ASHP_s_New_Statement_on_the_Pharmacist_s_Role_in_Substance_Use_Disorder_mixdownad5p2.mp3" length="63120539" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2622</itunes:duration>
                <itunes:episode>1428</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: ACLS — Pulseless Arrest</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: ACLS — Pulseless Arrest</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-acls-%e2%80%94-pulseless-arrest/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-acls-%e2%80%94-pulseless-arrest/#comments</comments>        <pubDate>Mon, 01 Dec 2025 11:53:49 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2604a321-be6c-31e1-aecf-4741f6a64193</guid>
                                    <description><![CDATA[<p>This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/57m6tgbab8m4wm7r/2_Recorded_Pharmacist_Series_ACLS_Pulseless_Arrest_mixdownay261.mp3" length="42262517" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1753</itunes:duration>
                <itunes:episode>1425</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Closer Look at the ASHP Strategic Plan</title>
        <itunes:title>Pharmacy Leadership: A Closer Look at the ASHP Strategic Plan</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-closer-look-at-the-ashp-strategic-plan/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-closer-look-at-the-ashp-strategic-plan/#comments</comments>        <pubDate>Mon, 24 Nov 2025 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6d29abb0-e4e6-36b0-8db1-8fb70e240581</guid>
                                    <description><![CDATA[<p>Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP’s newly updated strategic plan. Speakers share the story behind the plan’s development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP’s newly updated strategic plan. Speakers share the story behind the plan’s development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4au76v9ien3ym3sg/A_Closer_Look_at_the_New_ASHP_Strategic_Plan_mixdown6xeod.mp3" length="34774926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP’s newly updated strategic plan. Speakers share the story behind the plan’s development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1441</itunes:duration>
                <itunes:episode>1424</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with the ASHP Section of Clinical Specialists and Scientists Executive Committee</title>
        <itunes:title>We're Your Pharmacist Podcast Series with the ASHP Section of Clinical Specialists and Scientists Executive Committee</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-the-ashp-section-of-clinical-specialists-and-scientists-executive-committee/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-the-ashp-section-of-clinical-specialists-and-scientists-executive-committee/#comments</comments>        <pubDate>Mon, 24 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3c4f6136-58bc-37d3-9f5c-3e34a51b2f46</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sywnrcv5s37u9d44/SCSS_Executive_Committee_Panel_WYP_Mixdownbdykg.mp3" length="27728276" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>866</itunes:duration>
                <itunes:episode>1423</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Clinical Conversations: US Antibiotic Awareness Week: Pharmacist’s Role in Diagnostic Excellence</title>
        <itunes:title>Clinical Conversations: US Antibiotic Awareness Week: Pharmacist’s Role in Diagnostic Excellence</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinica-conversations-us-antibiotic-awareness-week-pharmacist-s-role-in-diagnostic-excellence/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinica-conversations-us-antibiotic-awareness-week-pharmacist-s-role-in-diagnostic-excellence/#comments</comments>        <pubDate>Wed, 19 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cafb599c-dbe4-3129-a0c8-72a3d385c215</guid>
                                    <description><![CDATA[<p>The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xpcaj38r53ppxtyj/ASHPOfficial_US_Antibiotic_Awareness_Week_Pharmacist_s_Role_in_Diagnostic_Excellence_mix_1_968nz.mp3" length="38979620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2436</itunes:duration>
                <itunes:episode>1420</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live With ASHP: Spark Notes: Leadership Brilliance in Action at MCM 2025</title>
        <itunes:title>Live With ASHP: Spark Notes: Leadership Brilliance in Action at MCM 2025</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-spark-notes-leadership-brilliance-in-action-at-mcm-2025/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-spark-notes-leadership-brilliance-in-action-at-mcm-2025/#comments</comments>        <pubDate>Tue, 18 Nov 2025 15:56:32 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a91644f2-f937-392a-9667-aba81030bb34</guid>
                                    <description><![CDATA[<p>Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting &amp; Exhibition and there’s no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting &amp; Exhibition and there’s no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/miq77dqxp3jzfq9j/Spark_Notes_Leadership_Brilliance_in_Action_at_MCM_2025_mixdownb80sj.mp3" length="53425727" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting &amp; Exhibition and there’s no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2218</itunes:duration>
                <itunes:episode>1422</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live with ASHP (Midyear Speaker Series): Midyear Speaker Series 2025: William Dager, PharmD, BCPS, FASHP, FCCM, FCCP, MCCM</title>
        <itunes:title>Live with ASHP (Midyear Speaker Series): Midyear Speaker Series 2025: William Dager, PharmD, BCPS, FASHP, FCCM, FCCP, MCCM</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-midyear-speaker-series-2025%c2%a0william-dager-pharmd-bcps-fashp-fccm-fccp-mccm/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-midyear-speaker-series-2025%c2%a0william-dager-pharmd-bcps-fashp-fccm-fccp-mccm/#comments</comments>        <pubDate>Mon, 17 Nov 2025 13:44:08 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d2b70a98-8944-3c32-9d67-946104a8f1f7</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h73qq59cgg64utnf/ASHP_Midyear_Speaker_Series_2025_William_Dager_PharmD_BCPS_FASHP_FCCM_FCCP_MCCM_mixdown7eqwt.mp3" length="26752889" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1107</itunes:duration>
                <itunes:episode>1421</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: Recorded Pharmacist Series: Pediatric Advanced Life Support</title>
        <itunes:title>Clinical Conversations: Recorded Pharmacist Series: Pediatric Advanced Life Support</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-recorded-pharmacist-series-pediatric-advanced-life-support/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-recorded-pharmacist-series-pediatric-advanced-life-support/#comments</comments>        <pubDate>Sat, 15 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dbb43e76-2aa9-3357-8808-2a7fbee57a19</guid>
                                    <description><![CDATA[<p>This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j2v34pszpr2s4zv8/Recorded_Pharmacist_Series_Pediatric_Advanced_Life_Support_mixdown64qlv.mp3" length="48838319" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2027</itunes:duration>
                <itunes:episode>1416</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics  in Pharmacy: Policy in Motion: How and Why Did ASHP's Policy on Pharmacist Payment Parity Evolve?</title>
        <itunes:title>Hot Topics  in Pharmacy: Policy in Motion: How and Why Did ASHP's Policy on Pharmacist Payment Parity Evolve?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-policy-in-motion-how-and-why-did-ashps-policy-on-pharmacist-payment-parity-evolve/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-policy-in-motion-how-and-why-did-ashps-policy-on-pharmacist-payment-parity-evolve/#comments</comments>        <pubDate>Thu, 13 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/49a46b84-06d4-32ed-95ce-a009edef9596</guid>
                                    <description><![CDATA[<p>This episode explores why ASHP’s Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council’s secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists’ Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP’s stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode explores why ASHP’s Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council’s secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists’ Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP’s stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/be8ncxi57ye29dyz/ASHPOfficial_-_Policy_in_Motion_-_How_and_Why_Did_ASHP_s_Policy_on_Pharmacist_Parity_Evolve_-_Mix_1_b5s53.mp3" length="44233288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode explores why ASHP’s Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council’s secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists’ Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP’s stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1843</itunes:duration>
                <itunes:episode>1415</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Veteran's Day: Duty, Honor, Pharmacy: A Veterans Day Salute</title>
        <itunes:title>Pharmacy Leadership: Veteran's Day: Duty, Honor, Pharmacy: A Veterans Day Salute</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-veterans-day-duty-honor-pharmacy-a-veterans-day-salute/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-veterans-day-duty-honor-pharmacy-a-veterans-day-salute/#comments</comments>        <pubDate>Mon, 10 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0289399b-dc5a-38c7-ab82-b48762fe31d7</guid>
                                    <description><![CDATA[<p>In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xa9vmgehtkwugz6q/ASHPOfficial_-_Duty_Honor_Pharmacy_A_Veterans_Day_Salute_-_Mix_Revised7ingj.mp3" length="61227936" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2551</itunes:duration>
                <itunes:episode>1412</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: What’s Next for 340B?: Federal Shifts, State Actions, and Court Challenges</title>
        <itunes:title>Advocating for Impact: What’s Next for 340B?: Federal Shifts, State Actions, and Court Challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-what-s-next-for-340b-federal-shifts-state-actions-and-court-challenges/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-what-s-next-for-340b-federal-shifts-state-actions-and-court-challenges/#comments</comments>        <pubDate>Fri, 07 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/af4f8288-e32f-3d9b-a473-9d71d93ec38a</guid>
                                    <description><![CDATA[<p>This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss where 340B advocacy goes from here. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss where 340B advocacy goes from here. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yjw2veirx86gfwma/GRD_340B_Update_Jillanne_Schulte_Wall_and_Tom_Kraus_mixdown_1104202590ve0.mp3" length="39353146" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss where 340B advocacy goes from here. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1229</itunes:duration>
                <itunes:episode>1419</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Let's Get Board! Technicians and State Boards of Pharmacy</title>
        <itunes:title>Technician Insights: Let's Get Board! Technicians and State Boards of Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-lets-get-board-technicians-and-state-boards-of-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-lets-get-board-technicians-and-state-boards-of-pharmacy/#comments</comments>        <pubDate>Wed, 05 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e6ffb870-0922-3aed-9e5d-1d2b67bbfdd0</guid>
                                    <description><![CDATA[<p class="elementtoproof" style="background: white;">Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="elementtoproof" style="background: white;">Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d9nwstaybpz5dpb7/ASHP_Technician_Insights_-_Let_s_Get_Board_-_Technicians_and_State_Boards_of_Pharmacy_-_Mix80fsj.mp3" length="41414410" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1725</itunes:duration>
                <itunes:episode>1407</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Live with ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Kristin Zimmerman, PharmD, BCGP, FCCP</title>
        <itunes:title>Live with ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Kristin Zimmerman, PharmD, BCGP, FCCP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-kristin-zimmerman-pharmd-bcgp-fccp/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-kristin-zimmerman-pharmd-bcgp-fccp/#comments</comments>        <pubDate>Tue, 04 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/060692f3-4a73-3efe-aada-266d87a11309</guid>
                                    <description><![CDATA[<p>ASHP’s Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gge4a6c2hnpg3zif/ASHP_Midyear_Speaker_Series_2025_Kristin_Zimmerman_PharmD_BCGP_mixdown67by1.mp3" length="10123568" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>414</itunes:duration>
                <itunes:episode>1418</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being and Resiliency in Practice: Reflections on the 2025 Implementing Solutions Workforce Summit</title>
        <itunes:title>Well-being and Resiliency in Practice: Reflections on the 2025 Implementing Solutions Workforce Summit</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-and-resiliency-in-practice-reflections-on-the-2025-implementing-solutions-workforce-summit/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-and-resiliency-in-practice-reflections-on-the-2025-implementing-solutions-workforce-summit/#comments</comments>        <pubDate>Tue, 04 Nov 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/59d8fb72-2716-36fc-9013-75bfbf80e376</guid>
                                    <description><![CDATA[<p>ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fz634u9rrpbx6e37/Reflections_on_the_2025_Implementing_Solutions_Workforce_Summit_mixdownbdlhb.mp3" length="43288405" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1796</itunes:duration>
                <itunes:episode>1411</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: RSI and Post Intubation Management (CE)</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: RSI and Post Intubation Management (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-rsi-and-post-intubation-management-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-rsi-and-post-intubation-management-ce/#comments</comments>        <pubDate>Sat, 01 Nov 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2ce129eb-1897-3dfc-bf73-aff52425b846</guid>
                                    <description><![CDATA[<p>This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3tqz4ipmkdrj2dr5/Repurposed_recorded_Pharmacist_Series_RSI_and_Post_Intubation_Management_mixdown_1_9ckr8.mp3" length="44853744" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1861</itunes:duration>
                <itunes:episode>1410</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series: Amber Lanae Martirosov, PharmD, BCPS, BCACP</title>
        <itunes:title>We're Your Pharmacist Podcast Series: Amber Lanae Martirosov, PharmD, BCPS, BCACP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-amber-lanae-martirosov-pharmd-bcps-bcacp/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-amber-lanae-martirosov-pharmd-bcps-bcacp/#comments</comments>        <pubDate>Fri, 31 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/66f4180b-b0b9-3def-8224-37636846abba</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hkpdcwjdqih5pg4n/We_re_Your_Pharmacists_Amber_Lanae_Martirosov_mixdown_102220257g8k3.mp3" length="13841391" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>432</itunes:duration>
                <itunes:episode>1414</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Honoring the 2024 Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners</title>
        <itunes:title>Pharmacy Leadership: Honoring the 2024 Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-honoring-the-2024-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-honoring-the-2024-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners/#comments</comments>        <pubDate>Thu, 30 Oct 2025 14:14:43 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/58784efd-cead-3751-94b1-1be0fc6e8cbf</guid>
                                    <description><![CDATA[<p>In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d8mhdy782s2uv9xf/2_ASHPOfficial_-_Honoring_the_2024_Distinguished_Service_Awardee_for_the_Section_of_Specialty_Pharmacy_mixdown9zahz.mp3" length="35693510" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1486</itunes:duration>
                <itunes:episode>1417</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Developing Tomorrow’s Leaders: Inside Rutgers' NxtGen</title>
        <itunes:title>Student Perspectives: Developing Tomorrow’s Leaders: Inside Rutgers' NxtGen</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-developing-tomorrow-s-leaders-inside-rutgers-nxtgen/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-developing-tomorrow-s-leaders-inside-rutgers-nxtgen/#comments</comments>        <pubDate>Thu, 30 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d6208746-a6fc-3d21-92d4-b74f479a0ae4</guid>
                                    <description><![CDATA[<p>In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it’s had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it’s had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vqm6t9m3vhndu2bx/Developing_Tomorrow_s_Leaders_Inside_Rutgers_NxtGen_Program_mixdown6foqs.mp3" length="29307194" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it’s had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1213</itunes:duration>
                <itunes:episode>1413</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy Practice: What is Moral Distress? Deconstructing a 2025 Policy from the Council on Pharmacy Practice</title>
        <itunes:title>Hot Topics in Pharmacy Practice: What is Moral Distress? Deconstructing a 2025 Policy from the Council on Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-what-is-moral-distress-deconstructing-a-2025-policy-from-the-council-on-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-what-is-moral-distress-deconstructing-a-2025-policy-from-the-council-on-pharmacy-practice/#comments</comments>        <pubDate>Wed, 29 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/28ad0578-89f7-326d-bc4e-ef710e2b8d76</guid>
                                    <description><![CDATA[<p>Join members of the Council on Pharmacy Practice to unpack ASHP’s newly approved policy on moral distress and moral injury. They’ll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join members of the Council on Pharmacy Practice to unpack ASHP’s newly approved policy on moral distress and moral injury. They’ll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v3mhv2k4kz8j8r6f/2_ASHPOFFICIAL_What_is_Moral_Distress_Deconstructing_a_2025_Policy_from_the_Council_on_Pharmacy_Practice_mixdown6i9b3.mp3" length="47264923" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join members of the Council on Pharmacy Practice to unpack ASHP’s newly approved policy on moral distress and moral injury. They’ll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1968</itunes:duration>
                <itunes:episode>1408</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Curtis Geier, PharmD, BCEMP</title>
        <itunes:title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Curtis Geier, PharmD, BCEMP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-curtis-geier-pharmd-bcemp/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-curtis-geier-pharmd-bcemp/#comments</comments>        <pubDate>Tue, 28 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3e13ec7b-d5f4-3e4f-8178-7c077186ab6f</guid>
                                    <description><![CDATA[<p>ASHP’s education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ekvha24aik534kdu/ASHP_Midyear_Speaker_Series_2025_Curtis_Geier_PharmD_BCEMP_mixdown8cl0i.mp3" length="8710726" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>355</itunes:duration>
                <itunes:episode>1409</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: RSI in Special Populations (CE)</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: RSI in Special Populations (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-rsi-in-special-populations-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-rsi-in-special-populations-ce/#comments</comments>        <pubDate>Sat, 18 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4bc26943-80b6-3ff0-96c2-6e977b26041e</guid>
                                    <description><![CDATA[<p>Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wh85vd8vi4rjk33k/Repurposed_REPS_RSI_in_Special_Population_mixdowna4m37.mp3" length="45119610" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1872</itunes:duration>
                <itunes:episode>1405</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: Leveraging an Inpatient Collaborative Practice Agreement to Expand Pharmacist Scope and Efficiency</title>
        <itunes:title>Clinical Conversations: Leveraging an Inpatient Collaborative Practice Agreement to Expand Pharmacist Scope and Efficiency</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-leveraging-an-inpatient-collaborative-practice-agreement-to-expand-pharmacist-scope-and-efficiency/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-leveraging-an-inpatient-collaborative-practice-agreement-to-expand-pharmacist-scope-and-efficiency/#comments</comments>        <pubDate>Thu, 16 Oct 2025 16:01:57 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ba346758-4215-34fa-bd71-2d9513744b5e</guid>
                                    <description><![CDATA[<p>Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ivrasn292eyux7ts/2_Leveraging_an_Inpatient_Collaborative_Practice_Agreement_to_Expand_Pharmacist_Scope_and_Efficiency_mixdown63rkb.mp3" length="41989611" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1749</itunes:duration>
                <itunes:episode>1406</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents</title>
        <itunes:title>AJHP Voices: Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-strategies-to-prevent-awareness-with-paralysis-following-administration-of-neuromuscular-blocking-agents/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-strategies-to-prevent-awareness-with-paralysis-following-administration-of-neuromuscular-blocking-agents/#comments</comments>        <pubDate>Thu, 16 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3d4706e0-8120-3711-b8dd-29960c45680a</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zt7w598zj7bdi944/Strategies_to_prevent_awareness_with_paralysis_FINAL7st1d.mp3" length="45516281" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1422</itunes:duration>
                <itunes:episode>1403</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Lisa Janssen Carlson, PharmD, BCOP, DPLA, and Craig Michael, PharmD</title>
        <itunes:title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Lisa Janssen Carlson, PharmD, BCOP, DPLA, and Craig Michael, PharmD</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-lisa-janssen-carlson-pharmd-bcop-dpla-and-craig-michael-pharmd/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-with-ashp-midyear-speaker-series-ashp-midyear-speaker-series-2025-lisa-janssen-carlson-pharmd-bcop-dpla-and-craig-michael-pharmd/#comments</comments>        <pubDate>Wed, 15 Oct 2025 13:30:52 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1fe780d0-1929-36c5-bd7e-0afa9b6218df</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vjad9kyuj344xsix/2_ASHP_Midyear_Speaker_Series_2025_Lisa_Janssen_Carlson_PharmD_BCOP_DPLA_and_Craig_Michael_PharmD_mixdownb3xxf.mp3" length="16332004" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>673</itunes:duration>
                <itunes:episode>1404</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy Practice: From Names to Numbers: Deconstructing Two 2025 Council on Therapeutics Policies</title>
        <itunes:title>Hot Topics in Pharmacy Practice: From Names to Numbers: Deconstructing Two 2025 Council on Therapeutics Policies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-from-names-to-numbers-deconstructing-two-2025-council-on-therapeutics-policies/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-from-names-to-numbers-deconstructing-two-2025-council-on-therapeutics-policies/#comments</comments>        <pubDate>Tue, 14 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0bbd7eba-e2c3-3b1d-b23d-2106db780e0e</guid>
                                    <description><![CDATA[<p>Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA’s proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA’s proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pmwigwxf9gbcc2f8/2_From_Names_to_Numbers_Deconstructing_Two_2025_Council_on_Therapeutics_Policies_mixdown8qkuv.mp3" length="40408240" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA’s proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1676</itunes:duration>
                <itunes:episode>1402</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)</title>
        <itunes:title>Clinical Conversations (C.E.): Pharmacogenomics: Implementation in Oncology and the Pharmacist's Role (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-pharmacogenomics-implementation-in-oncology-and-the-pharmacists-role-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-pharmacogenomics-implementation-in-oncology-and-the-pharmacists-role-ce/#comments</comments>        <pubDate>Sat, 11 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2c54d049-8850-3792-a91b-e5123529c202</guid>
                                    <description><![CDATA[<p>This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p3mrkt7fvps9yjdb/ASHPOfficial_-_Pharmacogenomics_Practice_Models_in_Oncology_-_Mix_1_b75vr.mp3" length="92477856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3853</itunes:duration>
                <itunes:episode>1396</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: ASHP Best Practice Award 2024: Automation of Payor-Driven Product Selection in the Electronic Health Record: Optimizing Utilization of Biosimilars, Iron, and 505(b)(2) Products</title>
        <itunes:title>Research in Pharmacy: ASHP Best Practice Award 2024: Automation of Payor-Driven Product Selection in the Electronic Health Record: Optimizing Utilization of Biosimilars, Iron, and 505(b)(2) Products</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2024-automation-of-payor-drivenproduct-selection-intheelectronichealth-recordoptimizing-utilization-of-bio/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2024-automation-of-payor-drivenproduct-selection-intheelectronichealth-recordoptimizing-utilization-of-bio/#comments</comments>        <pubDate>Thu, 09 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9ac07444-a80b-31fe-9104-1c506af56294</guid>
                                    <description><![CDATA[<p>In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission.  They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of  EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2)  products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission.  They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of  EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2)  products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e5mhvkc4rtnkq589/ASHP_Best_Practice_Award_OSU_mixdown7nej2.mp3" length="25292673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission.  They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of  EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2)  products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1046</itunes:duration>
                <itunes:episode>1401</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Angela Cassano, PharmD, BCPS, FASHP, William Hammonds, PharmD, MS, BCPS, and Carrington Huneycutt, PharmD, BCACP</title>
        <itunes:title>Live With ASHP (Midyear Speaker Series): ASHP Midyear Speaker Series 2025: Angela Cassano, PharmD, BCPS, FASHP, William Hammonds, PharmD, MS, BCPS, and Carrington Huneycutt, PharmD, BCACP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashpmidyear-speaker-seriesashpmidyear-speaker-series-2025angela-cassanopharmd-bcpsfashpwilliamhammondspharmd-msbcps-and-carrington-huneycutt-p/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashpmidyear-speaker-seriesashpmidyear-speaker-series-2025angela-cassanopharmd-bcpsfashpwilliamhammondspharmd-msbcps-and-carrington-huneycutt-p/#comments</comments>        <pubDate>Tue, 07 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e600078f-a0b5-38ed-bfeb-5e427cf7fb4b</guid>
                                    <description><![CDATA[<p>ASHP’s education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kashsdg9iytvzriy/ASHP_Midyear_Speaker_Series_2025_Angela_Cassano_PharmD_BCPS_FASHP_William_Hammonds_PharmD_MS_BCPS_and_Carrington_Huneycutt_PharmD_BCACP_mixdown_1_942mh.mp3" length="11132009" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>456</itunes:duration>
                <itunes:episode>1400</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Recorded Pharmacist Series: Toxidromes</title>
        <itunes:title>Clinical Conversations (CE): Recorded Pharmacist Series: Toxidromes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-toxidromes/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-toxidromes/#comments</comments>        <pubDate>Sat, 04 Oct 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c296ee17-7868-3d2b-89dd-b1470dc7e4e0</guid>
                                    <description><![CDATA[<p>Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9jmpw4z47j98w6zk/Repurposed_Toxidromes_mixdown.mp3" length="62519938" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2597</itunes:duration>
                <itunes:episode>1399</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Beyond-Use-Dating Basics in Sterile Compounding</title>
        <itunes:title>Technician Insights: Beyond-Use-Dating Basics in Sterile Compounding</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-beyond-use-dating-basics-in-sterile-compounding/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-beyond-use-dating-basics-in-sterile-compounding/#comments</comments>        <pubDate>Tue, 30 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/83c0b706-207f-3f29-bf54-9dcef6a36c23</guid>
                                    <description><![CDATA[<p>In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer’s expiration date? We’ll break it down, explore key insights from USP &lt;797&gt;, and highlight what every sterile compounder needs to know. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer’s expiration date? We’ll break it down, explore key insights from USP &lt;797&gt;, and highlight what every sterile compounder needs to know. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hrvztvinnv6ydvuf/ASHP_Technician_Insights_-_Beyond-Use-Dating_Basics_in_Sterile_Compounding_-_Mix_1_7t4v5.mp3" length="61287406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer’s expiration date? We’ll break it down, explore key insights from USP &lt;797&gt;, and highlight what every sterile compounder needs to know. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2553</itunes:duration>
                <itunes:episode>1398</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Charrai Byrd, PharmD, MBA</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Charrai Byrd, PharmD, MBA</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-charrai-byrd-pharmd-mba/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-charrai-byrd-pharmd-mba/#comments</comments>        <pubDate>Mon, 29 Sep 2025 11:09:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/00751f23-5743-330e-890d-8a735b8789d3</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h357keqr6qhqjm65/We_re_Your_Pharmacist_Charrai_Byrd_Mixdown_092620252cf4d9autosavetscproj8bz16.mp3" length="44969356" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                <itunes:episode>1397</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Fulbright Scholar, PharmD: Exploring Global Opportunities for Pharmacists</title>
        <itunes:title>Practice Journeys: Fulbright Scholar, PharmD: Exploring Global Opportunities for Pharmacists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-fulbright-scholar-pharmd-exploring-global-opportunities-for-pharmacists/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-fulbright-scholar-pharmd-exploring-global-opportunities-for-pharmacists/#comments</comments>        <pubDate>Mon, 29 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dfbca0fd-adb0-3f21-85cb-14bb615639f6</guid>
                                    <description><![CDATA[<p>This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/knbzdfdx59t6tzhk/ASHPOfficial_-_Idea_1_Fullbright_Scholar_PharmD_-_Mix9rkrl.mp3" length="23726780" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>988</itunes:duration>
                <itunes:episode>1387</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2025: James Hoffman, PharmD, MS, FASHP, and Joe DiPiro, PharmD</title>
        <itunes:title>ASHP Midyear Speaker Series 2025: James Hoffman, PharmD, MS, FASHP, and Joe DiPiro, PharmD</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-james-hoffman-pharmd-ms-fashp-and-joe-dipiro-pharmd/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-james-hoffman-pharmd-ms-fashp-and-joe-dipiro-pharmd/#comments</comments>        <pubDate>Thu, 25 Sep 2025 15:59:14 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c7695813-9e0f-3d68-bab8-6a7713c904bb</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7ed2gg6cjcrjckup/ASHP_Midyear_Speaker_Series_2025_James_Hoffman_PharmD_MS_FASHP_and_Joe_DiPiro_PharmD_mixdown67lvu.mp3" length="10417805" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>426</itunes:duration>
                <itunes:episode>1395</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: Results of the Health-System Specialty Pharmacy Work-from-Home Survey: Part 2</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: Results of the Health-System Specialty Pharmacy Work-from-Home Survey: Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/results-of-the-health-system-specialty-pharmacy-work-from-home-survey-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/results-of-the-health-system-specialty-pharmacy-work-from-home-survey-part-2/#comments</comments>        <pubDate>Wed, 24 Sep 2025 15:33:16 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e364a69d-4508-30f8-b799-8dad54c4e38c</guid>
                                    <description><![CDATA[<p>This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/s5cprhg7gwuefp75/Health-System_Specialty_Pharmacy_Work-From-Home_Survey_Results_Part_2_mixdown87jeq.mp3" length="32009021" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1326</itunes:duration>
                <itunes:episode>1394</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy Practice: Over-the-Counter Product Updates</title>
        <itunes:title>Hot Topics in Pharmacy Practice: Over-the-Counter Product Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-over-the-counter-product-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-over-the-counter-product-updates/#comments</comments>        <pubDate>Tue, 23 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/47b0aff4-3ca5-30a0-86f5-99b4cbeae31a</guid>
                                    <description><![CDATA[<p>This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sv94ripbb5gpxdjg/Over-the-Counter_Product_Updates_mixdownbhawg.mp3" length="22850616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>944</itunes:duration>
                <itunes:episode>1392</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2025: Tyler Vest, PharmD, MS, MSSCM, BCPS, BCSCP, FNCAP</title>
        <itunes:title>ASHP Midyear Speaker Series 2025: Tyler Vest, PharmD, MS, MSSCM, BCPS, BCSCP, FNCAP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-tyler-vest-pharmd-ms-msscm-bcps-bcscp-fncap/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-tyler-vest-pharmd-ms-msscm-bcps-bcscp-fncap/#comments</comments>        <pubDate>Tue, 23 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8e976bdd-c8cd-3bbb-89d7-ef9f3c257dd0</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yttx53ejd78wy6ve/ASHP_Midyear_Speaker_Series_2025_Tyler_Vest_PharmD_MS_MSSCM_BCPS_BCSCP_FNCAP_mixdown96nug.mp3" length="14453648" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>595</itunes:duration>
                <itunes:episode>1391</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Innovations in Medication Access and Marketplace Disruptors</title>
        <itunes:title>Pharmacy Leadership: Innovations in Medication Access and Marketplace Disruptors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-innovations-in-medication-access-and-marketplace-disruptors/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-innovations-in-medication-access-and-marketplace-disruptors/#comments</comments>        <pubDate>Mon, 22 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dfcd8d16-1fd4-3724-b14e-337dd1fe5cbf</guid>
                                    <description><![CDATA[<p>In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uect8m5a4fi33tsq/ASHPOfficial_-_Innovations_in_Medication_Access_and_Marketplace_Disruptors_MIX603zu.mp3" length="38927756" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>973</itunes:duration>
                <itunes:episode>1393</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2025: Mitchell Buckley, PharmD, BCCCP, BCPS, FASHP, FCCM, FCCP</title>
        <itunes:title>ASHP Midyear Speaker Series 2025: Mitchell Buckley, PharmD, BCCCP, BCPS, FASHP, FCCM, FCCP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-mitchell-buckley-pharmd-bcccp-bcps-fashp-fccm-fccp/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-mitchell-buckley-pharmd-bcccp-bcps-fashp-fccm-fccp/#comments</comments>        <pubDate>Wed, 17 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b9dbe2a1-c411-3ea5-a88b-ab0e7a983440</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8hg9spw63tc9j72x/_ASHP_Midyear_Speaker_Series_2025_Mitchell_Buckley_PharmD_BCCCP_BCPS_FASHP_FCCM_FCCP_mixdownbvvhq.mp3" length="14626905" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                <itunes:episode>1390</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: From Strategy to Execution for Agile Organizations</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: From Strategy to Execution for Agile Organizations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-from-strategy-to-execution-for-agile-organizations/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-from-strategy-to-execution-for-agile-organizations/#comments</comments>        <pubDate>Thu, 11 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b4727a7b-f124-3d62-a869-d8238ce74e61</guid>
                                    <description><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mmytwpymvfncerpa/_508-L04_From_Strategy_to_Execution_for_Agile_Organizations_mixdown95ncf.mp3" length="12053884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>495</itunes:duration>
                <itunes:episode>1388</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: Optimizing the Care of Patients with Diabetes: A Conversation with Pharmacist Researchers</title>
        <itunes:title>Research in Pharmacy: Optimizing the Care of Patients with Diabetes: A Conversation with Pharmacist Researchers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-optimizing-the-care-of-patients-with-diabetes-a-conversation-with-pharmacist-researchers/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-optimizing-the-care-of-patients-with-diabetes-a-conversation-with-pharmacist-researchers/#comments</comments>        <pubDate>Wed, 10 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1e1900da-f87d-34bf-89bc-6acc9e80c51f</guid>
                                    <description><![CDATA[<p>Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bmn3suhs3hutuzxr/Optimizing_the_Care_of_Patients_with_Diabetes_A_Conversation_with_Pharmacist_Researchers_mixdownajv14.mp3" length="34611620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1435</itunes:duration>
                <itunes:episode>1386</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resiliency in Practice: Thriving Through Change: Conversations on Mental Health and Suicide Prevention</title>
        <itunes:title>Wellbeing and Resiliency in Practice: Thriving Through Change: Conversations on Mental Health and Suicide Prevention</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-thriving-through-change-conversations-on-mental-health-and-suicide-prevention/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-thriving-through-change-conversations-on-mental-health-and-suicide-prevention/#comments</comments>        <pubDate>Tue, 09 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5f1c83dd-6ed3-3d72-83a5-54c9e309ef7e</guid>
                                    <description><![CDATA[<p>The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zae8ar6vwq35b58i/ASHPOfficial_-_Thriving_Through_Change_Conversations_on_Mental_Health_-_Mixa31kr.mp3" length="69001604" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2875</itunes:duration>
                <itunes:episode>1389</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: Embracing Innovation in Patient Care Services ꟷ Demonstrating Value Using Digital Tools, AI, and Integrated Technologies</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: Embracing Innovation in Patient Care Services ꟷ Demonstrating Value Using Digital Tools, AI, and Integrated Technologies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashpconferenceforpharmacy-leaders-speakerseries-embracing-innovation-in-patientcareservices-%ea%9f%b7demonstratingvalueusing-digitaltoolsaiandinteg/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashpconferenceforpharmacy-leaders-speakerseries-embracing-innovation-in-patientcareservices-%ea%9f%b7demonstratingvalueusing-digitaltoolsaiandinteg/#comments</comments>        <pubDate>Fri, 05 Sep 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5d566385-359e-360b-bed1-61098d25a26c</guid>
                                    <description><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Kathryn Brown, senior vice president and chief operating officer for national pharmacy at Kaiser Permanente and Elizabeth Rebo, executive director of medication safety at Kaiser Permanente, as they discuss their upcoming sessions Embracing Innovation in Patient Care Services: Demonstrating Value Using Digital Tools, AI, and Integrated Technologies &amp; Change Management in a Season with Generative AI. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Kathryn Brown, senior vice president and chief operating officer for national pharmacy at Kaiser Permanente and Elizabeth Rebo, executive director of medication safety at Kaiser Permanente, as they discuss their upcoming sessions Embracing Innovation in Patient Care Services: Demonstrating Value Using Digital Tools, AI, and Integrated Technologies &amp; Change Management in a Season with Generative AI. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yhmr5xmmzuhezbb7/Change_Management_in_a_Season_with_Generative_AI_mixdown7m2sy.mp3" length="14045950" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Kathryn Brown, senior vice president and chief operating officer for national pharmacy at Kaiser Permanente and Elizabeth Rebo, executive director of medication safety at Kaiser Permanente, as they discuss their upcoming sessions Embracing Innovation in Patient Care Services: Demonstrating Value Using Digital Tools, AI, and Integrated Technologies &amp; Change Management in a Season with Generative AI. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>578</itunes:duration>
                <itunes:episode>1384</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Success Through Mentorship: Exploring ASHP’s Guided Mentorship Program</title>
        <itunes:title>Practice Journeys: Success Through Mentorship: Exploring ASHP’s Guided Mentorship Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-success-through-mentorship-exploring-ashp-s-guided-mentorship-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-success-through-mentorship-exploring-ashp-s-guided-mentorship-program/#comments</comments>        <pubDate>Wed, 03 Sep 2025 18:37:17 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6ba43c76-736b-3570-98a6-91fa36ec5de8</guid>
                                    <description><![CDATA[<p>In this episode Kim Benner and Lauren Ashton discuss their experiences in the ASHP Guided Mentorship Program. They share how mentorship has shaped their professional growth, how the success of a Student Society of Health-System Pharmacy initiative implemented at Lauren’s school, and offer valuable advice for future mentor-mentee pairs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode Kim Benner and Lauren Ashton discuss their experiences in the ASHP Guided Mentorship Program. They share how mentorship has shaped their professional growth, how the success of a Student Society of Health-System Pharmacy initiative implemented at Lauren’s school, and offer valuable advice for future mentor-mentee pairs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cb5jxfaymv9p5ear/Success_Through_Mentorship_Exploring_ASHP_s_Guided_Mentorship_Program_mixdown6phnx.mp3" length="25571679" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode Kim Benner and Lauren Ashton discuss their experiences in the ASHP Guided Mentorship Program. They share how mentorship has shaped their professional growth, how the success of a Student Society of Health-System Pharmacy initiative implemented at Lauren’s school, and offer valuable advice for future mentor-mentee pairs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                <itunes:episode>1385</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: MOUD on the Move: The Hospital Pharmacist's Role in the Opioid Use Disorder Continuum of Care</title>
        <itunes:title>Clinical Conversations: MOUD on the Move: The Hospital Pharmacist's Role in the Opioid Use Disorder Continuum of Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-moud-on-the-move-the-hospital-pharmacists-role-in-the-opioid-use-disorder-continuum-of-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-moud-on-the-move-the-hospital-pharmacists-role-in-the-opioid-use-disorder-continuum-of-care/#comments</comments>        <pubDate>Wed, 03 Sep 2025 14:49:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/68f8f1cb-1551-31d4-bd70-5e862a0703ed</guid>
                                    <description><![CDATA[<p>Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/y85xjjhk485nkxhy/ASHPOfficial_-_MOUD_On_the_Move_-_Mix8z81c.mp3" length="42846698" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1785</itunes:duration>
                <itunes:episode>1383</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): From Dream to Reality: Process of Build Completion and Validation</title>
        <itunes:title>Informatics Bytes (CE): From Dream to Reality: Process of Build Completion and Validation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-from-dream-to-reality-process-of-build-completion-and-validation/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-from-dream-to-reality-process-of-build-completion-and-validation/#comments</comments>        <pubDate>Sat, 30 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/626f3c47-687c-3e76-b96c-155194ccf414</guid>
                                    <description><![CDATA[<p>This is the final episode in a three-part series unveiling how pharmacy technology change requests are taken from idea to implementation. This podcast discusses the next steps required for build validation, testing, implementation, and post-implementation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This is the final episode in a three-part series unveiling how pharmacy technology change requests are taken from idea to implementation. This podcast discusses the next steps required for build validation, testing, implementation, and post-implementation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7guvbs5vjzfiy6d9/ASHPOfficial_From_Dream_to_Reality_Process_of_Build_Completion_and_Validation_mix9rcgk.mp3" length="48329177" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This is the final episode in a three-part series unveiling how pharmacy technology change requests are taken from idea to implementation. This podcast discusses the next steps required for build validation, testing, implementation, and post-implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3020</itunes:duration>
                <itunes:episode>1375</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Joseph Marchiano, PharmD, BCGP, BCPS</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Joseph Marchiano, PharmD, BCGP, BCPS</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-joseph-marchiano-pharmd-bcgp-bcps/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-joseph-marchiano-pharmd-bcgp-bcps/#comments</comments>        <pubDate>Fri, 29 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/37171b14-d882-35a6-ae1f-a897fb6247d4</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w6h4i5kh3t7n3h7a/We_re_Your_Pharmacist_with_Joseph_Marchiano_Mixdown_08202025blt7q.mp3" length="21235316" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>663</itunes:duration>
                <itunes:episode>1380</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy Practice: The Future of Clinical Pharmacy Part 2</title>
        <itunes:title>Hot Topics in Pharmacy Practice: The Future of Clinical Pharmacy Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-the-future-of-clinical-pharmacy-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-practice-the-future-of-clinical-pharmacy-part-2/#comments</comments>        <pubDate>Wed, 27 Aug 2025 12:41:05 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b497bc7a-345d-38f7-93fd-bbc4411eab57</guid>
                                    <description><![CDATA[<p class="xmsonormal">In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. In part two of this series, we will explore what are the implications behind the numbers and what health systems can do to support the clinical pharmacists of tomorrow.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. In part two of this series, we will explore what are the implications behind the numbers and what health systems can do to support the clinical pharmacists of tomorrow.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2hazyg9b4mhdsevi/The_Future_of_Clinical_Pharmacy_Part_2_mixdown7qt9m.mp3" length="41691024" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. In part two of this series, we will explore what are the implications behind the numbers and what health systems can do to support the clinical pharmacists of tomorrow.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1730</itunes:duration>
                <itunes:episode>1382</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Building Trust for Safer Care: Pharmacists’ Role in Addressing Medication Misconceptions</title>
        <itunes:title>Hot Topics in Pharmacy: Building Trust for Safer Care: Pharmacists’ Role in Addressing Medication Misconceptions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-building-trust-for-safer-care-pharmacists-role-in-addressing-medication-misconceptions/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-building-trust-for-safer-care-pharmacists-role-in-addressing-medication-misconceptions/#comments</comments>        <pubDate>Wed, 27 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/edfa1a5e-c7d1-31de-bdf3-153c7044f2e9</guid>
                                    <description><![CDATA[<p>This podcast explores the vital role pharmacists play in addressing misinformation about medications. The discussion covers common sources of misconceptions, strategies for engaging patients in respectful, non-confrontational conversations, and challenges pharmacists face during these conversations. Listeners can learn practical insights on effective communication, the impact of misinformation on patient outcomes, and how health systems can better support pharmacists in promoting accurate, evidence-based medication information. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the vital role pharmacists play in addressing misinformation about medications. The discussion covers common sources of misconceptions, strategies for engaging patients in respectful, non-confrontational conversations, and challenges pharmacists face during these conversations. Listeners can learn practical insights on effective communication, the impact of misinformation on patient outcomes, and how health systems can better support pharmacists in promoting accurate, evidence-based medication information. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9njg2t944bibv6wx/ASHPOfficial_Building_Trust_for_Safer_Care_Pharmacists_Role_in_Addressing_Medication_Misconceptions_FULL_AUDIO_mix_1_9g43e.mp3" length="26156912" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the vital role pharmacists play in addressing misinformation about medications. The discussion covers common sources of misconceptions, strategies for engaging patients in respectful, non-confrontational conversations, and challenges pharmacists face during these conversations. Listeners can learn practical insights on effective communication, the impact of misinformation on patient outcomes, and how health systems can better support pharmacists in promoting accurate, evidence-based medication information. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1089</itunes:duration>
                <itunes:episode>1330</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: Tackling the Revenue Cycle Challenge- Processes, Politics, Payers, and Patients</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: Tackling the Revenue Cycle Challenge- Processes, Politics, Payers, and Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-tackling-the-revenue-cycle-challenge-processes-politics-payers-and-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-tackling-the-revenue-cycle-challenge-processes-politics-payers-and-patients/#comments</comments>        <pubDate>Mon, 25 Aug 2025 11:58:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3c35f83a-fd70-393e-a23c-6d21fc6f5758</guid>
                                    <description><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Venessa Goodnow, assistant vice president and chief pharmacy officer at Jackson Health System, as she discusses her upcoming sessions, Tackling the Revenue Cycle Challenge: Processes, Politics, Payers, and Patients. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Venessa Goodnow, assistant vice president and chief pharmacy officer at Jackson Health System, as she discusses her upcoming sessions, Tackling the Revenue Cycle Challenge: Processes, Politics, Payers, and Patients. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3rw6k3tm922h4rub/ASHP_Conference_for_Pharmacy_Leaders_Speaker_Series_Tackling_the_Revenue_Cycle_Challenge_Processes_Politics_Payers_and_Patients_mixdown7sl4h.mp3" length="11941602" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Venessa Goodnow, assistant vice president and chief pharmacy officer at Jackson Health System, as she discusses her upcoming sessions, Tackling the Revenue Cycle Challenge: Processes, Politics, Payers, and Patients. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>490</itunes:duration>
                <itunes:episode>1381</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Pharmacy Technology Build Structure: Governance and Processes Management</title>
        <itunes:title>Informatics Bytes (CE): Pharmacy Technology Build Structure: Governance and Processes Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-pharmacy-technology-build-structure-governance-and-build-processes-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-pharmacy-technology-build-structure-governance-and-build-processes-management/#comments</comments>        <pubDate>Sun, 24 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f60caf39-76f1-32aa-b8a9-9e9dd2757e0a</guid>
                                    <description><![CDATA[<p>This podcast reviews system governance and other approval steps prior to the technology team begins building the request. Panelists discuss prioritization considerations and methods to incorporate system standardization into the original requests.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast reviews system governance and other approval steps prior to the technology team begins building the request. Panelists discuss prioritization considerations and methods to incorporate system standardization into the original requests.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rpm8xtajiwes9k9h/ASHPOfficial_Pharmacy_Technology_Build_Structure_Governance_and_Build_Processes_Management_mixa6w42.mp3" length="29032085" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast reviews system governance and other approval steps prior to the technology team begins building the request. Panelists discuss prioritization considerations and methods to incorporate system standardization into the original requests.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1814</itunes:duration>
                <itunes:episode>1367</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Acute Coronary Syndrome</title>
        <itunes:title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Acute Coronary Syndrome</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-acute-coronary-syndrome/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-acute-coronary-syndrome/#comments</comments>        <pubDate>Sat, 23 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/687e5788-68f7-3347-912c-565fe6e7cc70</guid>
                                    <description><![CDATA[<p>Heart disease related costs in the United States amounted to nearly $239 billion between 2018 and 2019, and heart disease contributed to nearly 700,000 deaths. This activity will review the pathophysiology and clinical presentation of acute coronary syndromes and categorize the guideline-recommended pharmacologic management strategies for the treatment of unstable angina and acute myocardial infarction. These summaries will be supported by a review of the evidence that played a role in the development of these recommendations. CE for this episode expires two years after its original publication date.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Heart disease related costs in the United States amounted to nearly $239 billion between 2018 and 2019, and heart disease contributed to nearly 700,000 deaths. This activity will review the pathophysiology and clinical presentation of acute coronary syndromes and categorize the guideline-recommended pharmacologic management strategies for the treatment of unstable angina and acute myocardial infarction. These summaries will be supported by a review of the evidence that played a role in the development of these recommendations. CE for this episode expires two years after its original publication date.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rx2k2sgdmbk9kwpz/Recorded_Pharmacist_Series_Acute_Coronary_Syndrome_mixdown6d37x.mp3" length="52280380" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Heart disease related costs in the United States amounted to nearly $239 billion between 2018 and 2019, and heart disease contributed to nearly 700,000 deaths. This activity will review the pathophysiology and clinical presentation of acute coronary syndromes and categorize the guideline-recommended pharmacologic management strategies for the treatment of unstable angina and acute myocardial infarction. These summaries will be supported by a review of the evidence that played a role in the development of these recommendations. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2171</itunes:duration>
                <itunes:episode>1379</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: Two Roles, One Mission: The Dual Impact of Pharmacy Technicians and Community Health Workers</title>
        <itunes:title>Technician Insights: Two Roles, One Mission: The Dual Impact of Pharmacy Technicians and Community Health Workers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-two-roles-one-mission-the-dual-impact-of-pharmacy-technicians-and-community-health-workers/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-two-roles-one-mission-the-dual-impact-of-pharmacy-technicians-and-community-health-workers/#comments</comments>        <pubDate>Thu, 21 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a660258-674e-3c70-bbda-b83e981fa8ed</guid>
                                    <description><![CDATA[<p>This podcast highlights how pharmacy technicians incorporate community health worker roles into their practice - breaking barriers, expanding access, and improving patient outcomes. Join us as we dive into real-world stories, innovative models, and the future potential of this dynamic, dual-impact workforce. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast highlights how pharmacy technicians incorporate community health worker roles into their practice - breaking barriers, expanding access, and improving patient outcomes. Join us as we dive into real-world stories, innovative models, and the future potential of this dynamic, dual-impact workforce. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/77y5znhd6g3sub4e/Two_Roles_One_Mission_The_Dual_Impact_of_Pharmacy_Technicians_and_Community_Health_Workers_mixdown8vfeb.mp3" length="28081440" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast highlights how pharmacy technicians incorporate community health worker roles into their practice - breaking barriers, expanding access, and improving patient outcomes. Join us as we dive into real-world stories, innovative models, and the future potential of this dynamic, dual-impact workforce. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1163</itunes:duration>
                <itunes:episode>1378</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Informatics Bytes: The Ethics of Intelligence</title>
        <itunes:title>Informatics Bytes: The Ethics of Intelligence</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-the-ethics-of-intelligence/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-the-ethics-of-intelligence/#comments</comments>        <pubDate>Tue, 19 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9fc2028c-7159-3e0f-b8dd-5ba4f91ecbbd</guid>
                                    <description><![CDATA[<p>Artificial intelligence (AI) is a prominent topic across all healthcare professions. As we continue to explore its potential to enhance patient care, it is imperative to remain vigilant about the ethical and moral challenges this technology may present. Join our expert panel as they discuss the integration of ethical decision-making in the adoption of AI at a large academic medical center. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Artificial intelligence (AI) is a prominent topic across all healthcare professions. As we continue to explore its potential to enhance patient care, it is imperative to remain vigilant about the ethical and moral challenges this technology may present. Join our expert panel as they discuss the integration of ethical decision-making in the adoption of AI at a large academic medical center. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kbpbp8z7drka3cp7/ASHPOfficial_-_The_Ethics_of_Intelligence_AI_Ethics_Part_2_MIXa7kwo.mp3" length="82651520" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Artificial intelligence (AI) is a prominent topic across all healthcare professions. As we continue to explore its potential to enhance patient care, it is imperative to remain vigilant about the ethical and moral challenges this technology may present. Join our expert panel as they discuss the integration of ethical decision-making in the adoption of AI at a large academic medical center. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2066</itunes:duration>
                <itunes:episode>1377</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Unpacking the CY 2026 CMS Proposed Rules: PFS and OPPS Highlights</title>
        <itunes:title>Advocating for Impact: Unpacking the CY 2026 CMS Proposed Rules: PFS and OPPS Highlights</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-unpacking-the-cy-2026-cms-proposed-rules-pfs-and-opps-highlights/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-unpacking-the-cy-2026-cms-proposed-rules-pfs-and-opps-highlights/#comments</comments>        <pubDate>Tue, 19 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/78ebc2ff-dffd-38da-b714-e24c0b7b1599</guid>
                                    <description><![CDATA[<p>In this episode of Unpacking the CY 2026 Proposed Rules: PFS and OPPS Highlights, we break down key changes outlined by CMS in the 2026 Physician Fee Schedule and Outpatient Prospective Payment System proposed rules. We will offer insights on payment updates, policy shifts, and what these changes could mean for our members and their patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of <em>Unpacking the CY 2026 Proposed Rules: PFS and OPPS Highlights</em>, we break down key changes outlined by CMS in the 2026 Physician Fee Schedule and Outpatient Prospective Payment System proposed rules. We will offer insights on payment updates, policy shifts, and what these changes could mean for our members and their patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ibew78ddh6n2dpxt/Unpacking_the_CY_2026_CMS_Proposed_Rules_PFS_and_OPPS_Highlights_mixdownbbfw8.mp3" length="31820806" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Unpacking the CY 2026 Proposed Rules: PFS and OPPS Highlights, we break down key changes outlined by CMS in the 2026 Physician Fee Schedule and Outpatient Prospective Payment System proposed rules. We will offer insights on payment updates, policy shifts, and what these changes could mean for our members and their patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
 ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1318</itunes:duration>
                <itunes:episode>1374</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2025: Angela Goodhart, PharmD, BCACP, CTTS</title>
        <itunes:title>ASHP Midyear Speaker Series 2025: Angela Goodhart, PharmD, BCACP, CTTS</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-angela-goodhart-pharmd-bcacp-ctts/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-angela-goodhart-pharmd-bcacp-ctts/#comments</comments>        <pubDate>Mon, 18 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8b220ab0-e62f-36be-97b6-5f42283909de</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6t4vyhutea5azh6r/There_s_a_Lot_on_the_Table_Playing_Your_Best_Hand_for_Residency_Interviews_From_Memes_to_Meaningful_Feedback_Precepting_Gen_Z_mixdown7soqd.mp3" length="12244939" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>503</itunes:duration>
                <itunes:episode>1371</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: National trends in prescription drug expenditures and projections for 2025</title>
        <itunes:title>AJHP Voices: National trends in prescription drug expenditures and projections for 2025</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-national-trends-in-prescription-drug-expenditures-and-projections-for-2025/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-national-trends-in-prescription-drug-expenditures-and-projections-for-2025/#comments</comments>        <pubDate>Fri, 15 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/85cb7f80-4cf5-30fd-af99-a4fa27981ea1</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Eric Tichy and Dr. Matthew Rim discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2025” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Eric Tichy and Dr. Matthew Rim discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2025” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i2u4mgg79hpr3j87/Drug_Expenditures_2025_edited_br98w.mp3" length="62392466" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Eric Tichy and Dr. Matthew Rim discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2025” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1949</itunes:duration>
                <itunes:episode>1373</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Data Analytics Careers for Pharmacy Professionals</title>
        <itunes:title>Informatics Bytes: Data Analytics Careers for Pharmacy Professionals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-data-analytics-careers-for-pharmacy-professionals/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-data-analytics-careers-for-pharmacy-professionals/#comments</comments>        <pubDate>Thu, 14 Aug 2025 11:51:07 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/88dffa71-66c9-3596-990a-11f6441cbef1</guid>
                                    <description><![CDATA[<p>This podcast provides an overview of the growing field of data analytics. Panelists discuss their career paths in data analytics roles as well as transferrable skills and training and education they've received that have led successful careers in data analytics. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an overview of the growing field of data analytics. Panelists discuss their career paths in data analytics roles as well as transferrable skills and training and education they've received that have led successful careers in data analytics. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ftwtv5twb3z5h7iy/Data_Analytics_Careers_for_Pharmacy_Professionals_mixdownbdw6h.mp3" length="47943918" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an overview of the growing field of data analytics. Panelists discuss their career paths in data analytics roles as well as transferrable skills and training and education they've received that have led successful careers in data analytics. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1990</itunes:duration>
                <itunes:episode>1376</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Future of Clinical Pharmacy Part 1</title>
        <itunes:title>Hot Topics in Pharmacy: The Future of Clinical Pharmacy Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-future-of-clinical-pharmacy-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-future-of-clinical-pharmacy-part-1/#comments</comments>        <pubDate>Wed, 13 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/eb8142be-8738-3c19-bbfc-0d48493506fb</guid>
                                    <description><![CDATA[<p>Why is enrollment in residency programs dropping? And what does this decline mean for clinical pharmacists? In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Why is enrollment in residency programs dropping? And what does this decline mean for clinical pharmacists? In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/drucytzuv7xp2ay9/The_Future_of_Clinical_Pharmacy_Part_1_mixdown6uhsp.mp3" length="59122476" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Why is enrollment in residency programs dropping? And what does this decline mean for clinical pharmacists? In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2456</itunes:duration>
                <itunes:episode>1372</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Why Be a Mentor to Junior Faculty</title>
        <itunes:title>Educator Essentials: Why Be a Mentor to Junior Faculty</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-why-be-a-mentor-to-junior-faculty/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-why-be-a-mentor-to-junior-faculty/#comments</comments>        <pubDate>Tue, 12 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1c4735b2-4ea7-3789-b9cd-01f773000cd3</guid>
                                    <description><![CDATA[<p>This podcast discusses the importance of serving as a mentor to junior faculty. Two faculty mentors review motivations for becoming a mentor and the benefits and challenges of mentorship.</p>
<p> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast discusses the importance of serving as a mentor to junior faculty. Two faculty mentors review motivations for becoming a mentor and the benefits and challenges of mentorship.</p>
<p> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/45xd4xmx5h9qs7tt/Why_Be_a_Mentor_to_Junior_Faculty_mixdown6o4jo.mp3" length="52834106" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast discusses the importance of serving as a mentor to junior faculty. Two faculty mentors review motivations for becoming a mentor and the benefits and challenges of mentorship.
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2194</itunes:duration>
                <itunes:episode>1370</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live With ASHP (Leaders Podcast Series): ASHP Conference for Pharmacy Leaders Speaker Series: Innovative Leadership Strategies for the Entrepreneurial-Minded Leader</title>
        <itunes:title>Live With ASHP (Leaders Podcast Series): ASHP Conference for Pharmacy Leaders Speaker Series: Innovative Leadership Strategies for the Entrepreneurial-Minded Leader</itunes:title>
        <link>https://ashpofficial.podbean.com/e/livewithashpleaders-podcast-seriesashpconference-forpharmacyleaders-speakerseries-innovativeleadershipstrategies-fortheentrepreneurialminded-leader/</link>
                    <comments>https://ashpofficial.podbean.com/e/livewithashpleaders-podcast-seriesashpconference-forpharmacyleaders-speakerseries-innovativeleadershipstrategies-fortheentrepreneurialminded-leader/#comments</comments>        <pubDate>Mon, 11 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d1604155-8f50-33f1-9bdc-e8e0011f386e</guid>
                                    <description><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Joshua Hammonds, PhD, chair &amp; professor of communication at Rollins College as he discusses his upcoming session Innovative Leadership Strategies for the Entrepreneurial-Minded Leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Joshua Hammonds, PhD, chair &amp; professor of communication at Rollins College as he discusses his upcoming session Innovative Leadership Strategies for the Entrepreneurial-Minded Leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9rbhviprkzwixgy7/Innovative_Leadership_Strategies_for_the_Entrepreneurial-Minded_Leader_mixdown8tbpu.mp3" length="8485232" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Joshua Hammonds, PhD, chair &amp; professor of communication at Rollins College as he discusses his upcoming session Innovative Leadership Strategies for the Entrepreneurial-Minded Leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>346</itunes:duration>
                <itunes:episode>1366</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2025: John Armitstead, MS, RPh, FASHP, CPEL, Jeffrey Reichard, PharmD, MS, CPEL, FNCAP, and Amy Gutierrez, PharmD, CPEL</title>
        <itunes:title>ASHP Midyear Speaker Series 2025: John Armitstead, MS, RPh, FASHP, CPEL, Jeffrey Reichard, PharmD, MS, CPEL, FNCAP, and Amy Gutierrez, PharmD, CPEL</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-john-armitstead-ms-rph-fashp-cpel-jeffrey-reichard-pharmd-ms-cpel-fncap-and-amy-gutierrez-pharmd-cpel/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2025-john-armitstead-ms-rph-fashp-cpel-jeffrey-reichard-pharmd-ms-cpel-fncap-and-amy-gutierrez-pharmd-cpel/#comments</comments>        <pubDate>Thu, 07 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8b78f1a5-d6ac-3d30-9078-fadcc2ca0755</guid>
                                    <description><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zh53ria4cjmkpjra/Futurecasting_System-Level_Pharmacy_Key_Roles_of_Leaders_in_Driving_Value_mixdownbacsl.mp3" length="25073245" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1037</itunes:duration>
                <itunes:episode>1363</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting</title>
        <itunes:title>AJHP Voices: Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-implementing-standard-practices-in-the-safe-handling-of-gene-therapy-and-biohazardous-drugs-in-a-health-system-setting/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-implementing-standard-practices-in-the-safe-handling-of-gene-therapy-and-biohazardous-drugs-in-a-health-system-setting/#comments</comments>        <pubDate>Wed, 06 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/798347cb-bd17-35f5-8afa-90944be38c2d</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Zoe Ngo and Dr. Austin Wang discuss the AJHP Case Study "Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Zoe Ngo and Dr. Austin Wang discuss the AJHP Case Study "Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hw868d48cs4nmhpu/Safe_Handling_of_Gene_Therapy_Final7gvib.mp3" length="65596361" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Zoe Ngo and Dr. Austin Wang discuss the AJHP Case Study "Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2049</itunes:duration>
                <itunes:episode>1365</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Community Pharmacy: Utilizing Collaborative Practice Agreements to Facilitate Effective Care Transitions</title>
        <itunes:title>Community Pharmacy: Utilizing Collaborative Practice Agreements to Facilitate Effective Care Transitions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-utilizing-collaborative-practice-agreements-to-facilitate-effective-care-transitions/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-utilizing-collaborative-practice-agreements-to-facilitate-effective-care-transitions/#comments</comments>        <pubDate>Tue, 05 Aug 2025 15:20:22 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/793d716c-4288-3234-a70c-538d3e7c840d</guid>
                                    <description><![CDATA[<p>In this episode, community pharmacists share collaborative practice agreements that they use to improve access, ensure safety, and optimize patient care during transitions of care.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, community pharmacists share collaborative practice agreements that they use to improve access, ensure safety, and optimize patient care during transitions of care.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jr3y9y3pneeiwm6a/Utilizing_Collaborative_Practice_Agreements_mixdown6wzg7.mp3" length="21640566" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, community pharmacists share collaborative practice agreements that they use to improve access, ensure safety, and optimize patient care during transitions of care.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>894</itunes:duration>
                <itunes:episode>1369</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: Specialty Pharmacy Recruitment: Demonstrating Value and Best Practices for Quality Recruitment</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: Specialty Pharmacy Recruitment: Demonstrating Value and Best Practices for Quality Recruitment</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-specialty-pharmacy-recruitment-demonstrating-value-and-best-practices-for-quality-recruitment/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-specialty-pharmacy-recruitment-demonstrating-value-and-best-practices-for-quality-recruitment/#comments</comments>        <pubDate>Tue, 05 Aug 2025 15:15:08 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/587ecef1-58fa-3203-9d96-f4c60a4bbfad</guid>
                                    <description><![CDATA[<p>In recent years, pharmacy school enrollment and pursuit of pharmacy residency has declined nationally. This trend has impacted specialty pharmacy residencies in particular because pharmacy students tend to have less familiarity with specialty pharmacy as a practice setting. This podcast will target specific strategies to recruit highly successful candidates for careers in specialty pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In recent years, pharmacy school enrollment and pursuit of pharmacy residency has declined nationally. This trend has impacted specialty pharmacy residencies in particular because pharmacy students tend to have less familiarity with specialty pharmacy as a practice setting. This podcast will target specific strategies to recruit highly successful candidates for careers in specialty pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7xs7am3ww459f53g/ASHPOfficial_-_Specialty_Pharmacy_Recruitment_-_Demonstrating_Value_and_Best_Practices_for_Quality_Recruiting_-_Mix_1_bmrsy.mp3" length="54292482" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In recent years, pharmacy school enrollment and pursuit of pharmacy residency has declined nationally. This trend has impacted specialty pharmacy residencies in particular because pharmacy students tend to have less familiarity with specialty pharmacy as a practice setting. This podcast will target specific strategies to recruit highly successful candidates for careers in specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2262</itunes:duration>
                <itunes:episode>1368</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Mentorship Coffee Chat: Sip, Chat, and Level Up as a Junior Faculty</title>
        <itunes:title>Educator Essentials: Mentorship Coffee Chat: Sip, Chat, and Level Up as a Junior Faculty</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-mentorship-coffee-chat-sip-chat-and-level-up-as-a-junior-faculty/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-mentorship-coffee-chat-sip-chat-and-level-up-as-a-junior-faculty/#comments</comments>        <pubDate>Fri, 01 Aug 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1da8e404-457d-3e36-8add-5b659574fa14</guid>
                                    <description><![CDATA[<p>Navigating the world of pharmacy academia can be challenging. Having mentors assist with your career development and provide guidance is beneficial for junior faculty. This episode will discuss the benefits of having multiple mentors and how to find a mentor in academia.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Navigating the world of pharmacy academia can be challenging. Having mentors assist with your career development and provide guidance is beneficial for junior faculty. This episode will discuss the benefits of having multiple mentors and how to find a mentor in academia.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a8k52k7jnpxii547/ASHPOfficial_Mentorship_Coffee_Chat_Sip_Chat_and_Level_Up_as_a_Junior_Faculty_mix7vriw.mp3" length="34367183" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Navigating the world of pharmacy academia can be challenging. Having mentors assist with your career development and provide guidance is beneficial for junior faculty. This episode will discuss the benefits of having multiple mentors and how to find a mentor in academia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2147</itunes:duration>
                <itunes:episode>1364</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Navigating the End of Year Sprint: A Population Health Perspective</title>
        <itunes:title>Hot Topics in Pharmacy: Navigating the End of Year Sprint: A Population Health Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-navigating-the-end-of-year-sprint-a-population-health-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-navigating-the-end-of-year-sprint-a-population-health-perspective/#comments</comments>        <pubDate>Thu, 31 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c68ddb8e-34d9-393d-a91a-81a4546701ac</guid>
                                    <description><![CDATA[<p>Join us for a discussion from pharmacy and leadership perspectives about population health end of year efforts to meet quality measures.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a discussion from pharmacy and leadership perspectives about population health end of year efforts to meet quality measures.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/332skjbed8br9dfw/ASHPOfficial_-_Navigating_the_End_of_Year_Sprint_-_A_Population_Health_Perspective_-_Revisedb7zba.mp3" length="42574388" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a discussion from pharmacy and leadership perspectives about population health end of year efforts to meet quality measures.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1773</itunes:duration>
                <itunes:episode>1357</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: Unlocking Potential through Leadership Development</title>
        <itunes:title>Pharmacy Leadership: SPPL: Unlocking Potential through Leadership Development</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-unlocking-potential-through-leadership-development/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-unlocking-potential-through-leadership-development/#comments</comments>        <pubDate>Wed, 30 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/48fcc0e0-b3c7-397a-97e4-9eed983515e1</guid>
                                    <description><![CDATA[<p>This podcast explores the business of pharmacy, leadership growth, and career advancement, featuring expert interviews, practical strategies, and real-world experiences. Whether you're an established leader or preparing for your first leadership role, this podcast offers valuable guidance to support your professional journey.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the business of pharmacy, leadership growth, and career advancement, featuring expert interviews, practical strategies, and real-world experiences. Whether you're an established leader or preparing for your first leadership role, this podcast offers valuable guidance to support your professional journey.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/evzpwr9f9nbbcuus/Unlocking_Potential_through_Leadership_Development_mixdownbskp5.mp3" length="27398899" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the business of pharmacy, leadership growth, and career advancement, featuring expert interviews, practical strategies, and real-world experiences. Whether you're an established leader or preparing for your first leadership role, this podcast offers valuable guidance to support your professional journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1134</itunes:duration>
                <itunes:episode>1361</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Early-Career Faculty Life: Successfully Navigating the Journey from Assistant to Associate Professor</title>
        <itunes:title>Educator Essentials: Early-Career Faculty Life: Successfully Navigating the Journey from Assistant to Associate Professor</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-early-career-faculty-life-successfully-navigating-the-journey-from-assistant-to-associate-professor/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-early-career-faculty-life-successfully-navigating-the-journey-from-assistant-to-associate-professor/#comments</comments>        <pubDate>Tue, 29 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/704372d2-8ade-32f9-ac85-35bfaa30ef43</guid>
                                    <description><![CDATA[<p>This podcast provides junior faculty members with guidance on how to navigate life as an early-career faculty member and how to best position themselves to successfully advance in rank. A diverse panel of faculty members discusses their own careers, provides advice to junior faculty on how to advocate for themselves to their supervisor, and shares ways colleges can provide support to junior faculty.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides junior faculty members with guidance on how to navigate life as an early-career faculty member and how to best position themselves to successfully advance in rank. A diverse panel of faculty members discusses their own careers, provides advice to junior faculty on how to advocate for themselves to their supervisor, and shares ways colleges can provide support to junior faculty.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/putbg7wda53cw6ib/ASHPOfficial_Early_Career_Faculty_Life_Successfully_Navigating_the_Journey_from_Assistant_to_Associate_Professor_mix8qbu9.mp3" length="39027575" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides junior faculty members with guidance on how to navigate life as an early-career faculty member and how to best position themselves to successfully advance in rank. A diverse panel of faculty members discusses their own careers, provides advice to junior faculty on how to advocate for themselves to their supervisor, and shares ways colleges can provide support to junior faculty.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2439</itunes:duration>
                <itunes:episode>1353</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Why is it Taking So Long? Introduction to Healthcare Change Request Build (CE)</title>
        <itunes:title>Informatics Bytes (CE): Why is it Taking So Long? Introduction to Healthcare Change Request Build (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-why-is-it-taking-so-long-introduction-to-healthcare-change-request-build-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-why-is-it-taking-so-long-introduction-to-healthcare-change-request-build-ce/#comments</comments>        <pubDate>Sat, 26 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/58399ad0-d7ad-3a1c-8841-50c27a984980</guid>
                                    <description><![CDATA[<p>This is the first episode in a three-part series discussing how pharmacy technology change requests are taken from idea to implementation. This podcast introduces what pharmacy technology change requests entail, common request categories, and features of a clear request. CE for this episode expires on July 26, 2027.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This is the first episode in a three-part series discussing how pharmacy technology change requests are taken from idea to implementation. This podcast introduces what pharmacy technology change requests entail, common request categories, and features of a clear request. CE for this episode expires on July 26, 2027.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gjjjk3wxq3eaz63j/Why_Is_It_Taking_So_Long_An_Introduction_to_Healthcare_Change_Request_Build_mixdown6u5e8.mp3" length="26737982" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This is the first episode in a three-part series discussing how pharmacy technology change requests are taken from idea to implementation. This podcast introduces what pharmacy technology change requests entail, common request categories, and features of a clear request. CE for this episode expires on July 26, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1107</itunes:duration>
                <itunes:episode>1359</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: What Even Is Professionalism?</title>
        <itunes:title>Educator Essentials: What Even Is Professionalism?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-what-even-is-professionalism/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-what-even-is-professionalism/#comments</comments>        <pubDate>Thu, 24 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b7de4ecb-d989-3929-a5ed-e35d9e1d6b38</guid>
                                    <description><![CDATA[<p>Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4rg9c2ah3ryje9np/ASHPOfficial_-_To_Be_Or_Not_To_Be_-_What_Exactly_Even_is_Professionalism_MIX94dk3.mp3" length="77663288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1941</itunes:duration>
                <itunes:episode>1362</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>SOPIT DSA: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology Julie Pawola</title>
        <itunes:title>SOPIT DSA: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology Julie Pawola</itunes:title>
        <link>https://ashpofficial.podbean.com/e/sopit-dsa-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology-julie-pawola/</link>
                    <comments>https://ashpofficial.podbean.com/e/sopit-dsa-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology-julie-pawola/#comments</comments>        <pubDate>Thu, 24 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/04132923-831f-3f7d-806d-9bad1c997475</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Hesham Mourad, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2024, Julie Pawola, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Hesham Mourad, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2024, Julie Pawola, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nntmjz5ge5jh9bxr/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Pharmacy_Informatics_and_Technology_mixdown63ryv.mp3" length="16748138" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Hesham Mourad, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2024, Julie Pawola, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>691</itunes:duration>
                <itunes:episode>1358</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis</title>
        <itunes:title>AJHP Voices: Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-psychiatric-learning-experiences-in-pgy1-pharmacy-residency-training-a-5-year-analysis/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-psychiatric-learning-experiences-in-pgy1-pharmacy-residency-training-a-5-year-analysis/#comments</comments>        <pubDate>Wed, 23 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8c9ea4ba-a5b7-3ba6-8837-93b0f44d16c5</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pb5kupk3iqvzikz6/MP3_Psychiatric_learning_experiences629aa.mp3" length="39276801" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1636</itunes:duration>
                <itunes:episode>1355</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Informatics Bytes: The Future of Data Analytics for Pharmacy Professionals</title>
        <itunes:title>Informatics Bytes: The Future of Data Analytics for Pharmacy Professionals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-the-future-of-data-analytics-for-pharmacy-professionals/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-the-future-of-data-analytics-for-pharmacy-professionals/#comments</comments>        <pubDate>Tue, 22 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/54148c01-b23b-320c-939b-f9d6bdcefc48</guid>
                                    <description><![CDATA[<p>This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wyg929cvnwuqp5iz/2_The_Future_of_Data_Analytics_for_Pharmacy_Professionalsbmq83.mp3" length="56970903" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2373</itunes:duration>
                <itunes:episode>1360</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Mariah Hollabaugh, PharmD, MBA, BCPS, CPEL, Hayle Gillespie, CPht, CHW-C, and Jodie Gregg</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Mariah Hollabaugh, PharmD, MBA, BCPS, CPEL, Hayle Gillespie, CPht, CHW-C, and Jodie Gregg</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-mariah-hollabaugh-pharmd-mba-bcps-cpel-hayle-gillespie-cpht-chw-c-and-jodie-gregg/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-mariah-hollabaugh-pharmd-mba-bcps-cpel-hayle-gillespie-cpht-chw-c-and-jodie-gregg/#comments</comments>        <pubDate>Mon, 21 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/97965c2f-4bb5-3d34-8123-8e59e7e1a5b7</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xrjip485xkk93gyi/We_re_Your_Pharmacists_Mariah_Hollabaugh_Jodie_Gregg_Hayle_Gillespie_FINAL_mixdown8835b.mp3" length="24029264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>994</itunes:duration>
                <itunes:episode>1356</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201 — BRCA1 and BRCA2</title>
        <itunes:title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201 — BRCA1 and BRCA2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201-%e2%80%94-brca1-and-brca2/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201-%e2%80%94-brca1-and-brca2/#comments</comments>        <pubDate>Sat, 19 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/58ae4b06-3342-35d1-80ef-b841e9559f96</guid>
                                    <description><![CDATA[<p>This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bmefxz86dysudpjm/Recorded_Pharmacist_Series_Biomarkers_201_BRCA1_and_BRCA2_mixdownamzxa.mp3" length="18162326" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>749</itunes:duration>
                <itunes:episode>1348</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: 2025 State Legislative Recap</title>
        <itunes:title>Advocating for Impact: 2025 State Legislative Recap</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-2025-state-legislative-recap/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-2025-state-legislative-recap/#comments</comments>        <pubDate>Tue, 15 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3ffbc8c4-4642-3dfb-833d-bf7292077bca</guid>
                                    <description><![CDATA[<p>This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tk9qub2vc5wdv9db/2025_State_Legislative_Recap_mixdown77hnv.mp3" length="29916483" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1239</itunes:duration>
                <itunes:episode>1354</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Data for Access: Real World Challenges and Conditions</title>
        <itunes:title>Community Pharmacy: Data for Access: Real World Challenges and Conditions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-data-for-access-real-world-challenges-and-conditions/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-data-for-access-real-world-challenges-and-conditions/#comments</comments>        <pubDate>Tue, 15 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/72165bcb-28e2-3f10-9340-f16fdd9b3593</guid>
                                    <description><![CDATA[<p class="xmsonormal">Join us as we explore providing data for specialty medication access.  Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">Join us as we explore providing data for specialty medication access.  Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/n5sc2u794fh7nf4p/ASHPOfficial_Data_for_Access_Real_World_Challenges_and_Considerations_mixasmuo.mp3" length="28858613" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as we explore providing data for specialty medication access.  Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1803</itunes:duration>
                <itunes:episode>1351</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: The M3P Plan and Its Impact on Specialty Pharmacy</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: The M3P Plan and Its Impact on Specialty Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-the-m3p-plan-and-its-impact-on-specialty-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-the-m3p-plan-and-its-impact-on-specialty-pharmacy/#comments</comments>        <pubDate>Fri, 11 Jul 2025 12:33:27 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/73ed9f88-6722-3c3e-9083-e5f28d4b5890</guid>
                                    <description><![CDATA[<p>This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bvv9sq38hvaz2xhi/The_M3P_Plan_and_Its_Impact_on_Specialty_Pharmacy_mixdown5yix4.mp3" length="34560000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1433</itunes:duration>
                <itunes:episode>1352</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Della Bahmandar</title>
        <itunes:title>Pharmacy Leadership: SPPL DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Della Bahmandar</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-della-bahmandar/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-della-bahmandar/#comments</comments>        <pubDate>Mon, 07 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/16ed15f7-f558-39fe-93eb-f94959af7d30</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hqkvwevjtmir24x7/ASHPOfficial_A_Conversation_with_Distinguised_Service_Awardee_for_the_Section_of_Pharmacy_Practice_Leaders_and_Della_Bahmandar_mix6d9sw.mp3" length="21527753" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1345</itunes:duration>
                <itunes:episode>1349</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201 — Platelet Factor 4</title>
        <itunes:title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201 — Platelet Factor 4</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201-%e2%80%94-platelet-factor-4/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201-%e2%80%94-platelet-factor-4/#comments</comments>        <pubDate>Sat, 05 Jul 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/82fb3dfe-6b4a-3041-b398-c30c6bdebde8</guid>
                                    <description><![CDATA[<p>This episode discusses the use of Platelet Factor 4, which has several roles for applicability, limitations, and emerging areas for use. CE for this episode expires two years after its original publication date.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the use of Platelet Factor 4, which has several roles for applicability, limitations, and emerging areas for use. CE for this episode expires two years after its original publication date.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fb9pqpew75b34yd9/Recorded_Pharmacist_Series_Biomarkers_201_Platelet_Factor_4_mixdown811g6.mp3" length="48127180" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the use of Platelet Factor 4, which has several roles for applicability, limitations, and emerging areas for use. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1998</itunes:duration>
                <itunes:episode>1347</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: Results of the Health-System Specialty Pharmacy Work-from-Home Survey: Part 1</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: Results of the Health-System Specialty Pharmacy Work-from-Home Survey: Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-results-of-the-health-system-specialty-pharmacy-work-from-home-survey-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-results-of-the-health-system-specialty-pharmacy-work-from-home-survey-part-1/#comments</comments>        <pubDate>Tue, 01 Jul 2025 14:16:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f407c248-68a4-3d67-bda2-f53ff02d467e</guid>
                                    <description><![CDATA[<p>This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yixxpqmyrzhi5nws/ASHPOfficial_-_Health-System_Specialty_Pharmacy_Work-From-Home_Survey_Results_Part_1_-_Mix6hedd.mp3" length="42350280" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1764</itunes:duration>
                <itunes:episode>1350</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Elephant in the Home Office: Engaging a Hybrid Workforce</title>
        <itunes:title>Hot Topics in Pharmacy: The Elephant in the Home Office: Engaging a Hybrid Workforce</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-elephant-in-the-home-office-engaging-a-hybrid-workforce/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-elephant-in-the-home-office-engaging-a-hybrid-workforce/#comments</comments>        <pubDate>Thu, 26 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/779d9804-5999-337a-9bea-1cb498e7c60e</guid>
                                    <description><![CDATA[<p>During this podcast, members of the New Practitioners Forum speak with pharmacy administrators and practitioners to explore the evolving landscape of hybrid pharmacy practice. Guests share insights into both inpatient and outpatient roles and discuss the benefits, opportunities, and challenges of hybrid work models.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast, members of the New Practitioners Forum speak with pharmacy administrators and practitioners to explore the evolving landscape of hybrid pharmacy practice. Guests share insights into both inpatient and outpatient roles and discuss the benefits, opportunities, and challenges of hybrid work models.</p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r4seycwi85cy7fb7/ASHPOfficial_-_The_Elephant_in_the_Home_Office_-_Engaging_a_Hybrid_Workforce_-_Mix8y8k4.mp3" length="67504838" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast, members of the New Practitioners Forum speak with pharmacy administrators and practitioners to explore the evolving landscape of hybrid pharmacy practice. Guests share insights into both inpatient and outpatient roles and discuss the benefits, opportunities, and challenges of hybrid work models.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2812</itunes:duration>
                <itunes:episode>1344</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Leadership Beyond Pharmacy School: A Look into the Future</title>
        <itunes:title>Student Perspectives: Leadership Beyond Pharmacy School: A Look into the Future</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-leadership-beyond-pharmacy-school-a-look-into-the-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-leadership-beyond-pharmacy-school-a-look-into-the-future/#comments</comments>        <pubDate>Thu, 26 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/384d74f2-1577-3b5b-93fe-f8cf8bd33938</guid>
                                    <description><![CDATA[<p>This episode discusses the benefits of ASHP membership from the perspective of a student, seasoned practitioners, and professors. Speakers hope to inspire others to continue their involvement throughout their pharmacy career as a way to gain skills and further their careers and contribute to the advancement of the profession.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode discusses the benefits of ASHP membership from the perspective of a student, seasoned practitioners, and professors. Speakers hope to inspire others to continue their involvement throughout their pharmacy career as a way to gain skills and further their careers and contribute to the advancement of the profession.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wu4cefrujn6qr4ks/ASHPOfficial_Leadership_Beyond_Pharmacy_School_A_Look_into_the_Future_mix7s2jx.mp3" length="26517992" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode discusses the benefits of ASHP membership from the perspective of a student, seasoned practitioners, and professors. Speakers hope to inspire others to continue their involvement throughout their pharmacy career as a way to gain skills and further their careers and contribute to the advancement of the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1657</itunes:duration>
                <itunes:episode>1340</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: National Pharmacist Workforce Study – Data and Trends Essential to All Pharmacists</title>
        <itunes:title>Pharmacy Leadership: SPPL: National Pharmacist Workforce Study – Data and Trends Essential to All Pharmacists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-national-pharmacist-workforce-study-%e2%80%93-data-and-trends-essential-to-all-pharmacists/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-national-pharmacist-workforce-study-%e2%80%93-data-and-trends-essential-to-all-pharmacists/#comments</comments>        <pubDate>Wed, 25 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bbeaa4c1-1d7c-3673-8ecc-c03c0dae1315</guid>
                                    <description><![CDATA[<p>The National Pharmacist Workforce Study is a systematic, nationwide survey of licensed pharmacists in the United States and provides data and trends over time and on contemporary issues.  This most recent study includes information on job satisfaction, advancement opportunities, and workplace culture. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The National Pharmacist Workforce Study is a systematic, nationwide survey of licensed pharmacists in the United States and provides data and trends over time and on contemporary issues.  This most recent study includes information on job satisfaction, advancement opportunities, and workplace culture. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fr37mk8i5iw3xstm/ASHPOfficial_National_Pharmacist_Workforce_Study_Data_and_Trends_Essential_to_All_Pharmacists_mix98pa8.mp3" length="38391233" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The National Pharmacist Workforce Study is a systematic, nationwide survey of licensed pharmacists in the United States and provides data and trends over time and on contemporary issues.  This most recent study includes information on job satisfaction, advancement opportunities, and workplace culture. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2399</itunes:duration>
                <itunes:episode>1346</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Igniting the Spark: Strategies for Student Engagement in Specialty Pharmacy</title>
        <itunes:title>Hot Topics in Pharmacy: Igniting the Spark: Strategies for Student Engagement in Specialty Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-igniting-the-spark-strategies-for-student-engagement-in-specialty-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-igniting-the-spark-strategies-for-student-engagement-in-specialty-pharmacy/#comments</comments>        <pubDate>Tue, 24 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fc6e6a8d-fb8f-38e3-9d0b-a1802074b985</guid>
                                    <description><![CDATA[<p>During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6tqm4p8hxmrhg6p2/ASHPOfficial_Igniting_the_Spark_Strategies_for_Student_Engagement_in_Specialty_Pharmacy_mix7sies.mp3" length="29268941" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1829</itunes:duration>
                <itunes:episode>1345</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We're Your Pharmacist Podcast Series with Kathy Parrinello, PhD, RN</title>
        <itunes:title>We're Your Pharmacist Podcast Series with Kathy Parrinello, PhD, RN</itunes:title>
        <link>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-kathy-parrinello-phd-rn/</link>
                    <comments>https://ashpofficial.podbean.com/e/were-your-pharmacist-podcast-series-with-kathy-parrinello-phd-rn/#comments</comments>        <pubDate>Mon, 23 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b5860428-32d8-362d-9ada-a7550eb9f453</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Kathy Parrinello, CEO and President of University of Rochester Medical Center Strong Memorial Hospital and Highland Hospital as she shares what drew her to a career in nursing, and her perspectives on the critical contributions of pharmacists within the health system setting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Kathy Parrinello, CEO and President of University of Rochester Medical Center Strong Memorial Hospital and Highland Hospital as she shares what drew her to a career in nursing, and her perspectives on the critical contributions of pharmacists within the health system setting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3t49fhgh6kwvmzyy/We_re_Your_Pharmacists_K_Parrinello_REVISEDajt4g.m4a" length="25221778" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Kathy Parrinello, CEO and President of University of Rochester Medical Center Strong Memorial Hospital and Highland Hospital as she shares what drew her to a career in nursing, and her perspectives on the critical contributions of pharmacists within the health system setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1043</itunes:duration>
                <itunes:episode>1337</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201</title>
        <itunes:title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-biomarkers-201/#comments</comments>        <pubDate>Sat, 21 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ba74a45d-d161-33a5-a826-f0cc23bafa65</guid>
                                    <description><![CDATA[<p class="xmsonormal">This episode highlights changes made to the resource and revised categories of biomarkers and provides a resource for evidence-based application of biomarkers in clinical pharmacy practice. CE for this episode expires on June 21, 2027.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">This episode highlights changes made to the resource and revised categories of biomarkers and provides a resource for evidence-based application of biomarkers in clinical pharmacy practice. CE for this episode expires on June 21, 2027.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vvik2av2buww2sat/Recorded_Pharmacist_Series_Biomarkers_201_mixdown93lgt.mp3" length="31481605" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode highlights changes made to the resource and revised categories of biomarkers and provides a resource for evidence-based application of biomarkers in clinical pharmacy practice. CE for this episode expires on June 21, 2027.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1305</itunes:duration>
                <itunes:episode>1338</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>2024 ASHP Survey of Health-System Specialty Pharmacy: Key Takeaways from the Authors</title>
        <itunes:title>2024 ASHP Survey of Health-System Specialty Pharmacy: Key Takeaways from the Authors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-the-art-of-engagement-creating-experiences-that-motivate-learners-%e2%80%94-a-conversation-with-clinical-specialists/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-the-art-of-engagement-creating-experiences-that-motivate-learners-%e2%80%94-a-conversation-with-clinical-specialists/#comments</comments>        <pubDate>Wed, 18 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d35a1e1d-cfb0-3b43-83be-36014151d957</guid>
                                    <description><![CDATA[<p>In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vhk4dym39w9ezeuy/2024_ASHP_Survey_of_Health-System_Specialty_Pharmacy_Key_Takeaways_from_the_Authors_mixdownaob3e.mp3" length="72107232" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2997</itunes:duration>
                <itunes:episode>1343</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Jump into Wellness: A Conversation with Diane Ginsburg</title>
        <itunes:title>Practice Journeys: Jump into Wellness: A Conversation with Diane Ginsburg</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-jump-into-wellness-a-conversation-with-diane-ginsburg/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-jump-into-wellness-a-conversation-with-diane-ginsburg/#comments</comments>        <pubDate>Tue, 17 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5b20d751-487c-3fc4-b747-4835ab83a023</guid>
                                    <description><![CDATA[<p>This podcast explores the critical elements of physical wellness, offering tips for maintaining a healthy body through exercise, nutrition, and self-care. The episode also discusses building resilience and strategies for bouncing back from failure, highlighting the importance of mental fortitude and perseverance in both personal and professional growth. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the critical elements of physical wellness, offering tips for maintaining a healthy body through exercise, nutrition, and self-care. The episode also discusses building resilience and strategies for bouncing back from failure, highlighting the importance of mental fortitude and perseverance in both personal and professional growth. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9xba66dqvcp8y856/ASHPOfficial_Jump_into_Wellness_A_Conversation_with_Dr_Ginsburg_mix9mf4f.mp3" length="30981560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the critical elements of physical wellness, offering tips for maintaining a healthy body through exercise, nutrition, and self-care. The episode also discusses building resilience and strategies for bouncing back from failure, highlighting the importance of mental fortitude and perseverance in both personal and professional growth. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1936</itunes:duration>
                <itunes:episode>1342</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Policy Pulse: Key Updates on the 340B Program</title>
        <itunes:title>Advocating for Impact: Policy Pulse: Key Updates on the 340B Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-policy-pulse-key-updates-on-the-340b-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-policy-pulse-key-updates-on-the-340b-program/#comments</comments>        <pubDate>Tue, 17 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4be0c775-dca4-3640-9377-78bedb5ad142</guid>
                                    <description><![CDATA[<p>This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r7gizy2ixdrf2mcr/Policy_Pulse_Key_Updates_on_the_340B_Program_mixdown6t4d4.mp3" length="30719803" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1273</itunes:duration>
                <itunes:episode>1339</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: AJHP theme issue on the management of chronic kidney disease</title>
        <itunes:title>AJHP Voices: AJHP theme issue on the management of chronic kidney disease</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-ajhp-theme-issue-on-the-management-of-chronic-kidney-disease/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-ajhp-theme-issue-on-the-management-of-chronic-kidney-disease/#comments</comments>        <pubDate>Mon, 16 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bee91fb1-9231-3c3c-9056-a7dc16f14a60</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5dynd2537rmaebz3/CKD_Theme_Issue_Final9wb79.m4a" length="44606106" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1845</itunes:duration>
                <itunes:episode>1341</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Informatics Bytes (CE): Overcoming Challenges with Remote Learning: A Learner's Perspective</title>
        <itunes:title>Informatics Bytes (CE): Overcoming Challenges with Remote Learning: A Learner's Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-overcoming-challenges-with-remote-learning-a-learners-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-overcoming-challenges-with-remote-learning-a-learners-perspective/#comments</comments>        <pubDate>Sat, 14 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/338a554c-2ab9-305f-a867-f04fa30cd6ea</guid>
                                    <description><![CDATA[<p>This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e5xgkjtwd98ayu9a/Overcoming_Challenges_with_Remote_Learnin_A_Learner_s_Perspective_mixdown8kr8f.mp3" length="25838216" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1070</itunes:duration>
                <itunes:episode>1312</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations  (C.E.): 2025 Adult Immunization Updates</title>
        <itunes:title>Clinical Conversations  (C.E.): 2025 Adult Immunization Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-2025-adult-immunization-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-2025-adult-immunization-updates/#comments</comments>        <pubDate>Sat, 07 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e051149b-d55d-3ebc-87e7-8d0844742fe0</guid>
                                    <description><![CDATA[<p>Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wshixjzx4kpb3gtm/ASHPOfficial_2025_Immunization_Updates_for_Adults_mix61zsk.mp3" length="52077173" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3254</itunes:duration>
                <itunes:episode>1335</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practice Award 2024: Clinical Pharmacist Practitioner Led Substance Use Disorder Care Across an Integrated Health-System</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practice Award 2024: Clinical Pharmacist Practitioner Led Substance Use Disorder Care Across an Integrated Health-System</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacypracticeashpbestpracticeaward2024clinicalpharmacist-practitionerled-substance-use-disorder-care-across-an-integrated-healthsystem/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacypracticeashpbestpracticeaward2024clinicalpharmacist-practitionerled-substance-use-disorder-care-across-an-integrated-healthsystem/#comments</comments>        <pubDate>Fri, 06 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f4ca2a49-1d8c-3651-a90b-116dd3ef35bc</guid>
                                    <description><![CDATA[<p>In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices.  They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices.  They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xnxazp6uknr5z4r6/ASHP_Best_Practice_Award_2024_Clinical_Pharmacist_Practitioner_Led_Substance_Use_Disorder_Care_Across_an_Integrated_Health-System_mixdown8gmy5.mp3" length="19234258" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices.  They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>794</itunes:duration>
                <itunes:episode>1333</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: The Art of Engagement: Creating Experiences that Motivate Learners — A Conversation with Clinical Specialists</title>
        <itunes:title>Educator Essentials: The Art of Engagement: Creating Experiences that Motivate Learners — A Conversation with Clinical Specialists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-the-art-of-engagement-creating-experiences-that-motivate-learners-%e2%80%94-a-conversation-with-clinical-specialists/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-the-art-of-engagement-creating-experiences-that-motivate-learners-%e2%80%94-a-conversation-with-clinical-specialists/#comments</comments>        <pubDate>Thu, 05 Jun 2025 18:23:57 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c0014ace-13ea-337e-928d-770f42500db3</guid>
                                    <description><![CDATA[<p>In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tucwpxnzfwqgc9ek/ASHPOfficial_-_The_Art_of_Engagement_-_Creating_Experiences_that_Motivate_Learners_MIX7mbiv.mp3" length="48065888" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1201</itunes:duration>
                <itunes:episode>1336</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system</title>
        <itunes:title>AJHP Voices: Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-teleworking-by-hospital-pharmacists-another-step-to-achieve-decarbonization-of-the-healthcare-system/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-teleworking-by-hospital-pharmacists-another-step-to-achieve-decarbonization-of-the-healthcare-system/#comments</comments>        <pubDate>Thu, 05 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/06b94be7-ea78-3e8e-b12e-6dd60d651948</guid>
                                    <description><![CDATA[<p>In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/c7xtpzjs6fkqi9va/Teleworking_by_hospital_pharmacists_FINAL91yrc.m4a" length="37630706" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1556</itunes:duration>
                <itunes:episode>1327</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Practice Journeys: Meet the Leadership of the Infusion Services Strategy Committee</title>
        <itunes:title>Practice Journeys: Meet the Leadership of the Infusion Services Strategy Committee</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-meet-the-leadership-of-the-infusion-services-strategy-committee/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-meet-the-leadership-of-the-infusion-services-strategy-committee/#comments</comments>        <pubDate>Wed, 04 Jun 2025 18:21:11 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1ac1ed48-0a15-356f-aa00-65b444adb776</guid>
                                    <description><![CDATA[<p>A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/myddpmhwxq8a9wba/Meet_the_Leadership_of_the_Infusion_Services_Strategy_Committee_mixdownayra4.mp3" length="23482408" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>971</itunes:duration>
                <itunes:episode>1334</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Drug Shortage Landscape: Data, Disruptions, and the Drive for Solutions</title>
        <itunes:title>Hot Topics in Pharmacy: The Drug Shortage Landscape: Data, Disruptions, and the Drive for Solutions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-drug-shortage-landscape-data-disruptions-and-the-drive-for-solutions/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-drug-shortage-landscape-data-disruptions-and-the-drive-for-solutions/#comments</comments>        <pubDate>Wed, 04 Jun 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/148a38b4-a6f0-3021-a2a6-601f435c3e2c</guid>
                                    <description><![CDATA[<p>Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9pqu5auqyi85uv5h/ASHPOfficial_The_Drug_Shortage_Landscape_Data_Disruptions_and_the_Drive_for_Solutions_mix68o1z.mp3" length="28556705" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1784</itunes:duration>
                <itunes:episode>1331</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: The Price is Right? – The Administration’s Drug Pricing Plans</title>
        <itunes:title>Advocating for Impact: The Price is Right? – The Administration’s Drug Pricing Plans</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-the-price-is-right-%e2%80%93-the-administration-s-drug-pricing-plans/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-the-price-is-right-%e2%80%93-the-administration-s-drug-pricing-plans/#comments</comments>        <pubDate>Tue, 03 Jun 2025 14:21:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6d329f4f-31df-36ea-b246-ae4684ca5e3f</guid>
                                    <description><![CDATA[<p>This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m4v46h2bivdk32zn/2_Drug_Pricing_Executive_Order_mixdowna8d9w.mp3" length="32258995" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1343</itunes:duration>
                <itunes:episode>1332</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Navigating Artificial Intelligence in Pharmacy with a Data Science Pharmacist</title>
        <itunes:title>Informatics Bytes: Navigating Artificial Intelligence in Pharmacy with a Data Science Pharmacist</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-navigating-artificial-intelligence-in-pharmacy-with-a-data-science-pharmacist/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-navigating-artificial-intelligence-in-pharmacy-with-a-data-science-pharmacist/#comments</comments>        <pubDate>Mon, 02 Jun 2025 13:24:55 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dfbca5b0-34f2-309d-9ffe-e8ae0228c505</guid>
                                    <description><![CDATA[<p>In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kesntpvrywfhurg5/ASHPOfficial_Navigating_Artificial_Intelligence_in_Pharmacy_with_a_Data_Science_Pharmacist_AI_Ethics_Part_1_mix_1_ab7bp.mp3" length="21509822" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1344</itunes:duration>
                <itunes:episode>1329</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Gene &amp; Cell Therapy Educational Series Part 3 — In Vivo &amp; Viral-based Gene Therapy: Operational Considerations</title>
        <itunes:title>Clinical Conversations (C.E.): Recorded Pharmacist Series: Gene &amp; Cell Therapy Educational Series Part 3 — In Vivo &amp; Viral-based Gene Therapy: Operational Considerations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-cerecordedpharmacistseries-genecelltherapy-educationalseries-part-3%e2%80%94-invivoviral-based-gene-therapy-operationalconsi/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-cerecordedpharmacistseries-genecelltherapy-educationalseries-part-3%e2%80%94-invivoviral-based-gene-therapy-operationalconsi/#comments</comments>        <pubDate>Sat, 31 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/83fcf427-0fc3-32d2-a36e-61cd8ed5a592</guid>
                                    <description><![CDATA[<p>This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w62ad4sxvuxs7c2k/Recorded_Pharmacist_Series_Gene_Cell_Therapy_Educational_Series_Part_3_In_Vivo_Viral-based_Gene_Therapy_Operational_Considerations_mixdowna8uzk.mp3" length="77764733" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3233</itunes:duration>
                <itunes:episode>1326</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SACP DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners Jessica Skelley</title>
        <itunes:title>Pharmacy Leadership: SACP DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners Jessica Skelley</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadershipsacpdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-ambulatory-care-practitioners-jessicaskelley/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadershipsacpdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-ambulatory-care-practitioners-jessicaskelley/#comments</comments>        <pubDate>Fri, 30 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e627eade-30a8-3f21-b4ec-a9d9c56e4afb</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pkvk8rhtrwqxkajb/SACP_DSA_Jessica_Skelley_20256d7ap.m4a" length="19200532" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>794</itunes:duration>
                <itunes:episode>1324</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: The Engaged HSPAL Resident: Mastering Learning, Leadership, and Growth</title>
        <itunes:title>Pharmacy Leadership: The Engaged HSPAL Resident: Mastering Learning, Leadership, and Growth</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-the-engaged-hspal-resident-mastering-learning-leadership-and-growth/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-the-engaged-hspal-resident-mastering-learning-leadership-and-growth/#comments</comments>        <pubDate>Thu, 29 May 2025 15:34:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/de43e625-8976-34fe-a3f3-0eb45a4ce3e6</guid>
                                    <description><![CDATA[<p>In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 &amp; PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 &amp; PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hacvk4wcd8uaamnr/ASHPOfficial_-_The_Engaged_HSPAL_Resident_-_Mastering_Learning_Leadership_and_Growth_-_Mix70x7d.mp3" length="62802326" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 &amp; PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2616</itunes:duration>
                <itunes:episode>1328</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Breaking Barriers: Tackling Obesity Myths, Patient Challenges, and Long-term Success</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Breaking Barriers: Tackling Obesity Myths, Patient Challenges, and Long-term Success</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-breaking-barriers-tackling-obesity-myths-patient-challenges-and-long-term-success/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-breaking-barriers-tackling-obesity-myths-patient-challenges-and-long-term-success/#comments</comments>        <pubDate>Wed, 28 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5d3c93ca-61fa-3081-9770-7a4de358b3c4</guid>
                                    <description><![CDATA[<p>Learn from experts on treatments for patients with obesity. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts on treatments for patients with obesity. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3m46kwwgaimijr3v/ASHPOfficial_-_Adv_-_Tackling_Obesity_Myths_Patient_Challenges_and_Long-Term_Success_MIX8pdob.mp3" length="72232400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts on treatments for patients with obesity. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1805</itunes:duration>
                <itunes:episode>1325</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation and “The Need for Speed”—Efficient and Effective Residency CQI and Reporting</title>
        <itunes:title>Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation and “The Need for Speed”—Efficient and Effective Residency CQI and Reporting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/be-prepared-frequent-findingsandtrusty-tips-forpharmacyresidencyaccreditation-and-the-need-for-speed-%e2%80%94efficient-and-effective-residency-cq/</link>
                    <comments>https://ashpofficial.podbean.com/e/be-prepared-frequent-findingsandtrusty-tips-forpharmacyresidencyaccreditation-and-the-need-for-speed-%e2%80%94efficient-and-effective-residency-cq/#comments</comments>        <pubDate>Tue, 27 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff543b79-95ac-37c3-8b2e-f79bf2a4ab24</guid>
                                    <description><![CDATA[<p>In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting.  These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting.  These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qiyqcx5ehchhcsnu/PH5BAA_1.mp3" length="13469182" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting.  These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>554</itunes:duration>
                <itunes:episode>1323</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations  (C.E.): Recorded Pharmacist Series: Gene &amp; Cell Therapy Educational Series Part 2 — In Vivo &amp; Viral-Based Gene Therapy</title>
        <itunes:title>Clinical Conversations  (C.E.): Recorded Pharmacist Series: Gene &amp; Cell Therapy Educational Series Part 2 — In Vivo &amp; Viral-Based Gene Therapy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-gene-cell-therapy-educational-series-part-2-%e2%80%94-in-vivo-viral-based-gene-therapy/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-recorded-pharmacist-series-gene-cell-therapy-educational-series-part-2-%e2%80%94-in-vivo-viral-based-gene-therapy/#comments</comments>        <pubDate>Sat, 24 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fbee4ea5-19dc-382c-a895-1b087a5a19b4</guid>
                                    <description><![CDATA[<p>This episode reviews the viral replication process, common viral vectors for in vivo gene therapy, and Food and Drug Administration-approved therapies. The episode will also highlight novel in vivo gene therapies in the development pipeline. CE for this episode expires on May 25, 2027.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode reviews the viral replication process, common viral vectors for in vivo gene therapy, and Food and Drug Administration-approved therapies. The episode will also highlight novel in vivo gene therapies in the development pipeline. CE for this episode expires on May 25, 2027.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f9796c9fkmrvviap/Recorded_Pharmacist_Series_Gene_Cell_Therapy_Educational_Series_Part_2_In_Vivo_Viral-Based_Gene_Therapy_mixdown8409i.mp3" length="29274991" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode reviews the viral replication process, common viral vectors for in vivo gene therapy, and Food and Drug Administration-approved therapies. The episode will also highlight novel in vivo gene therapies in the development pipeline. CE for this episode expires on May 25, 2027.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1213</itunes:duration>
                <itunes:episode>1322</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series with Tammy McKinney, RN, BSN &amp; Tina Claypool, PharmD, CDCES, BCACP, FKSHP</title>
        <itunes:title>We’re Your Pharmacist Podcast Series with Tammy McKinney, RN, BSN &amp; Tina Claypool, PharmD, CDCES, BCACP, FKSHP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-tammy-mckinney-tina-claypool-pharmd-cdces-bcacp-fkshp/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-tammy-mckinney-tina-claypool-pharmd-cdces-bcacp-fkshp/#comments</comments>        <pubDate>Thu, 22 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c0120edc-7f41-3913-ac95-a383675e1e8c</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina’s expertise, dedication, and care improved her health and changed her life for the better. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina’s expertise, dedication, and care improved her health and changed her life for the better. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tibm2d53b93trh7x/We_re_Your_Pharmacist_Podcast_Series_with_Tammy_McKinney_Tina_Claypool_PharmD_CDCES_BCACP_FKSHP_mixdownbhdnv.mp3" length="23598690" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina’s expertise, dedication, and care improved her health and changed her life for the better. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>976</itunes:duration>
                <itunes:episode>1321</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: Connected to Advanced Therapeutics Education at ASHP Pharmacy Futures 2025: Oddis Ethics Colloquium</title>
        <itunes:title>Pharmacy Hot Topics: Connected to Advanced Therapeutics Education at ASHP Pharmacy Futures 2025: Oddis Ethics Colloquium</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-connected-to-advanced-therapeutics-education-at-ashp-pharmacy-futures-2025-oddis-ethics-colloquium/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-connected-to-advanced-therapeutics-education-at-ashp-pharmacy-futures-2025-oddis-ethics-colloquium/#comments</comments>        <pubDate>Wed, 21 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/493e95cd-7547-377b-9a43-47d90ea45a09</guid>
                                    <description><![CDATA[<p>In this episode, we are joined by expert Kenneth A. Richman, professor of philosophy and health care ethics at MCPHS University. Join us as we discuss real-world dilemmas, ethical decision-making frameworks, and how pharmacists can uphold integrity while navigating complex healthcare systems.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we are joined by expert Kenneth A. Richman, professor of philosophy and health care ethics at MCPHS University. Join us as we discuss real-world dilemmas, ethical decision-making frameworks, and how pharmacists can uphold integrity while navigating complex healthcare systems.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ienvq24neirvumic/ASHPOfficial_Connected_to_the_education_at_ASHP_Pharmacy_Futures_2025_mix.mp3" length="22616123" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we are joined by expert Kenneth A. Richman, professor of philosophy and health care ethics at MCPHS University. Join us as we discuss real-world dilemmas, ethical decision-making frameworks, and how pharmacists can uphold integrity while navigating complex healthcare systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1413</itunes:duration>
                <itunes:episode>1320</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Insights: A Closer Look at the TPTS Strategic Plan</title>
        <itunes:title>Technician Insights: A Closer Look at the TPTS Strategic Plan</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-insights-a-closer-look-at-the-tpts-strategic-plan/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-insights-a-closer-look-at-the-tpts-strategic-plan/#comments</comments>        <pubDate>Tue, 20 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/20dd92ea-9dcc-3256-bed4-1379b83f273a</guid>
                                    <description><![CDATA[<p>Join the TPTS Board of Directors as they walk through TPTS’s first strategic plan. Hear directly from the Board as they break down the key goals tied to each pillar and share what excites them most about the road ahead.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join the TPTS Board of Directors as they walk through TPTS’s first strategic plan. Hear directly from the Board as they break down the key goals tied to each pillar and share what excites them most about the road ahead.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9ytu863uqrw9vaes/2_A_Closer_Look_at_the_TPTS_Strategic_Plan_mixdown7xkul.mp3" length="45235915" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join the TPTS Board of Directors as they walk through TPTS’s first strategic plan. Hear directly from the Board as they break down the key goals tied to each pillar and share what excites them most about the road ahead.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1884</itunes:duration>
                <itunes:episode>1319</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Tailored Treatment Talks: Navigating Obesity Care, Outcomes, and Teamwork</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Tailored Treatment Talks: Navigating Obesity Care, Outcomes, and Teamwork</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-tailored-treatment-talks-navigating-obesity-care-outcomes-and-teamwork/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-tailored-treatment-talks-navigating-obesity-care-outcomes-and-teamwork/#comments</comments>        <pubDate>Tue, 20 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b355330a-cf6e-391b-9dec-8f1fa163792d</guid>
                                    <description><![CDATA[<p>Learn from experts on treatments for patients with obesity. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts on treatments for patients with obesity. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/57gh7kudwtywcjvt/ASHPOfficial_ADV_Tailored_Treatment_Talks_Navigating_Obesity_Care_Outcomes_and_Teamwork_MIX.mp3" length="73600040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts on treatments for patients with obesity. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1840</itunes:duration>
                <itunes:episode>1315</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Tips and Tricks for APPEs and Internships – A Perspective of Our Own</title>
        <itunes:title>Student Perspectives: Tips and Tricks for APPEs and Internships – A Perspective of Our Own</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-tips-and-tricks-for-appes-and-internships-%e2%80%93-a-perspective-of-our-own/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-tips-and-tricks-for-appes-and-internships-%e2%80%93-a-perspective-of-our-own/#comments</comments>        <pubDate>Fri, 16 May 2025 13:05:21 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/48f240d8-75d5-3395-ba7d-09bb9013b67e</guid>
                                    <description><![CDATA[<p>Follow ASHP Career and Leadership Advisory Group members as we discuss what we learned during our APPE rotations and internships, from applying to finding leadership within the new roles. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Follow ASHP Career and Leadership Advisory Group members as we discuss what we learned during our APPE rotations and internships, from applying to finding leadership within the new roles. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a8k7wu59jpiupb4j/Tips_and_Tricks_for_APPEs_and_Internships_A_Perspective_of_Our_Own_mixdowna9evo.mp3" length="30555871" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Follow ASHP Career and Leadership Advisory Group members as we discuss what we learned during our APPE rotations and internships, from applying to finding leadership within the new roles. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1266</itunes:duration>
                <itunes:episode>1318</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures 2025 “Can’t Miss” Precepting Sessions Episode 2: A Whole New World: Navigating Resident Selection Processes</title>
        <itunes:title>Pharmacy Futures 2025 “Can’t Miss” Precepting Sessions Episode 2: A Whole New World: Navigating Resident Selection Processes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-2025-can-t-miss-precepting-sessions-episode-2-a-whole-new-world-navigating-resident-selection-processes/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-2025-can-t-miss-precepting-sessions-episode-2-a-whole-new-world-navigating-resident-selection-processes/#comments</comments>        <pubDate>Fri, 16 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/328802c9-e79f-366f-b410-1ee337a3c82d</guid>
                                    <description><![CDATA[<p>In this episode, Julie Dagam sits down with Tiffany Pon to discuss the upcoming session entitled “A Whole New World: Navigating Resident Selection Processes”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Julie Dagam sits down with Tiffany Pon to discuss the upcoming session entitled “A Whole New World: Navigating Resident Selection Processes”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p397rzr96e9b973a/NPPC_Podcast_Series_with_Tiffany_Pon_mixdown7qons.mp3" length="6316483" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Julie Dagam sits down with Tiffany Pon to discuss the upcoming session entitled “A Whole New World: Navigating Resident Selection Processes”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>256</itunes:duration>
                <itunes:episode>1317</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practice Award 2024: Impact of a Pharmacist-Centered, Multi-Site Precision Oncology Program</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practice Award 2024: Impact of a Pharmacist-Centered, Multi-Site Precision Oncology Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2024-impact-of-a-pharmacist-centered-multi-site-precision-oncology-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2024-impact-of-a-pharmacist-centered-multi-site-precision-oncology-program/#comments</comments>        <pubDate>Wed, 14 May 2025 12:31:53 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8a0710fa-661b-3e63-80ab-47a217d55047</guid>
                                    <description><![CDATA[<p>In this episode, the team from UNC Health Medical Center discusses their award-winning submission to the ASHP Best Practices. They share how their precision oncology program allowed clinicians to integrate evidence-based personalized therapies into their practice to improve patient outcomes by reducing barriers to precision oncology.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from UNC Health Medical Center discusses their award-winning submission to the ASHP Best Practices. They share how their precision oncology program allowed clinicians to integrate evidence-based personalized therapies into their practice to improve patient outcomes by reducing barriers to precision oncology.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z3puaxvx5gny3b9w/ASHP_Best_Practice_Award_2024_Impact_of_a_Pharmacist-Centered_Multi-Site_Precision_Oncology_Program_mixdownajqov.mp3" length="19849847" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from UNC Health Medical Center discusses their award-winning submission to the ASHP Best Practices. They share how their precision oncology program allowed clinicians to integrate evidence-based personalized therapies into their practice to improve patient outcomes by reducing barriers to precision oncology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>820</itunes:duration>
                <itunes:episode>1316</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: USP  and Parenteral Nutrition: What’s New on the Menu</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: USP  and Parenteral Nutrition: What’s New on the Menu</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-usp-and-parenteral-nutrition-what-s-new-on-the-menu/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-usp-and-parenteral-nutrition-what-s-new-on-the-menu/#comments</comments>        <pubDate>Wed, 14 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/24d5b6ac-7f90-3930-872f-17ea43004a5c</guid>
                                    <description><![CDATA[<p>Faculty experts highlight USP &lt;797&gt; and discuss opportunities to reduce medication errors, with respect to sterility, stability, and compatibility when compounding parenteral nutrition and assigning a beyond use date.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty experts highlight USP &lt;797&gt; and discuss opportunities to reduce medication errors, with respect to sterility, stability, and compatibility when compounding parenteral nutrition and assigning a beyond use date.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zs7r2dgc2p4hhjf3/2_ASHPAdvantage_ADV_USP_797_mixed_mixdown.mp3" length="46035406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty experts highlight USP &lt;797&gt; and discuss opportunities to reduce medication errors, with respect to sterility, stability, and compatibility when compounding parenteral nutrition and assigning a beyond use date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1911</itunes:duration>
                <itunes:episode>1311</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Shining Light on Community-Based Pharmacy Residency Programs: A Panel Discussion</title>
        <itunes:title>Community Pharmacy: Shining Light on Community-Based Pharmacy Residency Programs: A Panel Discussion</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-shining-light-on-community-based-pharmacy-residency-programs-a-panel-discussion/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-shining-light-on-community-based-pharmacy-residency-programs-a-panel-discussion/#comments</comments>        <pubDate>Mon, 12 May 2025 14:18:30 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e6591cc3-fa9d-3b58-acdd-8db82928b023</guid>
                                    <description><![CDATA[<p>Community-based residency training programs provide unique opportunities to provide patient care, establish and expand pharmacy services, and conduct targeted research and other projects relevant to community pharmacy. This podcast features three residency directors of community-based residency programs sharing insights and perspectives on the value of community-based residency training.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Community-based residency training programs provide unique opportunities to provide patient care, establish and expand pharmacy services, and conduct targeted research and other projects relevant to community pharmacy. This podcast features three residency directors of community-based residency programs sharing insights and perspectives on the value of community-based residency training.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/idri5az8e9grmmz5/Shining_Light_on_Community-Based_Pharmacy_Residency_Programs_mixdowna43bg.mp3" length="31264257" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Community-based residency training programs provide unique opportunities to provide patient care, establish and expand pharmacy services, and conduct targeted research and other projects relevant to community pharmacy. This podcast features three residency directors of community-based residency programs sharing insights and perspectives on the value of community-based residency training.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1296</itunes:duration>
                <itunes:episode>1313</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures 2025 “Can’t Miss” Precepting Sessions Episode 1: Up your game: an interactive board game addressing preceptor challenges</title>
        <itunes:title>Pharmacy Futures 2025 “Can’t Miss” Precepting Sessions Episode 1: Up your game: an interactive board game addressing preceptor challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-2025-can-t-miss-precepting-sessions-episode-1-up-your-game-an-interactive-board-game-addressing-preceptor-challenges/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-2025-can-t-miss-precepting-sessions-episode-1-up-your-game-an-interactive-board-game-addressing-preceptor-challenges/#comments</comments>        <pubDate>Thu, 08 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/476d5986-5b4e-3a88-a50d-b86c2263062c</guid>
                                    <description><![CDATA[<p>In this episode, Julie Dagam sits down with Janet Cooley and Suzy Larson to discuss their upcoming session entitled “Up your game: an interactive board game addressing preceptor challenges”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Julie Dagam sits down with Janet Cooley and Suzy Larson to discuss their upcoming session entitled “Up your game: an interactive board game addressing preceptor challenges”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5cqrzgdnpveyuxpn/NPPC_Series_with_Suzy_Larson_Janet_Cooleyana3o.m4a" length="10805654" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, Julie Dagam sits down with Janet Cooley and Suzy Larson to discuss their upcoming session entitled “Up your game: an interactive board game addressing preceptor challenges”.  This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>446</itunes:duration>
                <itunes:episode>1305</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: ASHP Best Practice Award 2024: Implementation of Remote Certified Pharmacy Technician Ambulatory Care Services in a Large Physician Network</title>
        <itunes:title>Research in Pharmacy: ASHP Best Practice Award 2024: Implementation of Remote Certified Pharmacy Technician Ambulatory Care Services in a Large Physician Network</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2024-implementation-ofremote-certified-pharmacy-technician-ambulatory-care-services-ina-large-physician-n/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2024-implementation-ofremote-certified-pharmacy-technician-ambulatory-care-services-ina-large-physician-n/#comments</comments>        <pubDate>Wed, 07 May 2025 15:49:29 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f1c86054-9981-328b-93d3-b14bcd211229</guid>
                                    <description><![CDATA[<p>In this episode, the team from St. Elizabeth Physicians and the University of Cincinnati discuss their award-winning submission to the ASHP Best Practices.  They share how leveraging remote certified pharmacy technicians in ambulatory care helped expand clinical pharmacy services, improve value-based care, and impact their organization’s high performance on quality measures. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from St. Elizabeth Physicians and the University of Cincinnati discuss their award-winning submission to the ASHP Best Practices.  They share how leveraging remote certified pharmacy technicians in ambulatory care helped expand clinical pharmacy services, improve value-based care, and impact their organization’s high performance on quality measures. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dn88p36wrmru7fzj/ASHP_Best_Practice_Award_2024_Implementation_of_Remote_Certified_Pharmacy_Technician_Ambulatory_Care_Services_in_a_Large_Physician_Network_mixdown8pfzg.mp3" length="24686395" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from St. Elizabeth Physicians and the University of Cincinnati discuss their award-winning submission to the ASHP Best Practices.  They share how leveraging remote certified pharmacy technicians in ambulatory care helped expand clinical pharmacy services, improve value-based care, and impact their organization’s high performance on quality measures. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1022</itunes:duration>
                <itunes:episode>1310</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resiliency in Practice: Mind Matters: Conversations on Mental Health Awareness and Suicide</title>
        <itunes:title>Wellbeing and Resiliency in Practice: Mind Matters: Conversations on Mental Health Awareness and Suicide</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-mind-matters-conversations-on-mental-health-awareness-and-suicide/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resiliency-in-practice-mind-matters-conversations-on-mental-health-awareness-and-suicide/#comments</comments>        <pubDate>Tue, 06 May 2025 16:36:18 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bac6ec28-61f8-3db7-a6e3-51111cb12d73</guid>
                                    <description><![CDATA[<p>The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the intricacies and scope of suicide, review key research findings on the risk factors and warning signs for suicide, outline recommendations for suicide prevention, and provide guidance on addressing suicidal crisis or response. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the intricacies and scope of suicide, review key research findings on the risk factors and warning signs for suicide, outline recommendations for suicide prevention, and provide guidance on addressing suicidal crisis or response. </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z47stzrd27wrfjwy/ASHPOfficial_Mind_Matters_Conversations_on_Mental_Health_Awareness_and_Suicide_Prevention_FULL_AUDIO_mix.mp3" length="38034560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the intricacies and scope of suicide, review key research findings on the risk factors and warning signs for suicide, outline recommendations for suicide prevention, and provide guidance on addressing suicidal crisis or response. ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1584</itunes:duration>
                <itunes:episode>1309</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: Transitions of Care: Navigating Smooth Transition of Patient Care through Each Level of Acuity</title>
        <itunes:title>Pharmacy Hot Topics: Transitions of Care: Navigating Smooth Transition of Patient Care through Each Level of Acuity</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-transitions-of-care-navigating-smooth-transition-of-patient-care-through-each-level-of-acuity/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-transitions-of-care-navigating-smooth-transition-of-patient-care-through-each-level-of-acuity/#comments</comments>        <pubDate>Mon, 05 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4200d3c4-8e3c-3250-80d9-b2911c1f86c2</guid>
                                    <description><![CDATA[<p>Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fgqu4ys5zy7u7wpk/2_ASHPOfficial_Transitions_of_Care_Navigating_Smooth_Transition_of_Patient_Care_through_Each_Level_of_Acuity_MIX_mixdown.mp3" length="84491369" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3513</itunes:duration>
                <itunes:episode>1308</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: Overcoming Barriers to Sodium Glucose Cotransporter-2 Inhibitor Adoption</title>
        <itunes:title>Clinical Conversations: Overcoming Barriers to Sodium Glucose Cotransporter-2 Inhibitor Adoption</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-overcoming-barriers-to-sodium-glucose-cotransporter-2-inhibitor-adoption/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-overcoming-barriers-to-sodium-glucose-cotransporter-2-inhibitor-adoption/#comments</comments>        <pubDate>Thu, 01 May 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/05cb2c0c-f7a5-38be-ab60-3b1bc3472f24</guid>
                                    <description><![CDATA[<p>Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease.  Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease.  Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jfsp9hzd5r9y8xhp/ASHPOfficial_Overcoming_Barriers_to_Sodium_Glucose_Cotransporter_2_Inhibitor_Adoption_mix.mp3" length="34285868" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease.  Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2142</itunes:duration>
                <itunes:episode>1307</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: In Case You Missed It! A Recap of Emergency Medicine Talks from Midyear</title>
        <itunes:title>Clinical Conversations: SCSS: In Case You Missed It! A Recap of Emergency Medicine Talks from Midyear</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-in-case-you-missed-it-a-recap-of-emergency-medicine-talks-from-midyear/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-in-case-you-missed-it-a-recap-of-emergency-medicine-talks-from-midyear/#comments</comments>        <pubDate>Tue, 29 Apr 2025 16:41:14 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9c1ea9ea-7de0-3a69-8595-454a777ae365</guid>
                                    <description><![CDATA[<p>If you didn’t make it to the 2024 Midyear Clinical Meeting &amp; Exhibition or didn’t catch all of the emergency medicine related content, we have you covered!  Presenters will give pearl-style recaps of their talks and provide additional insight into application and implementation into practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>If you didn’t make it to the 2024 Midyear Clinical Meeting &amp; Exhibition or didn’t catch all of the emergency medicine related content, we have you covered!  Presenters will give pearl-style recaps of their talks and provide additional insight into application and implementation into practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6bm2e95whwwvbt84/ASHPOfficial_A_Recap_of_Emergency_Medicine_Talks_from_Midyear_Mix.mp3" length="65933578" type="audio/mpeg"/>
        <itunes:summary><![CDATA[If you didn’t make it to the 2024 Midyear Clinical Meeting &amp; Exhibition or didn’t catch all of the emergency medicine related content, we have you covered!  Presenters will give pearl-style recaps of their talks and provide additional insight into application and implementation into practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2747</itunes:duration>
                <itunes:episode>1306</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Pharmacy Student Resilience and Wellness: Insights from Pharmacy Professionals</title>
        <itunes:title>Student Perspectives: Pharmacy Student Resilience and Wellness: Insights from Pharmacy Professionals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-pharmacy-student-resilience-and-wellness-insights-from-pharmacy-professionals/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-pharmacy-student-resilience-and-wellness-insights-from-pharmacy-professionals/#comments</comments>        <pubDate>Fri, 25 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b2499b88-ff8f-3ce9-ad74-39a685a8c54a</guid>
                                    <description><![CDATA[<p>Navigating a pharmacy residency can be overwhelming, but resilience and support can make all the difference. Hear from Brody Maack and Jerica Lam as they reflect on the challenges they've faced, how they’ve prioritized wellness, and the lessons they’ve learned along the way. Whether you’re starting residency or supporting someone who is, this episode offers valuable insights and encouragement.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Navigating a pharmacy residency can be overwhelming, but resilience and support can make all the difference. Hear from Brody Maack and Jerica Lam as they reflect on the challenges they've faced, how they’ve prioritized wellness, and the lessons they’ve learned along the way. Whether you’re starting residency or supporting someone who is, this episode offers valuable insights and encouragement.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ehezvys5qap79pun/ASHPOfficial_Resilience_and_Wellness_Insights_from_Pharmacy_Professionals_MIX.mp3" length="118836560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Navigating a pharmacy residency can be overwhelming, but resilience and support can make all the difference. Hear from Brody Maack and Jerica Lam as they reflect on the challenges they've faced, how they’ve prioritized wellness, and the lessons they’ve learned along the way. Whether you’re starting residency or supporting someone who is, this episode offers valuable insights and encouragement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2970</itunes:duration>
                <itunes:episode>1300</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with the 2024 New Practitioners Forum Distinguished Service Awardee: Charnae Ross</title>
        <itunes:title>Pharmacy Leadership: A Conversation with the 2024 New Practitioners Forum Distinguished Service Awardee: Charnae Ross</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-the-2024-new-practitioners-forum-distinguished-service-awardee-charnae-ross/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-the-2024-new-practitioners-forum-distinguished-service-awardee-charnae-ross/#comments</comments>        <pubDate>Thu, 24 Apr 2025 09:21:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/af0ef6b0-89b4-3b9b-aa54-6d340e2d8cab</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Alfred Awuah, chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2024 NPF Distinguished Service Awardee, Charnae Ross, to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Alfred Awuah, chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2024 NPF Distinguished Service Awardee, Charnae Ross, to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fhyt9ifvh2t3w9b2/A_Conversation_with_the_2024_New_Practitioners_Forum_Distinguished_Service_AwardeeCharnae_Ross_mixdown785uo.mp3" length="15944129" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Alfred Awuah, chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2024 NPF Distinguished Service Awardee, Charnae Ross, to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>658</itunes:duration>
                <itunes:episode>1303</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: Prescription for Publication: A New Practitioner’s Guide to Research</title>
        <itunes:title>Research in Pharmacy: Prescription for Publication: A New Practitioner’s Guide to Research</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-prescription-for-publication-a-new-practitioner-s-guide-to-research/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-prescription-for-publication-a-new-practitioner-s-guide-to-research/#comments</comments>        <pubDate>Wed, 23 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dc876aed-a5f2-3b39-95a4-3d1d58675c42</guid>
                                    <description><![CDATA[<p>This podcast will empower new pharmacists to transform innovative ideas into impactful evidence. From developing research questions to navigating the peer-review process, this team will break down the steps to conducting meaningful studies and successfully sharing your findings. Join us as we uncover tips, tools, and expert insights to elevate pharmacy practice through research.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will empower new pharmacists to transform innovative ideas into impactful evidence. From developing research questions to navigating the peer-review process, this team will break down the steps to conducting meaningful studies and successfully sharing your findings. Join us as we uncover tips, tools, and expert insights to elevate pharmacy practice through research.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jbu3iwf3gr5iwxqi/ASHPOfficial_Prescription_for_Publication_A_New_Practitioner_s_Guide_to_Research_Mix_1_6aza4.mp3" length="33512333" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will empower new pharmacists to transform innovative ideas into impactful evidence. From developing research questions to navigating the peer-review process, this team will break down the steps to conducting meaningful studies and successfully sharing your findings. Join us as we uncover tips, tools, and expert insights to elevate pharmacy practice through research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2094</itunes:duration>
                <itunes:episode>1302</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Summit on Advanced Therapeutics in Pharmacy Practice</title>
        <itunes:title>Pharmacy Futures Podcast Series: Summit on Advanced Therapeutics in Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-summit-on-advanced-therapeutics-in-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-summit-on-advanced-therapeutics-in-pharmacy-practice/#comments</comments>        <pubDate>Mon, 21 Apr 2025 18:09:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1a8fc7f2-4053-344a-8a8b-00dc3bdcaa3b</guid>
                                    <description><![CDATA[<p>In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don’t miss this preview of one of the most anticipated events of the conference!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don’t miss this preview of one of the most anticipated events of the conference!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zngrgqhrfibduid8/2_Pharmacy_Futures_Podcast_Series_Kevin_Zinchuk_Denise_Scarpelli_and_Jill_Blind_mixdownaur27.mp3" length="14040262" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don’t miss this preview of one of the most anticipated events of the conference!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>584</itunes:duration>
                <itunes:episode>1301</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Overcoming Challenges with Remote Learning: A Preceptor's Perspective</title>
        <itunes:title>Informatics Bytes (CE): Overcoming Challenges with Remote Learning: A Preceptor's Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-overcoming-challenges-with-remote-learning-a-preceptors-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-overcoming-challenges-with-remote-learning-a-preceptors-perspective/#comments</comments>        <pubDate>Sat, 19 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9681c5d6-e805-3adc-a114-96c7f4859edd</guid>
                                    <description><![CDATA[<p>This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers will provide practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers will provide practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r4zvvu5bqesshqcj/ASHPOfficial_Overcoming_Challenges_with_Remote_Learning_A_Preceptor_s_Perspective_MIX.mp3" length="56811341" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers will provide practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2360</itunes:duration>
                <itunes:episode>1296</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series with Indrani Kar</title>
        <itunes:title>We’re Your Pharmacist Podcast Series with Indrani Kar</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-indrani-kar/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-indrani-kar/#comments</comments>        <pubDate>Fri, 18 Apr 2025 11:08:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/61cf4056-8d54-31e4-bc60-1dfcb4634905</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Indrani Kar, manager, formulary and drug policy at University Hospitals as she shares what drew her to a career in pharmacy, her experiences behind the scenes in a health-system setting, and the interdisciplinary team she works with to shape drug policy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Indrani Kar, manager, formulary and drug policy at University Hospitals as she shares what drew her to a career in pharmacy, her experiences behind the scenes in a health-system setting, and the interdisciplinary team she works with to shape drug policy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dumaga3iyg8qxrzi/We_re_Your_Pharmacist_Podcast_Series_with_Idrani_Kar_mixdown9qmmb.mp3" length="9426211" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Indrani Kar, manager, formulary and drug policy at University Hospitals as she shares what drew her to a career in pharmacy, her experiences behind the scenes in a health-system setting, and the interdisciplinary team she works with to shape drug policy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>386</itunes:duration>
                <itunes:episode>1295</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Advocating for Impact: Decoding the Executive Order on Drug Pricing</title>
        <itunes:title>Advocating for Impact: Decoding the Executive Order on Drug Pricing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-decoding-the-executive-order-on-drug-pricing/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-decoding-the-executive-order-on-drug-pricing/#comments</comments>        <pubDate>Fri, 18 Apr 2025 11:04:47 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/936962b4-3ee8-31dc-b78a-70823d667e2e</guid>
                                    <description><![CDATA[<p>This podcast will provide members with an analysis of the Trump Administration’s Executive Order (EO) on drug pricing. We’ll talk through what the EO means for the 340B program, the Inflation Reduction Act’s negotiated drug pricing program, and site neutral payment, and what ASHP will be watching in the coming weeks. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members with an analysis of the Trump Administration’s Executive Order (EO) on drug pricing. We’ll talk through what the EO means for the 340B program, the Inflation Reduction Act’s negotiated drug pricing program, and site neutral payment, and what ASHP will be watching in the coming weeks. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zjafe5iq3jx8ck5i/IRA_340B_EO_mixdown63o1u.mp3" length="40321824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members with an analysis of the Trump Administration’s Executive Order (EO) on drug pricing. We’ll talk through what the EO means for the 340B program, the Inflation Reduction Act’s negotiated drug pricing program, and site neutral payment, and what ASHP will be watching in the coming weeks. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1673</itunes:duration>
                <itunes:episode>1294</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Reducing readmissions with pharmacist-integrated care in Medicare value-based programs</title>
        <itunes:title>AJHP Voices: Reducing readmissions with pharmacist-integrated care in Medicare value-based programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-reducing-readmissions-with-pharmacist-integrated-care-in-medicare-value-based-programs/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-reducing-readmissions-with-pharmacist-integrated-care-in-medicare-value-based-programs/#comments</comments>        <pubDate>Thu, 17 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/88ba9fbb-3e0d-3f4f-88a3-cb1a8505063d</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Dor Partosh and Dr. Dovena Lazaridis discuss the AJHP Practice Research Report, “Reducing readmissions with pharmacist-integrated care in Medicare value-based programs,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Dor Partosh and Dr. Dovena Lazaridis discuss the AJHP Practice Research Report, “Reducing readmissions with pharmacist-integrated care in Medicare value-based programs,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/t9qxa2trbyqetap4/Reducing_readmissions_with_pharmacist-integrated_care_3_FINAL6ec1e.m4a" length="62154492" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Dor Partosh and Dr. Dovena Lazaridis discuss the AJHP Practice Research Report, “Reducing readmissions with pharmacist-integrated care in Medicare value-based programs,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2571</itunes:duration>
                <itunes:episode>1286</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Medication Safety Sessions with Sarah Stephens and Drew Stivers</title>
        <itunes:title>Pharmacy Futures Podcast Series: Medication Safety Sessions with Sarah Stephens and Drew Stivers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-medication-safety-sessions-with-sarah-stephens-and-drew-stivers/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-medication-safety-sessions-with-sarah-stephens-and-drew-stivers/#comments</comments>        <pubDate>Mon, 14 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3ccfcdf5-09e9-384b-b9ce-bc7bb6869529</guid>
                                    <description><![CDATA[<p>ASHP welcomes Sarah Stephens and Drew Stivers as they discuss two medication safety sessions planned for the ASHP Pharmacy Futures meeting June 7–11 in Charlotte, NC. Both active in the medication safety community, they share reflections on the benefits of the meeting’s networking offerings as a genuine highlight of their personal and professional satisfaction with attending the event.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP welcomes Sarah Stephens and Drew Stivers as they discuss two medication safety sessions planned for the ASHP Pharmacy Futures meeting June 7–11 in Charlotte, NC. Both active in the medication safety community, they share reflections on the benefits of the meeting’s networking offerings as a genuine highlight of their personal and professional satisfaction with attending the event.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tfkzrm4xujmspx4c/Pharmacy_Futures_Podcast_Series_with_Sarah_Stephens_Drew_Stivers_mixdown6e1fr.mp3" length="14946689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP welcomes Sarah Stephens and Drew Stivers as they discuss two medication safety sessions planned for the ASHP Pharmacy Futures meeting June 7–11 in Charlotte, NC. Both active in the medication safety community, they share reflections on the benefits of the meeting’s networking offerings as a genuine highlight of their personal and professional satisfaction with attending the event.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>616</itunes:duration>
                <itunes:episode>1285</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: Research that Moves Pharmacy Forward: Conversations with the 2024 ASHP Foundation Literature Award Winners</title>
        <itunes:title>Research in Pharmacy: Research that Moves Pharmacy Forward: Conversations with the 2024 ASHP Foundation Literature Award Winners</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-research-that-moves-pharmacy-forward-conversations-with-the-2024-ashp-foundation-literature-award-winners/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-research-that-moves-pharmacy-forward-conversations-with-the-2024-ashp-foundation-literature-award-winners/#comments</comments>        <pubDate>Thu, 10 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/17f8b931-887c-377f-968c-2390be2d5f04</guid>
                                    <description><![CDATA[<p>This podcast focuses on member research and scholarly activity along with pearls and best practices for pharmacist-driven research.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast focuses on member research and scholarly activity along with pearls and best practices for pharmacist-driven research.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yasabhw2nev7be7s/Research_that_Moves_Pharmacy_Forward_Conversations_with_the_2024_ASHP_Foundation_Literature_Awardees_mixdown8lqsd.mp3" length="27341393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast focuses on member research and scholarly activity along with pearls and best practices for pharmacist-driven research.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1132</itunes:duration>
                <itunes:episode>1284</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Theme Issue on Management of Infectious Diseases</title>
        <itunes:title>AJHP Voices: Theme Issue on Management of Infectious Diseases</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-theme-issue-on-management-of-infectious-diseases/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-theme-issue-on-management-of-infectious-diseases/#comments</comments>        <pubDate>Tue, 08 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6cdc8f11-0fb4-33bd-88f3-36b00bacbc9b</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Brandon Bookstaver and Dr. Kayla Stover discuss the AJHP theme issue on management of infectious diseases with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Brandon Bookstaver and Dr. Kayla Stover discuss the AJHP theme issue on management of infectious diseases with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/eytz3ph33g6b6v32/Infectious_Diseases_Theme_Issue8m9rp.m4a" length="45043520" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Brandon Bookstaver and Dr. Kayla Stover discuss the AJHP theme issue on management of infectious diseases with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1863</itunes:duration>
                <itunes:episode>1276</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacy Leadership: SICP DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Linda Spooner (2024)</title>
        <itunes:title>Pharmacy Leadership: SICP DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Linda Spooner (2024)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadershipsicpdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-inpatient-care-practitioners-linda-spooner2024/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadershipsicpdsaawardee-aconversation-with-distinguished-serviceawardee-for-the-sectionof-inpatient-care-practitioners-linda-spooner2024/#comments</comments>        <pubDate>Mon, 07 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f11c8f1f-7360-39c2-b83d-fc669945efa5</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Allison Porter is joined by the Section of Inpatient Care Practitioners 2024 Distinguished Service Awardee, Linda Spooner, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Allison Porter is joined by the Section of Inpatient Care Practitioners 2024 Distinguished Service Awardee, Linda Spooner, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4a88x2yuq3d5uysh/ASHPOfficial_Distinguished_Service_Awardee_for_the_Section_of_Inpatient_Care_Practitioners_Linda_Spooner_Mix.mp3" length="13999235" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Allison Porter is joined by the Section of Inpatient Care Practitioners 2024 Distinguished Service Awardee, Linda Spooner, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>874</itunes:duration>
                <itunes:episode>1277</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Brody Maack discusses workshops on Billing Strategies and Using Implementation Science for Controlled Substance Diversion Prevention</title>
        <itunes:title>Pharmacy Futures Podcast Series: Brody Maack discusses workshops on Billing Strategies and Using Implementation Science for Controlled Substance Diversion Prevention</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcastseries-brody-maackdiscussesworkshopson-billingstrategies-andusing-implementation-sciencefor-controlledsubstancediversionpreve/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcastseries-brody-maackdiscussesworkshopson-billingstrategies-andusing-implementation-sciencefor-controlledsubstancediversionpreve/#comments</comments>        <pubDate>Fri, 04 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9210c9a1-bf9e-3888-b8e9-52300f53a6f7</guid>
                                    <description><![CDATA[<p>ASHP is joined by Brody Maack for an overview of two interactive programs planned in Charlotte at the 2025 ASHP Pharmacy Futures Meeting. Along with Bonnie Kirschenbaum,  Brody will present Cracking the Code: Transforming Practice with Improved Billing Strategies.  </p>
<p>Joined By Evan Frasure,  Dr. Maack will tackle Bridging the Gap: Leveraging Implementation Science to Strengthen Controlled Substance Diversion Prevention Practices.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP is joined by Brody Maack for an overview of two interactive programs planned in Charlotte at the 2025 ASHP Pharmacy Futures Meeting. Along with Bonnie Kirschenbaum,  Brody will present Cracking the Code: Transforming Practice with Improved Billing Strategies.  </p>
<p>Joined By Evan Frasure,  Dr. Maack will tackle Bridging the Gap: Leveraging Implementation Science to Strengthen Controlled Substance Diversion Prevention Practices.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uzi4drfaw42qn3dw/2_Pharmacy_Futures_Podcast_Series_with_Brody_Maack_mixdown96n8x.mp3" length="15433081" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP is joined by Brody Maack for an overview of two interactive programs planned in Charlotte at the 2025 ASHP Pharmacy Futures Meeting. Along with Bonnie Kirschenbaum,  Brody will present Cracking the Code: Transforming Practice with Improved Billing Strategies.  
Joined By Evan Frasure,  Dr. Maack will tackle Bridging the Gap: Leveraging Implementation Science to Strengthen Controlled Substance Diversion Prevention Practices.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>636</itunes:duration>
                <itunes:episode>1274</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Pharmacy prevalence of second victim syndrome in a comprehensive cancer center</title>
        <itunes:title>AJHP Voices: Pharmacy prevalence of second victim syndrome in a comprehensive cancer center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacy-prevalence-of-second-victim-syndrome-in-a-comprehensive-cancer-center/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacy-prevalence-of-second-victim-syndrome-in-a-comprehensive-cancer-center/#comments</comments>        <pubDate>Thu, 03 Apr 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/31423caa-c0de-3d15-b95b-34c36fca3f0e</guid>
                                    <description><![CDATA[<p class="xmsonormal">In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/icjgp9kiv6sdd4qg/Pharmacy_Prevalence_of_Second_Victim_Syndrome_Final781u6.m4a" length="49775005" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2059</itunes:duration>
                <itunes:episode>1275</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: Inspiration by Innovation: Success Stories Utilizing Practice Advancement Initiative (PAI) 2030</title>
        <itunes:title>Hot Topics in Pharmacy: Inspiration by Innovation: Success Stories Utilizing Practice Advancement Initiative (PAI) 2030</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-inspiration-by-innovation-success-stories-utilizing-practice-advancement-initiative-pai-2030/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-inspiration-by-innovation-success-stories-utilizing-practice-advancement-initiative-pai-2030/#comments</comments>        <pubDate>Fri, 28 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7e901498-76a5-341b-80d9-b94f265edd38</guid>
                                    <description><![CDATA[<p>ASHP’s Practice Advancement Initiative (PAI) 2030 provides pharmacists with the tools and guidance they need to continue to lead and shape the profession through 59 unique recommendations.  This podcast highlights 3 pharmacist success stories in health systems across the country where they have implemented changes utilizing the PAI 2030 recommendations. Our guests were able to implement new services in New York, North Dakota, and South Dakota, strengthening patient care for their health systems.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s Practice Advancement Initiative (PAI) 2030 provides pharmacists with the tools and guidance they need to continue to lead and shape the profession through 59 unique recommendations.  This podcast highlights 3 pharmacist success stories in health systems across the country where they have implemented changes utilizing the PAI 2030 recommendations. Our guests were able to implement new services in New York, North Dakota, and South Dakota, strengthening patient care for their health systems.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/g5kepsiugc7ud6bd/ASHPOfficial_Success_Stories_Utilizing_Practice_Advancement_Initiative_2030_Mix.mp3" length="21904304" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s Practice Advancement Initiative (PAI) 2030 provides pharmacists with the tools and guidance they need to continue to lead and shape the profession through 59 unique recommendations.  This podcast highlights 3 pharmacist success stories in health systems across the country where they have implemented changes utilizing the PAI 2030 recommendations. Our guests were able to implement new services in New York, North Dakota, and South Dakota, strengthening patient care for their health systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1369</itunes:duration>
                <itunes:episode>1272</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Resilient Rx for Pharmacy Learners: From Stress to Success</title>
        <itunes:title>Hot Topics in Pharmacy: The Resilient Rx for Pharmacy Learners: From Stress to Success</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-resilient-rx-for-pharmacy-learners-from-stress-to-success/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-resilient-rx-for-pharmacy-learners-from-stress-to-success/#comments</comments>        <pubDate>Thu, 27 Mar 2025 13:04:30 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b3d529df-2871-33df-b6c6-d798f6b01cb9</guid>
                                    <description><![CDATA[<p>In this episode, we explore the unique challenges pharmacy students and residents face during their training, including the risk of burnout, and discuss practical strategies for maintaining balance, building resilience, and fostering a sense of community. Our conversation highlights real-life experiences, expert advice, and actionable tips to help pharmacy learners prioritize their well-being while thriving in their professional journey. Whether you're navigating the demands of rotations, studying for boards, or managing the pressures of residency, this episode offers a refreshing perspective on sustaining your passion and purpose in pharmacy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we explore the unique challenges pharmacy students and residents face during their training, including the risk of burnout, and discuss practical strategies for maintaining balance, building resilience, and fostering a sense of community. Our conversation highlights real-life experiences, expert advice, and actionable tips to help pharmacy learners prioritize their well-being while thriving in their professional journey. Whether you're navigating the demands of rotations, studying for boards, or managing the pressures of residency, this episode offers a refreshing perspective on sustaining your passion and purpose in pharmacy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ithg7pj2iunbkbgb/ASHPOfficial_The_Resilient_Rx_for_Pharmacy_Learners_Mix.mp3" length="32848052" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we explore the unique challenges pharmacy students and residents face during their training, including the risk of burnout, and discuss practical strategies for maintaining balance, building resilience, and fostering a sense of community. Our conversation highlights real-life experiences, expert advice, and actionable tips to help pharmacy learners prioritize their well-being while thriving in their professional journey. Whether you're navigating the demands of rotations, studying for boards, or managing the pressures of residency, this episode offers a refreshing perspective on sustaining your passion and purpose in pharmacy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2053</itunes:duration>
                <itunes:episode>1273</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty: Enhancing Pharmacy Practice Through Community-Based Residency Training</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty: Enhancing Pharmacy Practice Through Community-Based Residency Training</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-enhancing-pharmacy-practice-through-community-based-residency-training/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-enhancing-pharmacy-practice-through-community-based-residency-training/#comments</comments>        <pubDate>Thu, 27 Mar 2025 12:54:06 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8ddaa519-0f62-3874-80cd-7d1d0bc11af0</guid>
                                    <description><![CDATA[<p>During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jyfbpbqdhec8jim5/Enhancing_Pharmacy_Practice_through_Community-Based_Residency_Training_mixdown6jwtb.mp3" length="35780393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1484</itunes:duration>
                <itunes:episode>1271</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Fast Facts for Ambulatory Care Billing: 2025 Physician Fee Schedule Update</title>
        <itunes:title>Hot Topics in Pharmacy: Fast Facts for Ambulatory Care Billing: 2025 Physician Fee Schedule Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-fast-facts-for-ambulatory-care-billing-2025-physician-fee-schedule-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-fast-facts-for-ambulatory-care-billing-2025-physician-fee-schedule-update/#comments</comments>        <pubDate>Mon, 24 Mar 2025 14:47:11 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/39577adc-d212-36bd-8e8e-56eead542910</guid>
                                    <description><![CDATA[<p>Billing opportunities in ambulatory care can often be complicated to navigate and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast will provide an overview of the 2025 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Billing opportunities in ambulatory care can often be complicated to navigate and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast will provide an overview of the 2025 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x5t59vkvh462x9xb/ASHPOfficial_Fast_Facts_for_Ambulatory_Care_Billing_2025_Physician_Fee_Schedule_Update_FULL_AUDIO_mix.mp3" length="59763008" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Billing opportunities in ambulatory care can often be complicated to navigate and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast will provide an overview of the 2025 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2490</itunes:duration>
                <itunes:episode>1270</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS (CE): Pharmacogenomics in Solid Organ Transplant</title>
        <itunes:title>Clinical Conversations: SCSS (CE): Pharmacogenomics in Solid Organ Transplant</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-ce-pharmacogenomics-in-solid-organ-transplant/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-ce-pharmacogenomics-in-solid-organ-transplant/#comments</comments>        <pubDate>Sat, 22 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/73fdeb7d-4745-3718-90e7-28ee10fab8e9</guid>
                                    <description><![CDATA[<p>This podcast will highlight opportunities for pharmacogenomic testing in solid organ transplant. The speakers will discuss their experiences and challenges with utilizing pharmacogenomic testing in this patient population.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will highlight opportunities for pharmacogenomic testing in solid organ transplant. The speakers will discuss their experiences and challenges with utilizing pharmacogenomic testing in this patient population.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/k55yjshfkikef59c/Solid_Organ_Transplant_and_Pharmacogenomics_mixdown6mjup.mp3" length="21136772" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will highlight opportunities for pharmacogenomic testing in solid organ transplant. The speakers will discuss their experiences and challenges with utilizing pharmacogenomic testing in this patient population.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>874</itunes:duration>
                <itunes:episode>1267</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Speaker Series Podcast: Comprehensive Weight Management Workshop: A Multidisciplinary Approach for Pharmacists</title>
        <itunes:title>Pharmacy Futures Speaker Series Podcast: Comprehensive Weight Management Workshop: A Multidisciplinary Approach for Pharmacists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-speaker-series-podcast-comprehensive-weight-management-workshop-a-multidisciplinary-approach-for-pharmacists/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-speaker-series-podcast-comprehensive-weight-management-workshop-a-multidisciplinary-approach-for-pharmacists/#comments</comments>        <pubDate>Thu, 20 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dc22e3b7-83cf-3d1c-a72a-29ff55349661</guid>
                                    <description><![CDATA[<p>ASHP is joined by Megan Adelman as she describes the multidisciplinary workshop planned for Wednesday June 11th. Hands-on weight management instruction will be provided by two pharmacists, a nutritionist, a movement specialist, and a behavioral health expert. Learners will engage in active learning,  including case studies, role-playing motivational interviews, gaming, and design of personalized care plans.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP is joined by Megan Adelman as she describes the multidisciplinary workshop planned for Wednesday June 11th. Hands-on weight management instruction will be provided by two pharmacists, a nutritionist, a movement specialist, and a behavioral health expert. Learners will engage in active learning,  including case studies, role-playing motivational interviews, gaming, and design of personalized care plans.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8fr9dz7mv9hsjatj/2025_Pharmacy_Futures_with_Megan_Adelman_Revised_031325_FINAL7hds5.m4a" length="14912207" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[ASHP is joined by Megan Adelman as she describes the multidisciplinary workshop planned for Wednesday June 11th. Hands-on weight management instruction will be provided by two pharmacists, a nutritionist, a movement specialist, and a behavioral health expert. Learners will engage in active learning,  including case studies, role-playing motivational interviews, gaming, and design of personalized care plans.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>616</itunes:duration>
                <itunes:episode>1269</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: What Pharmacists Need to Know About Myasthenia Gravis</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: What Pharmacists Need to Know About Myasthenia Gravis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-pharmacists-need-to-know-about-myasthenia-gravis/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-pharmacists-need-to-know-about-myasthenia-gravis/#comments</comments>        <pubDate>Wed, 19 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/aece0f61-70bc-3053-a88e-9dd8094ea03a</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on the pharmacist’s role in Myasthenia Gravis.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on the pharmacist’s role in Myasthenia Gravis.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kbbt85ucrdnd6jus/ASHPOfficial_ADV_What_Pharmacists_Need_to_Know_About_Myasthenia_Gravis_MIX.mp3" length="100927784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on the pharmacist’s role in Myasthenia Gravis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2523</itunes:duration>
                <itunes:episode>1265</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pain Management Demystified: for the Ambulatory Care Pharmacist</title>
        <itunes:title>Pain Management Demystified: for the Ambulatory Care Pharmacist</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pain-management-demystified-for-the-ambulatory-care-pharmacist/</link>
                    <comments>https://ashpofficial.podbean.com/e/pain-management-demystified-for-the-ambulatory-care-pharmacist/#comments</comments>        <pubDate>Tue, 18 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f9e202e9-be82-3e5c-bf4a-b11bf70e864d</guid>
                                    <description><![CDATA[<p>This podcast will highlight common pain issues that may arise in the ambulatory care setting, providing recommendations and tools on how to appropriately triage and make recommendations. The speakers for this podcast are expert pain management practitioners.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will highlight common pain issues that may arise in the ambulatory care setting, providing recommendations and tools on how to appropriately triage and make recommendations. The speakers for this podcast are expert pain management practitioners.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ugq2338p4gsdcp2p/ASHPOfficial_Pain_Management_Demystified_FULL_AUDIO_revised_2_1_a4plq.mp3" length="37065588" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will highlight common pain issues that may arise in the ambulatory care setting, providing recommendations and tools on how to appropriately triage and make recommendations. The speakers for this podcast are expert pain management practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1544</itunes:duration>
                <itunes:episode>1268</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series with Allison Given, PharmD Candidate 2026</title>
        <itunes:title>We’re Your Pharmacist Podcast Series with Allison Given, PharmD Candidate 2026</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-allison-given-pharmd-candidate-2026/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-allison-given-pharmd-candidate-2026/#comments</comments>        <pubDate>Fri, 14 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/88a4cded-3eb9-3832-893d-fcb5bdafcfe2</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Allison Given, PharmD candidate at the University of Charleston, College of Pharmacy as she shares what drew her to a career in pharmacy, her experiences with clinical pharmacists as a cystic fibrosis patient, and the patient interactions she’s already had as a pharmacy student. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Allison Given, PharmD candidate at the University of Charleston, College of Pharmacy as she shares what drew her to a career in pharmacy, her experiences with clinical pharmacists as a cystic fibrosis patient, and the patient interactions she’s already had as a pharmacy student. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vyr6jcupzhhzb23g/We_re_Your_Pharmacist_AllisonGiven_mixdown7l1zx.mp3" length="19269653" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Allison Given, PharmD candidate at the University of Charleston, College of Pharmacy as she shares what drew her to a career in pharmacy, her experiences with clinical pharmacists as a cystic fibrosis patient, and the patient interactions she’s already had as a pharmacy student. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>796</itunes:duration>
                <itunes:episode>1262</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Research in Pharmacy: Changing Times in Research</title>
        <itunes:title>Research in Pharmacy: Changing Times in Research</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-changing-times-in-research/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-changing-times-in-research/#comments</comments>        <pubDate>Thu, 13 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fe46b25e-1659-3fd6-a87d-44e75f0b077d</guid>
                                    <description><![CDATA[<p>Join Sandra Kane-Gill and Katie Suda to discuss changes in research including open access requirements, getting funding, and artificial intelligence and implications for pharmacist researchers.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join Sandra Kane-Gill and Katie Suda to discuss changes in research including open access requirements, getting funding, and artificial intelligence and implications for pharmacist researchers.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kdub5gkv49cecdp3/Changing_Times_in_Research_mixdownan6o0.mp3" length="21959679" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join Sandra Kane-Gill and Katie Suda to discuss changes in research including open access requirements, getting funding, and artificial intelligence and implications for pharmacist researchers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>908</itunes:duration>
                <itunes:episode>1264</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPE DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Educators Lea Eiland</title>
        <itunes:title>Pharmacy Leadership: SPE DSA Awardee: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Educators Lea Eiland</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-spe-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-educators-lea-eiland/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-spe-dsa-awardee-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-educators-lea-eiland/#comments</comments>        <pubDate>Mon, 10 Mar 2025 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a84514aa-c77f-3c91-aa5f-f29ef3d137af</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Cher Enderby sits down with the Section of Pharmacy Educators Awardee Lea Eiland to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Cher Enderby sits down with the Section of Pharmacy Educators Awardee Lea Eiland to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hduscjq7hypq97m3/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Pharmacy_Educators_Lea_Eilan_mixdown5zisu.mp3" length="28637688" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Cher Enderby sits down with the Section of Pharmacy Educators Awardee Lea Eiland to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1186</itunes:duration>
                <itunes:episode>1263</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: How Pharmacists Can Be Engaged in Myasthenia Gravis Care</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: How Pharmacists Can Be Engaged in Myasthenia Gravis Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-how-pharmacists-can-be-engaged-in-myasthenia-gravis-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-how-pharmacists-can-be-engaged-in-myasthenia-gravis-care/#comments</comments>        <pubDate>Wed, 05 Mar 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/451f9d28-fa1f-31c0-a054-ade4ada99677</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on the pharmacists role in Myasthenia Gravis.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on the pharmacists role in Myasthenia Gravis.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tkg56hydqu225qhj/ASHPOfficial_ADV_Myasthenia_Gravis_Podcast_MIX.mp3" length="55348832" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on the pharmacists role in Myasthenia Gravis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1383</itunes:duration>
                <itunes:episode>1260</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Pharmacy Futures 2025: All about Compounding and the Designated Person Program</title>
        <itunes:title>ASHP Pharmacy Futures 2025: All about Compounding and the Designated Person Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-pharmacy-futures-2025-all-about-compounding-and-the-designated-person-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-pharmacy-futures-2025-all-about-compounding-and-the-designated-person-program/#comments</comments>        <pubDate>Fri, 28 Feb 2025 17:10:03 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e14e8ff4-e00d-3eeb-b715-32d82161100c</guid>
                                    <description><![CDATA[<p>Patricia Kienle, Cardinal Health, and Mike Ganio , ASHP , join us to discuss the compounding educational line up at the ASHP Pharmacy Futures meeting in June and explain the unique opportunity to participate in the Designated Person Program that offers a live skills workshop on Wednesday June 11th.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Patricia Kienle, Cardinal Health, and Mike Ganio , ASHP , join us to discuss the compounding educational line up at the ASHP Pharmacy Futures meeting in June and explain the unique opportunity to participate in the Designated Person Program that offers a live skills workshop on Wednesday June 11th.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/u8u4fde89z4n89fb/Pharmacy_Futures_Podcast_Series_with_Patti_Kienle_and_Mike_Ganio_mixdownayrvc.mp3" length="19892363" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Patricia Kienle, Cardinal Health, and Mike Ganio , ASHP , join us to discuss the compounding educational line up at the ASHP Pharmacy Futures meeting in June and explain the unique opportunity to participate in the Designated Person Program that offers a live skills workshop on Wednesday June 11th.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>822</itunes:duration>
                <itunes:episode>1261</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SCSS DSA Awardee: Pharmacy Leadership Distinguished Service Award: Bhivak Shah</title>
        <itunes:title>Pharmacy Leadership: SCSS DSA Awardee: Pharmacy Leadership Distinguished Service Award: Bhivak Shah</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-scss-dsa-awardee-pharmacy-leadership-distinguished-service-award-bhivak-shah/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-scss-dsa-awardee-pharmacy-leadership-distinguished-service-award-bhivak-shah/#comments</comments>        <pubDate>Wed, 26 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dbef1a4b-a270-3285-98f0-b7f30d8d7f44</guid>
                                    <description><![CDATA[<p>Nancy MacDonald, Immediate Past Chair of the Section of Clinical Specialists and Scientists sits down with Distinguished Service Awardee Bhavik Shah to discuss his service and leadership within ASHP.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Nancy MacDonald, Immediate Past Chair of the Section of Clinical Specialists and Scientists sits down with Distinguished Service Awardee Bhavik Shah to discuss his service and leadership within ASHP.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2fpk9uh5wk73n9bg/Pharmacy_Leadership_SCSS_DSA_Awardee_Bhavik_Shah_mixdown8ra42.mp3" length="19862845" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Nancy MacDonald, Immediate Past Chair of the Section of Clinical Specialists and Scientists sits down with Distinguished Service Awardee Bhavik Shah to discuss his service and leadership within ASHP.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>821</itunes:duration>
                <itunes:episode>1259</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation in Pharmacy Practice: Applying Machine Learning Models to Predict Medication Non-Adherence in IBD Patients</title>
        <itunes:title>Innovation in Pharmacy Practice: Applying Machine Learning Models to Predict Medication Non-Adherence in IBD Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-in-pharmacy-practice-applying-machine-learning-models-to-predict-medication-non-adherence-in-ibd-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-in-pharmacy-practice-applying-machine-learning-models-to-predict-medication-non-adherence-in-ibd-patients/#comments</comments>        <pubDate>Tue, 25 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c88f72b1-c534-3753-b0a4-8ed86450772b</guid>
                                    <description><![CDATA[<p>This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy’s recent ML model research, key findings, and the potential applications of these models across different patient populations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy’s recent ML model research, key findings, and the potential applications of these models across different patient populations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e5x3dmqr92autzkm/2_Applying_Machine_Learning_Models_to_Predict_Medication_Non-Adherence_in_IBD_Patients_mixdowna6z5r.mp3" length="35125326" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy’s recent ML model research, key findings, and the potential applications of these models across different patient populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1463</itunes:duration>
                <itunes:episode>1253</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model</title>
        <itunes:title>AJHP Voices: Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-ultra-complex-specialty-medicationsmeeting-the-challenges-ofsignificant-medication-requirements-throughan-integrated-specialty-pharmacy-mo/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-ultra-complex-specialty-medicationsmeeting-the-challenges-ofsignificant-medication-requirements-throughan-integrated-specialty-pharmacy-mo/#comments</comments>        <pubDate>Tue, 18 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/242f1a72-8c3c-3cbc-a5a6-79bc98301037</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fgjd5pntc3zxy4sk/Ultra-Complex_Specialty_Medications_Version_20_1_6hx7y.m4a" length="50967642" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2108</itunes:duration>
                <itunes:episode>1256</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series with Emily Bryant, PharmD, BCPS</title>
        <itunes:title>We’re Your Pharmacist Podcast Series with Emily Bryant, PharmD, BCPS</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-emily-bryant-pharmd-bcps/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-emily-bryant-pharmd-bcps/#comments</comments>        <pubDate>Fri, 14 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6d5b2627-ee46-3777-9a80-d23388a93a64</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Emily Bryant, Clinical Pharmacist and Residency Program Coordinator at Aurora Health Care, as she shares insights on her pharmacy career journey, her experiences working with pharmacy students and residents, and the various roles of pharmacists as medication experts in a hospital setting. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Emily Bryant, Clinical Pharmacist and Residency Program Coordinator at Aurora Health Care, as she shares insights on her pharmacy career journey, her experiences working with pharmacy students and residents, and the various roles of pharmacists as medication experts in a hospital setting. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vjsq7zu2vp457u9f/We_re_Your_Pharmacist_Emily_Bryant_mixdown766nn.mp3" length="19550495" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Emily Bryant, Clinical Pharmacist and Residency Program Coordinator at Aurora Health Care, as she shares insights on her pharmacy career journey, her experiences working with pharmacy students and residents, and the various roles of pharmacists as medication experts in a hospital setting. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>808</itunes:duration>
                <itunes:episode>1257</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Medication Safety: Redefining PGY2 Residency Training in Medication-Use Safety and Policy</title>
        <itunes:title>Medication Safety: Redefining PGY2 Residency Training in Medication-Use Safety and Policy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-redefining-pgy2-residency-training-in-medication-use-safety-and-policy/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-redefining-pgy2-residency-training-in-medication-use-safety-and-policy/#comments</comments>        <pubDate>Thu, 13 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3141a32-970c-3387-8e64-9b6fd6b6cfeb</guid>
                                    <description><![CDATA[<p>This podcast dives into the innovative PGY2 Medication-Use Safety and Policy (MUSP) residency programs at City of Hope. These groundbreaking programs, developed in collaboration with Chapman University and Becton Dickinson, offer residents unique opportunities in academia and medical technology, providing comprehensive training that redefines advanced pharmacy education. Join us as we explore how these residencies are shaping the future of medication safety, hear firsthand experiences from current residents, and discuss the impact of blending academic and industry expertise.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast dives into the innovative PGY2 Medication-Use Safety and Policy (MUSP) residency programs at City of Hope. These groundbreaking programs, developed in collaboration with Chapman University and Becton Dickinson, offer residents unique opportunities in academia and medical technology, providing comprehensive training that redefines advanced pharmacy education. Join us as we explore how these residencies are shaping the future of medication safety, hear firsthand experiences from current residents, and discuss the impact of blending academic and industry expertise.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cke3zcrpaciipe95/3_Redefining_PGY2_Residency_Training_in_Medication-Use_Safety_and_Policy_mixdown82d78.mp3" length="27817218" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast dives into the innovative PGY2 Medication-Use Safety and Policy (MUSP) residency programs at City of Hope. These groundbreaking programs, developed in collaboration with Chapman University and Becton Dickinson, offer residents unique opportunities in academia and medical technology, providing comprehensive training that redefines advanced pharmacy education. Join us as we explore how these residencies are shaping the future of medication safety, hear firsthand experiences from current residents, and discuss the impact of blending academic and industry expertise.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1158</itunes:duration>
                <itunes:episode>1258</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Technician Society Podcast: A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum Charlotte V. Hook</title>
        <itunes:title>Pharmacy Technician Society Podcast: A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum Charlotte V. Hook</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-technician-society-podcast-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum-charlotte-v-hook/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-technician-society-podcast-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum-charlotte-v-hook/#comments</comments>        <pubDate>Tue, 11 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bb3f4b6b-84c6-31e7-9f6c-f2bb14518f2a</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Kelli Johnson sits down with the Pharmacy Technician Forum (now The Pharmacy Technician Society) Awardee Charlotte Hook to discuss what forum membership, TPTS, and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Kelli Johnson sits down with the Pharmacy Technician Forum (now The Pharmacy Technician Society) Awardee Charlotte Hook to discuss what forum membership, TPTS, and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ui5ftnuvdzjv59i5/A_Conversation_with_Distinguished_Service_Awardee_for_the_Pharmacy_Technician_Forum_Charlotte_V_Hook_mixdown9e1hn.mp3" length="17205324" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Kelli Johnson sits down with the Pharmacy Technician Forum (now The Pharmacy Technician Society) Awardee Charlotte Hook to discuss what forum membership, TPTS, and ASHP means to her and how it has helped her develop as a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>710</itunes:duration>
                <itunes:episode>1254</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/2048_-_Podbean_Tile7gapp.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Opioid REMS – Beyond the basics</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Opioid REMS – Beyond the basics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-opioid-rems-%e2%80%93-beyond-the-basics/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-opioid-rems-%e2%80%93-beyond-the-basics/#comments</comments>        <pubDate>Wed, 05 Feb 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e1331038-0d9e-3ea0-ad7c-36517b593ac1</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on opioid REMS. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on opioid REMS. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2k6cpyvviitpdmiv/ASHPOfficial_ADV_Opioid_REMS_REVISED_MIX.mp3" length="80038388" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on opioid REMS. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2000</itunes:duration>
                <itunes:episode>1248</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: 2025 Pharmacy Forecast Report</title>
        <itunes:title>AJHP Voices: 2025 Pharmacy Forecast Report</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-2025-pharmacy-forecast-report/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-2025-pharmacy-forecast-report/#comments</comments>        <pubDate>Mon, 03 Feb 2025 17:12:23 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/da639566-81ae-353e-9622-c1a0229bb4aa</guid>
                                    <description><![CDATA[<p>In this podcast, Drs. Rena Gosser, Christopher Scott, and Johnathan Watanabe discuss the ASHP/ASHP Foundation 2025 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Drs. Rena Gosser, Christopher Scott, and Johnathan Watanabe discuss the ASHP/ASHP Foundation 2025 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hu563ddm32bnq2r5/2025_Pharmacy_Forecast_Report_Edited_10_1_1_629qm.m4a" length="67075895" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Drs. Rena Gosser, Christopher Scott, and Johnathan Watanabe discuss the ASHP/ASHP Foundation 2025 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2774</itunes:duration>
                <itunes:episode>1255</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Educator Essentials: Beyond Campus Walls: Successes and Lessons Learned in Developing Interprofessional Learning Experiences Across Institutions</title>
        <itunes:title>Educator Essentials: Beyond Campus Walls: Successes and Lessons Learned in Developing Interprofessional Learning Experiences Across Institutions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-beyond-campus-walls-successes-and-lessons-learned-in-developing-interprofessional-learning-experiences-across-institutions/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-beyond-campus-walls-successes-and-lessons-learned-in-developing-interprofessional-learning-experiences-across-institutions/#comments</comments>        <pubDate>Thu, 30 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5ab45595-7b9f-39ab-b3b3-1b396b399097</guid>
                                    <description><![CDATA[<p>Creating interprofessional experiences between didactic pharmacy students and perscribers can be challenging for all schools/colleges of pharmacy, yet these experiences remain an important part of the student experience and accreditation standards. Some schools face additional geographic and institutional barriers based on their physical location and the programs offered by their colleges/universities. Join us as we hear from a panel of faculty and administrators who have implemented creative solutions to successfully deliver exceptional interprofessional experiences. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Creating interprofessional experiences between didactic pharmacy students and perscribers can be challenging for all schools/colleges of pharmacy, yet these experiences remain an important part of the student experience and accreditation standards. Some schools face additional geographic and institutional barriers based on their physical location and the programs offered by their colleges/universities. Join us as we hear from a panel of faculty and administrators who have implemented creative solutions to successfully deliver exceptional interprofessional experiences. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vg5adwqu8pnbqngm/ASHPOfficial_Beyond_Campus_Walls_Successes_and_Lessons_Learned_MIX.mp3" length="60752576" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Creating interprofessional experiences between didactic pharmacy students and perscribers can be challenging for all schools/colleges of pharmacy, yet these experiences remain an important part of the student experience and accreditation standards. Some schools face additional geographic and institutional barriers based on their physical location and the programs offered by their colleges/universities. Join us as we hear from a panel of faculty and administrators who have implemented creative solutions to successfully deliver exceptional interprofessional experiences. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1518</itunes:duration>
                <itunes:episode>1252</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy/Clinical Conversations: NPF: Leadership Advice from 2024 ASHP Fellows</title>
        <itunes:title>Hot Topics in Pharmacy/Clinical Conversations: NPF: Leadership Advice from 2024 ASHP Fellows</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacyclinical-conversations-npf-leadership-advice-from-2024-ashp-fellows/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacyclinical-conversations-npf-leadership-advice-from-2024-ashp-fellows/#comments</comments>        <pubDate>Tue, 28 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/085c6946-6ee4-3f6a-b7cc-2e7bcd31d1ec</guid>
                                    <description><![CDATA[<p>Join us for this podcast episode where four 2024 ASHP Fellows discuss their journeys in pharmacy leadership. They’ll share valuable insights and advice for pharmacists, especially for new practitioners, who aspire to become leaders in the profession. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for this podcast episode where four 2024 ASHP Fellows discuss their journeys in pharmacy leadership. They’ll share valuable insights and advice for pharmacists, especially for new practitioners, who aspire to become leaders in the profession. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/aimpmi5a3nfxd4hw/Leadership_Advice_from_2024_ASHP_Fellows_mixdown7pswq.mp3" length="46439207" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for this podcast episode where four 2024 ASHP Fellows discuss their journeys in pharmacy leadership. They’ll share valuable insights and advice for pharmacists, especially for new practitioners, who aspire to become leaders in the profession. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1928</itunes:duration>
                <itunes:episode>1250</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations/Pharmacy Hot Topics: SICP: Rare Diseases and Everyday Pharmacy Practice</title>
        <itunes:title>Clinical Conversations/Pharmacy Hot Topics: SICP: Rare Diseases and Everyday Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversationspharmacy-hot-topics-sicp-rare-diseases-and-everyday-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversationspharmacy-hot-topics-sicp-rare-diseases-and-everyday-pharmacy-practice/#comments</comments>        <pubDate>Mon, 27 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7224a13b-4b54-3517-88b7-dfb60f408c6b</guid>
                                    <description><![CDATA[<p>How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xdx98hgrkyag2xuv/HOWRAR_1.mp3" length="35991251" type="audio/mpeg"/>
        <itunes:summary><![CDATA[How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1493</itunes:duration>
                <itunes:episode>1244</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series with Linda Gordon BSPharm, DPLA, and Rachel Hawley, PharmD</title>
        <itunes:title>We’re Your Pharmacist Podcast Series with Linda Gordon BSPharm, DPLA, and Rachel Hawley, PharmD</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-linda-gordon-bspharm-dpla-and-rachel-hawley-pharmd/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-with-linda-gordon-bspharm-dpla-and-rachel-hawley-pharmd/#comments</comments>        <pubDate>Thu, 23 Jan 2025 11:02:10 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b37b7fbe-8330-3cf6-b7de-9610eff32114</guid>
                                    <description><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. Hosted by Rachel Hawley, this month's episode features Linda Gordon, System Director of Diversion Prevention at UC Health, as she shares insights on her pharmacy career journey, the collaborative nature of interprofessional care teams, and the growing impact of AI in pharmacy practice. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. Hosted by Rachel Hawley, this month's episode features Linda Gordon, System Director of Diversion Prevention at UC Health, as she shares insights on her pharmacy career journey, the collaborative nature of interprofessional care teams, and the growing impact of AI in pharmacy practice. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/72dkndrpts5bcpnx/2_We_re_Your_Pharmacist_Linda_Gordon_mixdown9lgfc.mp3" length="11077139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. Hosted by Rachel Hawley, this month's episode features Linda Gordon, System Director of Diversion Prevention at UC Health, as she shares insights on her pharmacy career journey, the collaborative nature of interprofessional care teams, and the growing impact of AI in pharmacy practice. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>455</itunes:duration>
                <itunes:episode>1251</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: A new NIOSH list is out. Now what?</title>
        <itunes:title>Hot Topics in Pharmacy: A new NIOSH list is out. Now what?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-a-new-niosh-list-is-out-now-what/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-a-new-niosh-list-is-out-now-what/#comments</comments>        <pubDate>Thu, 23 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/48add7de-1ace-386f-a2e5-8af029d2551f</guid>
                                    <description><![CDATA[<p>NIOSH published an updated list of hazardous drugs in healthcare settings in December, 2024 – its first update in nearly 8 years. The new list includes significant changes that affect how USP Chapter &lt;800&gt; can be applied to some hazardous drugs. Experts discuss the updated list and its implications for pharmacy practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>NIOSH published an updated list of hazardous drugs in healthcare settings in December, 2024 – its first update in nearly 8 years. The new list includes significant changes that affect how USP Chapter &lt;800&gt; can be applied to some hazardous drugs. Experts discuss the updated list and its implications for pharmacy practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r4j6utrbavijtsi2/A_New_NIOSH_List_FINAL_011420257k3jl.m4a" length="28178069" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[NIOSH published an updated list of hazardous drugs in healthcare settings in December, 2024 – its first update in nearly 8 years. The new list includes significant changes that affect how USP Chapter &lt;800&gt; can be applied to some hazardous drugs. Experts discuss the updated list and its implications for pharmacy practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1165</itunes:duration>
                <itunes:episode>1249</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: PAI 2030: Shaping the Future of Pharmacy Teams and Technicians</title>
        <itunes:title>Practice Journeys: PAI 2030: Shaping the Future of Pharmacy Teams and Technicians</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-pai-2030-shaping-the-future-of-pharmacy-teams-and-technicians/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-pai-2030-shaping-the-future-of-pharmacy-teams-and-technicians/#comments</comments>        <pubDate>Sat, 18 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/17c57344-5ab4-32f3-8234-3de9d68d062b</guid>
                                    <description><![CDATA[<p>In this episode, we explore the evolving role of pharmacy technicians and how PAI 2030 is shaping the future of pharmacy practice. Our guests discuss advanced technician responsibilities like technician product verification, regulatory compliance, and the importance of formal career paths and certifications. Tune in to hear insights on how these changes are positively impacting patient care and the dynamics of pharmacy teams. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we explore the evolving role of pharmacy technicians and how PAI 2030 is shaping the future of pharmacy practice. Our guests discuss advanced technician responsibilities like technician product verification, regulatory compliance, and the importance of formal career paths and certifications. Tune in to hear insights on how these changes are positively impacting patient care and the dynamics of pharmacy teams. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m8vyprmhrwhz2hvb/ASHP_PAI_2030_Shaping_the_Future_of_Pharmacy_Teams_and_Technicians_FULL_AUDIO_mix.mp3" length="28516673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we explore the evolving role of pharmacy technicians and how PAI 2030 is shaping the future of pharmacy practice. Our guests discuss advanced technician responsibilities like technician product verification, regulatory compliance, and the importance of formal career paths and certifications. Tune in to hear insights on how these changes are positively impacting patient care and the dynamics of pharmacy teams. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1782</itunes:duration>
                <itunes:episode>1246</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate</title>
        <itunes:title>AJHP Voices: Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-moving-forward-from-cockcroft-gault-creatinine-clearance-to-race-free-estimated-glomerular-filtration-rate/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-moving-forward-from-cockcroft-gault-creatinine-clearance-to-race-free-estimated-glomerular-filtration-rate/#comments</comments>        <pubDate>Thu, 16 Jan 2025 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c6cc3fe5-55df-3045-a6f5-9d4de664d0bc</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Descriptive Report, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Descriptive Report, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ggi9apwc9ciamp8y/FINAL_18_Moving_forward_from_Cockcroft-Gault_creatinine_clearance_1_9mhap.m4a" length="51520101" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Descriptive Report, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2131</itunes:duration>
                <itunes:episode>1245</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Conversations: SCSS (C.E.): Solid Organ Transplant Pharmacy: The Ins and Outs of an Outpatient Clinic</title>
        <itunes:title>Clinical Conversations: SCSS (C.E.): Solid Organ Transplant Pharmacy: The Ins and Outs of an Outpatient Clinic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-ce-solid-organ-transplant-pharmacy-the-ins-and-outs-of-an-outpatient-clinic/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-ce-solid-organ-transplant-pharmacy-the-ins-and-outs-of-an-outpatient-clinic/#comments</comments>        <pubDate>Tue, 14 Jan 2025 11:30:42 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/416d70b2-3fbf-3112-a253-8adc7dfac0d2</guid>
                                    <description><![CDATA[<p>Solid organ transplant pharmacy is a multi-faceted field that offers opportunities to practice in either the inpatient or outpatient setting. This discussion focuses on what the role of a transplant pharmacist may look like in an ambulatory care setting, considerations when initiating or expanding outpatient pharmacy services, as well as the potential obstacles faced by solid organ transplant pharmacists.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Solid organ transplant pharmacy is a multi-faceted field that offers opportunities to practice in either the inpatient or outpatient setting. This discussion focuses on what the role of a transplant pharmacist may look like in an ambulatory care setting, considerations when initiating or expanding outpatient pharmacy services, as well as the potential obstacles faced by solid organ transplant pharmacists.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cqxqfgtg3tr45zhx/ASHP_PAI_2030_Shaping_the_Future_of_Pharmacy_Teams_and_Technicians_FULL_AUDIO_mix_1_b8tue.mp3" length="26467535" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Solid organ transplant pharmacy is a multi-faceted field that offers opportunities to practice in either the inpatient or outpatient setting. This discussion focuses on what the role of a transplant pharmacist may look like in an ambulatory care setting, considerations when initiating or expanding outpatient pharmacy services, as well as the potential obstacles faced by solid organ transplant pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1654</itunes:duration>
                <itunes:episode>1247</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Brigid Hurst</title>
        <itunes:title>Live from Midyear: A conversation with Brigid Hurst</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-brigid-hurst/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-brigid-hurst/#comments</comments>        <pubDate>Thu, 02 Jan 2025 12:17:09 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6844adc4-aeff-3596-b742-70ac4f2b0372</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fvcbvyvqft3nhf3f/MCM24_StudentPodcast_Brigid_Hurst_mixdown9brqf.mp3" length="10197066" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>418</itunes:duration>
                <itunes:episode>1243</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: AI-Powered Precepting: Enhancing Efficiency and Engagement in Clinical Rotations</title>
        <itunes:title>Educator Essentials: AI-Powered Precepting: Enhancing Efficiency and Engagement in Clinical Rotations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-ai-powered-precepting-enhancing-efficiency-and-engagement-in-clinical-rotations/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-ai-powered-precepting-enhancing-efficiency-and-engagement-in-clinical-rotations/#comments</comments>        <pubDate>Fri, 20 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cccded33-ad73-3059-9373-564b096bcb9b</guid>
                                    <description><![CDATA[<p>From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform pharmacy practice. This podcast will outline and discuss how artificial intelligence is and how can it be utilized within the profession of pharmacy and pharmacy education</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform pharmacy practice. This podcast will outline and discuss how artificial intelligence is and how can it be utilized within the profession of pharmacy and pharmacy education</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pn7f77y7fsicbnyp/AI-Powered_Precepting_Enhancing_Efficiency_and_Engagement_in_Clinical_Rotations_mixdown_2_7qu9n.mp3" length="49294010" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform pharmacy practice. This podcast will outline and discuss how artificial intelligence is and how can it be utilized within the profession of pharmacy and pharmacy education
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2047</itunes:duration>
                <itunes:episode>1241</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>We’re Your Pharmacist Podcast Series: Ashley Ramp, PharmD, MS, MEd</title>
        <itunes:title>We’re Your Pharmacist Podcast Series: Ashley Ramp, PharmD, MS, MEd</itunes:title>
        <link>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-ashley-ramp-pharmd-ms-med/</link>
                    <comments>https://ashpofficial.podbean.com/e/we-re-your-pharmacist-podcast-series-ashley-ramp-pharmd-ms-med/#comments</comments>        <pubDate>Thu, 19 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/37b62aef-d0dd-3620-876d-95783703c826</guid>
                                    <description><![CDATA[<p>In this episode of We’re Your Pharmacist podcast series, ASHP sits down with Ashley Ramp, Multi-Site Director of Pharmacy at Children's Hospital Colorado. Ashley shares her journey of becoming a pharmacist, where she draws inspiration, and her experience transitioning careers from being a high school teacher to health-system pharmacist.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of We’re Your Pharmacist podcast series, ASHP sits down with Ashley Ramp, Multi-Site Director of Pharmacy at Children's Hospital Colorado. Ashley shares her journey of becoming a pharmacist, where she draws inspiration, and her experience transitioning careers from being a high school teacher to health-system pharmacist.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3d6qvvapee8vrqhr/We_re_Your_Pharmacist_Ashley_M_Ramp_mixdown_1_9nnvq.mp3" length="12577404" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of We’re Your Pharmacist podcast series, ASHP sits down with Ashley Ramp, Multi-Site Director of Pharmacy at Children's Hospital Colorado. Ashley shares her journey of becoming a pharmacist, where she draws inspiration, and her experience transitioning careers from being a high school teacher to health-system pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>517</itunes:duration>
                <itunes:episode>1242</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/Your-Pharmacist-Podcast-thumbnail-3000x3000.png" />    </item>
    <item>
        <title>Live from Midyear: A conversation with Deanna Laughlin &amp; Rachel Hawley</title>
        <itunes:title>Live from Midyear: A conversation with Deanna Laughlin &amp; Rachel Hawley</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-deanna-laughlin-rachel-hawley/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-deanna-laughlin-rachel-hawley/#comments</comments>        <pubDate>Wed, 11 Dec 2024 08:29:17 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/67c119a3-51a2-3689-8298-607057e00366</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cmi4tnar8mwsenda/20_MCM24_StudentPodcast_Deanna_Laughlin_Rachel_Hawley_mixdown_1_7ggma.mp3" length="7020018" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>286</itunes:duration>
                <itunes:episode>1240</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Shannon Woods</title>
        <itunes:title>Live from Midyear: A conversation with Shannon Woods</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-shannon-woods/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-shannon-woods/#comments</comments>        <pubDate>Tue, 10 Dec 2024 14:52:08 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/16a4cc95-aed2-3576-9cd7-849d636e90f8</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5t4vqz8vxm43jvsf/MCM24_StudentPodcast_Shannon_Woods_mixdown_1_619zn.mp3" length="9741053" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>399</itunes:duration>
                <itunes:episode>1239</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Venise Govan</title>
        <itunes:title>Live from Midyear: A conversation with Venise Govan</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-venise-govan/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-venise-govan/#comments</comments>        <pubDate>Tue, 10 Dec 2024 12:48:35 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c5460742-cc50-3066-aaa4-9edc523b8ada</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/znr4vs2yubfqfu8w/MCM24_StudentPodcast_Venise_Govan_Alisha_Reed_mixdown_1_6o102.mp3" length="9799876" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>402</itunes:duration>
                <itunes:episode>1238</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Myra Anwar</title>
        <itunes:title>Live from Midyear: A conversation with Myra Anwar</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-myra-anwar/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-myra-anwar/#comments</comments>        <pubDate>Tue, 10 Dec 2024 12:45:38 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f46e54e1-d5d7-308c-898f-fde0a00a0222</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zkd4k47uxeevayf5/2_MCM24_StudentPodcast_Myra_Anwar_mixdown_1_7omee.mp3" length="8296678" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>339</itunes:duration>
                <itunes:episode>1237</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Live from Midyear: A conversation with Kayla Nueva</title>
        <itunes:title>Live from Midyear: A conversation with Kayla Nueva</itunes:title>
        <link>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-kayla-nueva/</link>
                    <comments>https://ashpofficial.podbean.com/e/live-from-midyear-a-conversation-with-kayla-nueva/#comments</comments>        <pubDate>Mon, 09 Dec 2024 18:18:54 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/68f4cf74-f3f1-3e7e-b5f7-7ccbed2f8196</guid>
                                    <description><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/88a6t9vz4p39zmv7/MCM24_StudentPodcast_Kayla_Nueva_Alisha_Reed_mixdownan9o4.mp3" length="7589061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting &amp; Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>310</itunes:duration>
                <itunes:episode>1236</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: There’s Nothing Like Clinical Pharmacy Leadership at Midyear 2024</title>
        <itunes:title>Pharmacy Leadership: There’s Nothing Like Clinical Pharmacy Leadership at Midyear 2024</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-there-s-nothing-like-clinical-pharmacy-leadership-at-midyear-2024/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-there-s-nothing-like-clinical-pharmacy-leadership-at-midyear-2024/#comments</comments>        <pubDate>Sat, 07 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/72878939-2378-338f-84e3-9178572529b9</guid>
                                    <description><![CDATA[<p>There’s Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p><em>There’s Nothing Like It</em> is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gn4pryuwsjgnshyg/There_s_Nothing_Like_Clinical_Pharmacy_Leadership_at_Midyear_2024_mixdown_1_6tn6x.mp3" length="26359948" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There’s Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1092</itunes:duration>
                <itunes:episode>1233</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations SCSS: Antifungal TDM Controversies</title>
        <itunes:title>Clinical Conversations SCSS: Antifungal TDM Controversies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-antifungal-tdm-controversies/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-antifungal-tdm-controversies/#comments</comments>        <pubDate>Fri, 06 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/79de896b-71e0-3fcf-a9a2-1957248673de</guid>
                                    <description><![CDATA[<p>Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pncczyyjzqnvesbb/ASHP_Antifungal_TDM_Controversies_FULL_AUDIO_mix_1_7wt9s.mp3" length="32035319" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2002</itunes:duration>
                <itunes:episode>1235</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: There is Something in my Eye! Discussion on Commonly Used Ophthalmologic Therapies Used in the Emergency Department</title>
        <itunes:title>Clinical Conversations: SCSS: There is Something in my Eye! Discussion on Commonly Used Ophthalmologic Therapies Used in the Emergency Department</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-there-is-something-in-my-eye-discussion-on-commonly-used-ophthalmologic-therapies-used-in-the-emergency-department/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-there-is-something-in-my-eye-discussion-on-commonly-used-ophthalmologic-therapies-used-in-the-emergency-department/#comments</comments>        <pubDate>Thu, 05 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b5acb93-7069-3135-add9-7f8a3716661e</guid>
                                    <description><![CDATA[<p>Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ndp83v2v827t8tc3/There_is_Something_in_my_Eye_mixdown_1_ahwmb.mp3" length="45038238" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1870</itunes:duration>
                <itunes:episode>1234</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SACP: Optimizing Chronic Medications to Promote Weight Loss</title>
        <itunes:title>Clinical Conversations: SACP: Optimizing Chronic Medications to Promote Weight Loss</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-optimizing-chronic-medications-to-promote-weight-loss/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-optimizing-chronic-medications-to-promote-weight-loss/#comments</comments>        <pubDate>Wed, 04 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/540477f2-abad-3481-9efa-20c70ee2d2ee</guid>
                                    <description><![CDATA[<p>According to the CDC, nearly 42% of Americans have obesity,  with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>According to the CDC, nearly 42% of Americans have obesity,  with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bbw74ca3zyx5dtar/Optimizing_Chronic_Medications_to_Promote_Weight_Loss_mixdown_1_87u3r.mp3" length="31082683" type="audio/mpeg"/>
        <itunes:summary><![CDATA[According to the CDC, nearly 42% of Americans have obesity,  with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1290</itunes:duration>
                <itunes:episode>1232</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: Implementing a Pharmacogenomics Program into Practice into Ambulatory Care</title>
        <itunes:title>Clinical Conversations: SCSS: Implementing a Pharmacogenomics Program into Practice into Ambulatory Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-implementing-a-pharmacogenomics-program-into-practice-into-ambulatory-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-implementing-a-pharmacogenomics-program-into-practice-into-ambulatory-care/#comments</comments>        <pubDate>Mon, 02 Dec 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/92ac7c3d-e405-36db-8a73-c8ed28fb32e7</guid>
                                    <description><![CDATA[<p>Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/va47egugfhxvhpnk/Implementing_a_Pharmacogenomics_Program_into_Practice_into_Ambulatory_Care_mixdown_1_7qnd6.mp3" length="35385693" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1468</itunes:duration>
                <itunes:episode>1229</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2024: Race-Based Clinical Calculations Causing Healthcare Disparities</title>
        <itunes:title>ASHP Midyear Speaker Series 2024: Race-Based Clinical Calculations Causing Healthcare Disparities</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-race-based-clinical-calculations-causing-healthcare-disparities/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-race-based-clinical-calculations-causing-healthcare-disparities/#comments</comments>        <pubDate>Mon, 25 Nov 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/60d852d0-1372-3c3c-9d80-7d1b5ff321c5</guid>
                                    <description><![CDATA[<p>Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/39tpb6w9w36idarr/MCM_2024_Race-Based_Clinical_Calculations_Causing_Healthcare_Disparities_mixdown_1_78cb0.mp3" length="10859461" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>445</itunes:duration>
                <itunes:episode>1225</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: Be Antibiotics Aware: Management of Community-acquired Pneumonia in Hospitalized Adults</title>
        <itunes:title>Clinical Conversations: Be Antibiotics Aware: Management of Community-acquired Pneumonia in Hospitalized Adults</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-be-antibiotics-aware-management-of-community-acquired-pneumonia-in-hospitalized-adults/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-be-antibiotics-aware-management-of-community-acquired-pneumonia-in-hospitalized-adults/#comments</comments>        <pubDate>Thu, 21 Nov 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fa3fd91d-ca75-3953-a893-44638549dc4f</guid>
                                    <description><![CDATA[<p>The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/upuq4myctv8ax58u/ASHPOfficial_Be_Antibiotics_Aware_Management_of_Community_acquired_Pneumonia_in_Hospitalized_Adults_FULL_AUDIO_mix_2_7ji2m.mp3" length="71490323" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2234</itunes:duration>
                <itunes:episode>1228</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership (C.E. , CPEL): Opioid Stewardship from the Leader’s Perspective: Development and Inception</title>
        <itunes:title>Pharmacy Leadership (C.E. , CPEL): Opioid Stewardship from the Leader’s Perspective: Development and Inception</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-ce-cpel-opioid-stewardship-from-the-leader-s-perspective-development-and-inception/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-ce-cpel-opioid-stewardship-from-the-leader-s-perspective-development-and-inception/#comments</comments>        <pubDate>Wed, 20 Nov 2024 14:59:48 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e7f360bc-2090-3788-9366-469fb9e53b86</guid>
                                    <description><![CDATA[<p>In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dpdzihrxjhb3pyus/Opioid_Stewardship_from_the_Leader_s_Perspective_Development_and_Inception_mixdown_1_6zlgd.mp3" length="29453961" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1221</itunes:duration>
                <itunes:episode>1231</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: AJHP theme issue on critical care pharmacy practice</title>
        <itunes:title>AJHP Voices: AJHP theme issue on critical care pharmacy practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-ajhp-theme-issue-on-critical-care-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-ajhp-theme-issue-on-critical-care-pharmacy-practice/#comments</comments>        <pubDate>Wed, 20 Nov 2024 14:54:42 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/882bb483-062d-3b57-a687-229c97b2d1a3</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8iytynh7w44i5r4f/Critical_Care_Theme_Issue_2_bhv8v.m4a" length="46696309" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1931</itunes:duration>
                <itunes:episode>1230</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Midyear Speaker Series 2024: Pharmacy Forecast 2025: Trends That Will Shape Your Future</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Midyear Speaker Series 2024: Pharmacy Forecast 2025: Trends That Will Shape Your Future</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-midyear-speaker-series-2024-pharmacy-forecast-2025-trends-that-will-shape-your-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-midyear-speaker-series-2024-pharmacy-forecast-2025-trends-that-will-shape-your-future/#comments</comments>        <pubDate>Wed, 13 Nov 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/70db2694-2f6f-3129-925c-91efca6b8fd4</guid>
                                    <description><![CDATA[<p>Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor).  The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor).  The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ffbpvixd86yyp6zu/MCM_2024_Pharmacy_Forecast_2025_Trends_That_Will_Shape_Your_Future_mixdown8vf2a.mp3" length="19141939" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor).  The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>790</itunes:duration>
                <itunes:episode>1222</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: ASHP on PBMs Part 4: What is a PBM GPO?</title>
        <itunes:title>Advocating for Impact: ASHP on PBMs Part 4: What is a PBM GPO?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-4-what-is-a-pbm-gpo/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-4-what-is-a-pbm-gpo/#comments</comments>        <pubDate>Tue, 12 Nov 2024 15:46:25 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/57c6b3f4-1827-3c53-941e-061d2a7bc586</guid>
                                    <description><![CDATA[<p class="xmsonormal">This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p class="xmsonormal">In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p class="xmsonormal">In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ykqpmnhbghu9wqa2/2_PBMs_4_mixdown_1_7kdp6.mp3" length="29275209" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. 
In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1219</itunes:duration>
                <itunes:episode>1227</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Veteran Voices: Pharmacists’ Journeys in Service</title>
        <itunes:title>Practice Journeys: Veteran Voices: Pharmacists’ Journeys in Service</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-veteran-voices-pharmacists-journeys-in-service/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-veteran-voices-pharmacists-journeys-in-service/#comments</comments>        <pubDate>Fri, 08 Nov 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/59fce137-d677-37f5-acb0-74c55c5414b0</guid>
                                    <description><![CDATA[<p>In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xnge2i4agab9nvsp/ASHPOfficial_Veteran_Voices_Pharmacists_Journeys_in_Service_Mix.mp3" length="43301825" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2706</itunes:duration>
                <itunes:episode>1221</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SACP: Rapid Administration of Undiluted Levetiracetam</title>
        <itunes:title>Clinical Conversations: SACP: Rapid Administration of Undiluted Levetiracetam</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-rapid-administration-of-undiluted-levetiracetam/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-rapid-administration-of-undiluted-levetiracetam/#comments</comments>        <pubDate>Thu, 07 Nov 2024 15:00:23 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/96a26da2-b2e3-3d85-818d-ec2c5acb550a</guid>
                                    <description><![CDATA[<p>In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7m57qwuuznmpeewt/Rapid_Administration_of_Undiluted_Levetiracetam_mixdown_1_60je5.mp3" length="30423642" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1261</itunes:duration>
                <itunes:episode>1224</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2024: A Pharmacist’s Role in Harm Reduction from Policy to Practice</title>
        <itunes:title>ASHP Midyear Speaker Series 2024: A Pharmacist’s Role in Harm Reduction from Policy to Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-a-pharmacist-s-role-in-harm-reduction-from-policy-to-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-a-pharmacist-s-role-in-harm-reduction-from-policy-to-practice/#comments</comments>        <pubDate>Mon, 04 Nov 2024 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2a5695c1-2db5-3646-8c87-494249f9faeb</guid>
                                    <description><![CDATA[<p>ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&amp;M University  and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&amp;M University  and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x45kth7erqtwziuu/MCM_2024_A_Pharmacist_s_Role_in_Harm_Reduction_from_Policy_to_Practice_mixdown9tubp.mp3" length="11689016" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&amp;M University  and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>480</itunes:duration>
                <itunes:episode>1219</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Treatment Disparities in Emergency Medicine: Time to D(E)-Ive into Change</title>
        <itunes:title>Treatment Disparities in Emergency Medicine: Time to D(E)-Ive into Change</itunes:title>
        <link>https://ashpofficial.podbean.com/e/treatment-disparities-in-emergency-medicine-time-to-de-ive-into-change/</link>
                    <comments>https://ashpofficial.podbean.com/e/treatment-disparities-in-emergency-medicine-time-to-de-ive-into-change/#comments</comments>        <pubDate>Thu, 31 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c201bb89-27f0-3446-8ae8-87bf4adf1e50</guid>
                                    <description><![CDATA[<p>Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4by7hy7dxsa2yi5e/Treatment_Disparities_in_Emergency_Medicine_Time_to_DE-Ive_into_Change_mixdown6ypj7.mp3" length="42935657" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1781</itunes:duration>
                <itunes:episode>1217</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2024: I Think I Am, Therefore I Am? Shaping Professional Identity Formation to Reduce Burnout and Improve Resilience Among Pharmacists and Technicians</title>
        <itunes:title>ASHP Midyear Speaker Series 2024: I Think I Am, Therefore I Am? Shaping Professional Identity Formation to Reduce Burnout and Improve Resilience Among Pharmacists and Technicians</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashpmidyear-speakerseries-2024-ithink-i-am-therefore-iam-shaping-professionalidentity-formation-to-reduce-burnout-andimprove-resilienceamongpharmacis/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashpmidyear-speakerseries-2024-ithink-i-am-therefore-iam-shaping-professionalidentity-formation-to-reduce-burnout-andimprove-resilienceamongpharmacis/#comments</comments>        <pubDate>Mon, 28 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/43067640-bd41-3f4d-b842-13749d080c7e</guid>
                                    <description><![CDATA[<p>ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman,  Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman,  Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/krbg7qjfxvesmsbp/3_ASHP_Midyear_Speaker_Series_2024_I_Think_I_Am_Therefore_I_Am_Shaping_Professional_Identity_Formation_mixdown8dwsp.mp3" length="11587733" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman,  Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>475</itunes:duration>
                <itunes:episode>1218</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Generative AI: Impact on Inpatient Pharmacy Practice</title>
        <itunes:title>Informatics Bytes (CE): Generative AI: Impact on Inpatient Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-inpatient-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-inpatient-pharmacy-practice/#comments</comments>        <pubDate>Fri, 25 Oct 2024 15:59:31 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/991c224c-a498-33d4-af72-fae27ff74240</guid>
                                    <description><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2kvw63s3tvydx7az/2_Generative_AI_Impact_on_Inpatient_Pharmacy_Practice_20240904T133243275093_mixdown6rq07.mp3" length="24618885" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1020</itunes:duration>
                <itunes:episode>1223</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: Down the Vein - Care Benefits of Home Infusion and Outpatient Infusion Therapy</title>
        <itunes:title>Pharmacy Leadership: SPPL: Down the Vein - Care Benefits of Home Infusion and Outpatient Infusion Therapy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-down-the-vein-care-benefits-of-home-infusion-and-outpatient-infusion-therapy/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-down-the-vein-care-benefits-of-home-infusion-and-outpatient-infusion-therapy/#comments</comments>        <pubDate>Thu, 24 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7453f7f8-c7ac-331b-8e5f-cf335e9a6c7e</guid>
                                    <description><![CDATA[<p>This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2ptgagcw7gyhnxgf/Down_the_Vein_Care_Benefits_of_Home_Infusion_and_Outpatient_FINAL6yacc.m4a" length="48706249" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2014</itunes:duration>
                <itunes:episode>1216</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Community Health Worker Collaboration and Impact on Student Pharmacists</title>
        <itunes:title>Community Pharmacy: Community Health Worker Collaboration and Impact on Student Pharmacists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-community-health-worker-collaboration-and-impact-on-student-pharmacists/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-community-health-worker-collaboration-and-impact-on-student-pharmacists/#comments</comments>        <pubDate>Mon, 21 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c7b5bc9c-a949-3dba-baad-e567047f4c4d</guid>
                                    <description><![CDATA[<p>Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i4yvu873y74wkczi/Community_Health_Worker_Collaboration_and_Impact_on_Student_Pharmacists_mixdownbn2nc.mp3" length="21461603" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>888</itunes:duration>
                <itunes:episode>1220</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2024: Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs</title>
        <itunes:title>ASHP Midyear Speaker Series 2024: Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashpmidyear-speakerseries-2024-empoweringtomorrowspharmacytechnicians-fostering-partnershipswithacademiato-developcutting-edge-techniciantraining-p/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashpmidyear-speakerseries-2024-empoweringtomorrowspharmacytechnicians-fostering-partnershipswithacademiato-developcutting-edge-techniciantraining-p/#comments</comments>        <pubDate>Fri, 18 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6ae904cc-5447-3909-9ada-634a82fe49e6</guid>
                                    <description><![CDATA[<p>John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs.</p>
<p>
The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, <em>Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs.</em></p>
<p><br>
The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4na2qquchwua8e72/MCM_Speaker_Series_Empowering_Tomorrows_Pharmacy_Technicians-Fostering_Partnerships_with_Academia_mixdown83rp4.mp3" length="21856352" type="audio/mpeg"/>
        <itunes:summary><![CDATA[John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs.
The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>903</itunes:duration>
                <itunes:episode>1215</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: ASHP on PBMs Part 3: White Bagging and Site of Care Restrictions</title>
        <itunes:title>Advocating for Impact: ASHP on PBMs Part 3: White Bagging and Site of Care Restrictions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-3-white-bagging-and-site-of-care-restrictions/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-3-white-bagging-and-site-of-care-restrictions/#comments</comments>        <pubDate>Fri, 11 Oct 2024 10:40:56 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/451fb662-e830-3632-ac8d-b964c8b0e8c4</guid>
                                    <description><![CDATA[<p>This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p>In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p>In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/aypt23vfr4myz7fn/ASHP_on_PBMs_Part_3_White_Bagging_and_Site_of_Care_Restrictions_mixdownbqtjv.mp3" length="37490822" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. 
In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1556</itunes:duration>
                <itunes:episode>1213</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Saving the Drugs That Kill the Bugs — Community Pharmacy Antimicrobial Stewardship</title>
        <itunes:title>Saving the Drugs That Kill the Bugs — Community Pharmacy Antimicrobial Stewardship</itunes:title>
        <link>https://ashpofficial.podbean.com/e/saving-the-drugs-that-kill-the-bugs-%e2%80%94-community-pharmacy-antimicrobial-stewardship/</link>
                    <comments>https://ashpofficial.podbean.com/e/saving-the-drugs-that-kill-the-bugs-%e2%80%94-community-pharmacy-antimicrobial-stewardship/#comments</comments>        <pubDate>Wed, 09 Oct 2024 15:25:05 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5211d732-0531-3f42-95eb-f7f407594e9a</guid>
                                    <description><![CDATA[<p>We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yqpbeychnk87c6ii/ASHP_Saving_the_Drugs_that_Kill_the_Bugs_Community_Pharmacy_Antimicrobial_Stewardship_FULL_AUDIO_mix.mp3" length="28829006" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1801</itunes:duration>
                <itunes:episode>1214</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Midyear Speaker Series 2024: When the Good Times Roll Too Far: Overview of "Party Drug" Management</title>
        <itunes:title>ASHP Midyear Speaker Series 2024: When the Good Times Roll Too Far: Overview of "Party Drug" Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-when-the-good-times-roll-too-far-overview-of-party-drug-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-midyear-speaker-series-2024-when-the-good-times-roll-too-far-overview-of-party-drug-management/#comments</comments>        <pubDate>Mon, 07 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/776a17d7-1fda-334b-8ce0-9086e6c6cdff</guid>
                                    <description><![CDATA[<p>Join us for an insightful episode where experts Brian W. Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS, Lance Ray, PharmD, BCEMP, BCPS, and Ruben D. Santiago, PharmD, BCCCP, BCPS discuss an upcoming educational session at the Midyear Clinical Meeting and Exhibition focused on the current state of illicit drug use in the United States. The session will cover both nonpharmacological and pharmacological management strategies, offering valuable insights for pharmacists via engaging case-based scenarios. Don’t miss this opportunity to stay informed on critical trends and treatment approaches!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for an insightful episode where experts Brian W. Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS, Lance Ray, PharmD, BCEMP, BCPS, and Ruben D. Santiago, PharmD, BCCCP, BCPS discuss an upcoming educational session at the Midyear Clinical Meeting and Exhibition focused on the current state of illicit drug use in the United States. The session will cover both nonpharmacological and pharmacological management strategies, offering valuable insights for pharmacists via engaging case-based scenarios. Don’t miss this opportunity to stay informed on critical trends and treatment approaches!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mi39yttacp6zdw6b/ASHP_Midyear_Clinical_Meeting_and_Exhibition_Speaker_SeriesWhen_the_Good_Times_Roll_Too_FarOverview_of_Party_Drug_Management_mixdown91qmq.mp3" length="13448650" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for an insightful episode where experts Brian W. Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS, Lance Ray, PharmD, BCEMP, BCPS, and Ruben D. Santiago, PharmD, BCCCP, BCPS discuss an upcoming educational session at the Midyear Clinical Meeting and Exhibition focused on the current state of illicit drug use in the United States. The session will cover both nonpharmacological and pharmacological management strategies, offering valuable insights for pharmacists via engaging case-based scenarios. Don’t miss this opportunity to stay informed on critical trends and treatment approaches!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>553</itunes:duration>
                <itunes:episode>1212</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: AI for Pharmacy Leaders, a two-part learning experience</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: AI for Pharmacy Leaders, a two-part learning experience</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-ai-for-pharmacy-leaders-a-two-part-learning-experience/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-ai-for-pharmacy-leaders-a-two-part-learning-experience/#comments</comments>        <pubDate>Sat, 05 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fc07042c-e1ef-3e35-af9d-a0229d6c974a</guid>
                                    <description><![CDATA[<p>In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Jared White, manager, pharmacy data analytics at UCSF and Ben Michaels, data science pharmacist at UCSF Medical Center at UCSF as they discuss their upcoming sessions AI for Pharmacy Leaders, Part 1 and Part 2. They will provide background information and forward-facing strategies expressly curated for leaders to stay abreast of this ever-changing landscape.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Jared White, manager, pharmacy data analytics at UCSF and Ben Michaels, data science pharmacist at UCSF Medical Center at UCSF as they discuss their upcoming sessions AI for Pharmacy Leaders, Part 1 and Part 2. They will provide background information and forward-facing strategies expressly curated for leaders to stay abreast of this ever-changing landscape.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ybys7re7im84cekf/2_Pharmacy_Leaders_Speaker_Series_AI_for_Pharmacy_Leaders_Part_1_The_What_and_the_Why_mixdownb5wx8.mp3" length="9581580" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Jared White, manager, pharmacy data analytics at UCSF and Ben Michaels, data science pharmacist at UCSF Medical Center at UCSF as they discuss their upcoming sessions AI for Pharmacy Leaders, Part 1 and Part 2. They will provide background information and forward-facing strategies expressly curated for leaders to stay abreast of this ever-changing landscape.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>392</itunes:duration>
                <itunes:episode>1208</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Wanted: Lot Numbers and Expiration Dates in Barcodes on All Immediate Drug Packages — Part 2</title>
        <itunes:title>Informatics Bytes: Wanted: Lot Numbers and Expiration Dates in Barcodes on All Immediate Drug Packages — Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-wanted-lot-numbers-and-expiration-dates-in-barcodes-on-all-immediate-drug-packages-%e2%80%94-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-wanted-lot-numbers-and-expiration-dates-in-barcodes-on-all-immediate-drug-packages-%e2%80%94-part-2/#comments</comments>        <pubDate>Thu, 03 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/241dfd20-c3ef-3a90-ad11-a87541fd2eb0</guid>
                                    <description><![CDATA[<p>Part 2 of this podcast series discusses the background for current barcode formats used on medication packages. Our speakers provide insight into regulations currently affecting barcoding practices, as well as changes that are needed for the future.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Part 2 of this podcast series discusses the background for current barcode formats used on medication packages. Our speakers provide insight into regulations currently affecting barcoding practices, as well as changes that are needed for the future.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9sa9py2fjthsvapc/2_Wanted_Lot_Numbers_and_Expiration_Dates_in_Barcodes_on_All_Immediate_Drug_Packages_Part_2_mixdown73v4v.mp3" length="42858669" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Part 2 of this podcast series discusses the background for current barcode formats used on medication packages. Our speakers provide insight into regulations currently affecting barcoding practices, as well as changes that are needed for the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1785</itunes:duration>
                <itunes:episode>1210</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: MCM24: ASHP Midyear Speaker Series 2024: From Textbooks to TikTok: Precepting the Gen Z Learner</title>
        <itunes:title>Hot Topics in Pharmacy: MCM24: ASHP Midyear Speaker Series 2024: From Textbooks to TikTok: Precepting the Gen Z Learner</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm24-ashp-midyear-speaker-series-2024-from-textbooks-to-tiktok-precepting-the-gen-z-learner/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm24-ashp-midyear-speaker-series-2024-from-textbooks-to-tiktok-precepting-the-gen-z-learner/#comments</comments>        <pubDate>Wed, 02 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a9efa90-1e18-33f0-a37b-683de06ca20d</guid>
                                    <description><![CDATA[<p>Join us for an insightful episode featuring an expert speaker, Megan Adelman, PharmD, BCGP, BCPS, CDCES from the upcoming Midyear Clinical Meeting and Exhibition. She will explore generational differences in the pharmacy workforce, offer strategies for precepting the newest generation, and highlight the unique skills and perspectives they bring to the field. Don’t miss this opportunity to learn how to foster collaboration across generations in your pharmacy practice! </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for an insightful episode featuring an expert speaker, Megan Adelman, PharmD, BCGP, BCPS, CDCES from the upcoming Midyear Clinical Meeting and Exhibition. She will explore generational differences in the pharmacy workforce, offer strategies for precepting the newest generation, and highlight the unique skills and perspectives they bring to the field. Don’t miss this opportunity to learn how to foster collaboration across generations in your pharmacy practice! </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i3dqtxqfmt288pwk/ASHP_Midyear_Clinical_Meeting_Speaker_Series-Megan_Adelman_mixdown8pw8k.mp3" length="9492400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for an insightful episode featuring an expert speaker, Megan Adelman, PharmD, BCGP, BCPS, CDCES from the upcoming Midyear Clinical Meeting and Exhibition. She will explore generational differences in the pharmacy workforce, offer strategies for precepting the newest generation, and highlight the unique skills and perspectives they bring to the field. Don’t miss this opportunity to learn how to foster collaboration across generations in your pharmacy practice! 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>388</itunes:duration>
                <itunes:episode>1211</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-how-strong-is-your-bench-developing-future-pharmacy-leaders-with-strategic-succession-planning/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-how-strong-is-your-bench-developing-future-pharmacy-leaders-with-strategic-succession-planning/#comments</comments>        <pubDate>Tue, 01 Oct 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/144ac205-6c7d-308a-85ac-c19501cf9f2a</guid>
                                    <description><![CDATA[<p>In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Denise Scarpelli, vice president and chief pharmacy officer at University of Chicago to discuss the upcoming session, How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning. Denise will give an overview of the session design and share a bit of her own story with this creative process for developing future leaders.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Denise Scarpelli, vice president and chief pharmacy officer at University of Chicago to discuss the upcoming session, How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning. Denise will give an overview of the session design and share a bit of her own story with this creative process for developing future leaders.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hf24aij5gq9jbahq/2_Pharmacy_Leaders_Speaker_Series_How_Strong_is_Your_Bench_Developing_Future_Pharmacy_Leaders_with_Strategic_Succession_Planning_mixdown808zc.mp3" length="9362040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Denise Scarpelli, vice president and chief pharmacy officer at University of Chicago to discuss the upcoming session, How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning. Denise will give an overview of the session design and share a bit of her own story with this creative process for developing future leaders.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>383</itunes:duration>
                <itunes:episode>1209</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Conference for Pharmacy Leaders Speaker Series: Sexual Harassment in the Workplace: Navigating Toward a Culture of Safety</title>
        <itunes:title>ASHP Conference for Pharmacy Leaders Speaker Series: Sexual Harassment in the Workplace: Navigating Toward a Culture of Safety</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-sexual-harassment-in-the-workplace-navigating-toward-a-culture-of-safety/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-conference-for-pharmacy-leaders-speaker-series-sexual-harassment-in-the-workplace-navigating-toward-a-culture-of-safety/#comments</comments>        <pubDate>Sat, 28 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b1439932-cd45-3c8c-a856-0897e0ca886d</guid>
                                    <description><![CDATA[<p>Join a conversation about unique education planned for a needed and sensitive topic at the upcoming conference for pharmacy leaders. Bill Kernan, a seasoned leader is joined by health system HR professional Adriana Ciltara as they give a preview of the program.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join a conversation about unique education planned for a needed and sensitive topic at the upcoming conference for pharmacy leaders. Bill Kernan, a seasoned leader is joined by health system HR professional Adriana Ciltara as they give a preview of the program.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m8v5yciae8xdf67y/2_Sexual_Harassment_in_the_Workplace_Navigating_Toward_a_Culture_of_Safety_mixdownbcjth.mp3" length="12170922" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join a conversation about unique education planned for a needed and sensitive topic at the upcoming conference for pharmacy leaders. Bill Kernan, a seasoned leader is joined by health system HR professional Adriana Ciltara as they give a preview of the program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>500</itunes:duration>
                <itunes:episode>1206</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practice Award 2023: Development and Implementation of an Oral Drug Repository Program</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practice Award 2023: Development and Implementation of an Oral Drug Repository Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2023-development-and-implementation-of-an-oral-drug-repository-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2023-development-and-implementation-of-an-oral-drug-repository-program/#comments</comments>        <pubDate>Fri, 27 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ef492740-a0a9-3c8c-9551-2ba1d4989626</guid>
                                    <description><![CDATA[<p>In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices.  They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices.  They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/eppbe5yx7q4zye7g/ASHP_Best_Practice_Award_2023Development_and_Implementation_of_an_Oral_Drug_Repository_Program_mixdownbby3l.mp3" length="24814289" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices.  They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1027</itunes:duration>
                <itunes:episode>1205</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Wanted: Lot Numbers and Expiration Dates in Barcodes on All Immediate Drug Packages — Part 1</title>
        <itunes:title>Informatics Bytes: Wanted: Lot Numbers and Expiration Dates in Barcodes on All Immediate Drug Packages — Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-wanted-lot-numbers-and-expiration-dates-in-barcodes-on-all-immediate-drug-packages-%e2%80%94-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-wanted-lot-numbers-and-expiration-dates-in-barcodes-on-all-immediate-drug-packages-%e2%80%94-part-1/#comments</comments>        <pubDate>Thu, 26 Sep 2024 12:22:18 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9567d70d-5369-307e-a6dc-55ddb9d5fe54</guid>
                                    <description><![CDATA[<p>This podcast examines issues surrounding current requirements for barcodes on unit-of-use medication packages and provides insight into the opportunities available for utilizing updated barcoding practices. Speakers discuss what is needed from vendors, federal agencies, and pharmacies to facilitate a change in current practices. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast examines issues surrounding current requirements for barcodes on unit-of-use medication packages and provides insight into the opportunities available for utilizing updated barcoding practices. Speakers discuss what is needed from vendors, federal agencies, and pharmacies to facilitate a change in current practices. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3jffdutn6zad5ycc/ASHPOfficial_Lot_Numbers_and_Expiration_Dates_in_Barcodes_on_All_Immediate_Drug_Packages_Part_1_FULL_AUDIO_mix_1_bearl.mp3" length="51934592" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast examines issues surrounding current requirements for barcodes on unit-of-use medication packages and provides insight into the opportunities available for utilizing updated barcoding practices. Speakers discuss what is needed from vendors, federal agencies, and pharmacies to facilitate a change in current practices. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1622</itunes:duration>
                <itunes:episode>1207</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders</title>
        <itunes:title>AJHP Voices: Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacist-implemented-intervention-to-surmount-covid-19-vaccination-hesitancy-in-adults-with-substance-use-disorders/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacist-implemented-intervention-to-surmount-covid-19-vaccination-hesitancy-in-adults-with-substance-use-disorders/#comments</comments>        <pubDate>Wed, 25 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/766267a7-8bfd-375b-ac08-7f5df72b388b</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Zoe Karavolis and Dr. Antoine Douaihy discuss the AJHP Practice Research Report, “Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Zoe Karavolis and Dr. Antoine Douaihy discuss the AJHP Practice Research Report, “Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ck534iqx3je3ryvt/COVID-19_vaccination_hesitancy_in_adults_with_substance_use_disorders_1_bbr8x.m4a" length="49680707" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Zoe Karavolis and Dr. Antoine Douaihy discuss the AJHP Practice Research Report, “Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2055</itunes:duration>
                <itunes:episode>1198</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>NPPC Highlight — Breaking Down Walls: Unraveling the Barriers to Constructive Feedback</title>
        <itunes:title>NPPC Highlight — Breaking Down Walls: Unraveling the Barriers to Constructive Feedback</itunes:title>
        <link>https://ashpofficial.podbean.com/e/nppc-highlight-%e2%80%94-breaking-down-walls-unraveling-the-barriers-to-constructive-feedback/</link>
                    <comments>https://ashpofficial.podbean.com/e/nppc-highlight-%e2%80%94-breaking-down-walls-unraveling-the-barriers-to-constructive-feedback/#comments</comments>        <pubDate>Mon, 23 Sep 2024 13:53:45 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a3400cd-dd1c-3db8-bc08-edc0f8505fd5</guid>
                                    <description><![CDATA[<p>Pharmacy preceptors often face the emotional strain of balancing their clinical responsibilities with the need to provide meaningful, constructive feedback to their learners. In addition, they often struggle with navigating learners’ emotions while delivering constructive feedback, aiming to be supportive yet honest in a way that doesn’t discourage growth. Join us at the National Pharmacy Preceptors Conference on October 2-3 to learn more.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacy preceptors often face the emotional strain of balancing their clinical responsibilities with the need to provide meaningful, constructive feedback to their learners. In addition, they often struggle with navigating learners’ emotions while delivering constructive feedback, aiming to be supportive yet honest in a way that doesn’t discourage growth. Join us at the National Pharmacy Preceptors Conference on October 2-3 to learn more.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ydmt23pkdvwyzku3/NPPC_Highlight_Breaking_Down_Walls_Constructive_Feedback_09162024agpx2.m4a" length="8321670" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Pharmacy preceptors often face the emotional strain of balancing their clinical responsibilities with the need to provide meaningful, constructive feedback to their learners. In addition, they often struggle with navigating learners’ emotions while delivering constructive feedback, aiming to be supportive yet honest in a way that doesn’t discourage growth. Join us at the National Pharmacy Preceptors Conference on October 2-3 to learn more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>344</itunes:duration>
                <itunes:episode>1204</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: Leveraging Data to Drive Change for Multi-Hospital Health Systems – A C-Suite Perspective</title>
        <itunes:title>Pharmacy Leadership: SPPL: Leveraging Data to Drive Change for Multi-Hospital Health Systems – A C-Suite Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-leveraging-data-to-drive-change-for-multi-hospital-health-systems-%e2%80%93-a-c-suite-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-leveraging-data-to-drive-change-for-multi-hospital-health-systems-%e2%80%93-a-c-suite-perspective/#comments</comments>        <pubDate>Fri, 20 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e272c0e8-2f48-34b4-8e94-e8e5ac3d7f70</guid>
                                    <description><![CDATA[<p>Harnessing the plethora of data is a critical success factor for hospital and health system executives and the sources of data are continually growing in complexity and reliability. This podcast will provide insights and instruction from two hospital and health system C-suite executives on examples and lessons learned on leveraging data to improve outcomes and decision making in a multi-hospital health system. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Harnessing the plethora of data is a critical success factor for hospital and health system executives and the sources of data are continually growing in complexity and reliability. This podcast will provide insights and instruction from two hospital and health system C-suite executives on examples and lessons learned on leveraging data to improve outcomes and decision making in a multi-hospital health system. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vdenrxtfykzcpwqb/Leveraging_Data_to_Drive_Change_for_Multi-Hospital_Health_Systems_A_C-Suite_Perspective_mixdown8mj04.mp3" length="45645271" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Harnessing the plethora of data is a critical success factor for hospital and health system executives and the sources of data are continually growing in complexity and reliability. This podcast will provide insights and instruction from two hospital and health system C-suite executives on examples and lessons learned on leveraging data to improve outcomes and decision making in a multi-hospital health system. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1895</itunes:duration>
                <itunes:episode>1203</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: ASHP on PBMs Part 2: Specialty Steering</title>
        <itunes:title>Advocating for Impact: ASHP on PBMs Part 2: Specialty Steering</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-2-specialty-steering/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-2-specialty-steering/#comments</comments>        <pubDate>Mon, 16 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/db3fe658-9931-3d02-ae96-1571e5526b01</guid>
                                    <description><![CDATA[<p>This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we discuss how PBMs have co-opted specialty pharmacy practice to maximize their profits at the direct expense of patients, how policymakers can address these practices and how pharmacists can push back against these actions.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we discuss how PBMs have co-opted specialty pharmacy practice to maximize their profits at the direct expense of patients, how policymakers can address these practices and how pharmacists can push back against these actions.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8y4p3nvpzqmirbdm/ASHP_on_PBMs_Part_2_Specialty_Steering_mixdown7t7sz.mp3" length="30895468" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we discuss how PBMs have co-opted specialty pharmacy practice to maximize their profits at the direct expense of patients, how policymakers can address these practices and how pharmacists can push back against these actions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                <itunes:episode>1201</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Generative AI: Impact on Outpatient Pharmacy Practice</title>
        <itunes:title>Generative AI: Impact on Outpatient Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/generative-ai-impact-on-outpatient-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/generative-ai-impact-on-outpatient-pharmacy-practice/#comments</comments>        <pubDate>Thu, 12 Sep 2024 11:18:20 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bcea2ca6-9efc-3549-b7a1-c8d804ba1de2</guid>
                                    <description><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hejv6c8pjpp53may/Generative_AI_Impact_on_Outpatient_Pharmacy_Practice_mixdownbk77b.mp3" length="21776692" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>901</itunes:duration>
                <itunes:episode>1202</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: NPPC Highlight — Pharmacy Experiential Precepting in the Era of Artificial Intelligence (AI)</title>
        <itunes:title>Educator Essentials: NPPC Highlight — Pharmacy Experiential Precepting in the Era of Artificial Intelligence (AI)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-nppc-highlight-%e2%80%94-pharmacy-experiential-precepting-in-the-era-of-artificial-intelligence-ai/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-nppc-highlight-%e2%80%94-pharmacy-experiential-precepting-in-the-era-of-artificial-intelligence-ai/#comments</comments>        <pubDate>Wed, 11 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bd8504e4-57dc-3cec-bfb4-9b845e563364</guid>
                                    <description><![CDATA[<p>This session, presented at the 2024 virtual National Pharmacy Preceptors Conference, will define the fundamentals of artificial intelligence (AI), apply AI utilization strategies to experiential learning, and discuss potential pitfalls and ethical challenges when using AI within pharmacy practice.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This session, presented at the 2024 virtual National Pharmacy Preceptors Conference, will define the fundamentals of artificial intelligence (AI), apply AI utilization strategies to experiential learning, and discuss potential pitfalls and ethical challenges when using AI within pharmacy practice.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zxizym8dzc3ukuv5/NPPC_Highlight_-_Pharmacy_Experiential_Precepting_in_the_Era_of_Artificial_Intelligence_AI_mixdown8m94b.mp3" length="10438907" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This session, presented at the 2024 virtual National Pharmacy Preceptors Conference, will define the fundamentals of artificial intelligence (AI), apply AI utilization strategies to experiential learning, and discuss potential pitfalls and ethical challenges when using AI within pharmacy practice.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>428</itunes:duration>
                <itunes:episode>1197</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Navigating the Skies of Drone Delivery in Health System Pharmacy</title>
        <itunes:title>Informatics Bytes: Navigating the Skies of Drone Delivery in Health System Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-navigating-the-skies-of-drone-delivery-in-health-system-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-navigating-the-skies-of-drone-delivery-in-health-system-pharmacy/#comments</comments>        <pubDate>Tue, 10 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a1b08414-c9a5-34e8-a6e1-aa4144a51390</guid>
                                    <description><![CDATA[<p>In this podcast, listeners will hear from a pharmacy leader about the pioneering experience of her health system’s pharmacy drone delivery program. Discussion will include implications for the medication-use process, lessons learned, and future considerations for pharmacy drone deliveries.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, listeners will hear from a pharmacy leader about the pioneering experience of her health system’s pharmacy drone delivery program. Discussion will include implications for the medication-use process, lessons learned, and future considerations for pharmacy drone deliveries.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ywnmaxcvrubjmbgp/ASHP_Navigating_the_Skies_of_Drone_Delivery_in_Health_System_Pharmacy_FULL_AUDIO_mix.mp3" length="28583810" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, listeners will hear from a pharmacy leader about the pioneering experience of her health system’s pharmacy drone delivery program. Discussion will include implications for the medication-use process, lessons learned, and future considerations for pharmacy drone deliveries.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1786</itunes:duration>
                <itunes:episode>1199</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: High-Cost Medication Stewardship: Perspectives from an Academic Medical Center</title>
        <itunes:title>Hot Topics in Pharmacy: High-Cost Medication Stewardship: Perspectives from an Academic Medical Center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-high-cost-medication-stewardship-perspectives-from-an-academic-medical-center/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-high-cost-medication-stewardship-perspectives-from-an-academic-medical-center/#comments</comments>        <pubDate>Mon, 09 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c577427e-9ea6-3a53-843e-598188751541</guid>
                                    <description><![CDATA[<p>With the increase in high-cost medication utilization in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the drug budget. Hospitals may vary in the resources dedicated to performing these assessments. Please join us as we discuss strategies for managing high-cost medications with pharmacy leaders from across the continuum of hospital/health-system sizes. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the increase in high-cost medication utilization in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the drug budget. Hospitals may vary in the resources dedicated to performing these assessments. Please join us as we discuss strategies for managing high-cost medications with pharmacy leaders from across the continuum of hospital/health-system sizes. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e6cexdcgkk5ik6nc/ASHPOfficial_High_Cost_Medication_Stewardship_Perspectives_from_an_Academic_Medical_Center_MIX.mp3" length="49432448" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the increase in high-cost medication utilization in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the drug budget. Hospitals may vary in the resources dedicated to performing these assessments. Please join us as we discuss strategies for managing high-cost medications with pharmacy leaders from across the continuum of hospital/health-system sizes. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1544</itunes:duration>
                <itunes:episode>1196</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: NPPC Highlight — Rx Gaming: Transforming Pharmacy Education Through Play</title>
        <itunes:title>Educator Essentials: NPPC Highlight — Rx Gaming: Transforming Pharmacy Education Through Play</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-nppc-highlight-%e2%80%94-rx-gaming-transforming-pharmacy-education-through-play/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-nppc-highlight-%e2%80%94-rx-gaming-transforming-pharmacy-education-through-play/#comments</comments>        <pubDate>Fri, 06 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b86ac760-9849-343d-94de-a01f154d7ad3</guid>
                                    <description><![CDATA[<p>The podcast explores the integration of gaming in pharmacy education, highlighting how interactive and immersive games can enhance student engagement and learning. Speakers discuss the benefits of gamified learning experiences in understanding pharmaceutical concepts and improving problem-solving skills in a dynamic educational environment.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The podcast explores the integration of gaming in pharmacy education, highlighting how interactive and immersive games can enhance student engagement and learning. Speakers discuss the benefits of gamified learning experiences in understanding pharmaceutical concepts and improving problem-solving skills in a dynamic educational environment.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/63r2rxutri8wfcvi/NPPC_Highlight_-_Rx_Gaming_Transforming_Pharmacy_Education_Through_Play_mixdownaeuqo.mp3" length="14816687" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The podcast explores the integration of gaming in pharmacy education, highlighting how interactive and immersive games can enhance student engagement and learning. Speakers discuss the benefits of gamified learning experiences in understanding pharmaceutical concepts and improving problem-solving skills in a dynamic educational environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>610</itunes:duration>
                <itunes:episode>1194</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Successful Strategies for Engaging the C-Suite</title>
        <itunes:title>Hot Topics in Pharmacy: Successful Strategies for Engaging the C-Suite</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-successful-strategies-for-engaging-the-c-suite/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-successful-strategies-for-engaging-the-c-suite/#comments</comments>        <pubDate>Thu, 05 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1aa60e9a-8349-3031-a5d6-50304746892f</guid>
                                    <description><![CDATA[<p>During this podcast, we will be discussing strategies to gain approval of potential new positions to an existing department or the creation of new clinic or service that would include pharmacy support. These positions are typically approved by the C-Suite of an organization.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast, we will be discussing strategies to gain approval of potential new positions to an existing department or the creation of new clinic or service that would include pharmacy support. These positions are typically approved by the C-Suite of an organization.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5ymyk9mxzkm5esig/Part_2_Successful_Strategies_for_Engaging_the_C-Suite_mixdown7e343.mp3" length="20292555" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast, we will be discussing strategies to gain approval of potential new positions to an existing department or the creation of new clinic or service that would include pharmacy support. These positions are typically approved by the C-Suite of an organization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>845</itunes:duration>
                <itunes:episode>1195</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: The vital role of clinical pharmacy services within the hospital at home interdisciplinary team</title>
        <itunes:title>AJHP Voices: The vital role of clinical pharmacy services within the hospital at home interdisciplinary team</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-the-vital-role-of-clinical-pharmacy-services-within-the-hospital-at-home-interdisciplinary-team/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-the-vital-role-of-clinical-pharmacy-services-within-the-hospital-at-home-interdisciplinary-team/#comments</comments>        <pubDate>Wed, 04 Sep 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/00b024cb-c992-375b-b62b-7c1310420120</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/66ti52yz8hehbzxq/Hospital_at_home_interdisciplinary_team_1_8kr3n.m4a" length="43702052" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1807</itunes:duration>
                <itunes:episode>1193</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacy Leadership: Prioritizing Patient Care Activities: What’s the Score?</title>
        <itunes:title>Pharmacy Leadership: Prioritizing Patient Care Activities: What’s the Score?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-prioritizing-patient-care-activities-what-s-the-score/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-prioritizing-patient-care-activities-what-s-the-score/#comments</comments>        <pubDate>Thu, 29 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e4b75d96-bc30-3936-8586-45f29cceff4a</guid>
                                    <description><![CDATA[<p>When your patient list seems insurmountable, how do you prioritize your patient care activities for the day? Join us to hear from pharmacy leaders in the informatics field who have experience with developing and implementing a scoring system within the electronic health record to triage patient care, identify intervention opportunities, and prioritize clinical pharmacy services.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>When your patient list seems insurmountable, how do you prioritize your patient care activities for the day? Join us to hear from pharmacy leaders in the informatics field who have experience with developing and implementing a scoring system within the electronic health record to triage patient care, identify intervention opportunities, and prioritize clinical pharmacy services.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sf3x9ckzcdg6why8/ASHPOfficial_Prioritizing_Patient_Scoring_Tools_What_s_the_Score_MIX_1_62svm.mp3" length="79840028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[When your patient list seems insurmountable, how do you prioritize your patient care activities for the day? Join us to hear from pharmacy leaders in the informatics field who have experience with developing and implementing a scoring system within the electronic health record to triage patient care, identify intervention opportunities, and prioritize clinical pharmacy services.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1996</itunes:duration>
                <itunes:episode>1191</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: A Benchmarking Journey: From Beginning to Ongoing</title>
        <itunes:title>Pharmacy Hot Topics: A Benchmarking Journey: From Beginning to Ongoing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-a-benchmarking-journey-from-beginning-to-ongoing/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-a-benchmarking-journey-from-beginning-to-ongoing/#comments</comments>        <pubDate>Mon, 26 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5fae920b-1ef0-3dc3-b316-c5b008d7f9ee</guid>
                                    <description><![CDATA[<p>The goal of this podcast is to help describe specific productivity, clinical and operational benchmarking metrics that are utilized in hospitals throughout the US. Listeners should walk away with a new understanding of meaningful metrics and how to develop them. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The goal of this podcast is to help describe specific productivity, clinical and operational benchmarking metrics that are utilized in hospitals throughout the US. Listeners should walk away with a new understanding of meaningful metrics and how to develop them. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vrpt3re28fimkuhz/ASHPOfficial_A_Benchmarking_Journey_From_Beginning_to_Ongoing_MIX.mp3" length="71107136" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The goal of this podcast is to help describe specific productivity, clinical and operational benchmarking metrics that are utilized in hospitals throughout the US. Listeners should walk away with a new understanding of meaningful metrics and how to develop them. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2539</itunes:duration>
                <itunes:episode>1188</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Drug Diversion Prevention—Strategies on Engaging the Interprofessional Team</title>
        <itunes:title>Pharmacy Leadership: Drug Diversion Prevention—Strategies on Engaging the Interprofessional Team</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-drug-diversion-prevention%e2%80%94strategies-on-engaging-the-interprofessional-team/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-drug-diversion-prevention%e2%80%94strategies-on-engaging-the-interprofessional-team/#comments</comments>        <pubDate>Fri, 23 Aug 2024 12:34:50 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/00ff1edd-12cb-39a9-b2cc-1aeb056be4b6</guid>
                                    <description><![CDATA[<p>With the advent of artificial intelligence, groundbreaking advancements are changing the landscape of drug diversion prevention. Advanced analytics are uncovering proactive strategies to prevent and address drug diversion more robustly. This transformative technology has reshaped the perception of drug diversion to one that requires a collaborative, interdisciplinary approach. In this podcast, we delve into the imperative for pharmacists, nurses, and other healthcare professionals to unite, taking collective responsibility for tackling this escalating challenge. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the advent of artificial intelligence, groundbreaking advancements are changing the landscape of drug diversion prevention. Advanced analytics are uncovering proactive strategies to prevent and address drug diversion more robustly. This transformative technology has reshaped the perception of drug diversion to one that requires a collaborative, interdisciplinary approach. In this podcast, we delve into the imperative for pharmacists, nurses, and other healthcare professionals to unite, taking collective responsibility for tackling this escalating challenge. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w2e3mi78z8qz9kw7/Drug_Diversion_Prevention_Strategies_on_Engaging_the_Interprofessional_Team_mixdown6ee5f.mp3" length="51205344" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the advent of artificial intelligence, groundbreaking advancements are changing the landscape of drug diversion prevention. Advanced analytics are uncovering proactive strategies to prevent and address drug diversion more robustly. This transformative technology has reshaped the perception of drug diversion to one that requires a collaborative, interdisciplinary approach. In this podcast, we delve into the imperative for pharmacists, nurses, and other healthcare professionals to unite, taking collective responsibility for tackling this escalating challenge. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2128</itunes:duration>
                <itunes:episode>1192</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center</title>
        <itunes:title>AJHP Voices: Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-impact-of-a-pharmacy-technician-on-an-interprofessional-antithrombotic-stewardship-program-at-an-academic-medical-center/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-impact-of-a-pharmacy-technician-on-an-interprofessional-antithrombotic-stewardship-program-at-an-academic-medical-center/#comments</comments>        <pubDate>Wed, 21 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a9d5a0a9-94c1-366c-a786-c3ff7856ae0a</guid>
                                    <description><![CDATA[<p class="xmsonormal">In this podcast, Dr. William Hammond and Patricia Valdez discuss the AJHP Descriptive Report, “Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">In this podcast, Dr. William Hammond and Patricia Valdez discuss the AJHP Descriptive Report, “Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xgurtqdx5j7xfjkr/Impact_of_a_pharmacy_technician_1_67pjk.m4a" length="33516919" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. William Hammond and Patricia Valdez discuss the AJHP Descriptive Report, “Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1386</itunes:duration>
                <itunes:episode>1186</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacy Hot Topics: High-Cost Medication Stewardship: Perspectives from Oncology Services</title>
        <itunes:title>Pharmacy Hot Topics: High-Cost Medication Stewardship: Perspectives from Oncology Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-high-cost-medication-stewardship-perspectives-from-oncology-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-high-cost-medication-stewardship-perspectives-from-oncology-services/#comments</comments>        <pubDate>Mon, 19 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f50cd46e-3a08-38e0-80e0-fda45bc366fd</guid>
                                    <description><![CDATA[<p>With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gn34tbki8qm7yprx/High-Cost_Medication_Stewardship_Project_1_08022024bio7u.m4a" length="35112781" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1452</itunes:duration>
                <itunes:episode>1190</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Episode 2: Hospital Administration Roles, Tiers of Excellence</title>
        <itunes:title>Practice Journeys: Episode 2: Hospital Administration Roles, Tiers of Excellence</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-episode-2-hospital-administration-roles-tiers-of-excellence/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-episode-2-hospital-administration-roles-tiers-of-excellence/#comments</comments>        <pubDate>Fri, 16 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3edf92e8-cf42-3539-bc16-50efdcc3f8e6</guid>
                                    <description><![CDATA[<p>This podcast is the second in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is the second in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/k33eskhjhdmsv7yp/Episode_2_Hospital_Administration_Roles_Tiers_of_Excellence_mixdown8chjm.mp3" length="33925116" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is the second in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1407</itunes:duration>
                <itunes:episode>1189</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeyes: SCSS: The Role of the Pharmacist in Clinical Research</title>
        <itunes:title>Practice Journeyes: SCSS: The Role of the Pharmacist in Clinical Research</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeyes-scss-the-role-of-the-pharmacist-in-clinical-research/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeyes-scss-the-role-of-the-pharmacist-in-clinical-research/#comments</comments>        <pubDate>Wed, 14 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/04ddd750-dc30-3876-863a-dc1da1670952</guid>
                                    <description><![CDATA[<p>This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kbcraybhuenvgaqa/ASHP_The_Role_of_the_Pharmacist_in_Clinical_Research_FULL_AUDIO_mix.mp3" length="32426465" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2026</itunes:duration>
                <itunes:episode>1180</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Mitigating Risks, Maximizing Care: Risk Evaluation and Mitigation Strategies (REMS) and Specialty Medications</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Mitigating Risks, Maximizing Care: Risk Evaluation and Mitigation Strategies (REMS) and Specialty Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mitigating-risks-maximizing-care-risk-evaluation-and-mitigation-strategies-rems-and-specialty-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mitigating-risks-maximizing-care-risk-evaluation-and-mitigation-strategies-rems-and-specialty-medications/#comments</comments>        <pubDate>Tue, 13 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ca442e33-2b38-32d1-b638-117c9ebac1be</guid>
                                    <description><![CDATA[<p>Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources.  Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources.  Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fndemj7rnx5jt339/Career_Pearls_for_Students_Ambulatory_Care_and_Medical_Writing_mixdown_1_9qnyh.mp3" length="27273840" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources.  Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1130</itunes:duration>
                <itunes:episode>1187</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Pharmacy Technician Education: Bringing Academia to the Pharmacy Technician Workforce</title>
        <itunes:title>Technician Topics: Pharmacy Technician Education: Bringing Academia to the Pharmacy Technician Workforce</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-pharmacy-technician-education-bringing-academia-to-the-pharmacy-technician-workforce/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-pharmacy-technician-education-bringing-academia-to-the-pharmacy-technician-workforce/#comments</comments>        <pubDate>Mon, 12 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4ade0d30-10dc-3466-a5a1-30e8e75092e9</guid>
                                    <description><![CDATA[<p>In this podcast, speakers will discuss both the tangible and intangible benefits of creating, implementing, and facilitating a comprehensive advanced-level ASHP/ACPE accredited pharmacy technician education and training program. Topics such as job satisfaction of preceptors, retention of graduates, and continual professional development of pharmacy technician colleagues will be explored and discussed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, speakers will discuss both the tangible and intangible benefits of creating, implementing, and facilitating a comprehensive advanced-level ASHP/ACPE accredited pharmacy technician education and training program. Topics such as job satisfaction of preceptors, retention of graduates, and continual professional development of pharmacy technician colleagues will be explored and discussed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9vipxii3zqt28wr4/ASHPOfficial_Bringing_Academia_to_the_Pharmacy_Technician_Workforce_Mix.mp3" length="29333993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, speakers will discuss both the tangible and intangible benefits of creating, implementing, and facilitating a comprehensive advanced-level ASHP/ACPE accredited pharmacy technician education and training program. Topics such as job satisfaction of preceptors, retention of graduates, and continual professional development of pharmacy technician colleagues will be explored and discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1833</itunes:duration>
                <itunes:episode>1179</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Career Pearls for Students: Ambulatory Care &amp; Medical Writing</title>
        <itunes:title>Practice Journeys: Career Pearls for Students: Ambulatory Care &amp; Medical Writing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-ambulatory-care-medical-writing/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-ambulatory-care-medical-writing/#comments</comments>        <pubDate>Fri, 09 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f8d841f3-288d-3345-8a45-2a173893be0b</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d3kqcr5p379ddt6m/Career_Pearls_for_Students_Ambulatory_Care_and_Medical_Writing_mixdown6gw6w.mp3" length="19807952" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>819</itunes:duration>
                <itunes:episode>1185</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: PALRC: The First 90 Days</title>
        <itunes:title>Pharmacy Leadership: PALRC: The First 90 Days</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-the-first-90-days/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-the-first-90-days/#comments</comments>        <pubDate>Thu, 08 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/632a4e91-a742-393e-aae2-7cc87f75bac4</guid>
                                    <description><![CDATA[<p>As the residency year comes to a close, many new practitioners are preparing for their first 90 days as a manager. This podcast features current PGY1 &amp; PGY2 health-system pharmacy administration and leadership (HSPAL) residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative interviewing experienced pharmacy leaders about potential pitfalls and opportunities to succeed in your first 90 days as a manager. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As the residency year comes to a close, many new practitioners are preparing for their first 90 days as a manager. This podcast features current PGY1 &amp; PGY2 health-system pharmacy administration and leadership (HSPAL) residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative interviewing experienced pharmacy leaders about potential pitfalls and opportunities to succeed in your first 90 days as a manager. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d7ktx5725m4zyyjg/ASHP_First_90_Days_as_a_Manager_FULL_AUDIO_mix.mp3" length="33113681" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As the residency year comes to a close, many new practitioners are preparing for their first 90 days as a manager. This podcast features current PGY1 &amp; PGY2 health-system pharmacy administration and leadership (HSPAL) residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative interviewing experienced pharmacy leaders about potential pitfalls and opportunities to succeed in your first 90 days as a manager. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2069</itunes:duration>
                <itunes:episode>1181</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response</title>
        <itunes:title>AJHP Voices: Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacy-residency-training-program-increases-residents-confidence-in-inpatient-medical-emergency-response/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-pharmacy-residency-training-program-increases-residents-confidence-in-inpatient-medical-emergency-response/#comments</comments>        <pubDate>Wed, 07 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c85b71bd-dbb6-39a6-bff1-2d4bbd1e40d6</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Amanda Jo Shigle and Dr. Blake Hays discuss the AJHP Descriptive Report, “Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Amanda Jo Shigle and Dr. Blake Hays discuss the AJHP Descriptive Report, “Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2tx3eruqqj5eq4ne/Pharmacy_residency_training_program_increases_residents_confidence_FINAL923zu.m4a" length="62235877" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Amanda Jo Shigle and Dr. Blake Hays discuss the AJHP Descriptive Report, “Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2574</itunes:duration>
                <itunes:episode>1183</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Advocating for Impact: ASHP on PBMs Part 1: Federal Trade Commission’s Report on PBMs</title>
        <itunes:title>Advocating for Impact: ASHP on PBMs Part 1: Federal Trade Commission’s Report on PBMs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-1-federal-trade-commission-s-report-on-pbms/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-ashp-on-pbms-part-1-federal-trade-commission-s-report-on-pbms/#comments</comments>        <pubDate>Tue, 06 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5db9627b-b2bc-3da0-adf3-db44b4eb18ce</guid>
                                    <description><![CDATA[<p>This podcast is part of a series unpacking harmful pharmacy benefit manager (PBM) practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p>This episode provides a high-level overview of key findings and conclusions from the Federal Trade Commission’s Report Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. The speakers will also discuss how the report can be leveraged to fight back against PBM practices that strain patient affordability, jeopardize patient safety, and imperil pharmacy sustainability. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is part of a series unpacking harmful pharmacy benefit manager (PBM) practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. </p>
<p>This episode provides a high-level overview of key findings and conclusions from the Federal Trade Commission’s Report <em>Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies</em>. The speakers will also discuss how the report can be leveraged to fight back against PBM practices that strain patient affordability, jeopardize patient safety, and imperil pharmacy sustainability. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r6c44wg9zhz4sm6t/2_ASHP_on_PBMs_Part_1_Federal_Trade_Commissions_Report_on_PBMs_mixdown9ow8o.mp3" length="47146476" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is part of a series unpacking harmful pharmacy benefit manager (PBM) practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. 
This episode provides a high-level overview of key findings and conclusions from the Federal Trade Commission’s Report Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. The speakers will also discuss how the report can be leveraged to fight back against PBM practices that strain patient affordability, jeopardize patient safety, and imperil pharmacy sustainability. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1958</itunes:duration>
                <itunes:episode>1184</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Transforming Pharmacy Residency Programs With AI: Where Do We Go From Here?</title>
        <itunes:title>Educator Essentials: Transforming Pharmacy Residency Programs With AI: Where Do We Go From Here?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-transforming-pharmacy-residency-programs-with-ai-where-do-we-go-from-here/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-transforming-pharmacy-residency-programs-with-ai-where-do-we-go-from-here/#comments</comments>        <pubDate>Mon, 05 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d2b7516b-50fd-3586-ab51-c0de58803d6a</guid>
                                    <description><![CDATA[<p>With the fast advancement of artificial intelligence (AI) and its widespread use, it is important to understand how residency programs can incorporate AI to improve administrative efficiency, residents’ learning experience, and recruitment and interview processes. This podcast will dive into the specifics of how AI can transform the current processes in residency programs from the field experts.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the fast advancement of artificial intelligence (AI) and its widespread use, it is important to understand how residency programs can incorporate AI to improve administrative efficiency, residents’ learning experience, and recruitment and interview processes. This podcast will dive into the specifics of how AI can transform the current processes in residency programs from the field experts.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ksbxfghwtbks7pkn/ASHPOfficial_Transforming_Pharmacy_Residency_Programs_with_AI_Where_Do_We_Go_From_Here_MIX_1_6ykt2.mp3" length="65695098" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the fast advancement of artificial intelligence (AI) and its widespread use, it is important to understand how residency programs can incorporate AI to improve administrative efficiency, residents’ learning experience, and recruitment and interview processes. This podcast will dive into the specifics of how AI can transform the current processes in residency programs from the field experts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2346</itunes:duration>
                <itunes:episode>1175</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Episode 1: Hospital Administration Roles, Tiers of Excellence</title>
        <itunes:title>Practice Journeys: Episode 1: Hospital Administration Roles, Tiers of Excellence</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-episode-1-hospital-administration-roles-tiers-of-excellence/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-episode-1-hospital-administration-roles-tiers-of-excellence/#comments</comments>        <pubDate>Fri, 02 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a3e3701-64a9-3b2e-b147-52415a0ddd79</guid>
                                    <description><![CDATA[<p>This podcast is the first in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is the first in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/55kcz9wfrb3jjfy5/2_Episode_1_Hospital_Administration_Roles_Tiers_of_Excellence_mixdownbwick.mp3" length="25679838" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is the first in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1063</itunes:duration>
                <itunes:episode>1182</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Student Well-Being and Resilience: A Conversation with PharmD Candidates</title>
        <itunes:title>Community Pharmacy: Student Well-Being and Resilience: A Conversation with PharmD Candidates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-student-well-being-and-resilience-a-conversation-with-pharmd-candidates/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-student-well-being-and-resilience-a-conversation-with-pharmd-candidates/#comments</comments>        <pubDate>Thu, 01 Aug 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6b38975c-473d-3079-87b8-aa241b1bcbe3</guid>
                                    <description><![CDATA[<p>This podcast, created for students, by students, serves as a starting point for discussion about student well-being and resilience. A panel of students representing various backgrounds, geographic locations, and times in their pharmacy career journey, discuss mental health, work/life/family balance, self-care, and support systems to improve overall well-being. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast, created for students, by students, serves as a starting point for discussion about student well-being and resilience. A panel of students representing various backgrounds, geographic locations, and times in their pharmacy career journey, discuss mental health, work/life/family balance, self-care, and support systems to improve overall well-being. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hp29jq4h75vs57bk/ASHP_Student_Well_Being_and_Resilience_A_Conversation_with_PharmD_Candidates_FULL_AUDIO_mix.mp3" length="22222058" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast, created for students, by students, serves as a starting point for discussion about student well-being and resilience. A panel of students representing various backgrounds, geographic locations, and times in their pharmacy career journey, discuss mental health, work/life/family balance, self-care, and support systems to improve overall well-being. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1388</itunes:duration>
                <itunes:episode>1177</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Post-Pandemic: Have You Changed How You Lead?</title>
        <itunes:title>Pharmacy Leadership: Post-Pandemic: Have You Changed How You Lead?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-post-pandemic-have-you-changed-how-you-lead/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-post-pandemic-have-you-changed-how-you-lead/#comments</comments>        <pubDate>Wed, 31 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b3ab7958-4a95-37c9-a230-6240e1132546</guid>
                                    <description><![CDATA[<p>The COVID-19 pandemic accentuated longstanding workforce issues and perpetuated a need for change. Burnout and well-being became a greater focus around the world but especially for healthcare workers. We will share ways in which leadership styles and focuses have changed since our teams have been impacted by the COVID-19 pandemic. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The COVID-19 pandemic accentuated longstanding workforce issues and perpetuated a need for change. Burnout and well-being became a greater focus around the world but especially for healthcare workers. We will share ways in which leadership styles and focuses have changed since our teams have been impacted by the COVID-19 pandemic. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bc2sev627pr24k73/Post-Pandemic_Have_You_Changed_How_You_Lead_mixdown9lppa.mp3" length="48309097" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The COVID-19 pandemic accentuated longstanding workforce issues and perpetuated a need for change. Burnout and well-being became a greater focus around the world but especially for healthcare workers. We will share ways in which leadership styles and focuses have changed since our teams have been impacted by the COVID-19 pandemic. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2006</itunes:duration>
                <itunes:episode>1176</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 5)</title>
        <itunes:title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 5)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-5/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-5/#comments</comments>        <pubDate>Tue, 30 Jul 2024 14:20:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dfce4206-94a8-312e-82d4-d05b217c19e0</guid>
                                    <description><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hgjm9hwbabebz358/Embracing_Leadership_Nurturing_Confidence_and_Professional_Advancement_in_Associations_Part_5_mixdown8xwyk.mp3" length="32745809" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1358</itunes:duration>
                <itunes:episode>1178</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials (CE): Rx ReRoute: Navigating Setbacks on Your Pharmacist Career Journey</title>
        <itunes:title>Educator Essentials (CE): Rx ReRoute: Navigating Setbacks on Your Pharmacist Career Journey</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-ce-rx-reroute-navigating-setbacks-on-your-pharmacist-career-journey/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-ce-rx-reroute-navigating-setbacks-on-your-pharmacist-career-journey/#comments</comments>        <pubDate>Sat, 27 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d614721c-7dfd-3c2f-8f5d-e45869efee35</guid>
                                    <description><![CDATA[<p>This podcast highlights experiences of pharmacy practice providers who did not get their “dream job.” Panelist share how they overcame perceived setbacks, and how they used their resilience to carve an authentic path forward.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast highlights experiences of pharmacy practice providers who did not get their “dream job.” Panelist share how they overcame perceived setbacks, and how they used their resilience to carve an authentic path forward.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rfprir79x8f5bh2g/Rx_ReRoute_Navigating_Setbacks_on_Your_Pharmacist_Career_Journey_mixdownaliz1.mp3" length="26846472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast highlights experiences of pharmacy practice providers who did not get their “dream job.” Panelist share how they overcame perceived setbacks, and how they used their resilience to carve an authentic path forward.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1113</itunes:duration>
                <itunes:episode>1174</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Hepatitis C Positive Donors in Solid Organ Transplant</title>
        <itunes:title>Clinical Conversations (CE): Hepatitis C Positive Donors in Solid Organ Transplant</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-hepatitis-c-positive-donors-in-solid-organ-transplant/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-hepatitis-c-positive-donors-in-solid-organ-transplant/#comments</comments>        <pubDate>Fri, 26 Jul 2024 13:28:39 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7fde7899-b619-3dea-83c0-449c78525c46</guid>
                                    <description><![CDATA[<p>Discover the ins and outs of utilizing hepatitis C positive donor organs. Why do we utilize, how do we protect the recipient’s liver from hepatitis related chronic injury, methods for prevention and treatment of hepatitis in organ recipients, and how to get insurance coverage of the medications. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Discover the ins and outs of utilizing hepatitis C positive donor organs. Why do we utilize, how do we protect the recipient’s liver from hepatitis related chronic injury, methods for prevention and treatment of hepatitis in organ recipients, and how to get insurance coverage of the medications. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9d9zmp9a3hh3fjz3/Hepatitis_C_Vaccine_mixdown7f7vf.mp3" length="30365486" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Discover the ins and outs of utilizing hepatitis C positive donor organs. Why do we utilize, how do we protect the recipient’s liver from hepatitis related chronic injury, methods for prevention and treatment of hepatitis in organ recipients, and how to get insurance coverage of the medications. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1259</itunes:duration>
                <itunes:episode>1173</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Technician Opportunities for Advancement in Informatics</title>
        <itunes:title>Informatics Bytes: Technician Opportunities for Advancement in Informatics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-technician-opportunities-for-advancement-in-informatics/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-technician-opportunities-for-advancement-in-informatics/#comments</comments>        <pubDate>Thu, 25 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a3663f2b-56fc-391d-8494-853c68164029</guid>
                                    <description><![CDATA[<p>Listeners will learn about technician experiences and opportunities within the information and technology role.  Three panelists from diverse backgrounds will discuss their career paths, advice for fellow technicians and where they envision additional opportunities for pharmacy technicians.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listeners will learn about technician experiences and opportunities within the information and technology role.  Three panelists from diverse backgrounds will discuss their career paths, advice for fellow technicians and where they envision additional opportunities for pharmacy technicians.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dz2a6pe9rwxebk7m/ASHPOfficial_Technician_Opportunities_for_Advancement_in_Informatics_MIX.mp3" length="31827137" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Listeners will learn about technician experiences and opportunities within the information and technology role.  Three panelists from diverse backgrounds will discuss their career paths, advice for fellow technicians and where they envision additional opportunities for pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1136</itunes:duration>
                <itunes:episode>1171</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program</title>
        <itunes:title>AJHP Voices: Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-implementation-of-clopidogrel-pharmacogenetic-clinical-decision-support-for-a-preemptive-return-of-results-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-implementation-of-clopidogrel-pharmacogenetic-clinical-decision-support-for-a-preemptive-return-of-results-program/#comments</comments>        <pubDate>Wed, 24 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a4cbc0d7-5545-30b1-b041-c95f0d5da301</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. David Kao discusses the AJHP Descriptive Report, “Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. David Kao discusses the AJHP Descriptive Report, “Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fppyaexzagavxniv/Implementation_of_clopidogrel_pharmacogenetic_clinical_decision_support_1_btwvt.m4a" length="51712076" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. David Kao discusses the AJHP Descriptive Report, “Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2139</itunes:duration>
                <itunes:episode>1172</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 4)</title>
        <itunes:title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 4)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-4/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-4/#comments</comments>        <pubDate>Tue, 23 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/71c66e5a-0d03-3597-94ca-bc6adf1596ff</guid>
                                    <description><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uwry5nqu4hmrwnin/Embracing_Leadership_Nurturing_Confidence_and_Professional_Advancement_in_Associations_Part_4_mixdownbalxt.mp3" length="20888057" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>864</itunes:duration>
                <itunes:episode>1170</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 3)</title>
        <itunes:title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 3)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-3/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-3/#comments</comments>        <pubDate>Tue, 16 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/63e714e2-016d-33b5-9619-056dde07897d</guid>
                                    <description><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h4gq5jsbvxzu9jyv/Embracing_Leadership_Nurturing_Confidence_and_Professional_Advancement_in_Associations_Part_3_mixdownbiy4t.mp3" length="25358177" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1050</itunes:duration>
                <itunes:episode>1168</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Generative AI: Impact on Data Analytics</title>
        <itunes:title>Informatics Bytes (CE): Generative AI: Impact on Data Analytics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-data-analytics/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-data-analytics/#comments</comments>        <pubDate>Mon, 15 Jul 2024 13:55:47 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0619195e-b3a6-3046-95e7-8d81c9b25a5f</guid>
                                    <description><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v5cikfahmzj647xe/Generative_AI_Impact_on_Data_Analytics_mixdown9rofw.mp3" length="19759184" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>817</itunes:duration>
                <itunes:episode>1169</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Scripting Change: How you can implement the Practice Advancement Initiative in your SSHP</title>
        <itunes:title>Student Perspectives: Scripting Change: How you can implement the Practice Advancement Initiative in your SSHP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-scripting-change-how-you-can-implement-the-practice-advancement-initiative-in-your-sshp/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-scripting-change-how-you-can-implement-the-practice-advancement-initiative-in-your-sshp/#comments</comments>        <pubDate>Mon, 15 Jul 2024 13:14:44 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e70b3ed1-45f7-30dc-95a6-5ef9fd57f678</guid>
                                    <description><![CDATA[<p>In this interview-panel of 4 student pharmacist leaders, we will discuss how they have promoted practice advancement within their schools of pharmacy, as well as the successes and room for improvement they have identified within their chapter for future implementation. We will dive deep into how other SSHP leaders can utilize these examples to successfully implement PAI 2030 initiatives at their chapter.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this interview-panel of 4 student pharmacist leaders, we will discuss how they have promoted practice advancement within their schools of pharmacy, as well as the successes and room for improvement they have identified within their chapter for future implementation. We will dive deep into how other SSHP leaders can utilize these examples to successfully implement PAI 2030 initiatives at their chapter.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fwkq9r8bgptmst6i/ASHPOfficial_Scripting_Change_How_You_Can_Implement_the_Practice_Advancement_Initiative_in_Your_SSHP_MIX.mp3" length="35830496" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this interview-panel of 4 student pharmacist leaders, we will discuss how they have promoted practice advancement within their schools of pharmacy, as well as the successes and room for improvement they have identified within their chapter for future implementation. We will dive deep into how other SSHP leaders can utilize these examples to successfully implement PAI 2030 initiatives at their chapter.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1279</itunes:duration>
                <itunes:episode>1167</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Medication Safety: Top Sterile Compounding Questions Answered</title>
        <itunes:title>Hot Topics in Pharmacy: Medication Safety: Top Sterile Compounding Questions Answered</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-medication-safety-top-sterile-compounding-questions-answered/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-medication-safety-top-sterile-compounding-questions-answered/#comments</comments>        <pubDate>Fri, 12 Jul 2024 04:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/55fd9b5a-20d5-3f68-ac99-9463c6feb281</guid>
                                    <description><![CDATA[<p>With USP &lt;800&gt; and revisions to USP &lt;797&gt; becoming official on November 1, 2023, sterile compounding experts have received numerous questions from hospital pharmacy leaders inquiring about the new standards. In this podcast, we answer the top 10 questions received across the country providing valuable information regarding current sterile compounding hot topics including: procedural areas, competencies, cleaning, lab reporting, COA (Certificate of Analysis) and DVO (Dose Vial Optimization). </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With USP &lt;800&gt; and revisions to USP &lt;797&gt; becoming official on November 1, 2023, sterile compounding experts have received numerous questions from hospital pharmacy leaders inquiring about the new standards. In this podcast, we answer the top 10 questions received across the country providing valuable information regarding current sterile compounding hot topics including: procedural areas, competencies, cleaning, lab reporting, COA (Certificate of Analysis) and DVO (Dose Vial Optimization). </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mnsghv36zgiz56nn/Top_10_Sterile_Compounding_Questions_Answered_mixdownba2dt.mp3" length="44776995" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With USP &lt;800&gt; and revisions to USP &lt;797&gt; becoming official on November 1, 2023, sterile compounding experts have received numerous questions from hospital pharmacy leaders inquiring about the new standards. In this podcast, we answer the top 10 questions received across the country providing valuable information regarding current sterile compounding hot topics including: procedural areas, competencies, cleaning, lab reporting, COA (Certificate of Analysis) and DVO (Dose Vial Optimization). 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1860</itunes:duration>
                <itunes:episode>1166</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Career Pearls: Pharmacists in the Government</title>
        <itunes:title>Student Perspectives: Career Pearls: Pharmacists in the Government</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-career-pearls-pharmacists-in-the-government/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-career-pearls-pharmacists-in-the-government/#comments</comments>        <pubDate>Wed, 10 Jul 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3d7ec26a-3a4a-3804-a2f1-9833d99820ce</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9nhaybujfs29subp/Career_Pearls_Pharmacists_in_the_Government_mixdown_1_9llz6.mp3" length="38257879" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1588</itunes:duration>
                <itunes:episode>1163</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 2)</title>
        <itunes:title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 2)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-2/#comments</comments>        <pubDate>Tue, 09 Jul 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d47ec4c9-f32d-3f41-bd92-cbd023394fb0</guid>
                                    <description><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nm75q7juywbnadkc/ASHPOfficial_Nurturing_Confidence_and_Professional_Advancement_in_Associations_Part_2_Mix.mp3" length="35048978" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2190</itunes:duration>
                <itunes:episode>1165</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: To Err is Human – Handling Mistakes as a New Practitioner</title>
        <itunes:title>Practice Journeys: To Err is Human – Handling Mistakes as a New Practitioner</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-to-err-is-human-%e2%80%93-handling-mistakes-as-a-new-practitioner/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-to-err-is-human-%e2%80%93-handling-mistakes-as-a-new-practitioner/#comments</comments>        <pubDate>Mon, 08 Jul 2024 15:28:17 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8eedf7d2-16db-3c65-8813-4ec9be5def7d</guid>
                                    <description><![CDATA[<p>This podcast features a panel discussion regarding handling medication errors as a new practitioner, providing self-help resources, and discussion around how a medication error can impact institutional policy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast features a panel discussion regarding handling medication errors as a new practitioner, providing self-help resources, and discussion around how a medication error can impact institutional policy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x8xgrpnsv3y2b3kk/ASHPOfficial_To_Err_is_Human_Handling_Mistakes_as_a_New_Practitioner_MIX.mp3" length="29656064" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast features a panel discussion regarding handling medication errors as a new practitioner, providing self-help resources, and discussion around how a medication error can impact institutional policy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1853</itunes:duration>
                <itunes:episode>1164</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Demystifying Immediate Use: What’s NOT Category 1, 2, or 3</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Demystifying Immediate Use: What’s NOT Category 1, 2, or 3</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-demystifying-immediate-use-what-s-not-category-1-2-or-3/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-demystifying-immediate-use-what-s-not-category-1-2-or-3/#comments</comments>        <pubDate>Wed, 03 Jul 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bd13200b-d30f-3429-bc18-9a6a0cfc1761</guid>
                                    <description><![CDATA[<p>Learn from experts on compliance with USP Chapter &lt;797&gt; in all size facilities.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts on compliance with USP Chapter &lt;797&gt; in all size facilities.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uz552cnnkvfnw4k7/ADV_Demystifying_Immediate_UseWhat_s_NOT_Category_1_2_or_3_mixdown9ak7s.mp3" length="32917003" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts on compliance with USP Chapter &lt;797&gt; in all size facilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1369</itunes:duration>
                <itunes:episode>1161</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 1)</title>
        <itunes:title>Technician Topics: Embracing Leadership: Nurturing Confidence and Professional Advancement in Associations (Part 1)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-embracing-leadership-nurturing-confidence-and-professional-advancement-in-associations-part-1/#comments</comments>        <pubDate>Tue, 02 Jul 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4071fb00-eba2-3366-8c98-b6bb7540f8f6</guid>
                                    <description><![CDATA[<p class="xmsonormal">Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p class="xmsonormal"> The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. </p>
<p class="xmsonormal"> <em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mfdrj5bnbkkjr2md/Embracing_Leadership_Nurturing_Confidence_and_Professional_Advancement_in_Associations_Part_1_mixdown6m4n4.mp3" length="12984933" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. 
 The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>535</itunes:duration>
                <itunes:episode>1162</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: ASHP Best Practice Award 2023: Improved Access and Outcomes for Patients with Interstitial Lung Disease in a Pharmacist-Led Medication Management Program</title>
        <itunes:title>Research in Pharmacy: ASHP Best Practice Award 2023: Improved Access and Outcomes for Patients with Interstitial Lung Disease in a Pharmacist-Led Medication Management Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2023-improved-access-and-outcomes-forpatientswithinterstitial-lung-diseasein-apharmacist-ledmedication-man/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacyashp-best-practiceaward-2023-improved-access-and-outcomes-forpatientswithinterstitial-lung-diseasein-apharmacist-ledmedication-man/#comments</comments>        <pubDate>Mon, 01 Jul 2024 11:44:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b17d6b6a-385b-3d81-97ae-b80cc470b960</guid>
                                    <description><![CDATA[<p>In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices.  They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices.  They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ie735b6f2vd7jvwh/ASHP_Best_Practices_Henry_Ford_Health_mixdowna04e5.mp3" length="41919662" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices.  They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1741</itunes:duration>
                <itunes:episode>1160</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: Reflections on Health Care and the Chief Pharmacy Officer Role: 2004 to 2024</title>
        <itunes:title>Pharmacy Leadership: SPPL: Reflections on Health Care and the Chief Pharmacy Officer Role: 2004 to 2024</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-reflections-on-health-care-and-the-chief-pharmacy-officer-role-2004-to-2024/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-reflections-on-health-care-and-the-chief-pharmacy-officer-role-2004-to-2024/#comments</comments>        <pubDate>Thu, 27 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/68afd5ee-b26c-323f-9bd4-134fb404f8c7</guid>
                                    <description><![CDATA[<p>This podcast provides an interview with one of the first pharmacist hospital CEOs, Bill Evans, retired CEO of St. Jude Children’s Research Hospital, and one of the first health system Vice Presidents of Pharmacy and author of the 2005 AJHP paper “Rationale for having a chief pharmacy officer in a health care organization”, Marianne Ivey. They will explore the evolution of pharmacy executives and the path of pharmacy practice and the opportunities still ahead.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an interview with one of the first pharmacist hospital CEOs, Bill Evans, retired CEO of St. Jude Children’s Research Hospital, and one of the first health system Vice Presidents of Pharmacy and author of the 2005 AJHP paper “Rationale for having a chief pharmacy officer in a health care organization”, Marianne Ivey. They will explore the evolution of pharmacy executives and the path of pharmacy practice and the opportunities still ahead.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5s6x9i6hjftxdz89/2_Reflections_on_Health_Care_and_the_Chief_Pharmacy_Officer_Role_2004_to_2024_mixdownbflse.mp3" length="58224319" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an interview with one of the first pharmacist hospital CEOs, Bill Evans, retired CEO of St. Jude Children’s Research Hospital, and one of the first health system Vice Presidents of Pharmacy and author of the 2005 AJHP paper “Rationale for having a chief pharmacy officer in a health care organization”, Marianne Ivey. They will explore the evolution of pharmacy executives and the path of pharmacy practice and the opportunities still ahead.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2420</itunes:duration>
                <itunes:episode>1158</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes (CE): Generative AI: Impact on Administrative Functions</title>
        <itunes:title>Informatics Bytes (CE): Generative AI: Impact on Administrative Functions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-administrative-functions/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-ce-generative-ai-impact-on-administrative-functions/#comments</comments>        <pubDate>Tue, 25 Jun 2024 15:39:31 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/15bd9df9-fc03-379f-a02c-4bf844d1e2fc</guid>
                                    <description><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x67gyye6swgmahym/ASHPOfficial_Gen_AI_Administrative_Start_Mix.mp3" length="16126769" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1007</itunes:duration>
                <itunes:episode>1159</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics (Pharmacy Leadership): A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum Julia Becker</title>
        <itunes:title>Technician Topics (Pharmacy Leadership): A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum Julia Becker</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum-julia-becker/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum-julia-becker/#comments</comments>        <pubDate>Tue, 25 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f1c8865a-94bd-3e23-adcb-0261e17d9a16</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Tyler Darcy sits down with the Pharmacy Technician Forum Awardee Julia Becker to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Tyler Darcy sits down with the Pharmacy Technician Forum Awardee Julia Becker to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mn8uidqkwackq7u3/A_Conversation_with_Distinguised_Service_Awardee_for_the_Pharmacy_Technician_Forum_Julia_Becker_mixdown911r7.mp3" length="13512357" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Tyler Darcy sits down with the Pharmacy Technician Forum Awardee Julia Becker to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>558</itunes:duration>
                <itunes:episode>1155</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SCSS: Incorporating Pharmacoequity into Formulary Management</title>
        <itunes:title>Pharmacy Leadership: SCSS: Incorporating Pharmacoequity into Formulary Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-scss-incorporating-pharmacoequity-into-formulary-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-scss-incorporating-pharmacoequity-into-formulary-management/#comments</comments>        <pubDate>Tue, 25 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0e5311c9-ee26-3d0e-aa6a-e21a7fec2324</guid>
                                    <description><![CDATA[<p>This podcast aims to explore what health disparity and equity is, examine their connection to Pharmacoequity and discuss how the P&amp;T committee can address these issues within the formulary review process. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast aims to explore what health disparity and equity is, examine their connection to Pharmacoequity and discuss how the P&amp;T committee can address these issues within the formulary review process. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z3chnr4wfp9b2dm4/2_Pharmacoequity_in_Formulary_Management_mixdown8ibv3.mp3" length="20748684" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast aims to explore what health disparity and equity is, examine their connection to Pharmacoequity and discuss how the P&amp;T committee can address these issues within the formulary review process. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
 ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>859</itunes:duration>
                <itunes:episode>1154</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: FLiRTing with COVID - Are We Out of the Woods Yet?</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: FLiRTing with COVID - Are We Out of the Woods Yet?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-flirting-with-covid-are-we-out-of-the-woods-yet/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-flirting-with-covid-are-we-out-of-the-woods-yet/#comments</comments>        <pubDate>Fri, 21 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d471024a-741f-3cab-83e7-e4f249a47874</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on the current status and future of COVID-19.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on the current status and future of COVID-19.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/99xsyavpuzqy57ew/3ADV_FLiRTing_with_COVID_-_Are_We_Out_of_the_Woods_Yet_mixdown5zafu.mp3" length="41447601" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on the current status and future of COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1721</itunes:duration>
                <itunes:episode>1156</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SICP: Impact and Challenges of Risk Evaluation and Mitigation Strategy (REMS) Programs in Practice</title>
        <itunes:title>Clinical Conversations: SICP: Impact and Challenges of Risk Evaluation and Mitigation Strategy (REMS) Programs in Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-sicp-impact-and-challenges-of-risk-evaluation-and-mitigation-strategy-rems-programs-in-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-sicp-impact-and-challenges-of-risk-evaluation-and-mitigation-strategy-rems-programs-in-practice/#comments</comments>        <pubDate>Thu, 20 Jun 2024 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1a4e6349-9487-32fc-8843-fa76984ca7ca</guid>
                                    <description><![CDATA[<p>The US Food and Drug Administration (FDA) implemented Risk Evaluation and Mitigation Strategy (REMS) programs to ensure benefits outweigh the safety risks of particular medications. With over 60 medications with REMS programs and varying requirements for each, operationalizing to comply with requirements can be challenging. In this podcast, we talk about some of those challenges and how to operationalize recommendations for those who routinely see these medications in practice, as well as for those who come across them sporadically. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The US Food and Drug Administration (FDA) implemented Risk Evaluation and Mitigation Strategy (REMS) programs to ensure benefits outweigh the safety risks of particular medications. With over 60 medications with REMS programs and varying requirements for each, operationalizing to comply with requirements can be challenging. In this podcast, we talk about some of those challenges and how to operationalize recommendations for those who routinely see these medications in practice, as well as for those who come across them sporadically. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jcw2wwrmbcc6pnci/ASHPOfficial_Impact_and_Challenges_of_Risk_Evaluation_and_Mitigation_Strategy_Mix.mp3" length="34561505" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The US Food and Drug Administration (FDA) implemented Risk Evaluation and Mitigation Strategy (REMS) programs to ensure benefits outweigh the safety risks of particular medications. With over 60 medications with REMS programs and varying requirements for each, operationalizing to comply with requirements can be challenging. In this podcast, we talk about some of those challenges and how to operationalize recommendations for those who routinely see these medications in practice, as well as for those who come across them sporadically. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2160</itunes:duration>
                <itunes:episode>1153</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Informatics and Technology</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-informatics-and-technology/#comments</comments>        <pubDate>Mon, 17 Jun 2024 14:30:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/68607fa9-3e84-32ac-add7-98660d493f71</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Benjamin Anderson, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2023, Maritza Lew, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Benjamin Anderson, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2023, Maritza Lew, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/473ngag2dbwk2ht8/DSA_Awardee_SOPIT_mixdown8tb2g.mp3" length="16350836" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Benjamin Anderson, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2023, Maritza Lew, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>676</itunes:duration>
                <itunes:episode>1151</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation in Pharmacy Practice: Exploring Pharmacists’ Perceptions in Delivering Patient Care through Telehealth</title>
        <itunes:title>Innovation in Pharmacy Practice: Exploring Pharmacists’ Perceptions in Delivering Patient Care through Telehealth</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-in-pharmacy-practice-exploring-pharmacists-perceptions-in-delivering-patient-care-through-telehealth/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-in-pharmacy-practice-exploring-pharmacists-perceptions-in-delivering-patient-care-through-telehealth/#comments</comments>        <pubDate>Sat, 15 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3961633c-a549-3eff-9d04-e1ff8dd0a600</guid>
                                    <description><![CDATA[<p>This podcast explores pharmacists’ perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores pharmacists’ perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rfh7zvsi2ynwpvu4/Exploring_Pharmacists_Perceptions_in_Delivering_Patient_Care_through_Telehealth_mixdownb0mdj.mp3" length="31041941" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast explores pharmacists’ perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1288</itunes:duration>
                <itunes:episode>1149</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: Navigating the Waters of Payer Contracting</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: Navigating the Waters of Payer Contracting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-navigating-the-waters-of-payer-contracting/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-navigating-the-waters-of-payer-contracting/#comments</comments>        <pubDate>Mon, 10 Jun 2024 12:59:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b5db8c7c-a839-3b48-8c4b-47414ca0ab27</guid>
                                    <description><![CDATA[<p>In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p>Any legal information included in this podcast is for our listeners' educational purposes only.  It is not intended as legal advice.  If you have specific legal questions, you should contact the legal department of your organization or outside counsel.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p><em>Any legal information included in this podcast is for our listeners' educational purposes only.  It is not intended as legal advice.  If you have specific legal questions, you should contact the legal department of your organization or outside counsel.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m9d49a9aykswsw79/ASHPOfficial_Navigating_the_Waters_of_Payer_Contracting_Mix_1_78pir.mp3" length="24472607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Any legal information included in this podcast is for our listeners' educational purposes only.  It is not intended as legal advice.  If you have specific legal questions, you should contact the legal department of your organization or outside counsel.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1529</itunes:duration>
                <itunes:episode>1143</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results with Amy Guiterrez</title>
        <itunes:title>Pharmacy Futures Podcast Series: Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results with Amy Guiterrez</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-pharmacist-personnel-puzzle-key-insights-into-workforce-recruitment-and-achieving-results-with-amy-guiterrez/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-pharmacist-personnel-puzzle-key-insights-into-workforce-recruitment-and-achieving-results-with-amy-guiterrez/#comments</comments>        <pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ef97728f-e727-3149-8ee1-83622853f7cc</guid>
                                    <description><![CDATA[<p>ASHP Official hosts Amy Gutierrez for a discussion about a unique session planned for the ASHP Pharmacy Futures focused on pharmacist recruitment and retention strategies. Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results will feature Amy and two additional experts and provide actionable takeaways specifically crafted for pharmacy leaders by pharmacy leaders.  This session is eligible for live CPEL recertification credit.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP Official hosts Amy Gutierrez for a discussion about a unique session planned for the ASHP Pharmacy Futures focused on pharmacist recruitment and retention strategies. Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results will feature Amy and two additional experts and provide actionable takeaways specifically crafted for pharmacy leaders by pharmacy leaders.  This session is eligible for live CPEL recertification credit.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ttr9zwgib9nvcser/PH1487_1.mp3" length="8780718" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP Official hosts Amy Gutierrez for a discussion about a unique session planned for the ASHP Pharmacy Futures focused on pharmacist recruitment and retention strategies. Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results will feature Amy and two additional experts and provide actionable takeaways specifically crafted for pharmacy leaders by pharmacy leaders.  This session is eligible for live CPEL recertification credit.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>361</itunes:duration>
                <itunes:episode>1146</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting with Sara Stallworth and Timothy Aungst</title>
        <itunes:title>Pharmacy Futures Podcast Series: Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting with Sara Stallworth and Timothy Aungst</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-navigating-the-future-ai-digital-health-and-technology-in-pharmacy-precepting-with-sara-stallworth-and-timothy-aungst/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-navigating-the-future-ai-digital-health-and-technology-in-pharmacy-precepting-with-sara-stallworth-and-timothy-aungst/#comments</comments>        <pubDate>Mon, 03 Jun 2024 11:54:16 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/caffe0ae-5db0-3bae-a0f3-0f353e160fb7</guid>
                                    <description><![CDATA[<p>ASHP Official welcomes Sara Stallworth and Timothy Aungst for a lively discussion about a session they collaborated on for the inaugural ASHP Pharmacy Futures in Portland. Using the future focused theme of AI, Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting, Sara and Tim have creatively designed strategies for preceptors to engage with learners using technology, and provide background knowledge for preceptors to guide safe use and adoption of new platforms in their experiential learning plans.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP Official welcomes Sara Stallworth and Timothy Aungst for a lively discussion about a session they collaborated on for the inaugural ASHP Pharmacy Futures in Portland. Using the future focused theme of AI, <em>Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting, </em>Sara and Tim have creatively designed strategies for preceptors to engage with learners using technology, and provide background knowledge for preceptors to guide safe use and adoption of new platforms in their experiential learning plans.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/868rjp55cq3c4gs2/PHC26E_1.mp3" length="10349209" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP Official welcomes Sara Stallworth and Timothy Aungst for a lively discussion about a session they collaborated on for the inaugural ASHP Pharmacy Futures in Portland. Using the future focused theme of AI, Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting, Sara and Tim have creatively designed strategies for preceptors to engage with learners using technology, and provide background knowledge for preceptors to guide safe use and adoption of new platforms in their experiential learning plans.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>426</itunes:duration>
                <itunes:episode>1147</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Vaccine Preventable Diseases: Shingles</title>
        <itunes:title>Clinical Conversations (CE): Vaccine Preventable Diseases: Shingles</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-shingles/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-shingles/#comments</comments>        <pubDate>Sat, 01 Jun 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/80c2048b-d347-3c54-b454-cf579a6701a7</guid>
                                    <description><![CDATA[<p>In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zecds9zqms5ynii8/Vaccine_Preventable_Diseases_Shingles_mixdownafu6f.mp3" length="27899493" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1157</itunes:duration>
                <itunes:episode>1144</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Navigating the AI Summit with Ben Michaels</title>
        <itunes:title>Pharmacy Futures Podcast Series: Navigating the AI Summit with Ben Michaels</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-navigating-the-ai-summit-with-ben-michaels/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-navigating-the-ai-summit-with-ben-michaels/#comments</comments>        <pubDate>Fri, 31 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ce241fff-d2e1-3f7f-9b14-3fd389e52a23</guid>
                                    <description><![CDATA[<p>UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ivx3sa6t576qkq9y/Pharmacy_Futures_Podcast_Series_Navigating_the_AI_Summit_with_Ben_Michaels_mixdown8djo5.mp3" length="9118985" type="audio/mpeg"/>
        <itunes:summary><![CDATA[UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>375</itunes:duration>
                <itunes:episode>1140</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Advocacy 101: How to Talk About Advocacy within and Outside the Profession</title>
        <itunes:title>Pharmacy Leadership: Advocacy 101: How to Talk About Advocacy within and Outside the Profession</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-advocacy-101-how-to-talk-about-advocacy-within-and-outside-the-profession/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-advocacy-101-how-to-talk-about-advocacy-within-and-outside-the-profession/#comments</comments>        <pubDate>Thu, 30 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8f9ac006-ceec-35fa-80f7-770e22f16dc8</guid>
                                    <description><![CDATA[<p>This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q5rdkntymgr8ek7f/ASHPOfficial_Advocacy_101_How_to_Talk_About_Advocacy_Within_and_Outside_the_Profession_MIX.mp3" length="62789792" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2242</itunes:duration>
                <itunes:episode>1145</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Bipartisan Senate Proposal to Address Drug Shortages</title>
        <itunes:title>Advocating for Impact: Bipartisan Senate Proposal to Address Drug Shortages</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-bipartisan-senate-proposal-to-address-drug-shortages/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-bipartisan-senate-proposal-to-address-drug-shortages/#comments</comments>        <pubDate>Wed, 29 May 2024 14:23:18 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5a8fe398-4ba9-3f07-9eb4-d0b21b24d965</guid>
                                    <description><![CDATA[<p>Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/s7a5y5wjky9ejivi/Bipartisan_Senate_Proposal_to_Address_Drug_Shortages_mixdownbj0nu.mp3" length="41237238" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1713</itunes:duration>
                <itunes:episode>1142</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Expert precepting perspectives with Michelle McCarthy and Andrea Haron</title>
        <itunes:title>Pharmacy Futures Podcast Series: Expert precepting perspectives with Michelle McCarthy and Andrea Haron</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-expert-precepting-perspectives-with-michelle-mccarthy-and-andrea-haron/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-expert-precepting-perspectives-with-michelle-mccarthy-and-andrea-haron/#comments</comments>        <pubDate>Sat, 25 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c53aa437-7d77-3b1b-aac0-3fecd11a1eb4</guid>
                                    <description><![CDATA[<p>ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/we628w4kzh6uq2gp/Pharmacy_Futures_Podcast_Series_Expert_precepting_perspectives_with_Michelle_McCarthy_and_Andrea_Haron_mixdown9ccye.mp3" length="9842073" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>405</itunes:duration>
                <itunes:episode>1139</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Compounding Education with Mike Ganio</title>
        <itunes:title>Pharmacy Futures Podcast Series: Compounding Education with Mike Ganio</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-compounding-education-with-mike-ganio/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-compounding-education-with-mike-ganio/#comments</comments>        <pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/543268c0-ccbb-3a64-933c-681a50635b9d</guid>
                                    <description><![CDATA[<p>ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9sdwztfpzvbeic5d/Pharmacy_Futures_Podcast_Series_Compounding_Education_with_Mike_Ganio_mixdown8cvk8.mp3" length="9053282" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>372</itunes:duration>
                <itunes:episode>1141</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Role of the Medication Safety Officer</title>
        <itunes:title>The Role of the Medication Safety Officer</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-role-of-the-medication-safety-officer/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-role-of-the-medication-safety-officer/#comments</comments>        <pubDate>Wed, 22 May 2024 11:11:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8a6cb2c1-3c5f-3057-80ae-0452527f4327</guid>
                                    <description><![CDATA[<p class="xmsonormal">This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3e5c98ivbsqev5md/ASHPOfficial_The_Role_of_the_Medication_Safety_Officer_Mix.mp3" length="38935001" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2433</itunes:duration>
                <itunes:episode>1138</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: The Journey Towards Developing Future Pharmacy Leaders Starts Today</title>
        <itunes:title>Pharmacy Leadership: SPPL: The Journey Towards Developing Future Pharmacy Leaders Starts Today</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-the-journey-towards-developing-future-pharmacy-leaders-starts-today/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-the-journey-towards-developing-future-pharmacy-leaders-starts-today/#comments</comments>        <pubDate>Tue, 21 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ca4e8258-a177-3b2b-912f-87571a417d7e</guid>
                                    <description><![CDATA[<p>This podcast features a conversation about engaging the next generation of pharmacy leaders.  As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations.      </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast features a conversation about engaging the next generation of pharmacy leaders.  As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations.      </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xxn4r9f4xbqnpatv/ASHPOfficial_The_Journey_Towards_Developing_Future_Pharmacy_Leaders_Starts_Today_MIX.mp3" length="26072960" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast features a conversation about engaging the next generation of pharmacy leaders.  As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations.      
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1629</itunes:duration>
                <itunes:episode>1136</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Drug Pricing’s New Frontier – The Inflation Reduction Act</title>
        <itunes:title>Drug Pricing’s New Frontier – The Inflation Reduction Act</itunes:title>
        <link>https://ashpofficial.podbean.com/e/drug-pricing-s-new-frontier-%e2%80%93-the-inflation-reduction-act/</link>
                    <comments>https://ashpofficial.podbean.com/e/drug-pricing-s-new-frontier-%e2%80%93-the-inflation-reduction-act/#comments</comments>        <pubDate>Mon, 20 May 2024 06:32:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b9565a6d-f4a2-38db-a938-b70c30a02aac</guid>
                                    <description><![CDATA[<p class="xparagraph" style="margin: 0in; vertical-align: baseline;">This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you.  </p>
<p class="xparagraph" style="margin: 0in; vertical-align: baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xparagraph" style="margin: 0in; vertical-align: baseline;">This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you.  </p>
<p class="xparagraph" style="margin: 0in; vertical-align: baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8pmsczjmn6hdrye3/2_IRA_Overview_mixdown8kfp4.mp3" length="31806939" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you.  
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1324</itunes:duration>
                <itunes:episode>1135</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity with Kristi Kelley and Morgan Stewart</title>
        <itunes:title>Pharmacy Futures Podcast Series: More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity with Kristi Kelley and Morgan Stewart</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcastseries-more-than-equalnavigating-the-changinglandscapeof-diabetes-care-topromote-care-equitywithkristi-kelleyand-morganstewart/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcastseries-more-than-equalnavigating-the-changinglandscapeof-diabetes-care-topromote-care-equitywithkristi-kelleyand-morganstewart/#comments</comments>        <pubDate>Sat, 18 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d05ecd5d-62c4-3181-89ed-9d158a1c8928</guid>
                                    <description><![CDATA[<p>ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. <em>More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity</em> highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5gkivuzj7u3uq9ei/Pharmacy_Futures_Podcast_Series_More_Than_Equal_Navigating_the_Changing_Landscape_of_Diabetes_Care_to_Promote_Care_Equity_with_Kristi_Kelley_and_Morgan_Stewart9rbv2.mp3" length="7720595" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>317</itunes:duration>
                <itunes:episode>1130</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Best Practice Award 2023: Real-World Clinical Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotyping Test on Fluoropyrimidine Dosing and Toxicity at a Multisite Cancer Center</title>
        <itunes:title>ASHP Best Practice Award 2023: Real-World Clinical Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotyping Test on Fluoropyrimidine Dosing and Toxicity at a Multisite Cancer Center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashpbestpractice-award2023realworld-clinicalimpact-ofan-in-house-dihydropyrimidinedehydrogenasedpydgenotyping-test-onfluoropyrimidine-dosingand-toxici/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashpbestpractice-award2023realworld-clinicalimpact-ofan-in-house-dihydropyrimidinedehydrogenasedpydgenotyping-test-onfluoropyrimidine-dosingand-toxici/#comments</comments>        <pubDate>Fri, 17 May 2024 16:24:39 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a48d0afc-0ab7-3149-8090-03d181a5f9e1</guid>
                                    <description><![CDATA[<p style="background: white;">In this episode, the team from the Atrium Health System discuss their award-winning submission to the ASHP Best Practices.  They will share how their program implemented a novel pharmacist-led DPYD testing program with CDS integration and demonstrated pre-treatment testing with genotype-guided fluoropyrimidine dosing improves patient safety by mitigating severe toxicities and hospitalizations in DPYD variant carriers.</p>
<p style="text-align: left;">The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="background: white;">In this episode, the team from the Atrium Health System discuss their award-winning submission to the ASHP Best Practices.  They will share how their program implemented a novel pharmacist-led DPYD testing program with CDS integration and demonstrated pre-treatment testing with genotype-guided fluoropyrimidine dosing improves patient safety by mitigating severe toxicities and hospitalizations in DPYD variant carriers.</p>
<p style="text-align: left;"><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cddqdjmxfundmse6/Best_Practices_Atrium_Health_mixdown8d72m.mp3" length="45562668" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from the Atrium Health System discuss their award-winning submission to the ASHP Best Practices.  They will share how their program implemented a novel pharmacist-led DPYD testing program with CDS integration and demonstrated pre-treatment testing with genotype-guided fluoropyrimidine dosing improves patient safety by mitigating severe toxicities and hospitalizations in DPYD variant carriers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1893</itunes:duration>
                <itunes:episode>1134</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Futures Podcast Series: Train the Trainer: Peer Support Workshop for Second Victim Program Implementation with Kristy deVries</title>
        <itunes:title>Pharmacy Futures Podcast Series: Train the Trainer: Peer Support Workshop for Second Victim Program Implementation with Kristy deVries</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-train-the-trainer-peer-support-workshop-for-second-victim-program-implementation-with-kristy-devries/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-futures-podcast-series-train-the-trainer-peer-support-workshop-for-second-victim-program-implementation-with-kristy-devries/#comments</comments>        <pubDate>Sun, 12 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7d6bab79-ed9a-321a-bd2b-ab8a940c4145</guid>
                                    <description><![CDATA[<p>ASHP National Meetings team education director Cynthia von Heeringen joins faculty member and licensed clinical social worker Kristy de Vries from Nationwide Children’s Hospital to discuss the upcoming Pharmacy Futures workshop on Second Victim Program Implementation. This half day program is included with registration and will provide attendees with background knowledge and skills to provide second victim support as well as a strategic toolkit to implement a second victims support program at their own facility.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP National Meetings team education director Cynthia von Heeringen joins faculty member and licensed clinical social worker Kristy de Vries from Nationwide Children’s Hospital to discuss the upcoming Pharmacy Futures workshop on Second Victim Program Implementation. This half day program is included with registration and will provide attendees with background knowledge and skills to provide second victim support as well as a strategic toolkit to implement a second victims support program at their own facility.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fbggyjikjhe3zuj7/Pharmacy_Futures_Podcast_Series_Train_the_Trainer_Peer_Support_Workshop_for_Second_Victim_Program_Implementation_with_Kristy_deVriesaga6z.mp3" length="9558098" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP National Meetings team education director Cynthia von Heeringen joins faculty member and licensed clinical social worker Kristy de Vries from Nationwide Children’s Hospital to discuss the upcoming Pharmacy Futures workshop on Second Victim Program Implementation. This half day program is included with registration and will provide attendees with background knowledge and skills to provide second victim support as well as a strategic toolkit to implement a second victims support program at their own facility.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>393</itunes:duration>
                <itunes:episode>1131</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations (CE): Vaccine Preventable Diseases: Polio</title>
        <itunes:title>Clinical Conversations (CE): Vaccine Preventable Diseases: Polio</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-polio/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-ce-vaccine-preventable-diseases-polio/#comments</comments>        <pubDate>Sat, 11 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/43c5cdfe-5d5c-3ecc-b09a-3b3b5e381559</guid>
                                    <description><![CDATA[<p>This episode of the series will provide an overview of the history of Polio, eradication, and the effect of vaccination on global health. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode of the series will provide an overview of the history of Polio, eradication, and the effect of vaccination on global health. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ysczqbfpnube83d6/Vaccine_Preventable_Diseases_Polio_mixdown9g958.mp3" length="28155858" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode of the series will provide an overview of the history of Polio, eradication, and the effect of vaccination on global health. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1168</itunes:duration>
                <itunes:episode>1133</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center</title>
        <itunes:title>AJHP Voices: Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-pharmacy-driven-performanceimprovement-initiative-to-increasecompliance-with-intravenous-smartpumpdrugerrorreductionsystems-at-a-largeurban/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-pharmacy-driven-performanceimprovement-initiative-to-increasecompliance-with-intravenous-smartpumpdrugerrorreductionsystems-at-a-largeurban/#comments</comments>        <pubDate>Fri, 10 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dc1ac215-f231-38c6-9b63-079dba727d36</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Eliana Abboudi and Dr. Emily Messing discuss the AJHP Practice Research Report, “Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Eliana Abboudi and Dr. Emily Messing discuss the AJHP Practice Research Report, “Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2tqk4spju3zmre8p/Pharmacy-driven_performance_improvement_initiative_1_7rgnf.m4a" length="53861725" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Eliana Abboudi and Dr. Emily Messing discuss the AJHP Practice Research Report, “Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2228</itunes:duration>
                <itunes:episode>1132</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Educator Essentials: What is Artificial Intelligence and How Is It Being Utilized?</title>
        <itunes:title>Educator Essentials: What is Artificial Intelligence and How Is It Being Utilized?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-what-is-artificial-intelligence-and-how-is-it-being-utilized/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-what-is-artificial-intelligence-and-how-is-it-being-utilized/#comments</comments>        <pubDate>Wed, 08 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d9c9b74e-706b-3239-b341-23ddef06b297</guid>
                                    <description><![CDATA[<p>From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform the way pharmacists practice.  In the first of a three-part series, this podcast will lay the foundation of knowledge for what artificial intelligence is and how it is being utilized within the profession of pharmacy and pharmacy education. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform the way pharmacists practice.  In the first of a three-part series, this podcast will lay the foundation of knowledge for what artificial intelligence is and how it is being utilized within the profession of pharmacy and pharmacy education. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qqivtbqu4tiktvwu/2_What_is_Artificial_Intelligence_and_How_is_it_Being_Utilized_mixdownanyb4.mp3" length="76144054" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform the way pharmacists practice.  In the first of a three-part series, this podcast will lay the foundation of knowledge for what artificial intelligence is and how it is being utilized within the profession of pharmacy and pharmacy education. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3168</itunes:duration>
                <itunes:episode>1129</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Rena Gosser</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Rena Gosser</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-clinical-specialists-and-scientists-rena-gosser/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-clinical-specialists-and-scientists-rena-gosser/#comments</comments>        <pubDate>Wed, 01 May 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c2b37285-84e9-3614-b136-f50ce17b813c</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z46bz3w9rrpin8dk/A_conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Clinical_Specialists_and_Scientists_Rena_Gosser_mixdownbdmnq.mp3" length="34603438" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1437</itunes:duration>
                <itunes:episode>1128</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: COVID-19: So What’s New?</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: COVID-19: So What’s New?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-covid-19-so-what-s-new/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-covid-19-so-what-s-new/#comments</comments>        <pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1b3bd40b-0884-30b4-b37f-b10bf8fa8394</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on the current status and future of COVID-19.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on the current status and future of COVID-19.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v6npiu4r3s48emtm/ADV-_Covid_Podcast_1_mixdown6is97.mp3" length="44867866" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on the current status and future of COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1867</itunes:duration>
                <itunes:episode>1127</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy: Establishing and Maintaining a Successful Research Career in Infectious Disease</title>
        <itunes:title>Research in Pharmacy: Establishing and Maintaining a Successful Research Career in Infectious Disease</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-establishing-and-maintaining-a-successful-research-career-in-infectious-disease/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-establishing-and-maintaining-a-successful-research-career-in-infectious-disease/#comments</comments>        <pubDate>Thu, 25 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fde4e8af-a7a0-301e-b9f2-ee49b4296cd6</guid>
                                    <description><![CDATA[<p style="background: white;">Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you!</p>
<p style="background: white;"> The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="background: white;">Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you!</p>
<p style="background: white;"> <em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hzsxsgc93d3j3ewm/ASHPOfficial_Establishing_and_Maintaining_a_Successful_Research_Career_in_Infectious_Diseases_Mix.mp3" length="30538706" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you!
 The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1908</itunes:duration>
                <itunes:episode>1126</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: NPF: Pharmacy Frontiers: Transitioning New Pharmacy Practitioners into Management Roles</title>
        <itunes:title>Pharmacy Leadership: NPF: Pharmacy Frontiers: Transitioning New Pharmacy Practitioners into Management Roles</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-pharmacy-frontiers-transitioning-new-pharmacy-practitioners-into-management-roles/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-pharmacy-frontiers-transitioning-new-pharmacy-practitioners-into-management-roles/#comments</comments>        <pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/571cfd2a-185a-3409-97be-902c08136fde</guid>
                                    <description><![CDATA[<p>This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v44r2jv8vqgq54ik/ASHPOfficial_Transitioning_New_Pharmacy_Practitioners_into_Management_Roles_Mix.mp3" length="35140301" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2196</itunes:duration>
                <itunes:episode>1124</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Interview Advice for New Leaders</title>
        <itunes:title>Pharmacy Leadership: Interview Advice for New Leaders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-interview-advice-for-new-leaders/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-interview-advice-for-new-leaders/#comments</comments>        <pubDate>Thu, 18 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0cd8e805-315e-3e6a-9b01-88f6c034a0b9</guid>
                                    <description><![CDATA[<p>This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hexnjyhq5awurfmx/ASHPOfficial_Interview_Advice_for_New_Leaders_Mix.mp3" length="30209693" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                <itunes:episode>1122</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Compliance with USP Chapter 797 in Small and Rural Hospitals</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Compliance with USP Chapter 797 in Small and Rural Hospitals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-compliance-with-usp-chapter-in-small-and-rural-hospitals/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-compliance-with-usp-chapter-in-small-and-rural-hospitals/#comments</comments>        <pubDate>Wed, 17 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff9414cc-d6d4-36a0-bf68-20bcb4722d3f</guid>
                                    <description><![CDATA[<p>Learn from experts on compliance with USP Chapter &lt;797&gt; in small and rural hospitals.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts on compliance with USP Chapter &lt;797&gt; in small and rural hospitals.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x7j954uma3kn8m8r/Compliance_with_USP_Chapter_797_in_Small_and_Rural_Hospitals_mixdownaegpi.mp3" length="32143364" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts on compliance with USP Chapter &lt;797&gt; in small and rural hospitals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1337</itunes:duration>
                <itunes:episode>1125</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: 340B State Laws Win Big in Court</title>
        <itunes:title>Advocating for Impact: 340B State Laws Win Big in Court</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-340b-state-laws-win-big-in-court/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-340b-state-laws-win-big-in-court/#comments</comments>        <pubDate>Tue, 16 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c4d64857-f848-32ec-a134-fea16a40b251</guid>
                                    <description><![CDATA[<p>In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p8yz88hs4p88j9mx/340B_State_Laws_Win_Big_in_Court_mixdown7yq73.mp3" length="41654656" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1731</itunes:duration>
                <itunes:episode>1121</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Post Match – What Happens Next?</title>
        <itunes:title>Practice Journeys: Post Match – What Happens Next?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-post-match-%e2%80%93-what-happens-next/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-post-match-%e2%80%93-what-happens-next/#comments</comments>        <pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/02f6edae-9111-3a86-b654-461863004d8e</guid>
                                    <description><![CDATA[<p>In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2kkrx4qeaimnxz8e/3_PALRC_Post_Match_mixdownb8pcg.mp3" length="19013545" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>787</itunes:duration>
                <itunes:episode>1123</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Considerations: SACP: The Skinny on GLP1 Agonists (Part 2)</title>
        <itunes:title>Clinical Considerations: SACP: The Skinny on GLP1 Agonists (Part 2)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-considerations-sacp-the-skinny-on-glp1-agonists-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-considerations-sacp-the-skinny-on-glp1-agonists-part-2/#comments</comments>        <pubDate>Thu, 11 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/883cb737-34c4-34f6-9570-83d81397938a</guid>
                                    <description><![CDATA[<p>Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q85ia7/The_Skinny_on_the_GLP-1_Agonists_Part_2_mixdownabfty.mp3" length="36666115" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1523</itunes:duration>
                <itunes:episode>1120</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: CPA Series: Collaborative Practice Agreements in Specialty Pharmacy - Qualitive Data Provides Guidance for Implementation</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: CPA Series: Collaborative Practice Agreements in Specialty Pharmacy - Qualitive Data Provides Guidance for Implementation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-cpa-seriescollaborativepractice-agreementsin-specialty-pharmacy-qualitive-data-provides-guidance-forimplement/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-cpa-seriescollaborativepractice-agreementsin-specialty-pharmacy-qualitive-data-provides-guidance-forimplement/#comments</comments>        <pubDate>Tue, 09 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7b4898f8-dacc-3969-abcb-efcde4cd9550</guid>
                                    <description><![CDATA[<p>In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ijg27h/CPA_Series_Collaborative_Practice_Agreements_in_Specialty_Pharmacy_-_Qualitative_Data_Provides_Guidance_for_Implementation_mixdowna1uai.mp3" length="23137180" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>959</itunes:duration>
                <itunes:episode>1119</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Lois Parker (2023)</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Inpatient Care Practitioners Lois Parker (2023)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-lois-parker-2023/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-lois-parker-2023/#comments</comments>        <pubDate>Mon, 08 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e6407a55-15b9-364c-a1dc-28ec9d68756d</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8fwsyr/DSA_Awardee_SICPA_conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Inpatient_Care_Practitioners_Lois_Parker_2023_mixdownaqnu9.mp3" length="21130010" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>875</itunes:duration>
                <itunes:episode>1113</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: Respiratory Syncytial Virus: What You Need to Know about the New RSV Vaccines</title>
        <itunes:title>Clinical Conversations: SCSS: Respiratory Syncytial Virus: What You Need to Know about the New RSV Vaccines</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-respiratory-syncytial-virus-what-you-need-to-know-about-the-new-rsv-vaccines/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-respiratory-syncytial-virus-what-you-need-to-know-about-the-new-rsv-vaccines/#comments</comments>        <pubDate>Thu, 04 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9ea78924-8b2f-3b21-9d9b-e61863370e27</guid>
                                    <description><![CDATA[<p>Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ig5ce3/Respiratory_Syncytial_Virus_What_You_Need_to_Know_about_the_New_RSV_Vaccines_mixdown9y6iy.mp3" length="23443244" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>971</itunes:duration>
                <itunes:episode>1116</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pratice Journeys: Happy Not Knowing: Reflections from Pharmacy Residents</title>
        <itunes:title>Pratice Journeys: Happy Not Knowing: Reflections from Pharmacy Residents</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pratice-journeys-happy-not-knowing-reflections-from-pharmacy-residents/</link>
                    <comments>https://ashpofficial.podbean.com/e/pratice-journeys-happy-not-knowing-reflections-from-pharmacy-residents/#comments</comments>        <pubDate>Wed, 03 Apr 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4c0c69af-dd9b-3dfa-9d92-d15217cf55d0</guid>
                                    <description><![CDATA[<p>Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gbdh8t/ASHPOfficial_Happy_Not_Knowing_MIX.mp3" length="19168256" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1198</itunes:duration>
                <itunes:episode>1118</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Research that Moves Pharmacy Forward: Conversations with the 2023 ASHP Foundation Literature Awardees</title>
        <itunes:title>Hot Topics: Research that Moves Pharmacy Forward: Conversations with the 2023 ASHP Foundation Literature Awardees</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-research-that-moves-pharmacy-forward-conversations-with-the-2023-ashp-foundation-literature-awardees/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-research-that-moves-pharmacy-forward-conversations-with-the-2023-ashp-foundation-literature-awardees/#comments</comments>        <pubDate>Tue, 02 Apr 2024 12:24:50 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fbdf8c7a-803a-3a8c-922d-101562c892b4</guid>
                                    <description><![CDATA[<p>4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mbf6c5/2023_ASHP_Foundation_Literature_Award_Interviews_mixdown9oy37.mp3" length="18046940" type="audio/mpeg"/>
        <itunes:summary><![CDATA[4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>747</itunes:duration>
                <itunes:episode>1117</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resilience: NIOSH Impact Wellbeing™ Campaign: Building a System Where Healthcare Workers Thrive</title>
        <itunes:title>Wellbeing and Resilience: NIOSH Impact Wellbeing™ Campaign: Building a System Where Healthcare Workers Thrive</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-niosh-impact-wellbeing%e2%84%a2-campaign-building-a-system-where-healthcare-workers-thrive/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-niosh-impact-wellbeing%e2%84%a2-campaign-building-a-system-where-healthcare-workers-thrive/#comments</comments>        <pubDate>Thu, 28 Mar 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fb3c1eb4-d646-3c61-ae52-ff1a6f32308f</guid>
                                    <description><![CDATA[<p>The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_niosh_impactwellbeing_guide_&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=rnR7eqCcR-IMhL8IzHiUWw&amp;m=Tg4_xXOhtdVsGV5J-aaxN2nrYC0qC3XPAoAZ_bblrDZ21EmtZn5cj2Z4HeyvWV_m&amp;s=GyI0iNSE5-b9d-NYgsaKNeq5A3t2fB1hO4M-E5zSfqc&amp;e='>Impact Wellbeing Guide</a>, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the <a href='https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_niosh_impactwellbeing_guide_&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=rnR7eqCcR-IMhL8IzHiUWw&amp;m=Tg4_xXOhtdVsGV5J-aaxN2nrYC0qC3XPAoAZ_bblrDZ21EmtZn5cj2Z4HeyvWV_m&amp;s=GyI0iNSE5-b9d-NYgsaKNeq5A3t2fB1hO4M-E5zSfqc&amp;e='>Impact Wellbeing Guide</a>, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j43g2r/2_ASHP_OFFICIAL_NIOSH_Impact_Wellbeing_Campaign_Building_a_System_where_Healthcare_Workers_Thrive_mixdownauas6.mp3" length="63409070" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the Impact Wellbeing Guide, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2641</itunes:duration>
                <itunes:episode>1115</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care setting</title>
        <itunes:title>AJHP Voices: Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care setting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-operationalizingthe-new-dea-exception-anovelprocess-for-dispensing-of-methadone-foropioid-use-disorderat-discharge-from-acutecaresetting/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-operationalizingthe-new-dea-exception-anovelprocess-for-dispensing-of-methadone-foropioid-use-disorderat-discharge-from-acutecaresetting/#comments</comments>        <pubDate>Wed, 27 Mar 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ef661f17-f942-32d2-88e9-985ef770a161</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4g5wvb/Operationalizing_the_new_DEA_exception_1_azul0.m4a" length="43293449" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1791</itunes:duration>
                <itunes:episode>1114</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacy Leadership: NPF: A Conversation with the 2023 New Practitioners Forum Distinguished Service Awardee: Joe Marchiano</title>
        <itunes:title>Pharmacy Leadership: NPF: A Conversation with the 2023 New Practitioners Forum Distinguished Service Awardee: Joe Marchiano</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-the-2023-new-practitioners-forum-distinguished-service-awardee-joe-marchiano/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-the-2023-new-practitioners-forum-distinguished-service-awardee-joe-marchiano/#comments</comments>        <pubDate>Thu, 21 Mar 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/16c51ef4-df75-3741-a529-912c80965777</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/n3tiyv/A_Conversation_with_the_2023_New_Practitioners_Forum_Distinguished_Service_Awardee_Joe_Marchiano_mixdown9vlj1.mp3" length="43197740" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1795</itunes:duration>
                <itunes:episode>1111</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Optimizing PARP Inhibitors Through Applying Evolving Technology and Clinical Evidence for Markers of Homologous Recombination Repair</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Optimizing PARP Inhibitors Through Applying Evolving Technology and Clinical Evidence for Markers of Homologous Recombination Repair</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-ashp-advantageoptimizingparpinhibitors-throughapplying-evolving-technology-and-clinical-evidenceformarkers-ofhomologous-recombin/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-ashp-advantageoptimizingparpinhibitors-throughapplying-evolving-technology-and-clinical-evidenceformarkers-ofhomologous-recombin/#comments</comments>        <pubDate>Wed, 20 Mar 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fc105bd7-0f28-3c8d-b238-449f12cb3434</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pmadiq/ASHPOfficial_ADV_Optimizing_PARP_Inhibitors_Through_Applying_Evolving_Technology_and_Clinical_Evidence_for_Markers_of_MIX.mp3" length="62369867" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1559</itunes:duration>
                <itunes:episode>1112</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Improvement Science and Implementation Science: Driving What We Learn into Practice</title>
        <itunes:title>Research in Pharmacy Practice: Improvement Science and Implementation Science: Driving What We Learn into Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-improvement-science-and-implementation-science-driving-what-we-learn-into-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-improvement-science-and-implementation-science-driving-what-we-learn-into-practice/#comments</comments>        <pubDate>Mon, 18 Mar 2024 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d6ec8d2e-9d86-32f5-ad99-26c118f0a145</guid>
                                    <description><![CDATA[<p>Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9fa8dw/Improvement_Science_and_Implementation_Science_Driving_What_We_Learn_into_Practice_mixdown79wrg.mp3" length="50393964" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2095</itunes:duration>
                <itunes:episode>1108</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SACP: The Skinny on the GLP-1 Agonists (Part 1)</title>
        <itunes:title>Clinical Conversations: SACP: The Skinny on the GLP-1 Agonists (Part 1)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-the-skinny-on-the-glp-1-agonists-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-the-skinny-on-the-glp-1-agonists-part-1/#comments</comments>        <pubDate>Fri, 15 Mar 2024 15:07:14 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9ea96135-bebf-3ffa-9a7f-6e69620eb0d9</guid>
                                    <description><![CDATA[<p>Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ncw9vn/The_Skinny_on_the_GLP-1_Agonists_Part_1_mixdown65q74.mp3" length="25509265" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar.  As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1058</itunes:duration>
                <itunes:episode>1110</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: CMS Audits of Pharmacy Residency Programs – What You Need to Know Now</title>
        <itunes:title>Advocating for Impact: CMS Audits of Pharmacy Residency Programs – What You Need to Know Now</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-cms-audits-of-pharmacy-residency-programs-%e2%80%93-what-you-need-to-know-now/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-cms-audits-of-pharmacy-residency-programs-%e2%80%93-what-you-need-to-know-now/#comments</comments>        <pubDate>Tue, 05 Mar 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c3c8e23a-deea-3792-84da-b0e81615901b</guid>
                                    <description><![CDATA[<p>This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bjbv9i/CMS_Audits_of_Pharmacy_Residency_Programs_What_You_Need_to_Know_Now_mixdownajwvs.mp3" length="28139875" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1168</itunes:duration>
                <itunes:episode>1106</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners (2023) – Megan Dorrell, Pharm.D., BCACP</title>
        <itunes:title>Research in Pharmacy Practice: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners (2023) – Megan Dorrell, Pharm.D., BCACP</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacypracticea-conversationwithdistinguishedservice-awardeeforthe-section-ofambulatorycarepractitioners2023%e2%80%93-megandorrell-pharm/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacypracticea-conversationwithdistinguishedservice-awardeeforthe-section-ofambulatorycarepractitioners2023%e2%80%93-megandorrell-pharm/#comments</comments>        <pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3aebff2-fc48-3d2c-828f-73cf950b9f33</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2023 Awardee, Megan Dorrell, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2023 Awardee, Megan Dorrell, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ehbf68/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Specialty_Pharmacy_Practitioners_Megan_Dorrell_mixdown6ej81.mp3" length="20662805" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2023 Awardee, Megan Dorrell, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>857</itunes:duration>
                <itunes:episode>1104</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: What You Need to Know About Obesity and Newer Treatments – Part 2</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: What You Need to Know About Obesity and Newer Treatments – Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-you-need-to-know-about-obesity-and-newer-treatments-%e2%80%93-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-you-need-to-know-about-obesity-and-newer-treatments-%e2%80%93-part-2/#comments</comments>        <pubDate>Fri, 01 Mar 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/942a3305-fb41-3f93-b538-52eed70512dc</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on pharmacotherapy for obesity.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on pharmacotherapy for obesity.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xxur8s/ADV_What_You_Need_to_Know_About_Obesity_and_Newer_Treatments_Part_2_mixdown9zpin.mp3" length="43932733" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on pharmacotherapy for obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1827</itunes:duration>
                <itunes:episode>1105</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: PALRC: Advice for New Leaders Completing Job Applications</title>
        <itunes:title>Pharmacy Leadership: PALRC: Advice for New Leaders Completing Job Applications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-advice-for-new-leaders-completing-job-applications/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-palrc-advice-for-new-leaders-completing-job-applications/#comments</comments>        <pubDate>Thu, 29 Feb 2024 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1b1db2bd-9cb2-3f76-af85-49f7b959cfee</guid>
                                    <description><![CDATA[<p>Pharmacy leaders discuss tips for both HSPAL residents completing job applications following residency and current practicing pharmacists looking to move up within their organization. Discussion points include strategies for looking for jobs, reference selection, CV preparation, and what to make sure to include- and leave out- of your applications. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacy leaders discuss tips for both HSPAL residents completing job applications following residency and current practicing pharmacists looking to move up within their organization. Discussion points include strategies for looking for jobs, reference selection, CV preparation, and what to make sure to include- and leave out- of your applications. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/is8tpa/_Advice_for_New_Leaders_Completing_Job_Applications_mixdownbpaf0.mp3" length="23752264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacy leaders discuss tips for both HSPAL residents completing job applications following residency and current practicing pharmacists looking to move up within their organization. Discussion points include strategies for looking for jobs, reference selection, CV preparation, and what to make sure to include- and leave out- of your applications. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>985</itunes:duration>
                <itunes:episode>1102</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Pharmacy Technician Product Verification Model Legislation</title>
        <itunes:title>Advocating for Impact: Pharmacy Technician Product Verification Model Legislation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-pharmacy-technician-product-verification-model-legislation/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-pharmacy-technician-product-verification-model-legislation/#comments</comments>        <pubDate>Thu, 29 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/64ac2441-92ad-3c8e-a891-6147a9b5f4d1</guid>
                                    <description><![CDATA[<p>Policies in support of pharmacy technician product verification enable pharmacists to spend more time on clinical and cognitive functions, create advanced opportunities for pharmacy technicians and streamline workflows. This podcast highlights recently developed advocacy resources for organizations seeking to leverage pharmacy technicians for product verification. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Policies in support of pharmacy technician product verification enable pharmacists to spend more time on clinical and cognitive functions, create advanced opportunities for pharmacy technicians and streamline workflows. This podcast highlights recently developed advocacy resources for organizations seeking to leverage pharmacy technicians for product verification. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2phgnm/Pharmacy_Technician_Product_Verification_Model_Legislation_mixdownbq723.mp3" length="34189248" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Policies in support of pharmacy technician product verification enable pharmacists to spend more time on clinical and cognitive functions, create advanced opportunities for pharmacy technicians and streamline workflows. This podcast highlights recently developed advocacy resources for organizations seeking to leverage pharmacy technicians for product verification. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1420</itunes:duration>
                <itunes:episode>1101</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process</title>
        <itunes:title>AJHP Voices: Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-training-the-next-generation-of-peer-reviewers-steps-for-guiding-pharmacy-learners-through-the-peer-review-process/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-training-the-next-generation-of-peer-reviewers-steps-for-guiding-pharmacy-learners-through-the-peer-review-process/#comments</comments>        <pubDate>Wed, 28 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/435eebed-4217-371a-b33e-b565c836852e</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Pete Johnson, Dr. Avery Parman, and Dr. Jamie Miller discuss the AJHP Commentary, “Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Pete Johnson, Dr. Avery Parman, and Dr. Jamie Miller discuss the AJHP Commentary, “Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ixizfk/Training_the_next_generation_of_peer_reviewers_1_6fpsu.m4a" length="34826036" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Pete Johnson, Dr. Avery Parman, and Dr. Jamie Miller discuss the AJHP Commentary, “Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1440</itunes:duration>
                <itunes:episode>1098</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: What You Need to Know About Obesity and Newer Treatments – Part 1</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: What You Need to Know About Obesity and Newer Treatments – Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-you-need-to-know-about-obesity-and-newer-treatments-%e2%80%93-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-you-need-to-know-about-obesity-and-newer-treatments-%e2%80%93-part-1/#comments</comments>        <pubDate>Fri, 23 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8dd9e0c7-d0f2-3fc6-973a-6a02c169f7c7</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on pharmacotherapy for obesity.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on pharmacotherapy for obesity.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qx9ctt/22024ADV_What_You_Need_to_Know_About_Obesity_and_Newer_Treatments_Part_1_mixdown6xuwj.mp3" length="42600805" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on pharmacotherapy for obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1771</itunes:duration>
                <itunes:episode>1100</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners: Matthew Rim</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners: Matthew Rim</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners-matthew-rim/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners-matthew-rim/#comments</comments>        <pubDate>Mon, 12 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2fb988b3-e2fd-3154-96ac-c01f69ac260a</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Denise Scarpelli, the Chair for the Section of Specialty Pharmacy Practitioners, sits down with SSPP’s Distinguished Service Awardee Matt Rim to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Denise Scarpelli, the Chair for the Section of Specialty Pharmacy Practitioners, sits down with SSPP’s Distinguished Service Awardee Matt Rim to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kv2pfj/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Specialty_Pharmacy_Practitioners_Matthew_Rim_mixdown7mj5k.mp3" length="21736447" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Denise Scarpelli, the Chair for the Section of Specialty Pharmacy Practitioners, sits down with SSPP’s Distinguished Service Awardee Matt Rim to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>901</itunes:duration>
                <itunes:episode>1087</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Conversations: SCSS: Midyear 2023 Highlights - Research Best Practices for Students</title>
        <itunes:title>Clinical Conversations: SCSS: Midyear 2023 Highlights - Research Best Practices for Students</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-scss-midyear-2023-highlights-research-best-practices-for-students/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-scss-midyear-2023-highlights-research-best-practices-for-students/#comments</comments>        <pubDate>Fri, 09 Feb 2024 14:46:18 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c712aa6f-82bd-339d-b624-e932ee740c53</guid>
                                    <description><![CDATA[<p>Amy Barton Alston chats with Drs. Kamakshi Rao and Katie Cho after their presentation titled The Way to Begin is to Begin: Writing Yor First Research Proposal at the Midyear Clinical Meeting.  In this episode, they identify tips and trips for students who are interested in pursuing research projects.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Amy Barton Alston chats with Drs. Kamakshi Rao and Katie Cho after their presentation titled The Way to Begin is to Begin: Writing Yor First Research Proposal at the Midyear Clinical Meeting.  In this episode, they identify tips and trips for students who are interested in pursuing research projects.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4q4y6c/Midyear_2023_Highlights_-_Research_Best_Practices_for_Students_mixdowna4cwm.mp3" length="13674220" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Amy Barton Alston chats with Drs. Kamakshi Rao and Katie Cho after their presentation titled The Way to Begin is to Begin: Writing Yor First Research Proposal at the Midyear Clinical Meeting.  In this episode, they identify tips and trips for students who are interested in pursuing research projects.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>567</itunes:duration>
                <itunes:episode>1095</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Navigating the Residency Rank Process</title>
        <itunes:title>Practice Journeys: Navigating the Residency Rank Process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-navigating-the-residency-rank-process/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-navigating-the-residency-rank-process/#comments</comments>        <pubDate>Fri, 09 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/275902c1-edf4-348d-b51d-6f2b0674423b</guid>
                                    <description><![CDATA[<p>This podcast episode discusses the residency ranking process, how the process works, and tips for finalizing your Rank Order List for the Match. Current health-system pharmacy administration and leadership residents share their personal experiences with the ranking process and advice to residency candidates.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses the residency ranking process, how the process works, and tips for finalizing your Rank Order List for the Match. Current health-system pharmacy administration and leadership residents share their personal experiences with the ranking process and advice to residency candidates.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/un9avd/Navigating_the_Residency_Rank_Process_mixdown72grh.mp3" length="28837341" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses the residency ranking process, how the process works, and tips for finalizing your Rank Order List for the Match. Current health-system pharmacy administration and leadership residents share their personal experiences with the ranking process and advice to residency candidates.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                <itunes:episode>1094</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Job Negotiations – Focus on First Post-Residency Positions</title>
        <itunes:title>Pharmacy Leadership: Job Negotiations – Focus on First Post-Residency Positions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-job-negotiations-%e2%80%93-focus-on-first-post-residency-positions/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-job-negotiations-%e2%80%93-focus-on-first-post-residency-positions/#comments</comments>        <pubDate>Wed, 07 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/de1b5db8-d450-38d3-99ab-fd250861c10c</guid>
                                    <description><![CDATA[<p>Job negotiation is more than salary negotiation. In this podcast, we explore considerations for post-residency positions, including personal finance and budgeting, salary and benefits, start date, additional items to negotiate, and negotiation timeline and principles. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Job negotiation is more than salary negotiation. In this podcast, we explore considerations for post-residency positions, including personal finance and budgeting, salary and benefits, start date, additional items to negotiate, and negotiation timeline and principles. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tq456i/ASHPOfficial_Job_Negotiations_Focus_on_First_Post_Residency_Positions_MIX.mp3" length="33213824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Job negotiation is more than salary negotiation. In this podcast, we explore considerations for post-residency positions, including personal finance and budgeting, salary and benefits, start date, additional items to negotiate, and negotiation timeline and principles. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2075</itunes:duration>
                <itunes:episode>1091</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Congressional Site-Neutral Legislative Proposals Impact on Patients and Providers</title>
        <itunes:title>Advocating for Impact: Congressional Site-Neutral Legislative Proposals Impact on Patients and Providers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-congressional-site-neutral-legislative-proposals-impact-on-patients-and-providers/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-congressional-site-neutral-legislative-proposals-impact-on-patients-and-providers/#comments</comments>        <pubDate>Tue, 06 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/08cd2952-f426-3da9-82b8-ddc240237575</guid>
                                    <description><![CDATA[<p>Over the last year, Congress has considered proposals to reimburse hospitals and out-patient medical centers at the lower rate of free-standing sites, hoping to reap savings. Unfortunately, these proposals fail to comprehend the significant differences between the pharmacy care and services as well as regulatory framework of care provided in out-patient medical centers in contrast to free-standing sites. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Over the last year, Congress has considered proposals to reimburse hospitals and out-patient medical centers at the lower rate of free-standing sites, hoping to reap savings. Unfortunately, these proposals fail to comprehend the significant differences between the pharmacy care and services as well as regulatory framework of care provided in out-patient medical centers in contrast to free-standing sites. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8pt4hn/Congressional_Site-Neutral_Legislative_Proposals_Impact_on_Patients_and_Providers_mixdown8s7s9.mp3" length="16918307" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Over the last year, Congress has considered proposals to reimburse hospitals and out-patient medical centers at the lower rate of free-standing sites, hoping to reap savings. Unfortunately, these proposals fail to comprehend the significant differences between the pharmacy care and services as well as regulatory framework of care provided in out-patient medical centers in contrast to free-standing sites. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>701</itunes:duration>
                <itunes:episode>1092</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Screening for quality with process analytical technology in a health-system pharmacy: A primer</title>
        <itunes:title>AJHP Voices: Screening for quality with process analytical technology in a health-system pharmacy: A primer</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-screening-for-quality-with-process-analytical-technology-in-a-health-system-pharmacy-a-primer/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-screening-for-quality-with-process-analytical-technology-in-a-health-system-pharmacy-a-primer/#comments</comments>        <pubDate>Thu, 01 Feb 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0afa3eb1-9078-384d-98a9-3eadc6c8c821</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Philip Almeter and Dr. Robert Lodder discuss the AJHP Primer, “Screening for quality with process analytical technology in a health-system pharmacy: A primer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Philip Almeter and Dr. Robert Lodder discuss the AJHP Primer, “Screening for quality with process analytical technology in a health-system pharmacy: A primer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pnt9d6/EDITS_Screening_for_quality_with_process_analytical_technology_1_8ktrl.m4a" length="46205335" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Philip Almeter and Dr. Robert Lodder discuss the AJHP Primer, “Screening for quality with process analytical technology in a health-system pharmacy: A primer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1911</itunes:duration>
                <itunes:episode>1090</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Student Perspectives: Tips for Acing Your Residency Interview Presentations</title>
        <itunes:title>Student Perspectives: Tips for Acing Your Residency Interview Presentations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-tips-for-acing-your-residency-interview-presentations/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-tips-for-acing-your-residency-interview-presentations/#comments</comments>        <pubDate>Wed, 31 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ae28cb49-e8a3-3a58-9c81-264066879c91</guid>
                                    <description><![CDATA[<p>Join our expert panel as they delve into key aspects of residency interview presentations. This podcast covers crucial topics such as structuring impactful presentations, selecting compelling topics, handling challenging questions, and empowering advice for those navigating their residency interview journey. Don't miss this valuable advice to enhance your presentation skills and approach your residency interviews with confidence!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join our expert panel as they delve into key aspects of residency interview presentations. This podcast covers crucial topics such as structuring impactful presentations, selecting compelling topics, handling challenging questions, and empowering advice for those navigating their residency interview journey. Don't miss this valuable advice to enhance your presentation skills and approach your residency interviews with confidence!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yvb8jx/Tips_for_Acing_your_residency_interview_mixdown6e4gu.mp3" length="42007547" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join our expert panel as they delve into key aspects of residency interview presentations. This podcast covers crucial topics such as structuring impactful presentations, selecting compelling topics, handling challenging questions, and empowering advice for those navigating their residency interview journey. Don't miss this valuable advice to enhance your presentation skills and approach your residency interviews with confidence!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1746</itunes:duration>
                <itunes:episode>1088</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 3)</title>
        <itunes:title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 3)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-3/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-3/#comments</comments>        <pubDate>Thu, 25 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/865ecd89-630b-3700-92a5-949c13a35cb2</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations. Wendy Horton, Tad Gomez, and James Klauck will share their insights on their professional journeys as pharmacists, hospital executives, and association leaders. This discussion will include essential skills to becoming an effective leader and perspectives on being successful in today’s health care environment.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations. Wendy Horton, Tad Gomez, and James Klauck will share their insights on their professional journeys as pharmacists, hospital executives, and association leaders. This discussion will include essential skills to becoming an effective leader and perspectives on being successful in today’s health care environment.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m6phjx/2_Pharmacists_in_the_C-Suite_Professional_Journeys_and_Perspectives_on_Healthcare_Part_3_121123_mixdown_1_b2kw4.mp3" length="48310555" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations. Wendy Horton, Tad Gomez, and James Klauck will share their insights on their professional journeys as pharmacists, hospital executives, and association leaders. This discussion will include essential skills to becoming an effective leader and perspectives on being successful in today’s health care environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2009</itunes:duration>
                <itunes:episode>1085</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Prioritizing Wellbeing Throughout the Residency Application Process</title>
        <itunes:title>Student Perspectives: Prioritizing Wellbeing Throughout the Residency Application Process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-prioritizing-wellbeing-throughout-the-residency-application-process/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-prioritizing-wellbeing-throughout-the-residency-application-process/#comments</comments>        <pubDate>Wed, 24 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e0768e9f-f342-33c7-b263-53a56ab993c9</guid>
                                    <description><![CDATA[<p>Prioritizing wellbeing and mental health throughout the stressful season of residency applications and the match process can easily become overlooked. In this podcast, current and past residents will provide advice and tips to help guide current pharmacy students through this season.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Prioritizing wellbeing and mental health throughout the stressful season of residency applications and the match process can easily become overlooked. In this podcast, current and past residents will provide advice and tips to help guide current pharmacy students through this season.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pr2b8y/Prioritizing_Wellbeing_Throughout_the_Residency_Application_Process_mixdown7p5g7.mp3" length="36359139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Prioritizing wellbeing and mental health throughout the stressful season of residency applications and the match process can easily become overlooked. In this podcast, current and past residents will provide advice and tips to help guide current pharmacy students through this season.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1511</itunes:duration>
                <itunes:episode>1086</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: SPPL: Leadership Reflections; “If I knew then what I know now”</title>
        <itunes:title>Pharmacy Leadership: SPPL: Leadership Reflections; “If I knew then what I know now”</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-leadership-reflections-if-i-knew-then-what-i-know-now/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-sppl-leadership-reflections-if-i-knew-then-what-i-know-now/#comments</comments>        <pubDate>Tue, 23 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8ad70542-ef67-3e03-831e-81651f4be0aa</guid>
                                    <description><![CDATA[<p>Two leaders with twenty years’ experience each in pharmacy and leadership roles chat with a current HSPAL resident about lessons learned and areas to consider and grow in during a career progression.  Everyone can benefit from a reflection on what you know now and how it could have helped you earlier in your career. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Two leaders with twenty years’ experience each in pharmacy and leadership roles chat with a current HSPAL resident about lessons learned and areas to consider and grow in during a career progression.  Everyone can benefit from a reflection on what you know now and how it could have helped you earlier in your career. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tvk7ag/SPPL_-_If_I_knew_then_what_I_know_nowgrowing_as_a_leader_mixdownaaega.mp3" length="29474023" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two leaders with twenty years’ experience each in pharmacy and leadership roles chat with a current HSPAL resident about lessons learned and areas to consider and grow in during a career progression.  Everyone can benefit from a reflection on what you know now and how it could have helped you earlier in your career. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1224</itunes:duration>
                <itunes:episode>1084</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>There’s immunosuppression medications in my queue, what do I do? (CE)</title>
        <itunes:title>There’s immunosuppression medications in my queue, what do I do? (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hold-for-titledescription/</link>
                    <comments>https://ashpofficial.podbean.com/e/hold-for-titledescription/#comments</comments>        <pubDate>Sat, 20 Jan 2024 12:30:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3608cd51-d533-368f-a7b2-06223ba8dcb7</guid>
                                    <description><![CDATA[<p>During pharmacy school, we had one lecture on solid organ transplantation. With this podcast, we hope to provide tips and tricks to help non-transplant pharmacists decide the best course of action when they come across a solid organ transplant recipient.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During pharmacy school, we had one lecture on solid organ transplantation. With this podcast, we hope to provide tips and tricks to help non-transplant pharmacists decide the best course of action when they come across a solid organ transplant recipient.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j8akwe/3_There_s_immunosuppression_medications_in_my_queue_what_do_I_do_mixdownbc1w2.mp3" length="34145689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During pharmacy school, we had one lecture on solid organ transplantation. With this podcast, we hope to provide tips and tricks to help non-transplant pharmacists decide the best course of action when they come across a solid organ transplant recipient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1418</itunes:duration>
                <itunes:episode>1089</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: ASHP/ASHP Foundation 2024 Pharmacy Forecast Report</title>
        <itunes:title>AJHP Voices: ASHP/ASHP Foundation 2024 Pharmacy Forecast Report</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-recent-and-anticipated-novel-drug-approvals-for-2023-and-2024-1704732706/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-recent-and-anticipated-novel-drug-approvals-for-2023-and-2024-1704732706/#comments</comments>        <pubDate>Wed, 17 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/54223c10-c775-3d22-82bd-0edd68f49475</guid>
                                    <description><![CDATA[<p>In this podcast, Drs. Denise Scarpelli, Katie Derry, Mandy Leonard, and Suzanne Shea discuss the ASHP/ASHP Foundation 2024 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Drs. Denise Scarpelli, Katie Derry, Mandy Leonard, and Suzanne Shea discuss the ASHP/ASHP Foundation 2024 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dqe5pt/2024_Pharmacy_Forecast_Report6sn38.m4a" length="60985348" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Drs. Denise Scarpelli, Katie Derry, Mandy Leonard, and Suzanne Shea discuss the ASHP/ASHP Foundation 2024 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2522</itunes:duration>
                <itunes:episode>1082</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Conversations: SACP: Telehealth: Connecting Clinical Pharmacists with Patients in Palliative Care</title>
        <itunes:title>Clinical Conversations: SACP: Telehealth: Connecting Clinical Pharmacists with Patients in Palliative Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-telehealth-connecting-clinical-pharmacists-with-patients-in-palliative-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-conversations-sacp-telehealth-connecting-clinical-pharmacists-with-patients-in-palliative-care/#comments</comments>        <pubDate>Thu, 11 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/943b83c5-1035-3525-8939-5f03b55c1f20</guid>
                                    <description><![CDATA[<p>The emergence of healthcare delivery during the COVID-19 pandemic demonstrated the potential advantages of leveraging technology to bring the clinician to the patient. Telehealth remains a viable and sustainable option for patients that have limited access to in-person care. Palliative care teams can utilize technology to optimize access and delivery of clinical pharmacy services to patients in palliative care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The emergence of healthcare delivery during the COVID-19 pandemic demonstrated the potential advantages of leveraging technology to bring the clinician to the patient. Telehealth remains a viable and sustainable option for patients that have limited access to in-person care. Palliative care teams can utilize technology to optimize access and delivery of clinical pharmacy services to patients in palliative care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/94vm4f/Telehealth_Connecting_Clinical_NEW_1424_Pharmacists_with_Patients_in_Palliative_Care_mixdown6qppc.mp3" length="23937592" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The emergence of healthcare delivery during the COVID-19 pandemic demonstrated the potential advantages of leveraging technology to bring the clinician to the patient. Telehealth remains a viable and sustainable option for patients that have limited access to in-person care. Palliative care teams can utilize technology to optimize access and delivery of clinical pharmacy services to patients in palliative care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>993</itunes:duration>
                <itunes:episode>1081</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Managing Biosimilar Adoption in Specialty Pharmacy</title>
        <itunes:title>Hot Topics: Managing Biosimilar Adoption in Specialty Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-managing-biosimilar-adoption-in-specialty-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-managing-biosimilar-adoption-in-specialty-pharmacy/#comments</comments>        <pubDate>Wed, 10 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/041f22c8-dd58-39b7-95db-ae0b854d6d78</guid>
                                    <description><![CDATA[<p>As many new adalimumab biosimilars have been hitting the market, three experts discuss current market trends and how their organizations are projecting the future impact of these biosimilar products. During this podcast, speakers discuss modeling strategies, planning for resources, and operational changes needed to support biosimilar adoption.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As many new adalimumab biosimilars have been hitting the market, three experts discuss current market trends and how their organizations are projecting the future impact of these biosimilar products. During this podcast, speakers discuss modeling strategies, planning for resources, and operational changes needed to support biosimilar adoption.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q8yt96/2_Managing_Biosimilar_Adoption_in_Specialty_Pharmacy_mixdownb766u.mp3" length="39457786" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As many new adalimumab biosimilars have been hitting the market, three experts discuss current market trends and how their organizations are projecting the future impact of these biosimilar products. During this podcast, speakers discuss modeling strategies, planning for resources, and operational changes needed to support biosimilar adoption.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1640</itunes:duration>
                <itunes:episode>1083</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Kristi Gullickson</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Kristi Gullickson</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-kristi-gullickson/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-kristi-gullickson/#comments</comments>        <pubDate>Tue, 09 Jan 2024 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/72a6be76-18df-3ed4-8c1d-21405bba6b83</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, David Chen sits down with the Section of Pharmacy Practice Leaders Distinguished Service Awardee Kristi Gullickson to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, David Chen sits down with the Section of Pharmacy Practice Leaders Distinguished Service Awardee Kristi Gullickson to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iyjd88/ASHPOfficial_A_Conversation_with_Kristi_Gullickson_MIX.mp3" length="50623649" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, David Chen sits down with the Section of Pharmacy Practice Leaders Distinguished Service Awardee Kristi Gullickson to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1265</itunes:duration>
                <itunes:episode>1080</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Presentation Jitters: First Hand Guidance from Midyear Presenters</title>
        <itunes:title>Pharmacy Leadership: Presentation Jitters: First Hand Guidance from Midyear Presenters</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-presentation-jitters-first-hand-guidance-from-midyear-presenters/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-presentation-jitters-first-hand-guidance-from-midyear-presenters/#comments</comments>        <pubDate>Tue, 12 Dec 2023 21:41:56 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9f879f26-7e60-3f09-92e2-ea33045f7a2d</guid>
                                    <description><![CDATA[<p>This podcast will focus on the process related to submitting educational session proposals for ASHP Midyear to provide the audience with greater understanding of what is involved. Examples for prior Midyear presenters will be provided to outline processes they each followed from session idea generation through proposal submission, presentation drafting, and final presentation at Midyear. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on the process related to submitting educational session proposals for ASHP Midyear to provide the audience with greater understanding of what is involved. Examples for prior Midyear presenters will be provided to outline processes they each followed from session idea generation through proposal submission, presentation drafting, and final presentation at Midyear. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/y9b76t/Presentation_Jitters_First_Head_Guidance_from_Midyear_Presenters_mixdown6jnse.mp3" length="43884703" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on the process related to submitting educational session proposals for ASHP Midyear to provide the audience with greater understanding of what is involved. Examples for prior Midyear presenters will be provided to outline processes they each followed from session idea generation through proposal submission, presentation drafting, and final presentation at Midyear. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1825</itunes:duration>
                <itunes:episode>1076</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Administration and Leadership Residency Application and Interview Preparation</title>
        <itunes:title>Administration and Leadership Residency Application and Interview Preparation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/administration-and-leadership-residency-application-and-interview-preparation/</link>
                    <comments>https://ashpofficial.podbean.com/e/administration-and-leadership-residency-application-and-interview-preparation/#comments</comments>        <pubDate>Tue, 12 Dec 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/07659fd4-964f-32ca-9bb5-5293d350eaad</guid>
                                    <description><![CDATA[<p>Residency application and interview season is right around the corner! This podcast features current PGY1 &amp; PGY2 HSPAL residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) to discuss the residency application process, interview tips &amp; tricks and post interview follow up for those interested in pursuing an administration and leadership residency program.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Residency application and interview season is right around the corner! This podcast features current PGY1 &amp; PGY2 HSPAL residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) to discuss the residency application process, interview tips &amp; tricks and post interview follow up for those interested in pursuing an administration and leadership residency program.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pz8bjb/PALRC_HSPAL_Mentorship_mixdownav7fa.mp3" length="22096434" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Residency application and interview season is right around the corner! This podcast features current PGY1 &amp; PGY2 HSPAL residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) to discuss the residency application process, interview tips &amp; tricks and post interview follow up for those interested in pursuing an administration and leadership residency program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>917</itunes:duration>
                <itunes:episode>1074</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hospital Leadership and Administration</title>
        <itunes:title>Hospital Leadership and Administration</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hospital-leadership-and-administration/</link>
                    <comments>https://ashpofficial.podbean.com/e/hospital-leadership-and-administration/#comments</comments>        <pubDate>Sun, 10 Dec 2023 23:02:56 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a13473fe-e3e2-3f9f-b235-073908ba56e9</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q2ra66/Career_Pearls_Podcast_Hospital_Administration_Leadership_mixdowna64dz.mp3" length="29290120" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1216</itunes:duration>
                <itunes:episode>1075</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Recent and anticipated novel drug approvals for 2023 and 2024</title>
        <itunes:title>AJHP Voices: Recent and anticipated novel drug approvals for 2023 and 2024</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-recent-and-anticipated-novel-drug-approvals-for-2023-and-2024/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-recent-and-anticipated-novel-drug-approvals-for-2023-and-2024/#comments</comments>        <pubDate>Sat, 02 Dec 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a0561d1-8aa5-35bd-bb50-d5f57ec09762</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and anticipated novel drug approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and anticipated novel drug approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dqr5xq/Recent_and_anticipated_novel_drug_approvals_for_2023_and_2024_1_946pg.m4a" length="36336784" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and anticipated novel drug approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1503</itunes:duration>
                <itunes:episode>1069</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Drs. Angela Cheng-Lai and Angela Slampak-Cindric</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Drs. Angela Cheng-Lai and Angela Slampak-Cindric</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-angela-cheng-lai-and-angela-slampak-cindric/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-angela-cheng-lai-and-angela-slampak-cindric/#comments</comments>        <pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e401b821-6cd9-3b10-8c78-b57d5895f83b</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Angela Cheng-Lai and Angela Slampak-Cindric and learning more about their session, Simple Acts of Inclusion: Practice Advancement Begins with You. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Angela Cheng-Lai and Angela Slampak-Cindric and learning more about their session, Simple Acts of Inclusion: Practice Advancement Begins with You. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/574q5e/Midyear_Clinical_Meeting_Speaker_Series_Drs_Angela_Cheng-Lai_and_Angela_Slampak-Cindric_Episode_9_mixdown7jj5w.mp3" length="12922162" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Angela Cheng-Lai and Angela Slampak-Cindric and learning more about their session, Simple Acts of Inclusion: Practice Advancement Begins with You. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>535</itunes:duration>
                <itunes:episode>1072</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Possibilities are Endless at the Midyear Clinical Meeting 2023</title>
        <itunes:title>The Possibilities are Endless at the Midyear Clinical Meeting 2023</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-possibilities-are-endless-at-the-midyear-clinical-meeting-2023/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-possibilities-are-endless-at-the-midyear-clinical-meeting-2023/#comments</comments>        <pubDate>Tue, 28 Nov 2023 14:38:39 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a175d545-dcc4-3eea-ae0c-8d1400d17c72</guid>
                                    <description><![CDATA[<p>Imagine the Possibilities is the theme for Midyear Clinical Meeting 2023 and the possibilities are endless! Join experienced conference attendees and upcoming speakers presenting at the meeting and learn more about all Midyear has to offer!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Imagine the Possibilities is the theme for Midyear Clinical Meeting 2023 and the possibilities are endless! Join experienced conference attendees and upcoming speakers presenting at the meeting and learn more about all Midyear has to offer!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ficikx/The_Possibilities_are_Endless_at_Midyear_2023_mixdown7g2le.mp3" length="37692377" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Imagine the Possibilities is the theme for Midyear Clinical Meeting 2023 and the possibilities are endless! Join experienced conference attendees and upcoming speakers presenting at the meeting and learn more about all Midyear has to offer!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1567</itunes:duration>
                <itunes:episode>1073</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Safety: MCM 2022: Medication Safety and Quality Pearls</title>
        <itunes:title>Medication Safety: MCM 2022: Medication Safety and Quality Pearls</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-mcm-2022-medication-safety-and-quality-pearls/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-mcm-2022-medication-safety-and-quality-pearls/#comments</comments>        <pubDate>Sun, 26 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e18d838b-39bd-34e2-9923-468d47783eee</guid>
                                    <description><![CDATA[<p>In this dynamic session from the 2022 Midyear Clinical Meeting, content matter experts present pearls of knowledge focusing on medication safety and quality.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this dynamic session from the 2022 Midyear Clinical Meeting, content matter experts present pearls of knowledge focusing on medication safety and quality.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tstt87/2_MCM_2022_Medication_Safety_and_Quality_Pearls_mixdown90xsh.mp3" length="35817792" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this dynamic session from the 2022 Midyear Clinical Meeting, content matter experts present pearls of knowledge focusing on medication safety and quality.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1490</itunes:duration>
                <itunes:episode>1071</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance</title>
        <itunes:title>AJHP Voices: Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-developmentof-complexity-categoriesfor-an-investigational-drug-services-complexity-scoringtoolto-assesspharmacyeffort-inclinical-trialiniti/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-developmentof-complexity-categoriesfor-an-investigational-drug-services-complexity-scoringtoolto-assesspharmacyeffort-inclinical-trialiniti/#comments</comments>        <pubDate>Sat, 25 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/df2599cd-e093-315d-ad7c-e3627a898478</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Christina Song, Dr. Kim Redic, and Dr. Michelle Yu discuss the AJHP Practice Research Report, “Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Christina Song, Dr. Kim Redic, and Dr. Michelle Yu discuss the AJHP Practice Research Report, “Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/b23hna/Development_of_complexity_categories8muje.m4a" length="41043427" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Christina Song, Dr. Kim Redic, and Dr. Michelle Yu discuss the AJHP Practice Research Report, “Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1837</itunes:duration>
                <itunes:episode>1068</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Top 4 Tips for Residency Success: Insights from ”Get The Residency” Book</title>
        <itunes:title>Top 4 Tips for Residency Success: Insights from ”Get The Residency” Book</itunes:title>
        <link>https://ashpofficial.podbean.com/e/top-4-tips-for-residency-success-insights-from-get-the-residency-book/</link>
                    <comments>https://ashpofficial.podbean.com/e/top-4-tips-for-residency-success-insights-from-get-the-residency-book/#comments</comments>        <pubDate>Tue, 21 Nov 2023 15:14:05 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9c344181-19e9-3454-8435-e54bc4bba12e</guid>
                                    <description><![CDATA[<p>In this episode, the editors of Get the Residency, 3rd Edition share their expertise and discuss the importance of residency preparation. They delve deep into the top 4 tips from their book that have proven to be instrumental in achieving residency success.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the editors of Get the Residency, 3rd Edition share their expertise and discuss the importance of residency preparation. They delve deep into the top 4 tips from their book that have proven to be instrumental in achieving residency success.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/spziik/Top_4_Tips_for_Residency_Success_Insights_from_Get_The_Residency_Book_mixdown_2_asetq.mp3" length="29509757" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the editors of Get the Residency, 3rd Edition share their expertise and discuss the importance of residency preparation. They delve deep into the top 4 tips from their book that have proven to be instrumental in achieving residency success.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1226</itunes:duration>
                <itunes:episode>1070</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Be Antibiotics Aware:  Pharmacists Collaborating with State and Local Health Departments to Optimize Antibiotic Use</title>
        <itunes:title>Hot Topics: Be Antibiotics Aware:  Pharmacists Collaborating with State and Local Health Departments to Optimize Antibiotic Use</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-be-antibiotics-aware-pharmacists-collaborating-with-state-and-local-health-departments-to-optimize-antibiotic-use/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-be-antibiotics-aware-pharmacists-collaborating-with-state-and-local-health-departments-to-optimize-antibiotic-use/#comments</comments>        <pubDate>Mon, 20 Nov 2023 12:24:55 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3170e933-0281-3d22-9247-d7534993fb2c</guid>
                                    <description><![CDATA[<p>CDC recently released the Core Elements of Antibiotic Stewardship for Health Departments to outline the structure and activities of state and local health department antibiotic stewardship programs. The podcast will highlight opportunities for pharmacists to partner with state and local health departments to optimize antibiotic use in their communities.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CDC recently released the Core Elements of Antibiotic Stewardship for Health Departments to outline the structure and activities of state and local health department antibiotic stewardship programs. The podcast will highlight opportunities for pharmacists to partner with state and local health departments to optimize antibiotic use in their communities.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r52fkc/CDC_s_Core_Elements_of_Antibiotic_Stewardship_for_Health_Departments_mixdownbk1ye.mp3" length="49569378" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CDC recently released the Core Elements of Antibiotic Stewardship for Health Departments to outline the structure and activities of state and local health department antibiotic stewardship programs. The podcast will highlight opportunities for pharmacists to partner with state and local health departments to optimize antibiotic use in their communities.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2062</itunes:duration>
                <itunes:episode>1067</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: The Long and Short of Long COVID</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: The Long and Short of Long COVID</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-long-and-short-of-long-covid/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-long-and-short-of-long-covid/#comments</comments>        <pubDate>Fri, 17 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6a6d77f7-b9d1-3090-85f6-69bf55cd66c4</guid>
                                    <description><![CDATA[<p>Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/az9xbs/ADV_The_Long_and_Short_of_Long_COVID_mixdown9zlw2.mp3" length="49550444" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2061</itunes:duration>
                <itunes:episode>1065</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 2)</title>
        <itunes:title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 2)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-2/#comments</comments>        <pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7f7abdfe-3b02-38c5-8056-4deb22fcbc41</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ginreq/ASHPOfficial_Pharmacists_in_the_C_Suite_Professional_Journeys_and_Perspectives_on_Healthcare_Part_2_Mix_1_8iykg.mp3" length="30383165" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1898</itunes:duration>
                <itunes:episode>1066</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Evaluating the Need to Evolve Workforce Models as the Pharmacy Landscape Change</title>
        <itunes:title>Pharmacy Leadership: Evaluating the Need to Evolve Workforce Models as the Pharmacy Landscape Change</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-evaluating-the-need-to-evolve-workforce-models-as-the-pharmacy-landscape-change/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-evaluating-the-need-to-evolve-workforce-models-as-the-pharmacy-landscape-change/#comments</comments>        <pubDate>Tue, 14 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5496ad13-bef9-3470-98a8-1b7215d4dfe3</guid>
                                    <description><![CDATA[<p>Describe the evolution of the pharmacy enterprise and the changes necessary for sustainability.  Share challenges in designing workforce models and techniques to overcome these challenges. Recognize the resulting workforce models and factors that impacted these changes. Provide examples of communication techniques for success model change. Identify future needs for the pharmacy profession to address landscape changes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Describe the evolution of the pharmacy enterprise and the changes necessary for sustainability.  Share challenges in designing workforce models and techniques to overcome these challenges. Recognize the resulting workforce models and factors that impacted these changes. Provide examples of communication techniques for success model change. Identify future needs for the pharmacy profession to address landscape changes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wqvgc9/2NEW_Evaluating_the_Need_to_Evolve_Workforce_Models_as_the_Pharmacy_Landscape_Change_mixdown6y1zz.mp3" length="48776217" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Describe the evolution of the pharmacy enterprise and the changes necessary for sustainability.  Share challenges in designing workforce models and techniques to overcome these challenges. Recognize the resulting workforce models and factors that impacted these changes. Provide examples of communication techniques for success model change. Identify future needs for the pharmacy profession to address landscape changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2029</itunes:duration>
                <itunes:episode>1063</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: ISMP Targeted Medication Best Practices for Community Pharmacy Practice</title>
        <itunes:title>Community Pharmacy: ISMP Targeted Medication Best Practices for Community Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-ismp-targeted-medication-best-practices-for-community-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-ismp-targeted-medication-best-practices-for-community-pharmacy-practice/#comments</comments>        <pubDate>Mon, 13 Nov 2023 15:55:10 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/60689439-6bc0-3601-a35b-0bd86d6cf267</guid>
                                    <description><![CDATA[<p>Medication safety issues continue to cause harmful or fatal errors across all settings. Recently, The Institute for Safe Medication Practices (ISMP) published new guidance on best practices for medication safety in the community pharmacy setting.  Join Dr. Brooke Hudspeth as she interviews Dr. Alex Swick and Dr. Shanna Whitwell to discuss this new document and mobilize widespread adoption of these consensus-based best practices.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Medication safety issues continue to cause harmful or fatal errors across all settings. Recently, The Institute for Safe Medication Practices (ISMP) published new guidance on best practices for medication safety in the community pharmacy setting.  Join Dr. Brooke Hudspeth as she interviews Dr. Alex Swick and Dr. Shanna Whitwell to discuss this new document and mobilize widespread adoption of these consensus-based best practices.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qy7k6d/_ISMP_Targeted_Medication_Best_Practices_for_Community_Pharmacy_Practice_mixdown8nys4.mp3" length="23186977" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Medication safety issues continue to cause harmful or fatal errors across all settings. Recently, The Institute for Safe Medication Practices (ISMP) published new guidance on best practices for medication safety in the community pharmacy setting.  Join Dr. Brooke Hudspeth as she interviews Dr. Alex Swick and Dr. Shanna Whitwell to discuss this new document and mobilize widespread adoption of these consensus-based best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>963</itunes:duration>
                <itunes:episode>1064</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-antonia-akrap-delaram-bahmander-and-samantha-roberts/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-antonia-akrap-delaram-bahmander-and-samantha-roberts/#comments</comments>        <pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5eaa45ba-d974-3504-b20e-9c1fb1fb83cf</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts and learning more about their session, It's a Small World After All: Diversion Prevention Software Challenges. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts and learning more about their session, It's a Small World After All: Diversion Prevention Software Challenges. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yz4qe9/Midyear_Clinical_Meeting_Speaker_Series_Drs_Samantha_Roberts_Antonia_Akrap_and_Delaram_Bahmander_Episode_8_mixdown83wlz.mp3" length="12418749" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts and learning more about their session, It's a Small World After All: Diversion Prevention Software Challenges. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>514</itunes:duration>
                <itunes:episode>1062</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): Hot-Blooded: Oral Beta Lactam Therapy for Gram Negative Rod Bloodstream Infections</title>
        <itunes:title>Therapeutics Thursday (SCSS): Hot-Blooded: Oral Beta Lactam Therapy for Gram Negative Rod Bloodstream Infections</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-hot-blooded-oral-beta-lactam-therapy-for-gram-negative-rod-bloodstream-infections/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-hot-blooded-oral-beta-lactam-therapy-for-gram-negative-rod-bloodstream-infections/#comments</comments>        <pubDate>Thu, 09 Nov 2023 13:04:21 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e4f15841-ded7-3f66-874b-0e5cbdaeb7af</guid>
                                    <description><![CDATA[<p>In this episode, Dev Chatterji and Lois Lee discuss role the oral-beta lactams may serve in the treatment of Gram-Negative Rod bloodstream infections, the data behind the recommendation and identify the patients who may be ideal candidates for this therapy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Dev Chatterji and Lois Lee discuss role the oral-beta lactams may serve in the treatment of Gram-Negative Rod bloodstream infections, the data behind the recommendation and identify the patients who may be ideal candidates for this therapy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fjaxwz/ASHPOfficial_Hot_Blooded_Oral_Beta_Lactam_Therapy_for_Gram_Negative_Rod_Bloodstream_Infections_MIX.mp3" length="76898042" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Dev Chatterji and Lois Lee discuss role the oral-beta lactams may serve in the treatment of Gram-Negative Rod bloodstream infections, the data behind the recommendation and identify the patients who may be ideal candidates for this therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1922</itunes:duration>
                <itunes:episode>1061</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Solid Organ Transplant Pharmacy? What’s that?  (C.E., CPL credit)</title>
        <itunes:title>Therapeutic Thursdays: Solid Organ Transplant Pharmacy? What’s that?  (C.E., CPL credit)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-solid-organ-transplant-pharmacy-what-s-that-ce-cpl-credit/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-solid-organ-transplant-pharmacy-what-s-that-ce-cpl-credit/#comments</comments>        <pubDate>Thu, 09 Nov 2023 13:02:47 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9dfddd2b-ae74-3cbf-b559-fff2124084da</guid>
                                    <description><![CDATA[<p>There are many career avenues one can take as pharmacist. One area within clinical pharmacy that many individuals do not get much exposure to in pharmacy school or practice is solid organ transplant. This podcast will review what a career as a solid organ transplant pharmacist looks like and potential career avenues if one was to pursue this track of pharmacy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>There are many career avenues one can take as pharmacist. One area within clinical pharmacy that many individuals do not get much exposure to in pharmacy school or practice is solid organ transplant. This podcast will review what a career as a solid organ transplant pharmacist looks like and potential career avenues if one was to pursue this track of pharmacy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z3gf2f/Solid_Organ_Transplant_Pharmacy_What_s_that_mixdown7moub.mp3" length="44767505" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There are many career avenues one can take as pharmacist. One area within clinical pharmacy that many individuals do not get much exposure to in pharmacy school or practice is solid organ transplant. This podcast will review what a career as a solid organ transplant pharmacist looks like and potential career avenues if one was to pursue this track of pharmacy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1862</itunes:duration>
                <itunes:episode>1060</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Bravo Zulu: A Conversation with Three ASHP Member Veterans</title>
        <itunes:title>Practice Journeys: Bravo Zulu: A Conversation with Three ASHP Member Veterans</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-bravo-zulu-a-conversation-with-three-ashp-member-veterans/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-bravo-zulu-a-conversation-with-three-ashp-member-veterans/#comments</comments>        <pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4362cd37-d25a-37f6-bf82-29106f5714cf</guid>
                                    <description><![CDATA[<p>In celebration of Veterans Day 2023, ASHPOfficial is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with John Spain, Eugene de Lara, and Stephen LaHaye about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In celebration of Veterans Day 2023, ASHPOfficial is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with John Spain, Eugene de Lara, and Stephen LaHaye about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ysndg3/Bravo_Zulu_A_Conversation_with_Three_ASHP_Member_Veterans_mixdown96pt8.mp3" length="66191092" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In celebration of Veterans Day 2023, ASHPOfficial is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with John Spain, Eugene de Lara, and Stephen LaHaye about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2757</itunes:duration>
                <itunes:episode>1059</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Career Pearls for Students: Pain Stewardship &amp; Harm Reduction</title>
        <itunes:title>Career Pearls for Students: Pain Stewardship &amp; Harm Reduction</itunes:title>
        <link>https://ashpofficial.podbean.com/e/career-pearls-for-students-pain-stewardship-harm-reduction/</link>
                    <comments>https://ashpofficial.podbean.com/e/career-pearls-for-students-pain-stewardship-harm-reduction/#comments</comments>        <pubDate>Sat, 04 Nov 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0cea53e5-c724-3a0f-a73b-f68250cdc2d1</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kaxki6/Career_Pearls_for_Students_Pain_Stewardship_Harm_Reduction_mixdown6okfg.mp3" length="50472541" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2100</itunes:duration>
                <itunes:episode>1058</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Patti Kienle and Dr. Michael Ganio discuss sterile compounding education</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Patti Kienle and Dr. Michael Ganio discuss sterile compounding education</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-patti-kienle-and-dr-michael-ganio-discuss-sterile-compounding-education/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-patti-kienle-and-dr-michael-ganio-discuss-sterile-compounding-education/#comments</comments>        <pubDate>Fri, 03 Nov 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c4fa9e77-416b-39d9-8d7d-cac96e13e2df</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Patti Kienle and Dr. Michael Ganio and learning more about the  sessions related to sterile compounding .If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Patti Kienle and Dr. Michael Ganio and learning more about the  sessions related to sterile compounding .If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2uqhbe/Midyear_Clinical_Meeting_Speaker_Series_Patti_Kienle_and_Dr_Michael_Ganio_Episode_7_mixdown8m0va.mp3" length="9160424" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Patti Kienle and Dr. Michael Ganio and learning more about the  sessions related to sterile compounding .If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>379</itunes:duration>
                <itunes:episode>1056</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How I Did It: Finding Career Success at the Midyear (Ella Domingo)</title>
        <itunes:title>How I Did It: Finding Career Success at the Midyear (Ella Domingo)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/how-i-did-it-finding-career-success-at-the-midyear-ella-domingo/</link>
                    <comments>https://ashpofficial.podbean.com/e/how-i-did-it-finding-career-success-at-the-midyear-ella-domingo/#comments</comments>        <pubDate>Thu, 02 Nov 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/955f3a3d-c5f3-390c-be11-30f90766ec3a</guid>
                                    <description><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we're sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. This special short-form podcast series highlights the impact attending career-focused events at the Midyear meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we're sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. This special short-form podcast series highlights the impact attending career-focused events at the Midyear meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x3s4ss/Residency_Showcase_Success_Stories_Ella_Domingo_mixdown8ue5f.mp3" length="5023507" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we're sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. This special short-form podcast series highlights the impact attending career-focused events at the Midyear meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>206</itunes:duration>
                <itunes:episode>1057</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Drs. Kate Cozart &amp; Lisa Buss Preszler</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Drs. Kate Cozart &amp; Lisa Buss Preszler</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-kate-cozart-lisa-buss-preszler/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-drs-kate-cozart-lisa-buss-preszler/#comments</comments>        <pubDate>Wed, 01 Nov 2023 12:55:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/60a1135b-af58-3193-87ad-2c727ed414b5</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Kate Cozart and Lisa Buss Preszler and learning more about their session, The Art and Science of Compassion. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Kate Cozart and Lisa Buss Preszler and learning more about their session, The Art and Science of Compassion. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kf95qw/MCM_Speaker_Series_Drs_Kate_Cozart_and_Lisa_Buss_Preszler_Episode_6_mixdown7gf4k.mp3" length="9753399" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Kate Cozart and Lisa Buss Preszler and learning more about their session, The Art and Science of Compassion. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>403</itunes:duration>
                <itunes:episode>1055</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: A hospital within a hospital: An innovative pharmacy model to improve the continuum of care</title>
        <itunes:title>AJHP Voices: A hospital within a hospital: An innovative pharmacy model to improve the continuum of care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-a-hospital-within-a-hospital-an-innovative-pharmacy-model-to-improve-the-continuum-of-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-a-hospital-within-a-hospital-an-innovative-pharmacy-model-to-improve-the-continuum-of-care/#comments</comments>        <pubDate>Wed, 01 Nov 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/07845c3b-5aa2-3b19-a613-293270e5096a</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Niaz Deyhim and Dr. Anita Saini discuss the AJHP Case Study, “A hospital within a hospital: An innovative pharmacy model to improve the continuum of care,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Niaz Deyhim and Dr. Anita Saini discuss the AJHP Case Study, “A hospital within a hospital: An innovative pharmacy model to improve the continuum of care,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m8esn7/AJHP_A_hospital_within_a_hospital_An_innovative_pharmacy_model_to_improve_the_continuum_of_care_MIX_1_aeqsk.mp3" length="26678144" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Niaz Deyhim and Dr. Anita Saini discuss the AJHP Case Study, “A hospital within a hospital: An innovative pharmacy model to improve the continuum of care,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1667</itunes:duration>
                <itunes:episode>1048</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>How I Did It: Finding Career Success at the Midyear (Savanna Scott)</title>
        <itunes:title>How I Did It: Finding Career Success at the Midyear (Savanna Scott)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/how-i-did-it-finding-career-success-at-the-midyear-savanna-scott/</link>
                    <comments>https://ashpofficial.podbean.com/e/how-i-did-it-finding-career-success-at-the-midyear-savanna-scott/#comments</comments>        <pubDate>Mon, 30 Oct 2023 14:30:13 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/806a5102-f9e5-3da7-8607-09e665449aa7</guid>
                                    <description><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gb2nt7/PPS_Success_Stories_Podcast_Series_Savanna_Scott_mixdown6v808.mp3" length="8964872" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>370</itunes:duration>
                <itunes:episode>1054</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Insights into a Successful Midyear Poster Presentation</title>
        <itunes:title>Student Perspectives: Insights into a Successful Midyear Poster Presentation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-insights-into-a-successful-midyear-poster-presentation/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-insights-into-a-successful-midyear-poster-presentation/#comments</comments>        <pubDate>Mon, 30 Oct 2023 11:51:33 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/068725ba-9b49-3984-b46d-5f88b36167c3</guid>
                                    <description><![CDATA[<p>This episode covers the ins and outs of developing and presenting a professional poster at the ASHP Midyear Clinical Meeting. New practitioner speakers share their personal experiences presenting posters and offer invaluable tips on presentation delivery, poster design, and networking strategies. Gain practical advice to ensure your research presentation is a success.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode covers the ins and outs of developing and presenting a professional poster at the ASHP Midyear Clinical Meeting. New practitioner speakers share their personal experiences presenting posters and offer invaluable tips on presentation delivery, poster design, and networking strategies. Gain practical advice to ensure your research presentation is a success.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nyqw2n/Insights_into_a_Successful_Midyear_Poster_Presentation_mixdown86o05.mp3" length="22930814" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode covers the ins and outs of developing and presenting a professional poster at the ASHP Midyear Clinical Meeting. New practitioner speakers share their personal experiences presenting posters and offer invaluable tips on presentation delivery, poster design, and networking strategies. Gain practical advice to ensure your research presentation is a success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>952</itunes:duration>
                <itunes:episode>1053</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Career Pearls for Students: Emergency Medicine</title>
        <itunes:title>Practice Journeys: Career Pearls for Students: Emergency Medicine</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-emergency-medicine/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-emergency-medicine/#comments</comments>        <pubDate>Fri, 27 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dc23df27-3b89-3d81-9060-04b398c670a7</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3hs367/Career_Pearls_for_Students_Emergency_Medicine_mixdownbivrh.mp3" length="49136147" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2044</itunes:duration>
                <itunes:episode>1051</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Marylyn Ritchie</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Marylyn Ritchie</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-marylyn-ritchie/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-marylyn-ritchie/#comments</comments>        <pubDate>Thu, 26 Oct 2023 16:49:04 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/88b71c33-76f1-387a-bac2-aa214e1c4563</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Marylyn Ritchie and learning more about her session, AI and Direct-to-Consumer Genetic Testing: The Good, the Bad, and the Ugly. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Marylyn Ritchie and learning more about her session, AI and Direct-to-Consumer Genetic Testing: The Good, the Bad, and the Ugly. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qew8kq/Midyear_Clinical_Meeting_Speaker_Series_Spotlight_on_Science_Dr_Marylyn_Ritchie_Episode_5_mixdown7bbf9.mp3" length="10474028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Marylyn Ritchie and learning more about her session, AI and Direct-to-Consumer Genetic Testing: The Good, the Bad, and the Ugly. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>433</itunes:duration>
                <itunes:episode>1050</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Navigating Midyear: Guidance from Fellowship Program Directors for Aspiring Industry Fellows</title>
        <itunes:title>Practice Journeys: Navigating Midyear: Guidance from Fellowship Program Directors for Aspiring Industry Fellows</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-navigating-midyear-guidance-from-fellowship-program-directors-for-aspiring-industry-fellows/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-navigating-midyear-guidance-from-fellowship-program-directors-for-aspiring-industry-fellows/#comments</comments>        <pubDate>Sat, 21 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/778c54b3-241f-3f8d-a46f-8677d24792c1</guid>
                                    <description><![CDATA[<p>In this ASHP podcast, Pharmaceutical Industry Fellowship Program Directors provide valuable insight on the role of Personnel Placement Services (PPS) and how to effectively prepare for industry interviews at Midyear. Find out how to navigate the fellowship recruitment process at Midyear and hear strategies on how to succeed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this ASHP podcast, Pharmaceutical Industry Fellowship Program Directors provide valuable insight on the role of Personnel Placement Services (PPS) and how to effectively prepare for industry interviews at Midyear. Find out how to navigate the fellowship recruitment process at Midyear and hear strategies on how to succeed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/424kz5/Navigating_Midyear_Guidance_from_Fellowship_Program_Directors_for_Aspiring_Industry_Fellows_mixdownamdz8.mp3" length="43323669" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this ASHP podcast, Pharmaceutical Industry Fellowship Program Directors provide valuable insight on the role of Personnel Placement Services (PPS) and how to effectively prepare for industry interviews at Midyear. Find out how to navigate the fellowship recruitment process at Midyear and hear strategies on how to succeed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1802</itunes:duration>
                <itunes:episode>1049</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: How I Did It: Finding Success at the Midyear Meeting (Summer Byerley)</title>
        <itunes:title>Practice Journeys: How I Did It: Finding Success at the Midyear Meeting (Summer Byerley)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-how-i-did-it-finding-success-at-the-midyear-meeting-summer-byerley/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-how-i-did-it-finding-success-at-the-midyear-meeting-summer-byerley/#comments</comments>        <pubDate>Wed, 18 Oct 2023 05:43:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9674fff6-9f61-3614-983b-4dc83cd09e6c</guid>
                                    <description><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cw3tsi/2_Residency_Showcase_Success_Stories_Summer_Byerley_mixdown9gqig.mp3" length="6375640" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>262</itunes:duration>
                <itunes:episode>1047</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Andrew Gainey</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Andrew Gainey</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-andrew-gainey/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-andrew-gainey/#comments</comments>        <pubDate>Tue, 17 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1c5816f7-61be-3cf8-83bc-c6be30b21b79</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Andrew Gainey and learning more about his session, The New Age of Phage Therapy: Utilizing Viruses to Treat Antimicrobial Resistant Infections. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Andrew Gainey and learning more about his session, The New Age of Phage Therapy: Utilizing Viruses to Treat Antimicrobial Resistant Infections. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fwguav/MCM_Speaker_Series_Spotlight_on_Science_Andrew_Gainey_mixdown7sq26.mp3" length="7108663" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Andrew Gainey and learning more about his session, The New Age of Phage Therapy: Utilizing Viruses to Treat Antimicrobial Resistant Infections. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>293</itunes:duration>
                <itunes:episode>1046</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How I Did It: Finding Success at the Midyear Meeting (Teodor Lazarvoski)</title>
        <itunes:title>How I Did It: Finding Success at the Midyear Meeting (Teodor Lazarvoski)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/how-i-did-it-finding-success-at-the-midyear-meeting-teodor-lazarvoski/</link>
                    <comments>https://ashpofficial.podbean.com/e/how-i-did-it-finding-success-at-the-midyear-meeting-teodor-lazarvoski/#comments</comments>        <pubDate>Sat, 14 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/51f2d277-592a-37bb-94c2-0621bb5308d6</guid>
                                    <description><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8zsfrz/PPS_Success_Stories_Podcast_Series_Teodor_Lazarvoski_mixdown_1_7o469.mp3" length="5279136" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As we prepare for the ASHP Midyear Clinical Meeting &amp; Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>217</itunes:duration>
                <itunes:episode>1045</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 1)</title>
        <itunes:title>Pharmacy Leadership: Pharmacists in the C-Suite: Professional Journeys and Perspectives on Healthcare (Part 1)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacists-in-the-c-suite-professional-journeys-and-perspectives-on-healthcare-part-1/#comments</comments>        <pubDate>Fri, 13 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ba1bfb8a-8549-32a3-95c9-4f10db7e413e</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/83dtw2/ASHP_Official_Pharmacists_in_the_C_Suite_Professional_Journeys_and_Perspectives_on_Healthcare_Part_1_MIX.mp3" length="41110073" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2569</itunes:duration>
                <itunes:episode>1043</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series Podcast: Dr. Arjun Srinivasan</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series Podcast: Dr. Arjun Srinivasan</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-podcast-dr-arjun-srinivasan/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-podcast-dr-arjun-srinivasan/#comments</comments>        <pubDate>Thu, 12 Oct 2023 11:43:56 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/504e27e9-bfd6-30b4-b060-dd3fe9f73687</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Arjun Srinivasan and learning more about his session, New CDC Requirements for Antibiotic Use Reporting and Opportunities for Antibiotic Stewardship. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Arjun Srinivasan and learning more about his session, New CDC Requirements for Antibiotic Use Reporting and Opportunities for Antibiotic Stewardship. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/u97bru/Midyear_Clinical_Meeting_Speaker_Series_Dr_Arjun_Srinivasan_mixdown793gs.mp3" length="13465826" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Arjun Srinivasan and learning more about his session, New CDC Requirements for Antibiotic Use Reporting and Opportunities for Antibiotic Stewardship. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>558</itunes:duration>
                <itunes:episode>1044</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM Podcast Speaker Series: Midyear Clinical Meeting Speaker Series: Drs. Diana Isaacs and Jennifer Clements</title>
        <itunes:title>MCM Podcast Speaker Series: Midyear Clinical Meeting Speaker Series: Drs. Diana Isaacs and Jennifer Clements</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-podcast-speaker-series-midyear-clinical-meeting-speaker-series-drs-diana-isaacs-and-jennifer-clements/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-podcast-speaker-series-midyear-clinical-meeting-speaker-series-drs-diana-isaacs-and-jennifer-clements/#comments</comments>        <pubDate>Fri, 06 Oct 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/69df040b-fea5-3a0e-98db-211fee518055</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Jennifer Clements and Diana Isaacs and learning more about their session, Another Great Debate — Semaglutide versus Tirzepatide for Type 2 Diabetes and Obesity. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Jennifer Clements and Diana Isaacs and learning more about their session, Another Great Debate — Semaglutide versus Tirzepatide for Type 2 Diabetes and Obesity. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cx2dvq/MCM_Speaker_Series_Another_Great_Debate-Semaglutide_versus_Tirzepatide_for_Type_2_Diabetes_and_Obesity_mixdown9ui66.mp3" length="13294010" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Jennifer Clements and Diana Isaacs and learning more about their session, Another Great Debate — Semaglutide versus Tirzepatide for Type 2 Diabetes and Obesity. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>551</itunes:duration>
                <itunes:episode>1041</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Update of the 2023 American Geriatric Society’s Beers Criteria List for Potentially Inappropriate Medications (PIMs) in Older Adults</title>
        <itunes:title>Therapeutic Thursdays: Update of the 2023 American Geriatric Society’s Beers Criteria List for Potentially Inappropriate Medications (PIMs) in Older Adults</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-updateof-the-2023-americangeriatricsociety-sbeers-criterialistforpotentially-inappropriatemedications-pimsin-older-adults/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-updateof-the-2023-americangeriatricsociety-sbeers-criterialistforpotentially-inappropriatemedications-pimsin-older-adults/#comments</comments>        <pubDate>Thu, 05 Oct 2023 16:21:49 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/65b4fe48-4d41-3bf5-b54c-0fc4392a3d43</guid>
                                    <description><![CDATA[<p>This 2023 revision of the American Geriatric Society’s Beers Criteria for Potentially Inappropriate Medications (PIMs) in older adults includes major recommendations for the safe use of anticoagulants and for avoiding the initiation of aspirin for primary cardiovascular disease, oral and transdermal estrogens in postmenopausal women, sulfonylureas as first, second or add-on therapy for diabetes, and the use of highly anticholinergic medications. Additional areas that have been updated include how PIMs can exacerbate drug-disease and drug syndromes, important drug-drug interactions, and drugs that require alterations in dosing in renal impairment. Pharmacists should be cognizant of these changes to the AGS Beers Criteria so that they can use this tool to help optimize their older adults’ medication regimens. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This 2023 revision of the American Geriatric Society’s Beers Criteria for Potentially Inappropriate Medications (PIMs) in older adults includes major recommendations for the safe use of anticoagulants and for avoiding the initiation of aspirin for primary cardiovascular disease, oral and transdermal estrogens in postmenopausal women, sulfonylureas as first, second or add-on therapy for diabetes, and the use of highly anticholinergic medications. Additional areas that have been updated include how PIMs can exacerbate drug-disease and drug syndromes, important drug-drug interactions, and drugs that require alterations in dosing in renal impairment. Pharmacists should be cognizant of these changes to the AGS Beers Criteria so that they can use this tool to help optimize their older adults’ medication regimens. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5y97bx/ASHPOfficial_Update_of_the_2023_American_Geriatric_Society_s_Beers_Criteria_List_MIX_1_7p5ln.mp3" length="123711058" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This 2023 revision of the American Geriatric Society’s Beers Criteria for Potentially Inappropriate Medications (PIMs) in older adults includes major recommendations for the safe use of anticoagulants and for avoiding the initiation of aspirin for primary cardiovascular disease, oral and transdermal estrogens in postmenopausal women, sulfonylureas as first, second or add-on therapy for diabetes, and the use of highly anticholinergic medications. Additional areas that have been updated include how PIMs can exacerbate drug-disease and drug syndromes, important drug-drug interactions, and drugs that require alterations in dosing in renal impairment. Pharmacists should be cognizant of these changes to the AGS Beers Criteria so that they can use this tool to help optimize their older adults’ medication regimens. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3092</itunes:duration>
                <itunes:episode>1042</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: NPPC Series: Cooking Up experiences and Evaluations that Nourish Learners Without Poisoning Preceptors</title>
        <itunes:title>Educator Essentials: NPPC Series: Cooking Up experiences and Evaluations that Nourish Learners Without Poisoning Preceptors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-nppc-series-cooking-up-experiences-and-evaluations-that-nourish-learners-without-poisoning-preceptors-1696422539/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-nppc-series-cooking-up-experiences-and-evaluations-that-nourish-learners-without-poisoning-preceptors-1696422539/#comments</comments>        <pubDate>Wed, 04 Oct 2023 08:28:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5bf91e03-960e-37d3-b32b-a5280c7f335b</guid>
                                    <description><![CDATA[<p>This podcast will discuss Drs. Lindsay Davis and Erin Raney’s upcoming sessions titled “Precepting Effectiveness: A Habits of Preceptors Workshop” at ASHP’s National Pharmacy Preceptors Conference and “Kaleidoscopes: Viewing Self/Team Enhancement Frameworks Through the Lens of Pharmacist Practitioners.”</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss Drs. Lindsay Davis and Erin Raney’s upcoming sessions titled “Precepting Effectiveness: A Habits of Preceptors Workshop” at ASHP’s National Pharmacy Preceptors Conference and “Kaleidoscopes: Viewing Self/Team Enhancement Frameworks Through the Lens of Pharmacist Practitioners.”</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7enefb/NPPC_Series_-_Precepting_and_Professional_Development_mixdown7av6j.mp3" length="26874745" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss Drs. Lindsay Davis and Erin Raney’s upcoming sessions titled “Precepting Effectiveness: A Habits of Preceptors Workshop” at ASHP’s National Pharmacy Preceptors Conference and “Kaleidoscopes: Viewing Self/Team Enhancement Frameworks Through the Lens of Pharmacist Practitioners.”
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1117</itunes:duration>
                <itunes:episode>1040</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Ending Drug Shortages: ASHP Testifies Before Congress</title>
        <itunes:title>Advocating for Impact: Ending Drug Shortages: ASHP Testifies Before Congress</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-ending-drug-shortages-ashp-testifies-before-congress/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-ending-drug-shortages-ashp-testifies-before-congress/#comments</comments>        <pubDate>Wed, 04 Oct 2023 08:25:18 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/54d7dd7f-878e-3106-b938-d3e5d9b7fbcd</guid>
                                    <description><![CDATA[<p>ASHP expert, Michael Ganio, shares highlights from his recent testimony before the House Energy and Commerce Committee regarding drug shortages.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP expert, Michael Ganio, shares highlights from his recent testimony before the House Energy and Commerce Committee regarding drug shortages.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m9u3ji/Ending_Drug_Shortages_ASHP_Testifies_Before_Congress_mixdown8i0l7.mp3" length="30054138" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP expert, Michael Ganio, shares highlights from his recent testimony before the House Energy and Commerce Committee regarding drug shortages.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1249</itunes:duration>
                <itunes:episode>1039</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): HPV Vaccination: Changing Landscapes and New Challenges</title>
        <itunes:title>Therapeutics Thursday (SCSS): HPV Vaccination: Changing Landscapes and New Challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-hpv-vaccination-changing-landscapes-and-new-challenges/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-hpv-vaccination-changing-landscapes-and-new-challenges/#comments</comments>        <pubDate>Wed, 04 Oct 2023 08:23:02 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7c07a6f9-ac1b-39d6-8821-2e68eabb935e</guid>
                                    <description><![CDATA[<p>Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/b9g6rp/HPV_Vaccination_Changing_Landscapes_and_New_Challenges_mixdown75tu8.mp3" length="30561699" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1270</itunes:duration>
                <itunes:episode>1038</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Ryan Haumschild</title>
        <itunes:title>Midyear Clinical Meeting Speaker Series: Spotlight on Science with Dr. Ryan Haumschild</itunes:title>
        <link>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-ryan-haumschild/</link>
                    <comments>https://ashpofficial.podbean.com/e/midyear-clinical-meeting-speaker-series-spotlight-on-science-with-dr-ryan-haumschild/#comments</comments>        <pubDate>Mon, 02 Oct 2023 19:38:40 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5741348e-b531-31f3-9137-15eeb18aff39</guid>
                                    <description><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Ryan Haumschild and learning more about his session, Putting Oncology into Practice: Modern Treatment Approaches in Women's Health. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Ryan Haumschild and learning more about his session, Putting Oncology into Practice: Modern Treatment Approaches in Women's Health. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uczysq/2_MCM_Speaker_Series_Putting_Oncology_into_Practice_Modern_Treatment_Approaches_in_Womens_Health_mixdown8p776.mp3" length="7978915" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Ryan Haumschild and learning more about his session, Putting Oncology into Practice: Modern Treatment Approaches in Women's Health. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>330</itunes:duration>
                <itunes:episode>1037</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: A Look at ASHP’s Summer Internship Experience</title>
        <itunes:title>Student Perspectives: A Look at ASHP’s Summer Internship Experience</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-a-look-at-ashp-s-summer-internship-experience/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-a-look-at-ashp-s-summer-internship-experience/#comments</comments>        <pubDate>Sat, 30 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a193d1b8-5687-3fe3-af34-f5eaa2f163a1</guid>
                                    <description><![CDATA[<p>Join us for a discussion with ASHP's 2023 summer interns, Quinn and Jordan, as they share their unique perspectives and experiences during their internship. Dive into their pharmacy backgrounds, the essential skills they've developed throughout pharmacy school, and their motivations for choosing an internship with ASHP. Get a behind-the-scenes glimpse of the internship and hear about their daily experiences, standout moments, and valuable advice for aspiring interns. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a discussion with ASHP's 2023 summer interns, Quinn and Jordan, as they share their unique perspectives and experiences during their internship. Dive into their pharmacy backgrounds, the essential skills they've developed throughout pharmacy school, and their motivations for choosing an internship with ASHP. Get a behind-the-scenes glimpse of the internship and hear about their daily experiences, standout moments, and valuable advice for aspiring interns. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cvkuka/ASHPOfficial_A_Look_at_ASHP_s_Summer_Internship_Experience_MIX.mp3" length="66505016" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a discussion with ASHP's 2023 summer interns, Quinn and Jordan, as they share their unique perspectives and experiences during their internship. Dive into their pharmacy backgrounds, the essential skills they've developed throughout pharmacy school, and their motivations for choosing an internship with ASHP. Get a behind-the-scenes glimpse of the internship and hear about their daily experiences, standout moments, and valuable advice for aspiring interns. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1662</itunes:duration>
                <itunes:episode>1036</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: NPPC Series: Cooking Up experiences and Evaluations that Nourish Learners Without Poisoning Preceptors</title>
        <itunes:title>Educator Essentials: NPPC Series: Cooking Up experiences and Evaluations that Nourish Learners Without Poisoning Preceptors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-nppc-series-cooking-up-experiences-and-evaluations-that-nourish-learners-without-poisoning-preceptors/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-nppc-series-cooking-up-experiences-and-evaluations-that-nourish-learners-without-poisoning-preceptors/#comments</comments>        <pubDate>Thu, 28 Sep 2023 12:37:29 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/67673973-3227-307b-bfb2-cda0fc0d35b3</guid>
                                    <description><![CDATA[<p>This podcast will discuss Dr. Slampak-Cindric's upcoming session titled “Cooking Up Experiences and Evaluations that Nourish Learners Without Poisoning Preceptors” at ASHP’s National Pharmacy Preceptors Conference.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss Dr. Slampak-Cindric's upcoming session titled “Cooking Up Experiences and Evaluations that Nourish Learners Without Poisoning Preceptors” at ASHP’s National Pharmacy Preceptors Conference.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5xsvjh/NPPC_Series_-_Cooking_Up_Experiences_and_Evaluations_that_Nourish_Learners_Without_Poisoning_Preceptors_mixdown90z83.mp3" length="16482184" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss Dr. Slampak-Cindric's upcoming session titled “Cooking Up Experiences and Evaluations that Nourish Learners Without Poisoning Preceptors” at ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>684</itunes:duration>
                <itunes:episode>1035</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Putting Patients First: Exploring Medication-Use for Skin and Soft Tissue Infections in the Emergency Department</title>
        <itunes:title>Research in Pharmacy Practice: Putting Patients First: Exploring Medication-Use for Skin and Soft Tissue Infections in the Emergency Department</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-putting-patients-first-exploring-medication-use-for-skin-and-soft-tissue-infections-in-the-emergency-department/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-putting-patients-first-exploring-medication-use-for-skin-and-soft-tissue-infections-in-the-emergency-department/#comments</comments>        <pubDate>Wed, 27 Sep 2023 10:51:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f8be5ce7-2796-3bb1-a3db-f0ba75783596</guid>
                                    <description><![CDATA[<p>Learn from experts in the field as they discuss opportunities and key strategies for developing and conducting a medication use evaluation for the treatment of skin and soft tissue infections (SSTIs) in the emergency department/urgent care setting. They will share how new evidence, new drug approvals, changing resistance patterns, and patient-specific considerations can be integrated into the MUE. You will gain insights into optimizing the patient experience and outcomes by applying MUE findings as part of their outpatient antibiotic stewardship strategy. This podcast is part of a project supported by a grant from Paratek.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field as they discuss opportunities and key strategies for developing and conducting a medication use evaluation for the treatment of skin and soft tissue infections (SSTIs) in the emergency department/urgent care setting. They will share how new evidence, new drug approvals, changing resistance patterns, and patient-specific considerations can be integrated into the MUE. You will gain insights into optimizing the patient experience and outcomes by applying MUE findings as part of their outpatient antibiotic stewardship strategy. This podcast is part of a project supported by a grant from Paratek.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/68v3ge/ASHPOfficial_Exploring_Medication_Use_for_Skin_and_Soft_Tissue_Infections_Mix.mp3" length="24526817" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field as they discuss opportunities and key strategies for developing and conducting a medication use evaluation for the treatment of skin and soft tissue infections (SSTIs) in the emergency department/urgent care setting. They will share how new evidence, new drug approvals, changing resistance patterns, and patient-specific considerations can be integrated into the MUE. You will gain insights into optimizing the patient experience and outcomes by applying MUE findings as part of their outpatient antibiotic stewardship strategy. This podcast is part of a project supported by a grant from Paratek.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1532</itunes:duration>
                <itunes:episode>1034</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Provider Status Update</title>
        <itunes:title>Pharmacy Leadership: Provider Status Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-provider-status-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-provider-status-update/#comments</comments>        <pubDate>Mon, 25 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/57389df2-af9b-3ab3-ad34-891cbe40cb98</guid>
                                    <description><![CDATA[<p>This podcast will update members on ASHP’s ongoing efforts to advance pharmacist provider status. We’ll cover the new bills making their way through Congress and the latest developments in the states.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will update members on ASHP’s ongoing efforts to advance pharmacist provider status. We’ll cover the new bills making their way through Congress and the latest developments in the states.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9hrfpm/Provider_Status_Update_mixdown_1_av7l8.mp3" length="15697527" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will update members on ASHP’s ongoing efforts to advance pharmacist provider status. We’ll cover the new bills making their way through Congress and the latest developments in the states.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>650</itunes:duration>
                <itunes:episode>1028</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2022: Vax On, Vax Off: Implementing a Comprehensive Vaccination Program in Specialty Pharmacy Patients</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2022: Vax On, Vax Off: Implementing a Comprehensive Vaccination Program in Specialty Pharmacy Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2022-vax-on-vax-off-implementing-a-comprehensive-vaccination-program-in-specialty-pharmacy-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2022-vax-on-vax-off-implementing-a-comprehensive-vaccination-program-in-specialty-pharmacy-patients/#comments</comments>        <pubDate>Sun, 24 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/907b4813-c147-3a1c-8433-9b6a08eaa01d</guid>
                                    <description><![CDATA[<p>In this episode featuring Specialty Pharmacy practitioners presenting at the 2022 Midyear Clinical Meeting, our content matter experts will share the role of the specialty pharmacist in providing vaccine education and how they design vaccination plans for a patient on specialty medication. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode featuring Specialty Pharmacy practitioners presenting at the 2022 Midyear Clinical Meeting, our content matter experts will share the role of the specialty pharmacist in providing vaccine education and how they design vaccination plans for a patient on specialty medication. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rwjn43/_MCM_2022_Vax_on_Vax_Off_Implementing_a_Comprehensive_Vaccination_Program_in_Specialty_Pharmacy_Patients_mixdown7c1n1.mp3" length="26111609" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode featuring Specialty Pharmacy practitioners presenting at the 2022 Midyear Clinical Meeting, our content matter experts will share the role of the specialty pharmacist in providing vaccine education and how they design vaccination plans for a patient on specialty medication. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1085</itunes:duration>
                <itunes:episode>1032</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: A New Landscape: Biosimilars in Multiple Sclerosis</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: A New Landscape: Biosimilars in Multiple Sclerosis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-a-new-landscape-biosimilars-in-multiple-sclerosis/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-a-new-landscape-biosimilars-in-multiple-sclerosis/#comments</comments>        <pubDate>Fri, 22 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7fced6bd-f130-3fdd-9993-25d5ef45a126</guid>
                                    <description><![CDATA[<p>Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/88gijn/ADV_A_New_Landscape_Biosimilars_in_Multiple_Sclerosis_mixdown6cpoe.mp3" length="56975612" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2372</itunes:duration>
                <itunes:episode>1030</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: A Primer on Pharmacist Board Certification</title>
        <itunes:title>Practice Journeys: A Primer on Pharmacist Board Certification</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-a-primer-on-pharmacist-board-certification/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-a-primer-on-pharmacist-board-certification/#comments</comments>        <pubDate>Thu, 21 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3513de94-82fe-33b4-9d24-37ed9380c084</guid>
                                    <description><![CDATA[<p>Following pharmacy residency, many new practitioners seek to obtain board certification in a pharmacy specialty to demonstrate their expertise in a defined area of pharmacy practice. In this podcast, board certified pharmacists share practical tips for preparation and maintenance of specialty board certification.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Following pharmacy residency, many new practitioners seek to obtain board certification in a pharmacy specialty to demonstrate their expertise in a defined area of pharmacy practice. In this podcast, board certified pharmacists share practical tips for preparation and maintenance of specialty board certification.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2krbat/A_Primer_on_Pharmacist_Board_Certification_mixdown6t5hn.mp3" length="24367707" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Following pharmacy residency, many new practitioners seek to obtain board certification in a pharmacy specialty to demonstrate their expertise in a defined area of pharmacy practice. In this podcast, board certified pharmacists share practical tips for preparation and maintenance of specialty board certification.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1013</itunes:duration>
                <itunes:episode>1031</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Thriving in a PharmD Dual Degree Program – Tips and Strategies for Success</title>
        <itunes:title>Student Perspectives: Thriving in a PharmD Dual Degree Program – Tips and Strategies for Success</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-thriving-in-a-pharmd-dual-degree-program-%e2%80%93-tips-and-strategies-for-success/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-thriving-in-a-pharmd-dual-degree-program-%e2%80%93-tips-and-strategies-for-success/#comments</comments>        <pubDate>Wed, 20 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f783c61a-4ab4-33b4-b592-ea536b8aabff</guid>
                                    <description><![CDATA[<p>In this podcast, a student pharmacist and two recent graduates discuss their experiences completing a dual degree PharmD program. Panelists explore areas related to time management, the pros and cons of pursuing dual graduate degrees, and the changing role of pharmacy professionals today. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, a student pharmacist and two recent graduates discuss their experiences completing a dual degree PharmD program. Panelists explore areas related to time management, the pros and cons of pursuing dual graduate degrees, and the changing role of pharmacy professionals today. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wyvpzg/Thriving_in_a_PharmD_Dual_Degree_Program_Tips_and_Strategies_for_Success_mixdown91rlf.mp3" length="51245991" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, a student pharmacist and two recent graduates discuss their experiences completing a dual degree PharmD program. Panelists explore areas related to time management, the pros and cons of pursuing dual graduate degrees, and the changing role of pharmacy professionals today. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2133</itunes:duration>
                <itunes:episode>1029</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Resident Research Spotlight: The Impact of Health-System Specialty Pharmacy Services and Interventions</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Resident Research Spotlight: The Impact of Health-System Specialty Pharmacy Services and Interventions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-resident-research-spotlight-the-impact-of-health-system-specialty-pharmacy-services-and-interventions/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-resident-research-spotlight-the-impact-of-health-system-specialty-pharmacy-services-and-interventions/#comments</comments>        <pubDate>Tue, 19 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bcb2f922-2e81-3d8b-8841-5398785fd686</guid>
                                    <description><![CDATA[<p>In this episode, three PGY1 pharmacy residents join us to discuss their specialty pharmacy-focused research projects. Topics to be discussed include the impact of pharmacist interventions on treatment outcomes in patients with hepatitis C, the impact of specialty pharmacist interventions in the treatment of multiple sclerosis, and the impact of specialty pharmacy services on medication access for asthma biologics.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a  comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, three PGY1 pharmacy residents join us to discuss their specialty pharmacy-focused research projects. Topics to be discussed include the impact of pharmacist interventions on treatment outcomes in patients with hepatitis C, the impact of specialty pharmacist interventions in the treatment of multiple sclerosis, and the impact of specialty pharmacy services on medication access for asthma biologics.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a  comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pvzwsz/ASHPOfficial_Resident_Research_Spotlight_Impact_of_Health_System_Specialty_Pharmacy_Services_and_Interventions_MIX_1_90x8m.mp3" length="34693760" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, three PGY1 pharmacy residents join us to discuss their specialty pharmacy-focused research projects. Topics to be discussed include the impact of pharmacist interventions on treatment outcomes in patients with hepatitis C, the impact of specialty pharmacist interventions in the treatment of multiple sclerosis, and the impact of specialty pharmacy services on medication access for asthma biologics.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a  comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2168</itunes:duration>
                <itunes:episode>1027</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Description of patient questions received by clinical pharmacists in the Nudge Study</title>
        <itunes:title>AJHP Voices: Description of patient questions received by clinical pharmacists in the Nudge Study</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-description-of-patient-questions-received-by-clinical-pharmacists-in-the-nudge-study/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-description-of-patient-questions-received-by-clinical-pharmacists-in-the-nudge-study/#comments</comments>        <pubDate>Sat, 16 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e7f9a55b-8d74-337d-852b-f66229c2eeeb</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Joel Marrs discusses the AJHP Practice Report, “Description of patient questions received by clinical pharmacists in the Nudge Study,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Joel Marrs discusses the AJHP Practice Report, “Description of patient questions received by clinical pharmacists in the Nudge Study,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bwp9zz/AJHP_Voices_The_Nudge_Study_Revised.mp3" length="12664418" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Joel Marrs discusses the AJHP Practice Report, “Description of patient questions received by clinical pharmacists in the Nudge Study,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>791</itunes:duration>
                <itunes:episode>1026</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>MCM 2022: ISMP Updates</title>
        <itunes:title>MCM 2022: ISMP Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2022-ismp-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2022-ismp-updates/#comments</comments>        <pubDate>Thu, 14 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/15cb786e-3977-3c30-be45-a0e15399e5eb</guid>
                                    <description><![CDATA[<p>In this episode that features presentations from the 2022 Midyear Clinical Meeting, our content matter experts discuss the ISMP Targeted Medication Safety Best Practices for Community Pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode that features presentations from the 2022 Midyear Clinical Meeting, our content matter experts discuss the ISMP Targeted Medication Safety Best Practices for Community Pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h2whqn/MCM_2022_ISMP_Updates_mixdownaujwk.mp3" length="52630186" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode that features presentations from the 2022 Midyear Clinical Meeting, our content matter experts discuss the ISMP Targeted Medication Safety Best Practices for Community Pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2190</itunes:duration>
                <itunes:episode>1025</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Understanding Continuous Glucose Monitors</title>
        <itunes:title>Therapeutic Thursdays: Understanding Continuous Glucose Monitors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-understanding-continuous-glucose-monitors/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-understanding-continuous-glucose-monitors/#comments</comments>        <pubDate>Tue, 12 Sep 2023 14:36:01 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4cb4618d-8cfe-33a8-ac6d-7bfbf305a206</guid>
                                    <description><![CDATA[<p>This episode provides an overview of continuous glucose monitors (CGMs). We discuss the different brands and models of CGMs available, and how to determine which one is right for the patient. We explore who typically qualifies for using these devices and what patients can do if their insurance doesn’t cover them. We also explain the data that CGM’s provide and how healthcare teams can access and review this information to better inform patient care. We conclude with practical counseling points on using CGMs day to day. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides an overview of continuous glucose monitors (CGMs). We discuss the different brands and models of CGMs available, and how to determine which one is right for the patient. We explore who typically qualifies for using these devices and what patients can do if their insurance doesn’t cover them. We also explain the data that CGM’s provide and how healthcare teams can access and review this information to better inform patient care. We conclude with practical counseling points on using CGMs day to day. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zsqhd7/ASHPOfficial_Understanding_Continuous_Glucose_Monitors_REVISED.mp3" length="49630256" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode provides an overview of continuous glucose monitors (CGMs). We discuss the different brands and models of CGMs available, and how to determine which one is right for the patient. We explore who typically qualifies for using these devices and what patients can do if their insurance doesn’t cover them. We also explain the data that CGM’s provide and how healthcare teams can access and review this information to better inform patient care. We conclude with practical counseling points on using CGMs day to day. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1240</itunes:duration>
                <itunes:episode>1024</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: MCM 2022: Investing in the Future: Development of a Pharmacy Technician Leadership Residency to Address Technician Leadership Gaps</title>
        <itunes:title>Technician Topics: MCM 2022: Investing in the Future: Development of a Pharmacy Technician Leadership Residency to Address Technician Leadership Gaps</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-mcm-2022-investing-in-the-future-development-of-a-pharmacy-technician-leadership-residency-to-address-technician-leadership-gaps/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-mcm-2022-investing-in-the-future-development-of-a-pharmacy-technician-leadership-residency-to-address-technician-leadership-gaps/#comments</comments>        <pubDate>Sun, 10 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3de0bca-648b-3224-a30a-91f305cf2a78</guid>
                                    <description><![CDATA[<p>In this pharmacy technician focused session from the Midyear Clinical Meeting, our speakers identify key attributes of a residency-based learning experience in the development of valued technician leadership behaviors and give examples of an intensive technician leadership residency through the modification of an established pharmacy residency program. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this pharmacy technician focused session from the Midyear Clinical Meeting, our speakers identify key attributes of a residency-based learning experience in the development of valued technician leadership behaviors and give examples of an intensive technician leadership residency through the modification of an established pharmacy residency program. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8c55tb/MCM_2022_Investing_in_the_Future_mixdown9qmzo.mp3" length="25496565" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this pharmacy technician focused session from the Midyear Clinical Meeting, our speakers identify key attributes of a residency-based learning experience in the development of valued technician leadership behaviors and give examples of an intensive technician leadership residency through the modification of an established pharmacy residency program. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1060</itunes:duration>
                <itunes:episode>1019</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: A Spoonful of Preparation Helps the Cyber-Attacks Go Down: Episode 2: Cyber-Attacks 102: We’ve Been Attacked! Now What?</title>
        <itunes:title>Informatics Bytes: A Spoonful of Preparation Helps the Cyber-Attacks Go Down: Episode 2: Cyber-Attacks 102: We’ve Been Attacked! Now What?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-a-spoonful-of-preparation-helps-the-cyber-attacks-go-down-episode-2-cyber-attacks-102-we-ve-been-attacked-now-what/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-a-spoonful-of-preparation-helps-the-cyber-attacks-go-down-episode-2-cyber-attacks-102-we-ve-been-attacked-now-what/#comments</comments>        <pubDate>Fri, 08 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d1372da6-adcc-302d-9f6f-46177ccd4d3a</guid>
                                    <description><![CDATA[<p>In this podcast, listeners will hear an interview with a pharmacy leader whose health system experienced a cyberattack in 2017.  Discussion will include how the attack occurred, how patient care services were maintained and recovered, and lessons learned from the attack. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, listeners will hear an interview with a pharmacy leader whose health system experienced a cyberattack in 2017.  Discussion will include how the attack occurred, how patient care services were maintained and recovered, and lessons learned from the attack. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/94f6u2/ASHP_Official_Cybersecurity_Alert_Now_What_Mix.mp3" length="16329014" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, listeners will hear an interview with a pharmacy leader whose health system experienced a cyberattack in 2017.  Discussion will include how the attack occurred, how patient care services were maintained and recovered, and lessons learned from the attack. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1020</itunes:duration>
                <itunes:episode>1015</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resilience: MCM 2022: It’s Ok If You’re Not Okay: Supporting Well-Being and Resilience</title>
        <itunes:title>Wellbeing and Resilience: MCM 2022: It’s Ok If You’re Not Okay: Supporting Well-Being and Resilience</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-mcm-2022-it-s-ok-if-you-re-not-okay-supporting-well-being-and-resilience/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-mcm-2022-it-s-ok-if-you-re-not-okay-supporting-well-being-and-resilience/#comments</comments>        <pubDate>Wed, 06 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/06adecdf-0fdc-3ebe-a3ba-281f822a338e</guid>
                                    <description><![CDATA[<p>In this episode focusing on Well-Being and Resilience presentations at the 2022 Midyear Clinical Meeting, our content matter experts discuss burnout and the indicators and influences of burnout in yourself and other and apply strategies to promote well-being and resilience to minimize burnout. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode focusing on Well-Being and Resilience presentations at the 2022 Midyear Clinical Meeting, our content matter experts discuss burnout and the indicators and influences of burnout in yourself and other and apply strategies to promote well-being and resilience to minimize burnout. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vzgmxc/MCM_2022_It_s_Ok_If_You_re_Not_Okay_Supporting_Well-Being_and_Resilience_mixdownaxnfl.mp3" length="48576003" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode focusing on Well-Being and Resilience presentations at the 2022 Midyear Clinical Meeting, our content matter experts discuss burnout and the indicators and influences of burnout in yourself and other and apply strategies to promote well-being and resilience to minimize burnout. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2021</itunes:duration>
                <itunes:episode>1023</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2022: Improving Health-System Specialty Pharmacy One Audit at a Time</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2022: Improving Health-System Specialty Pharmacy One Audit at a Time</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2022-improving-health-system-specialty-pharmacy-one-audit-at-a-time/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2022-improving-health-system-specialty-pharmacy-one-audit-at-a-time/#comments</comments>        <pubDate>Mon, 04 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/10ab2271-e0c1-333a-b976-33d401781e9b</guid>
                                    <description><![CDATA[<p>In this episode featuring Specialty Pharmacy Faculty presenting at the 2022 Midyear Clinical Meeting, our speakers will describe the quality and compliance process for health system specialty pharmacies and evaluate the use of audits to assess compliance. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode featuring Specialty Pharmacy Faculty presenting at the 2022 Midyear Clinical Meeting, our speakers will describe the quality and compliance process for health system specialty pharmacies and evaluate the use of audits to assess compliance. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/74wsex/_MCM_2022_Improving_Health_System_Specialty_Pharmacy_One_Audit_at_a_Time_mixdownbw65y.mp3" length="49839644" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode featuring Specialty Pharmacy Faculty presenting at the 2022 Midyear Clinical Meeting, our speakers will describe the quality and compliance process for health system specialty pharmacies and evaluate the use of audits to assess compliance. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2074</itunes:duration>
                <itunes:episode>1018</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Safety: MCM 2022: High on Safety</title>
        <itunes:title>Medication Safety: MCM 2022: High on Safety</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-mcm-2022-high-on-safety/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-mcm-2022-high-on-safety/#comments</comments>        <pubDate>Sun, 03 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/04c786fc-c009-3676-8ede-cec1c20b1f89</guid>
                                    <description><![CDATA[<p>In this episode from the Midyear Clinical Meeting in Las Vegas, our content matter experts discuss the characteristics of high-reliability organizations (HROs) and how high reliability impacts safety and quality. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the Midyear Clinical Meeting in Las Vegas, our content matter experts discuss the characteristics of high-reliability organizations (HROs) and how high reliability impacts safety and quality. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r43ifx/MCM_2022_High_on_Safety_mixdown69i2c.mp3" length="44203487" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode from the Midyear Clinical Meeting in Las Vegas, our content matter experts discuss the characteristics of high-reliability organizations (HROs) and how high reliability impacts safety and quality. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1839</itunes:duration>
                <itunes:episode>1017</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Optimizing Patient Care Through Clinical Pharmacy Collaborations</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Optimizing Patient Care Through Clinical Pharmacy Collaborations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-optimizing-patient-care-through-clinical-pharmacy-collaborations/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-optimizing-patient-care-through-clinical-pharmacy-collaborations/#comments</comments>        <pubDate>Fri, 01 Sep 2023 13:49:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/76fe5dd6-8860-33dd-b170-b5b2daeadeb5</guid>
                                    <description><![CDATA[<p>This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jtkkjp/ASHP_Official_Optimizing_Patient_Care_Through_Clinical_Pharmacy_Collaborations_MIX.mp3" length="35711174" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2231</itunes:duration>
                <itunes:episode>1020</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Virtual Vitals: How to Provide Telehealth Pharmacy Services</title>
        <itunes:title>Therapeutic Thursdays: Virtual Vitals: How to Provide Telehealth Pharmacy Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-virtual-vitals-how-to-provide-telehealth-pharmacy-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-virtual-vitals-how-to-provide-telehealth-pharmacy-services/#comments</comments>        <pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fc2bb509-fd7f-3bd8-b47a-36c7afb2c47b</guid>
                                    <description><![CDATA[<p>Other disciplines have used telehealth in the past with much success and the current healthcare landscape necessitates flexibility &amp; innovation in delivery of care. This podcast will describe how pharmacists have incorporated telehealth into practice and how practitioners can use it to improve access to care.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Other disciplines have used telehealth in the past with much success and the current healthcare landscape necessitates flexibility &amp; innovation in delivery of care. This podcast will describe how pharmacists have incorporated telehealth into practice and how practitioners can use it to improve access to care.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vpcgxm/ASHP_Official_How_to_Provide_Telehealth_Pharmacy_Services_Mix.mp3" length="31689209" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Other disciplines have used telehealth in the past with much success and the current healthcare landscape necessitates flexibility &amp; innovation in delivery of care. This podcast will describe how pharmacists have incorporated telehealth into practice and how practitioners can use it to improve access to care.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1980</itunes:duration>
                <itunes:episode>1016</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Peeling Back the Layers of Layered Learning: An Outpatient Perspective</title>
        <itunes:title>Educator Essentials: Peeling Back the Layers of Layered Learning: An Outpatient Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-peeling-back-the-layers-of-layered-learning-an-outpatient-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-peeling-back-the-layers-of-layered-learning-an-outpatient-perspective/#comments</comments>        <pubDate>Wed, 30 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4c854571-197b-37d8-89a8-f4110510a2df</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three outpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the outpatient setting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three outpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the outpatient setting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/siyq7r/ASHP_Podcast_21_Peeling_Back_the_Layers_of_Layered_Learning_An_Outpatient_Perspective_MIX.mp3" length="81391412" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three outpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the outpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2034</itunes:duration>
                <itunes:episode>1007</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Making the Right Decisions Around Clinical Decision Support</title>
        <itunes:title>Informatics Bytes: Making the Right Decisions Around Clinical Decision Support</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-making-the-right-decisions-around-clinical-decision-support/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-making-the-right-decisions-around-clinical-decision-support/#comments</comments>        <pubDate>Mon, 28 Aug 2023 13:15:53 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8f8d0f98-4ecb-31fb-8a1c-a1497f51bdba</guid>
                                    <description><![CDATA[<p>The podcast will discuss challenges with clinical decision support implementation, including common problems and solutions to ensure effective and timely implementation. We will cover working with third party data, maintenance considerations, prioritization and governance, and communication strategies to support implementation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The podcast will discuss challenges with clinical decision support implementation, including common problems and solutions to ensure effective and timely implementation. We will cover working with third party data, maintenance considerations, prioritization and governance, and communication strategies to support implementation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yxsi8d/Making_the_Right_Decisions_Around_Clinical_Decision_Support_mixdown7mra2.mp3" length="30321994" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The podcast will discuss challenges with clinical decision support implementation, including common problems and solutions to ensure effective and timely implementation. We will cover working with third party data, maintenance considerations, prioritization and governance, and communication strategies to support implementation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1260</itunes:duration>
                <itunes:episode>1014</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Establishing EM Pharmacists Value and Expanding Services</title>
        <itunes:title>Pharmacy Leadership: Establishing EM Pharmacists Value and Expanding Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-establishing-em-pharmacists-value-and-expanding-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-establishing-em-pharmacists-value-and-expanding-services/#comments</comments>        <pubDate>Mon, 28 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/064fd9d4-ecaa-358f-9147-4f23479000ae</guid>
                                    <description><![CDATA[<p>This podcast focuses on how to place value on the services that emergency medicine pharmacists provide and how to use that data to expand services in the emergency department. Both EM pharmacists and their leaders will find this podcast of value when evaluation services in your institution.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast focuses on how to place value on the services that emergency medicine pharmacists provide and how to use that data to expand services in the emergency department. Both EM pharmacists and their leaders will find this podcast of value when evaluation services in your institution.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w7geds/ASHP_Podcast_20_ED_Clinical_Leadership_Establishing_EM_Pharmacists_Value_and_Expanding_Services_MIX.mp3" length="65231336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast focuses on how to place value on the services that emergency medicine pharmacists provide and how to use that data to expand services in the emergency department. Both EM pharmacists and their leaders will find this podcast of value when evaluation services in your institution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1630</itunes:duration>
                <itunes:episode>1010</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resilience: MCM 2022: Hit the Reset Button: Mastering Mind SET, HeartSET, SoulSET and SkillSET in your Practice</title>
        <itunes:title>Wellbeing and Resilience: MCM 2022: Hit the Reset Button: Mastering Mind SET, HeartSET, SoulSET and SkillSET in your Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-mcm-2022-hit-the-reset-button-mastering-mind-set-heartset-soulset-and-skillset-in-your-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-mcm-2022-hit-the-reset-button-mastering-mind-set-heartset-soulset-and-skillset-in-your-practice/#comments</comments>        <pubDate>Sun, 27 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7567d787-e5d6-3024-b7a2-32a92f9aeb15</guid>
                                    <description><![CDATA[<p>In this episode featuring speakers from the ASHP Midyear Clinical Meeting in 2022, our content matter expert discusses the goals of emotional awareness and regulation and shares the key ingredients to becoming a reset master in your pharmacy practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode featuring speakers from the ASHP Midyear Clinical Meeting in 2022, our content matter expert discusses the goals of emotional awareness and regulation and shares the key ingredients to becoming a reset master in your pharmacy practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qbvfpg/_MCM_2022_Hit_the_Reset_Button_Mastering_MindSET_HeartSET_SoulSET_and_SkillSET_in_Your_Practice_mixdown73j2k.mp3" length="65219348" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode featuring speakers from the ASHP Midyear Clinical Meeting in 2022, our content matter expert discusses the goals of emotional awareness and regulation and shares the key ingredients to becoming a reset master in your pharmacy practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2715</itunes:duration>
                <itunes:episode>1009</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: The Pharmacist at Music Festivals</title>
        <itunes:title>Practice Journeys: The Pharmacist at Music Festivals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-the-pharmacist-at-music-festivals/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-the-pharmacist-at-music-festivals/#comments</comments>        <pubDate>Sat, 26 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/294ecd15-78d9-371b-954f-84afaf3fde9b</guid>
                                    <description><![CDATA[<p>In this episode of Practice Journeys, Juliana Zschoche shares her experiences working at a large outdoor music festival as a part of the Emergency Medical Team.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of Practice Journeys, Juliana Zschoche shares her experiences working at a large outdoor music festival as a part of the Emergency Medical Team.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3yrv29/_The_Pharmacist_at_Music_Festivals_mixdowna98os.mp3" length="22581911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of Practice Journeys, Juliana Zschoche shares her experiences working at a large outdoor music festival as a part of the Emergency Medical Team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>937</itunes:duration>
                <itunes:episode>1006</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: The (COVID-19) Eris Tour</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: The (COVID-19) Eris Tour</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-covid-19-eris-tour/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-the-covid-19-eris-tour/#comments</comments>        <pubDate>Fri, 25 Aug 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0e648643-6e4d-3b12-bb42-c1a58886bec7</guid>
                                    <description><![CDATA[<p>Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zhuhhn/ASHPOfficial_The_Eris_Tour_Mix.mp3" length="20399351" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1274</itunes:duration>
                <itunes:episode>1013</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: A New Landscape: Biosimilars in Autoimmune Indications</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: A New Landscape: Biosimilars in Autoimmune Indications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-a-new-landscape-biosimilars-in-autoimmune-indications/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-a-new-landscape-biosimilars-in-autoimmune-indications/#comments</comments>        <pubDate>Fri, 25 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7fb1cb97-1951-3320-a004-3b8c0bfe0a17</guid>
                                    <description><![CDATA[<p>Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mbequn/2_ADV_Biosimilar_podcast_1_mixdownbof5s.mp3" length="26125567" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1088</itunes:duration>
                <itunes:episode>1012</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practice Award 2022: Advancing Pharmacy Practice Through Selection: A Pharmacist-Driven COVID-19 Outpatient Treatment Referral Process</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practice Award 2022: Advancing Pharmacy Practice Through Selection: A Pharmacist-Driven COVID-19 Outpatient Treatment Referral Process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacypracticeashpbestpracticeaward2022advancing-pharmacypracticethrough-selection-apharmacist-driven-covid19-outpatient-treatment-r/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacypracticeashpbestpracticeaward2022advancing-pharmacypracticethrough-selection-apharmacist-driven-covid19-outpatient-treatment-r/#comments</comments>        <pubDate>Thu, 24 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c38de63b-62c3-3198-89ba-5415acfc9203</guid>
                                    <description><![CDATA[<p style="background:#FFFFFF;">In this episode, the team from the Kettering Health to discuss their award-winning submission to the ASHP Best Practices. They will share how their COVID-19 treatment referral program has proven to be highly successful at addressing several challenges associated with outpatient treatment selection for patients with COVID-19 including fair allocation of resources, patient access to inventory, and drug-specific considerations through a pharmacist-driven and collaborative approach to care.</p>
<p style="background:#FFFFFF;"> The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="background:#FFFFFF;">In this episode, the team from the Kettering Health to discuss their award-winning submission to the ASHP Best Practices. They will share how their COVID-19 treatment referral program has proven to be highly successful at addressing several challenges associated with outpatient treatment selection for patients with COVID-19 including fair allocation of resources, patient access to inventory, and drug-specific considerations through a pharmacist-driven and collaborative approach to care.</p>
<p style="background:#FFFFFF;"> <em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5za34e/2_ASHP_Best_Practice_Award_2022_Advancing_Pharmacy_Practice_Through_Selection_A_Pharmacist-Driven_COVID-19_Outpatient_Treatment_Referral_Process_mixdown6wase.mp3" length="39512613" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from the Kettering Health to discuss their award-winning submission to the ASHP Best Practices. They will share how their COVID-19 treatment referral program has proven to be highly successful at addressing several challenges associated with outpatient treatment selection for patients with COVID-19 including fair allocation of resources, patient access to inventory, and drug-specific considerations through a pharmacist-driven and collaborative approach to care.
 The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1645</itunes:duration>
                <itunes:episode>1008</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Unusual Skin &amp; Soft Tissue Infections in Your Emergency Room</title>
        <itunes:title>Therapeutic Thursdays: Unusual Skin &amp; Soft Tissue Infections in Your Emergency Room</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-unusual-skin-soft-tissue-infections-in-your-emergency-room/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-unusual-skin-soft-tissue-infections-in-your-emergency-room/#comments</comments>        <pubDate>Wed, 23 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5c45d933-e17b-3549-a12e-91013c12793b</guid>
                                    <description><![CDATA[<p>Skin and soft tissue infections are commonly seen and treated in the emergency department. While most practitioners are comfortable with the typical infections it is important to consider unusual exposures and environmental factors that may result in atypical skin and soft tissue infections. This podcast will discuss some of these infections that may be seen due to exposures to water (salt &amp; fresh) and soils and how to identify and manage these situations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Skin and soft tissue infections are commonly seen and treated in the emergency department. While most practitioners are comfortable with the typical infections it is important to consider unusual exposures and environmental factors that may result in atypical skin and soft tissue infections. This podcast will discuss some of these infections that may be seen due to exposures to water (salt &amp; fresh) and soils and how to identify and manage these situations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ma5qzd/2_ASHP_Podcast_Unusual_Skin_Soft_Tissue_Infections_in_Your_Emergency_Room_mixdown7jmh8.mp3" length="47767689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Skin and soft tissue infections are commonly seen and treated in the emergency department. While most practitioners are comfortable with the typical infections it is important to consider unusual exposures and environmental factors that may result in atypical skin and soft tissue infections. This podcast will discuss some of these infections that may be seen due to exposures to water (salt &amp; fresh) and soils and how to identify and manage these situations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1989</itunes:duration>
                <itunes:episode>1011</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Section of Community Pharmacy: Pneumococcal Vaccine - 2023 Updates</title>
        <itunes:title>Section of Community Pharmacy: Pneumococcal Vaccine - 2023 Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/section-of-community-pharmacy-pneumococcal-vaccine-2023-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/section-of-community-pharmacy-pneumococcal-vaccine-2023-updates/#comments</comments>        <pubDate>Tue, 22 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/390bfa8e-ad5d-357b-9c33-ef0b4d798f32</guid>
                                    <description><![CDATA[<p>Pneumococcal vaccination recommendations are arguably some of the most difficult to maneuver. With the approval of two new pneumococcal vaccines, guidelines have significantly changed. This podcast aims to discuss these changes in vaccines and recommendations, and provide resources to ensure patients are receiving the right vaccine at the right time.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pneumococcal vaccination recommendations are arguably some of the most difficult to maneuver. With the approval of two new pneumococcal vaccines, guidelines have significantly changed. This podcast aims to discuss these changes in vaccines and recommendations, and provide resources to ensure patients are receiving the right vaccine at the right time.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3gd3w6/Pneumococcal_Vaccine_2023_Updates_mixdown65o3j.mp3" length="25893576" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pneumococcal vaccination recommendations are arguably some of the most difficult to maneuver. With the approval of two new pneumococcal vaccines, guidelines have significantly changed. This podcast aims to discuss these changes in vaccines and recommendations, and provide resources to ensure patients are receiving the right vaccine at the right time.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1075</itunes:duration>
                <itunes:episode>1003</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Human Capital Management- Optimizing Organizational Work Structures for Recruitment and Retention</title>
        <itunes:title>Pharmacy Leadership: Human Capital Management- Optimizing Organizational Work Structures for Recruitment and Retention</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-human-capital-management-optimizing-organizational-work-structures-for-recruitment-and-retention/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-human-capital-management-optimizing-organizational-work-structures-for-recruitment-and-retention/#comments</comments>        <pubDate>Mon, 21 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/08ae15a0-3212-35d6-930f-8cad6cf33715</guid>
                                    <description><![CDATA[<p>Recruiting and retaining pharmacists and pharmacy technicians has become increasingly challenging for pharmacy leaders. This podcast explores strategies for optimizing the pharmacy workforce, addressing recruitment and retention challenges, sharing success stories, and offering practical tips from two hospital pharmacy leaders.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Recruiting and retaining pharmacists and pharmacy technicians has become increasingly challenging for pharmacy leaders. This podcast explores strategies for optimizing the pharmacy workforce, addressing recruitment and retention challenges, sharing success stories, and offering practical tips from two hospital pharmacy leaders.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hd9ih2/ASHP_Podcast_18_Human_Capital_Management_Optimizing_Organizational_Work_Structures_for_Recruitment_and_Retention_MIX.mp3" length="60616856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Recruiting and retaining pharmacists and pharmacy technicians has become increasingly challenging for pharmacy leaders. This podcast explores strategies for optimizing the pharmacy workforce, addressing recruitment and retention challenges, sharing success stories, and offering practical tips from two hospital pharmacy leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1515</itunes:duration>
                <itunes:episode>1005</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: MCM 2022: Designing A Pharmacy Technician Career Ladder</title>
        <itunes:title>Technician Topics: MCM 2022: Designing A Pharmacy Technician Career Ladder</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-mcm-2022-designing-a-pharmacy-technician-career-ladder/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-mcm-2022-designing-a-pharmacy-technician-career-ladder/#comments</comments>        <pubDate>Sun, 20 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/25835495-55fe-3cd0-9667-1144297833fd</guid>
                                    <description><![CDATA[<p>In this episode featuring technician focused programming at the Midyear Clinical Meeting our content matter experts describe successful elements of career ladder and share career ladders that have resulted in the retention of pharmacy technicians. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode featuring technician focused programming at the Midyear Clinical Meeting our content matter experts describe successful elements of career ladder and share career ladders that have resulted in the retention of pharmacy technicians. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7etxue/MCM_2022_Designing_A_Pharmacy_Technician_Career_Ladder_mixdown9kkai.mp3" length="43880898" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode featuring technician focused programming at the Midyear Clinical Meeting our content matter experts describe successful elements of career ladder and share career ladders that have resulted in the retention of pharmacy technicians. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1825</itunes:duration>
                <itunes:episode>999</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hop Topics in Pharmacy: Population Health from the Ground Up: Managing, Billing, Supporting, and Executing</title>
        <itunes:title>Hop Topics in Pharmacy: Population Health from the Ground Up: Managing, Billing, Supporting, and Executing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hop-topics-in-pharmacy-population-health-from-the-ground-up-managing-billing-supporting-and-executing/</link>
                    <comments>https://ashpofficial.podbean.com/e/hop-topics-in-pharmacy-population-health-from-the-ground-up-managing-billing-supporting-and-executing/#comments</comments>        <pubDate>Sat, 19 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/67c0a230-0c68-31f3-9b82-090d045d413d</guid>
                                    <description><![CDATA[<p>Population health is a growing practice setting within the field of pharmacy. Have you considered becoming involved with population health in your practice? If so, join us for this podcast where we hear from population health experts who have boots on the ground as it relates to management, billing/benefits, IT/analytics, and clinical pharmacy support roles in the field. After listening, we trust you’ll feel more ready to embark on your own population health venture.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Population health is a growing practice setting within the field of pharmacy. Have you considered becoming involved with population health in your practice? If so, join us for this podcast where we hear from population health experts who have boots on the ground as it relates to management, billing/benefits, IT/analytics, and clinical pharmacy support roles in the field. After listening, we trust you’ll feel more ready to embark on your own population health venture.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xexm34/Population_Health_from_the_Ground_Up_Managing_Billing_Supporting_and_Executing_mixdowna7866.mp3" length="58934673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Population health is a growing practice setting within the field of pharmacy. Have you considered becoming involved with population health in your practice? If so, join us for this podcast where we hear from population health experts who have boots on the ground as it relates to management, billing/benefits, IT/analytics, and clinical pharmacy support roles in the field. After listening, we trust you’ll feel more ready to embark on your own population health venture.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2452</itunes:duration>
                <itunes:episode>1002</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: RX for Success: Navigating Pharmacy Metrics in Small and Rural Hospitals</title>
        <itunes:title>Hot Topics in Pharmacy: RX for Success: Navigating Pharmacy Metrics in Small and Rural Hospitals</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-rx-for-success-navigating-pharmacy-metrics-in-small-and-rural-hospitals/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-rx-for-success-navigating-pharmacy-metrics-in-small-and-rural-hospitals/#comments</comments>        <pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2c97f166-043b-33df-b608-58727234eddb</guid>
                                    <description><![CDATA[<p>RX for Success focuses on pharmacy productivity and metrics in small and rural hospitals. We will be evaluating and discussing the differences between quantitative and qualitative metrics, survey results from commonly utilized metrics in small and rural hospitals throughout the country, and metrics that hold particular value to C-suite staff.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>RX for Success focuses on pharmacy productivity and metrics in small and rural hospitals. We will be evaluating and discussing the differences between quantitative and qualitative metrics, survey results from commonly utilized metrics in small and rural hospitals throughout the country, and metrics that hold particular value to C-suite staff.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3itpqq/2_RX_for_Success_Navigating_Pharmacy_Metrics_in_Small_and_Rural_Hospitals_mixdown6g86f.mp3" length="27028384" type="audio/mpeg"/>
        <itunes:summary><![CDATA[RX for Success focuses on pharmacy productivity and metrics in small and rural hospitals. We will be evaluating and discussing the differences between quantitative and qualitative metrics, survey results from commonly utilized metrics in small and rural hospitals throughout the country, and metrics that hold particular value to C-suite staff.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1123</itunes:duration>
                <itunes:episode>996</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: What in the World is the Difference; CQI, DUR, IRb, and MUE?</title>
        <itunes:title>Educator Essentials: What in the World is the Difference; CQI, DUR, IRb, and MUE?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-what-in-the-world-is-the-difference-cqi-dur-irb-and-mue/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-what-in-the-world-is-the-difference-cqi-dur-irb-and-mue/#comments</comments>        <pubDate>Wed, 16 Aug 2023 13:27:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f50e4700-affd-3d57-80c1-bafad957a709</guid>
                                    <description><![CDATA[<p>Residency programs often provide residents the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare various types of project methodologies, reviewing benefits and opportunities for each. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Residency programs often provide residents the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare various types of project methodologies, reviewing benefits and opportunities for each. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tiykxr/ASHP_Podcast_17_What_in_the_World_is_the_Difference_CQI_DUR_IRb_and_MUE_MIX.mp3" length="113774204" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Residency programs often provide residents the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare various types of project methodologies, reviewing benefits and opportunities for each. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2844</itunes:duration>
                <itunes:episode>1004</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Peeling Back the Layers of Layered Learning - An Inpatient Educator Perspective</title>
        <itunes:title>Peeling Back the Layers of Layered Learning - An Inpatient Educator Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/peeling-back-the-layers-of-layered-learning-an-inpatient-educator-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/peeling-back-the-layers-of-layered-learning-an-inpatient-educator-perspective/#comments</comments>        <pubDate>Tue, 15 Aug 2023 11:53:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/16f53f8a-670d-3677-85b5-68a1df7822c4</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three inpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the inpatient setting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three inpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the inpatient setting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3iw9a8/2_Peeling_back_the_Layers_of_Layered_Learning_An_Inpatient_Perspective_mixdown8vo6e.mp3" length="32788821" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three inpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the inpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1365</itunes:duration>
                <itunes:episode>1001</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Introduction to Peer Review</title>
        <itunes:title>Pharmacy Leadership: Introduction to Peer Review</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-introduction-to-peer-review/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-introduction-to-peer-review/#comments</comments>        <pubDate>Mon, 14 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7a94daf1-0811-366f-a777-f4f0c92df591</guid>
                                    <description><![CDATA[<p>Please join us on this week’s pharmacy leadership episode as leaders in the field provide insights and guidance on the peer review podcast. Hear their story of how they first got introduced to the peer review process and the benefits they experienced. In addition, they answer frequently asked questions one might have who is considering becoming a peer reviewer and why you too should consider trying it out!  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Please join us on this week’s pharmacy leadership episode as leaders in the field provide insights and guidance on the peer review podcast. Hear their story of how they first got introduced to the peer review process and the benefits they experienced. In addition, they answer frequently asked questions one might have who is considering becoming a peer reviewer and why you too should consider trying it out!  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6jnwwq/ASHP_Podcast_16_Introduction_to_the_Peer_Review_Process_MIX.mp3" length="86898512" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Please join us on this week’s pharmacy leadership episode as leaders in the field provide insights and guidance on the peer review podcast. Hear their story of how they first got introduced to the peer review process and the benefits they experienced. In addition, they answer frequently asked questions one might have who is considering becoming a peer reviewer and why you too should consider trying it out!  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2172</itunes:duration>
                <itunes:episode>1000</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Beat the Heat: Best Practices for Specialty Pharmacy Accreditation</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Beat the Heat: Best Practices for Specialty Pharmacy Accreditation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-beat-the-heat-best-practices-for-specialty-pharmacy-accreditation/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-beat-the-heat-best-practices-for-specialty-pharmacy-accreditation/#comments</comments>        <pubDate>Sun, 13 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8d95b148-b24b-3939-88fb-383ca549c27c</guid>
                                    <description><![CDATA[<p>In this episode, our Specialty Pharmacy content matter experts share best practices for compliance and maintenance of dual/tertiary specialty pharmacy accreditation including dual and tertiary certifications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our Specialty Pharmacy content matter experts share best practices for compliance and maintenance of dual/tertiary specialty pharmacy accreditation including dual and tertiary certifications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mewsqt/MCM_2022-_Beat_the_Heat-_Best_Practices_for_Specialty_Pharmacy_Accreditation77fi5.m4a" length="19818474" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, our Specialty Pharmacy content matter experts share best practices for compliance and maintenance of dual/tertiary specialty pharmacy accreditation including dual and tertiary certifications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>860</itunes:duration>
                <itunes:episode>994</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Tips for Bringing Well-Being Principles in Pharmacy Education - Part III</title>
        <itunes:title>Educator Essentials: Tips for Bringing Well-Being Principles in Pharmacy Education - Part III</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-tips-for-bringing-well-being-principles-in-pharmacy-education-part-iii/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-tips-for-bringing-well-being-principles-in-pharmacy-education-part-iii/#comments</comments>        <pubDate>Sat, 12 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/82e96e39-a174-3fbc-8c42-d7ae555414a7</guid>
                                    <description><![CDATA[<p>Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. The episode will discuss their journey exploring and implementing WBR principles, while leading the way for their learners and organizations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. The episode will discuss their journey exploring and implementing WBR principles, while leading the way for their learners and organizations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5phhr4/Tips_for_Bringing_Well-Being_Principles_in_Pharmacy_Education_-_Part_III_mixdown80zfk.mp3" length="31100153" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. The episode will discuss their journey exploring and implementing WBR principles, while leading the way for their learners and organizations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1293</itunes:duration>
                <itunes:episode>998</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When the Unexpected Happens: Tales from the Specialty Pharmacy Frontlines</title>
        <itunes:title>When the Unexpected Happens: Tales from the Specialty Pharmacy Frontlines</itunes:title>
        <link>https://ashpofficial.podbean.com/e/when-the-unexpected-happens-tales-from-the-specialty-pharmacy-frontlines/</link>
                    <comments>https://ashpofficial.podbean.com/e/when-the-unexpected-happens-tales-from-the-specialty-pharmacy-frontlines/#comments</comments>        <pubDate>Fri, 11 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f50a8e24-23dd-3892-b2b3-491973cf67aa</guid>
                                    <description><![CDATA[<p>In this episode, leaders from five different health system specialty pharmacies share examples of disasters and emergencies that their specialty pharmacies have encountered. Speakers will share their experiences, and describe the business continuity plans they implemented to sustain operations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, leaders from five different health system specialty pharmacies share examples of disasters and emergencies that their specialty pharmacies have encountered. Speakers will share their experiences, and describe the business continuity plans they implemented to sustain operations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9e8mqp/When_the_Unexpected_Happens_Tales_from_the_Specialty_Pharmacy_Frontlines_mixdown6rwfc.mp3" length="27634697" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, leaders from five different health system specialty pharmacies share examples of disasters and emergencies that their specialty pharmacies have encountered. Speakers will share their experiences, and describe the business continuity plans they implemented to sustain operations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1148</itunes:duration>
                <itunes:episode>997</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A New Frontier: Establishing Clinical Pharmacy Services in the Pediatric Emergency Department</title>
        <itunes:title>Pharmacy Leadership: A New Frontier: Establishing Clinical Pharmacy Services in the Pediatric Emergency Department</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-new-frontier-establishing-clinical-pharmacy-services-in-the-pediatric-emergency-department/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-new-frontier-establishing-clinical-pharmacy-services-in-the-pediatric-emergency-department/#comments</comments>        <pubDate>Thu, 10 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/14530717-c855-3dff-8e18-ffeaa4a24fd9</guid>
                                    <description><![CDATA[<p>This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/245cg7/A_New_Frontier-_Establishing_Clinical_Pharmacy_Services_in_the_Pediatric_Emergency_Department7o4ta.m4a" length="22775434" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1018</itunes:duration>
                <itunes:episode>992</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation: Digital Health 101: Interventions for Maximum Pharmacist Impact</title>
        <itunes:title>Innovation: Digital Health 101: Interventions for Maximum Pharmacist Impact</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-digital-health-101-interventions-for-maximum-pharmacist-impact/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-digital-health-101-interventions-for-maximum-pharmacist-impact/#comments</comments>        <pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a136260b-a9dc-309d-90dc-d5ba48269949</guid>
                                    <description><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/n7jrp4/MCM_2022_Digital_Health_101_Interventions_for_Maximum_Pharmacist_Impact_mixdownbf1r3.mp3" length="52376788" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2180</itunes:duration>
                <itunes:episode>987</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: GOT Policy? Insights into the ASHP Policy Process</title>
        <itunes:title>Practice Journeys: GOT Policy? Insights into the ASHP Policy Process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-got-policy-insights-into-the-ashp-policy-process/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-got-policy-insights-into-the-ashp-policy-process/#comments</comments>        <pubDate>Mon, 07 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3c760baa-04c3-33ad-a38f-312cdaf5ef3e</guid>
                                    <description><![CDATA[<p>This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/miw2kd/2_GOT_Policy_Overview_of_ASHP_Policy_Process_mixdownb4u1o.mp3" length="29776865" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1240</itunes:duration>
                <itunes:episode>995</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2022: Betting on Safety: Medication Safety Dashboard Metric Design</title>
        <itunes:title>MCM 2022: Betting on Safety: Medication Safety Dashboard Metric Design</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2022-betting-on-safety-medication-safety-dashboard-metric-design/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2022-betting-on-safety-medication-safety-dashboard-metric-design/#comments</comments>        <pubDate>Sun, 06 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e226d330-afa8-3ea3-adcc-184fdb4c2bbc</guid>
                                    <description><![CDATA[<p>In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mneqpx/2_Betting_on_Safety_Medication_Safety_Dashboard_Metric_Design_mixdown74uwt.mp3" length="49215724" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2048</itunes:duration>
                <itunes:episode>984</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Treatment of Vaccine Preventable Diseases: Measles (CE)</title>
        <itunes:title>Therapeutic Thursdays: Treatment of Vaccine Preventable Diseases: Measles (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-treatment-of-vaccine-preventable-diseases-measles-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-treatment-of-vaccine-preventable-diseases-measles-ce/#comments</comments>        <pubDate>Sat, 05 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/21c16300-87e7-339a-93d0-5da66044095b</guid>
                                    <description><![CDATA[<p>Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9hwzq6/Treatment_of_Vaccine_Preventable_Diseases-_Measles_CE_8m9ww.m4a" length="44458041" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2005</itunes:duration>
                <itunes:episode>990</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation Fridays: MCM 2022: Sick Enough to Stay Home: Trailblazing Acute Hospital at Home</title>
        <itunes:title>Innovation Fridays: MCM 2022: Sick Enough to Stay Home: Trailblazing Acute Hospital at Home</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-fridays-mcm-2022-sick-enough-to-stay-home-trailblazing-acute-hospital-at-home/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-fridays-mcm-2022-sick-enough-to-stay-home-trailblazing-acute-hospital-at-home/#comments</comments>        <pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a1f89c98-56c1-376d-bc71-3e1988f8d8f4</guid>
                                    <description><![CDATA[<p>In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5kitzz/_MCM_2022_Sick_Enough_to_Stay_Home_Trailblazing_Acute_Hospital_at_Home_mixdown_1_7u0lu.mp3" length="32971474" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1371</itunes:duration>
                <itunes:episode>985</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellness as an Opportunity for Thriving as Individuals and as a Profession</title>
        <itunes:title>Wellness as an Opportunity for Thriving as Individuals and as a Profession</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellness-as-an-opportunity-for-thriving-as-individuals-and-as-a-profession/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellness-as-an-opportunity-for-thriving-as-individuals-and-as-a-profession/#comments</comments>        <pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/623315ea-f7b3-3dde-9336-250bd1401abf</guid>
                                    <description><![CDATA[<p>Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hi5ukd/ASHP_Podcast_15_Wellness_as_an_Opportunity_for_Thriving_as_Individuals_and_as_a_Profession_MIX.mp3" length="70764536" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1769</itunes:duration>
                <itunes:episode>991</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Obstetric Clinical Pharmacy: A Necessary Birth of a New Specialty</title>
        <itunes:title>AJHP Voices: Obstetric Clinical Pharmacy: A Necessary Birth of a New Specialty</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-obstetric-clinical-pharmacy-a-necessary-birth-of-a-new-specialty/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-obstetric-clinical-pharmacy-a-necessary-birth-of-a-new-specialty/#comments</comments>        <pubDate>Tue, 01 Aug 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/073d4731-9027-3488-b171-77bb3e2752e2</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8iny4g/ASHP_Podcast_2_Obstetric_clinical_pharmacy_A_necessary_birth_of_a_new_specialty_REVISED.mp3" length="53273360" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1331</itunes:duration>
                <itunes:episode>989</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Innovation: MCM 2022: Rise of the Machine: Empowering a Diversion Monitoring Program Using Machine Learning</title>
        <itunes:title>Innovation: MCM 2022: Rise of the Machine: Empowering a Diversion Monitoring Program Using Machine Learning</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-mcm-2022-rise-of-the-machine-empowering-a-diversion-monitoring-program-using-machine-learning/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-mcm-2022-rise-of-the-machine-empowering-a-diversion-monitoring-program-using-machine-learning/#comments</comments>        <pubDate>Sun, 30 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6a444b2c-75ed-3482-91df-a5335eeeff11</guid>
                                    <description><![CDATA[<p>In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xh4tei/MCM_2022-_Rise_of_the_Machine-_Empowering_a_Diversion_Monitoring_Program_Using_Machine_Learningb9c5h.m4a" length="25341131" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1117</itunes:duration>
                <itunes:episode>976</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Little L’s, Big impact: The Importance of Leading from Behind</title>
        <itunes:title>Little L’s, Big impact: The Importance of Leading from Behind</itunes:title>
        <link>https://ashpofficial.podbean.com/e/little-l-s-big-impact-the-importance-of-leading-from-behind/</link>
                    <comments>https://ashpofficial.podbean.com/e/little-l-s-big-impact-the-importance-of-leading-from-behind/#comments</comments>        <pubDate>Sat, 29 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d6af1b6a-8d7d-3b2b-af20-ed7b4d951faf</guid>
                                    <description><![CDATA[<p>Leadership is often associated with a leader taking charge at the frontline. Oftentimes we describe these types of leaders as strong, inspirational, or courageous, however, the biggest impacts don’t always come from the individuals leading the charge. Although they sometimes go unrecognized, “Little L” leaders can be found scattered within the group where they work behind the scenes to empower their teammates and steer them towards success. That is why the concept of “leading from behind” is such a crucial component of ensuring effective team dynamics. If you apply this philosophy to the healthcare landscape, it becomes apparent that the nature of our profession allows pharmacists to act as a prime example of how this leadership style can be effectively utilized. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Leadership is often associated with a leader taking charge at the frontline. Oftentimes we describe these types of leaders as strong, inspirational, or courageous, however, the biggest impacts don’t always come from the individuals leading the charge. Although they sometimes go unrecognized, “Little L” leaders can be found scattered within the group where they work behind the scenes to empower their teammates and steer them towards success. That is why the concept of “leading from behind” is such a crucial component of ensuring effective team dynamics. If you apply this philosophy to the healthcare landscape, it becomes apparent that the nature of our profession allows pharmacists to act as a prime example of how this leadership style can be effectively utilized. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5yiyr4/ASHP_Podcast_13_Little_L_s_Big_impact_The_Importance_of_Leading_from_Behind_MIX.mp3" length="67476980" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Leadership is often associated with a leader taking charge at the frontline. Oftentimes we describe these types of leaders as strong, inspirational, or courageous, however, the biggest impacts don’t always come from the individuals leading the charge. Although they sometimes go unrecognized, “Little L” leaders can be found scattered within the group where they work behind the scenes to empower their teammates and steer them towards success. That is why the concept of “leading from behind” is such a crucial component of ensuring effective team dynamics. If you apply this philosophy to the healthcare landscape, it becomes apparent that the nature of our profession allows pharmacists to act as a prime example of how this leadership style can be effectively utilized. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1686</itunes:duration>
                <itunes:episode>981</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage - Engaging the Experts: Putting the Patient First: Updates in the Management of Acute Agitation</title>
        <itunes:title>ASHP Advantage - Engaging the Experts: Putting the Patient First: Updates in the Management of Acute Agitation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-advantage-engaging-the-experts-putting-the-patient-first-updates-in-the-management-of-acute-agitation/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-advantage-engaging-the-experts-putting-the-patient-first-updates-in-the-management-of-acute-agitation/#comments</comments>        <pubDate>Fri, 28 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ca6a4791-49fc-3725-b94a-60b9296b79db</guid>
                                    <description><![CDATA[<p>Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9e3ru9/ASHP_Podcast_5_Adv_BioXcel_MIX.mp3" length="129831968" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3245</itunes:duration>
                <itunes:episode>988</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: An Interview with ID Pharmacists: New Joint Commission Antibiotic Stewardship Requirements</title>
        <itunes:title>Hot Topics in Pharmacy: An Interview with ID Pharmacists: New Joint Commission Antibiotic Stewardship Requirements</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-an-interview-with-id-pharmacists-new-joint-commission-antibiotic-stewardship-requirements/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-an-interview-with-id-pharmacists-new-joint-commission-antibiotic-stewardship-requirements/#comments</comments>        <pubDate>Thu, 27 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/34f895eb-1bc2-3956-9bb1-ab752d182b12</guid>
                                    <description><![CDATA[<p>This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.  </p>
<p>Show notes:</p>
<ul><li>R3 Report Antibiotic Stewardship: <a href='https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf'>https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf</a></li>
<li>The Joint Commission Antibiotic Stewardship Resources: <a href='https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship'>https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship</a></li>
</ul>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.  </p>
<p>Show notes:</p>
<ul><li>R3 Report Antibiotic Stewardship: <a href='https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf'>https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf</a></li>
<li>The Joint Commission Antibiotic Stewardship Resources: <a href='https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship'>https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship</a></li>
</ul>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ihm3yq/ASHPOfficial_An_Interview_with_ID_Pharmacists_New_Joint_Commission_Antibiotic_Stewardship_Requirements_MIX.mp3" length="70983776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.  
Show notes:
R3 Report Antibiotic Stewardship: https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf
The Joint Commission Antibiotic Stewardship Resources: https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1774</itunes:duration>
                <itunes:episode>980</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Back to the Basics: Project Planning 101</title>
        <itunes:title>Pharmacy Leadership: Back to the Basics: Project Planning 101</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-back-to-the-basics-project-planning-101/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-back-to-the-basics-project-planning-101/#comments</comments>        <pubDate>Tue, 25 Jul 2023 09:34:22 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1f1f68de-c0dc-3244-adca-68b592a0625b</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with a seasoned pharmacy leader to provide listeners with an overview of successful project management. All too often, new leaders and frontline staff involved in projects can become overwhelmed with the steps involved to see a project through. Tina Do, of Yale New Haven Health, will take us through the basics of creating a strong project plan. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with a seasoned pharmacy leader to provide listeners with an overview of successful project management. All too often, new leaders and frontline staff involved in projects can become overwhelmed with the steps involved to see a project through. Tina Do, of Yale New Haven Health, will take us through the basics of creating a strong project plan. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rp4p3u/Back_to_the_Basics_Project_Planning_101_mixdown86ba1.mp3" length="33630884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with a seasoned pharmacy leader to provide listeners with an overview of successful project management. All too often, new leaders and frontline staff involved in projects can become overwhelmed with the steps involved to see a project through. Tina Do, of Yale New Haven Health, will take us through the basics of creating a strong project plan. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1398</itunes:duration>
                <itunes:episode>986</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation: MCM 2022: Validated Artificial Intelligence: The Future of Pharmacy and its Applications</title>
        <itunes:title>Innovation: MCM 2022: Validated Artificial Intelligence: The Future of Pharmacy and its Applications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-mcm-2022-validated-artificial-intelligence-the-future-of-pharmacy-and-its-applications/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-mcm-2022-validated-artificial-intelligence-the-future-of-pharmacy-and-its-applications/#comments</comments>        <pubDate>Sun, 23 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/541b4b40-dd3f-3aca-80a7-a5c6e7249b3f</guid>
                                    <description><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter expert reviews what artificial intelligence is (and isn’t) and identifies  opportunities in health-system pharmacies where artificial intelligence (AI) can be used.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter expert reviews what artificial intelligence is (and isn’t) and identifies  opportunities in health-system pharmacies where artificial intelligence (AI) can be used.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/aq9mpe/MCM_2022_Validated_AI_The_Future_of_Pharmacy_mixdown8ovyr.mp3" length="27318856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this feature from the 2022 Midyear Clinical Meeting, our content matter expert reviews what artificial intelligence is (and isn’t) and identifies  opportunities in health-system pharmacies where artificial intelligence (AI) can be used.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1135</itunes:duration>
                <itunes:episode>978</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vaccine Navigators: The Next Wave: Mpox</title>
        <itunes:title>Vaccine Navigators: The Next Wave: Mpox</itunes:title>
        <link>https://ashpofficial.podbean.com/e/vaccine-navigators-the-next-wave-mpox/</link>
                    <comments>https://ashpofficial.podbean.com/e/vaccine-navigators-the-next-wave-mpox/#comments</comments>        <pubDate>Sat, 22 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/59388fe4-71fe-3c5d-8a63-11d0d6280b21</guid>
                                    <description><![CDATA[<p>Mpox, formerly known as monkeypox, has been reported in all 50 states. The Navigators discuss how lessons learned from COVID-19 can be applied to manage this latest outbreak and provide insight on current efforts by departments of health and pharmacies to address this newest public health need.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Mpox, formerly known as monkeypox, has been reported in all 50 states. The Navigators discuss how lessons learned from COVID-19 can be applied to manage this latest outbreak and provide insight on current efforts by departments of health and pharmacies to address this newest public health need.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/knagzu/ASHPOfficial_The_Next_Wave_Mpox_MIX.mp3" length="50262464" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Mpox, formerly known as monkeypox, has been reported in all 50 states. The Navigators discuss how lessons learned from COVID-19 can be applied to manage this latest outbreak and provide insight on current efforts by departments of health and pharmacies to address this newest public health need.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1256</itunes:duration>
                <itunes:episode>965</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients</title>
        <itunes:title>AJHP Voices: Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-payer-site-of-care-mandates-with-oncology-medications-it-s-time-to-demand-payer-accountability-on-behalf-of-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-payer-site-of-care-mandates-with-oncology-medications-it-s-time-to-demand-payer-accountability-on-behalf-of-patients/#comments</comments>        <pubDate>Fri, 21 Jul 2023 14:27:44 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/980c08c5-9d0a-3794-a5e9-90029f14f543</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Kenneth Komorny and Nicole Bennett discuss the AJHP Commentary, “Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Kenneth Komorny and Nicole Bennett discuss the AJHP Commentary, “Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a6by25/ASHPOfficial_Payer_site_of_care_mandates_with_oncology_medications_It_s_time_to_demand_payer_accountability_REVISED_1_9dqgy.mp3" length="69466688" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Kenneth Komorny and Nicole Bennett discuss the AJHP Commentary, “Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1736</itunes:duration>
                <itunes:episode>983</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Leadership in Pharmacy: Lifelong Learning</title>
        <itunes:title>Leadership in Pharmacy: Lifelong Learning</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leadership-in-pharmacy-lifelong-learning/</link>
                    <comments>https://ashpofficial.podbean.com/e/leadership-in-pharmacy-lifelong-learning/#comments</comments>        <pubDate>Thu, 20 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a1d0877f-90ed-30dd-9f73-eeb9c3bb0d89</guid>
                                    <description><![CDATA[<p>This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6923sk/ASHP_Podcast_12_Leadership_in_Pharmacy_Lifelong_Learning_MIX.mp3" length="81942644" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2048</itunes:duration>
                <itunes:episode>982</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Compounding Conundrums: Return of the BUD... What are Category 1, 2, and 3 Compounded Sterile Products?</title>
        <itunes:title>Hot Topics in Pharmacy: Compounding Conundrums: Return of the BUD... What are Category 1, 2, and 3 Compounded Sterile Products?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-compounding-conundrums-return-of-the-bud-what-are-category-1-2-and-3-compounded-sterile-products/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-compounding-conundrums-return-of-the-bud-what-are-category-1-2-and-3-compounded-sterile-products/#comments</comments>        <pubDate>Wed, 19 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5ecdfaf9-ead3-3f91-9068-9d2144ce6f29</guid>
                                    <description><![CDATA[<p>With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kbp3ip/ASHP_Podcast_10_Compounding_Conundrums_Beyond_Use_Date_what_a_BUD_IS_and_what_a_BUD_ISN_T_Part_2_MIX.mp3" length="71464016" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1786</itunes:duration>
                <itunes:episode>974</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Facilitating Non-US Citizen Recruitment into US-Based Pharmacy Residencies</title>
        <itunes:title>Practice Journeys: Facilitating Non-US Citizen Recruitment into US-Based Pharmacy Residencies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-facilitating-non-us-citizen-recruitment-into-us-based-pharmacy-residencies/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-facilitating-non-us-citizen-recruitment-into-us-based-pharmacy-residencies/#comments</comments>        <pubDate>Tue, 18 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9689761e-7a99-32e6-8221-feacd0c70ab5</guid>
                                    <description><![CDATA[<p>International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/eivx9i/ASHP_Podcast_11_Facilitating_Non_US_Citizen_Recruitment_Into_US_Based_Pharmacy_Residencies_MIX.mp3" length="90487784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2262</itunes:duration>
                <itunes:episode>979</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Tips for Bringing Well-Being Principles in Pharmacy Education - Part II</title>
        <itunes:title>Educator Essentials: Tips for Bringing Well-Being Principles in Pharmacy Education - Part II</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-tips-for-bringing-well-being-principles-in-pharmacy-education-part-ii/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-tips-for-bringing-well-being-principles-in-pharmacy-education-part-ii/#comments</comments>        <pubDate>Mon, 17 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/609b947b-095e-352f-aa13-9aaa127c9b5d</guid>
                                    <description><![CDATA[<p>Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vbistj/Tips_for_Bringing_Well-Being_Principles_in_Pharmacy_Education_-_Part_I_mixdown9e7gq.mp3" length="28423407" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1181</itunes:duration>
                <itunes:episode>977</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation: MCM 2022: (Management Case Study) Using an IV Chemotherapy Compounding Robot Within a Comprehensive Cancer Center</title>
        <itunes:title>Innovation: MCM 2022: (Management Case Study) Using an IV Chemotherapy Compounding Robot Within a Comprehensive Cancer Center</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-mcm-2022-management-case-study-using-an-iv-chemotherapy-compounding-robot-within-a-comprehensive-cancer-center/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-mcm-2022-management-case-study-using-an-iv-chemotherapy-compounding-robot-within-a-comprehensive-cancer-center/#comments</comments>        <pubDate>Sun, 16 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0bc24cf0-03a0-30d9-898d-409d5cc6a023</guid>
                                    <description><![CDATA[<p>In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wnp5nb/MCM_2022_Chemotherapy_Compounding_Robot_mixdownbcuce.mp3" length="34174005" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1421</itunes:duration>
                <itunes:episode>975</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Compounding Conundrums: Beyond-Use Date, what a BUD IS and what a BUD ISN’T</title>
        <itunes:title>Hot Topics in Pharmacy: Compounding Conundrums: Beyond-Use Date, what a BUD IS and what a BUD ISN’T</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-compounding-conundrums-beyond-use-date-what-a-bud-is-and-what-a-bud-isn-t/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-compounding-conundrums-beyond-use-date-what-a-bud-is-and-what-a-bud-isn-t/#comments</comments>        <pubDate>Sat, 15 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7dc4ce13-abeb-3528-bb4f-5ef2d49c9515</guid>
                                    <description><![CDATA[<p>With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iveyk5/ASHPOfficial_Compounding_Conundrums_Beyond_Use_Date_what_a_BUD_IS_and_what_a_BUD_ISN_T_Part_3_MIX.mp3" length="54067844" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the release of the revised USP &lt;797&gt; guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1351</itunes:duration>
                <itunes:episode>973</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: MCM 2022 Highlights: Revisions to USP Compounding Standards ＜795＞ and ＜797＞</title>
        <itunes:title>Hot Topics in Pharmacy: MCM 2022 Highlights: Revisions to USP Compounding Standards ＜795＞ and ＜797＞</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-highlights-revisions-to-usp-compounding-standards-%ef%bc%9c795%ef%bc%9e-and-%ef%bc%9c797%ef%bc%9e/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-highlights-revisions-to-usp-compounding-standards-%ef%bc%9c795%ef%bc%9e-and-%ef%bc%9c797%ef%bc%9e/#comments</comments>        <pubDate>Fri, 14 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7ae814e6-79ca-38ca-8d80-6090078704f8</guid>
                                    <description><![CDATA[<p>In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2h3p8r/MCM_2022_Highlights-_Revisions_to_USP_Compounding_Standards_795_and_797_6i5hp.m4a" length="28509067" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1253</itunes:duration>
                <itunes:episode>969</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Successful Succession Planning – a Key to a Strong Leadership Team</title>
        <itunes:title>Pharmacy Leadership: Successful Succession Planning – a Key to a Strong Leadership Team</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-successful-succession-planning-%e2%80%93-a-key-to-a-strong-leadership-team/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-successful-succession-planning-%e2%80%93-a-key-to-a-strong-leadership-team/#comments</comments>        <pubDate>Mon, 10 Jul 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/300e9e67-2d90-3dd1-9137-47ed57dff46e</guid>
                                    <description><![CDATA[<p>Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/evvxva/Successful_Succession_Planning_a_Key_to_a_Strong_Leadership_Team_mixdown9vm98.mp3" length="30479221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1267</itunes:duration>
                <itunes:episode>971</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): Pharmacoequity</title>
        <itunes:title>Therapeutics Thursday (SCSS): Pharmacoequity</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-pharmacoequity/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-pharmacoequity/#comments</comments>        <pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1251dfa8-e057-38f1-9265-96a178beafab</guid>
                                    <description><![CDATA[<p>This podcast will focus on Pharmacoequity; what it is and ways to address it.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will focus on Pharmacoequity; what it is and ways to address it.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2h3v9f/Pharmacoequity.m4a" length="25247765" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will focus on Pharmacoequity; what it is and ways to address it.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1110</itunes:duration>
                <itunes:episode>967</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation: MCM2022: Protect the Children: Machine Learning Methods to Predict Adverse Drug Events (ADEs)</title>
        <itunes:title>Innovation: MCM2022: Protect the Children: Machine Learning Methods to Predict Adverse Drug Events (ADEs)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-mcm2022-protect-the-children-machine-learning-methods-to-predict-adverse-drug-events-ades/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-mcm2022-protect-the-children-machine-learning-methods-to-predict-adverse-drug-events-ades/#comments</comments>        <pubDate>Sun, 09 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/90a776ae-49c8-3610-ac1c-b263f71015ee</guid>
                                    <description><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fureug/NEW_MCM2022_Protect_the_Children_Machine_Learning_Methods_to_Predict_Adverse_Drug_Events_ADEs_mixdownbnz58.mp3" length="32287925" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1343</itunes:duration>
                <itunes:episode>968</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Best Practice Award 2022: Implementation of a Comprehensive Pharmacy Revenue Integrity Program to Ensure Financial Stewardship</title>
        <itunes:title>ASHP Best Practice Award 2022: Implementation of a Comprehensive Pharmacy Revenue Integrity Program to Ensure Financial Stewardship</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-best-practice-award-2022-implementation-of-a-comprehensive-pharmacy-revenue-integrity-program-to-ensure-financial-stewardship/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-best-practice-award-2022-implementation-of-a-comprehensive-pharmacy-revenue-integrity-program-to-ensure-financial-stewardship/#comments</comments>        <pubDate>Sat, 08 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8b276714-6dca-3e9d-bf9e-f0afe1630ea9</guid>
                                    <description><![CDATA[<p>In this episode, the team from the UNC Health to discuss their award winning submission to the ASHP Best Practices.  They will share how they established a comprehensive Pharmacy Revenue Integrity program for outpatient medical benefit claims within pharmacy services, aligning financial, clinical and operational areas to ensure department and institutional long‐term financial strength. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from the UNC Health to discuss their award winning submission to the ASHP Best Practices.  They will share how they established a comprehensive Pharmacy Revenue Integrity program for outpatient medical benefit claims within pharmacy services, aligning financial, clinical and operational areas to ensure department and institutional long‐term financial strength. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sbujcb/ASHP_Best_Practice_Award_2022_Implementation_of_a_Comprehensive_Pharmacy_Revenue_Integrity_Program_to_Ensure_Financial_Stewardship_mixdown61yyq.mp3" length="44645253" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, the team from the UNC Health to discuss their award winning submission to the ASHP Best Practices.  They will share how they established a comprehensive Pharmacy Revenue Integrity program for outpatient medical benefit claims within pharmacy services, aligning financial, clinical and operational areas to ensure department and institutional long‐term financial strength. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1858</itunes:duration>
                <itunes:episode>970</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: What is the Metaverse?</title>
        <itunes:title>Informatics Bytes: What is the Metaverse?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-what-is-the-metaverse/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-what-is-the-metaverse/#comments</comments>        <pubDate>Fri, 07 Jul 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3a5c5fff-dee0-34b7-b83d-ef91e85d8625</guid>
                                    <description><![CDATA[<p>In a short period of time, the “metaverse” has become a buzzword in the technology industry and beyond. The question in many people’s minds is, “when will the metaverse hit me?” Join us as we explore what the metaverse is today and how pharmacy could be impacted.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a short period of time, the “metaverse” has become a buzzword in the technology industry and beyond. The question in many people’s minds is, “when will the metaverse hit me?” Join us as we explore what the metaverse is today and how pharmacy could be impacted.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vqzmsc/What_is_the_Metaverse_mixdownaiggx.mp3" length="12814766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a short period of time, the “metaverse” has become a buzzword in the technology industry and beyond. The question in many people’s minds is, “when will the metaverse hit me?” Join us as we explore what the metaverse is today and how pharmacy could be impacted.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>531</itunes:duration>
                <itunes:episode>966</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Pharmacist Recruitment, Retention and Engagement</title>
        <itunes:title>Pharmacy Leadership: Pharmacist Recruitment, Retention and Engagement</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacist-recruitment-retention-and-engagement/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-pharmacist-recruitment-retention-and-engagement/#comments</comments>        <pubDate>Fri, 07 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4e8448cc-e692-3f25-8fb3-29c3314871bb</guid>
                                    <description><![CDATA[<p>This podcast episode focuses on pharmacy workforce issues. Listen in to learn more about key takeaways applicable to the pharmacist workforce from the SPPL Virtual Roundtable: Technician &amp; Pharmacist Recruitment, Retention, and Engagement that occurred on April 20, 2023. Additionally, listen in to learn about specific successes for addressing common concerns and additional insights from our guests.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode focuses on pharmacy workforce issues. Listen in to learn more about key takeaways applicable to the pharmacist workforce from the SPPL Virtual Roundtable: Technician &amp; Pharmacist Recruitment, Retention, and Engagement that occurred on April 20, 2023. Additionally, listen in to learn about specific successes for addressing common concerns and additional insights from our guests.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r7pj8b/ASHP_Podcast_9_Pharmacist_Recruitment_Retention_and_Engagement_MIX.mp3" length="68441636" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode focuses on pharmacy workforce issues. Listen in to learn more about key takeaways applicable to the pharmacist workforce from the SPPL Virtual Roundtable: Technician &amp; Pharmacist Recruitment, Retention, and Engagement that occurred on April 20, 2023. Additionally, listen in to learn about specific successes for addressing common concerns and additional insights from our guests.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1711</itunes:duration>
                <itunes:episode>964</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Pharmacogenomic Considerations for Pain Management</title>
        <itunes:title>Hot Topics in Pharmacy: Pharmacogenomic Considerations for Pain Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-pharmacogenomic-considerations-for-pain-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-pharmacogenomic-considerations-for-pain-management/#comments</comments>        <pubDate>Thu, 06 Jul 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e461ada1-174c-3b55-8c39-d77a7708c5ce</guid>
                                    <description><![CDATA[<p>As approaches to pain management evolve, it is a natural progression to consider the influence and role pharmacogenomics play in optimizing patient medication regimens. In this episode, our content matter experts discuss pharmacogenomic testing, resources and education surrounding pain management.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As approaches to pain management evolve, it is a natural progression to consider the influence and role pharmacogenomics play in optimizing patient medication regimens. In this episode, our content matter experts discuss pharmacogenomic testing, resources and education surrounding pain management.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v84ewb/Pharmacogenomic_Considerations_for_Pain_Management__mixdownbsctu.mp3" length="24156236" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As approaches to pain management evolve, it is a natural progression to consider the influence and role pharmacogenomics play in optimizing patient medication regimens. In this episode, our content matter experts discuss pharmacogenomic testing, resources and education surrounding pain management.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1003</itunes:duration>
                <itunes:episode>962</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2022: A Complex Constellation Making Sense of the Interstitial Lung Disease</title>
        <itunes:title>Therapeutic Thursdays: MCM 2022: A Complex Constellation Making Sense of the Interstitial Lung Disease</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2022-a-complex-constellation-making-sense-of-the-interstitial-lung-disease/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2022-a-complex-constellation-making-sense-of-the-interstitial-lung-disease/#comments</comments>        <pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7afd5d66-3363-3e47-93b3-e4b9571da83f</guid>
                                    <description><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter experts differentiate the most common interstitial lung diseases and recommendations in supportive care and future directions for this patient population.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter experts differentiate the most common interstitial lung diseases and recommendations in supportive care and future directions for this patient population.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jsgncw/MCM_2022-_A_Complex_Constellation_Making_Sense_of_the_Intersitital_Lung_Disease6484q.m4a" length="22400623" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2022 Midyear Clinical Meeting, our content matter experts differentiate the most common interstitial lung diseases and recommendations in supportive care and future directions for this patient population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>979</itunes:duration>
                <itunes:episode>961</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Wellbeing and Resilience: Tips for Bringing Well-Being Principles in Pharmacy Education Part I</title>
        <itunes:title>Wellbeing and Resilience: Tips for Bringing Well-Being Principles in Pharmacy Education Part I</itunes:title>
        <link>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-tips-for-bringing-well-being-principles-in-pharmacy-education-part-i/</link>
                    <comments>https://ashpofficial.podbean.com/e/wellbeing-and-resilience-tips-for-bringing-well-being-principles-in-pharmacy-education-part-i/#comments</comments>        <pubDate>Wed, 05 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e29a9b23-f50a-355e-8d10-fdac8356ad84</guid>
                                    <description><![CDATA[<p>Join this three-part conversation with Dr. Shareen El-Ibiary, Dr. Blake Porter, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join this three-part conversation with Dr. Shareen El-Ibiary, Dr. Blake Porter, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/emtk53/Tips_for_Bringing_Well-Being_Principles_in_Pharmacy_Education_-_THE_REAL_Part_I_mixdown8aceo.mp3" length="29755344" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join this three-part conversation with Dr. Shareen El-Ibiary, Dr. Blake Porter, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1237</itunes:duration>
                <itunes:episode>963</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services</title>
        <itunes:title>AJHP Voices: 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-2022-ashp-survey-of-health-system-specialty-pharmacy-practice-clinical-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-2022-ashp-survey-of-health-system-specialty-pharmacy-practice-clinical-services/#comments</comments>        <pubDate>Mon, 03 Jul 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5ff9df52-1f82-3b8c-8d11-ce9a97b5faa5</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Autumn Zuckerman, Dr. Jennifer Donovan, and Dr. Melissa Ortega discuss the AJHP Practice Research Report, “2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Autumn Zuckerman, Dr. Jennifer Donovan, and Dr. Melissa Ortega discuss the AJHP Practice Research Report, “2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m9vjkx/ASHP_Podcast_1_2022_ASHP_Survey_of_Health_System_Specialty_Pharmacy_Practice_Clinical_Services_REVISED.mp3" length="48876032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Autumn Zuckerman, Dr. Jennifer Donovan, and Dr. Melissa Ortega discuss the AJHP Practice Research Report, “2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1221</itunes:duration>
                <itunes:episode>960</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Specialty Pharmacy Accreditation and Compliance FTE Position Justification</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Specialty Pharmacy Accreditation and Compliance FTE Position Justification</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-specialty-pharmacy-accreditation-and-compliance-fte-position-justification/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-specialty-pharmacy-accreditation-and-compliance-fte-position-justification/#comments</comments>        <pubDate>Fri, 30 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e33111d9-40eb-381f-a2dd-6e1ffd1866cc</guid>
                                    <description><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this podcast episode, listeners will learn about the many roles Specialty Pharmacy Accreditation & Compliance positions play in specialty pharmacy leadership and operations. In addition, listeners will be provided with examples of duties and responsibilities coordinated and/or managed by these positions that necessitate advocacy for these roles.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this podcast episode, listeners will learn about the many roles Specialty Pharmacy Accreditation & Compliance positions play in specialty pharmacy leadership and operations. In addition, listeners will be provided with examples of duties and responsibilities coordinated and/or managed by these positions that necessitate advocacy for these roles.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/776jg8/Specialty_Pharmacy_Accreditation_and_Compliance_FTE_Position_Justification8koxn.m4a" length="26440047" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast episode, listeners will learn about the many roles Specialty Pharmacy Accreditation & Compliance positions play in specialty pharmacy leadership and operations. In addition, listeners will be provided with examples of duties and responsibilities coordinated and/or managed by these positions that necessitate advocacy for these roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1166</itunes:duration>
                <itunes:episode>957</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: MCM2022: The Invisible Giant Among Us: Genetic Tests Used in the Early Identification of Respiratory Pathogens - COVID-19</title>
        <itunes:title>COVID-19: MCM2022: The Invisible Giant Among Us: Genetic Tests Used in the Early Identification of Respiratory Pathogens - COVID-19</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-mcm2022-the-invisible-giant-among-us-genetic-tests-used-in-the-early-identification-of-respiratory-pathogens-covid-19/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-mcm2022-the-invisible-giant-among-us-genetic-tests-used-in-the-early-identification-of-respiratory-pathogens-covid-19/#comments</comments>        <pubDate>Thu, 29 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b10328a4-4787-38c5-a9d3-ea00b39150fa</guid>
                                    <description><![CDATA[<p>This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wbpcet/MCM2022_The_Invisible_Giant_Amongst_Us_Genetic_Tests_Used_in_the_Early_Identification_of_Respiratory_Pathogens_-_COVID-19__mixdown9eq5x.mp3" length="19224943" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>798</itunes:duration>
                <itunes:episode>958</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Interprofessional Education Resources and Best Practices</title>
        <itunes:title>Educator Essentials: Interprofessional Education Resources and Best Practices</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-interprofessional-education-resources-and-best-practices/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-interprofessional-education-resources-and-best-practices/#comments</comments>        <pubDate>Wed, 28 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6b57310d-e5f6-37ac-bcc0-5fd6c4945a8b</guid>
                                    <description><![CDATA[<p>This podcast will highlight a recently added ASHP resource center on interprofessional education (IPE). Discussion will cover the need for an IPE resource center, how to use the resource center, and some best practice from our experts' experience. Access the ASHP <a href='https://www.ashp.org/pharmacy-practice/resource-centers/interprofessional-practice-and-education'>Interprofessional Practice and Education Resource Center</a>.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will highlight a recently added ASHP resource center on interprofessional education (IPE). Discussion will cover the need for an IPE resource center, how to use the resource center, and some best practice from our experts' experience. Access the ASHP <a href='https://www.ashp.org/pharmacy-practice/resource-centers/interprofessional-practice-and-education'>Interprofessional Practice and Education Resource Center</a>.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rpxxk9/ASHP_Podcast_8_Interprofessional_Education_Resourced_and_Best_Practices_MIX.mp3" length="58861892" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will highlight a recently added ASHP resource center on interprofessional education (IPE). Discussion will cover the need for an IPE resource center, how to use the resource center, and some best practice from our experts' experience. Access the ASHP Interprofessional Practice and Education Resource Center.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1471</itunes:duration>
                <itunes:episode>959</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2022: ASHP 2022 National Survey: Pharmacist Workforce Trends</title>
        <itunes:title>MCM 2022: ASHP 2022 National Survey: Pharmacist Workforce Trends</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2022-ashp-2022-national-survey-pharmacist-workforce-trends/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2022-ashp-2022-national-survey-pharmacist-workforce-trends/#comments</comments>        <pubDate>Tue, 27 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/06f993a1-d28b-3854-b439-f3a9c03b985a</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r4wzus/MCM22_Clinical_ASHP_2022_National_Survey_Pharmacist_Workforce_Trends_mixdown9a9kw.mp3" length="18935251" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey. 
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>786</itunes:duration>
                <itunes:episode>955</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Are There PROS of PRObiotics over Other Microbiome Restoration Products for C. difficile Infections?</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Are There PROS of PRObiotics over Other Microbiome Restoration Products for C. difficile Infections?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-are-there-pros-of-probiotics-over-other-microbiome-restoration-products-for-c-difficile-infections/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-are-there-pros-of-probiotics-over-other-microbiome-restoration-products-for-c-difficile-infections/#comments</comments>        <pubDate>Fri, 23 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e8e7d864-789b-3783-9f80-4c22d0a649a3</guid>
                                    <description><![CDATA[<p>Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gbcxb6/ASHP_Podcast_Microbiome_C_Diff_podcast_2_MIX.mp3" length="69836420" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1745</itunes:duration>
                <itunes:episode>953</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Pharmacogenomics Considerations for Mental Health Disorders</title>
        <itunes:title>Hot Topics in Pharmacy: Pharmacogenomics Considerations for Mental Health Disorders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-pharmacogenomics-considerations-for-mental-health-disorders/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-pharmacogenomics-considerations-for-mental-health-disorders/#comments</comments>        <pubDate>Thu, 22 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/25b89303-f7d1-3842-90bb-42b88590e5ff</guid>
                                    <description><![CDATA[<p>Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/t47xps/Pharmacogenomic_Considerations_for_Mental_Health_Disorders_mixdown60z8w.mp3" length="27602984" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1147</itunes:duration>
                <itunes:episode>956</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: DSCSA Update</title>
        <itunes:title>Advocating for Impact: DSCSA Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-dscsa-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-dscsa-update/#comments</comments>        <pubDate>Wed, 21 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/76242df4-39ea-3fc1-b7e1-da86c77a2658</guid>
                                    <description><![CDATA[<p>This podcast will provide members a refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as track and trace.  We’ll get recommendations from two leading experts on preparing for full DSCSA implementation in November 2023 and talk about what to expect as we approach that date.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members a refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as track and trace.  We’ll get recommendations from two leading experts on preparing for full DSCSA implementation in November 2023 and talk about what to expect as we approach that date.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p8xrm4/DSCSA_Update_mixdown8edro.mp3" length="38580560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide members a refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as track and trace.  We’ll get recommendations from two leading experts on preparing for full DSCSA implementation in November 2023 and talk about what to expect as we approach that date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1605</itunes:duration>
                <itunes:episode>950</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Treatment of vaccine-preventable diseases – Rabies (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Treatment of vaccine-preventable diseases – Rabies (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-treatment-of-vaccine-preventable-diseases-%e2%80%93-rabies-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-treatment-of-vaccine-preventable-diseases-%e2%80%93-rabies-ce/#comments</comments>        <pubDate>Sat, 17 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5b3d2ba5-c620-3795-bc2a-640d790f7b66</guid>
                                    <description><![CDATA[<p>Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/aakybj/Vaccine_Preventable_Diseases_Series_Rabies_CE_mixdown6ger1.mp3" length="33542962" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1395</itunes:duration>
                <itunes:episode>945</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022</title>
        <itunes:title>AJHP Voices: ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-ashp-national-survey-of-pharmacy-practice-in-hospital-settings-workforce-%e2%80%94-2022/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-ashp-national-survey-of-pharmacy-practice-in-hospital-settings-workforce-%e2%80%94-2022/#comments</comments>        <pubDate>Thu, 15 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5f643d9e-fb86-3b02-8463-afe4be500314</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Craig Pedersen and Dr. Michael Ganio discuss the AJHP Practice Research Report, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Craig Pedersen and Dr. Michael Ganio discuss the AJHP Practice Research Report, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vxmybt/ASHP_Podcast_AJHP_Voices_ASHP_National_Survey_of_Pharmacy_Practice_in_Hospital_Settings_Workforce_2022_MIX.mp3" length="68469824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Craig Pedersen and Dr. Michael Ganio discuss the AJHP Practice Research Report, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1711</itunes:duration>
                <itunes:episode>932</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics: Pharmacy Services in Indigenous and Tribal Facilities</title>
        <itunes:title>Hot Topics: Pharmacy Services in Indigenous and Tribal Facilities</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-pharmacy-services-in-indigenous-and-tribal-facilities/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-pharmacy-services-in-indigenous-and-tribal-facilities/#comments</comments>        <pubDate>Tue, 13 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1272ea80-e7a0-3ac1-9626-7945791270f9</guid>
                                    <description><![CDATA[<p>In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/62htym/ASHP_Podcast_Pharmacy_Services_in_Indigenous_and_Tribal_Facilities_MIX.mp3" length="97706000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2442</itunes:duration>
                <itunes:episode>949</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): Out of this World:  Hemgenix® (etranacogene dezaparvovec), the Recently Approved Gene Therapy for Hemophilia B and the Most Expensive Drug in the World!</title>
        <itunes:title>Therapeutics Thursday (SCSS): Out of this World:  Hemgenix® (etranacogene dezaparvovec), the Recently Approved Gene Therapy for Hemophilia B and the Most Expensive Drug in the World!</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scssout-of-this-worldhemgenix%c2%aeetranacogene-dezaparvovec-the-recently-approvedgenetherapy-for-hemophilia-bandthe-most-expens/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scssout-of-this-worldhemgenix%c2%aeetranacogene-dezaparvovec-the-recently-approvedgenetherapy-for-hemophilia-bandthe-most-expens/#comments</comments>        <pubDate>Sun, 11 Jun 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/65cb1bd4-7cc0-3c8c-954a-fcb87fee2d78</guid>
                                    <description><![CDATA[<p>Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/shtvx4/3_Out_of_this_World_Hemgenix_etranacogene_dezaparvovec_mixdown7sfl7.mp3" length="32129843" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1338</itunes:duration>
                <itunes:episode>938</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2022: Acute Care vs Ambulatory Focused Stewardship</title>
        <itunes:title>Therapeutic Thursdays: MCM 2022: Acute Care vs Ambulatory Focused Stewardship</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2022-acute-care-vs-ambulatory-focused-stewardship/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2022-acute-care-vs-ambulatory-focused-stewardship/#comments</comments>        <pubDate>Thu, 08 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff376aea-2885-3b3a-af35-9bf5430ebccb</guid>
                                    <description><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/psfvub/MCM_2022-_Acute_Care_vs_Ambulatory_Focused_Stewardship966oa.m4a" length="50268679" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2216</itunes:duration>
                <itunes:episode>941</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2022: ASHP 2022 National Survey: Pharmacy Technician Workforce Trends</title>
        <itunes:title>MCM 2022: ASHP 2022 National Survey: Pharmacy Technician Workforce Trends</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2022-ashp-2022-national-survey-pharmacy-technician-workforce-trends/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2022-ashp-2022-national-survey-pharmacy-technician-workforce-trends/#comments</comments>        <pubDate>Wed, 07 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f5c878f0-c20d-3e53-8413-535e1051375a</guid>
                                    <description><![CDATA[<p>In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4qi392/MCM_2022_ASHP_2022_National_Survey_Pharmacy_Technician_Workforce_Trends__mixdown61flt.mp3" length="39535625" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1645</itunes:duration>
                <itunes:episode>943</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Integrating Comprehensive Medication Management Through Legislation</title>
        <itunes:title>Advocating for Impact: Integrating Comprehensive Medication Management Through Legislation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-integrating-comprehensive-medication-management-through-legislation/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-integrating-comprehensive-medication-management-through-legislation/#comments</comments>        <pubDate>Tue, 06 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ecf5b1e7-a1cf-3919-9cbe-e90a8f03d542</guid>
                                    <description><![CDATA[<p>This podcast will highlight a recently enacted North Dakota law requiring health plans to cover comprehensive medication management services provided by clinical pharmacists. The legislation, developed in collaboration with and supported by ASHP, will increase patients’ access to team-based services, better enabling pharmacists and clinicians to collaboratively optimize medication use and improve outcomes. Building on the success of the North Dakota bill, ASHP has drafted model legislation that other states can adopt to ensure patients have access to CMM services.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will highlight a recently enacted North Dakota law requiring health plans to cover comprehensive medication management services provided by clinical pharmacists. The legislation, developed in collaboration with and supported by ASHP, will increase patients’ access to team-based services, better enabling pharmacists and clinicians to collaboratively optimize medication use and improve outcomes. Building on the success of the North Dakota bill, ASHP has drafted model legislation that other states can adopt to ensure patients have access to CMM services.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vjwqj5/Integrating_Comprehensive_Medication_Management_Through_Legislation6woxq.m4a" length="24362684" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will highlight a recently enacted North Dakota law requiring health plans to cover comprehensive medication management services provided by clinical pharmacists. The legislation, developed in collaboration with and supported by ASHP, will increase patients’ access to team-based services, better enabling pharmacists and clinicians to collaboratively optimize medication use and improve outcomes. Building on the success of the North Dakota bill, ASHP has drafted model legislation that other states can adopt to ensure patients have access to CMM services.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1073</itunes:duration>
                <itunes:episode>934</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Demystifying the ASHP House of Delegates</title>
        <itunes:title>Pharmacy Leadership: Demystifying the ASHP House of Delegates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-demystifying-the-ashp-house-of-delegates/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-demystifying-the-ashp-house-of-delegates/#comments</comments>        <pubDate>Sun, 04 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b908dac1-2f9d-3af3-8fc0-6e0f40936f9f</guid>
                                    <description><![CDATA[<p>Interested in ASHP policy but don’t know where to start? Heard of the House of Delegates but unsure of what it is or how to get there? Please join host Elyse MacDonald as she chats with the House of Delegates Chair, Melanie Dodd, as well as Delegates Mindy Burnworth and Brittany Tschaen, for a discussion of the House, ASHP policy, and how you can get involved!)  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Interested in ASHP policy but don’t know where to start? Heard of the House of Delegates but unsure of what it is or how to get there? Please join host Elyse MacDonald as she chats with the House of Delegates Chair, Melanie Dodd, as well as Delegates Mindy Burnworth and Brittany Tschaen, for a discussion of the House, ASHP policy, and how you can get involved!)  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/b7aigh/Demystifying_the_ASHP_House_of_Delegates7eqor.m4a" length="38334928" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Interested in ASHP policy but don’t know where to start? Heard of the House of Delegates but unsure of what it is or how to get there? Please join host Elyse MacDonald as she chats with the House of Delegates Chair, Melanie Dodd, as well as Delegates Mindy Burnworth and Brittany Tschaen, for a discussion of the House, ASHP policy, and how you can get involved!)  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1703</itunes:duration>
                <itunes:episode>933</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Career Pearls for Students: Neurocritical Care</title>
        <itunes:title>Career Pearls for Students: Neurocritical Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/career-pearls-for-students-neurocritical-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/career-pearls-for-students-neurocritical-care/#comments</comments>        <pubDate>Sun, 04 Jun 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/37c7cf24-8ffb-3bb5-ba23-3d2e6e2e57b9</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9wxgjv/Career_Pearls_for_Students_Neurocritical_Care_mixdown73a2f.mp3" length="22468300" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>933</itunes:duration>
                <itunes:episode>931</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Coming Around the Bend: The Management of Pain in Patients with Sickle Cell Disease (C.E.)</title>
        <itunes:title>Coming Around the Bend: The Management of Pain in Patients with Sickle Cell Disease (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hold-for-scd-info/</link>
                    <comments>https://ashpofficial.podbean.com/e/hold-for-scd-info/#comments</comments>        <pubDate>Sat, 03 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5af27735-443c-33e3-a195-6f5f26826598</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Two experts in pain management in patients with Sickle Cell Disease (SCD) will discuss the causes of pain in patients with SCD as well the best practices in approaches to managing pain from pediatric patients and as they transition into adulthood.  Challenges in pain management for patients with SCD will also be discussed including some strategies to overcome these challenges.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Two experts in pain management in patients with Sickle Cell Disease (SCD) will discuss the causes of pain in patients with SCD as well the best practices in approaches to managing pain from pediatric patients and as they transition into adulthood.  Challenges in pain management for patients with SCD will also be discussed including some strategies to overcome these challenges.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zegmrj/CE_Podcast_SCD_Management__mixdown832qj.mp3" length="52702611" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Two experts in pain management in patients with Sickle Cell Disease (SCD) will discuss the causes of pain in patients with SCD as well the best practices in approaches to managing pain from pediatric patients and as they transition into adulthood.  Challenges in pain management for patients with SCD will also be discussed including some strategies to overcome these challenges.  
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2193</itunes:duration>
                <itunes:episode>940</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Reframing the Conversation Surrounding Harms Reduction and How to Check Your Stigma</title>
        <itunes:title>Hot Topics: Reframing the Conversation Surrounding Harms Reduction and How to Check Your Stigma</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-reframing-the-conversation-surrounding-harms-reduction-and-how-to-check-your-stigma/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-reframing-the-conversation-surrounding-harms-reduction-and-how-to-check-your-stigma/#comments</comments>        <pubDate>Fri, 02 Jun 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ce7787c3-627b-3d94-9823-8827476b7a9d</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j777qa/Reframing_the_Conversation_Surrounding_Harms_Reduction_and_How_to_Check_Your_Stigmaa48s8.m4a" length="24761846" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment.  
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1092</itunes:duration>
                <itunes:episode>929</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exploring RFID Technology and Medication Safety</title>
        <itunes:title>Exploring RFID Technology and Medication Safety</itunes:title>
        <link>https://ashpofficial.podbean.com/e/exploring-rfid-technology-and-medication-safety/</link>
                    <comments>https://ashpofficial.podbean.com/e/exploring-rfid-technology-and-medication-safety/#comments</comments>        <pubDate>Sun, 28 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2071df8a-4dc4-35fe-a709-24e14e330767</guid>
                                    <description><![CDATA[<p>Radio frequency identification (RFID) technology is utilized in health systems throughout the medication use process, primarily for inventory management and revenue capture. In this episode, health-system pharmacy leaders delve into the results of previous research and explore the potential impact of RFID on patient and medication safety. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Radio frequency identification (RFID) technology is utilized in health systems throughout the medication use process, primarily for inventory management and revenue capture. In this episode, health-system pharmacy leaders delve into the results of previous research and explore the potential impact of RFID on patient and medication safety. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bznwai/ASHP_Podcast_Exploring_RFID_Technology_and_Medication_Safety_A_Discussion_with_Pharmacy_Leaders_MIX.mp3" length="62160932" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Radio frequency identification (RFID) technology is utilized in health systems throughout the medication use process, primarily for inventory management and revenue capture. In this episode, health-system pharmacy leaders delve into the results of previous research and explore the potential impact of RFID on patient and medication safety. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1554</itunes:duration>
                <itunes:episode>909</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Successfully Navigate the Transition to PGY1 Residency</title>
        <itunes:title>Successfully Navigate the Transition to PGY1 Residency</itunes:title>
        <link>https://ashpofficial.podbean.com/e/successfully-navigate-the-transition-to-pgy1-residency/</link>
                    <comments>https://ashpofficial.podbean.com/e/successfully-navigate-the-transition-to-pgy1-residency/#comments</comments>        <pubDate>Sat, 27 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5596b4bf-0105-3adb-948e-044d2bb3f7fe</guid>
                                    <description><![CDATA[<p>Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about what it is like to be a PGY1 pharmacy resident. This podcast will cover the day-to-day of a pharmacy resident and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a residency.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about what it is like to be a PGY1 pharmacy resident. This podcast will cover the day-to-day of a pharmacy resident and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a residency.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rbkcmy/ASHP_Podcast_Successfully_Navigate_the_Transition_to_PGY1_Residency_MIX.mp3" length="137891648" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about what it is like to be a PGY1 pharmacy resident. This podcast will cover the day-to-day of a pharmacy resident and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3447</itunes:duration>
                <itunes:episode>911</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID Updates - Pregnancy, Lactation, and Pediatrics</title>
        <itunes:title>COVID Updates - Pregnancy, Lactation, and Pediatrics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-updates-pregnancy-lactation-and-pediatrics/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-updates-pregnancy-lactation-and-pediatrics/#comments</comments>        <pubDate>Fri, 26 May 2023 10:27:44 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a94008d9-5e35-3a44-b674-80e9efe68244</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nee2i2/MCM22_COVID_Podcast_172b0d.m4a" length="35691666" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1578</itunes:duration>
                <itunes:episode>912</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursdays (CE): Vaccine Preventable Diseases Series: Tetanus (C.E.)</title>
        <itunes:title>Therapeutics Thursdays (CE): Vaccine Preventable Diseases Series: Tetanus (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursdays-ce-vaccine-preventable-diseases-series-tetanus-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursdays-ce-vaccine-preventable-diseases-series-tetanus-ce/#comments</comments>        <pubDate>Thu, 25 May 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8048a75f-8830-3bb7-9969-b0da74905238</guid>
                                    <description><![CDATA[<p>In this series, our content matter experts will present and discuss patient cases and management of vaccine preventable diseases.  In this episode Norm Fenn reviews a patient.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this series, our content matter experts will present and discuss patient cases and management of vaccine preventable diseases.  In this episode Norm Fenn reviews a patient.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/77eypi/Vaccine_Preventable_Diseases_Series_Tetanus_CE_mixdown76xdz.mp3" length="36694337" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this series, our content matter experts will present and discuss patient cases and management of vaccine preventable diseases.  In this episode Norm Fenn reviews a patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1526</itunes:duration>
                <itunes:episode>910</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: MCM 2022 Highlights: 340B Update: Breaking Down Emerging Medicaid Trends</title>
        <itunes:title>Hot Topics in Pharmacy: MCM 2022 Highlights: 340B Update: Breaking Down Emerging Medicaid Trends</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-highlights-340b-update-breaking-down-emerging-medicaid-trends/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-highlights-340b-update-breaking-down-emerging-medicaid-trends/#comments</comments>        <pubDate>Thu, 25 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/aca70de7-e4e3-35ef-867e-2960913403b7</guid>
                                    <description><![CDATA[<p>In this episode featuring content from the 2022 Midyear Clinical Meeting, content matter experts discuss the developing trends in the Medicaid reimbursement of the 340 B Program and available resources.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode featuring content from the 2022 Midyear Clinical Meeting, content matter experts discuss the developing trends in the Medicaid reimbursement of the 340 B Program and available resources.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f3b2h6/MCM_2022_Highlights-_340B_Update-_Breaking_Down_Emerging_Medicaid_Trendsafkn9.m4a" length="24822827" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode featuring content from the 2022 Midyear Clinical Meeting, content matter experts discuss the developing trends in the Medicaid reimbursement of the 340 B Program and available resources.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1092</itunes:duration>
                <itunes:episode>905</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Taking the Road Less Traveled: Exploring Health-System Pharmacy Administration and Leadership Residency Programs</title>
        <itunes:title>Practice Journeys: Taking the Road Less Traveled: Exploring Health-System Pharmacy Administration and Leadership Residency Programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-taking-the-road-less-traveled-exploring-health-system-pharmacy-administration-and-leadership-residency-programs/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-taking-the-road-less-traveled-exploring-health-system-pharmacy-administration-and-leadership-residency-programs/#comments</comments>        <pubDate>Wed, 24 May 2023 13:57:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/86caa048-d338-3c48-9717-c6bec8c5083e</guid>
                                    <description><![CDATA[<p>This podcast dives into Health-System Pharmacy Administration and Leadership residency programs to provide current pharmacy students with information about this specialized residency program. Members of ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) Leadership Committee share their knowledge and experiences with students interested in learning more about a career in health-system pharmacy administration. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast dives into Health-System Pharmacy Administration and Leadership residency programs to provide current pharmacy students with information about this specialized residency program. Members of ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) Leadership Committee share their knowledge and experiences with students interested in learning more about a career in health-system pharmacy administration. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vtp93s/ASHP_Podcast_Taking_the_Road_Less_Traveled_Exploring_Health_System_Pharmacy_Administration_and_Leadership_Residency_Programs_MIX.mp3" length="70222700" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast dives into Health-System Pharmacy Administration and Leadership residency programs to provide current pharmacy students with information about this specialized residency program. Members of ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) Leadership Committee share their knowledge and experiences with students interested in learning more about a career in health-system pharmacy administration. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1755</itunes:duration>
                <itunes:episode>908</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Considerations for Implementation of Vancomycin Bayesian Software Monitoring in a Level IV NICU Population Within a Multisite Health System</title>
        <itunes:title>AJHP Voices: Considerations for Implementation of Vancomycin Bayesian Software Monitoring in a Level IV NICU Population Within a Multisite Health System</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-considerations-for-implementation-ofvancomycinbayesiansoftware-monitoringin-aleveliv-nicu-populationwithin-a-multisite-healthsystem/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-considerations-for-implementation-ofvancomycinbayesiansoftware-monitoringin-aleveliv-nicu-populationwithin-a-multisite-healthsystem/#comments</comments>        <pubDate>Wed, 24 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c7c27964-3c26-3848-a2d0-93c4edcbb780</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Meredith Oliver and Dr. Lizbeth Hansen discuss the AJHP Descriptive Report, “Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Meredith Oliver and Dr. Lizbeth Hansen discuss the AJHP Descriptive Report, “Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bhrpfm/ASHP_Podcast_AJHP_Voices_Considerations_for_implementation_of_vancomycin_Bayesian_software_REVISED_2.mp3" length="74090720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Meredith Oliver and Dr. Lizbeth Hansen discuss the AJHP Descriptive Report, “Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1852</itunes:duration>
                <itunes:episode>906</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Educator Essentials: Implementing Layered Learning Principles in IPPEs</title>
        <itunes:title>Educator Essentials: Implementing Layered Learning Principles in IPPEs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-implementing-layered-learning-principles-in-ippes/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-implementing-layered-learning-principles-in-ippes/#comments</comments>        <pubDate>Tue, 23 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff635599-9f7a-3ff7-8566-772e3f853f1e</guid>
                                    <description><![CDATA[<p>IPPE learners present unique challenges in designing and implementing experiences that allow them to explore health-systems practice, while growing towards independent practice. This podcast explores implementation of a layered learning system that involved pharmacy residents and third-year student pharmacists learning from one another and advancing practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>IPPE learners present unique challenges in designing and implementing experiences that allow them to explore health-systems practice, while growing towards independent practice. This podcast explores implementation of a layered learning system that involved pharmacy residents and third-year student pharmacists learning from one another and advancing practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8i3qbz/Implementing_Layered_Learning_Princples_in_IPPEsb08s0.m4a" length="29047011" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[IPPE learners present unique challenges in designing and implementing experiences that allow them to explore health-systems practice, while growing towards independent practice. This podcast explores implementation of a layered learning system that involved pharmacy residents and third-year student pharmacists learning from one another and advancing practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1285</itunes:duration>
                <itunes:episode>907</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Well-Being &amp; Residency: Cincinnati Children’s Hospital Medical Center’s Story of Success</title>
        <itunes:title>Educator Essentials: Well-Being &amp; Residency: Cincinnati Children’s Hospital Medical Center’s Story of Success</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-well-being-residency-cincinnati-children-s-hospital-medical-center-s-story-of-success/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-well-being-residency-cincinnati-children-s-hospital-medical-center-s-story-of-success/#comments</comments>        <pubDate>Mon, 22 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2c64671f-b5e8-3896-a491-9aa8b035ee89</guid>
                                    <description><![CDATA[<p>Stephen Deptola, PharmD, and Bri Hemmann, PharmD BCPPS, join us today to share their experience of creating, implementing, and continuing to challenge or adjust their resident wellness curriculum at his Cincinnati Children’s Hospital Medical Center. Resident well-being is a major aspect of ASHP’s new standards and successful, tactful integration of these programs is critical to preventing burnout and creating well-rounded, successful practitioners.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Stephen Deptola, PharmD, and Bri Hemmann, PharmD BCPPS, join us today to share their experience of creating, implementing, and continuing to challenge or adjust their resident wellness curriculum at his Cincinnati Children’s Hospital Medical Center. Resident well-being is a major aspect of ASHP’s new standards and successful, tactful integration of these programs is critical to preventing burnout and creating well-rounded, successful practitioners.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/g3q64c/Well-Being_Residency_Cincinnati_Childrens_Hospital_Medical_Centers_Story_of_Success_mixdown8x6it.mp3" length="39494164" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Stephen Deptola, PharmD, and Bri Hemmann, PharmD BCPPS, join us today to share their experience of creating, implementing, and continuing to challenge or adjust their resident wellness curriculum at his Cincinnati Children’s Hospital Medical Center. Resident well-being is a major aspect of ASHP’s new standards and successful, tactful integration of these programs is critical to preventing burnout and creating well-rounded, successful practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1643</itunes:duration>
                <itunes:episode>904</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation: MCM 2022: ASHP and University of Minnesota Pharmacogenomics Accelerator: Update from Inaugural Cohort</title>
        <itunes:title>Innovation: MCM 2022: ASHP and University of Minnesota Pharmacogenomics Accelerator: Update from Inaugural Cohort</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-mcm-2022-ashp-and-university-of-minnesota-pharmacogenomics-accelerator-update-from-inaugural-cohort/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-mcm-2022-ashp-and-university-of-minnesota-pharmacogenomics-accelerator-update-from-inaugural-cohort/#comments</comments>        <pubDate>Sun, 21 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b409c9e5-5a48-3072-9f4f-b73bbdf0ce97</guid>
                                    <description><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our presenters describe the science behind implementation science and the Pharmacogenomics Accelerator Program, successful implementation strategies identified through the Pharmacogenomics Accelerator Program and will summarize the benefits of collaborative community including coaches and subject matter experts for implementing pharmacogenomics at your site.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the 2022 Midyear Clinical Meeting, our presenters describe the science behind implementation science and the Pharmacogenomics Accelerator Program, successful implementation strategies identified through the Pharmacogenomics Accelerator Program and will summarize the benefits of collaborative community including coaches and subject matter experts for implementing pharmacogenomics at your site.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pvd843/MCM_2022-_ASHP_and_University_of_Minnesota_Pharmacogenomics_Acceleratora6vf3.m4a" length="29661406" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode from the 2022 Midyear Clinical Meeting, our presenters describe the science behind implementation science and the Pharmacogenomics Accelerator Program, successful implementation strategies identified through the Pharmacogenomics Accelerator Program and will summarize the benefits of collaborative community including coaches and subject matter experts for implementing pharmacogenomics at your site.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                <itunes:episode>900</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: What’s the Scoop on Poop in C. difficile Infections?</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: What’s the Scoop on Poop in C. difficile Infections?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-s-the-scoop-on-poop-in-c-difficile-infections/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-what-s-the-scoop-on-poop-in-c-difficile-infections/#comments</comments>        <pubDate>Fri, 19 May 2023 10:07:25 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1c27ce6b-9f86-388e-8269-2c08a41d1667</guid>
                                    <description><![CDATA[<p>Join our experts as they review the current epidemiology of Clostridioides difficile infection (CDI), discuss the risks and complications associated with recurrent CDI, and compare and contrast live biotherapeutic products (LBPs) and traditional fecal microbiota transplantation (FMT).</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join our experts as they review the current epidemiology of <em>Clostridioides difficile </em>infection (CDI), discuss the risks and complications associated with recurrent CDI, and compare and contrast live biotherapeutic products (LBPs) and traditional fecal microbiota transplantation (FMT).</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2hrzng/Microbiome-C_Diff_Podcast_1am82w.m4a" length="42737775" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Join our experts as they review the current epidemiology of Clostridioides difficile infection (CDI), discuss the risks and complications associated with recurrent CDI, and compare and contrast live biotherapeutic products (LBPs) and traditional fecal microbiota transplantation (FMT).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                <itunes:episode>903</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): MCM 2022: Hematology/Oncology Gems</title>
        <itunes:title>Therapeutics Thursday (SCSS): MCM 2022: Hematology/Oncology Gems</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-mcm-2022-hematologyoncology-gems/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-mcm-2022-hematologyoncology-gems/#comments</comments>        <pubDate>Thu, 18 May 2023 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cc13b8e6-06ea-3484-b8f2-916a8ebc8e5c</guid>
                                    <description><![CDATA[<p>In this fast-paced feature from the 2022 Midyear Clinical Meeting, content matter experts discuss medication management strategies in difficult or controversial patient populations and  clinical scenarios that might not be widely used or published within hematology/oncology pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this fast-paced feature from the 2022 Midyear Clinical Meeting, content matter experts discuss medication management strategies in difficult or controversial patient populations and  clinical scenarios that might not be widely used or published within hematology/oncology pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/czknw6/MCM_2022_Clinical_Hematology_Oncology_Clinical_Gems_mixdowna1piu.mp3" length="54098396" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this fast-paced feature from the 2022 Midyear Clinical Meeting, content matter experts discuss medication management strategies in difficult or controversial patient populations and  clinical scenarios that might not be widely used or published within hematology/oncology pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2251</itunes:duration>
                <itunes:episode>902</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership (NPF): A Conversation with Distinguished Service Awardee for the New Practitioners Forum – Kellie Musch</title>
        <itunes:title>Pharmacy Leadership (NPF): A Conversation with Distinguished Service Awardee for the New Practitioners Forum – Kellie Musch</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-distinguished-service-awardee-for-the-new-practitioners-forum-%e2%80%93-kellie-musch/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-npf-a-conversation-with-distinguished-service-awardee-for-the-new-practitioners-forum-%e2%80%93-kellie-musch/#comments</comments>        <pubDate>Thu, 18 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/303a9e8d-428c-37dd-9d9c-b0ca4a96d712</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Charnae Ross sits down with the New Practitioners Forum 2022 Distinguished Service Awardee, Kellie Musch, to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Charnae Ross sits down with the New Practitioners Forum 2022 Distinguished Service Awardee, Kellie Musch, to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/44gd2t/A_Conversation_with_Distinguished_Service_Awardee_for_the_New_Practitioners_Forum_Kellie_Muschbhkew.m4a" length="21686342" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Charnae Ross sits down with the New Practitioners Forum 2022 Distinguished Service Awardee, Kellie Musch, to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>982</itunes:duration>
                <itunes:episode>899</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Employment Opportunities for Pharmacy Students in Health System Specialty Pharmacy</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Employment Opportunities for Pharmacy Students in Health System Specialty Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-employment-opportunities-for-pharmacy-students-in-health-system-specialty-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-employment-opportunities-for-pharmacy-students-in-health-system-specialty-pharmacy/#comments</comments>        <pubDate>Wed, 17 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/96cd18e4-c919-3419-95c7-f11369fff388</guid>
                                    <description><![CDATA[<p>In this episode, we will explore employment opportunities for pharmacy students within health system specialty pharmacies. This podcast will also provide the framework of how to design and establish such opportunities within a health system specialty pharmacy. Lastly, this podcast will review enrichment opportunities for pharmacy students employed within a health system specialty pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we will explore employment opportunities for pharmacy students within health system specialty pharmacies. This podcast will also provide the framework of how to design and establish such opportunities within a health system specialty pharmacy. Lastly, this podcast will review enrichment opportunities for pharmacy students employed within a health system specialty pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/khqb5u/ASHP_Podcast_Employment_Opportunities_for_Pharmacy_Students_in_Health_System_Specialty_Pharmacy_MIX8o1l0.mp3" length="75361268" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we will explore employment opportunities for pharmacy students within health system specialty pharmacies. This podcast will also provide the framework of how to design and establish such opportunities within a health system specialty pharmacy. Lastly, this podcast will review enrichment opportunities for pharmacy students employed within a health system specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1884</itunes:duration>
                <itunes:episode>894</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Incorporating Research into Cardiology Practice</title>
        <itunes:title>Research in Pharmacy Practice: Incorporating Research into Cardiology Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-incorporating-research-into-cardiology-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-incorporating-research-into-cardiology-practice/#comments</comments>        <pubDate>Tue, 16 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff75bc31-94e0-3f4a-91a7-88a7af986c58</guid>
                                    <description><![CDATA[<p>Pharmacists are medication experts and have an important role in conducting research studies. In this podcast, Dr. Sarah Spinler, a past ASHP Foundation Literature Award for Sustained Contributions recipient, and Dr. Laney Jones discuss making research relevant to practice and building a research career through mentorship and interprofessional collaboration.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists are medication experts and have an important role in conducting research studies. In this podcast, Dr. Sarah Spinler, a past ASHP Foundation Literature Award for Sustained Contributions recipient, and Dr. Laney Jones discuss making research relevant to practice and building a research career through mentorship and interprofessional collaboration.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/txnaa2/ASHP_Podcast_Incorporating_Research_into_Cardiology_Practice_MIX.mp3" length="84986948" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists are medication experts and have an important role in conducting research studies. In this podcast, Dr. Sarah Spinler, a past ASHP Foundation Literature Award for Sustained Contributions recipient, and Dr. Laney Jones discuss making research relevant to practice and building a research career through mentorship and interprofessional collaboration.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2124</itunes:duration>
                <itunes:episode>897</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Burnout and Stress in Community Pharmacy</title>
        <itunes:title>Community Pharmacy: Burnout and Stress in Community Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-burnout-and-stress-in-community-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-burnout-and-stress-in-community-pharmacy/#comments</comments>        <pubDate>Mon, 15 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/29616ec5-526d-3c8e-8f6c-0c33bc5d684a</guid>
                                    <description><![CDATA[<p>Join this panel of pharmacists for a review of the difference between burnout and stress, examples in the community pharmacy setting, and ways to cope with stress and burnout on the individual and organizational level. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join this panel of pharmacists for a review of the difference between burnout and stress, examples in the community pharmacy setting, and ways to cope with stress and burnout on the individual and organizational level. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wr748p/Burnout_and_Stress_in_Community_Pharmacy6j9dk.m4a" length="22987048" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Join this panel of pharmacists for a review of the difference between burnout and stress, examples in the community pharmacy setting, and ways to cope with stress and burnout on the individual and organizational level. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1019</itunes:duration>
                <itunes:episode>901</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: COVID updates and the end of the PHE: What it Means for You</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: COVID updates and the end of the PHE: What it Means for You</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-covid-updates-and-the-end-of-the-phe-what-it-means-for-you/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-covid-updates-and-the-end-of-the-phe-what-it-means-for-you/#comments</comments>        <pubDate>Sun, 14 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0ff72387-32b1-3738-8079-cb089b913272</guid>
                                    <description><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/k9e3e7/ASHPOfficial_ADV_COVID_19_Prevention_and_Treatment_Strategies_for_the_Immunocompromised_podcast_REVISED_MIX.mp3" length="68701592" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1717</itunes:duration>
                <itunes:episode>895</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Career Pearls for Students: Infectious Disease</title>
        <itunes:title>Career Pearls for Students: Infectious Disease</itunes:title>
        <link>https://ashpofficial.podbean.com/e/career-pearls-for-students-infectious-disease/</link>
                    <comments>https://ashpofficial.podbean.com/e/career-pearls-for-students-infectious-disease/#comments</comments>        <pubDate>Sat, 13 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a7fde016-b286-3aad-98de-17f47bd675d4</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3wxbrq/Career_Pearls_for_Students_Infectious_Diseases_mixdown6s6ao.mp3" length="31371897" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1305</itunes:duration>
                <itunes:episode>896</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: ASHP Best Practice Award 2022: Success of an Expedited Pharmacy Technician Training</title>
        <itunes:title>Research in Pharmacy Practice: ASHP Best Practice Award 2022: Success of an Expedited Pharmacy Technician Training</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2022-success-of-an-expedited-pharmacy-technician-training/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-ashp-best-practice-award-2022-success-of-an-expedited-pharmacy-technician-training/#comments</comments>        <pubDate>Fri, 12 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7e042a71-a03e-375c-9c03-02ae6c4d20fa</guid>
                                    <description><![CDATA[<p>In this episode, the team from the Duke University Hospital discuss their award-winning submission to the ASHP Best Practices. They will share how establishing a pharmacy technician training program provides a mechanism to ensure continuity and uniformity as health care continues to evolve. By providing a source of well-trained pharmacy technicians, the program allows the profession to continue to achieve its overarching aims. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, the team from the Duke University Hospital discuss their award-winning submission to the ASHP Best Practices. They will share how establishing a pharmacy technician training program provides a mechanism to ensure continuity and uniformity as health care continues to evolve. By providing a source of well-trained pharmacy technicians, the program allows the profession to continue to achieve its overarching aims. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wv8nd6/ASHP_Best_Practice_Award_2022-_Success_of_an_Expedited_Pharmacy_Technician_Training7bz1b.m4a" length="22692005" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, the team from the Duke University Hospital discuss their award-winning submission to the ASHP Best Practices. They will share how establishing a pharmacy technician training program provides a mechanism to ensure continuity and uniformity as health care continues to evolve. By providing a source of well-trained pharmacy technicians, the program allows the profession to continue to achieve its overarching aims. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>994</itunes:duration>
                <itunes:episode>898</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Drug Interactions with Oral Anticancer Medications</title>
        <itunes:title>Drug Interactions with Oral Anticancer Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/drug-interactions-with-oral-anticancer-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/drug-interactions-with-oral-anticancer-medications/#comments</comments>        <pubDate>Wed, 10 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6033063b-0d34-37e3-87cb-d643c65d8168</guid>
                                    <description><![CDATA[<p>Oral anticancer medications are increasingly being incorporated into cancer treatment regimens and pharmacists may be encountering patients on these medications in their practices more frequently. This podcast episode will explore common questions that pharmacists may be asked about oral anticancer medications including potential interactions with other medications patients may be taking.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Oral anticancer medications are increasingly being incorporated into cancer treatment regimens and pharmacists may be encountering patients on these medications in their practices more frequently. This podcast episode will explore common questions that pharmacists may be asked about oral anticancer medications including potential interactions with other medications patients may be taking.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sbcrh2/Drug_Interactions_with_Oral_Anticancer_Medications__mixdown8ty8c.mp3" length="27765404" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Oral anticancer medications are increasingly being incorporated into cancer treatment regimens and pharmacists may be encountering patients on these medications in their practices more frequently. This podcast episode will explore common questions that pharmacists may be asked about oral anticancer medications including potential interactions with other medications patients may be taking.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1154</itunes:duration>
                <itunes:episode>892</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AAPI Month: Leading for Practice: Career Directions and Influencing Change: “The Journey takes you!”</title>
        <itunes:title>AAPI Month: Leading for Practice: Career Directions and Influencing Change: “The Journey takes you!”</itunes:title>
        <link>https://ashpofficial.podbean.com/e/aapi-month-leading-for-practice-career-directions-and-influencing-change-the-journey-takes-you/</link>
                    <comments>https://ashpofficial.podbean.com/e/aapi-month-leading-for-practice-career-directions-and-influencing-change-the-journey-takes-you/#comments</comments>        <pubDate>Tue, 09 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e1a407fa-295a-3da3-a33b-0d9e841b3bd0</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Hannah Kim Vanderpool, Deepak Sisodiya, and Arpit Mehta will share their insights on their professional journeys as pharmacists and association leaders. This discussion will include essential skills to becoming an effective leader, career transitions, and the power of networking through organizations.  In this special edition, we would also like to highlight their personal views and heritage as an Asian American/Pacific Islander leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Hannah Kim Vanderpool, Deepak Sisodiya, and Arpit Mehta will share their insights on their professional journeys as pharmacists and association leaders. This discussion will include essential skills to becoming an effective leader, career transitions, and the power of networking through organizations.  In this special edition, we would also like to highlight their personal views and heritage as an Asian American/Pacific Islander leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hkdc3x/ASHP_Podcast_Leading_for_Practice_Career_Directions_and_Influencing_Change_MIX.mp3" length="90226784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Hannah Kim Vanderpool, Deepak Sisodiya, and Arpit Mehta will share their insights on their professional journeys as pharmacists and association leaders. This discussion will include essential skills to becoming an effective leader, career transitions, and the power of networking through organizations.  In this special edition, we would also like to highlight their personal views and heritage as an Asian American/Pacific Islander leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2255</itunes:duration>
                <itunes:episode>893</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Conversation with Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners</title>
        <itunes:title>A Conversation with Distinguished Service Awardee for the Section of Specialty Pharmacy Practitioners</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-conversation-with-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-conversation-with-distinguished-service-awardee-for-the-section-of-specialty-pharmacy-practitioners/#comments</comments>        <pubDate>Mon, 08 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cd2ffd38-eff2-37c5-8dea-eec04eb41b35</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, Scott Canfield sits down with the Section of Specialty Pharmacy Practitioners’ Awardee, Autumn Zuckerman, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, Scott Canfield sits down with the Section of Specialty Pharmacy Practitioners’ Awardee, Autumn Zuckerman, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/twfkjx/Distinguished_Service_Awardee_SSPP_mixdown86det.mp3" length="23121261" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, Scott Canfield sits down with the Section of Specialty Pharmacy Practitioners’ Awardee, Autumn Zuckerman, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>961</itunes:duration>
                <itunes:episode>891</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Clinical Decision Support…It’s Not Just IT!</title>
        <itunes:title>Informatics Bytes: Clinical Decision Support…It’s Not Just IT!</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-clinical-decision-support%e2%80%a6it-s-not-just-it/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-clinical-decision-support%e2%80%a6it-s-not-just-it/#comments</comments>        <pubDate>Fri, 05 May 2023 13:25:14 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/62143909-c518-32aa-b6f0-a129df1fd9ef</guid>
                                    <description><![CDATA[<p>The purpose of this podcast is to highlight the skills that all pharmacists have to assist in the creation and maintenance of CDS. Listeners will learn about how to be involved in CDS, and why it is important for pharmacists to be involved in CDS.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The purpose of this podcast is to highlight the skills that all pharmacists have to assist in the creation and maintenance of CDS. Listeners will learn about how to be involved in CDS, and why it is important for pharmacists to be involved in CDS.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3zpbq9/2_Clinical_Decision_Support_It_s_Not_Just_IT__mixdowna9tpx.mp3" length="22308682" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The purpose of this podcast is to highlight the skills that all pharmacists have to assist in the creation and maintenance of CDS. Listeners will learn about how to be involved in CDS, and why it is important for pharmacists to be involved in CDS.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>927</itunes:duration>
                <itunes:episode>890</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Pharmacy Technician Forum</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-pharmacy-technician-forum/#comments</comments>        <pubDate>Thu, 04 May 2023 16:18:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/960fee5d-d3df-3766-8ef5-ddc6419ee159</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Cindy Jeter, Chair of the ASHP Pharmacy Technician Forum Executive Committee sits down with the Pharmacy Technician Forum’s Awardee Mary Mercer to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Cindy Jeter, Chair of the ASHP Pharmacy Technician Forum Executive Committee sits down with the Pharmacy Technician Forum’s Awardee Mary Mercer to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ugubn2/A_conversation_with_Distinguished_Service_Awardee_for_the_Pharmacy_Technician_Forum_mixdownbg2mw.mp3" length="17353660" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Cindy Jeter, Chair of the ASHP Pharmacy Technician Forum Executive Committee sits down with the Pharmacy Technician Forum’s Awardee Mary Mercer to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>720</itunes:duration>
                <itunes:episode>889</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: MCM 2022: Mobilizing Health-System Ambulatory Care Pharmacists in the Treatment of COVID-19</title>
        <itunes:title>COVID-19: MCM 2022: Mobilizing Health-System Ambulatory Care Pharmacists in the Treatment of COVID-19</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-mcm-2022-mobilizing-health-system-ambulatory-care-pharmacists-in-the-treatment-of-covid-19/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-mcm-2022-mobilizing-health-system-ambulatory-care-pharmacists-in-the-treatment-of-covid-19/#comments</comments>        <pubDate>Wed, 03 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/946e520e-3d34-3f06-baea-03baa7159292</guid>
                                    <description><![CDATA[<p>In this Management Case Study feature, ambulatory care pharmacists share their processes that promoted the optimal allocation of COVID-19 therapies that were in limited supply and discussed the pharmacist skill sets that benefit managing workflow triage of COVID-19 therapies.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Management Case Study feature, ambulatory care pharmacists share their processes that promoted the optimal allocation of COVID-19 therapies that were in limited supply and discussed the pharmacist skill sets that benefit managing workflow triage of COVID-19 therapies.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a923j2/MCM_2022-_Mobilizing_Health-System_Ambulatory_Care_Pharmacists_in_the_Treatment_of_COVID-19b49xm.m4a" length="19960609" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this Management Case Study feature, ambulatory care pharmacists share their processes that promoted the optimal allocation of COVID-19 therapies that were in limited supply and discussed the pharmacist skill sets that benefit managing workflow triage of COVID-19 therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>873</itunes:duration>
                <itunes:episode>887</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Get Ready: Tips and Tricks for the ASHP Summer Meetings &amp; Exhibition</title>
        <itunes:title>Student Perspectives: Get Ready: Tips and Tricks for the ASHP Summer Meetings &amp; Exhibition</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-get-ready-tips-and-tricks-for-the-ashp-summer-meetings-exhibition/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-get-ready-tips-and-tricks-for-the-ashp-summer-meetings-exhibition/#comments</comments>        <pubDate>Mon, 01 May 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3ef39738-97e9-3b24-b0f5-8dec932f84a3</guid>
                                    <description><![CDATA[<p>Join current and past members of the ASHP Pharmacy Student Forum as they share advice for the 2023 ASHP Summer Meetings & Exhibition in Baltimore, Maryland. We will discuss everything from what to wear, what to pack, navigating the student educational track, networking tips, and more.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join current and past members of the ASHP Pharmacy Student Forum as they share advice for the 2023 ASHP Summer Meetings & Exhibition in Baltimore, Maryland. We will discuss everything from what to wear, what to pack, navigating the student educational track, networking tips, and more.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nkwbyv/NEW_Get_Ready_Tips_and_Tricks_for_the_ASHP_Summer_Meetings_Exhibition__mixdown6fdzd.mp3" length="32203462" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join current and past members of the ASHP Pharmacy Student Forum as they share advice for the 2023 ASHP Summer Meetings & Exhibition in Baltimore, Maryland. We will discuss everything from what to wear, what to pack, navigating the student educational track, networking tips, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1341</itunes:duration>
                <itunes:episode>884</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Ketamine Use in Pediatrics (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Ketamine Use in Pediatrics (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ketamine-use-in-pediatrics-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ketamine-use-in-pediatrics-ce/#comments</comments>        <pubDate>Sat, 29 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6f442f1f-9388-3312-9487-d299f89904d3</guid>
                                    <description><![CDATA[<p>This podcast will aim to review various indications of ketamine use within the pediatric population. Relevant dosing, adverse effects, and contraindications will be discussed. Listeners will become familiar with appropriate monitoring parameters to safely use ketamine for pediatrics.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will aim to review various indications of ketamine use within the pediatric population. Relevant dosing, adverse effects, and contraindications will be discussed. Listeners will become familiar with appropriate monitoring parameters to safely use ketamine for pediatrics.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4v8ihv/CE_Ketamine_Pediatrics6p9fv.m4a" length="33203459" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will aim to review various indications of ketamine use within the pediatric population. Relevant dosing, adverse effects, and contraindications will be discussed. Listeners will become familiar with appropriate monitoring parameters to safely use ketamine for pediatrics.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1463</itunes:duration>
                <itunes:episode>886</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Updates in the Management of Atopic Dermatitis</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Updates in the Management of Atopic Dermatitis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-updates-in-the-management-of-atopic-dermatitis/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-updates-in-the-management-of-atopic-dermatitis/#comments</comments>        <pubDate>Fri, 28 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/39e39511-9092-39a8-bf4a-e693879ce027</guid>
                                    <description><![CDATA[<p>In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of atopic dermatitis.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of atopic dermatitis.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jj8ghz/ASHPOfficial_2_ADV_Updates_in_the_Management_of_Atopic_Dermatitis_Alopecia_MIX.mp3" length="70205996" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of atopic dermatitis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1755</itunes:duration>
                <itunes:episode>885</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: MCM 2022: Monkeypox Management: Best Practices in an Evolving Scenario</title>
        <itunes:title>Hot Topics in Pharmacy: MCM 2022: Monkeypox Management: Best Practices in an Evolving Scenario</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-monkeypox-management-best-practices-in-an-evolving-scenario/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-2022-monkeypox-management-best-practices-in-an-evolving-scenario/#comments</comments>        <pubDate>Thu, 27 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ea39075f-0c91-3595-b48c-a69f6391ae83</guid>
                                    <description><![CDATA[<p>In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4v3nir/MCM_2022-_Monkeypox_Managment-_Best_Practices_in_an_Evolving_Scenario74crn.m4a" length="26627384" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1163</itunes:duration>
                <itunes:episode>882</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Foundation Podcast (Research in Pharmacy Practice): Perspectives on the Potential Impact of RFID Technology on Medication Safety</title>
        <itunes:title>Foundation Podcast (Research in Pharmacy Practice): Perspectives on the Potential Impact of RFID Technology on Medication Safety</itunes:title>
        <link>https://ashpofficial.podbean.com/e/foundation-podcast-research-in-pharmacy-practice-perspectives-on-the-potential-impact-of-rfid-technology-on-medication-safety/</link>
                    <comments>https://ashpofficial.podbean.com/e/foundation-podcast-research-in-pharmacy-practice-perspectives-on-the-potential-impact-of-rfid-technology-on-medication-safety/#comments</comments>        <pubDate>Wed, 26 Apr 2023 15:41:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/80a50452-b585-349c-9e4e-6ed1ffa0fc2a</guid>
                                    <description><![CDATA[<p>In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wbs5x5/ASHP_ADV_Perspectives_in_the_Potential_Impact_of_RFID_Technology_on_Medication_Safety_REVISED.mp3" length="86676140" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2166</itunes:duration>
                <itunes:episode>888</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: This Interaction is a “Pain”: Cancer Pain Management Optimization During Treatment with Immune Checkpoint Inhibitors</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: This Interaction is a “Pain”: Cancer Pain Management Optimization During Treatment with Immune Checkpoint Inhibitors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-ashp-advantagethisinteraction-isa-paincancer-pain-management-optimizationduring-treatment-with-immunecheckpointinhibitors/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-ashp-advantagethisinteraction-isa-paincancer-pain-management-optimizationduring-treatment-with-immunecheckpointinhibitors/#comments</comments>        <pubDate>Fri, 21 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ad6e2f84-e6a5-3c45-a63a-f8789cd3245c</guid>
                                    <description><![CDATA[<p>This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/k7ipw4/ASHP_ADV_This_Interaction_is_a_Pain_Inhibitors_MIX.mp3" length="61635800" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1540</itunes:duration>
                <itunes:episode>881</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Career Pearls for Students: Critical Care</title>
        <itunes:title>Practice Journeys: Career Pearls for Students: Critical Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-critical-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-critical-care/#comments</comments>        <pubDate>Thu, 20 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5698417c-c39e-3fe7-ad04-34ef0accf3f6</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/57jnk7/Career_Pearls_for_Students_Critical_Care_mixdown8k99q.mp3" length="25215891" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1048</itunes:duration>
                <itunes:episode>880</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy Choice (Hot Topics): Advanced Roles of Community-Based Pharmacy Practitioners</title>
        <itunes:title>Community Pharmacy Choice (Hot Topics): Advanced Roles of Community-Based Pharmacy Practitioners</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-choice-hot-topics-advanced-roles-of-community-based-pharmacy-practitioners/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-choice-hot-topics-advanced-roles-of-community-based-pharmacy-practitioners/#comments</comments>        <pubDate>Wed, 19 Apr 2023 16:08:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/23dda6db-2a90-314e-9d43-2546333f46b0</guid>
                                    <description><![CDATA[<p style="background:#FFFFFF;">This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice.   Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="background:#FFFFFF;">This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice.   Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gwxyc5/NEW_ASHP_Advanced_Roles_of_Community-Based_Pharmacy_Practitioners__mixdownbfl7f.mp3" length="78920485" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice.   Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3287</itunes:duration>
                <itunes:episode>883</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: It’s ok to not be ok: Ketamine and esketamine for treatment resistant depression (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: It’s ok to not be ok: Ketamine and esketamine for treatment resistant depression (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-it-s-ok-to-not-be-ok-ketamine-and-esketamine-for-treatment-resistant-depression-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-it-s-ok-to-not-be-ok-ketamine-and-esketamine-for-treatment-resistant-depression-ce/#comments</comments>        <pubDate>Sat, 15 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/07491806-0ca0-3168-9fad-77bf4872f6fb</guid>
                                    <description><![CDATA[<p>Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden.  Treatment for this condition may require multiple medication trials.  Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant.  The management of treatment resistant depression (TRD) often requires novel approaches.  One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine.  This session will review the use of ketamine and esketamine for TRD.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden.  Treatment for this condition may require multiple medication trials.  Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant.  The management of treatment resistant depression (TRD) often requires novel approaches.  One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine.  This session will review the use of ketamine and esketamine for TRD.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rchufe/It_s_Ok_to_Not_Be_Ok-_Ketamine_and_Esketamine_for_Treatment_Resistant_Depression_CE_bezw5.m4a" length="23904236" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden.  Treatment for this condition may require multiple medication trials.  Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant.  The management of treatment resistant depression (TRD) often requires novel approaches.  One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine.  This session will review the use of ketamine and esketamine for TRD.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1064</itunes:duration>
                <itunes:episode>875</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Updates in the Management of Alopecia Areata</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Updates in the Management of Alopecia Areata</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-updates-in-the-management-of-alopecia-areata/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-updates-in-the-management-of-alopecia-areata/#comments</comments>        <pubDate>Fri, 14 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/75fee540-d5ab-3b66-a7f3-fb0fe8d0d3e7</guid>
                                    <description><![CDATA[<p>In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2fxudu/ASHP_ADV_Updates_in_the_Management_of_Atopic_Dermatitis_MIX.mp3" length="35267492" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>881</itunes:duration>
                <itunes:episode>879</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: MCM 22 Highlights: NIOSH List of Hazardous Drugs in Healthcare Settings</title>
        <itunes:title>Hot Topics in Pharmacy: MCM 22 Highlights: NIOSH List of Hazardous Drugs in Healthcare Settings</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-22-highlights-niosh-list-of-hazardous-drugs-in-healthcare-settings/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-mcm-22-highlights-niosh-list-of-hazardous-drugs-in-healthcare-settings/#comments</comments>        <pubDate>Thu, 13 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2ec80859-0f82-3556-b8e9-11f8c98dcc51</guid>
                                    <description><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hw52qi/MCM_2022_Highlights-_NIOSH_List_of_Hazardous_Drugs_in_Healthcare_Settings7n1rb.m4a" length="9575643" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>415</itunes:duration>
                <itunes:episode>878</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): Nanomedicines in clinical therapeutics: decades of progress but still evolving (Part 2)</title>
        <itunes:title>Therapeutics Thursday (SCSS): Nanomedicines in clinical therapeutics: decades of progress but still evolving (Part 2)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-nanomedicines-in-clinical-therapeutics-decades-of-progress-but-still-evolving-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-nanomedicines-in-clinical-therapeutics-decades-of-progress-but-still-evolving-part-2/#comments</comments>        <pubDate>Wed, 12 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3f5ec5a-e82a-3cbb-afe8-06229ca4fece</guid>
                                    <description><![CDATA[<p class="xxparagraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.</p>
<p class="xxparagraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxparagraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.</p>
<p class="xxparagraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q5pvqn/Nanotechnology_Part_2aibzi.m4a" length="32558408" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1434</itunes:duration>
                <itunes:episode>876</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Multivitamins and Multi-Shortages</title>
        <itunes:title>Therapeutic Thursdays: Multivitamins and Multi-Shortages</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-multivitamins-and-multi-shortages/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-multivitamins-and-multi-shortages/#comments</comments>        <pubDate>Tue, 11 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ab47be39-3f96-3654-b7f2-6e1bd7909b01</guid>
                                    <description><![CDATA[<p>This episode will provide an overview of the parenteral multivitamin shortage and the impact this shortage has on neonatal and pediatric nutrition. Additionally, the use of alternative vitamin products and their availability will be discussed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will provide an overview of the parenteral multivitamin shortage and the impact this shortage has on neonatal and pediatric nutrition. Additionally, the use of alternative vitamin products and their availability will be discussed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pyewrw/Therapeutics_Thursdays__MVI_Shortages_mixdown9nq9a.mp3" length="13855620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will provide an overview of the parenteral multivitamin shortage and the impact this shortage has on neonatal and pediatric nutrition. Additionally, the use of alternative vitamin products and their availability will be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>575</itunes:duration>
                <itunes:episode>877</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: When Low is the Way to Go: The Skinny on Low-dose Buprenorphine Inductions (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: When Low is the Way to Go: The Skinny on Low-dose Buprenorphine Inductions (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-when-low-is-the-way-to-go-the-skinny-on-low-dose-buprenorphine-inductions-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-when-low-is-the-way-to-go-the-skinny-on-low-dose-buprenorphine-inductions-ce/#comments</comments>        <pubDate>Sat, 08 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/98b9b53b-de2f-3bb4-b06d-819f140c1c18</guid>
                                    <description><![CDATA[<p>In the era of illicit fentanyl, the approach to buprenorphine induction has been adapted. Starting with low doses of buprenorphine can be applied to anyone taking a full agonist opioid, including cases of buprenorphine for chronic pain. We will discuss why, how, and what to consider as part of realistic implementation of low-dose buprenorphine induction therapy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the era of illicit fentanyl, the approach to buprenorphine induction has been adapted. Starting with low doses of buprenorphine can be applied to anyone taking a full agonist opioid, including cases of buprenorphine for chronic pain. We will discuss why, how, and what to consider as part of realistic implementation of low-dose buprenorphine induction therapy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5ats55/_When_Low_is_the_Way_to_Go__The_Skinny_on_Low-dose_Buprenorphine_Inductions_CE__mixdown87yqo.mp3" length="48648243" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the era of illicit fentanyl, the approach to buprenorphine induction has been adapted. Starting with low doses of buprenorphine can be applied to anyone taking a full agonist opioid, including cases of buprenorphine for chronic pain. We will discuss why, how, and what to consider as part of realistic implementation of low-dose buprenorphine induction therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2025</itunes:duration>
                <itunes:episode>874</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Beyond the Interaction Checker: A Deep Dive on Non-Traditional Drug Interactions with Immune Checkpoint Inhibitors</title>
        <itunes:title>ASHP Advantage: Beyond the Interaction Checker: A Deep Dive on Non-Traditional Drug Interactions with Immune Checkpoint Inhibitors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advantage-beyond-the-interaction-checker-a-deep-dive-on-non-traditional-drug-interactions-with-immune-checkpoint-inhibitors/</link>
                    <comments>https://ashpofficial.podbean.com/e/advantage-beyond-the-interaction-checker-a-deep-dive-on-non-traditional-drug-interactions-with-immune-checkpoint-inhibitors/#comments</comments>        <pubDate>Wed, 05 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/931863c2-40a1-3ee2-9c96-4a4b95f93615</guid>
                                    <description><![CDATA[<p>Does risk level “C” always mean “continue”? Join us as we delve into the current state of immune checkpoint inhibitor drug interaction reporting in common drug information resources and discuss how these interactions may be interpreted in daily clinical practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Does risk level “C” always mean “continue”? Join us as we delve into the current state of immune checkpoint inhibitor drug interaction reporting in common drug information resources and discuss how these interactions may be interpreted in daily clinical practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nqp3vs/ASHP_ADV_Beyond_the_Interaction_Checker_A_Deep_Dive_on_Non_Traditional_Drug_Interactions_with_Immune_Checkpoint_Inhibitors_MIX.mp3" length="63294716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Does risk level “C” always mean “continue”? Join us as we delve into the current state of immune checkpoint inhibitor drug interaction reporting in common drug information resources and discuss how these interactions may be interpreted in daily clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1582</itunes:duration>
                <itunes:episode>872</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Empowering Pharmacists to Treat Opioid Use Disorder</title>
        <itunes:title>Advocating for Impact: Empowering Pharmacists to Treat Opioid Use Disorder</itunes:title>
        <link>https://ashpofficial.podbean.com/e/empowering-pharmacists-to-treat-opioid-use-disorder/</link>
                    <comments>https://ashpofficial.podbean.com/e/empowering-pharmacists-to-treat-opioid-use-disorder/#comments</comments>        <pubDate>Tue, 04 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3276b9ec-6aac-3f14-9acf-0cf172da3121</guid>
                                    <description><![CDATA[<p>Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2pcfpv/Empowering_Pharmacists_to_Treat_Opioid_Use_Disorder_mixdown9c2hs.mp3" length="34314602" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1428</itunes:duration>
                <itunes:episode>873</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday: Intrathecal Targeted Drug Delivery (ITDD) (C.E.)</title>
        <itunes:title>Therapeutics Thursday: Intrathecal Targeted Drug Delivery (ITDD) (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-intrathecal-targeted-drug-delivery-itdd-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-intrathecal-targeted-drug-delivery-itdd-ce/#comments</comments>        <pubDate>Sat, 01 Apr 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3d9a18f4-0513-3999-ac4e-acd763510166</guid>
                                    <description><![CDATA[<p>Despite being developed in the late 1980s, Intrathecal pumps have been underutilized clinically for pain management for multiple reasons. With the opioid crisis and the significant increase in the proportion of the population with refractory pain, intrathecal pumps are gaining popularity.  Intrathecal pumps may be an appropriate option for improved pain control while minimizing side effects from systemic opioids.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Despite being developed in the late 1980s, Intrathecal pumps have been underutilized clinically for pain management for multiple reasons. With the opioid crisis and the significant increase in the proportion of the population with refractory pain, intrathecal pumps are gaining popularity.  Intrathecal pumps may be an appropriate option for improved pain control while minimizing side effects from systemic opioids.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cya2vx/ASHPOfficial_C_E_Intrathecal_Pain_Management_MIX.mp3" length="31363115" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Despite being developed in the late 1980s, Intrathecal pumps have been underutilized clinically for pain management for multiple reasons. With the opioid crisis and the significant increase in the proportion of the population with refractory pain, intrathecal pumps are gaining popularity.  Intrathecal pumps may be an appropriate option for improved pain control while minimizing side effects from systemic opioids.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1960</itunes:duration>
                <itunes:episode>867</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Pharmacy Technician Development: Advancing the Career Trajectory</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Pharmacy Technician Development: Advancing the Career Trajectory</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-pharmacy-technician-development-advancing-the-career-trajectory/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-pharmacy-technician-development-advancing-the-career-trajectory/#comments</comments>        <pubDate>Fri, 31 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/54608eb6-fd24-3738-957c-26bce4641513</guid>
                                    <description><![CDATA[<p>Learn from pharmacy technicians who lead technician education and training in their institutions as they discuss advancing pharmacy technician career development.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from pharmacy technicians who lead technician education and training in their institutions as they discuss advancing pharmacy technician career development.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v3zafm/ADV_-_Pharmacy_Technician_Development-_Advancing_the_Career_Trajectory_mixdown974e8.mp3" length="52347813" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from pharmacy technicians who lead technician education and training in their institutions as they discuss advancing pharmacy technician career development.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2179</itunes:duration>
                <itunes:episode>871</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday: Excipients, Preservatives, and Dyes in Children’s Medications</title>
        <itunes:title>Therapeutics Thursday: Excipients, Preservatives, and Dyes in Children’s Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-excipients-preservatives-and-dyes-in-children-s-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-excipients-preservatives-and-dyes-in-children-s-medications/#comments</comments>        <pubDate>Thu, 30 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c163de2a-c341-3355-9d7b-c72d6daf4c19</guid>
                                    <description><![CDATA[<p>This episode will provide an overview of excipients and dyes used in medications that often consumed by children. Topics will include an overview of specific excipients and dyes, allergies vs intolerance to substances, and an explanation of regulatory oversight.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode will provide an overview of excipients and dyes used in medications that often consumed by children. Topics will include an overview of specific excipients and dyes, allergies vs intolerance to substances, and an explanation of regulatory oversight.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jwt27n/Excipients_and_Dyes_mixdownbpzao.mp3" length="29623014" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode will provide an overview of excipients and dyes used in medications that often consumed by children. Topics will include an overview of specific excipients and dyes, allergies vs intolerance to substances, and an explanation of regulatory oversight.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1232</itunes:duration>
                <itunes:episode>870</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Can’t Touch This! Minimizing Hazardous Drug Exposures Across the Institution</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Can’t Touch This! Minimizing Hazardous Drug Exposures Across the Institution</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-can-t-touch-this-minimizing-hazardous-drug-exposures-across-the-institution/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-can-t-touch-this-minimizing-hazardous-drug-exposures-across-the-institution/#comments</comments>        <pubDate>Mon, 27 Mar 2023 13:19:37 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/779c6b90-4b25-3eef-8629-b699a6a32cd3</guid>
                                    <description><![CDATA[<p>This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vhppvt/ASHP_ADV_ADV_Can_t_Touch_This_Minimizing_Hazardous_Drug_Exposures_Across_the_Institution_MIX.mp3" length="50871116" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1271</itunes:duration>
                <itunes:episode>869</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Ketamine Use in Special (K) Populations - The Kritically Ill (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Ketamine Use in Special (K) Populations - The Kritically Ill (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ketamine-use-in-special-k-populations-the-kritically-ill-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ketamine-use-in-special-k-populations-the-kritically-ill-ce/#comments</comments>        <pubDate>Sat, 25 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8ac3e24b-da4a-3bba-b255-4843975ca7a1</guid>
                                    <description><![CDATA[<p>Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting.  This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting.  This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7fjt2s/CE_Ketamine_2_Critical_Care__mixdownb4chn.mp3" length="41880665" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting.  This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1743</itunes:duration>
                <itunes:episode>868</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Specialty Pharmacy: Navigating Specialty Pharmacy Accreditation Changes</title>
        <itunes:title>Hot Topics in Specialty Pharmacy: Navigating Specialty Pharmacy Accreditation Changes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-navigating-specialty-pharmacy-accreditation-changes/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-specialty-pharmacy-navigating-specialty-pharmacy-accreditation-changes/#comments</comments>        <pubDate>Thu, 23 Mar 2023 12:35:59 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/539a8c27-1a71-3ae5-9436-9f296a67f025</guid>
                                    <description><![CDATA[<p>In this episode, subject matter experts in health system organizations discuss the impact and changes in their organizations, due to accreditation updates in the specialty pharmacy space. This podcast is presented by members of the Accreditation and Compliance Section Advisory Group of the Section of Specialty Pharmacy Practitioners.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, subject matter experts in health system organizations discuss the impact and changes in their organizations, due to accreditation updates in the specialty pharmacy space. This podcast is presented by members of the Accreditation and Compliance Section Advisory Group of the Section of Specialty Pharmacy Practitioners.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/enusfi/Navigating_Specialty_Pharmacy_Accreditation_Changes60hoj.m4a" length="48635406" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, subject matter experts in health system organizations discuss the impact and changes in their organizations, due to accreditation updates in the specialty pharmacy space. This podcast is presented by members of the Accreditation and Compliance Section Advisory Group of the Section of Specialty Pharmacy Practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1964</itunes:duration>
                <itunes:episode>866</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Career Pearls for Students: Pediatric Pharmacy</title>
        <itunes:title>Practice Journeys: Career Pearls for Students: Pediatric Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-pediatric-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-pediatric-pharmacy/#comments</comments>        <pubDate>Wed, 22 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/82ce0a38-6eb6-3026-951b-3d87436b38c1</guid>
                                    <description><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/est6x9/Career_Pearls_for_Students_Pediatric_Pharmacy__mixdown8aduw.mp3" length="25689375" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1068</itunes:duration>
                <itunes:episode>865</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Compounding Conundrums: Compounding, what it IS and what it ISN’T</title>
        <itunes:title>Hot Topics: Compounding Conundrums: Compounding, what it IS and what it ISN’T</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-compounding-conundrums-compounding-what-it-is-and-what-it-isn-t/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-compounding-conundrums-compounding-what-it-is-and-what-it-isn-t/#comments</comments>        <pubDate>Sat, 18 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b5e007b0-beb2-3c43-89db-0cb039b23e0a</guid>
                                    <description><![CDATA[<p>With the release of the revised USP  guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With the release of the revised USP  guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4p6iz3/New_New_Compounding_what_it_IS_and_what_it_ISN_T__mixdown8z7yj.mp3" length="35469729" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With the release of the revised USP  guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1476</itunes:duration>
                <itunes:episode>864</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Kate Schaafsma</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Pharmacy Practice Leaders Kate Schaafsma</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-kate-schaafsma/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-pharmacy-practice-leaders-kate-schaafsma/#comments</comments>        <pubDate>Tue, 14 Mar 2023 11:41:41 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cfe37e15-8633-36a7-82a1-a4570e2ec8bb</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ Awardee, Kate Schaafsma, to discuss what membership within the Section and ASHP means to her and how it has helped him develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ Awardee, Kate Schaafsma, to discuss what membership within the Section and ASHP means to her and how it has helped him develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kctu6g/ASHPOfficial_Distinguished_Service_Awardee_SPPL_MIX.mp3" length="64370036" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ Awardee, Kate Schaafsma, to discuss what membership within the Section and ASHP means to her and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1609</itunes:duration>
                <itunes:episode>863</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting</title>
        <itunes:title>AJHP Voices: Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-implementation-of-radio-frequency-identification-technology-to-optimize-medication-inventory-management-in-the-intraoperative-setting/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-implementation-of-radio-frequency-identification-technology-to-optimize-medication-inventory-management-in-the-intraoperative-setting/#comments</comments>        <pubDate>Mon, 13 Mar 2023 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5c0a7c7a-cb14-3a02-865e-8fe963a20514</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Ashley Bowden and Dr. Carlie Wilke discuss the AJHP Commentary, “Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Ashley Bowden and Dr. Carlie Wilke discuss the AJHP Commentary, “Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ra57p8/ASHP_Podcast_AJHP_Voices_Implementation_of_radio_frequency_identification_technology_to_optimize_medication_inventory_management_in_the_intraoperative_setting_MIX.mp3" length="61447880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Ashley Bowden and Dr. Carlie Wilke discuss the AJHP Commentary, “Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1536</itunes:duration>
                <itunes:episode>855</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Therapeutic Thursdays (CE): How special is ketamine in the emergency department setting? (CE)</title>
        <itunes:title>Therapeutic Thursdays (CE): How special is ketamine in the emergency department setting? (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-how-special-is-ketamine-in-the-emergency-department-setting-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-how-special-is-ketamine-in-the-emergency-department-setting-ce/#comments</comments>        <pubDate>Sat, 11 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/70fca2b8-6f90-34d2-9c3c-05008ea3dd71</guid>
                                    <description><![CDATA[<p>Ketamine has experienced a recent resurgence in utilization, particularly in the Emergency Department setting. This agent has several indications, each with different considerations and adverse effect profile and our guests on this episode review and discuss these and example patient cases from an Emergency Medicine pharmacist perspective.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Ketamine has experienced a recent resurgence in utilization, particularly in the Emergency Department setting. This agent has several indications, each with different considerations and adverse effect profile and our guests on this episode review and discuss these and example patient cases from an Emergency Medicine pharmacist perspective.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f4275p/How_special_is_ketamine_in_the_emergency_department_setting_CE__mixdown6gunu.mp3" length="42270147" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ketamine has experienced a recent resurgence in utilization, particularly in the Emergency Department setting. This agent has several indications, each with different considerations and adverse effect profile and our guests on this episode review and discuss these and example patient cases from an Emergency Medicine pharmacist perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1760</itunes:duration>
                <itunes:episode>861</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: A Spoonful of Preparation Helps the Cyberattacks Go Down- Cyberattacks 101: A Pharmacy Perspective</title>
        <itunes:title>Informatics Bytes: A Spoonful of Preparation Helps the Cyberattacks Go Down- Cyberattacks 101: A Pharmacy Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-a-spoonful-of-preparation-helps-the-cyberattacks-go-down-cyberattacks-101-a-pharmacy-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-a-spoonful-of-preparation-helps-the-cyberattacks-go-down-cyberattacks-101-a-pharmacy-perspective/#comments</comments>        <pubDate>Fri, 10 Mar 2023 12:56:07 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/84dc54b3-3622-397a-8df3-28aa9f97b30b</guid>
                                    <description><![CDATA[<p>In this episode, speakers explore cyber-attacks in a pharmacy setting. Listeners will be given a general overview of cyber-attacks, phases of cyber emergency management, and common best practices.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, speakers explore cyber-attacks in a pharmacy setting. Listeners will be given a general overview of cyber-attacks, phases of cyber emergency management, and common best practices.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/t9thcf/A_Spoonful_of_Preparation_Helps_the_Cyberattacks_Go_Down-_Cyberattacks_101-_A_Pharmacy_Perspective6a0ig.m4a" length="14160069" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, speakers explore cyber-attacks in a pharmacy setting. Listeners will be given a general overview of cyber-attacks, phases of cyber emergency management, and common best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>630</itunes:duration>
                <itunes:episode>860</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being and Resilience: Insights from the Well-Being Ambassador Program</title>
        <itunes:title>Well-being and Resilience: Insights from the Well-Being Ambassador Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-and-resilience-insights-from-the-well-being-ambassador-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-and-resilience-insights-from-the-well-being-ambassador-program/#comments</comments>        <pubDate>Wed, 08 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0c0258c6-604d-38e8-bb47-5c9fabc55fac</guid>
                                    <description><![CDATA[<p>Join us as we hear from Dr. Brooke Griffin, Vice Chair of Clinical Services and Midwestern University and implementation coach for the Well-Being Ambassador Program. Brooke has led many initiatives in her career to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce and mentoring to inspire bold ideas from within. Dr. Griffin will share her journey to becoming a career coach and how it informs her engagement style with Well-Being Ambassadors.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as we hear from Dr. Brooke Griffin, Vice Chair of Clinical Services and Midwestern University and implementation coach for the Well-Being Ambassador Program. Brooke has led many initiatives in her career to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce and mentoring to inspire bold ideas from within. Dr. Griffin will share her journey to becoming a career coach and how it informs her engagement style with Well-Being Ambassadors.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/95muvg/Insights_from_the_Well-Being_Ambassador_Program7w49l.m4a" length="22656075" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Join us as we hear from Dr. Brooke Griffin, Vice Chair of Clinical Services and Midwestern University and implementation coach for the Well-Being Ambassador Program. Brooke has led many initiatives in her career to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce and mentoring to inspire bold ideas from within. Dr. Griffin will share her journey to becoming a career coach and how it informs her engagement style with Well-Being Ambassadors.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1011</itunes:duration>
                <itunes:episode>858</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Safety: Patient Safety Awareness Week</title>
        <itunes:title>Medication Safety: Patient Safety Awareness Week</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-patient-safety-awareness-week/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-patient-safety-awareness-week/#comments</comments>        <pubDate>Tue, 07 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b70879dd-c654-3b26-8fae-f6d807e0b1e0</guid>
                                    <description><![CDATA[<p>Developed by the Section Advisory Group on Medication Safety, members discuss Patient Safety Awareness Week and share ideas that organizations can use to bring more awareness to medication safety.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Developed by the Section Advisory Group on Medication Safety, members discuss Patient Safety Awareness Week and share ideas that organizations can use to bring more awareness to medication safety.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gd2mez/Patient_Safety_Awareness_Week7xvu1.m4a" length="13694731" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Developed by the Section Advisory Group on Medication Safety, members discuss Patient Safety Awareness Week and share ideas that organizations can use to bring more awareness to medication safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>604</itunes:duration>
                <itunes:episode>857</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Women in History Month: Leadership in Pharmacy: Women Making an Impact in Practice and Professional Associations-2023</title>
        <itunes:title>Women in History Month: Leadership in Pharmacy: Women Making an Impact in Practice and Professional Associations-2023</itunes:title>
        <link>https://ashpofficial.podbean.com/e/women-in-history-month-leadership-in-pharmacy-women-making-an-impact-in-practice-and-professional-associations-2023/</link>
                    <comments>https://ashpofficial.podbean.com/e/women-in-history-month-leadership-in-pharmacy-women-making-an-impact-in-practice-and-professional-associations-2023/#comments</comments>        <pubDate>Mon, 06 Mar 2023 15:08:11 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/40f7c2fe-8fa4-31ff-b0c6-cc02056e78ab</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with four pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Amerine, Lindsey Kelley, Alexsandra Nilges, and Noemie Kanene will share their insights on their professional journeys as pharmacists and association leaders. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with four pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Amerine, Lindsey Kelley, Alexsandra Nilges, and Noemie Kanene will share their insights on their professional journeys as pharmacists and association leaders. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/248r6d/ASHP_Podcast_Leadership_in_Pharmacy_Women_Making_an_Impact_in_Practice_and_Professional_Associations_MIX_1_7r1ga.mp3" length="77021228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with four pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Amerine, Lindsey Kelley, Alexsandra Nilges, and Noemie Kanene will share their insights on their professional journeys as pharmacists and association leaders. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1925</itunes:duration>
                <itunes:episode>859</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Opioid Stewardship (CE)</title>
        <itunes:title>Therapeutic Thursdays: Opioid Stewardship (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-opioid-stewardship-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-opioid-stewardship-ce/#comments</comments>        <pubDate>Sat, 04 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1ada65e5-7d86-33b5-bcc9-85c6aaceae5d</guid>
                                    <description><![CDATA[<p>This podcast will provide an overview of Opioid Stewardship including  rationale for program development, a description of the critical stakeholders in these programs, and the role of the pharmacist in Opioid Stewardship.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide an overview of Opioid Stewardship including  rationale for program development, a description of the critical stakeholders in these programs, and the role of the pharmacist in Opioid Stewardship.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4ktxbw/Opioid_Stewardship_CE_mixdown88syf.mp3" length="28961284" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will provide an overview of Opioid Stewardship including  rationale for program development, a description of the critical stakeholders in these programs, and the role of the pharmacist in Opioid Stewardship.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1205</itunes:duration>
                <itunes:episode>854</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Evaluation of Insulin Requirements with Initiation of Glucagon-Like Peptide-1 Agonists and Sodium-Glucose Co-transporter-2 Inhibitors: A Retrospective Cohort Trial</title>
        <itunes:title>AJHP Voices: Evaluation of Insulin Requirements with Initiation of Glucagon-Like Peptide-1 Agonists and Sodium-Glucose Co-transporter-2 Inhibitors: A Retrospective Cohort Trial</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhpvoices-evaluation-of-insulinrequirements-with-initiation-of-glucagonlikepeptide-1agonistsand-sodiumglucose-co-transporter-2inhibitors-aretrospect/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhpvoices-evaluation-of-insulinrequirements-with-initiation-of-glucagonlikepeptide-1agonistsand-sodiumglucose-co-transporter-2inhibitors-aretrospect/#comments</comments>        <pubDate>Fri, 03 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d929807c-3bd4-341b-9e06-065be57fe82a</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Nada Farhat and Dr. Jamie George discuss the AJHP Clinical Report, “Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Nada Farhat and Dr. Jamie George discuss the AJHP Clinical Report, “Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jswhug/ASHP_Podcast_AJHP_Voices_Evaluation_of_Insulin_Requirements_with_Initiation_of_Glucagon_REVISED_2.mp3" length="55537796" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Nada Farhat and Dr. Jamie George discuss the AJHP Clinical Report, “Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1388</itunes:duration>
                <itunes:episode>856</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Educator Essentials: ASHP’s Updated Pharmacy Residency Accreditation Standards at a Glance</title>
        <itunes:title>Educator Essentials: ASHP’s Updated Pharmacy Residency Accreditation Standards at a Glance</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-ashp-s-updated-pharmacy-residency-accreditation-standards-at-a-glance/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-ashp-s-updated-pharmacy-residency-accreditation-standards-at-a-glance/#comments</comments>        <pubDate>Thu, 02 Mar 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/222bc144-6ce6-3059-b1ae-ff0f2b6bda0c</guid>
                                    <description><![CDATA[<p>This podcast will explore the recent updates to the ASHP accreditation standard for post graduate residency programs. Members from the ASHP Commission on Credentialing discuss the process for updating the standards, key changes, and helpful resources for residency programs nationwide.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will explore the recent updates to the ASHP accreditation standard for post graduate residency programs. Members from the ASHP Commission on Credentialing discuss the process for updating the standards, key changes, and helpful resources for residency programs nationwide.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i7wnkh/ASHP_s_Updated_Pharmacy_Residency_Accreditation_Standards_at_a_Glance7c1n8.m4a" length="43865982" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will explore the recent updates to the ASHP accreditation standard for post graduate residency programs. Members from the ASHP Commission on Credentialing discuss the process for updating the standards, key changes, and helpful resources for residency programs nationwide.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1934</itunes:duration>
                <itunes:episode>850</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with the Distinguished Service Awardee for the Section of Inpatient Care Practitioners, Daniel Degnan</title>
        <itunes:title>Pharmacy Leadership: A Conversation with the Distinguished Service Awardee for the Section of Inpatient Care Practitioners, Daniel Degnan</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-the-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-daniel-degnan/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-the-distinguished-service-awardee-for-the-section-of-inpatient-care-practitioners-daniel-degnan/#comments</comments>        <pubDate>Mon, 27 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9d8a319e-3a21-3cba-a2f0-9f2f3ff7a514</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, SICP Chair, Sarah Stephens, sits down with the Section of Inpatient Care Practitioner’s Awardee Daniel Degnan to discuss what membership within the section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, SICP Chair, Sarah Stephens, sits down with the Section of Inpatient Care Practitioner’s Awardee Daniel Degnan to discuss what membership within the section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6sva4c/ASHP_Podcast_A_Conversation_with_the_Distinguished_Service_Awardee_for_the_Section_of_Inpatient_Care_Practitioners_Daniel_Degnan_MIX_1_acxji.mp3" length="36896132" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, SICP Chair, Sarah Stephens, sits down with the Section of Inpatient Care Practitioner’s Awardee Daniel Degnan to discuss what membership within the section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>922</itunes:duration>
                <itunes:episode>852</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Models for Pharmacy Technician Training Programs</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Models for Pharmacy Technician Training Programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-models-for-pharmacy-technician-training-programs/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-models-for-pharmacy-technician-training-programs/#comments</comments>        <pubDate>Fri, 24 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1bd64e66-302a-3733-92dd-3343dd8ce861</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on various models of technician training programs.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on various models of technician training programs.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2g8mc3/ASHP_ADV_ADV_Models_for_Pharmacy_Technician_Training_Programs_MIX.mp3" length="83528480" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on various models of technician training programs.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2088</itunes:duration>
                <itunes:episode>849</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Best Practices for Collaboration Between Colleges of Pharmacy and Health-System Institutions</title>
        <itunes:title>Educator Essentials: Best Practices for Collaboration Between Colleges of Pharmacy and Health-System Institutions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-best-practices-for-collaboration-between-colleges-of-pharmacy-and-health-system-institutions/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-best-practices-for-collaboration-between-colleges-of-pharmacy-and-health-system-institutions/#comments</comments>        <pubDate>Thu, 23 Feb 2023 11:23:33 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e648cdd4-1a55-3417-b4db-dc663990e6e1</guid>
                                    <description><![CDATA[<p>During this podcast, listeners will hear perspectives from key players required to create and maintain meaningful collaborations between colleges of pharmacy and health-system institutions. Successes and challenges, and tips for successful collaboration will be discussed.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast, listeners will hear perspectives from key players required to create and maintain meaningful collaborations between colleges of pharmacy and health-system institutions. Successes and challenges, and tips for successful collaboration will be discussed.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/b99qxr/ASHP_Podcast_Best_Practices_for_Collaboration_Between_Colleges_of_Pharmacy_and_Health_System_Institutions_REVISED_1_bb3pa.mp3" length="72963200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast, listeners will hear perspectives from key players required to create and maintain meaningful collaborations between colleges of pharmacy and health-system institutions. Successes and challenges, and tips for successful collaboration will be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1824</itunes:duration>
                <itunes:episode>853</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SICP): More than DNA: The Role of Pharmacogenomics in Pharmacy Practice</title>
        <itunes:title>Therapeutics Thursday (SICP): More than DNA: The Role of Pharmacogenomics in Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-sicp-more-than-dna-the-role-of-pharmacogenomics-in-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-sicp-more-than-dna-the-role-of-pharmacogenomics-in-pharmacy-practice/#comments</comments>        <pubDate>Thu, 23 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d9509198-ddbc-374f-9e58-eeb5fe7eb54f</guid>
                                    <description><![CDATA[<p>Pharmacogenomics can be daunting to pharmacy practitioners who may not have much experience in the area. This podcast will explain the role of a pharmacogenomics clinical specialist and how to successfully implement the service into practice. In addition, the podcast will include the learner’s perspective on the pharmacogenomics rotation experience and integration into research, as well as tools pharmacists can use that provide additional education and training in pharmacogenomics. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacogenomics can be daunting to pharmacy practitioners who may not have much experience in the area. This podcast will explain the role of a pharmacogenomics clinical specialist and how to successfully implement the service into practice. In addition, the podcast will include the learner’s perspective on the pharmacogenomics rotation experience and integration into research, as well as tools pharmacists can use that provide additional education and training in pharmacogenomics. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/u7bv79/More_than_DNA_The_Role_of_Pharmacogenomics_in_Pharmacy_Practice_mixdown_1_6a1z3.mp3" length="34249400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacogenomics can be daunting to pharmacy practitioners who may not have much experience in the area. This podcast will explain the role of a pharmacogenomics clinical specialist and how to successfully implement the service into practice. In addition, the podcast will include the learner’s perspective on the pharmacogenomics rotation experience and integration into research, as well as tools pharmacists can use that provide additional education and training in pharmacogenomics. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1426</itunes:duration>
                <itunes:episode>843</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 4</title>
        <itunes:title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 4</itunes:title>
        <link>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi-1677105914/</link>
                    <comments>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi-1677105914/#comments</comments>        <pubDate>Wed, 22 Feb 2023 17:45:14 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ed8eada7-f95c-32bb-b561-a5374d47f494</guid>
                                    <description><![CDATA[<p class="xmsonormal">ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xmsonormal">ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xvashv/ASHP_Podcast_Part_IV_Reflections_on_the_ASHP_Pharmacy_Technician_Shortage_Administrator_Survey_MIX.mp3" length="49039940" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1225</itunes:duration>
                <itunes:episode>851</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research in Pharmacy Practice: Initiating and Maintaining a Relevant Research Career Across Decades</title>
        <itunes:title>Research in Pharmacy Practice: Initiating and Maintaining a Relevant Research Career Across Decades</itunes:title>
        <link>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-initiating-and-maintaining-a-relevant-research-career-across-decades/</link>
                    <comments>https://ashpofficial.podbean.com/e/research-in-pharmacy-practice-initiating-and-maintaining-a-relevant-research-career-across-decades/#comments</comments>        <pubDate>Tue, 21 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c03ceb31-81c8-3ed8-8d33-665a035ab2d8</guid>
                                    <description><![CDATA[<p class="xxxxxmsonormal" style="background:#FFFFFF;">Pharmacists must be seen as both generators of biomedical literature and consumers of literature in order to be at the table when major decisions regarding healthcare are made. In this podcast, Craig I. Coleman, Pharm.D., FASHP, the recipient of the 2022 ASHP Foundation Literature Award for Sustained Contributions, will describe how he started his career and how he trains his research fellows to succeed in the research environment. He will describe some of his highest impact work and then describe how researchers need to pivot into new areas to maintain long term research viability. If you are just starting out or have had success but wonder what is next for your research career, this podcast is for you.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxxxmsonormal" style="background:#FFFFFF;">Pharmacists must be seen as both generators of biomedical literature and consumers of literature in order to be at the table when major decisions regarding healthcare are made. In this podcast, Craig I. Coleman, Pharm.D., FASHP, the recipient of the 2022 ASHP Foundation Literature Award for Sustained Contributions, will describe how he started his career and how he trains his research fellows to succeed in the research environment. He will describe some of his highest impact work and then describe how researchers need to pivot into new areas to maintain long term research viability. If you are just starting out or have had success but wonder what is next for your research career, this podcast is for you.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uf4tdf/ASHPOfficial_Initiating_and_Maintaining_a_Relevant_Research_Career_Across_Decades_MIX_1_9wzz8.mp3" length="34909568" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacists must be seen as both generators of biomedical literature and consumers of literature in order to be at the table when major decisions regarding healthcare are made. In this podcast, Craig I. Coleman, Pharm.D., FASHP, the recipient of the 2022 ASHP Foundation Literature Award for Sustained Contributions, will describe how he started his career and how he trains his research fellows to succeed in the research environment. He will describe some of his highest impact work and then describe how researchers need to pivot into new areas to maintain long term research viability. If you are just starting out or have had success but wonder what is next for your research career, this podcast is for you.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2181</itunes:duration>
                <itunes:episode>848</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 3</title>
        <itunes:title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 3</itunes:title>
        <link>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi-1675700571/</link>
                    <comments>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi-1675700571/#comments</comments>        <pubDate>Wed, 15 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cd927e4b-e01f-36a6-ad35-83824883135b</guid>
                                    <description><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/yqi5f2/ASHP_Podcast_Part_III_Reflections_on_the_ASHP_Pharmacy_Technician_Shortage_Administrator_Survey_MIX_1_8lxei.mp3" length="52299308" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1307</itunes:duration>
                <itunes:episode>841</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: COVID INTERACT - INTeraction Education focused on Real-time Assessment, data Collection, and timely Training</title>
        <itunes:title>Hot Topics: COVID INTERACT - INTeraction Education focused on Real-time Assessment, data Collection, and timely Training</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-covid-interact-interaction-education-focused-on-real-time-assessment-data-collection-and-timely-training/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-covid-interact-interaction-education-focused-on-real-time-assessment-data-collection-and-timely-training/#comments</comments>        <pubDate>Tue, 14 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a76dc88c-bdad-39ac-a967-b0b0e8ec4bae</guid>
                                    <description><![CDATA[<p>In this episode, Renee Robinson, Cathy Oliphant and Mary Spatafore discuss the INTERACT program, whose goals are to better prepare rural healthcare providers to provide safe and effective COVID-19 outpatient treatment, improving healthcare service utilization and health outcomes of patients diagnosed with COVID-19. This includes assessing and meeting unmet drug-drug training and support needs for pharmacists treating patients for COVID-19 in the outpatient setting. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Renee Robinson, Cathy Oliphant and Mary Spatafore discuss the INTERACT program, whose goals are to better prepare rural healthcare providers to provide safe and effective COVID-19 outpatient treatment, improving healthcare service utilization and health outcomes of patients diagnosed with COVID-19. This includes assessing and meeting unmet drug-drug training and support needs for pharmacists treating patients for COVID-19 in the outpatient setting. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/whp42i/COVID_INTERACT_-_INTeraction9p1wi.m4a" length="16098786" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, Renee Robinson, Cathy Oliphant and Mary Spatafore discuss the INTERACT program, whose goals are to better prepare rural healthcare providers to provide safe and effective COVID-19 outpatient treatment, improving healthcare service utilization and health outcomes of patients diagnosed with COVID-19. This includes assessing and meeting unmet drug-drug training and support needs for pharmacists treating patients for COVID-19 in the outpatient setting. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>704</itunes:duration>
                <itunes:episode>847</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Compounding Update – What to Know in 2023</title>
        <itunes:title>Advocating for Impact: Compounding Update – What to Know in 2023</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-compounding-update-%e2%80%93-what-to-know-in-2023/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-compounding-update-%e2%80%93-what-to-know-in-2023/#comments</comments>        <pubDate>Mon, 13 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/758b8627-7ce7-3336-a871-7731c8f6988c</guid>
                                    <description><![CDATA[<p>This podcast will provide members an overview of where FDA draft guidance for hospital and health system compounding stands. We’ll provide a refresher on the guidance, as well as a discussion on how the revised USP chapters might impact practice compliance and what comes next with FDA advocacy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will provide members an overview of where FDA draft guidance for hospital and health system compounding stands. We’ll provide a refresher on the guidance, as well as a discussion on how the revised USP chapters might impact practice compliance and what comes next with FDA advocacy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6xzbbb/Compounding_Update_What_to_Know_in_202364xxq.m4a" length="31962602" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will provide members an overview of where FDA draft guidance for hospital and health system compounding stands. We’ll provide a refresher on the guidance, as well as a discussion on how the revised USP chapters might impact practice compliance and what comes next with FDA advocacy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1412</itunes:duration>
                <itunes:episode>846</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation Friday: Impact of Telehealth Services on Outcomes and the Future of Healthcare Delivery</title>
        <itunes:title>Innovation Friday: Impact of Telehealth Services on Outcomes and the Future of Healthcare Delivery</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-friday-impact-of-telehealth-services-on-outcomes-and-the-future-of-healthcare-delivery/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-friday-impact-of-telehealth-services-on-outcomes-and-the-future-of-healthcare-delivery/#comments</comments>        <pubDate>Fri, 10 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4a0c0122-7475-37c5-b3fc-eff24db87bd5</guid>
                                    <description><![CDATA[<p>In this podcast, we will be discussing how telehealth has been utilized to deliver pharmacy services within the ambulatory care setting and its impact on outcomes. This podcast also explores ASHP’s strategic initiatives and efforts in the areas of telehealth, digital health, and data driven healthcare as pharmacists and other providers begin to think innovatively about how care is delivered now and in the future. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, we will be discussing how telehealth has been utilized to deliver pharmacy services within the ambulatory care setting and its impact on outcomes. This podcast also explores ASHP’s strategic initiatives and efforts in the areas of telehealth, digital health, and data driven healthcare as pharmacists and other providers begin to think innovatively about how care is delivered now and in the future. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ev6uxm/Impact_of_Telehealth_Services_on_Outcomes_and_the_Future_of_Healthcare_Deliveryaigmg.m4a" length="32607051" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, we will be discussing how telehealth has been utilized to deliver pharmacy services within the ambulatory care setting and its impact on outcomes. This podcast also explores ASHP’s strategic initiatives and efforts in the areas of telehealth, digital health, and data driven healthcare as pharmacists and other providers begin to think innovatively about how care is delivered now and in the future. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1436</itunes:duration>
                <itunes:episode>844</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Practice to Leadership: Transitioning in the ED</title>
        <itunes:title>Pharmacy Leadership: Practice to Leadership: Transitioning in the ED</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-practice-to-leadership-transitioning-in-the-ed/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-practice-to-leadership-transitioning-in-the-ed/#comments</comments>        <pubDate>Thu, 09 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8567af20-bc90-3c7c-bc53-39d31fbd2d6a</guid>
                                    <description><![CDATA[<p>Many practitioners find as they grow in their practice that they move into leadership roles.  These roles can come after completing a PGY2 in Emergency Medicine or during their career. This podcast will the transition two pharmacists have done as they moved from practicing as emergency medicine pharmacists into taking leadership roles over emergency medicine pharmacy practices. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Many practitioners find as they grow in their practice that they move into leadership roles.  These roles can come after completing a PGY2 in Emergency Medicine or during their career. This podcast will the transition two pharmacists have done as they moved from practicing as emergency medicine pharmacists into taking leadership roles over emergency medicine pharmacy practices. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/stqjgc/Practice_to_Leadership_Transitioning_in_the_ED_mixdownacdbe.mp3" length="24704289" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Many practitioners find as they grow in their practice that they move into leadership roles.  These roles can come after completing a PGY2 in Emergency Medicine or during their career. This podcast will the transition two pharmacists have done as they moved from practicing as emergency medicine pharmacists into taking leadership roles over emergency medicine pharmacy practices. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1028</itunes:duration>
                <itunes:episode>842</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 2</title>
        <itunes:title>Technician Topics: ASHP Pharmacy Technician Shortage Survey Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi/</link>
                    <comments>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-thepharmacytechnicianforum-andsection-of-pharmacypracticeleaders-executi/#comments</comments>        <pubDate>Tue, 07 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7d1da8e4-8f6e-3277-aca7-37ad4a669be4</guid>
                                    <description><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/77myq8/ASHP_Podcast_Part_II_Reflections_on_the_ASHP_Pharmacy_Technician_Shortage_Administrator_Survey_MIX.mp3" length="58147796" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1453</itunes:duration>
                <itunes:episode>840</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Good Grief! I Need Pain Relief! Treatment of Acute Pain (CE)</title>
        <itunes:title>Good Grief! I Need Pain Relief! Treatment of Acute Pain (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/good-grief-i-need-pain-relief-treatment-of-acute-pain-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/good-grief-i-need-pain-relief-treatment-of-acute-pain-ce/#comments</comments>        <pubDate>Sat, 04 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/105cc248-53f5-3d90-9b94-34220c5e2c53</guid>
                                    <description><![CDATA[<p>Acute pain management can be challenging, especially in patients receiving chronic opioid therapy. Multimodal therapy using a combination of pharmacologic and non-pharmacologic interventions provides a synergistic approach to treating moderate to severe pain versus use of opioid monotherapy for pain control.  This session will review multimodal interventions recommended for acute pain management and highlight approaches for acute pain control in the opioid tolerant patient. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Acute pain management can be challenging, especially in patients receiving chronic opioid therapy. Multimodal therapy using a combination of pharmacologic and non-pharmacologic interventions provides a synergistic approach to treating moderate to severe pain versus use of opioid monotherapy for pain control.  This session will review multimodal interventions recommended for acute pain management and highlight approaches for acute pain control in the opioid tolerant patient. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sdkt2y/Good_Grief_I_Need_Pain_Relief_Treatment_of_Acute_Pain_CE__mixdownbwlw8.mp3" length="37590451" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Acute pain management can be challenging, especially in patients receiving chronic opioid therapy. Multimodal therapy using a combination of pharmacologic and non-pharmacologic interventions provides a synergistic approach to treating moderate to severe pain versus use of opioid monotherapy for pain control.  This session will review multimodal interventions recommended for acute pain management and highlight approaches for acute pain control in the opioid tolerant patient. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1565</itunes:duration>
                <itunes:episode>839</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Turn the Page for New Perspectives on USP Chapter 800</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Turn the Page for New Perspectives on USP Chapter 800</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-turn-the-page-for-new-perspectives-on-usp-chapter-800/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-turn-the-page-for-new-perspectives-on-usp-chapter-800/#comments</comments>        <pubDate>Fri, 03 Feb 2023 09:12:35 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d40d8588-a03e-3e5a-973d-8ca595c42cf1</guid>
                                    <description><![CDATA[<p>This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ns9dqz/ASHP_Advantage_Equashield_Part_1_EDIT_mixdownaylis.mp3" length="39220214" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1633</itunes:duration>
                <itunes:episode>838</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursday (SCSS): New and Pipeline Meds for HIV</title>
        <itunes:title>Therapeutics Thursday (SCSS): New and Pipeline Meds for HIV</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-new-and-pipeline-meds-for-hiv/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursday-scss-new-and-pipeline-meds-for-hiv/#comments</comments>        <pubDate>Thu, 02 Feb 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b614fbe4-4f1a-33ee-8359-c7451482bc8c</guid>
                                    <description><![CDATA[<p class="xxmsonormal" style="margin-bottom:12pt;">This podcast will focus on therapies for HIV management. The primary focus will be on new and emerging pipeline therapies in addition to what pharmacists can do to promote access and adherence.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxmsonormal" style="margin-bottom:12pt;">This podcast will focus on therapies for HIV management. The primary focus will be on new and emerging pipeline therapies in addition to what pharmacists can do to promote access and adherence.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d6ysbx/Emerging_Sciences__New_and_Pipeline_Meds_for_HIV__mixdown6wfsy.mp3" length="20246520" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will focus on therapies for HIV management. The primary focus will be on new and emerging pipeline therapies in addition to what pharmacists can do to promote access and adherence.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>842</itunes:duration>
                <itunes:episode>835</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: System Integration: Establishing Governance, Accountabilities, and Policies</title>
        <itunes:title>Pharmacy Leadership: System Integration: Establishing Governance, Accountabilities, and Policies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-system-integration-establishing-governance-accountabilities-and-policies/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-system-integration-establishing-governance-accountabilities-and-policies/#comments</comments>        <pubDate>Tue, 31 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4084754a-0365-360f-a974-342272f89a44</guid>
                                    <description><![CDATA[<p>Health system mergers and acquisitions provide unique opportunities for pharmacy leadership as well as unique challenges. This podcast is going to address how different pharmacy leaders have approached governance and assigning responsibilities during these transitions. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Health system mergers and acquisitions provide unique opportunities for pharmacy leadership as well as unique challenges. This podcast is going to address how different pharmacy leaders have approached governance and assigning responsibilities during these transitions. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qtkrkr/ASHP_Official_Establishing_Governance_Accountabilities_and_Policies_Mix.mp3" length="28015856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Health system mergers and acquisitions provide unique opportunities for pharmacy leadership as well as unique challenges. This podcast is going to address how different pharmacy leaders have approached governance and assigning responsibilities during these transitions. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1750</itunes:duration>
                <itunes:episode>837</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: 2023 ASHP/ASHP Foundation Pharmacy Forecast</title>
        <itunes:title>AJHP Voices: 2023 ASHP/ASHP Foundation Pharmacy Forecast</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-2023-ashpashp-foundation-pharmacy-forecast/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-2023-ashpashp-foundation-pharmacy-forecast/#comments</comments>        <pubDate>Fri, 27 Jan 2023 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5b77ba09-0c4f-3540-94bb-cb62ed8b4856</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Francesca Cunningham, Dr. Joseph DiPiro, and Dr. Scott Nelson discuss the 2023 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Francesca Cunningham, Dr. Joseph DiPiro, and Dr. Scott Nelson discuss the 2023 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ckyj9f/ASHP_Podcast_-_2023_Pharmacy_Forecast_Report_MIX8t36j.mp3" length="90010676" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Francesca Cunningham, Dr. Joseph DiPiro, and Dr. Scott Nelson discuss the 2023 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2250</itunes:duration>
                <itunes:episode>836</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: New Year, New Subvariants- COVID Therapeutics in 2023</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: New Year, New Subvariants- COVID Therapeutics in 2023</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-new-year-new-subvariants-covid-therapeutics-in-2023/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-new-year-new-subvariants-covid-therapeutics-in-2023/#comments</comments>        <pubDate>Fri, 27 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/90bd0bd1-cb7a-3873-b7d4-7b8d12fdae90</guid>
                                    <description><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/apyecn/ADV_-_New_Year_New_Subvariants-_COVID_Therapeutics_in_2023_EDIT_mixdown7g32p.mp3" length="48388041" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2015</itunes:duration>
                <itunes:episode>834</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: ASHP Pharmacy Technician Shortage Survey: Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 1</title>
        <itunes:title>Technician Topics: ASHP Pharmacy Technician Shortage Survey: Reflections from the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders Executive Committees: Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-the-pharmacytechnician-forum-and-sectionof-pharmacy-practiceleaders-execut/</link>
                    <comments>https://ashpofficial.podbean.com/e/techniciantopics-ashp-pharmacy-technician-shortage-surveyreflections-from-the-pharmacytechnician-forum-and-sectionof-pharmacy-practiceleaders-execut/#comments</comments>        <pubDate>Tue, 24 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3f87034-d693-359f-8b57-bd3427f623ae</guid>
                                    <description><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders met during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders met during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ebwrsf/ASHP_Podcast_Part_I_Reflections_on_the_ASHP_Pharmacy_Technician_Shortage_Administrator_Survey_MIX.mp3" length="32812004" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders met during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>820</itunes:duration>
                <itunes:episode>830</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners (2022) – Mollie Ashe Scott</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Ambulatory Care Practitioners (2022) – Mollie Ashe Scott</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadershipa-conversationwithdistinguishedservice-awardeeforthe-section-ofambulatorycarepractitioners2022%e2%80%93-mollieashescott/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadershipa-conversationwithdistinguishedservice-awardeeforthe-section-ofambulatorycarepractitioners2022%e2%80%93-mollieashescott/#comments</comments>        <pubDate>Mon, 23 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4a740429-0326-3dc1-b25d-e5bd8a968d8b</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2022 Awardee, Mollie Ashe Scott, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2022 Awardee, Mollie Ashe Scott, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/93imtb/A_conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Ambulatory_Care_Practitioners_2022__mixdownaldgm.mp3" length="17499794" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2022 Awardee, Mollie Ashe Scott, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>728</itunes:duration>
                <itunes:episode>829</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Prioritizing Prickly Pain Policy</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Prioritizing Prickly Pain Policy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-prioritizing-prickly-pain-policy/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-prioritizing-prickly-pain-policy/#comments</comments>        <pubDate>Fri, 20 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e86e0e5-3513-3fa4-b7f2-3a1afd8bc923</guid>
                                    <description><![CDATA[<p>This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/km2epa/ASHPOfficial_ADV_Prioritizing_Prickly_Pain_Policy_MIX.mp3" length="79525784" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1988</itunes:duration>
                <itunes:episode>831</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Career Pearls for Students: Inpatient Cardiology</title>
        <itunes:title>Practice Journeys: Career Pearls for Students: Inpatient Cardiology</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-inpatient-cardiology/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-career-pearls-for-students-inpatient-cardiology/#comments</comments>        <pubDate>Wed, 18 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/01c64680-aa1f-35eb-889d-f60c42acb387</guid>
                                    <description><![CDATA[<p class="xfluidplugincopy" style="background:#FFFFFF;">Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xfluidplugincopy" style="background:#FFFFFF;">Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ke7gdr/_Career_Pearls_for_Students_Cardiology_mixdown6zsz9.mp3" length="41426246" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1725</itunes:duration>
                <itunes:episode>828</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Enhanced Recovery After Surgery/Enhanced Surgical Recovery (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Enhanced Recovery After Surgery/Enhanced Surgical Recovery (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-enhanced-recovery-after-surgeryenhanced-surgical-recovery-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-enhanced-recovery-after-surgeryenhanced-surgical-recovery-ce/#comments</comments>        <pubDate>Sat, 14 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ece53035-f4e2-3807-a0b9-df0d083e1990</guid>
                                    <description><![CDATA[<p>The opioid epidemic continues to be problematic across the country with increases in deaths from addiction leading to overdose. In an effort to minimize use of opioids postoperatively, the ERAS society developed guidelines and protocols pre-,intra-, and postoperatively to enhance recovery from surgical procedures while limiting use of opioids. Pharmacists play an integral part in the development of individual  hospital protocols for ERAS, monitoring patients postoperatively, and preparing appropriate and individualized regimens for pain management on discharge.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The opioid epidemic continues to be problematic across the country with increases in deaths from addiction leading to overdose. In an effort to minimize use of opioids postoperatively, the ERAS society developed guidelines and protocols pre-,intra-, and postoperatively to enhance recovery from surgical procedures while limiting use of opioids. Pharmacists play an integral part in the development of individual  hospital protocols for ERAS, monitoring patients postoperatively, and preparing appropriate and individualized regimens for pain management on discharge.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sxq64k/Enhanced_Recovery_After_Surgery_Enhanced_Surgical_Recovery__mixdown7borh.mp3" length="32790868" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The opioid epidemic continues to be problematic across the country with increases in deaths from addiction leading to overdose. In an effort to minimize use of opioids postoperatively, the ERAS society developed guidelines and protocols pre-,intra-, and postoperatively to enhance recovery from surgical procedures while limiting use of opioids. Pharmacists play an integral part in the development of individual  hospital protocols for ERAS, monitoring patients postoperatively, and preparing appropriate and individualized regimens for pain management on discharge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1365</itunes:duration>
                <itunes:episode>823</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: The Importance of Student Advocacy</title>
        <itunes:title>Student Perspectives: The Importance of Student Advocacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-the-importance-of-student-advocacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-the-importance-of-student-advocacy/#comments</comments>        <pubDate>Fri, 13 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e6724032-bc27-3deb-b841-0241209f1681</guid>
                                    <description><![CDATA[<p>Tom Kraus, Vice President of ASHP Office of Government Relations, discusses with current members of the Advancement of Professional Practice Advisory Group how and why students should get involved with state and federal advocacy efforts, as well as how local SSHP chapters can help their members to advocate for the profession.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom Kraus, Vice President of ASHP Office of Government Relations, discusses with current members of the Advancement of Professional Practice Advisory Group how and why students should get involved with state and federal advocacy efforts, as well as how local SSHP chapters can help their members to advocate for the profession.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ybk2ug/The_Importance_of_Student_Advocacy8l95m.m4a" length="41725208" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Tom Kraus, Vice President of ASHP Office of Government Relations, discusses with current members of the Advancement of Professional Practice Advisory Group how and why students should get involved with state and federal advocacy efforts, as well as how local SSHP chapters can help their members to advocate for the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1847</itunes:duration>
                <itunes:episode>824</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Safety: ISMP Targeted Medication Safety Best Practices for Hospitals Goal #17 - Safeguard Against Errors for Oxytocin Use</title>
        <itunes:title>Medication Safety: ISMP Targeted Medication Safety Best Practices for Hospitals Goal #17 - Safeguard Against Errors for Oxytocin Use</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-ismp-targeted-medication-safety-best-practices-for-hospitals-goal-17-safeguard-against-errors-for-oxytocin-use/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-ismp-targeted-medication-safety-best-practices-for-hospitals-goal-17-safeguard-against-errors-for-oxytocin-use/#comments</comments>        <pubDate>Wed, 11 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5ada438c-5bdd-3ff2-bd87-ab88c5a9ac76</guid>
                                    <description><![CDATA[<p>This episode provides a review of ISMP Best Practice #17 recommendations for safeguards against errors with oxytocin use. Speakers discuss how to understand the risks involved in oxytocin utilization with antepartum and postpartum management and describe considerations for implementing such safeguards. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides a review of ISMP Best Practice #17 recommendations for safeguards against errors with oxytocin use. Speakers discuss how to understand the risks involved in oxytocin utilization with antepartum and postpartum management and describe considerations for implementing such safeguards. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6hm2bh/ISMP_Targeted_Medication_Safety_Best_Practices_for_Hospitals_Goal_17btt2j.m4a" length="16201026" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This episode provides a review of ISMP Best Practice #17 recommendations for safeguards against errors with oxytocin use. Speakers discuss how to understand the risks involved in oxytocin utilization with antepartum and postpartum management and describe considerations for implementing such safeguards. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>722</itunes:duration>
                <itunes:episode>822</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Drone Delivery of Specialty Medications</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Drone Delivery of Specialty Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-drone-delivery-of-specialty-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-drone-delivery-of-specialty-medications/#comments</comments>        <pubDate>Tue, 10 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4bd9b059-9f71-3044-98e7-2849a22f5fcb</guid>
                                    <description><![CDATA[<p>In this episode, Dr. Brittany Meilinger joins us to talk about one health system’s experiences using drones for delivery of specialty medications – including a discussion of their policies, challenges and opportunities related to their drone delivery program. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Dr. Brittany Meilinger joins us to talk about one health system’s experiences using drones for delivery of specialty medications – including a discussion of their policies, challenges and opportunities related to their drone delivery program. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jr7b2h/ASHP_Drone_Delivery_of_Specialty_Medications_MIX.mp3" length="56814608" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Dr. Brittany Meilinger joins us to talk about one health system’s experiences using drones for delivery of specialty medications – including a discussion of their policies, challenges and opportunities related to their drone delivery program. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1420</itunes:duration>
                <itunes:episode>826</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Curtis Collins</title>
        <itunes:title>Pharmacy Leadership: A Conversation with Distinguished Service Awardee for the Section of Clinical Specialists and Scientists Curtis Collins</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-clinical-specialists-and-scientists-curtis-collins/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-a-conversation-with-distinguished-service-awardee-for-the-section-of-clinical-specialists-and-scientists-curtis-collins/#comments</comments>        <pubDate>Mon, 09 Jan 2023 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a46efe6b-a381-3cff-9060-dfee404f97f5</guid>
                                    <description><![CDATA[<p>In this Pharmacy Leadership Episode, Doug Slain sits down with the Section of Clinical Specialists and Scientists Awardee Curt Collins to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this Pharmacy Leadership Episode, Doug Slain sits down with the Section of Clinical Specialists and Scientists Awardee Curt Collins to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bwzsa6/A_Conversation_with_Distinguished_Service_Awardee_for_the_Section_of_Clinical_Specialists_and_Scientists_Curtis_Collins_mixdown6w9op.mp3" length="18171317" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this Pharmacy Leadership Episode, Doug Slain sits down with the Section of Clinical Specialists and Scientists Awardee Curt Collins to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>756</itunes:duration>
                <itunes:episode>821</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services – 2022</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services – 2022</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-ashp-survey-of-health-system-specialty-pharmacy-practice-clinical-services-%e2%80%93-2022/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-ashp-survey-of-health-system-specialty-pharmacy-practice-clinical-services-%e2%80%93-2022/#comments</comments>        <pubDate>Tue, 20 Dec 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8bc3ce83-a955-3eaa-a0b3-13931968e141</guid>
                                    <description><![CDATA[<p>The lead author team for the recent 2022 ASHP Survey of Health-System Specialty Pharmacy Practice – Clinical Services discuss key findings from the survey, as well as challenges and opportunities for the future of health system specialty pharmacy practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The lead author team for the recent 2022 ASHP Survey of Health-System Specialty Pharmacy Practice – Clinical Services discuss key findings from the survey, as well as challenges and opportunities for the future of health system specialty pharmacy practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/htq8xn/ASHPOfficial_ASHP_Survey_of_Health_System_Specialty_Pharmacy_Practice_Clinical_Services_2022_MIX.mp3" length="88982336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The lead author team for the recent 2022 ASHP Survey of Health-System Specialty Pharmacy Practice – Clinical Services discuss key findings from the survey, as well as challenges and opportunities for the future of health system specialty pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2224</itunes:duration>
                <itunes:episode>820</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Community Pharmacy: Taking Your Daily Vitamins - Helpful, Harmful, or Somewhere in Between?</title>
        <itunes:title>Hot Topics in Pharmacy: Community Pharmacy: Taking Your Daily Vitamins - Helpful, Harmful, or Somewhere in Between?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-community-pharmacy-taking-your-daily-vitamins-helpful-harmful-or-somewhere-in-between/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-community-pharmacy-taking-your-daily-vitamins-helpful-harmful-or-somewhere-in-between/#comments</comments>        <pubDate>Tue, 13 Dec 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6e76bc78-2e2c-340e-92f6-44f4e1839945</guid>
                                    <description><![CDATA[<p>With new guidance from the United States Preventive Services Task Force that recommends against the use of some vitamins for disease prevention, it can be difficult to know when vitamins should and should not be encouraged.  This Podcast will summarize the new recommendations and review clinical situations when vitamins may be helpful or harmful. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With new guidance from the United States Preventive Services Task Force that recommends against the use of some vitamins for disease prevention, it can be difficult to know when vitamins should and should not be encouraged.  This Podcast will summarize the new recommendations and review clinical situations when vitamins may be helpful or harmful. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w2spg7/ASHP_Official_Exploring_the_Latest_USPSTF_Guidance_MIX.mp3" length="25502597" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With new guidance from the United States Preventive Services Task Force that recommends against the use of some vitamins for disease prevention, it can be difficult to know when vitamins should and should not be encouraged.  This Podcast will summarize the new recommendations and review clinical situations when vitamins may be helpful or harmful. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1593</itunes:duration>
                <itunes:episode>817</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Alternative Routes of Administration for Acute Pain Management (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Alternative Routes of Administration for Acute Pain Management (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-alternative-routes-of-administration-for-acute-pain-management-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-alternative-routes-of-administration-for-acute-pain-management-ce/#comments</comments>        <pubDate>Mon, 12 Dec 2022 16:10:46 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/25aac7e9-0b84-39e0-81fa-92e4476bcdec</guid>
                                    <description><![CDATA[<p>In this podcast we will discuss alternate routes of analgesic administration for when intravenous and/or oral access is not available. This will include sublingual, subcutaneous, intranasal, inhalation, and others as well as what medications are best suited for these routes based on their pharmacokinetics.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we will discuss alternate routes of analgesic administration for when intravenous and/or oral access is not available. This will include sublingual, subcutaneous, intranasal, inhalation, and others as well as what medications are best suited for these routes based on their pharmacokinetics.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e7ftry/Alternative_Routes_of_Administration_for_Acute_Pain_Management_CE_1_6t90h.m4a" length="26543643" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast we will discuss alternate routes of analgesic administration for when intravenous and/or oral access is not available. This will include sublingual, subcutaneous, intranasal, inhalation, and others as well as what medications are best suited for these routes based on their pharmacokinetics.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1111</itunes:duration>
                <itunes:episode>819</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation Fridays: Implementing Digital Health &amp; Health Information Technology in Pharmacy</title>
        <itunes:title>Innovation Fridays: Implementing Digital Health &amp; Health Information Technology in Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-fridays-implementing-digital-health-health-information-technology-in-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-fridays-implementing-digital-health-health-information-technology-in-pharmacy/#comments</comments>        <pubDate>Fri, 09 Dec 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c84abbf7-c3d2-3997-ba9e-9ef5d8b0a6bb</guid>
                                    <description><![CDATA[<p>In this podcast, we will be discussing how digital health will further expand the patient-doctor relationship and its potential impact on disease prevention, management of chronic illnesses, and reducing healthcare costs. Digital health technologies offer a holistic view of the patient by providing access to data in real-time, bidirectional communication between provider and patient, and a more personalized approach to care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, we will be discussing how digital health will further expand the patient-doctor relationship and its potential impact on disease prevention, management of chronic illnesses, and reducing healthcare costs. Digital health technologies offer a holistic view of the patient by providing access to data in real-time, bidirectional communication between provider and patient, and a more personalized approach to care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/azdsy8/Edit_Implementing_Digital_Health_Health_Information_Technology_in_Pharmacy_mixdownbidx3.mp3" length="41251914" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, we will be discussing how digital health will further expand the patient-doctor relationship and its potential impact on disease prevention, management of chronic illnesses, and reducing healthcare costs. Digital health technologies offer a holistic view of the patient by providing access to data in real-time, bidirectional communication between provider and patient, and a more personalized approach to care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1718</itunes:duration>
                <itunes:episode>818</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Have You Thought About Gout Lately?</title>
        <itunes:title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Have You Thought About Gout Lately?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-have-you-thought-about-gout-lately/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-have-you-thought-about-gout-lately/#comments</comments>        <pubDate>Fri, 02 Dec 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/19b905b2-4469-3a58-9feb-62822201ffe0</guid>
                                    <description><![CDATA[<p>In this excerpt from the Midyear Clinical Meeting, the Section of Clinical Specialists and Scientists present an update to the 2020 American College of Rheumatology Guideline for the Management of Gout and evaluate nonpharmacologic therapies and lifestyle modifications in the treatment of gout.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this excerpt from the Midyear Clinical Meeting, the Section of Clinical Specialists and Scientists present an update to the 2020 American College of Rheumatology Guideline for the Management of Gout and evaluate nonpharmacologic therapies and lifestyle modifications in the treatment of gout.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jsfwyr/Have_You_Thought_About_Gout_Lately_mixdown8lq15.mp3" length="48405220" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this excerpt from the Midyear Clinical Meeting, the Section of Clinical Specialists and Scientists present an update to the 2020 American College of Rheumatology Guideline for the Management of Gout and evaluate nonpharmacologic therapies and lifestyle modifications in the treatment of gout.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2015</itunes:duration>
                <itunes:episode>816</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursdays: MCM 2021 Clinical Feature: Clinical Controversies Related to Acute Kidney Injury</title>
        <itunes:title>Therapeutics Thursdays: MCM 2021 Clinical Feature: Clinical Controversies Related to Acute Kidney Injury</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursdays-mcm-2021-clinical-feature-clinical-controversies-related-to-acute-kidney-injury/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursdays-mcm-2021-clinical-feature-clinical-controversies-related-to-acute-kidney-injury/#comments</comments>        <pubDate>Thu, 01 Dec 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/41497d15-80c3-321e-afd5-c07eb64b6d71</guid>
                                    <description><![CDATA[<p>This featurette from the 2021 Midyear Clinical Meeting presentation “More than Just a Hill of Beans: Clinical Controversies Related to Acute Kidney Injury in the ICU” summarizes the clinical usefulness of furosemide stress testing in acute kidney injury.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This featurette from the 2021 Midyear Clinical Meeting presentation “More than Just a Hill of Beans: Clinical Controversies Related to Acute Kidney Injury in the ICU” summarizes the clinical usefulness of furosemide stress testing in acute kidney injury.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kdhts5/MCM_2021_Clinical_Feature-_Clinical_Controversies_Related_to_Acute_Kidney_Injury9xopz.m4a" length="34475932" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This featurette from the 2021 Midyear Clinical Meeting presentation “More than Just a Hill of Beans: Clinical Controversies Related to Acute Kidney Injury in the ICU” summarizes the clinical usefulness of furosemide stress testing in acute kidney injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1444</itunes:duration>
                <itunes:episode>810</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: What Would You Do? Clinical Dilemmas in Anticoagulation Part 2</title>
        <itunes:title>Therapeutic Thursdays: What Would You Do? Clinical Dilemmas in Anticoagulation Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-what-would-you-do-clinical-dilemmas-in-anticoagulation-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-what-would-you-do-clinical-dilemmas-in-anticoagulation-part-2/#comments</comments>        <pubDate>Wed, 30 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b37af5a3-7507-3676-8373-bc9ca81b1f7c</guid>
                                    <description><![CDATA[<p>In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care.  In this episode, our patient-specific cases include inpatient management of a pulmonary embolism, management of coagulopathy with liver disease, and management of anticoagulants in acute kidney injury.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care.  In this episode, our patient-specific cases include inpatient management of a pulmonary embolism, management of coagulopathy with liver disease, and management of anticoagulants in acute kidney injury.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wfvk3b/MCM_2021_Clinical_Feature_What_Would_You_Do_-_Clinical_Dilemmas_in_Anticoagulation_Part_2_mixdown8yb3t.mp3" length="42269111" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care.  In this episode, our patient-specific cases include inpatient management of a pulmonary embolism, management of coagulopathy with liver disease, and management of anticoagulants in acute kidney injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1760</itunes:duration>
                <itunes:episode>814</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Navigating Midyear 2022: Expert Advice and Must-Watch Sessions</title>
        <itunes:title>Hot Topics: Navigating Midyear 2022: Expert Advice and Must-Watch Sessions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-navigating-midyear-2022-expert-advice-and-must-watch-sessions/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-navigating-midyear-2022-expert-advice-and-must-watch-sessions/#comments</comments>        <pubDate>Tue, 29 Nov 2022 11:38:12 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1726c4eb-458b-3ea6-84dd-779c5bff7b5c</guid>
                                    <description><![CDATA[<p>Join Brittany Tschaen as she sits down with Joe Marchiano and Nancy Macdonald who will share their lessons learned and best practices for returning to in-person Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the full midyear experience.  Later in the episode, Brittany and Joe sit down with program chairs from the 2022 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join Brittany Tschaen as she sits down with Joe Marchiano and Nancy Macdonald who will share their lessons learned and best practices for returning to in-person Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the full midyear experience.  Later in the episode, Brittany and Joe sit down with program chairs from the 2022 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hkf9ae/Midyear_Clinical_Meeting_Preview_2022__Featured_Presentations_and_Attendance_Tips_and_Tricks_mixdown9s90v.mp3" length="73352431" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join Brittany Tschaen as she sits down with Joe Marchiano and Nancy Macdonald who will share their lessons learned and best practices for returning to in-person Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the full midyear experience.  Later in the episode, Brittany and Joe sit down with program chairs from the 2022 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3055</itunes:duration>
                <itunes:episode>815</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2021 Clinical Feature: What Would You Do - Clinical Dilemmas in Anticoagulation Part 1</title>
        <itunes:title>Therapeutic Thursdays: MCM 2021 Clinical Feature: What Would You Do - Clinical Dilemmas in Anticoagulation Part 1</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-what-would-you-do-clinical-dilemmas-in-anticoagulation-part-1/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-what-would-you-do-clinical-dilemmas-in-anticoagulation-part-1/#comments</comments>        <pubDate>Tue, 29 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a1210645-2187-3e89-8ad5-9f059492c885</guid>
                                    <description><![CDATA[<p>In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include cancer-associated thrombocytopenia, spinal hematoma and apical thrombous.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include cancer-associated thrombocytopenia, spinal hematoma and apical thrombous.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ady2r2/MCM_2021_Clinical_Feature-_What_Would_You_Do_-_Clinical_Dilemmas_in_Anticoagulatahzgd.m4a" length="31388728" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include cancer-associated thrombocytopenia, spinal hematoma and apical thrombous.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1314</itunes:duration>
                <itunes:episode>812</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Tips for Students on How to Maximize Your Midyear Experience</title>
        <itunes:title>Student Perspectives: Tips for Students on How to Maximize Your Midyear Experience</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-tips-for-students-on-how-to-maximize-your-midyear-experience/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-tips-for-students-on-how-to-maximize-your-midyear-experience/#comments</comments>        <pubDate>Mon, 28 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e961f9bd-f76a-3ce9-b5d4-416e0de91b2c</guid>
                                    <description><![CDATA[<p>Interested in learning how to maximize your time at the Midyear Clinical Meeting? This podcast episode features two New Practitioners sharing their tips and tricks on how to successfully navigate the Midyear Clinical Meeting and Residency Showcase.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Interested in learning how to maximize your time at the Midyear Clinical Meeting? This podcast episode features two New Practitioners sharing their tips and tricks on how to successfully navigate the Midyear Clinical Meeting and Residency Showcase.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jpit5r/Tips_for_Studentsaoljo.m4a" length="29746162" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Interested in learning how to maximize your time at the Midyear Clinical Meeting? This podcast episode features two New Practitioners sharing their tips and tricks on how to successfully navigate the Midyear Clinical Meeting and Residency Showcase.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1246</itunes:duration>
                <itunes:episode>813</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: What Fluids Are on the Menu? Fluid Stewardship in Acute Care Settings</title>
        <itunes:title>Therapeutic Thursdays: What Fluids Are on the Menu? Fluid Stewardship in Acute Care Settings</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-what-fluids-are-on-the-menu-fluid-stewardship-in-acute-care-settings/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-what-fluids-are-on-the-menu-fluid-stewardship-in-acute-care-settings/#comments</comments>        <pubDate>Tue, 22 Nov 2022 12:11:50 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ff80f553-9f60-35c0-85af-f7e69b57f5a9</guid>
                                    <description><![CDATA[<p>In this featurette episode from the 2021 Midyear Clinical Meeting, listeners will learn about the “four D’s” of fluid therapy in appropriate fluid stewardship, review individual changes to fluid therapy that can improve patient outcomes, and hear about a real-world experience in developing a protocol and policy for the systemic adoption of fluid stewardship program. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this featurette episode from the 2021 Midyear Clinical Meeting, listeners will learn about the “four D’s” of fluid therapy in appropriate fluid stewardship, review individual changes to fluid therapy that can improve patient outcomes, and hear about a real-world experience in developing a protocol and policy for the systemic adoption of fluid stewardship program. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jxcm8n/MCM_2021_Clinical_Feature_What_Fluids_are_on_the_Menu_-_Fluid_Stewardship_in_Acute_Care_Settings_mixdownbg4yc.mp3" length="128454022" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this featurette episode from the 2021 Midyear Clinical Meeting, listeners will learn about the “four D’s” of fluid therapy in appropriate fluid stewardship, review individual changes to fluid therapy that can improve patient outcomes, and hear about a real-world experience in developing a protocol and policy for the systemic adoption of fluid stewardship program. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>5351</itunes:duration>
                <itunes:episode>811</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Put a Little PEP in Your Step! PrEParing Pharmacists to Prescribe and Monitor HIV Prevention Medications</title>
        <itunes:title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Put a Little PEP in Your Step! PrEParing Pharmacists to Prescribe and Monitor HIV Prevention Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinicalfeatureput-alittle-pep-inyoursteppreparingpharmacists-toprescribeandmonitor-hiv-prevention-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinicalfeatureput-alittle-pep-inyoursteppreparingpharmacists-toprescribeandmonitor-hiv-prevention-medications/#comments</comments>        <pubDate>Mon, 21 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5bb38764-04c4-38a7-a0a4-a4325bdd33f2</guid>
                                    <description><![CDATA[<p>This episode highlights the key takeaways from the 2021 Midyear Clinical Meeting on how pharmacists can apply data supporting pre-exposure prophylaxis (PrEP) and guideline-based testing to implement PrEP prescribing and monitoring into your existing practice.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode highlights the key takeaways from the 2021 Midyear Clinical Meeting on how pharmacists can apply data supporting pre-exposure prophylaxis (PrEP) and guideline-based testing to implement PrEP prescribing and monitoring into your existing practice.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9rk3xc/MCM_2021_Clinical_Feature-_Put_a_Little_PEP_in_Your_Step_PrEParing_Pharmacists7g0ld.m4a" length="53913963" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This episode highlights the key takeaways from the 2021 Midyear Clinical Meeting on how pharmacists can apply data supporting pre-exposure prophylaxis (PrEP) and guideline-based testing to implement PrEP prescribing and monitoring into your existing practice.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2258</itunes:duration>
                <itunes:episode>807</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: Preview of Midyear 2022: An Emergency Medicine Focus</title>
        <itunes:title>Pharmacy Hot Topics: Preview of Midyear 2022: An Emergency Medicine Focus</itunes:title>
        <link>https://ashpofficial.podbean.com/e/preview-of-midyear-2022-an-emergency-medicine-focus/</link>
                    <comments>https://ashpofficial.podbean.com/e/preview-of-midyear-2022-an-emergency-medicine-focus/#comments</comments>        <pubDate>Sun, 20 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c19326bc-7aae-331f-9b90-481f9b47ced7</guid>
                                    <description><![CDATA[<p>In a sneak peak for the upcoming Midyear in Las Vegas, the SCSS Advisory Group on Emergency Medicine sits down with some can’t-miss educational session presenters to discuss what attendees can hope to learn about new and emerging areas of practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a sneak peak for the upcoming Midyear in Las Vegas, the SCSS Advisory Group on Emergency Medicine sits down with some can’t-miss educational session presenters to discuss what attendees can hope to learn about new and emerging areas of practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hkzbs5/Preview_of_Midyear_2022_An_Emergency_Medicine_Focus_mixdownbaqoj.mp3" length="12776612" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a sneak peak for the upcoming Midyear in Las Vegas, the SCSS Advisory Group on Emergency Medicine sits down with some can’t-miss educational session presenters to discuss what attendees can hope to learn about new and emerging areas of practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>531</itunes:duration>
                <itunes:episode>808</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Be Antibiotics Aware: Pharmacists Leveraging the NHSN AU Option</title>
        <itunes:title>Hot Topics in Pharmacy: Be Antibiotics Aware: Pharmacists Leveraging the NHSN AU Option</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-be-antibiotics-aware-pharmacists-leveraging-the-nhsn-au-option/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-be-antibiotics-aware-pharmacists-leveraging-the-nhsn-au-option/#comments</comments>        <pubDate>Sat, 19 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1a2ed672-20eb-3152-b883-efc5915a96fb</guid>
                                    <description><![CDATA[<p>In honor of U.S. Antibiotic Awareness Week November 18-24, 2022, join us for a podcast discussion on the CDC National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. The availability of this Option is another opportunity to improve antimicrobial use for patient and public health.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In honor of U.S. Antibiotic Awareness Week November 18-24, 2022, join us for a podcast discussion on the CDC National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. The availability of this Option is another opportunity to improve antimicrobial use for patient and public health.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vfdm7m/Be_Antibiotics_Aware-_Pharmacists_Leveraging_the_NHSN_AU_Optionbn834.m4a" length="50662840" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In honor of U.S. Antibiotic Awareness Week November 18-24, 2022, join us for a podcast discussion on the CDC National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. The availability of this Option is another opportunity to improve antimicrobial use for patient and public health.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2122</itunes:duration>
                <itunes:episode>809</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Adult and Pediatric Safety Considerations for Lipid Injectable Emulsions</title>
        <itunes:title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Adult and Pediatric Safety Considerations for Lipid Injectable Emulsions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-adult-and-pediatric-safety-considerations-for-lipid-injectable-emulsions/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-adult-and-pediatric-safety-considerations-for-lipid-injectable-emulsions/#comments</comments>        <pubDate>Thu, 17 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8d60a459-220a-325d-ba19-38943aa91a10</guid>
                                    <description><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/43i922/autosave_MCM_2021_Clinical_Feature-_Adult_and_Pediatric_Safety_Considerations_fo6c5yl.m4a" length="55083549" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2307</itunes:duration>
                <itunes:episode>804</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Navigating the Industry Fellowship Application Process</title>
        <itunes:title>Practice Journeys: Navigating the Industry Fellowship Application Process</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-navigating-the-industry-fellowship-application-process/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-navigating-the-industry-fellowship-application-process/#comments</comments>        <pubDate>Wed, 16 Nov 2022 11:55:55 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/85304157-3424-314e-ab7d-60151ddff31a</guid>
                                    <description><![CDATA[<p>Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about industry PharmD Fellowships. This podcast will cover the process of applying for a fellowship and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a career in industry.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about industry PharmD Fellowships. This podcast will cover the process of applying for a fellowship and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a career in industry.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r5gc5n/2_Navigating_the_Industry_Fellowship_Application_Process_mixdown78lo7.mp3" length="26981567" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about industry PharmD Fellowships. This podcast will cover the process of applying for a fellowship and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a career in industry.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1123</itunes:duration>
                <itunes:episode>806</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Become a Wiz at Urine Drug Screens (UDS) Part 2</title>
        <itunes:title>Hot Topics in Pharmacy: Become a Wiz at Urine Drug Screens (UDS) Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-become-a-wiz-at-urine-drug-screens-uds-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-become-a-wiz-at-urine-drug-screens-uds-part-2/#comments</comments>        <pubDate>Tue, 15 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ec3e77e4-6a18-3646-a539-327fa24af966</guid>
                                    <description><![CDATA[<p>Tailored to the unique needs of pain providers, this podcast jumps in the deep end of urine drug screen (UDS) discussions. Speakers will talk about some of the more complicated situations that arise secondary to urine drug screening. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tailored to the unique needs of pain providers, this podcast jumps in the deep end of urine drug screen (UDS) discussions. Speakers will talk about some of the more complicated situations that arise secondary to urine drug screening. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sfn9ce/Become_a_Wiz_at_Urine_Drug_Screens_UDS_Part_2_mixdownbrpol.mp3" length="22906486" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tailored to the unique needs of pain providers, this podcast jumps in the deep end of urine drug screen (UDS) discussions. Speakers will talk about some of the more complicated situations that arise secondary to urine drug screening. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>953</itunes:duration>
                <itunes:episode>805</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: Preview of Midyear 2022: Emerging Sciences Content</title>
        <itunes:title>Pharmacy Hot Topics: Preview of Midyear 2022: Emerging Sciences Content</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-preview-of-midyear-2022-emerging-sciences-content/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-preview-of-midyear-2022-emerging-sciences-content/#comments</comments>        <pubDate>Mon, 14 Nov 2022 16:32:02 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/30a1db1a-7bdf-372f-82da-0709b28da009</guid>
                                    <description><![CDATA[<p>In a sneak peek for the Midyear 2022, Gift Neweke from the SCSS Advisory Group on Emerging Sciences sits down with some of the can’t miss educational session presenters to discuss what attendees can hope to about new and emerging areas of practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a sneak peek for the Midyear 2022, Gift Neweke from the SCSS Advisory Group on Emerging Sciences sits down with some of the can’t miss educational session presenters to discuss what attendees can hope to about new and emerging areas of practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iw5s4t/ASHP_Podcast_Preview_of_Midyear_2022_Emerging_Sciences_Content_MIX_1_7708n.mp3" length="27598268" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In a sneak peek for the Midyear 2022, Gift Neweke from the SCSS Advisory Group on Emerging Sciences sits down with some of the can’t miss educational session presenters to discuss what attendees can hope to about new and emerging areas of practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>689</itunes:duration>
                <itunes:episode>803</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Voices of Veterans – Honoring the Military Service of ASHP Members</title>
        <itunes:title>Practice Journeys: Voices of Veterans – Honoring the Military Service of ASHP Members</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-voices-of-veterans-%e2%80%93-honoring-the-military-service-of-ashp-members/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-voices-of-veterans-%e2%80%93-honoring-the-military-service-of-ashp-members/#comments</comments>        <pubDate>Thu, 10 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4aeffc66-5862-3eae-892e-01ce8aa57f17</guid>
                                    <description><![CDATA[<p>In celebration of Veterans Day 2022, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with W. Mike Heath, Heather Rovey, and Amanda Ferguson about their stories, reflections, and perspectives on how their military experience helped shape their pharmacy careers and how their stories provide an inspiration for the next generation of pharmacy professionals.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In celebration of Veterans Day 2022, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with W. Mike Heath, Heather Rovey, and Amanda Ferguson about their stories, reflections, and perspectives on how their military experience helped shape their pharmacy careers and how their stories provide an inspiration for the next generation of pharmacy professionals.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/smqe29/ASHP_Voices_of_Veterans_Honoring_the_Military_Service_of_ASHP_Members_MIX_1_8b8i3.mp3" length="102628460" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In celebration of Veterans Day 2022, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with W. Mike Heath, Heather Rovey, and Amanda Ferguson about their stories, reflections, and perspectives on how their military experience helped shape their pharmacy careers and how their stories provide an inspiration for the next generation of pharmacy professionals.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2565</itunes:duration>
                <itunes:episode>801</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Hot Topics: Preview of Midyear 2022: Therapeutic Debates</title>
        <itunes:title>Pharmacy Hot Topics: Preview of Midyear 2022: Therapeutic Debates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-preview-of-midyear-2022-therapeutic-debates/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-hot-topics-preview-of-midyear-2022-therapeutic-debates/#comments</comments>        <pubDate>Thu, 10 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e583ce4-2345-3d64-8c9b-e60c40c2f48b</guid>
                                    <description><![CDATA[<p>In a sneak peak of everyone’s favorite collegially contentious Midyear session – Therapeutic Debates – Karen Whalen sits down with SCSS Educational Steering Committee members Kellie Goodlet, Amy Sipe, and Jessica Star to preview this can’t-miss educational session. This year’s debates are management of patients with penicillin allergy, provision of safe supply to patients with opioid use disorder, and monitoring of anti-Xa levels in patients receiving DOAC therapy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In a sneak peak of everyone’s favorite collegially contentious Midyear session – Therapeutic Debates – Karen Whalen sits down with SCSS Educational Steering Committee members Kellie Goodlet, Amy Sipe, and Jessica Star to preview this can’t-miss educational session. This year’s debates are management of patients with penicillin allergy, provision of safe supply to patients with opioid use disorder, and monitoring of anti-Xa levels in patients receiving DOAC therapy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9rmhvv/Preview_of_Midyear_2022-_Therapeutic_Debates8jfhs.m4a" length="15308519" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In a sneak peak of everyone’s favorite collegially contentious Midyear session – Therapeutic Debates – Karen Whalen sits down with SCSS Educational Steering Committee members Kellie Goodlet, Amy Sipe, and Jessica Star to preview this can’t-miss educational session. This year’s debates are management of patients with penicillin allergy, provision of safe supply to patients with opioid use disorder, and monitoring of anti-Xa levels in patients receiving DOAC therapy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>641</itunes:duration>
                <itunes:episode>799</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Advancing the Pharmacist’s Role in Primary Care</title>
        <itunes:title>Advocating for Impact: Advancing the Pharmacist’s Role in Primary Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-advancing-the-pharmacist-s-role-in-primary-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-advancing-the-pharmacist-s-role-in-primary-care/#comments</comments>        <pubDate>Wed, 09 Nov 2022 10:57:59 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/311d7056-7407-35ef-adbe-43723715218e</guid>
                                    <description><![CDATA[<p>Tom and Jillanne discuss recent conversations ASHP has had with the U.S. Department of Health & Human Services regarding the role of pharmacists in primary care. We touch on the types of services pharmacists are providing and highlight the pressing need for reimbursement and residency training support to sustain those models, and discuss the importance of partner organizations to our overall advocacy strategy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom and Jillanne discuss recent conversations ASHP has had with the U.S. Department of Health & Human Services regarding the role of pharmacists in primary care. We touch on the types of services pharmacists are providing and highlight the pressing need for reimbursement and residency training support to sustain those models, and discuss the importance of partner organizations to our overall advocacy strategy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8xa6mh/2_EDIT_Advancing_the_Pharmacist_s_Role_in_Primary_Care_mixdown9g345.mp3" length="25139349" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tom and Jillanne discuss recent conversations ASHP has had with the U.S. Department of Health & Human Services regarding the role of pharmacists in primary care. We touch on the types of services pharmacists are providing and highlight the pressing need for reimbursement and residency training support to sustain those models, and discuss the importance of partner organizations to our overall advocacy strategy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1047</itunes:duration>
                <itunes:episode>802</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Putting the We in Well-Being; Resiliency in Pharmacy School</title>
        <itunes:title>Student Perspectives: Putting the We in Well-Being; Resiliency in Pharmacy School</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-putting-the-we-in-well-being-resiliency-in-pharmacy-school/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-putting-the-we-in-well-being-resiliency-in-pharmacy-school/#comments</comments>        <pubDate>Mon, 07 Nov 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b9f1e560-aeee-3785-988e-13207de052e3</guid>
                                    <description><![CDATA[<p>Maintaining wellness while pursuing your Doctor of Pharmacy degree can be challenging. To address this, Student Societies of Health-System Pharmacists (SSHPs) are actively promoting wellbeing and resilience within their chapters. Through this podcast, we hope to highlight examples of how to incorporate wellness and wellbeing into SSHP initiatives, as well as share some tips on how to foster and sustain well-being and resilience during pharmacy school.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Maintaining wellness while pursuing your Doctor of Pharmacy degree can be challenging. To address this, Student Societies of Health-System Pharmacists (SSHPs) are actively promoting wellbeing and resilience within their chapters. Through this podcast, we hope to highlight examples of how to incorporate wellness and wellbeing into SSHP initiatives, as well as share some tips on how to foster and sustain well-being and resilience during pharmacy school.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j2h9rq/Putting_the_We_in_Well-Being_Resiliency_in_Pharmacy_School_mixdown80l4m.mp3" length="14914336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Maintaining wellness while pursuing your Doctor of Pharmacy degree can be challenging. To address this, Student Societies of Health-System Pharmacists (SSHPs) are actively promoting wellbeing and resilience within their chapters. Through this podcast, we hope to highlight examples of how to incorporate wellness and wellbeing into SSHP initiatives, as well as share some tips on how to foster and sustain well-being and resilience during pharmacy school.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>620</itunes:duration>
                <itunes:episode>800</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Another Ouchie: Unintended Consequences of the Opioid Epidemic on Pediatric Pain Management (CE)</title>
        <itunes:title>Therapeutic Thursdays: Another Ouchie: Unintended Consequences of the Opioid Epidemic on Pediatric Pain Management (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-another-ouchie-unintended-consequences-of-the-opioid-epidemic-on-pediatric-pain-management-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-another-ouchie-unintended-consequences-of-the-opioid-epidemic-on-pediatric-pain-management-ce/#comments</comments>        <pubDate>Sat, 05 Nov 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a90088e4-ff51-30b1-9ba0-6b2f4a70ff25</guid>
                                    <description><![CDATA[<p>The opioid epidemic is a dynamic multi-layered situation with regulatory changes affecting patients and providers in a variety of ways.  Although many regulation changes were designed with the best intentions, unintended consequences have surfaced in acute pain management for pediatric patients.  This podcast will discuss some of the implications and safety issues while providing information regarding appropriate pediatric medication therapy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The opioid epidemic is a dynamic multi-layered situation with regulatory changes affecting patients and providers in a variety of ways.  Although many regulation changes were designed with the best intentions, unintended consequences have surfaced in acute pain management for pediatric patients.  This podcast will discuss some of the implications and safety issues while providing information regarding appropriate pediatric medication therapy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nggytg/Another_Ouchie-_Unintended_Consequences_of_the_Opioid_Epidemic_on_Pediatric_Pain8orz5.m4a" length="31621877" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[The opioid epidemic is a dynamic multi-layered situation with regulatory changes affecting patients and providers in a variety of ways.  Although many regulation changes were designed with the best intentions, unintended consequences have surfaced in acute pain management for pediatric patients.  This podcast will discuss some of the implications and safety issues while providing information regarding appropriate pediatric medication therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1324</itunes:duration>
                <itunes:episode>798</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Antimicrobial Optimization in the Critically Ill</title>
        <itunes:title>Therapeutic Thursdays: Antimicrobial Optimization in the Critically Ill</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-antimicrobial-optimization-in-the-critically-ill/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-antimicrobial-optimization-in-the-critically-ill/#comments</comments>        <pubDate>Thu, 03 Nov 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/047bb051-520e-3c60-bb16-9a533d0955f9</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacdynamic characteristics a pharmacist must take into consideration when designing.</p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacdynamic characteristics a pharmacist must take into consideration when designing.</p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nqd7bh/MCM_2021_Clinical_Feature_Antimicrobial_Optimization_in_the_Critically_Ill__mixdown7jgio.mp3" length="65567077" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacdynamic characteristics a pharmacist must take into consideration when designing.
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2730</itunes:duration>
                <itunes:episode>796</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Acute Pain Management in Patients Treated with Buprenorphine</title>
        <itunes:title>Therapeutic Thursdays: Acute Pain Management in Patients Treated with Buprenorphine</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-acute-pain-management-in-patients-treated-with-buprenorphine/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-acute-pain-management-in-patients-treated-with-buprenorphine/#comments</comments>        <pubDate>Wed, 02 Nov 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/47314800-5774-3686-8f4a-e2beed9aab0d</guid>
                                    <description><![CDATA[<p>This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nzfua9/MCM_2021_Clinical_Feature_Acute_Pain_Mangement_in_Patients_Treated_with_Buprenorphine_mixdownap9yb.mp3" length="30430356" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1266</itunes:duration>
                <itunes:episode>795</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: USP Chapter Revisions: What’s Next?</title>
        <itunes:title>Hot Topics in Pharmacy: USP Chapter Revisions: What’s Next?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-usp-chapter-revisions-what-s-next/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-usp-chapter-revisions-what-s-next/#comments</comments>        <pubDate>Tue, 01 Nov 2022 09:49:48 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3acc6988-ff3c-3a9a-8bd9-2d7c0bd9362a</guid>
                                    <description><![CDATA[<p>USP recently published final revisions to the nonsterile compounding chapter  and the sterile compounding chapter . ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter  with compounding expert Patti Kienle. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>USP recently published final revisions to the nonsterile compounding chapter  and the sterile compounding chapter . ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter  with compounding expert Patti Kienle. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5b5iub/USP_Chapter_Revisions_What_s_Next_Final_mixdown6w3rk.mp3" length="20794171" type="audio/mpeg"/>
        <itunes:summary><![CDATA[USP recently published final revisions to the nonsterile compounding chapter  and the sterile compounding chapter . ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter  with compounding expert Patti Kienle. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>866</itunes:duration>
                <itunes:episode>797</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: How to Find Your Best Fit for Residency: A Resident Perspective</title>
        <itunes:title>Practice Journeys: How to Find Your Best Fit for Residency: A Resident Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-resident-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-resident-perspective/#comments</comments>        <pubDate>Mon, 31 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/89c03096-6c79-3926-b37e-e376594a3398</guid>
                                    <description><![CDATA[<p>This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/st5tji/ASHP_Podcast_How_to_Find_Your_Best_Fit_for_Residency_A_Resident_Perspective_MIX.mp3" length="91570412" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2289</itunes:duration>
                <itunes:episode>793</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Boosters, Biologics, Antivirals- Oh My!- COVID-19 in the Immunocompromised</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Boosters, Biologics, Antivirals- Oh My!- COVID-19 in the Immunocompromised</itunes:title>
        <link>https://ashpofficial.podbean.com/e/tbd-awaiting-info-from-adv-team-1028-release/</link>
                    <comments>https://ashpofficial.podbean.com/e/tbd-awaiting-info-from-adv-team-1028-release/#comments</comments>        <pubDate>Fri, 28 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6d08077d-7343-31bd-8cf0-d279779357d3</guid>
                                    <description><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bviums/ADV_COVID-19_Prevention_and_Treatment_Strategies_for_the_Immunocompromised_podcast_1_mixdownaosax.mp3" length="47877163" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1994</itunes:duration>
                <itunes:episode>794</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutics Thursdays: MCM 2021 Clinical Feature: Old Drugs, New Drugs and New Evidence for Dyslipidemia Management</title>
        <itunes:title>Therapeutics Thursdays: MCM 2021 Clinical Feature: Old Drugs, New Drugs and New Evidence for Dyslipidemia Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutics-thursdays-mcm-2021-clinical-feature-old-drugs-new-drugs-and-new-evidence-for-dyslipidemia-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutics-thursdays-mcm-2021-clinical-feature-old-drugs-new-drugs-and-new-evidence-for-dyslipidemia-management/#comments</comments>        <pubDate>Thu, 27 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cacc4d76-1f13-3600-824d-8ef51d2e9097</guid>
                                    <description><![CDATA[<p>In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f6dw9y/MCM_2021_Clinical_Feature-_Old_Drugs_New_Drugs_and_New_Evidence_for_Dyslipidemiac2w0.m4a" length="68900720" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2886</itunes:duration>
                <itunes:episode>789</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Current State of Asks to Congress</title>
        <itunes:title>Current State of Asks to Congress</itunes:title>
        <link>https://ashpofficial.podbean.com/e/current-state-of-asks-to-congress/</link>
                    <comments>https://ashpofficial.podbean.com/e/current-state-of-asks-to-congress/#comments</comments>        <pubDate>Wed, 26 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b7e00f5-37a7-3096-ab93-6b901616fde2</guid>
                                    <description><![CDATA[<p>Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September.  They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September.  They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5ufqpu/Current_State_of_Asks_to_Congress_mixdown6ul4i.mp3" length="34797230" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September.  They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1448</itunes:duration>
                <itunes:episode>791</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: Aligning Talent and Opportunity: Building a Pharmacy Technician Talent Pipeline Through Community College Partnerships</title>
        <itunes:title>Technician Topics: Aligning Talent and Opportunity: Building a Pharmacy Technician Talent Pipeline Through Community College Partnerships</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-aligning-talent-and-opportunity-building-a-pharmacy-technician-talent-pipeline-through-community-college-partnerships/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-aligning-talent-and-opportunity-building-a-pharmacy-technician-talent-pipeline-through-community-college-partnerships/#comments</comments>        <pubDate>Mon, 24 Oct 2022 12:12:04 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/11d64f4b-bed8-3985-ad01-4fd00bca339f</guid>
                                    <description><![CDATA[<p>This curated feature from the 2021 Midyear Clinical Meeting focuses on the impact that pharmacy technician vacancies have on pharmacy department operations and how Hartford Healthcare’s development of a yearlong internship with their local Community College created an effective pharmacy technician talent pipeline. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This curated feature from the 2021 Midyear Clinical Meeting focuses on the impact that pharmacy technician vacancies have on pharmacy department operations and how Hartford Healthcare’s development of a yearlong internship with their local Community College created an effective pharmacy technician talent pipeline. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gs6uqf/MCM_2021_Technician_Topics_Aligning_Talent_and_Opportunity___Building_a_Pharmacy_Technician_Talent_Pipeline_Through_Community_College_Partners_mixdown6d1vk.mp3" length="25680364" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This curated feature from the 2021 Midyear Clinical Meeting focuses on the impact that pharmacy technician vacancies have on pharmacy department operations and how Hartford Healthcare’s development of a yearlong internship with their local Community College created an effective pharmacy technician talent pipeline. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1068</itunes:duration>
                <itunes:episode>792</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Best Practices in Specialty Pharmacy Clinical Protocols</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Best Practices in Specialty Pharmacy Clinical Protocols</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-feature-best-practices-in-specialty-pharmacy-clinical-protocols/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-feature-best-practices-in-specialty-pharmacy-clinical-protocols/#comments</comments>        <pubDate>Sat, 22 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/13dbdfbc-5b36-342c-a9c5-5ad02063e321</guid>
                                    <description><![CDATA[<p>In this preview from the 2021 Midyear Clinical Meeting, our content matter experts will review the best practices for establishing a specialty patient management program, strategies for assessment, education, reassessment and identifying measures for a successful clinical pharmacy specialty service.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this preview from the 2021 Midyear Clinical Meeting, our content matter experts will review the best practices for establishing a specialty patient management program, strategies for assessment, education, reassessment and identifying measures for a successful clinical pharmacy specialty service.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p2z422/MCM_2021_Specialty_Pharmacy_Feature-_Best_Practices_in_Specialty_Pharmacy_Clinic949wf.m4a" length="48576528" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this preview from the 2021 Midyear Clinical Meeting, our content matter experts will review the best practices for establishing a specialty patient management program, strategies for assessment, education, reassessment and identifying measures for a successful clinical pharmacy specialty service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2034</itunes:duration>
                <itunes:episode>780</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: New CMS DIR Rules Explained</title>
        <itunes:title>Community Pharmacy: New CMS DIR Rules Explained</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-new-cms-dir-rules-explained/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-new-cms-dir-rules-explained/#comments</comments>        <pubDate>Fri, 21 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f73e1c1c-239d-3574-8b0d-1bddf32bdc75</guid>
                                    <description><![CDATA[<p>In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h8yw8f/ASHP_Community_Pharmacy_New_CMS_DIR_Rules_Explained_MIX.mp3" length="80689844" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2017</itunes:duration>
                <itunes:episode>786</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Biologics and Biomarkers - Management of Severe Asthma</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Biologics and Biomarkers - Management of Severe Asthma</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-biologics-and-biomarkers-management-of-severe-asthma/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-biologics-and-biomarkers-management-of-severe-asthma/#comments</comments>        <pubDate>Thu, 20 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9300329b-bd16-3214-ad1d-c4a0308be9a6</guid>
                                    <description><![CDATA[<p>Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xrjni9/MCM_2021_Specialty_Pharmacy_Feature__Biologics_and_Biomarkers_Management_of_Severe_Asthma_mixdown6ckdn.mp3" length="27998405" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1165</itunes:duration>
                <itunes:episode>790</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: How to Find Your Best Fit for Residency: A Residency Program Director Perspective</title>
        <itunes:title>Practice Journeys: How to Find Your Best Fit for Residency: A Residency Program Director Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-residency-program-director-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-residency-program-director-perspective/#comments</comments>        <pubDate>Wed, 19 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fddfd336-0941-3e37-a389-e7cde742e5b1</guid>
                                    <description><![CDATA[<p>This podcast focuses on the perspective of two Residency Program Directors who have extensive experience with residency training and the Match process. Speakers share their experiences and guidance on how applicants can align their expectations and goals with a program that best matches their aspirations. This podcast episode will help future applicants prepare for the process of identifying and applying to their best fit residency program.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast focuses on the perspective of two Residency Program Directors who have extensive experience with residency training and the Match process. Speakers share their experiences and guidance on how applicants can align their expectations and goals with a program that best matches their aspirations. This podcast episode will help future applicants prepare for the process of identifying and applying to their best fit residency program.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vawfq9/ASHP_Podcast_How_to_Find_Your_Best_Fit_for_Residency_MIX.mp3" length="63502472" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast focuses on the perspective of two Residency Program Directors who have extensive experience with residency training and the Match process. Speakers share their experiences and guidance on how applicants can align their expectations and goals with a program that best matches their aspirations. This podcast episode will help future applicants prepare for the process of identifying and applying to their best fit residency program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1587</itunes:duration>
                <itunes:episode>785</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Advanced Roles for Pharmacy Technicians in Primary Care and Anticoagulation</title>
        <itunes:title>Hot Topics in Pharmacy: Advanced Roles for Pharmacy Technicians in Primary Care and Anticoagulation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-advanced-roles-for-pharmacy-technicians-in-primary-care-and-anticoagulation/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-advanced-roles-for-pharmacy-technicians-in-primary-care-and-anticoagulation/#comments</comments>        <pubDate>Tue, 18 Oct 2022 14:31:23 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f8f2e5ff-a0a7-32ca-891a-b34240a42bd1</guid>
                                    <description><![CDATA[<p>This podcast will highlight advanced roles for pharmacy technicians in outpatient primary care and anticoagulation clinics.  Listeners will learn about the work that pharmacy technicians do in these clinics and how they interact with pharmacists and patients in these settings.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will highlight advanced roles for pharmacy technicians in outpatient primary care and anticoagulation clinics.  Listeners will learn about the work that pharmacy technicians do in these clinics and how they interact with pharmacists and patients in these settings.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d9udai/Advanced_Roles_for_Pharmacy_Technicians_in_Primary_Care_and_Anticoagulation_Clinics_mixdown92q69.mp3" length="18940282" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will highlight advanced roles for pharmacy technicians in outpatient primary care and anticoagulation clinics.  Listeners will learn about the work that pharmacy technicians do in these clinics and how they interact with pharmacists and patients in these settings.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>787</itunes:duration>
                <itunes:episode>788</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: MCM 2021 Technician Topics: Climbing to Success- Implementation of a Pharmacy Technician Career Ladder in a Health System</title>
        <itunes:title>Technician Topics: MCM 2021 Technician Topics: Climbing to Success- Implementation of a Pharmacy Technician Career Ladder in a Health System</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-mcm-2021-technician-topics-climbing-to-success-implementation-of-a-pharmacy-technician-career-ladder-in-a-health-system/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-mcm-2021-technician-topics-climbing-to-success-implementation-of-a-pharmacy-technician-career-ladder-in-a-health-system/#comments</comments>        <pubDate>Mon, 17 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5d010bf1-d610-3737-8c09-aed0a054dcf2</guid>
                                    <description><![CDATA[<p>In this curated feature from the 2021 Midyear Clinical Meeting, our content matter expert from University of Louisville Hospital shares the organizational approach to specialized technician opportunities and advancement within a multi-site health system and technician career ladder implementation, staff perception of change, and re-assessment strategies. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this curated feature from the 2021 Midyear Clinical Meeting, our content matter expert from University of Louisville Hospital shares the organizational approach to specialized technician opportunities and advancement within a multi-site health system and technician career ladder implementation, staff perception of change, and re-assessment strategies. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9d8szu/MCM_2021_Technician_Topics-_Climbing_to_Successbuau2.m4a" length="34277916" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this curated feature from the 2021 Midyear Clinical Meeting, our content matter expert from University of Louisville Hospital shares the organizational approach to specialized technician opportunities and advancement within a multi-site health system and technician career ladder implementation, staff perception of change, and re-assessment strategies. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1435</itunes:duration>
                <itunes:episode>782</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Induction of Buprenorphine &amp; Management of Patients with OUD in the Prehospital Setting (C.E.)</title>
        <itunes:title>Therapeutic Thursdays: Induction of Buprenorphine &amp; Management of Patients with OUD in the Prehospital Setting (C.E.)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-induction-of-buprenorphine-management-of-patients-with-oud-in-the-prehospital-setting-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-induction-of-buprenorphine-management-of-patients-with-oud-in-the-prehospital-setting-ce/#comments</comments>        <pubDate>Sat, 15 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1fd45fae-c2be-3d66-ab4d-447705a1fe28</guid>
                                    <description><![CDATA[<p>In this podcast, Simon Taxel will discuss his experience in the prehospital setting with a brand new bupenorphine induction strategy protocol. Additional discussion on analgesia management in patients with opioid use disorder. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Simon Taxel will discuss his experience in the prehospital setting with a brand new bupenorphine induction strategy protocol. Additional discussion on analgesia management in patients with opioid use disorder. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sdnwdc/Induction_of_Buprenorphine_Management_of_Patients_with_OUD_in_the_Prehospital6ptuu.m4a" length="34035963" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, Simon Taxel will discuss his experience in the prehospital setting with a brand new bupenorphine induction strategy protocol. Additional discussion on analgesia management in patients with opioid use disorder. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1425</itunes:duration>
                <itunes:episode>784</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Managing Transitions in COPD: A Focus on Multi-Morbidity</title>
        <itunes:title>Therapeutic Thursdays: Managing Transitions in COPD: A Focus on Multi-Morbidity</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-managing-transitions-in-copd-a-focus-on-multi-morbidity/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-managing-transitions-in-copd-a-focus-on-multi-morbidity/#comments</comments>        <pubDate>Fri, 14 Oct 2022 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/edc12833-2196-366f-bbb5-831a03b115ef</guid>
                                    <description><![CDATA[<p>From the great clinical content at the 2021 Midyear Clinical meeting, our content matter experts will be discussing managing transition of care in the COPD patient care population and identifying strategies to overcome the challenges that comorbidities present when managing a COPD exacerbation. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the great clinical content at the 2021 Midyear Clinical meeting, our content matter experts will be discussing managing transition of care in the COPD patient care population and identifying strategies to overcome the challenges that comorbidities present when managing a COPD exacerbation. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/shy779/MCM_2021_Clinical_Feature_Managing_Transitions_in_COPD_A_Focus_in_MultiMorbidity__mixdown6uuun.mp3" length="43706187" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From the great clinical content at the 2021 Midyear Clinical meeting, our content matter experts will be discussing managing transition of care in the COPD patient care population and identifying strategies to overcome the challenges that comorbidities present when managing a COPD exacerbation. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1820</itunes:duration>
                <itunes:episode>783</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2021 Technician Topics: Level Up Your Ambulatory Care Practice: Why Technicians Are Game Changers</title>
        <itunes:title>MCM 2021 Technician Topics: Level Up Your Ambulatory Care Practice: Why Technicians Are Game Changers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2021-technician-topics-level-up-your-ambulatory-care-practice-why-technicians-are-game-changers/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2021-technician-topics-level-up-your-ambulatory-care-practice-why-technicians-are-game-changers/#comments</comments>        <pubDate>Thu, 13 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/000f9cea-bd87-3654-b3be-2213f87ec9e9</guid>
                                    <description><![CDATA[<p>From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting. They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting. They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3g6xar/MCM_2021_Technician_Topics-_Level_Up_Your_Ambulatory_Care_Practice-_Why_Technici6qmef.m4a" length="51332051" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting. They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2150</itunes:duration>
                <itunes:episode>776</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Technician Topics: A Novel Technician Role for Medication Utilization Strategy at an Academic Health System</title>
        <itunes:title>Technician Topics: A Novel Technician Role for Medication Utilization Strategy at an Academic Health System</itunes:title>
        <link>https://ashpofficial.podbean.com/e/technician-topics-a-novel-technician-role-for-medication-utilization-strategy-at-an-academic-health-system/</link>
                    <comments>https://ashpofficial.podbean.com/e/technician-topics-a-novel-technician-role-for-medication-utilization-strategy-at-an-academic-health-system/#comments</comments>        <pubDate>Wed, 12 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5e7da886-f99b-3b7f-83d4-9725267415ed</guid>
                                    <description><![CDATA[<p>In this curated feature from the 2021 Midyear Clinical Meeting, the University of Virginia shares the role the Medication Utilization Strategy Team’s advanced technician plays in managing drug shortages, nonformulary management, recall management, and refrigerator and temperature management. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this curated feature from the 2021 Midyear Clinical Meeting, the University of Virginia shares the role the Medication Utilization Strategy Team’s advanced technician plays in managing drug shortages, nonformulary management, recall management, and refrigerator and temperature management. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cfuc4j/A_Novel_Technician_Role_for_Medication_Utilization_Strategy_at_an_Academic_Health_System_MCM_21_mixdown8e92p.mp3" length="32498969" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this curated feature from the 2021 Midyear Clinical Meeting, the University of Virginia shares the role the Medication Utilization Strategy Team’s advanced technician plays in managing drug shortages, nonformulary management, recall management, and refrigerator and temperature management. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1353</itunes:duration>
                <itunes:episode>779</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Addressing Implicit Bias and Cultural Alignment in Residency Program Recruitment</title>
        <itunes:title>Educator Essentials: Addressing Implicit Bias and Cultural Alignment in Residency Program Recruitment</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-addressing-implicit-bias-and-cultural-alignment-in-residency-program-recruitment/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-addressing-implicit-bias-and-cultural-alignment-in-residency-program-recruitment/#comments</comments>        <pubDate>Tue, 11 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d83b8f4e-445c-3dcc-b80e-f6c6e7084d45</guid>
                                    <description><![CDATA[<p>This podcast will discuss strategies for reducing implicit bias and increasing cultural alignment throughout the recruitment and selection processes for incoming residents.  Dr. Todd A. Walroth will share some successful recruitment elements for improving inclusion, in advance of his upcoming session during the ASHP National Pharmacy Preceptors Conference.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss strategies for reducing implicit bias and increasing cultural alignment throughout the recruitment and selection processes for incoming residents.  Dr. Todd A. Walroth will share some successful recruitment elements for improving inclusion, in advance of his upcoming session during the ASHP National Pharmacy Preceptors Conference.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/94h6kp/Addressing_Implicit_Bias_and_Cultural_Alignment_in_Residency_Program_Recruitment_mixdowna478c.mp3" length="14418019" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss strategies for reducing implicit bias and increasing cultural alignment throughout the recruitment and selection processes for incoming residents.  Dr. Todd A. Walroth will share some successful recruitment elements for improving inclusion, in advance of his upcoming session during the ASHP National Pharmacy Preceptors Conference.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>598</itunes:duration>
                <itunes:episode>778</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Outside the Box: Review of Antipsychotics and Their Lesser Known Side Effects</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Outside the Box: Review of Antipsychotics and Their Lesser Known Side Effects</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-featureoutside-the-box-reviewof-antipsychotics-and-their-lesserknownsideeffects/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-featureoutside-the-box-reviewof-antipsychotics-and-their-lesserknownsideeffects/#comments</comments>        <pubDate>Mon, 10 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e2a3772-9fd0-307c-ac83-3ee3b21db58d</guid>
                                    <description><![CDATA[<p>In this sneak peak from the 2021 Midyear Clinical Meeting, our content matter experts review the pharmacological profiles of antipsychotic medications, describe their side effects, and how pharmacists can design a therapeutic monitoring plan for a patient receiving these medications. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this sneak peak from the 2021 Midyear Clinical Meeting, our content matter experts review the pharmacological profiles of antipsychotic medications, describe their side effects, and how pharmacists can design a therapeutic monitoring plan for a patient receiving these medications. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jpwr8i/MCM_2021_Specialty_Pharmacy-_Outside_the_Box-_Review_of_Antipsychotics_and_Theira4h6l.m4a" length="53526611" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this sneak peak from the 2021 Midyear Clinical Meeting, our content matter experts review the pharmacological profiles of antipsychotic medications, describe their side effects, and how pharmacists can design a therapeutic monitoring plan for a patient receiving these medications. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2242</itunes:duration>
                <itunes:episode>777</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Hospital at Home: Operational Considerations</title>
        <itunes:title>Pharmacy Leadership: Hospital at Home: Operational Considerations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-hospital-at-home-operational-considerations/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-hospital-at-home-operational-considerations/#comments</comments>        <pubDate>Sun, 09 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1e071092-e6aa-386d-83f8-f10a9daef5b9</guid>
                                    <description><![CDATA[<p>Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home. This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home. This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jjuvwj/Hospital_at_Home_-_Operational_considerations_mixdowna0fez.mp3" length="34397178" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home. This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1431</itunes:duration>
                <itunes:episode>773</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Keeping Pace with the Guidelines.  C diff Past, Present, and Future</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Keeping Pace with the Guidelines.  C diff Past, Present, and Future</itunes:title>
        <link>https://ashpofficial.podbean.com/e/keeping-pace-with-the-guidelines-c-diff-past-present-and-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/keeping-pace-with-the-guidelines-c-diff-past-present-and-future/#comments</comments>        <pubDate>Sat, 08 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/234f03f1-3c88-3315-8481-6322c1211a21</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on treatment and management of C diff infection. Topics will include treatment plans and management strategies for our patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on treatment and management of C diff infection. Topics will include treatment plans and management strategies for our patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3dk3vy/ASHPOfficial_-_ADV_-_Keeping_Pace_with_the_Guidelines_C_diff_Past_Present_and_Future_-_MIX9curo.mp3" length="50540168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on treatment and management of C diff infection. Topics will include treatment plans and management strategies for our patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1263</itunes:duration>
                <itunes:episode>774</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: Student Roles in Health System Specialty Pharmacy: Specialty Internships</title>
        <itunes:title>Student Perspectives: Student Roles in Health System Specialty Pharmacy: Specialty Internships</itunes:title>
        <link>https://ashpofficial.podbean.com/e/student-perspectives-student-roles-in-health-system-specialty-pharmacy-specialty-internships/</link>
                    <comments>https://ashpofficial.podbean.com/e/student-perspectives-student-roles-in-health-system-specialty-pharmacy-specialty-internships/#comments</comments>        <pubDate>Fri, 07 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6c13b651-bb09-3590-b410-cda5d21f9827</guid>
                                    <description><![CDATA[<p>Specialty pharmacy is a rapidly growing practice area within pharmacy, and has many unique career opportunities for students and new practitioners. In this episode, pharmacy students who currently work at health system specialty pharmacies discuss their roles and experiences in specialty pharmacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Specialty pharmacy is a rapidly growing practice area within pharmacy, and has many unique career opportunities for students and new practitioners. In this episode, pharmacy students who currently work at health system specialty pharmacies discuss their roles and experiences in specialty pharmacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i2yfkn/Student_Roles_in_Health_System_Specialty_Pharmacy_Specialty_Internships_Revision_mixdown64kb4.mp3" length="23461673" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Specialty pharmacy is a rapidly growing practice area within pharmacy, and has many unique career opportunities for students and new practitioners. In this episode, pharmacy students who currently work at health system specialty pharmacies discuss their roles and experiences in specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>977</itunes:duration>
                <itunes:episode>775</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Navigating Immunotherapy Toxicity Management for Non-Oncology Specialists</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: MCM 2021 Specialty Pharmacy Feature: Navigating Immunotherapy Toxicity Management for Non-Oncology Specialists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-featurenavigating-immunotherapytoxicitymanagementfornon-oncology-specialists/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topicsin-pharmacy-specialty-pharmacy-mcm-2021-specialty-pharmacy-featurenavigating-immunotherapytoxicitymanagementfornon-oncology-specialists/#comments</comments>        <pubDate>Thu, 06 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9a18c16f-e535-3150-9cda-8e909855b512</guid>
                                    <description><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9kd5sg/MCM_2021_Specialty_Pharmacy_Feature-_Navigating_Immunotherapy_Toxicity_Managemen8bldi.m4a" length="28123258" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1178</itunes:duration>
                <itunes:episode>768</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Therapeutic Debates - Gabapentin as an Opioid Sparing Agent</title>
        <itunes:title>Therapeutic Thursdays: MCM 2021 Clinical Feature: Therapeutic Debates - Gabapentin as an Opioid Sparing Agent</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-therapeutic-debates-gabapentin-as-an-opioid-sparing-agent/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-mcm-2021-clinical-feature-therapeutic-debates-gabapentin-as-an-opioid-sparing-agent/#comments</comments>        <pubDate>Wed, 05 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/81b65e26-af07-350c-b8a2-be75820b21df</guid>
                                    <description><![CDATA[<p>In this fun, informative, debate-style presentation from the 2021 Midyear Clinical Meeting, our content matter experts debate the use of gabapentin as an agent for pain in opioid-sparing multimodal pain regimens or is it a wolf in sheep’s clothing?</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this fun, informative, debate-style presentation from the 2021 Midyear Clinical Meeting, our content matter experts debate the use of gabapentin as an agent for pain in opioid-sparing multimodal pain regimens or is it a wolf in sheep’s clothing?</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vtnqyb/MCM_2021_Clinical_Feature-_Therapeutic_Debates_-_Gabapentin_as_an_Opioid_Sparingbc9s0.m4a" length="37991339" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this fun, informative, debate-style presentation from the 2021 Midyear Clinical Meeting, our content matter experts debate the use of gabapentin as an agent for pain in opioid-sparing multimodal pain regimens or is it a wolf in sheep’s clothing?
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1591</itunes:duration>
                <itunes:episode>767</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Climbing the Leadership Ladder, from Practice to Academia, and Beyond</title>
        <itunes:title>Educator Essentials: Climbing the Leadership Ladder, from Practice to Academia, and Beyond</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-climbing-the-leadership-ladder-from-practice-to-academia-and-beyond/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-climbing-the-leadership-ladder-from-practice-to-academia-and-beyond/#comments</comments>        <pubDate>Tue, 04 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fca0cd3f-d9ac-3799-b661-f1e3904b823a</guid>
                                    <description><![CDATA[<p>The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers' practice journeys. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers' practice journeys. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4gqeez/ASHP_Podcast_Climbing_the_Leadership_Ladder_from_Practice_to_Academia_and_Beyond_REVISED.mp3" length="108170012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers' practice journeys. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2704</itunes:duration>
                <itunes:episode>772</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Hospital at Home: Clinical Considerations</title>
        <itunes:title>Pharmacy Leadership: Hospital at Home: Clinical Considerations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-hospital-at-home-clinical-considerations/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-hospital-at-home-clinical-considerations/#comments</comments>        <pubDate>Mon, 03 Oct 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f0a72001-1520-3ded-8ce6-39555c8f0bad</guid>
                                    <description><![CDATA[<p>Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home.  This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home.  This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/weqmn5/Hospital_at_Home_-_Clinical_considerations_mixdown9f3cu.mp3" length="35739485" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home.  This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1487</itunes:duration>
                <itunes:episode>771</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: SICP Educational Steering Committee: Therapeutics: Aspirin Use for Primary Prevention</title>
        <itunes:title>Therapeutic Thursdays: SICP Educational Steering Committee: Therapeutics: Aspirin Use for Primary Prevention</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-sicp-educational-steering-committee-therapeutics-aspirin-use-for-primary-prevention/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-sicp-educational-steering-committee-therapeutics-aspirin-use-for-primary-prevention/#comments</comments>        <pubDate>Fri, 30 Sep 2022 13:43:40 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8d467a9b-1951-33fb-945d-ec4446ccf911</guid>
                                    <description><![CDATA[<p>This podcast will review the current guidelines and summarize recent literature evaluating the use of aspirin for primary prevention. Additionally, the speakers will discuss how to talk with patients about the use of aspirin in primary prevention and when to desprescribe vs. continue therapy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will review the current guidelines and summarize recent literature evaluating the use of aspirin for primary prevention. Additionally, the speakers will discuss how to talk with patients about the use of aspirin in primary prevention and when to desprescribe vs. continue therapy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9thaar/ASHP_Podcast_Aspirin_Use_for_Primary_Prevention_MIX.mp3" length="61577336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will review the current guidelines and summarize recent literature evaluating the use of aspirin for primary prevention. Additionally, the speakers will discuss how to talk with patients about the use of aspirin in primary prevention and when to desprescribe vs. continue therapy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1539</itunes:duration>
                <itunes:episode>770</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: September Washington Update</title>
        <itunes:title>Advocating for Impact: September Washington Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-september-washington-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-september-washington-update/#comments</comments>        <pubDate>Fri, 30 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3dc0260f-209c-3695-992b-332cc39cba90</guid>
                                    <description><![CDATA[<p>Tom and Jillanne will discuss recent developments in manufacturer efforts to undercut the 340B program, as well as the recent Supreme Court ruling that requires CMS refund 340B underpayments to hospitals. We’ll cover ASHP’s advocacy strategy and touch on how covered entities can protect themselves in the current climate.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom and Jillanne will discuss recent developments in manufacturer efforts to undercut the 340B program, as well as the recent Supreme Court ruling that requires CMS refund 340B underpayments to hospitals. We’ll cover ASHP’s advocacy strategy and touch on how covered entities can protect themselves in the current climate.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xnygnb/September_Washington_Update_1_mixdown8ei6d.mp3" length="38378662" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tom and Jillanne will discuss recent developments in manufacturer efforts to undercut the 340B program, as well as the recent Supreme Court ruling that requires CMS refund 340B underpayments to hospitals. We’ll cover ASHP’s advocacy strategy and touch on how covered entities can protect themselves in the current climate.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1598</itunes:duration>
                <itunes:episode>769</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics: Monkeypox and What You Need to Know</title>
        <itunes:title>Hot Topics: Monkeypox and What You Need to Know</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-monkeypox-and-what-you-need-to-know/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-monkeypox-and-what-you-need-to-know/#comments</comments>        <pubDate>Wed, 28 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f26ec5fc-c423-31df-872d-7259c5b36b3d</guid>
                                    <description><![CDATA[<p>Monkeypox was first detected in the United States in May and earlier in August, the Department of Health and Human Services (HHS) declared monkeypox a public health emergency (PHE), signaling increased urgency as the Biden administration broadens the push to contain the virus. The World Health Organization (WHO) declared monkeypox a global health emergency on July 23, and health officials in many states, including New York, California, and Illinois, have made similar declarations. This podcast will highlight what you need to know for yourself, your community, and your patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Monkeypox was first detected in the United States in May and earlier in August, the Department of Health and Human Services (HHS) declared monkeypox a public health emergency (PHE), signaling increased urgency as the Biden administration broadens the push to contain the virus. The World Health Organization (WHO) declared monkeypox a global health emergency on July 23, and health officials in many states, including New York, California, and Illinois, have made similar declarations. This podcast will highlight what you need to know for yourself, your community, and your patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7sy4it/Monkeypox_and_What_You_Need_to_Know9xhjh.m4a" length="24619566" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Monkeypox was first detected in the United States in May and earlier in August, the Department of Health and Human Services (HHS) declared monkeypox a public health emergency (PHE), signaling increased urgency as the Biden administration broadens the push to contain the virus. The World Health Organization (WHO) declared monkeypox a global health emergency on July 23, and health officials in many states, including New York, California, and Illinois, have made similar declarations. This podcast will highlight what you need to know for yourself, your community, and your patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1031</itunes:duration>
                <itunes:episode>766</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Navigators Podcast Series: Public Health and Community Pharmacy Vaccination Efforts: Best Practices, Opportunities and Lessons Learned from the COVID-19 Pandemic</title>
        <itunes:title>Navigators Podcast Series: Public Health and Community Pharmacy Vaccination Efforts: Best Practices, Opportunities and Lessons Learned from the COVID-19 Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/navigatorspodcast-seriespublic-healthandcommunitypharmacy-vaccinationeffortsbestpracticesopportunitiesand-lessons-learnedfromthe-covid19-pandemic/</link>
                    <comments>https://ashpofficial.podbean.com/e/navigatorspodcast-seriespublic-healthandcommunitypharmacy-vaccinationeffortsbestpracticesopportunitiesand-lessons-learnedfromthe-covid19-pandemic/#comments</comments>        <pubDate>Tue, 27 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/32269095-4be8-398b-9c9c-d82c5963120a</guid>
                                    <description><![CDATA[<p>In this next episode with the Navigators, Vicki Basalyga sits down with Jason Briscoe, Director of Pharmacy Operations with Discount Drug Mart and Dave McCormick, Division Director, Immunization Division of the Indiana Department of Public Health to discuss their initial experiences with vaccination roll out at the beginning of the pandemic and the best practices they implemented to vaccinate their patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this next episode with the Navigators, Vicki Basalyga sits down with Jason Briscoe, Director of Pharmacy Operations with Discount Drug Mart and Dave McCormick, Division Director, Immunization Division of the Indiana Department of Public Health to discuss their initial experiences with vaccination roll out at the beginning of the pandemic and the best practices they implemented to vaccinate their patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d9sagz/Public_Health_and_Community_Pharmacy_Vaccination_Effortsbleoj.m4a" length="48916059" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this next episode with the Navigators, Vicki Basalyga sits down with Jason Briscoe, Director of Pharmacy Operations with Discount Drug Mart and Dave McCormick, Division Director, Immunization Division of the Indiana Department of Public Health to discuss their initial experiences with vaccination roll out at the beginning of the pandemic and the best practices they implemented to vaccinate their patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2049</itunes:duration>
                <itunes:episode>765</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: How to Find Your Best Fit for Residency: A Student Perspective</title>
        <itunes:title>Practice Journeys: How to Find Your Best Fit for Residency: A Student Perspective</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-student-perspective/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-how-to-find-your-best-fit-for-residency-a-student-perspective/#comments</comments>        <pubDate>Mon, 26 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0a0809db-ffec-3b4b-a8f3-db448eeb15dd</guid>
                                    <description><![CDATA[<p>This podcast takes a deep dive into a student’s perspective on a myriad of residency application topics including reference letter writing, role of the Midyear Clinical Meeting, and factors to consider when choosing the best fit residency.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast takes a deep dive into a student’s perspective on a myriad of residency application topics including reference letter writing, role of the Midyear Clinical Meeting, and factors to consider when choosing the best fit residency.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2svt5g/How_to_Find_Your_Best_Fit_for_Residency-_A_Student_Perspectiveax7mw.m4a" length="47409813" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast takes a deep dive into a student’s perspective on a myriad of residency application topics including reference letter writing, role of the Midyear Clinical Meeting, and factors to consider when choosing the best fit residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1986</itunes:duration>
                <itunes:episode>762</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Leveraging Pharmacy Technician Training Programs to Increase Recruitment Pool – Johns Hopkins Hospital</title>
        <itunes:title>Pharmacy Leadership: Leveraging Pharmacy Technician Training Programs to Increase Recruitment Pool – Johns Hopkins Hospital</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-leveraging-pharmacy-technician-training-programs-to-increase-recruitment-pool-%e2%80%93-johns-hopkins-hospital/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-leveraging-pharmacy-technician-training-programs-to-increase-recruitment-pool-%e2%80%93-johns-hopkins-hospital/#comments</comments>        <pubDate>Fri, 23 Sep 2022 13:03:15 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/70a9a9c5-9298-3f61-a0b4-3c1ce6acc219</guid>
                                    <description><![CDATA[<p>In this podcast we will be interviewing a pharmacy leader to discuss their Pharmacy Technician Training programs at their respective site. We will discuss the structure of their program, the successes they found in having a program, and the challenges they’ve faced along the way.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we will be interviewing a pharmacy leader to discuss their Pharmacy Technician Training programs at their respective site. We will discuss the structure of their program, the successes they found in having a program, and the challenges they’ve faced along the way.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dksfge/Leveraging_Pharmacy_Technician_Training_Programs_Johns_Hopkins_Hospital9nu1y.m4a" length="20728681" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast we will be interviewing a pharmacy leader to discuss their Pharmacy Technician Training programs at their respective site. We will discuss the structure of their program, the successes they found in having a program, and the challenges they’ve faced along the way.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>868</itunes:duration>
                <itunes:episode>764</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Medication Safety: Navigating Medication Safety and ISMP Best Practices in the Small and Rural Setting</title>
        <itunes:title>Medication Safety: Navigating Medication Safety and ISMP Best Practices in the Small and Rural Setting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/medication-safety-navigating-medication-safety-and-ismp-best-practices-in-the-small-and-rural-setting/</link>
                    <comments>https://ashpofficial.podbean.com/e/medication-safety-navigating-medication-safety-and-ismp-best-practices-in-the-small-and-rural-setting/#comments</comments>        <pubDate>Fri, 23 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/25abbaf4-b72a-3a0f-8e4a-fdb86d65ccb2</guid>
                                    <description><![CDATA[<p>This podcast will discuss strategies used in small and rural hospitals to improve medication safety and address barriers that may accompany small sites when implementing safety initiatives. Speakers will also touch on how to implement select ISMP Targeted Medication Safety Best Practices for Hospitals and how implementation may look different in the small or rural sector.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss strategies used in small and rural hospitals to improve medication safety and address barriers that may accompany small sites when implementing safety initiatives. Speakers will also touch on how to implement select ISMP Targeted Medication Safety Best Practices for Hospitals and how implementation may look different in the small or rural sector.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w7jter/ASHP_Podcast_Navigating_Medication_Safety_and_ISMP_Best_Practices_in_the_Small_and_Rural_Setting_MIX.mp3" length="58813868" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss strategies used in small and rural hospitals to improve medication safety and address barriers that may accompany small sites when implementing safety initiatives. Speakers will also touch on how to implement select ISMP Targeted Medication Safety Best Practices for Hospitals and how implementation may look different in the small or rural sector.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1470</itunes:duration>
                <itunes:episode>761</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practice Journeys: Finding Your Path in Specialty Pharmacy – The Importance of Building Bridges and Getting Excited</title>
        <itunes:title>Practice Journeys: Finding Your Path in Specialty Pharmacy – The Importance of Building Bridges and Getting Excited</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practice-journeys-finding-your-path-in-specialty-pharmacy-%e2%80%93-the-importance-of-building-bridges-and-getting-excited/</link>
                    <comments>https://ashpofficial.podbean.com/e/practice-journeys-finding-your-path-in-specialty-pharmacy-%e2%80%93-the-importance-of-building-bridges-and-getting-excited/#comments</comments>        <pubDate>Thu, 22 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/882e3542-55b3-3846-b998-7450477972b4</guid>
                                    <description><![CDATA[<p>A conversation with the 2022-2023 Chair of the ASHP Section of Specialty Pharmacy Practitioners (SSPP), Dr. Scott Canfield. Listeners will learn about Scott’s pharmacy practice experience and practice journey thus far, as well as his experiences as a leader in health system specialty pharmacy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A conversation with the 2022-2023 Chair of the ASHP Section of Specialty Pharmacy Practitioners (SSPP), Dr. Scott Canfield. Listeners will learn about Scott’s pharmacy practice experience and practice journey thus far, as well as his experiences as a leader in health system specialty pharmacy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ijt3xs/ASHP_Podcast_Finding_Your_Path_in_Specialty_Pharmacy_The_Importance_of_Building_Bridges_and_Getting_Excited_MIX1.mp3" length="49839644" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A conversation with the 2022-2023 Chair of the ASHP Section of Specialty Pharmacy Practitioners (SSPP), Dr. Scott Canfield. Listeners will learn about Scott’s pharmacy practice experience and practice journey thus far, as well as his experiences as a leader in health system specialty pharmacy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1245</itunes:duration>
                <itunes:episode>760</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer</title>
        <itunes:title>AJHP Voices: Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-stabilizing-the-pharmacy-technician-workforce-as-an-imperative-for-the-chief-pharmacy-officer/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-stabilizing-the-pharmacy-technician-workforce-as-an-imperative-for-the-chief-pharmacy-officer/#comments</comments>        <pubDate>Wed, 21 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/46f19763-4437-3f5c-9aaa-0f1ec57da82a</guid>
                                    <description><![CDATA[<p>In this podcast, Matthew Rewald, Tom Woller, and Dr. Mark Sullivan discuss the AJHP CPO Perspective, “Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Matthew Rewald, Tom Woller, and Dr. Mark Sullivan discuss the AJHP CPO Perspective, “Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e98rcx/ASHP_Podcast_AJHP_Voices_Stabilizing_the_Pharmacy_Technician_Workforce_as_an_Imperative_for_the_Chief_Pharmacy_Officer_MIX.mp3" length="91314632" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Matthew Rewald, Tom Woller, and Dr. Mark Sullivan discuss the AJHP CPO Perspective, “Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2282</itunes:duration>
                <itunes:episode>763</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Hot Topics in Pharmacy: Calling All Pharmacists: Palliative Care Specialists and Champions Needed</title>
        <itunes:title>Hot Topics in Pharmacy: Calling All Pharmacists: Palliative Care Specialists and Champions Needed</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-calling-all-pharmacists-palliative-care-specialists-and-champions-needed/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-calling-all-pharmacists-palliative-care-specialists-and-champions-needed/#comments</comments>        <pubDate>Tue, 20 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/79032fb8-9496-3e98-be1b-b6a6a101daf6</guid>
                                    <description><![CDATA[<p>This podcast will explore palliative care as a specialty and why and how all pharmacists should incorporate palliative care principles into their practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will explore palliative care as a specialty and why and how all pharmacists should incorporate palliative care principles into their practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/n3pqxn/Calling_All_Pharmacists-_Palliative_Care_Specialists_and_Champions_Needed9nlot.m4a" length="22941891" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will explore palliative care as a specialty and why and how all pharmacists should incorporate palliative care principles into their practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>961</itunes:duration>
                <itunes:episode>757</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Project Management Principles for Precepting</title>
        <itunes:title>Educator Essentials: Project Management Principles for Precepting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-project-management-principles-for-precepting/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-project-management-principles-for-precepting/#comments</comments>        <pubDate>Mon, 19 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/97869816-3a60-329c-94c0-0b2607bb229a</guid>
                                    <description><![CDATA[<p>This podcast will discuss how to incorporate project management principles for student precepting.  Dr. Kathryn Sawyer will share validated project management tools applicable to pharmacy education, in advance of her upcoming session during the ASHP National Pharmacy Preceptors Conference.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss how to incorporate project management principles for student precepting.  Dr. Kathryn Sawyer will share validated project management tools applicable to pharmacy education, in advance of her upcoming session during the ASHP National Pharmacy Preceptors Conference.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/assqhf/Project_Management_Principles_for_Precepting_NPPC_9v85j.m4a" length="15579347" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will discuss how to incorporate project management principles for student precepting.  Dr. Kathryn Sawyer will share validated project management tools applicable to pharmacy education, in advance of her upcoming session during the ASHP National Pharmacy Preceptors Conference.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>652</itunes:duration>
                <itunes:episode>759</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being &amp; Resiliency: Navigating Wellness During COVID-19: Perspectives from Across Pharmacy</title>
        <itunes:title>Well-being &amp; Resiliency: Navigating Wellness During COVID-19: Perspectives from Across Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-resiliency-navigating-wellness-during-covid-19-perspectives-from-across-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-resiliency-navigating-wellness-during-covid-19-perspectives-from-across-pharmacy/#comments</comments>        <pubDate>Fri, 16 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ed88ff24-f643-3c8d-b765-eb1960744e86</guid>
                                    <description><![CDATA[<p>Please join Brittany Tschaen and Joe Marchiano for a SCSS and NPF collaboration as they speak with New Practitioner Brooke Barlow, PharmD and clinical leader Cassie Bellamy for new perspectives about the unique wellness challenges posed by COVID-19. This podcast will add to the existing COVID-19 resources by showcasing a conversation between a New Practitioner and clinical leader to better understand how members of our profession can come together to maintain wellness. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Please join Brittany Tschaen and Joe Marchiano for a SCSS and NPF collaboration as they speak with New Practitioner Brooke Barlow, PharmD and clinical leader Cassie Bellamy for new perspectives about the unique wellness challenges posed by COVID-19. This podcast will add to the existing COVID-19 resources by showcasing a conversation between a New Practitioner and clinical leader to better understand how members of our profession can come together to maintain wellness. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4zar3p/Navigating_Wellness_During_COVID-19_Perspectives_from_Across_Pharmacy_mixdown7qa7x.mp3" length="39545012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Please join Brittany Tschaen and Joe Marchiano for a SCSS and NPF collaboration as they speak with New Practitioner Brooke Barlow, PharmD and clinical leader Cassie Bellamy for new perspectives about the unique wellness challenges posed by COVID-19. This podcast will add to the existing COVID-19 resources by showcasing a conversation between a New Practitioner and clinical leader to better understand how members of our profession can come together to maintain wellness. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1646</itunes:duration>
                <itunes:episode>754</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being &amp; Resiliency: Establishing a Support System During Pharmacy School – Advice for Incoming Students</title>
        <itunes:title>Well-being &amp; Resiliency: Establishing a Support System During Pharmacy School – Advice for Incoming Students</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-resiliency-establishing-a-support-system-during-pharmacy-school-%e2%80%93-advice-for-incoming-students/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-resiliency-establishing-a-support-system-during-pharmacy-school-%e2%80%93-advice-for-incoming-students/#comments</comments>        <pubDate>Thu, 15 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6b8d2ea8-0f15-3e8c-9a56-68d2d0ce07fa</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This episode will provide insight on how to establish and maintain wellbeing during the first year of pharmacy school.  Listeners will here from three rising P2 students that were able to create support systems that helped them be successful academically and mentally.       </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">This episode will provide insight on how to establish and maintain wellbeing during the first year of pharmacy school.  Listeners will here from three rising P2 students that were able to create support systems that helped them be successful academically and mentally.       </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wb3taj/Establishing_a_Support_System_During_Pharmacy_School_Advice_for_Incoming_Stude99nj8.m4a" length="16979085" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This episode will provide insight on how to establish and maintain wellbeing during the first year of pharmacy school.  Listeners will here from three rising P2 students that were able to create support systems that helped them be successful academically and mentally.       
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>711</itunes:duration>
                <itunes:episode>758</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Community Pharmacy: Community Pharmacy: Explore SafeMedication for Your Patients</title>
        <itunes:title>Hot Topics in Pharmacy: Community Pharmacy: Community Pharmacy: Explore SafeMedication for Your Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-community-pharmacy-community-pharmacy-explore-safemedication-for-your-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-community-pharmacy-community-pharmacy-explore-safemedication-for-your-patients/#comments</comments>        <pubDate>Tue, 13 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fcb29bd5-e83f-3d30-8297-6b596f0f75f9</guid>
                                    <description><![CDATA[<p>In this podcast episode, we host Dr. Melody Berg, ASHP’s editorial director for medication information. The discussion will explore ASHP’s Safemedication.com page as a source of information about prescription and over-the-counter medications for patients. Written by pharmacists, the easy-to-read articles include information about vaccines, tips for taking or giving medications, and answers to common safety questions.      </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we host Dr. Melody Berg, ASHP’s editorial director for medication information. The discussion will explore ASHP’s Safemedication.com page as a source of information about prescription and over-the-counter medications for patients. Written by pharmacists, the easy-to-read articles include information about vaccines, tips for taking or giving medications, and answers to common safety questions.      </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/k5ibcz/Community_Pharmacy-_Explore_Safemedication_for_Your_Patients6drmb.m4a" length="21317973" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast episode, we host Dr. Melody Berg, ASHP’s editorial director for medication information. The discussion will explore ASHP’s Safemedication.com page as a source of information about prescription and over-the-counter medications for patients. Written by pharmacists, the easy-to-read articles include information about vaccines, tips for taking or giving medications, and answers to common safety questions.      
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>893</itunes:duration>
                <itunes:episode>756</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays (C.E.): I Am Not Comfortable With That! Treatment of Pain in Palliative Care</title>
        <itunes:title>Therapeutic Thursdays (C.E.): I Am Not Comfortable With That! Treatment of Pain in Palliative Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-i-am-not-comfortable-with-that-treatment-of-pain-in-palliative-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-i-am-not-comfortable-with-that-treatment-of-pain-in-palliative-care/#comments</comments>        <pubDate>Sat, 10 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fdcf365a-d24f-3ff3-a746-b767de4a074f</guid>
                                    <description><![CDATA[<p>Opioid analgesic therapy is a common treatment for severe pain in the palliative care population.  As the population ages, more patients with a history of opioid misuse are experiencing chronic, severe, difficult to treat pain, often related to cancer.  This session will review various pain therapies for severe pain in the palliative care population and outline strategies for pain management in patients with comorbid use disorders. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Opioid analgesic therapy is a common treatment for severe pain in the palliative care population.  As the population ages, more patients with a history of opioid misuse are experiencing chronic, severe, difficult to treat pain, often related to cancer.  This session will review various pain therapies for severe pain in the palliative care population and outline strategies for pain management in patients with comorbid use disorders. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m4pskx/I_Am_Not_Comfortable_With_That_Treatment_of_Pain_in_Palliative_Care_CE_84ghq.m4a" length="49978560" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Opioid analgesic therapy is a common treatment for severe pain in the palliative care population.  As the population ages, more patients with a history of opioid misuse are experiencing chronic, severe, difficult to treat pain, often related to cancer.  This session will review various pain therapies for severe pain in the palliative care population and outline strategies for pain management in patients with comorbid use disorders. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2093</itunes:duration>
                <itunes:episode>753</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Insights and Perspectives on Autoverification</title>
        <itunes:title>Informatics Bytes: Insights and Perspectives on Autoverification</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-insights-and-perspectives-on-autoverification/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-insights-and-perspectives-on-autoverification/#comments</comments>        <pubDate>Fri, 09 Sep 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/57aa64bb-8ab9-34fc-ad3b-432452003c95</guid>
                                    <description><![CDATA[<p>During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9p2uhi/Insights_and_Perspectives_on_Autoverification6a72z.m4a" length="25131974" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                <itunes:episode>755</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Leveraging Outcomes Data and Developing Relationships with Payers</title>
        <itunes:title>Pharmacy Leadership: Leveraging Outcomes Data and Developing Relationships with Payers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-leveraging-outcomes-data-and-developing-relationships-with-payers/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-leveraging-outcomes-data-and-developing-relationships-with-payers/#comments</comments>        <pubDate>Fri, 02 Sep 2022 15:05:43 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a9b210c9-9d54-35ef-94e7-c1c978c05622</guid>
                                    <description><![CDATA[<p>This podcast will address opportunities to develop relationships with payers to optimize patient outcomes.  With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.     </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will address opportunities to develop relationships with payers to optimize patient outcomes.  With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.     </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uruiu8/Leveraging_Outcomes_Data_and_Developing_Relationships_with_Payers_mixdown7xqq3.mp3" length="36820138" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will address opportunities to develop relationships with payers to optimize patient outcomes.  With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.     
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1532</itunes:duration>
                <itunes:episode>752</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: PGY2 Pharmacy Informatics Residency – Insights from Current Residents</title>
        <itunes:title>Informatics Bytes: PGY2 Pharmacy Informatics Residency – Insights from Current Residents</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-pgy2-pharmacy-informatics-residency-%e2%80%93-insights-from-current-residents/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-pgy2-pharmacy-informatics-residency-%e2%80%93-insights-from-current-residents/#comments</comments>        <pubDate>Fri, 02 Sep 2022 15:01:14 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a78e9b4d-f543-3785-96e4-f4b57d43a4ef</guid>
                                    <description><![CDATA[<p>Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/whz9b5/ASHP_Podcast_PGY2_Pharmacy_Informatics_Residency_Insights_from_Current_Residents_MIX.mp3" length="62149448" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1553</itunes:duration>
                <itunes:episode>751</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Topical Hemostat Use in the ED</title>
        <itunes:title>Therapeutic Thursdays: Topical Hemostat Use in the ED</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-topical-hemostat-use-in-the-ed/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-topical-hemostat-use-in-the-ed/#comments</comments>        <pubDate>Sat, 27 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/48a68606-a4b5-36f2-a43b-729cc2676b08</guid>
                                    <description><![CDATA[<p>While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f6g374/Topical_Hemostat_Use_in_the_ED80lgk.m4a" length="23087753" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>967</itunes:duration>
                <itunes:episode>745</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: Implementation of a Central Pharmacist Hybrid: Remote Staffing Model at an Academic Medical Center During COVID-19</title>
        <itunes:title>COVID-19: Implementation of a Central Pharmacist Hybrid: Remote Staffing Model at an Academic Medical Center During COVID-19</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-implementation-of-a-central-pharmacist-hybrid-remote-staffing-model-at-an-academic-medical-center-during-covid-19/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-implementation-of-a-central-pharmacist-hybrid-remote-staffing-model-at-an-academic-medical-center-during-covid-19/#comments</comments>        <pubDate>Thu, 25 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/14b15e6e-fd86-3544-8424-f3d11186cb98</guid>
                                    <description><![CDATA[<p>In the Management Case Study, our content matter experts discuss the need for remote work for a world-wide pandemic, identify metrics used to elevate the sustainability of a central pharmacist stagging work model and describe the elements of a successful remote work model for a hospital or health system.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the Management Case Study, our content matter experts discuss the need for remote work for a world-wide pandemic, identify metrics used to elevate the sustainability of a central pharmacist stagging work model and describe the elements of a successful remote work model for a hospital or health system.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ietic9/MCM_2021_COVID-19_Implementation_of_a_Central_Pharmacist_Hybrid-_Remote_Staffing_Model_at_an_Academic_Medical_Center_During_COVID-19__mixdown5z06x.mp3" length="33038586" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In the Management Case Study, our content matter experts discuss the need for remote work for a world-wide pandemic, identify metrics used to elevate the sustainability of a central pharmacist stagging work model and describe the elements of a successful remote work model for a hospital or health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1375</itunes:duration>
                <itunes:episode>743</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Provider Status for Pharmacists: Lessons Learned</title>
        <itunes:title>Pharmacy Leadership: Provider Status for Pharmacists: Lessons Learned</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-provider-status-for-pharmacists-lessons-learned/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-provider-status-for-pharmacists-lessons-learned/#comments</comments>        <pubDate>Wed, 24 Aug 2022 14:39:10 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/944c062f-d24d-30f0-a2f1-6c9b6604f31c</guid>
                                    <description><![CDATA[<p>This podcast episode focuses on the journey to obtaining pharmacist provider status from pharmacy leaders in Minnesota, North Carolina, and Wisconsin who have been advocating on the frontlines. Listen in to learn about the growing need for pharmacist provider status, speakers’ experiences, and advice for those interested in getting involved in pursuing provider status.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode focuses on the journey to obtaining pharmacist provider status from pharmacy leaders in Minnesota, North Carolina, and Wisconsin who have been advocating on the frontlines. Listen in to learn about the growing need for pharmacist provider status, speakers’ experiences, and advice for those interested in getting involved in pursuing provider status.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5tyr4s/Provider_Status_for_Pharmacists__Lessons_Learned__mixdown887jf.mp3" length="58319016" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode focuses on the journey to obtaining pharmacist provider status from pharmacy leaders in Minnesota, North Carolina, and Wisconsin who have been advocating on the frontlines. Listen in to learn about the growing need for pharmacist provider status, speakers’ experiences, and advice for those interested in getting involved in pursuing provider status.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2428</itunes:duration>
                <itunes:episode>744</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: Review of Dobbs v. Jackson’s Implications for State Law and Pharmacist Practice</title>
        <itunes:title>Advocating for Impact: Review of Dobbs v. Jackson’s Implications for State Law and Pharmacist Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-review-of-dobbs-v-jackson-s-implications-for-state-law-and-pharmacist-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-review-of-dobbs-v-jackson-s-implications-for-state-law-and-pharmacist-practice/#comments</comments>        <pubDate>Mon, 22 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/151855d4-25f6-3e75-9ac8-7a0325962467</guid>
                                    <description><![CDATA[<p>In the recent weeks since the Supreme Court issued a decision in Dobbs v. Jackson, there have been widespread media reports of patients experiencing new barriers to access to medication therapies that are seemingly unrelated to reproductive health care or abortion services. During this podcast, we are going to explore the basis of these reports, provide background on the current status of state and federal laws governing access to abortion services, and discuss potential implications for pharmacist practice and patients’ access to medications. Further reading: <a href='https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly'>https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly</a></p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In the recent weeks since the Supreme Court issued a decision in <em>Dobbs v. Jackson</em>, there have been widespread media reports of patients experiencing new barriers to access to medication therapies that are seemingly unrelated to reproductive health care or abortion services. During this podcast, we are going to explore the basis of these reports, provide background on the current status of state and federal laws governing access to abortion services, and discuss potential implications for pharmacist practice and patients’ access to medications. Further reading: <a href='https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly'>https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly</a></p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/spdrvu/Review_of_Dobbs_v_Jackson_s_Implications_for_State_Law_and_Pharmacist_Practiceb8n8m.m4a" length="33360806" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In the recent weeks since the Supreme Court issued a decision in Dobbs v. Jackson, there have been widespread media reports of patients experiencing new barriers to access to medication therapies that are seemingly unrelated to reproductive health care or abortion services. During this podcast, we are going to explore the basis of these reports, provide background on the current status of state and federal laws governing access to abortion services, and discuss potential implications for pharmacist practice and patients’ access to medications. Further reading: https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1397</itunes:duration>
                <itunes:episode>738</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays (C.E.): Alternative to Opioids (ALTO) (CE)</title>
        <itunes:title>Therapeutic Thursdays (C.E.): Alternative to Opioids (ALTO) (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-alternative-to-opioids-alto-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-alternative-to-opioids-alto-ce/#comments</comments>        <pubDate>Sat, 20 Aug 2022 13:28:04 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/992111dd-3cb6-3975-b71b-d20c520c8042</guid>
                                    <description><![CDATA[<p>Abuse of and addiction to opioid medications continues to be a growing issue worldwide with opioid abuse often beginning with prescribed products in medical care.  Multimodal pain management uses alternatives to opioids to prevent the initial exposure that may lead to addiction and abuse. This podcast is focused on describing the management of acute and chronic pain conditions with opioid sparing modalities and analgesic optimization.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Abuse of and addiction to opioid medications continues to be a growing issue worldwide with opioid abuse often beginning with prescribed products in medical care.  Multimodal pain management uses alternatives to opioids to prevent the initial exposure that may lead to addiction and abuse. This podcast is focused on describing the management of acute and chronic pain conditions with opioid sparing modalities and analgesic optimization.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j5yh76/Alternative_to_Opioids_ALTO_With_CE_Code__mixdown9625s.mp3" length="29897703" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Abuse of and addiction to opioid medications continues to be a growing issue worldwide with opioid abuse often beginning with prescribed products in medical care.  Multimodal pain management uses alternatives to opioids to prevent the initial exposure that may lead to addiction and abuse. This podcast is focused on describing the management of acute and chronic pain conditions with opioid sparing modalities and analgesic optimization.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1244</itunes:duration>
                <itunes:episode>742</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Clinical Practice or Academia - Which is right for you?</title>
        <itunes:title>Educator Essentials: Clinical Practice or Academia - Which is right for you?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-clinical-practice-or-academia-which-is-right-for-you/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-clinical-practice-or-academia-which-is-right-for-you/#comments</comments>        <pubDate>Fri, 19 Aug 2022 11:42:30 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6478698f-1b2b-316b-b394-36daa561534b</guid>
                                    <description><![CDATA[<p>The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers’ practice journeys.     </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers’ practice journeys.     </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vkfrdu/Clinical_Practice_or_Academia-_Which_is_right_for_you_mixdownax501.mp3" length="24109678" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers’ practice journeys.     
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1003</itunes:duration>
                <itunes:episode>741</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Accelerating Biosimilar Adoption: Conversation with the Experts</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Accelerating Biosimilar Adoption: Conversation with the Experts</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-accelerating-biosimilar-adoption-conversation-with-the-experts/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-accelerating-biosimilar-adoption-conversation-with-the-experts/#comments</comments>        <pubDate>Fri, 19 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4fdd726d-4a9b-3e78-b344-4fcb2458f9a2</guid>
                                    <description><![CDATA[<p>Learn from experts in the field as they discuss barriers and key strategies for biosimilar adoption.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field as they discuss barriers and key strategies for biosimilar adoption.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uvf4d2/ASHP_ADV_Accelerating_Biosimilar_Adoption_Conversation_with_the_Experts_MIX.mp3" length="71310548" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field as they discuss barriers and key strategies for biosimilar adoption.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1782</itunes:duration>
                <itunes:episode>740</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: MCM 2021 COVID-19 Coverage: Responding to the COVID-19 Pandemic in an Anticoagulation Clinic- A Precipitance for Practice Model Change</title>
        <itunes:title>COVID-19: MCM 2021 COVID-19 Coverage: Responding to the COVID-19 Pandemic in an Anticoagulation Clinic- A Precipitance for Practice Model Change</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-mcm-2021-covid-19-coverage-responding-to-the-covid-19-pandemic-in-an-anticoagulation-clinic-a-precipitance-for-practice-model-change/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-mcm-2021-covid-19-coverage-responding-to-the-covid-19-pandemic-in-an-anticoagulation-clinic-a-precipitance-for-practice-model-change/#comments</comments>        <pubDate>Thu, 18 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8420f00b-4286-3fc0-9ef8-d4092ece1fe8</guid>
                                    <description><![CDATA[<p>During the COVID19 pandemic, primary care and specialty office practices in Michigan were closed or consolidated with laboratory services in outlying clinics closed or experienced a significant reduction in hours. In this episode, our speakers share how their practice continued to see patients during the COVID19 pandemic without any interruption to services provided by offering curbside INR checks and monitoring of INRs remotely while preserving patient and employee safety. Through implementing a practice model that included incorporating pharmacy technicians into workflows and leveraging telehealth visits, ambulatory care clinics can manage stable INRs to better serve patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During the COVID19 pandemic, primary care and specialty office practices in Michigan were closed or consolidated with laboratory services in outlying clinics closed or experienced a significant reduction in hours. In this episode, our speakers share how their practice continued to see patients during the COVID19 pandemic without any interruption to services provided by offering curbside INR checks and monitoring of INRs remotely while preserving patient and employee safety. Through implementing a practice model that included incorporating pharmacy technicians into workflows and leveraging telehealth visits, ambulatory care clinics can manage stable INRs to better serve patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ayc3kb/MCM_2021_COVID-19-_Responding_to_the_COVID-19_Pandemic_in_an_Anticoagulation_Cli9pj64.m4a" length="32438248" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[During the COVID19 pandemic, primary care and specialty office practices in Michigan were closed or consolidated with laboratory services in outlying clinics closed or experienced a significant reduction in hours. In this episode, our speakers share how their practice continued to see patients during the COVID19 pandemic without any interruption to services provided by offering curbside INR checks and monitoring of INRs remotely while preserving patient and employee safety. Through implementing a practice model that included incorporating pharmacy technicians into workflows and leveraging telehealth visits, ambulatory care clinics can manage stable INRs to better serve patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1358</itunes:duration>
                <itunes:episode>730</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Establishing Infrastructure to Develop Pharmacy Population Health and Service Line Payer Engagement</title>
        <itunes:title>Pharmacy Leadership: Establishing Infrastructure to Develop Pharmacy Population Health and Service Line Payer Engagement</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-establishing-infrastructure-to-develop-pharmacy-population-health-and-service-line-payer-engagement/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-establishing-infrastructure-to-develop-pharmacy-population-health-and-service-line-payer-engagement/#comments</comments>        <pubDate>Wed, 17 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b8e66f7-92a5-304d-8312-ace2f52dac49</guid>
                                    <description><![CDATA[<p>This podcast will discuss strategies to develop pharmacy practice infrastructure in population health and service line settings, discuss options to measure this practice success on patient outcomes, and opportunities to utilize this data in organizational payer engagement.    </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will discuss strategies to develop pharmacy practice infrastructure in population health and service line settings, discuss options to measure this practice success on patient outcomes, and opportunities to utilize this data in organizational payer engagement.    </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vdnhf9/ASHP_Podcast_Establishing_Infrastructure_to_Develop_Pharmacy_Population_Health_and_Service_Line_Payer_Engagement_MIX_1_a8702.mp3" length="61822676" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will discuss strategies to develop pharmacy practice infrastructure in population health and service line settings, discuss options to measure this practice success on patient outcomes, and opportunities to utilize this data in organizational payer engagement.    
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1545</itunes:duration>
                <itunes:episode>739</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Future of Ambulatory Care Pharmacy: Practicing in a Post-COVID Era</title>
        <itunes:title>Hot Topics in Pharmacy: The Future of Ambulatory Care Pharmacy: Practicing in a Post-COVID Era</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-future-of-ambulatory-care-pharmacy-practicing-in-a-post-covid-era/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-future-of-ambulatory-care-pharmacy-practicing-in-a-post-covid-era/#comments</comments>        <pubDate>Tue, 16 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/58ea2121-2369-3a50-8653-edeb634f93c3</guid>
                                    <description><![CDATA[<p>Ambulatory care pharmacy practice has evolved greatly throughout the COVID-19 pandemic.  As healthcare begins to think about life beyond COVID, ambulatory care pharmacists are evaluating their role and what practice may look like as services continue to develop to meet the healthcare needs of the ever growing pool of patients who have experienced COVID19. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Ambulatory care pharmacy practice has evolved greatly throughout the COVID-19 pandemic.  As healthcare begins to think about life beyond COVID, ambulatory care pharmacists are evaluating their role and what practice may look like as services continue to develop to meet the healthcare needs of the ever growing pool of patients who have experienced COVID19. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/w9dn6r/The_Future_of_Ambulatory_Care_Pharmacy_Practicing_in_a_Post_COVID_Era_mixdown5ykvp.mp3" length="23279876" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Ambulatory care pharmacy practice has evolved greatly throughout the COVID-19 pandemic.  As healthcare begins to think about life beyond COVID, ambulatory care pharmacists are evaluating their role and what practice may look like as services continue to develop to meet the healthcare needs of the ever growing pool of patients who have experienced COVID19. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>968</itunes:duration>
                <itunes:episode>737</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Educator Essentials: Leveling Up Your Precepting Through Gamification</title>
        <itunes:title>Educator Essentials: Leveling Up Your Precepting Through Gamification</itunes:title>
        <link>https://ashpofficial.podbean.com/e/educator-essentials-leveling-up-your-precepting-through-gamification/</link>
                    <comments>https://ashpofficial.podbean.com/e/educator-essentials-leveling-up-your-precepting-through-gamification/#comments</comments>        <pubDate>Mon, 15 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/40b56f86-ec1f-3c12-9814-8e0b1b6c3d83</guid>
                                    <description><![CDATA[<p>This podcast will explore how to incorporate gaming into residency/institutional teaching to help foster engagement for the learners.  Dr. Megan Adelman will share some key strategies and instructional techniques, in advance of her upcoming educational session during the ASHP National Pharmacy Preceptors Conference.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will explore how to incorporate gaming into residency/institutional teaching to help foster engagement for the learners.  Dr. Megan Adelman will share some key strategies and instructional techniques, in advance of her upcoming educational session during the ASHP National Pharmacy Preceptors Conference.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kskz7i/2_Leveling_Up_Your_Precepting_Through_Gamification__mixdown6siie.mp3" length="18891379" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will explore how to incorporate gaming into residency/institutional teaching to help foster engagement for the learners.  Dr. Megan Adelman will share some key strategies and instructional techniques, in advance of her upcoming educational session during the ASHP National Pharmacy Preceptors Conference.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>786</itunes:duration>
                <itunes:episode>736</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Navigators Podcast Series: Expansion of Community Pharmacies’ Role in Public Vaccine Delivery to Children: The Landscape, the Opportunities, and the Need</title>
        <itunes:title>Navigators Podcast Series: Expansion of Community Pharmacies’ Role in Public Vaccine Delivery to Children: The Landscape, the Opportunities, and the Need</itunes:title>
        <link>https://ashpofficial.podbean.com/e/navigators-podcast-series-expansion-of-community-pharmacies-role-in-public-vaccine-delivery-to-children-the-landscape-the-opportunities-and-the-need/</link>
                    <comments>https://ashpofficial.podbean.com/e/navigators-podcast-series-expansion-of-community-pharmacies-role-in-public-vaccine-delivery-to-children-the-landscape-the-opportunities-and-the-need/#comments</comments>        <pubDate>Sat, 13 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/234dd672-a8cb-3ba3-acd0-761ebb772f41</guid>
                                    <description><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this next episode in our series of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the Jude Aldean and Renee Robinson who will discuss the Vaccines for Children Program and how this program can support public health goals for childhood immunization. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this next episode in our series of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the Jude Aldean and Renee Robinson who will discuss the Vaccines for Children Program and how this program can support public health goals for childhood immunization. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hcec5c/ASHP_Podcast_Expansion_of_Community_Pharmacies_Role_in_Public_Vaccine_Delivery_to_Children_MIX.mp3" length="51640544" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this next episode in our series of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the Jude Aldean and Renee Robinson who will discuss the Vaccines for Children Program and how this program can support public health goals for childhood immunization. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1291</itunes:duration>
                <itunes:episode>735</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Informatics Bytes: Staying Current in Healthcare, Information and Technology: Perspectives from Pharmacy Leaders Part 2 of 2</title>
        <itunes:title>Informatics Bytes: Staying Current in Healthcare, Information and Technology: Perspectives from Pharmacy Leaders Part 2 of 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/informatics-bytes-staying-current-in-healthcare-information-and-technology-perspectives-from-pharmacy-leaders-part-2-of-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/informatics-bytes-staying-current-in-healthcare-information-and-technology-perspectives-from-pharmacy-leaders-part-2-of-2/#comments</comments>        <pubDate>Fri, 12 Aug 2022 09:38:07 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9f6abba5-0fdb-3fb2-a736-076b5966e8c9</guid>
                                    <description><![CDATA[<p>This podcast will explore leadership strategies and skills needed to stay relevant in healthcare.  The speakers will describe how they keep up with the changes in managing healthcare technology. They will describe how ASHP has contributed to their ability to keep pace with these changes. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will explore leadership strategies and skills needed to stay relevant in healthcare.  The speakers will describe how they keep up with the changes in managing healthcare technology. They will describe how ASHP has contributed to their ability to keep pace with these changes. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cpz2ft/ASHP_Podcast_Staying_Current_in_Healthcare_Information_and_Technology_Perspectives_from_Pharmacy_Leaders_Part_2_of_2_MIX.mp3" length="69981536" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will explore leadership strategies and skills needed to stay relevant in healthcare.  The speakers will describe how they keep up with the changes in managing healthcare technology. They will describe how ASHP has contributed to their ability to keep pace with these changes. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1749</itunes:duration>
                <itunes:episode>734</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Specialty Pharmacy: Controlled Room Temperature Shipping Validations</title>
        <itunes:title>Hot Topics in Pharmacy: Specialty Pharmacy: Controlled Room Temperature Shipping Validations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-controlled-room-temperature-shipping-validations/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-specialty-pharmacy-controlled-room-temperature-shipping-validations/#comments</comments>        <pubDate>Tue, 09 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9f98c1f1-0896-3d1c-8449-587e7bce74f0</guid>
                                    <description><![CDATA[<p>Shipping validations are a requirement for many accrediting bodies of health system specialty pharmacies. However, a lack of industry guidance and minimal packaging solutions available on the market pose many challenges for specialty pharmacy teams. In this episode of Hot Topics in Pharmacy, we talk about the process undergone by one health system specialty pharmacy to create and validate packouts for room temperature medication shipping.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Shipping validations are a requirement for many accrediting bodies of health system specialty pharmacies. However, a lack of industry guidance and minimal packaging solutions available on the market pose many challenges for specialty pharmacy teams. In this episode of Hot Topics in Pharmacy, we talk about the process undergone by one health system specialty pharmacy to create and validate packouts for room temperature medication shipping.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mnv69z/2_Controlled_Room_Temperature_Shipping_Validations_mixdownajx2z.mp3" length="14907605" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Shipping validations are a requirement for many accrediting bodies of health system specialty pharmacies. However, a lack of industry guidance and minimal packaging solutions available on the market pose many challenges for specialty pharmacy teams. In this episode of Hot Topics in Pharmacy, we talk about the process undergone by one health system specialty pharmacy to create and validate packouts for room temperature medication shipping.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>620</itunes:duration>
                <itunes:episode>731</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: The Ohio Story: Pursuits of Pharmacy Provider Status</title>
        <itunes:title>Hot Topics in Pharmacy: The Ohio Story: Pursuits of Pharmacy Provider Status</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-ohio-story-pursuits-of-pharmacy-provider-status/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-the-ohio-story-pursuits-of-pharmacy-provider-status/#comments</comments>        <pubDate>Mon, 08 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/89790993-40e6-35e0-8f9e-ea037e5f821e</guid>
                                    <description><![CDATA[<p>This podcast episode discusses the journey that resulted in Ohio’s Provider Status Law. Listeners will learn about provider status, the challenges that were overcome to have Ohio’s Provider Status Law signed, future directions, and how to get involved.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses the journey that resulted in Ohio’s Provider Status Law. Listeners will learn about provider status, the challenges that were overcome to have Ohio’s Provider Status Law signed, future directions, and how to get involved.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/phf9iz/The_Ohio_Storybw7ij.m4a" length="26569159" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode discusses the journey that resulted in Ohio’s Provider Status Law. Listeners will learn about provider status, the challenges that were overcome to have Ohio’s Provider Status Law signed, future directions, and how to get involved.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1600</itunes:duration>
                <itunes:episode>726</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocating for Impact: August Washington Update</title>
        <itunes:title>Advocating for Impact: August Washington Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/advocating-for-impact-august-washington-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/advocating-for-impact-august-washington-update/#comments</comments>        <pubDate>Fri, 05 Aug 2022 17:05:39 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c238dfaf-1ace-3991-ad86-41b3789fbcb6</guid>
                                    <description><![CDATA[<p>Tom Kraus, ASHP’s vice president of government relations, and Jillanne Schulte Wall, ASHP’s senior director of health and regulatory policy provide an update on the top policy issues impacting pharmacy practice that are being considered by congress and regulatory agencies this month.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physic</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom Kraus, ASHP’s vice president of government relations, and Jillanne Schulte Wall, ASHP’s senior director of health and regulatory policy provide an update on the top policy issues impacting pharmacy practice that are being considered by congress and regulatory agencies this month.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physic</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/32icsx/Advocacy_Roundtable_Podcast_Update9whux.mp3" length="19300367" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tom Kraus, ASHP’s vice president of government relations, and Jillanne Schulte Wall, ASHP’s senior director of health and regulatory policy provide an update on the top policy issues impacting pharmacy practice that are being considered by congress and regulatory agencies this month.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physic]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1205</itunes:duration>
                <itunes:episode>732</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovation Fridays: Innovation at Work: Leveraging Pharmacists to Close Gaps in Mental Health and Pain Care</title>
        <itunes:title>Innovation Fridays: Innovation at Work: Leveraging Pharmacists to Close Gaps in Mental Health and Pain Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/innovation-fridays-innovation-at-work-leveraging-pharmacists-to-close-gaps-in-mental-health-and-pain-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/innovation-fridays-innovation-at-work-leveraging-pharmacists-to-close-gaps-in-mental-health-and-pain-care/#comments</comments>        <pubDate>Fri, 05 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5cc7e5e8-6398-3679-9aa0-2db184145070</guid>
                                    <description><![CDATA[<p>This episode from the 2021 Midyear Clinical Meeting explores practice models that include pharmacists as a part of the health care team in the primary care setting and foundational elements of practice for mental health and pain management where pharmacists play a pivotal role.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode from the 2021 Midyear Clinical Meeting explores practice models that include pharmacists as a part of the health care team in the primary care setting and foundational elements of practice for mental health and pain management where pharmacists play a pivotal role.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ccwfu9/Innovation_at_Work__Leveraging_Pharmacists_to_Close_Gaps_in_Mental_Health_and_Pain_Care_MCM_Clinical_mixdownbbvd3.mp3" length="64340607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode from the 2021 Midyear Clinical Meeting explores practice models that include pharmacists as a part of the health care team in the primary care setting and foundational elements of practice for mental health and pain management where pharmacists play a pivotal role.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2679</itunes:duration>
                <itunes:episode>727</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: Impact of Remote Medication History Technician Workflow during COVID-19 on the Bedside Discharge Medication Delivery Services Acceptance Rate</title>
        <itunes:title>COVID-19: Impact of Remote Medication History Technician Workflow during COVID-19 on the Bedside Discharge Medication Delivery Services Acceptance Rate</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-impact-of-remote-medication-history-technician-workflow-during-covid-19-on-the-bedside-discharge-medication-delivery-services-acceptance-rate/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-impact-of-remote-medication-history-technician-workflow-during-covid-19-on-the-bedside-discharge-medication-delivery-services-acceptance-rate/#comments</comments>        <pubDate>Thu, 04 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1c95862a-ff0b-3376-93d0-74aae21ae57a</guid>
                                    <description><![CDATA[<p>In this episode, our content matter experts describe how they identified and procured the necessary technology to facilitate remote work for medication history technicians. This included developing procedures for contacting patients/caregivers remotely to conduct medication history interviews, and training technicians on new technology and workflow and metrics related to the services. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our content matter experts describe how they identified and procured the necessary technology to facilitate remote work for medication history technicians. This included developing procedures for contacting patients/caregivers remotely to conduct medication history interviews, and training technicians on new technology and workflow and metrics related to the services. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/p74zkf/Impact_of_Remote_Medication_History_Technician_Workflow_during_COVID-19_on_the_Bedside_Discharge_Medication_Delivery_Services_Acceptance_Rate__mixdownak532.mp3" length="31899087" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, our content matter experts describe how they identified and procured the necessary technology to facilitate remote work for medication history technicians. This included developing procedures for contacting patients/caregivers remotely to conduct medication history interviews, and training technicians on new technology and workflow and metrics related to the services. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                <itunes:episode>724</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being and Resiliency: Incorporating Resident Wellbeing Into Your Residency Program</title>
        <itunes:title>Well-being and Resiliency: Incorporating Resident Wellbeing Into Your Residency Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-and-resiliency-incorporating-resident-wellbeing-into-your-residency-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-and-resiliency-incorporating-resident-wellbeing-into-your-residency-program/#comments</comments>        <pubDate>Wed, 03 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/80a8d11b-4352-395a-87c6-1c1a12259139</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">The draft revision of the ASHP Accreditation Standard for Postgraduate Residency Programs was released for comment on 12/9/2021. One notable addition to the harmonized draft standards is the focus on resident wellbeing. This podcast is intended to highlight how some programs have worked to incorporate residency wellbeing into their program structure and how that could positively impact residency training. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">The draft revision of the ASHP Accreditation Standard for Postgraduate Residency Programs was released for comment on 12/9/2021. One notable addition to the harmonized draft standards is the focus on resident wellbeing. This podcast is intended to highlight how some programs have worked to incorporate residency wellbeing into their program structure and how that could positively impact residency training. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/teitvr/Incorporating_Resident_Wellbeing_Into_Your_Residency_Program_mixdown7m3or.mp3" length="47620205" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The draft revision of the ASHP Accreditation Standard for Postgraduate Residency Programs was released for comment on 12/9/2021. One notable addition to the harmonized draft standards is the focus on resident wellbeing. This podcast is intended to highlight how some programs have worked to incorporate residency wellbeing into their program structure and how that could positively impact residency training. 
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1983</itunes:duration>
                <itunes:episode>729</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Multistate Licensure and Compliance Best Practices</title>
        <itunes:title>Hot Topics in Pharmacy: Multistate Licensure and Compliance Best Practices</itunes:title>
        <link>https://ashpofficial.podbean.com/e/multistate-licensure-and-compliance-best-practices/</link>
                    <comments>https://ashpofficial.podbean.com/e/multistate-licensure-and-compliance-best-practices/#comments</comments>        <pubDate>Mon, 01 Aug 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bac95f76-0051-3aad-98b8-3ac344adac24</guid>
                                    <description><![CDATA[<p>This podcast will cover current challenges and best practices for hospitals and health systems looking to maintain multistate pharmacy and pharmacy workforce compliance.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will cover current challenges and best practices for hospitals and health systems looking to maintain multistate pharmacy and pharmacy workforce compliance.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iy8xbv/Multistate_Licensure_and_Compliance_Best_Practicesaaf3d.m4a" length="34481966" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast will cover current challenges and best practices for hospitals and health systems looking to maintain multistate pharmacy and pharmacy workforce compliance.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1444</itunes:duration>
                <itunes:episode>716</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays (C.E.): Opioid De-escalation: Are We Exceeding the Speed Limit?</title>
        <itunes:title>Therapeutic Thursdays (C.E.): Opioid De-escalation: Are We Exceeding the Speed Limit?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-opioid-de-escalation-are-we-exceeding-the-speed-limit/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-ce-opioid-de-escalation-are-we-exceeding-the-speed-limit/#comments</comments>        <pubDate>Sat, 30 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/677d17f4-4bbd-3e5f-9340-f2fc12289872</guid>
                                    <description><![CDATA[<p>Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zx4yuh/ASHP_Opioid_De_escalation_Are_we_exceeding_the_speed_limit_CE_MIX.mp3" length="62481440" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1562</itunes:duration>
                <itunes:episode>728</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: ASHP Advantage: Standardize for Safety: The Role and Reflections of the Pharmacy Technician</title>
        <itunes:title>Hot Topics in Pharmacy: ASHP Advantage: Standardize for Safety: The Role and Reflections of the Pharmacy Technician</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-standardize-for-safety-the-role-and-reflections-of-the-pharmacy-technician/</link>
                    <comments>https://ashpofficial.podbean.com/e/hot-topics-in-pharmacy-ashp-advantage-standardize-for-safety-the-role-and-reflections-of-the-pharmacy-technician/#comments</comments>        <pubDate>Fri, 29 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/80adae17-72aa-37cd-9859-c1d11a0ee5f2</guid>
                                    <description><![CDATA[<p>In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/32iafr/ASHPOfficial_ADV_The_Role_and_Reflections_of_the_Pharmacy_Technician_MIX.mp3" length="18468224" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1154</itunes:duration>
                <itunes:episode>725</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: SICP Educational Steering Committee: “It’s The Remix”: Mixing and Matching COVID Vaccine Boosters</title>
        <itunes:title>Therapeutic Thursdays: SICP Educational Steering Committee: “It’s The Remix”: Mixing and Matching COVID Vaccine Boosters</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-sicp-educational-steering-committee-it-s-the-remix-mixing-and-matching-covid-vaccine-boosters/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-sicp-educational-steering-committee-it-s-the-remix-mixing-and-matching-covid-vaccine-boosters/#comments</comments>        <pubDate>Thu, 28 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/21a48799-f639-3588-b736-d24d1cb5bf6d</guid>
                                    <description><![CDATA[<p>The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations. </p>
<p>Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: <a href='https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf'>https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf</a>  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations. </p>
<p>Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: <a href='https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf'>https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf</a>  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/abt3af/_It_s_The_Remix_Mixing_and_Matching_COVID_Vaccine_Boosters_mixdownbte72.mp3" length="30320890" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations. 
Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1262</itunes:duration>
                <itunes:episode>723</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices: National trends in prescription drug expenditures and projections for 2022</title>
        <itunes:title>AJHP Voices: National trends in prescription drug expenditures and projections for 2022</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-national-trends-in-prescription-drug-expenditures-and-projections-for-2022/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-national-trends-in-prescription-drug-expenditures-and-projections-for-2022/#comments</comments>        <pubDate>Wed, 27 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/087085d2-502d-3999-b0a0-65f45489c0b9</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zvxsdy/ASHP_Podcast_National_trends_in_prescription_drug_expenditures_and_projections_for_2022_MIX_1_7teso.mp3" length="62772716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1569</itunes:duration>
                <itunes:episode>721</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>COVID-19: Telehealth in Small and Rural Hospitals: Pandemic Acceleration and Beyond</title>
        <itunes:title>COVID-19: Telehealth in Small and Rural Hospitals: Pandemic Acceleration and Beyond</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-telehealth-in-small-and-rural-hospitals-pandemic-acceleration-and-beyond/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-telehealth-in-small-and-rural-hospitals-pandemic-acceleration-and-beyond/#comments</comments>        <pubDate>Tue, 26 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5bbc91bb-2d33-31b8-9891-6a40d1372ead</guid>
                                    <description><![CDATA[<p>In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rbqb6m/Telehealth_in_Small_and_Rural_Hospitals_Pandemic_Acceleration_and_Beyond_mixdownamgrk.mp3" length="78274895" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3260</itunes:duration>
                <itunes:episode>722</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Research Topics: Introduction to the Specialty Pharmacy Outcomes Literature Library</title>
        <itunes:title>Research Topics: Introduction to the Specialty Pharmacy Outcomes Literature Library</itunes:title>
        <link>https://ashpofficial.podbean.com/e/introduction-to-the-specialty-pharmacy-outcomes-literature-library/</link>
                    <comments>https://ashpofficial.podbean.com/e/introduction-to-the-specialty-pharmacy-outcomes-literature-library/#comments</comments>        <pubDate>Mon, 25 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/73652bf7-2376-3848-9c88-ced35ff0c23a</guid>
                                    <description><![CDATA[<p>Listeners will be introduced to the background and purpose of the <a href='https://www.ashp.org/pharmacy-practice/resource-centers/health-system-specialty-pharmacy-resource-center/outcomes-literature-library'>Specialty Pharmacy Outcomes Literature Library</a>, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listeners will be introduced to the background and purpose of the <a href='https://www.ashp.org/pharmacy-practice/resource-centers/health-system-specialty-pharmacy-resource-center/outcomes-literature-library'>Specialty Pharmacy Outcomes Literature Library</a>, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mh3yaq/Introduction_to_the_Specialty_Pharmacy_Outcomes_Literature_Library8zdxc.m4a" length="10500631" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Listeners will be introduced to the background and purpose of the Specialty Pharmacy Outcomes Literature Library, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>439</itunes:duration>
                <itunes:episode>703</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vaccine Navigators: Meet the Navigators</title>
        <itunes:title>Vaccine Navigators: Meet the Navigators</itunes:title>
        <link>https://ashpofficial.podbean.com/e/meet-the-navigators/</link>
                    <comments>https://ashpofficial.podbean.com/e/meet-the-navigators/#comments</comments>        <pubDate>Sat, 23 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e5472863-b719-3f3b-8aef-6c2dfc46a08f</guid>
                                    <description><![CDATA[<p>In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gnw2mn/Meet_the_Navigators70qgs.m4a" length="23741131" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>994</itunes:duration>
                <itunes:episode>713</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership: Leadership in Pharmacy: Traditional/Non-Traditional Career Paths</title>
        <itunes:title>Pharmacy Leadership: Leadership in Pharmacy: Traditional/Non-Traditional Career Paths</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-leadership-in-pharmacy-traditionalnon-traditional-career-paths/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-leadership-in-pharmacy-traditionalnon-traditional-career-paths/#comments</comments>        <pubDate>Fri, 22 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/956618cd-bbce-3658-ae59-0ebd44187266</guid>
                                    <description><![CDATA[<p>This podcast, produced by ASHP’s Pharmacy Administration and Leadership Resident Collaborative, provides an engaging interview with two pharmacy leaders who have had successful careers after completing a Health System Pharmacy Administration and Leadership residency. Although both leaders have completed the same type of residency training, they have pursued different career paths, one being traditional and the other being non-traditional. David Dawka and Samm Anderegg will share their insights on their professional journeys after residency.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast, produced by ASHP’s Pharmacy Administration and Leadership Resident Collaborative, provides an engaging interview with two pharmacy leaders who have had successful careers after completing a Health System Pharmacy Administration and Leadership residency. Although both leaders have completed the same type of residency training, they have pursued different career paths, one being traditional and the other being non-traditional. David Dawka and Samm Anderegg will share their insights on their professional journeys after residency.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/txj2uw/ASHPOfficial_Leadership_in_Pharmacy_Traditional_Non_Traditional_Career_Paths_MIX_1_8m9jb.mp3" length="22490606" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast, produced by ASHP’s Pharmacy Administration and Leadership Resident Collaborative, provides an engaging interview with two pharmacy leaders who have had successful careers after completing a Health System Pharmacy Administration and Leadership residency. Although both leaders have completed the same type of residency training, they have pursued different career paths, one being traditional and the other being non-traditional. David Dawka and Samm Anderegg will share their insights on their professional journeys after residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                <itunes:episode>720</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Pediatrics: Overcoming Challenges in Parenteral Nutrition Taking Care of Small Patients in Big Places Small Patients and their PN Challenges</title>
        <itunes:title>Therapeutic Thursdays: Pediatrics: Overcoming Challenges in Parenteral Nutrition Taking Care of Small Patients in Big Places Small Patients and their PN Challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/overcoming-challenges-in-parenteral-nutrition-taking-care-of-small-patients-in-big-places-small-patients-and-their-pn-challenges/</link>
                    <comments>https://ashpofficial.podbean.com/e/overcoming-challenges-in-parenteral-nutrition-taking-care-of-small-patients-in-big-places-small-patients-and-their-pn-challenges/#comments</comments>        <pubDate>Thu, 21 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/66e1c22e-40f1-3f2a-b5fd-0a1b4e93d12d</guid>
                                    <description><![CDATA[<p>In this pediatric-focused presentation planned in cooperation with the Section of Clinical Specialists and Scientists, our content matter expert reviews the neonatal and pediatric requirements for macronutrients and micronutrients and the characteristics of this population’s specific parenteral nutrition products affect the solubility and stability of the formulation. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this pediatric-focused presentation planned in cooperation with the Section of Clinical Specialists and Scientists, our content matter expert reviews the neonatal and pediatric requirements for macronutrients and micronutrients and the characteristics of this population’s specific parenteral nutrition products affect the solubility and stability of the formulation. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/npbd6f/MCM-_Small_Patients_and_their_PN_Challenges6fq8m.m4a" length="28382887" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this pediatric-focused presentation planned in cooperation with the Section of Clinical Specialists and Scientists, our content matter expert reviews the neonatal and pediatric requirements for macronutrients and micronutrients and the characteristics of this population’s specific parenteral nutrition products affect the solubility and stability of the formulation. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1189</itunes:duration>
                <itunes:episode>710</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Student Perspectives: The Value of Mentorship</title>
        <itunes:title>Student Perspectives: The Value of Mentorship</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-value-of-mentorship/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-value-of-mentorship/#comments</comments>        <pubDate>Wed, 20 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b38521bd-44c9-3217-955a-946ce87bf655</guid>
                                    <description><![CDATA[<p>Finding and engaging a mentor can be one of the most intimidating and challenging parts of pharmacy school. During this podcast, Megan Wright, PharmD Candidate at the UNC Eshelman School of Pharmacy and Dr. Katelynn Granger, a PGY-1 resident at MUSC Health, will talk discuss their own personal mentorship relationship and how it can be fostered and maintained through busy times.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Finding and engaging a mentor can be one of the most intimidating and challenging parts of pharmacy school. During this podcast, Megan Wright, PharmD Candidate at the UNC Eshelman School of Pharmacy and Dr. Katelynn Granger, a PGY-1 resident at MUSC Health, will talk discuss their own personal mentorship relationship and how it can be fostered and maintained through busy times.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gx46pq/Value_of_Mentorship_mixdownb7kg1.mp3" length="16817952" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Finding and engaging a mentor can be one of the most intimidating and challenging parts of pharmacy school. During this podcast, Megan Wright, PharmD Candidate at the UNC Eshelman School of Pharmacy and Dr. Katelynn Granger, a PGY-1 resident at MUSC Health, will talk discuss their own personal mentorship relationship and how it can be fostered and maintained through busy times.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>699</itunes:duration>
                <itunes:episode>719</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hot Topics in Pharmacy: Don’t Get Stuck! Treating Acute Pain in Patients Taking Buprenorphine</title>
        <itunes:title>Hot Topics in Pharmacy: Don’t Get Stuck! Treating Acute Pain in Patients Taking Buprenorphine</itunes:title>
        <link>https://ashpofficial.podbean.com/e/don-t-get-stuck-treating-acute-pain-in-patients-taking-buprenorphine/</link>
                    <comments>https://ashpofficial.podbean.com/e/don-t-get-stuck-treating-acute-pain-in-patients-taking-buprenorphine/#comments</comments>        <pubDate>Tue, 19 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/37784956-b984-3a23-9cc5-42bbec8566e9</guid>
                                    <description><![CDATA[<p>This episode provides an overview of treatment options for acute pain in patients taking buprenorphine and how pharmacists can provide optimal care for patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides an overview of treatment options for acute pain in patients taking buprenorphine and how pharmacists can provide optimal care for patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zu93np/Don_t_Get_Stuck_Treating_Acute_Pain_in_Patients_Taking_Buprenorphine_mixdown7qhoo.mp3" length="25463062" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode provides an overview of treatment options for acute pain in patients taking buprenorphine and how pharmacists can provide optimal care for patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1060</itunes:duration>
                <itunes:episode>715</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leadership Conversations: Establishing an Student Internship Program</title>
        <itunes:title>Leadership Conversations: Establishing an Student Internship Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leadership-conversations-establishing-an-student-internship-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/leadership-conversations-establishing-an-student-internship-program/#comments</comments>        <pubDate>Mon, 18 Jul 2022 12:53:01 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/746762f0-480e-35a4-98e6-e529b392ee2d</guid>
                                    <description><![CDATA[<p>There are a wide variety of student internship programs across the country. This podcast, hosted by the New Practitioners Forum, focuses on unique summer internship programs and shares advice for practitioners to consider when establishing or enhancing internship programs at their institution.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>There are a wide variety of student internship programs across the country. This podcast, hosted by the New Practitioners Forum, focuses on unique summer internship programs and shares advice for practitioners to consider when establishing or enhancing internship programs at their institution.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j8n96e/ASHP_Podcast_Leadership_Conversations_Establishing_an_Internship_MIX.mp3" length="107489324" type="audio/mpeg"/>
        <itunes:summary><![CDATA[There are a wide variety of student internship programs across the country. This podcast, hosted by the New Practitioners Forum, focuses on unique summer internship programs and shares advice for practitioners to consider when establishing or enhancing internship programs at their institution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2687</itunes:duration>
                <itunes:episode>718</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Leadership and oversite of additional service lines</title>
        <itunes:title>Pharmacy Leadership and oversite of additional service lines</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-leadership-and-oversite-of-additional-service-lines/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-leadership-and-oversite-of-additional-service-lines/#comments</comments>        <pubDate>Mon, 18 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/741e66fe-463d-3c95-8d3b-acca6382333c</guid>
                                    <description><![CDATA[<p>We speak with three pharmacy leaders that have organizational responsibility for pharmacy and other clinical service lines. This is a growing phenomenon in healthcare and this podcast episode shares their insights and learnings with managing additional service lines. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We speak with three pharmacy leaders that have organizational responsibility for pharmacy and other clinical service lines. This is a growing phenomenon in healthcare and this podcast episode shares their insights and learnings with managing additional service lines. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/azt3bx/ASHP_Podcast_Pharmacy_Leadership_and_oversite_of_additional_service_lines_MIX.mp3" length="58778372" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We speak with three pharmacy leaders that have organizational responsibility for pharmacy and other clinical service lines. This is a growing phenomenon in healthcare and this podcast episode shares their insights and learnings with managing additional service lines. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1469</itunes:duration>
                <itunes:episode>717</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It’s a Balancing Act: Cultivating Passions In and Outside of the Pharmacy Profession</title>
        <itunes:title>It’s a Balancing Act: Cultivating Passions In and Outside of the Pharmacy Profession</itunes:title>
        <link>https://ashpofficial.podbean.com/e/it-s-a-balancing-act-cultivating-passions-in-and-outside-of-the-pharmacy-profession/</link>
                    <comments>https://ashpofficial.podbean.com/e/it-s-a-balancing-act-cultivating-passions-in-and-outside-of-the-pharmacy-profession/#comments</comments>        <pubDate>Thu, 14 Jul 2022 19:33:27 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7affef8a-c892-36e1-a9a2-6ad0bcd6f91d</guid>
                                    <description><![CDATA[<p>This episode features a conversation with Alsean Bryant, an HIV pharmacy specialist with the AIDS Healthcare Foundation. Listeners will learn about his thriving pharmacy practice as well as his work with national recording artists, a professional football team, and mentees. Alsean will share how he is able to explore all of his interests and leave a lasting impact on the community.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode features a conversation with Alsean Bryant, an HIV pharmacy specialist with the AIDS Healthcare Foundation. Listeners will learn about his thriving pharmacy practice as well as his work with national recording artists, a professional football team, and mentees. Alsean will share how he is able to explore all of his interests and leave a lasting impact on the community.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/twkj9q/It_s_a_Balancing_Act_Cultivating_Passions_In_and_Outside_of_the_Pharmacy_Profession_mixdown9abvc.mp3" length="31381260" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode features a conversation with Alsean Bryant, an HIV pharmacy specialist with the AIDS Healthcare Foundation. Listeners will learn about his thriving pharmacy practice as well as his work with national recording artists, a professional football team, and mentees. Alsean will share how he is able to explore all of his interests and leave a lasting impact on the community.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1306</itunes:duration>
                <itunes:episode>714</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sick and Tired of Being Sick and Tired: New Perspectives on Occupational Burnout During the COVID-19 Pandemic</title>
        <itunes:title>Sick and Tired of Being Sick and Tired: New Perspectives on Occupational Burnout During the COVID-19 Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/sick-and-tired-of-being-sick-and-tired-new-perspectives-on-occupational-burnout-during-the-covid-19-pandemic/</link>
                    <comments>https://ashpofficial.podbean.com/e/sick-and-tired-of-being-sick-and-tired-new-perspectives-on-occupational-burnout-during-the-covid-19-pandemic/#comments</comments>        <pubDate>Wed, 13 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/86187228-4247-3863-afda-4234e9578f32</guid>
                                    <description><![CDATA[<p>This podcast features excerpts from the presentation at the 2021 Midyear Clinical Meeting where Bryan McCarthy and Lalita Prasad-Reddy discuss the effects of work-related stress on productivity during the COVID-19 pandemic and identify methods that can prevent occupational burnout in the pharmacy department.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast features excerpts from the presentation at the 2021 Midyear Clinical Meeting where Bryan McCarthy and Lalita Prasad-Reddy discuss the effects of work-related stress on productivity during the COVID-19 pandemic and identify methods that can prevent occupational burnout in the pharmacy department.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/92dham/MCM_2021_COVID-19_Coverage_Sick_and_Tired_of_Being_Sick_and_Tired_-_New_Perspectives_on_Occupational_Burnout_During_the_COVID-19_Pandemic_mixdowna6i7h.mp3" length="65881228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast features excerpts from the presentation at the 2021 Midyear Clinical Meeting where Bryan McCarthy and Lalita Prasad-Reddy discuss the effects of work-related stress on productivity during the COVID-19 pandemic and identify methods that can prevent occupational burnout in the pharmacy department.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2744</itunes:duration>
                <itunes:episode>711</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Innovative Partnerships for Health Systems</title>
        <itunes:title>Community Pharmacy: Innovative Partnerships for Health Systems</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-innovative-partnerships-for-health-systems/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-innovative-partnerships-for-health-systems/#comments</comments>        <pubDate>Tue, 12 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/51ee7c04-b853-3f66-a70e-4d38e4b6e14d</guid>
                                    <description><![CDATA[<p>In this podcast we discuss the development of an innovative partnership model between a department of pharmacy within a health system and an external community pharmacy network.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we discuss the development of an innovative partnership model between a department of pharmacy within a health system and an external community pharmacy network.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sddxpj/Community_Pharmacy_Innovative_Partnerships_for_Health_Systems_mixdown92dhv.mp3" length="46975500" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast we discuss the development of an innovative partnership model between a department of pharmacy within a health system and an external community pharmacy network.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1956</itunes:duration>
                <itunes:episode>709</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Little Dab Should Do It: Pain Management with Cannabis</title>
        <itunes:title>A Little Dab Should Do It: Pain Management with Cannabis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-little-dab-should-do-it-pain-management-with-cannabis/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-little-dab-should-do-it-pain-management-with-cannabis/#comments</comments>        <pubDate>Sat, 09 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e4fa5799-1522-38d5-9471-f5ec65771aeb</guid>
                                    <description><![CDATA[<p>Chronic pain is one of the main reasons patients seek medical care in the United States. Cannabis is being investigated as an alternate to opioid therapy due the potential to decrease opioid requirements and a better safety profile compared to opioids. This session will review cannabis use as an analgesic and highlight the pharmacist consultative role in cannabis education for pain.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Chronic pain is one of the main reasons patients seek medical care in the United States. Cannabis is being investigated as an alternate to opioid therapy due the potential to decrease opioid requirements and a better safety profile compared to opioids. This session will review cannabis use as an analgesic and highlight the pharmacist consultative role in cannabis education for pain.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/48uap2/ASHP_Podcast_A_Little_Dab_Should_Do_It_Pain_Management_with_Cannabis_CE_MIX.mp3" length="79062248" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Chronic pain is one of the main reasons patients seek medical care in the United States. Cannabis is being investigated as an alternate to opioid therapy due the potential to decrease opioid requirements and a better safety profile compared to opioids. This session will review cannabis use as an analgesic and highlight the pharmacist consultative role in cannabis education for pain.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1976</itunes:duration>
                <itunes:episode>705</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The State of Health Informatics in Pharmacy Education</title>
        <itunes:title>The State of Health Informatics in Pharmacy Education</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-state-of-health-informatics-in-pharmacy-education/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-state-of-health-informatics-in-pharmacy-education/#comments</comments>        <pubDate>Fri, 08 Jul 2022 09:12:48 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8bb8b122-fef4-341a-8287-03173f9f4680</guid>
                                    <description><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this podcast, we will discuss how artificial intelligence machine learning, data science and analytics are being incorporated into pharmacy education and how pharmacists can be better prepared to enter the ever-changing workforce.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">In this podcast, we will discuss how artificial intelligence machine learning, data science and analytics are being incorporated into pharmacy education and how pharmacists can be better prepared to enter the ever-changing workforce.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v74u89/The_State_of_Health_Informatics_in_Pharmacy_Education75547.m4a" length="21289778" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast, we will discuss how artificial intelligence machine learning, data science and analytics are being incorporated into pharmacy education and how pharmacists can be better prepared to enter the ever-changing workforce.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>891</itunes:duration>
                <itunes:episode>708</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Maximizing Medicaid: How Provider Status Intersects with Medicaid Coverage</title>
        <itunes:title>Maximizing Medicaid: How Provider Status Intersects with Medicaid Coverage</itunes:title>
        <link>https://ashpofficial.podbean.com/e/maximizing-medicaid-how-provider-status-intersects-with-medicaid-coverage/</link>
                    <comments>https://ashpofficial.podbean.com/e/maximizing-medicaid-how-provider-status-intersects-with-medicaid-coverage/#comments</comments>        <pubDate>Thu, 07 Jul 2022 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b0a997bc-7bcd-35c3-b40f-33b2ae862df8</guid>
                                    <description><![CDATA[<p>Tom and Jillanne will cover a recent communication from Medicaid to the states, directing them to allow providers authorized under the PREP Act to order and administer vaccines to enroll in Medicaid. We’ll discuss what this tone shift signals for pharmacists and how it intersects with broader provider status efforts.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tom and Jillanne will cover a recent communication from Medicaid to the states, directing them to allow providers authorized under the PREP Act to order and administer vaccines to enroll in Medicaid. We’ll discuss what this tone shift signals for pharmacists and how it intersects with broader provider status efforts.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/y6thzv/2_Maximizing_Medicaid_How_Provider_Status_Intersects_with_Medicaid_Coverage_Tom_Kraus_Jillanne_Schulte_Wall_mixdownatt58.mp3" length="23650640" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tom and Jillanne will cover a recent communication from Medicaid to the states, directing them to allow providers authorized under the PREP Act to order and administer vaccines to enroll in Medicaid. We’ll discuss what this tone shift signals for pharmacists and how it intersects with broader provider status efforts.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>984</itunes:duration>
                <itunes:episode>707</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The long and short of long-acting antiretroviral therapy for HIV</title>
        <itunes:title>The long and short of long-acting antiretroviral therapy for HIV</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-long-and-short-of-long-acting-antiretroviral-therapy-for-hiv/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-long-and-short-of-long-acting-antiretroviral-therapy-for-hiv/#comments</comments>        <pubDate>Thu, 07 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/376e60ef-a718-3968-9d9e-00695ad83189</guid>
                                    <description><![CDATA[<p>The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gihszz/The_long_and_short_of_long-acting_antiretroviral_therapy_for_HIV_Shah_Sherman_Cocohoba_mixdown9rai8.mp3" length="39585229" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1648</itunes:duration>
                <itunes:episode>706</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-being and Resiliency in Pharmacy Practice and Training</title>
        <itunes:title>Well-being and Resiliency in Pharmacy Practice and Training</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-and-resiliency-in-pharmacy-practice-and-training/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-and-resiliency-in-pharmacy-practice-and-training/#comments</comments>        <pubDate>Wed, 06 Jul 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/61bba3eb-52c7-322c-9f8c-147e5d82ff70</guid>
                                    <description><![CDATA[<p>Residency program directors (RPD) from across the country will discuss successful personal and health system resiliency strategies across the spectrum for supporting individual well-being and cultivating organizational cultures committed to mitigating occupational burnout. Content will include members sharing experiences related to individual and organizational resiliency, implementation of solutions, and strategies for self-care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Residency program directors (RPD) from across the country will discuss successful personal and health system resiliency strategies across the spectrum for supporting individual well-being and cultivating organizational cultures committed to mitigating occupational burnout. Content will include members sharing experiences related to individual and organizational resiliency, implementation of solutions, and strategies for self-care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nwyrkm/ASHP_Well_being_and_Resiliency_in_Pharmacy_Practice_and_Training_MIX.mp3" length="97219496" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Residency program directors (RPD) from across the country will discuss successful personal and health system resiliency strategies across the spectrum for supporting individual well-being and cultivating organizational cultures committed to mitigating occupational burnout. Content will include members sharing experiences related to individual and organizational resiliency, implementation of solutions, and strategies for self-care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2430</itunes:duration>
                <itunes:episode>704</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advocacy Roundtable Discussion</title>
        <itunes:title>Advocacy Roundtable Discussion</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-federal-and-state-policy-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-federal-and-state-policy-update/#comments</comments>        <pubDate>Thu, 30 Jun 2022 14:37:48 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f33c6ee1-626b-36af-926f-075d6e50d38b</guid>
                                    <description><![CDATA[<p>Listen to our <a href='https://d1447f04.na1.hubspotlinks.com/Ctc/V+113/d1447f04/VVq0JX3SNXttN3TmK-2ypDwMW22vCbp4LYghZKqPt5nKv5V3Zsc37CgMK2W5P7nPx7j6J8ZW4CVLMY1m6CsPMgCVCX9nmtlMqsQGGQWYHyW5TQbyq9cgKJLW40Fg8L1vdF6dVYCCyf7FMlhTW74p3G27TfxcRN7D_hnqRStDXN2z-7SMRNVvgW3Ms9994kTVXPVCTs2C75VQN7V_wtgY9jtL6hVdxpdK5n6VlpW75Q5Wf2FWR3GW3GFWhW5hjPx0W4bJL13605rdkW6bTlPX4x2bkdW8phwfz4wSMpQW917P9H3p5tfDW8Fcssk65pXQbW9fLs-Y1WK2XPW2ShCRK7CDRwRW4sDlTv1TqcjkW9lp_Lm2VX_PzW3KVGz95kPC3NW46hRlJ84cWMMN6c98r9hP810W8yqgJ48S5PglMBgpqc9328WW5QJK03482zbmW33rmF94vg7Jy2cg1'>Advocacy Roundtable Discussion</a> with ASHP’s government relations team regarding our top advocacy priorities. This discussion with Tom Kraus, vice president of government relations, Jillanne Schulte Wall, senior director of Health and Regulatory Policy, and Kyle Robb, director of state policy advocacy, provides ASHP members with an inside look at federal advocacy topics impacting the practice of pharmacy. Topics discussed include pharmacist provider status, 340B, elimination of the X-waiver for buprenorphine prescribing, white bagging, and more.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen to our <a href='https://d1447f04.na1.hubspotlinks.com/Ctc/V+113/d1447f04/VVq0JX3SNXttN3TmK-2ypDwMW22vCbp4LYghZKqPt5nKv5V3Zsc37CgMK2W5P7nPx7j6J8ZW4CVLMY1m6CsPMgCVCX9nmtlMqsQGGQWYHyW5TQbyq9cgKJLW40Fg8L1vdF6dVYCCyf7FMlhTW74p3G27TfxcRN7D_hnqRStDXN2z-7SMRNVvgW3Ms9994kTVXPVCTs2C75VQN7V_wtgY9jtL6hVdxpdK5n6VlpW75Q5Wf2FWR3GW3GFWhW5hjPx0W4bJL13605rdkW6bTlPX4x2bkdW8phwfz4wSMpQW917P9H3p5tfDW8Fcssk65pXQbW9fLs-Y1WK2XPW2ShCRK7CDRwRW4sDlTv1TqcjkW9lp_Lm2VX_PzW3KVGz95kPC3NW46hRlJ84cWMMN6c98r9hP810W8yqgJ48S5PglMBgpqc9328WW5QJK03482zbmW33rmF94vg7Jy2cg1'>Advocacy Roundtable Discussion</a> with ASHP’s government relations team regarding our top advocacy priorities. This discussion with Tom Kraus, vice president of government relations, Jillanne Schulte Wall, senior director of Health and Regulatory Policy, and Kyle Robb, director of state policy advocacy, provides ASHP members with an inside look at federal advocacy topics impacting the practice of pharmacy. Topics discussed include pharmacist provider status, 340B, elimination of the X-waiver for buprenorphine prescribing, white bagging, and more.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kshy2r/3_GRD_Updates_Revision_63022_mixdownbf01e.mp3" length="45698012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Listen to our Advocacy Roundtable Discussion with ASHP’s government relations team regarding our top advocacy priorities. This discussion with Tom Kraus, vice president of government relations, Jillanne Schulte Wall, senior director of Health and Regulatory Policy, and Kyle Robb, director of state policy advocacy, provides ASHP members with an inside look at federal advocacy topics impacting the practice of pharmacy. Topics discussed include pharmacist provider status, 340B, elimination of the X-waiver for buprenorphine prescribing, white bagging, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
 ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1903</itunes:duration>
                <itunes:episode>702</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ensuring Technician Voices in the Department</title>
        <itunes:title>Ensuring Technician Voices in the Department</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ensuring-technician-voices-in-department/</link>
                    <comments>https://ashpofficial.podbean.com/e/ensuring-technician-voices-in-department/#comments</comments>        <pubDate>Thu, 30 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/16743865-1a33-355b-ae77-aa4faf24682d</guid>
                                    <description><![CDATA[<p>This podcast episode discusses strategies to ensure pharmacy technicians have a voice in pharmacy, associated committees, and outcomes. With the heightened national issue around the pharmacy technician workforce the conversation shares how these processes impacts professional satisfaction, engagement, and retention for pharmacy technicians.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses strategies to ensure pharmacy technicians have a voice in pharmacy, associated committees, and outcomes. With the heightened national issue around the pharmacy technician workforce the conversation shares how these processes impacts professional satisfaction, engagement, and retention for pharmacy technicians.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iqkw6h/Ensuring_technician_voices_in_the_dept_mixdownaxcni.mp3" length="16098175" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses strategies to ensure pharmacy technicians have a voice in pharmacy, associated committees, and outcomes. With the heightened national issue around the pharmacy technician workforce the conversation shares how these processes impacts professional satisfaction, engagement, and retention for pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>670</itunes:duration>
                <itunes:episode>700</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>PAIring SSHP initiatives with PAI 2030</title>
        <itunes:title>PAIring SSHP initiatives with PAI 2030</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pairing-sshp-initiatives-with-pai-2030/</link>
                    <comments>https://ashpofficial.podbean.com/e/pairing-sshp-initiatives-with-pai-2030/#comments</comments>        <pubDate>Wed, 29 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d50ece89-a874-3738-ab0f-06db2398e031</guid>
                                    <description><![CDATA[<p>The ASHP Practice Advancement Initiative (PAI) 2030 provides aspiration guidance and is intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. Student Societies of Health-System Pharmacists (SSHPs) are actively promoting the pillars of PAI 2030 within their chapters. In this podcast episode, we will highlight examples of how to incorporate PAI into SSHP initiatives.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The ASHP Practice Advancement Initiative (PAI) 2030 provides aspiration guidance and is intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. Student Societies of Health-System Pharmacists (SSHPs) are actively promoting the pillars of PAI 2030 within their chapters. In this podcast episode, we will highlight examples of how to incorporate PAI into SSHP initiatives.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7cfp53/PAIring_SSHP_initiatives_with_PAI_20307hwt4.m4a" length="25315969" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[The ASHP Practice Advancement Initiative (PAI) 2030 provides aspiration guidance and is intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. Student Societies of Health-System Pharmacists (SSHPs) are actively promoting the pillars of PAI 2030 within their chapters. In this podcast episode, we will highlight examples of how to incorporate PAI into SSHP initiatives.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1060</itunes:duration>
                <itunes:episode>699</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Establishing Professional Identity as a New Practitioner</title>
        <itunes:title>Establishing Professional Identity as a New Practitioner</itunes:title>
        <link>https://ashpofficial.podbean.com/e/establishing-professional-identity-as-a-new-practitioner/</link>
                    <comments>https://ashpofficial.podbean.com/e/establishing-professional-identity-as-a-new-practitioner/#comments</comments>        <pubDate>Mon, 27 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/11628cbf-e2f4-3236-b6a0-fec16c2bcc08</guid>
                                    <description><![CDATA[<p>During this podcast, listeners learn about establishing a professional identify as a new practitioner. Speakers include new practitioner members ranging from new graduates to practitioners with a few years of experience. Speakers share their insight and advice on crafting a professional identity and how that identity can evolve throughout your training and career. For additional resources related to establishing a professional identity, check out the ASHP <a href='https://www.ashp.org/-/media/assets/new-practitioner/docs/Professional-Identity-Formation-Worksheet_ASHP-NPF_Final.pdf'>Professional Identify Formation Worksheet</a>, developed by members of the New Practitioners Forum. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast, listeners learn about establishing a professional identify as a new practitioner. Speakers include new practitioner members ranging from new graduates to practitioners with a few years of experience. Speakers share their insight and advice on crafting a professional identity and how that identity can evolve throughout your training and career. For additional resources related to establishing a professional identity, check out the ASHP <a href='https://www.ashp.org/-/media/assets/new-practitioner/docs/Professional-Identity-Formation-Worksheet_ASHP-NPF_Final.pdf'>Professional Identify Formation Worksheet</a>, developed by members of the New Practitioners Forum. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8urkad/Establishing_Professional_Identity_as_a_New_Practitioner9opwp.m4a" length="38603278" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[During this podcast, listeners learn about establishing a professional identify as a new practitioner. Speakers include new practitioner members ranging from new graduates to practitioners with a few years of experience. Speakers share their insight and advice on crafting a professional identity and how that identity can evolve throughout your training and career. For additional resources related to establishing a professional identity, check out the ASHP Professional Identify Formation Worksheet, developed by members of the New Practitioners Forum. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1617</itunes:duration>
                <itunes:episode>698</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Standardize 4 Safety: Taking Aim at Strategies for Adoption</title>
        <itunes:title>ASHP Advantage: Standardize 4 Safety: Taking Aim at Strategies for Adoption</itunes:title>
        <link>https://ashpofficial.podbean.com/e/standardize-4-safety-taking-aim-at-strategies-for-adoption/</link>
                    <comments>https://ashpofficial.podbean.com/e/standardize-4-safety-taking-aim-at-strategies-for-adoption/#comments</comments>        <pubDate>Fri, 24 Jun 2022 08:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/510cd3e5-f13f-3f8f-9a9e-532cb308d464</guid>
                                    <description><![CDATA[<p>Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago. </p>
<p>ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago. </p>
<p>ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dxrj5y/ASHP_ADV_Standardize_4_Safety_Taking_Aim_at_Strategies_for_Adoption_MIX.mp3" length="69904280" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago. 
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1747</itunes:duration>
                <itunes:episode>697</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Ups and Downs of Pharmacist Career Ladders</title>
        <itunes:title>The Ups and Downs of Pharmacist Career Ladders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-ups-and-downs-of-pharmacist-career-ladders/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-ups-and-downs-of-pharmacist-career-ladders/#comments</comments>        <pubDate>Thu, 23 Jun 2022 15:22:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6bce1359-c844-3bce-bd58-5843fde77640</guid>
                                    <description><![CDATA[<p>Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8k6zxa/2_The_Ups_and_Downs_of_pharmacist_career_ladders_mixdown9vdax.mp3" length="31616589" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1316</itunes:duration>
                <itunes:episode>694</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Propel Your Professional Development with ASHP’s Guided Mentorship Program</title>
        <itunes:title>Propel Your Professional Development with ASHP’s Guided Mentorship Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/propel-your-professional-development-with-ashp-s-guided-mentorship-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/propel-your-professional-development-with-ashp-s-guided-mentorship-program/#comments</comments>        <pubDate>Wed, 22 Jun 2022 15:30:17 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/76c16d2e-7e2a-38c0-beed-7afc200d49d8</guid>
                                    <description><![CDATA[<p>This podcast will feature mentor-mentee pairs that participated in the inaugural cohort of the ASHP Guided Mentorship Program. Mentors and mentees will share insights of their experience with the program, reasons for pursuing a professional mentoring relationship, and tips for candidates considering the program.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will feature mentor-mentee pairs that participated in the inaugural cohort of the ASHP Guided Mentorship Program. Mentors and mentees will share insights of their experience with the program, reasons for pursuing a professional mentoring relationship, and tips for candidates considering the program.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v5e5td/Propel_your_professional_development_mixdown7y1i5.mp3" length="40065143" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will feature mentor-mentee pairs that participated in the inaugural cohort of the ASHP Guided Mentorship Program. Mentors and mentees will share insights of their experience with the program, reasons for pursuing a professional mentoring relationship, and tips for candidates considering the program.  ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1668</itunes:duration>
                <itunes:episode>695</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Compassionate Approach to Acute Opioid Withdrawal</title>
        <itunes:title>A Compassionate Approach to Acute Opioid Withdrawal</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-compassionate-approach-to-acute-opioid-withdrawal/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-compassionate-approach-to-acute-opioid-withdrawal/#comments</comments>        <pubDate>Sat, 18 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d39c4a51-86af-3bb8-bafb-7de9bfdf3c33</guid>
                                    <description><![CDATA[<p>Harms from opioid misuse continue despite significant attention to this public health crisis.  Symptoms of acute opioid withdrawal are incredibly disabling and a leading driver in returning to use.  Numerous methods exist to palliate withdrawal symptoms and improve the likelihood a patient who uses opioids may achieve long term recovery.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Harms from opioid misuse continue despite significant attention to this public health crisis.  Symptoms of acute opioid withdrawal are incredibly disabling and a leading driver in returning to use.  Numerous methods exist to palliate withdrawal symptoms and improve the likelihood a patient who uses opioids may achieve long term recovery.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pucbe4/LMS-_A_Compassionate_Approach_to_Acute_Opioid_Withdrawal_CE_6x7u7.m4a" length="28396493" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Harms from opioid misuse continue despite significant attention to this public health crisis.  Symptoms of acute opioid withdrawal are incredibly disabling and a leading driver in returning to use.  Numerous methods exist to palliate withdrawal symptoms and improve the likelihood a patient who uses opioids may achieve long term recovery.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1189</itunes:duration>
                <itunes:episode>688</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ask the 2021 Fellows: What I Wish I Knew as a New Practitioner</title>
        <itunes:title>Ask the 2021 Fellows: What I Wish I Knew as a New Practitioner</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ask-the-2021-fellows-what-i-wish-i-knew-as-a-new-practitioner/</link>
                    <comments>https://ashpofficial.podbean.com/e/ask-the-2021-fellows-what-i-wish-i-knew-as-a-new-practitioner/#comments</comments>        <pubDate>Fri, 17 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e800cf55-da2d-34ce-b09d-397283b8a3e4</guid>
                                    <description><![CDATA[<p>This podcast episode is an interview with five speakers recognized in 2021 as ASHP Fellows (FASHP). Fellows provide advice and encouragement for new practitioners in their career transitions, including recommendations on staying up to date with practice changes, professional involvement, and other timely topics such as burnout and resilience.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode is an interview with five speakers recognized in 2021 as ASHP Fellows (FASHP). Fellows provide advice and encouragement for new practitioners in their career transitions, including recommendations on staying up to date with practice changes, professional involvement, and other timely topics such as burnout and resilience.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xe96ip/Ask_the_2021_Fellows-_What_I_Wish_I_Knew_as_a_New_Practitionerblgah.m4a" length="36530528" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode is an interview with five speakers recognized in 2021 as ASHP Fellows (FASHP). Fellows provide advice and encouragement for new practitioners in their career transitions, including recommendations on staying up to date with practice changes, professional involvement, and other timely topics such as burnout and resilience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1530</itunes:duration>
                <itunes:episode>690</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Therapeutic Thursdays: Nanomedicine</title>
        <itunes:title>Therapeutic Thursdays: Nanomedicine</itunes:title>
        <link>https://ashpofficial.podbean.com/e/therapeutic-thursdays-nanomedicine/</link>
                    <comments>https://ashpofficial.podbean.com/e/therapeutic-thursdays-nanomedicine/#comments</comments>        <pubDate>Thu, 16 Jun 2022 11:02:29 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9bd36158-79cd-357c-ac48-30437bd2289a</guid>
                                    <description><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="xxxmsonormal" style="margin-bottom:12pt;">The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3k3fak/Nanomedicine_Mix_new_mixdown813v3.mp3" length="43531697" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1813</itunes:duration>
                <itunes:episode>692</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Building a Multisite PGY-1 Residency Program</title>
        <itunes:title>Building a Multisite PGY-1 Residency Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/building-a-multisite-pgy-1-residency-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/building-a-multisite-pgy-1-residency-program/#comments</comments>        <pubDate>Tue, 14 Jun 2022 10:19:49 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/99e06721-ef3e-3317-8747-dd30c95c9cff</guid>
                                    <description><![CDATA[<p>For a school of pharmacy, developing a cohesive PGY-1 residency program can be challenging when faculty work across a large number of different health systems. With the growing demand of post-graduate training opportunities, what can these institutions do to help meet that demand? In this episode of Educator Essentials, we talk about some innovative approaches in creating a PGY-1 residency experience utilizing multiple learning sites.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For a school of pharmacy, developing a cohesive PGY-1 residency program can be challenging when faculty work across a large number of different health systems. With the growing demand of post-graduate training opportunities, what can these institutions do to help meet that demand? In this episode of Educator Essentials, we talk about some innovative approaches in creating a PGY-1 residency experience utilizing multiple learning sites.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/czvutc/Building_a_multisite_PGY1_mixdownarsr2.mp3" length="32037564" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For a school of pharmacy, developing a cohesive PGY-1 residency program can be challenging when faculty work across a large number of different health systems. With the growing demand of post-graduate training opportunities, what can these institutions do to help meet that demand? In this episode of Educator Essentials, we talk about some innovative approaches in creating a PGY-1 residency experience utilizing multiple learning sites.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1334</itunes:duration>
                <itunes:episode>689</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>2021 CHEST Guideline Updates: Antithrombotic Therapy for Venous Thromboembolism</title>
        <itunes:title>2021 CHEST Guideline Updates: Antithrombotic Therapy for Venous Thromboembolism</itunes:title>
        <link>https://ashpofficial.podbean.com/e/2021-chest-guideline-updates-antithrombotic-therapy-for-venous-thromboembolism/</link>
                    <comments>https://ashpofficial.podbean.com/e/2021-chest-guideline-updates-antithrombotic-therapy-for-venous-thromboembolism/#comments</comments>        <pubDate>Thu, 09 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f36b3a22-06c4-395d-81bc-d2245f27d8d5</guid>
                                    <description><![CDATA[<p>A conversation highlighting updates to the 2021 CHEST guideline updates on antithrombotic therapy for venous thromboembolism (VTE). </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A conversation highlighting updates to the 2021 CHEST guideline updates on antithrombotic therapy for venous thromboembolism (VTE). </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wyayhb/2021_CHEST_Guideline_Updates-_Antithrombotic_Therapy_for_Venous_Thromboembolisma8rxm.m4a" length="19090457" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[A conversation highlighting updates to the 2021 CHEST guideline updates on antithrombotic therapy for venous thromboembolism (VTE). 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>799</itunes:duration>
                <itunes:episode>677</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Level Up Your Ambulatory Care Practice: Why Technicians Are Game Changers</title>
        <itunes:title>Level Up Your Ambulatory Care Practice: Why Technicians Are Game Changers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/level-up-your-ambulatory-care-practice-why-technicians-are-game-changers/</link>
                    <comments>https://ashpofficial.podbean.com/e/level-up-your-ambulatory-care-practice-why-technicians-are-game-changers/#comments</comments>        <pubDate>Wed, 08 Jun 2022 15:30:10 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d6448861-22ae-3feb-9c3a-e7eeef0ae521</guid>
                                    <description><![CDATA[<p>From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting.  They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting.  They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/a6xg5n/Level_up_your_Amb_Care_mixdown6hnea.mp3" length="60331833" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting.  They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2513</itunes:duration>
                <itunes:episode>687</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The State of Wisconsin’s Approach to PAI 2030</title>
        <itunes:title>The State of Wisconsin’s Approach to PAI 2030</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-state-of-wisconsin-s-approach-to-pai-2030/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-state-of-wisconsin-s-approach-to-pai-2030/#comments</comments>        <pubDate>Tue, 07 Jun 2022 11:19:02 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/589ce615-1d5c-3014-8667-38baf66336ca</guid>
                                    <description><![CDATA[<p>ASHP has set the vision of advancing pharmacy practice with the Practice Advancement Initiative (PAI) 2030. This podcast will discuss how Wisconsin Health-System Pharmacy Administration and Leadership residents through the Practice Advancement Leadership Team (PALT) collaborated with the Pharmacy Society of Wisconsin (PSW) to support Wisconsin hospitals in filling out the <a href='https://pai2030tool.ashp.org/'>PAI 2030 Self-Assessment Tool</a> and raise awareness of PAI 2030. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP has set the vision of advancing pharmacy practice with the Practice Advancement Initiative (PAI) 2030. This podcast will discuss how Wisconsin Health-System Pharmacy Administration and Leadership residents through the Practice Advancement Leadership Team (PALT) collaborated with the Pharmacy Society of Wisconsin (PSW) to support Wisconsin hospitals in filling out the <a href='https://pai2030tool.ashp.org/'>PAI 2030 Self-Assessment Tool</a> and raise awareness of PAI 2030. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vtwu4s/1_PAI_mixdown.mp3" length="41216960" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP has set the vision of advancing pharmacy practice with the Practice Advancement Initiative (PAI) 2030. This podcast will discuss how Wisconsin Health-System Pharmacy Administration and Leadership residents through the Practice Advancement Leadership Team (PALT) collaborated with the Pharmacy Society of Wisconsin (PSW) to support Wisconsin hospitals in filling out the PAI 2030 Self-Assessment Tool and raise awareness of PAI 2030. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1716</itunes:duration>
                <itunes:episode>686</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Logistics Behind Specialty Pharmacy Shipping Requirements</title>
        <itunes:title>The Logistics Behind Specialty Pharmacy Shipping Requirements</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-logistics-behind-specialty-pharmacy-shipping-requirements/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-logistics-behind-specialty-pharmacy-shipping-requirements/#comments</comments>        <pubDate>Tue, 07 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/02488ad4-eca2-35db-8dcd-a5856d514193</guid>
                                    <description><![CDATA[<p>Shipping for specialty pharmacy patients is becoming increasingly more difficult. Compliance with cold chain and room temperature accreditation requirements, managing lost or delayed items, and managing rising costs are critical to ensure patients are receiving medication in a timely manner. This podcast episode covers current challenges in managing shipping operations and offers insight on how three Health System Specialty Pharmacies address these challenges.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Shipping for specialty pharmacy patients is becoming increasingly more difficult. Compliance with cold chain and room temperature accreditation requirements, managing lost or delayed items, and managing rising costs are critical to ensure patients are receiving medication in a timely manner. This podcast episode covers current challenges in managing shipping operations and offers insight on how three Health System Specialty Pharmacies address these challenges.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d379qx/ASHP_Official_The_Logistics_Behind_Specialty_Pharmacy_Shipping_Requirements_Mix.mp3" length="33816743" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Shipping for specialty pharmacy patients is becoming increasingly more difficult. Compliance with cold chain and room temperature accreditation requirements, managing lost or delayed items, and managing rising costs are critical to ensure patients are receiving medication in a timely manner. This podcast episode covers current challenges in managing shipping operations and offers insight on how three Health System Specialty Pharmacies address these challenges.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2113</itunes:duration>
                <itunes:episode>682</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Using a Patient-Tailored Pharmacist Interventions to Improve Specialty Medication Adherence: A Pragmatic Randomized Controlled Trial</title>
        <itunes:title>Using a Patient-Tailored Pharmacist Interventions to Improve Specialty Medication Adherence: A Pragmatic Randomized Controlled Trial</itunes:title>
        <link>https://ashpofficial.podbean.com/e/using-a-patient-tailored-pharmacist-interventions-to-improve-specialty-medication-adherence-a-pragmatic-randomized-controlled-trial/</link>
                    <comments>https://ashpofficial.podbean.com/e/using-a-patient-tailored-pharmacist-interventions-to-improve-specialty-medication-adherence-a-pragmatic-randomized-controlled-trial/#comments</comments>        <pubDate>Mon, 06 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/07cf6c3a-fc99-328d-8d1f-f564e77e7ea9</guid>
                                    <description><![CDATA[<p>This podcast episode discusses results from a recently completed pragmatic, prospective, randomized controlled study evaluating a patient-tailored intervention to improve specialty medication adherence. Listeners will learn how this rigorous study design was executed and the significant impact it had on patient outcomes.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses results from a recently completed pragmatic, prospective, randomized controlled study evaluating a patient-tailored intervention to improve specialty medication adherence. Listeners will learn how this rigorous study design was executed and the significant impact it had on patient outcomes.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ikvpe5/ASHPOfficial_Using_a_Patient_Tailored_Pharmacist_Interventions_to_Improve_Specialty_Medication_Adherence_a_Pragmatic_Randomized_Controlled_Trial_MIX.mp3" length="27130112" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses results from a recently completed pragmatic, prospective, randomized controlled study evaluating a patient-tailored intervention to improve specialty medication adherence. Listeners will learn how this rigorous study design was executed and the significant impact it had on patient outcomes.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1695</itunes:duration>
                <itunes:episode>679</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Naloxone Distribution from the Hospital and So Can You! (CE)</title>
        <itunes:title>Naloxone Distribution from the Hospital and So Can You! (CE)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/naloxone-distribution-from-the-hospital-and-so-can-you-ce/</link>
                    <comments>https://ashpofficial.podbean.com/e/naloxone-distribution-from-the-hospital-and-so-can-you-ce/#comments</comments>        <pubDate>Sat, 04 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/eed44a35-2a22-37b4-8cf4-744aa40d2327</guid>
                                    <description><![CDATA[<p>The ongoing opioid epidemic in the United States (US) is entering a new phase with the Covid-19 pandemic. Overdose deaths are increasing in the US and opioid use disorder (OUD) is one of the main contributors to this issue. Naloxone is a life saving medication for opioid reversal but requires timely administration. Unfortunately, due to cost and other limitations such as prescription status, naloxone is not always available when it is needed most. Emergency Departments (ED) and hospitals can play a vital role in establishing naloxone distribution services and put this life-saving medications directly into the hands of patients that may need it. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The ongoing opioid epidemic in the United States (US) is entering a new phase with the Covid-19 pandemic. Overdose deaths are increasing in the US and opioid use disorder (OUD) is one of the main contributors to this issue. Naloxone is a life saving medication for opioid reversal but requires timely administration. Unfortunately, due to cost and other limitations such as prescription status, naloxone is not always available when it is needed most. Emergency Departments (ED) and hospitals can play a vital role in establishing naloxone distribution services and put this life-saving medications directly into the hands of patients that may need it. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dyd678/Opioid_De-escalation_mixdown_1_6dpvx.mp3" length="40942393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The ongoing opioid epidemic in the United States (US) is entering a new phase with the Covid-19 pandemic. Overdose deaths are increasing in the US and opioid use disorder (OUD) is one of the main contributors to this issue. Naloxone is a life saving medication for opioid reversal but requires timely administration. Unfortunately, due to cost and other limitations such as prescription status, naloxone is not always available when it is needed most. Emergency Departments (ED) and hospitals can play a vital role in establishing naloxone distribution services and put this life-saving medications directly into the hands of patients that may need it. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1705</itunes:duration>
                <itunes:episode>685</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmaceutical Cold Chain Management in Health Systems</title>
        <itunes:title>Pharmaceutical Cold Chain Management in Health Systems</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmaceutical-cold-chain-management-in-health-systems/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmaceutical-cold-chain-management-in-health-systems/#comments</comments>        <pubDate>Fri, 03 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/20d8f344-0311-3fc4-8c92-aaee546a683a</guid>
                                    <description><![CDATA[<p>ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hved2t/1_Cold_Chain_Management_mixdowna7fwt.mp3" length="17270138" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>718</itunes:duration>
                <itunes:episode>684</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Choosing Between First-Line Treatment Options for Relapsed or Stage IV Clear Cell Renal Cell Carcinoma (RCC)</title>
        <itunes:title>Choosing Between First-Line Treatment Options for Relapsed or Stage IV Clear Cell Renal Cell Carcinoma (RCC)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/choosing-between-first-line-treatment-options-for-relapsed-or-stage-iv-clear-cell-renal-cell-carcinoma-rcc/</link>
                    <comments>https://ashpofficial.podbean.com/e/choosing-between-first-line-treatment-options-for-relapsed-or-stage-iv-clear-cell-renal-cell-carcinoma-rcc/#comments</comments>        <pubDate>Thu, 02 Jun 2022 11:55:30 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6b7582fe-e57f-3672-9801-23fc9a7cfad6</guid>
                                    <description><![CDATA[<p>We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kma2d3/ASHP_Podcast_Choosing_Between_First_Line_Treatment_Options_for_Relapsed_or_Stage_IV_Clear_Cell_Renal_Cell_Carcinoma_RCC_MIX.mp3" length="75576332" type="audio/mpeg"/>
        <itunes:summary><![CDATA[We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1889</itunes:duration>
                <itunes:episode>683</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mainstreaming Addiction Treatment Act and What it Means For Patients</title>
        <itunes:title>Mainstreaming Addiction Treatment Act and What it Means For Patients</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mainstreaming-addiction-treatment-act-and-what-it-means-for-patients/</link>
                    <comments>https://ashpofficial.podbean.com/e/mainstreaming-addiction-treatment-act-and-what-it-means-for-patients/#comments</comments>        <pubDate>Wed, 01 Jun 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3553354b-7c6b-357e-94ce-5b77f3f6ae64</guid>
                                    <description><![CDATA[<p>The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ehs9tk/Mainstreaming_Addiction_Treatment_Act_and_What_it_Means_For_Pharmacistsa2272.m4a" length="22324089" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>935</itunes:duration>
                <itunes:episode>680</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Caring for Transgender People: Insight and Points of Controversy in Medication Therapy</title>
        <itunes:title>Caring for Transgender People: Insight and Points of Controversy in Medication Therapy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/caring-for-transgender-people-insight-and-points-of-controversy-in-medication-therapy/</link>
                    <comments>https://ashpofficial.podbean.com/e/caring-for-transgender-people-insight-and-points-of-controversy-in-medication-therapy/#comments</comments>        <pubDate>Tue, 31 May 2022 11:15:30 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/75118c23-f589-39d6-98a2-399d7274eb48</guid>
                                    <description><![CDATA[<p>In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z3s8gc/MCM_2021_DEI_Feature-_Caring_for_Transgender_Peoplea5aps.m4a" length="75123931" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3147</itunes:duration>
                <itunes:episode>681</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Getting Started with Transitions of Care Pharmacy Services</title>
        <itunes:title>Getting Started with Transitions of Care Pharmacy Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/getting-started-with-transitions-of-care-pharmacy-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/getting-started-with-transitions-of-care-pharmacy-services/#comments</comments>        <pubDate>Fri, 27 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/76bad8f3-3b6b-30a8-ae1d-ea06abd64818</guid>
                                    <description><![CDATA[<p>This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mf3by8/Getting_started_W_transitions_of_care_Pharm_Services_mixdownadn2q.mp3" length="43053281" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1789</itunes:duration>
                <itunes:episode>676</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pneumococcal Vaccine Updates</title>
        <itunes:title>Pneumococcal Vaccine Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pneumococcal-vaccine-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/pneumococcal-vaccine-updates/#comments</comments>        <pubDate>Thu, 26 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3d3034ea-a0a9-39ca-8504-5299b6a543eb</guid>
                                    <description><![CDATA[<p>The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x9gby8/Pneumococcal_Vaccine_Updates_mixdown8j4sd.mp3" length="16805050" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>695</itunes:duration>
                <itunes:episode>674</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Technician Practice Vision: A Roundtable Conversation of Future Directions, Challenges, and Incentives</title>
        <itunes:title>Pharmacy Technician Practice Vision: A Roundtable Conversation of Future Directions, Challenges, and Incentives</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-technician-practice-vision-a-roundtable-conversation-of-future-directions-challenges-and-incentives/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-technician-practice-vision-a-roundtable-conversation-of-future-directions-challenges-and-incentives/#comments</comments>        <pubDate>Wed, 25 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/89974361-9de0-323b-add7-52b016392b1c</guid>
                                    <description><![CDATA[<p>This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d4rvpr/Pharmacy_Technician_Practice_Visionaddvl.m4a" length="38569965" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1615</itunes:duration>
                <itunes:episode>678</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AJHP Voices - Telehealth Theme Issue</title>
        <itunes:title>AJHP Voices - Telehealth Theme Issue</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ajhp-voices-telehealth-theme-issue/</link>
                    <comments>https://ashpofficial.podbean.com/e/ajhp-voices-telehealth-theme-issue/#comments</comments>        <pubDate>Wed, 25 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ba6ca990-de8e-3d2a-9f07-7d89a033315c</guid>
                                    <description><![CDATA[<p>In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zdxfgq/ASHPOfficial_AJHP_Voices_AJHP_Theme_Issue_on_Telehealth_MIX_REV_1_88dse.mp3" length="99318848" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2482</itunes:duration>
                <itunes:episode>673</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Involving Your Student Society of Health-System Pharmacists (SSHP) with your State Affiliate</title>
        <itunes:title>Involving Your Student Society of Health-System Pharmacists (SSHP) with your State Affiliate</itunes:title>
        <link>https://ashpofficial.podbean.com/e/involving-your-student-society-of-health-system-pharmacists-sshp-with-your-state-affiliate/</link>
                    <comments>https://ashpofficial.podbean.com/e/involving-your-student-society-of-health-system-pharmacists-sshp-with-your-state-affiliate/#comments</comments>        <pubDate>Tue, 24 May 2022 08:20:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/29f5e13f-7048-343e-9168-78515b9c66d5</guid>
                                    <description><![CDATA[<p>During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6rkpn8/Involving_Your_Student_Society_With_Your_State_Affiliate93jdj.mp3" length="32956700" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2059</itunes:duration>
                <itunes:episode>675</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Standardize 4 Safety- Past, Present, and Future of Safer Care</title>
        <itunes:title>ASHP Advantage: Standardize 4 Safety- Past, Present, and Future of Safer Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/standardize-4-safety-past-present-and-future-of-safer-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/standardize-4-safety-past-present-and-future-of-safer-care/#comments</comments>        <pubDate>Mon, 23 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/de97ba4c-ab35-389a-8ff0-e21244f05947</guid>
                                    <description><![CDATA[<p>Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.</p>
<p>ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.</p>
<p>Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.</p>
<p>ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.</p>
<p>Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pdaygu/ASHP_ADV_Standardize_4_Safety_Past_Present_and_Future_of_Safer_Care_MIX.mp3" length="94219040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.
Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2355</itunes:duration>
                <itunes:episode>671</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Opportunities and Successes for Developing Patient Mental Health Support Programs</title>
        <itunes:title>Opportunities and Successes for Developing Patient Mental Health Support Programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/opportunities-and-successes-for-developing-patient-mental-health-support-programs/</link>
                    <comments>https://ashpofficial.podbean.com/e/opportunities-and-successes-for-developing-patient-mental-health-support-programs/#comments</comments>        <pubDate>Sat, 21 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/abdd64cf-9afe-3c42-9d08-16cb2164bdda</guid>
                                    <description><![CDATA[<p>This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nvt8ca/Developing_Patient_Mental_Health_Support_program_mixdownbgbvl.mp3" length="48526774" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2017</itunes:duration>
                <itunes:episode>672</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leading for Practice: Career Directions and Influencing Change</title>
        <itunes:title>Leading for Practice: Career Directions and Influencing Change</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leading-for-practice-career-directions-and-influencing-change-1652788679/</link>
                    <comments>https://ashpofficial.podbean.com/e/leading-for-practice-career-directions-and-influencing-change-1652788679/#comments</comments>        <pubDate>Fri, 20 May 2022 12:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0899e6b7-c1b3-3ffa-8a4a-1698fc140971</guid>
                                    <description><![CDATA[<p>This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p><em>This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. </em>This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/88ut68/Leading_for_Practice-_Career_Directions_and_Influencing_Change75lot.m4a" length="46988825" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1968</itunes:duration>
                <itunes:episode>670</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Don’t Skip a Beat: Practical Considerations When Choosing an Anticoagulant for Nonvalvular Atrial Fibrillation</title>
        <itunes:title>ASHP Advantage: Don’t Skip a Beat: Practical Considerations When Choosing an Anticoagulant for Nonvalvular Atrial Fibrillation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/hold-for-upcoming-adv-release-520/</link>
                    <comments>https://ashpofficial.podbean.com/e/hold-for-upcoming-adv-release-520/#comments</comments>        <pubDate>Fri, 20 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/96555886-60e0-39e8-8a87-7ef917664622</guid>
                                    <description><![CDATA[<p>With several choices for oral anticoagulation in Nonvalvular Atrial Fibrillation (NVAF), it is critical for pharmacists to be able to account for patient specific factors when selecting the most appropriate anticoagulant. </p>
<p>To learn more, visit <a href='http://www.ashpadvantage.com/nvaf'>www.ashpadvantage.com/nvaf</a></p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>With several choices for oral anticoagulation in Nonvalvular Atrial Fibrillation (NVAF), it is critical for pharmacists to be able to account for patient specific factors when selecting the most appropriate anticoagulant. </p>
<p>To learn more, visit <a href='http://www.ashpadvantage.com/nvaf'>www.ashpadvantage.com/nvaf</a></p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/8a32t3/ASHP_ADV_Don_t_Skip_a_Beat_Practical_Considerations_When_Choosing_an_Anticoagulant_for_Nonvalvular_Atrial_Fibrillation_MIX.mp3" length="45250220" type="audio/mpeg"/>
        <itunes:summary><![CDATA[With several choices for oral anticoagulation in Nonvalvular Atrial Fibrillation (NVAF), it is critical for pharmacists to be able to account for patient specific factors when selecting the most appropriate anticoagulant. 
To learn more, visit www.ashpadvantage.com/nvaf
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1131</itunes:duration>
                <itunes:episode>668</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Overview of Vaping in Pediatrics</title>
        <itunes:title>Overview of Vaping in Pediatrics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/overview-of-vaping-in-pediatrics/</link>
                    <comments>https://ashpofficial.podbean.com/e/overview-of-vaping-in-pediatrics/#comments</comments>        <pubDate>Thu, 19 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/60d71c80-d436-348e-8f55-6a75e0108785</guid>
                                    <description><![CDATA[<p>This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qm3sx9/Overview_of_Vaping_in_Pediatrics_v2acp3d.m4a" length="34773404" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1456</itunes:duration>
                <itunes:episode>665</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Understanding and Combatting Impostor Syndrome</title>
        <itunes:title>Understanding and Combatting Impostor Syndrome</itunes:title>
        <link>https://ashpofficial.podbean.com/e/understanding-and-combatting-impostor-syndrome/</link>
                    <comments>https://ashpofficial.podbean.com/e/understanding-and-combatting-impostor-syndrome/#comments</comments>        <pubDate>Wed, 18 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2b594041-15cd-3d55-9342-b9a47cb4a553</guid>
                                    <description><![CDATA[<p>In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new <a href='https://www.ashp.org/-/media/assets/new-practitioner/docs/Impostor-Syndrome-Resources-Annotated-Bib_FInal.pdf'>resource outline</a> developed the New Practitioners Forum.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new <a href='https://www.ashp.org/-/media/assets/new-practitioner/docs/Impostor-Syndrome-Resources-Annotated-Bib_FInal.pdf'>resource outline</a> developed the New Practitioners Forum.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3gn79c/IMPOSTER_SYNDROME_mixdownatraw.mp3" length="44019767" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new resource outline developed the New Practitioners Forum.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1830</itunes:duration>
                <itunes:episode>669</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Documenting the Clinical Impact of Student Pharmacists</title>
        <itunes:title>Documenting the Clinical Impact of Student Pharmacists</itunes:title>
        <link>https://ashpofficial.podbean.com/e/documenting-the-clinical-impact-of-student-pharmacists/</link>
                    <comments>https://ashpofficial.podbean.com/e/documenting-the-clinical-impact-of-student-pharmacists/#comments</comments>        <pubDate>Tue, 17 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c80909e0-6584-37b8-ad98-3346d3a795a0</guid>
                                    <description><![CDATA[<p>Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/awwmtz/Documenting_the_clinical_impact_of_Student_Pharmacists_mixdown70s8e.mp3" length="37173494" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1544</itunes:duration>
                <itunes:episode>667</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Specialized Roles Within Specialty Pharmacy</title>
        <itunes:title>Specialized Roles Within Specialty Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/specialized-roles-within-specialty-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/specialized-roles-within-specialty-pharmacy/#comments</comments>        <pubDate>Mon, 16 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0a9bd249-c520-3758-9a3e-e0618d5ccc1c</guid>
                                    <description><![CDATA[<p>Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/y6q2cb/1_Specialized_roles_W_Specialty_pharmacy_mixdownbl4v5.mp3" length="44959133" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1869</itunes:duration>
                <itunes:episode>666</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Weighing the Options: A Patient-Centered Approach to Weight Loss Medications</title>
        <itunes:title>Weighing the Options: A Patient-Centered Approach to Weight Loss Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/weighing-the-options-a-patient-centered-approach-to-weight-loss-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/weighing-the-options-a-patient-centered-approach-to-weight-loss-medications/#comments</comments>        <pubDate>Thu, 12 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3e4f8809-384c-3c17-896e-aa645e457910</guid>
                                    <description><![CDATA[<p>This episode provides an overview of the available weight loss medications and walks through how to approach a patient case. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides an overview of the available weight loss medications and walks through how to approach a patient case. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/522bng/1_Weighing_the_options_mixdownbtsyb.mp3" length="26652760" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode provides an overview of the available weight loss medications and walks through how to approach a patient case. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1106</itunes:duration>
                <itunes:episode>663</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Safe Medication Management for Patients with Medication Excipient Allergies and Intolerances</title>
        <itunes:title>Safe Medication Management for Patients with Medication Excipient Allergies and Intolerances</itunes:title>
        <link>https://ashpofficial.podbean.com/e/safe-medication-management-for-patients-with-medication-excipient-allergies-and-intolerances/</link>
                    <comments>https://ashpofficial.podbean.com/e/safe-medication-management-for-patients-with-medication-excipient-allergies-and-intolerances/#comments</comments>        <pubDate>Wed, 11 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9003644d-9e54-3ae6-bcfc-8fe9da6781f8</guid>
                                    <description><![CDATA[<p>Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients.  </p>
<p>This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients.  </p>
<p>This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ijruhy/Safe_Medication_Management_for_Patients_with_Medication_Excipient_Allergies_and8gft5.m4a" length="32318834" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients.  
This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1353</itunes:duration>
                <itunes:episode>664</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pain Management and Opioid Stewardship: One and the Same or Distant Cousins?</title>
        <itunes:title>Pain Management and Opioid Stewardship: One and the Same or Distant Cousins?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pain-management-and-opioid-stewardship-one-in-the-same-or-distant-cousins/</link>
                    <comments>https://ashpofficial.podbean.com/e/pain-management-and-opioid-stewardship-one-in-the-same-or-distant-cousins/#comments</comments>        <pubDate>Tue, 10 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4eb6c7f3-6077-3990-ab5e-5cda661735bd</guid>
                                    <description><![CDATA[<p>This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4xkuwq/Pain_Management_and_Opioid_Stewardship-_One_in_the_Same_or_Distant_Cousins6xvqv.m4a" length="15033316" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>629</itunes:duration>
                <itunes:episode>658</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Information on Informatics: Pharmacy Informatics Residency Programs</title>
        <itunes:title>Information on Informatics: Pharmacy Informatics Residency Programs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/information-on-informatics-pharmacy-informatics-residency-programs/</link>
                    <comments>https://ashpofficial.podbean.com/e/information-on-informatics-pharmacy-informatics-residency-programs/#comments</comments>        <pubDate>Mon, 09 May 2022 11:45:24 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/35d2abf4-adbf-3caf-a4bd-262a2097d370</guid>
                                    <description><![CDATA[<p>This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2mx4in/Pharmacy_informatics_residency_programs_mixdown9l0k6.mp3" length="8638177" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>356</itunes:duration>
                <itunes:episode>662</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Compounding Conundrums 2022</title>
        <itunes:title>Compounding Conundrums 2022</itunes:title>
        <link>https://ashpofficial.podbean.com/e/compounding-conundrums-2022/</link>
                    <comments>https://ashpofficial.podbean.com/e/compounding-conundrums-2022/#comments</comments>        <pubDate>Sat, 07 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f7c20ed7-d726-37bb-b1f1-78fa91dcded6</guid>
                                    <description><![CDATA[<p>Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/grrcy7/ASHP_Compounding_Conundrums_2022_MIX.mp3" length="59871440" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1496</itunes:duration>
                <itunes:episode>656</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Staying Current in Healthcare, Information and Technology: Perspectives from Pharmacy Leaders Part 1 of 2</title>
        <itunes:title>Staying Current in Healthcare, Information and Technology: Perspectives from Pharmacy Leaders Part 1 of 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/staying-current-in-healthcare-information-and-technology-perspectives-from-pharmacy-leaders-part-1-of-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/staying-current-in-healthcare-information-and-technology-perspectives-from-pharmacy-leaders-part-1-of-2/#comments</comments>        <pubDate>Fri, 06 May 2022 14:20:31 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f38838ba-4d60-35f0-9371-c534f6c7f919</guid>
                                    <description><![CDATA[<p>This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/iamnge/ASHP_Podcast_Staying_Current_in_Healthcare_Information_and_Technology_Perspectives_from_Pharmacy_Leaders_Part_1_of_2_MIX.mp3" length="53945696" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1348</itunes:duration>
                <itunes:episode>661</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Digging into Specialty Pharmacy Accreditation: Value, Credibility and Challenges</title>
        <itunes:title>Digging into Specialty Pharmacy Accreditation: Value, Credibility and Challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-value-credibility-and-challenges-1651860486/</link>
                    <comments>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-value-credibility-and-challenges-1651860486/#comments</comments>        <pubDate>Fri, 06 May 2022 14:08:06 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1caf267c-4f89-3e0f-9873-a4429eaebbf1</guid>
                                    <description><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/np43mv/Digging_Into_Specialty_Pharmacy_Accreditations_Part_26oepa.m4a" length="38453709" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1610</itunes:duration>
                <itunes:episode>660</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Digging into Specialty Pharmacy Accreditation: Value, Credibility and Challenges</title>
        <itunes:title>Digging into Specialty Pharmacy Accreditation: Value, Credibility and Challenges</itunes:title>
        <link>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-value-credibility-and-challenges/</link>
                    <comments>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-value-credibility-and-challenges/#comments</comments>        <pubDate>Thu, 05 May 2022 14:06:18 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4eb2bd82-58eb-3aa1-bea7-dbaeb0a8bdff</guid>
                                    <description><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ntvdit/ASHP_Digging_into_Specialty_Pharmacy_Accreditation_Value_Credibility_and_Challenges_MIX.mp3" length="64351244" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1608</itunes:duration>
                <itunes:episode>659</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The ASHP Well-Being Ambassador Program</title>
        <itunes:title>The ASHP Well-Being Ambassador Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-ashp-well-being-ambassador-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-ashp-well-being-ambassador-program/#comments</comments>        <pubDate>Wed, 04 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3fb3d27c-7e5e-35be-932f-a0b31c1b9489</guid>
                                    <description><![CDATA[<p>The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: <a href='https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program'>https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program</a></p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: <a href='https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program'>https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program</a></p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jqba7x/ASHP_Podcast_The_ASHP_Well_Being_Ambassador_Program_MIX.mp3" length="49488860" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1237</itunes:duration>
                <itunes:episode>657</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Discussion on the Introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213)</title>
        <itunes:title>A Discussion on the Introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-discussion-on-the-introduction-of-the-equitable-community-access-to-pharmacist-services-act-hr-7213/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-discussion-on-the-introduction-of-the-equitable-community-access-to-pharmacist-services-act-hr-7213/#comments</comments>        <pubDate>Tue, 03 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0af6da2b-a871-3cb4-bbfd-debdd2c0da83</guid>
                                    <description><![CDATA[<p>This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cepgh5/A_Discussion_on_the_Introduction_of_the_Equitable_Community_Access6kocv.m4a" length="11101516" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>465</itunes:duration>
                <itunes:episode>653</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Candid conversations: Developing integrated interprofessional teams that embrace pharmacy learners and improve patient outcomes</title>
        <itunes:title>Candid conversations: Developing integrated interprofessional teams that embrace pharmacy learners and improve patient outcomes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/candid-conversations-developing-integrated-interprofessional-teams-that-embrace-pharmacy-learners-and-improve-patient-outcomes/</link>
                    <comments>https://ashpofficial.podbean.com/e/candid-conversations-developing-integrated-interprofessional-teams-that-embrace-pharmacy-learners-and-improve-patient-outcomes/#comments</comments>        <pubDate>Mon, 02 May 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dd50a5f1-9493-3094-a49c-fa9fb596097f</guid>
                                    <description><![CDATA[<p>In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/thrdhf/Candid_Conversations-_Developing_integrated_interprofessional_teams_that_embrace9tsdp.m4a" length="39535022" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1656</itunes:duration>
                <itunes:episode>655</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Finding Hidden Stroke Risk: Screening for Atrial Fibrillation</title>
        <itunes:title>ASHP Advantage: Finding Hidden Stroke Risk: Screening for Atrial Fibrillation</itunes:title>
        <link>https://ashpofficial.podbean.com/e/finding-hidden-stroke-risk-screening-for-atrial-fibrillation/</link>
                    <comments>https://ashpofficial.podbean.com/e/finding-hidden-stroke-risk-screening-for-atrial-fibrillation/#comments</comments>        <pubDate>Fri, 29 Apr 2022 12:01:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/10ad9553-a879-38c7-85bf-3e7292fbcd60</guid>
                                    <description><![CDATA[<p>Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation.</p>
<p>To learn more, visit www.ashpadvantage.com/nvaf</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation.</p>
<p>To learn more, visit www.ashpadvantage.com/nvaf</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v9t3xw/ASHP_ADV_Finding_Hidden_Stroke_Risk_MIX.mp3" length="18646700" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation.
To learn more, visit www.ashpadvantage.com/nvaf
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1165</itunes:duration>
                <itunes:episode>654</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice</title>
        <itunes:title>From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/from-theory-to-bedside-implementation-of-fluid-stewardship-in-a-medical-icu-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/from-theory-to-bedside-implementation-of-fluid-stewardship-in-a-medical-icu-pharmacy-practice/#comments</comments>        <pubDate>Wed, 27 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7646e9e7-2ea7-39c1-aae3-bc79fe1ae171</guid>
                                    <description><![CDATA[<p>In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6zgty8/ASHPOfficial_AJHP_Voices_From_Theory_to_Bedside_Implementation_of_Fluid_Stewardship_in_a_Medical_ICU_Pharmacy_Practice_MIX_REV.mp3" length="73907648" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1847</itunes:duration>
                <itunes:episode>649</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Pharmacist by Day, “Finfluencer” by Night</title>
        <itunes:title>Pharmacist by Day, “Finfluencer” by Night</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacist-by-day-finfluencer-by-night/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacist-by-day-finfluencer-by-night/#comments</comments>        <pubDate>Tue, 26 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8c4879c9-fe99-37df-a440-6e06ebaec548</guid>
                                    <description><![CDATA[<p>Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gs6m2q/Pharmacist_by_Day_Finfluencer_by_Nightbn8pz.m4a" length="59779670" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2504</itunes:duration>
                <itunes:episode>651</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Teaching to Teach: The 4 Preceptor Roles for Residents</title>
        <itunes:title>Teaching to Teach: The 4 Preceptor Roles for Residents</itunes:title>
        <link>https://ashpofficial.podbean.com/e/teaching-to-teach-the-4-preceptor-roles-for-residents/</link>
                    <comments>https://ashpofficial.podbean.com/e/teaching-to-teach-the-4-preceptor-roles-for-residents/#comments</comments>        <pubDate>Mon, 25 Apr 2022 18:43:47 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bb870a5d-b362-3514-96b8-c73ceeefb28b</guid>
                                    <description><![CDATA[<p>One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kvzudx/Teaching_to_Teach-_The_4_Preceptor_Roles_for_Residentsahkuv.m4a" length="45531150" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1907</itunes:duration>
                <itunes:episode>652</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Reflections on Implementation of Central Fill</title>
        <itunes:title>ASHP Advantage: Reflections on Implementation of Central Fill</itunes:title>
        <link>https://ashpofficial.podbean.com/e/reflections-on-implementation-of-central-fill/</link>
                    <comments>https://ashpofficial.podbean.com/e/reflections-on-implementation-of-central-fill/#comments</comments>        <pubDate>Fri, 22 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/928ce602-82d8-3e0c-8e4f-720f53e6baec</guid>
                                    <description><![CDATA[<p>During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation).</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation).</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9qi8jt/ASHP_ADV_Reflections_on_Implementation_of_Central_Fill_MIX.mp3" length="43056776" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1076</itunes:duration>
                <itunes:episode>650</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2021 COVID-19 Coverage: Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 3: Anticoagulation Management Considerations in the Critically Ill COVID Patient</title>
        <itunes:title>MCM 2021 COVID-19 Coverage: Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 3: Anticoagulation Management Considerations in the Critically Ill COVID Patient</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2021-covid19-coverage-critical-care-pharmacotherapy-reflectionon-the-covid-19pandemicpart3-anticoagulation-managementconsiderationsin-the-critical/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2021-covid19-coverage-critical-care-pharmacotherapy-reflectionon-the-covid-19pandemicpart3-anticoagulation-managementconsiderationsin-the-critical/#comments</comments>        <pubDate>Thu, 21 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b67a1b3e-7069-3156-8b78-cf7e342a2806</guid>
                                    <description><![CDATA[<p>In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hbgrwr/Part_3-_Anticoagulation_Management_Considerations_in_the_Critically_Ill_COVID_Patient8t042.m4a" length="48104583" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2015</itunes:duration>
                <itunes:episode>648</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Framework to Support Pharmacist-Provided Health Services</title>
        <itunes:title>A Framework to Support Pharmacist-Provided Health Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-framework-to-support-pharmacist-provided-health-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-framework-to-support-pharmacist-provided-health-services/#comments</comments>        <pubDate>Tue, 19 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/30159407-47d6-3347-ab5b-baf5f6aefc96</guid>
                                    <description><![CDATA[<p>In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/d27x9j/A_Framework_to_Support_Pharmacist-Provided_Health_Services6e15d.m4a" length="34496611" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1445</itunes:duration>
                <itunes:episode>644</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2021 COVID-19 Coverage: Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 2: Antivirals and Immunomodulators</title>
        <itunes:title>MCM 2021 COVID-19 Coverage: Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 2: Antivirals and Immunomodulators</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2021-covid-19-coverage-critical-care-pharmacotherapy-reflection-on-the-covid-19-pandemic-part-2-antivirals-and-immunomodulators/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2021-covid-19-coverage-critical-care-pharmacotherapy-reflection-on-the-covid-19-pandemic-part-2-antivirals-and-immunomodulators/#comments</comments>        <pubDate>Mon, 18 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8e60affd-e1bd-3e9f-b65e-8ccbdfbc3c7c</guid>
                                    <description><![CDATA[<p>In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ya9y4p/Reflection_on_the_COVID-19_Pandemic_Part_2-_Antivirals_and_Immunomodulators89x3v.m4a" length="28584015" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                <itunes:episode>647</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>An Update on Sexually Transmitted Infections: Treatment Strategies and Considerations</title>
        <itunes:title>An Update on Sexually Transmitted Infections: Treatment Strategies and Considerations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/an-update-on-sexually-transmitted-infections-treatment-strategies-and-considerations/</link>
                    <comments>https://ashpofficial.podbean.com/e/an-update-on-sexually-transmitted-infections-treatment-strategies-and-considerations/#comments</comments>        <pubDate>Thu, 14 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/18e6f443-e4d9-3d8d-b280-b35cf51cef90</guid>
                                    <description><![CDATA[<p>This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zsv78h/An_Update_on_Sexually_Transmitted_Infections-_Treatment_Strategies_and_Considera8vlak.m4a" length="19923349" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>834</itunes:duration>
                <itunes:episode>632</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Digging into Specialty Pharmacy Accreditation: Initiation, Ongoing Compliance &amp; Maintenance</title>
        <itunes:title>Digging into Specialty Pharmacy Accreditation: Initiation, Ongoing Compliance &amp; Maintenance</itunes:title>
        <link>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-initiation-ongoing-compliance-maintenance/</link>
                    <comments>https://ashpofficial.podbean.com/e/digging-into-specialty-pharmacy-accreditation-initiation-ongoing-compliance-maintenance/#comments</comments>        <pubDate>Tue, 12 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5911e0a8-3b0e-3acb-971e-8656495184ad</guid>
                                    <description><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2eut3c/ASHPOfficial_Digging_into_Specialty_Pharmacy_Accreditation_MIX.mp3" length="26726909" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1670</itunes:duration>
                <itunes:episode>642</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Strategies for Technician Retention and Recognition</title>
        <itunes:title>Strategies for Technician Retention and Recognition</itunes:title>
        <link>https://ashpofficial.podbean.com/e/strategies-for-technician-retention-and-recognition/</link>
                    <comments>https://ashpofficial.podbean.com/e/strategies-for-technician-retention-and-recognition/#comments</comments>        <pubDate>Mon, 11 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e8a76e78-109b-3e77-991f-bfa143ce1753</guid>
                                    <description><![CDATA[<p>This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3y8a7u/ASHP_Podcast_Strategies_for_Technician_Retention_and_Recognition_MIX.mp3" length="50224880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1255</itunes:duration>
                <itunes:episode>641</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Closer Look Into the New Pharmacogenomics Accelerator Program</title>
        <itunes:title>A Closer Look Into the New Pharmacogenomics Accelerator Program</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-closer-look-into-the-new-pharmacogenomics-accelerator-program/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-closer-look-into-the-new-pharmacogenomics-accelerator-program/#comments</comments>        <pubDate>Fri, 08 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3586bc75-38c3-3fd0-901f-8c87611d8264</guid>
                                    <description><![CDATA[<p>ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kkwdnj/A_closer_look_into_pharmaco_Acceleraotr_Program_Edit_mixdownawmet.mp3" length="43379555" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1807</itunes:duration>
                <itunes:episode>643</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 1: Sedation, Analgesia and Post-ICU Syndrome</title>
        <itunes:title>Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 1: Sedation, Analgesia and Post-ICU Syndrome</itunes:title>
        <link>https://ashpofficial.podbean.com/e/critical-care-pharmacotherapy-reflection-on-the-covid-19-pandemic-part-1-sedation-analgesia-and-post-icu-syndrome/</link>
                    <comments>https://ashpofficial.podbean.com/e/critical-care-pharmacotherapy-reflection-on-the-covid-19-pandemic-part-1-sedation-analgesia-and-post-icu-syndrome/#comments</comments>        <pubDate>Thu, 07 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9edea6a5-024e-33e9-abdd-262fe2081b32</guid>
                                    <description><![CDATA[<p>In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/f7ft7i/Critical_care_pharmacotherapy_reflection_MCM_21_Covid_mixdown9zzkw.mp3" length="44364350" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1843</itunes:duration>
                <itunes:episode>638</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Institute for Healthcare Improvement (IHI): Joy in Work Framework</title>
        <itunes:title>Institute for Healthcare Improvement (IHI): Joy in Work Framework</itunes:title>
        <link>https://ashpofficial.podbean.com/e/institute-for-healthcare-improvement-ihi-joy-in-work-framework/</link>
                    <comments>https://ashpofficial.podbean.com/e/institute-for-healthcare-improvement-ihi-joy-in-work-framework/#comments</comments>        <pubDate>Wed, 06 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/36eff48f-27ba-31b7-a517-c180ccf641ee</guid>
                                    <description><![CDATA[<p>Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on <a href='http://www.ihi.org/Topics/Joy-In-Work/Pages/default.aspx'>restoring joy to the health care workforce,</a> and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on <a href='http://www.ihi.org/Topics/Joy-In-Work/Pages/default.aspx'>restoring joy to the health care workforce,</a> and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e7fb6j/Institute_for_Healthcare_Improvement_IHI_Joy_in_Work_Framework_v28k3an.m4a" length="28403395" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1189</itunes:duration>
                <itunes:episode>637</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CDC’s Draft Clinical Practice Guideline for Prescribing Opioids: What It Means for Practice</title>
        <itunes:title>CDC’s Draft Clinical Practice Guideline for Prescribing Opioids: What It Means for Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/cdc-s-draft-clinical-practice-guideline-for-prescribing-opioids-what-it-means-for-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/cdc-s-draft-clinical-practice-guideline-for-prescribing-opioids-what-it-means-for-practice/#comments</comments>        <pubDate>Tue, 05 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/24adb484-f12c-3a05-abb1-89a7230bc7ea</guid>
                                    <description><![CDATA[<p>This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/6fw58r/CDC_s_CPG_for_Prescribing_Opioids7gdxn.m4a" length="41621996" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1743</itunes:duration>
                <itunes:episode>639</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rural Health System Leadership in Pharmacist Prescribing of COVID-19 Antiviral Medications</title>
        <itunes:title>Rural Health System Leadership in Pharmacist Prescribing of COVID-19 Antiviral Medications</itunes:title>
        <link>https://ashpofficial.podbean.com/e/rural-health-system-leadership-in-pharmacist-prescribing-of-covid-19-antiviral-medications/</link>
                    <comments>https://ashpofficial.podbean.com/e/rural-health-system-leadership-in-pharmacist-prescribing-of-covid-19-antiviral-medications/#comments</comments>        <pubDate>Mon, 04 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3ed8aa16-0ad8-36d2-abcc-03f4b39fb897</guid>
                                    <description><![CDATA[<p>Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.    </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.    </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rfqs89/Rural_Health_Covid19_Antiviral_mixdown7vops.mp3" length="28901139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.    
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1199</itunes:duration>
                <itunes:episode>640</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Training Future Pharmacists on Social Determinants of Health</title>
        <itunes:title>Training Future Pharmacists on Social Determinants of Health</itunes:title>
        <link>https://ashpofficial.podbean.com/e/training-future-pharmacists-on-social-determinants-of-health/</link>
                    <comments>https://ashpofficial.podbean.com/e/training-future-pharmacists-on-social-determinants-of-health/#comments</comments>        <pubDate>Fri, 01 Apr 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7c9e018e-91c7-3bc8-8224-b262c57bd844</guid>
                                    <description><![CDATA[<p>This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3m9u99/Training_Future_Pharmacists_on_Social_Determinants_of_Health7cw1k.m4a" length="34173740" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1431</itunes:duration>
                <itunes:episode>630</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rapid Sequence Intubation in Special Populations</title>
        <itunes:title>Rapid Sequence Intubation in Special Populations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/rapid-sequence-intubation-in-special-populations/</link>
                    <comments>https://ashpofficial.podbean.com/e/rapid-sequence-intubation-in-special-populations/#comments</comments>        <pubDate>Thu, 31 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d2489568-4e79-3cc8-be22-21756248e4a3</guid>
                                    <description><![CDATA[<p>Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xkfiyq/Rapid_Sequence_Intubation_in_Special_Populations732u3.m4a" length="13398870" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>561</itunes:duration>
                <itunes:episode>635</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF Part 2</title>
        <itunes:title>Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF Part 2</itunes:title>
        <link>https://ashpofficial.podbean.com/e/refining-the-who-when-and-how-of-sglt2-inhibitors-of-patients-with-hfpef-part-2/</link>
                    <comments>https://ashpofficial.podbean.com/e/refining-the-who-when-and-how-of-sglt2-inhibitors-of-patients-with-hfpef-part-2/#comments</comments>        <pubDate>Wed, 30 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/87afea3b-4615-3417-840e-bed3590b0127</guid>
                                    <description><![CDATA[<p>As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/vcegb6/HFPEF_PART_2_mixdown6zokl.mp3" length="13175285" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>544</itunes:duration>
                <itunes:episode>634</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Give It Your Best Shot! Evaluating Covid-19 Vaccine Best Practices</title>
        <itunes:title>Give It Your Best Shot! Evaluating Covid-19 Vaccine Best Practices</itunes:title>
        <link>https://ashpofficial.podbean.com/e/give-it-your-best-shot-evaluating-covid-19-vaccine-best-practices/</link>
                    <comments>https://ashpofficial.podbean.com/e/give-it-your-best-shot-evaluating-covid-19-vaccine-best-practices/#comments</comments>        <pubDate>Tue, 29 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4c80d608-1c77-3c2d-b93f-d1255fc3f8d5</guid>
                                    <description><![CDATA[<p>From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9jwtrs/Give_It_Your_Best_Shot_Evaluating_Covid-19_Vaccine_Best_Practices7xgof.m4a" length="68004918" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2848</itunes:duration>
                <itunes:episode>636</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Promoting the Profession: Highlighting a Unique Shadowing Program for Pre-Health Students</title>
        <itunes:title>Promoting the Profession: Highlighting a Unique Shadowing Program for Pre-Health Students</itunes:title>
        <link>https://ashpofficial.podbean.com/e/promoting-the-profession-highlighting-a-unique-shadowing-program-for-pre-health-students/</link>
                    <comments>https://ashpofficial.podbean.com/e/promoting-the-profession-highlighting-a-unique-shadowing-program-for-pre-health-students/#comments</comments>        <pubDate>Mon, 28 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cace53ab-edbf-3001-a281-fea23e03898f</guid>
                                    <description><![CDATA[<p>This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: <a href='https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/'>https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/</a> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: <a href='https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/'>https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/</a> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7vrnrn/Promoting_the_profession_mixdowna3bma.mp3" length="45338475" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/ 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1884</itunes:duration>
                <itunes:episode>633</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Where Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment</title>
        <itunes:title>ASHP Advantage: Where Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment</itunes:title>
        <link>https://ashpofficial.podbean.com/e/where-do-we-go-from-here-discussing-the-future-of-eosinophilic-esophagitis-treatment/</link>
                    <comments>https://ashpofficial.podbean.com/e/where-do-we-go-from-here-discussing-the-future-of-eosinophilic-esophagitis-treatment/#comments</comments>        <pubDate>Fri, 25 Mar 2022 17:06:58 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/59cd7e7a-cee6-33d5-acd0-6882767cca52</guid>
                                    <description><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;">Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. </p>
<p class="paragraph" style="margin:0in;margin-bottom:.0001pt;vertical-align:baseline;"> </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r8vkct/ASHPOfficial_Adv_Where_Do_We_Go_from_Here_MIX.mp3" length="12723632" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. 
 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>795</itunes:duration>
                <itunes:episode>631</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Updates in Management of ICU Delirium</title>
        <itunes:title>Updates in Management of ICU Delirium</itunes:title>
        <link>https://ashpofficial.podbean.com/e/updates-in-management-of-icu-delirium/</link>
                    <comments>https://ashpofficial.podbean.com/e/updates-in-management-of-icu-delirium/#comments</comments>        <pubDate>Thu, 24 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/da7f6f09-0514-3106-8638-ffd6310036d0</guid>
                                    <description><![CDATA[<p>Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bkh78x/Updates_in_Management_of_ICU_Delirium60csb.m4a" length="38449498" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1610</itunes:duration>
                <itunes:episode>628</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice</title>
        <itunes:title>ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-standard-for-certification-as-a-center-of-excellence-in-medication-use-safety-and-pharmacy-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-standard-for-certification-as-a-center-of-excellence-in-medication-use-safety-and-pharmacy-practice/#comments</comments>        <pubDate>Wed, 23 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1128b19f-e590-3c13-971b-3e01489da916</guid>
                                    <description><![CDATA[<p>In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dqcn87/AJHP_Voices_ASHP_Standard_for_Certification_Revised.mp3" length="37226969" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2326</itunes:duration>
                <itunes:episode>625</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Assessment of Pharmacy Technician Job Satisfaction in Unique Ambulatory Pharmacy Settings: A Mixed-Method Analysis</title>
        <itunes:title>Assessment of Pharmacy Technician Job Satisfaction in Unique Ambulatory Pharmacy Settings: A Mixed-Method Analysis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/assessment-of-pharmacy-technician-job-satisfaction-in-unique-ambulatory-pharmacy-settings-a-mixed-method-analysis/</link>
                    <comments>https://ashpofficial.podbean.com/e/assessment-of-pharmacy-technician-job-satisfaction-in-unique-ambulatory-pharmacy-settings-a-mixed-method-analysis/#comments</comments>        <pubDate>Tue, 22 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7c239952-259e-3a45-8959-c110e519a968</guid>
                                    <description><![CDATA[<p>From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ccjqiz/Assessment_of_Pharm_Tech_Job_satisfaction_in_Amb_Care_mixdown9ryyj.mp3" length="29593028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1228</itunes:duration>
                <itunes:episode>629</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breaking Outside the Box: Use of Escape Rooms for Residency Interviews</title>
        <itunes:title>Breaking Outside the Box: Use of Escape Rooms for Residency Interviews</itunes:title>
        <link>https://ashpofficial.podbean.com/e/breaking-outside-the-box-use-of-escape-rooms-for-residency-interviews/</link>
                    <comments>https://ashpofficial.podbean.com/e/breaking-outside-the-box-use-of-escape-rooms-for-residency-interviews/#comments</comments>        <pubDate>Mon, 21 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2a1fdbbd-61d9-3591-a070-1c9775858e3d</guid>
                                    <description><![CDATA[<p>This episode of educator essentials explores the use of escape rooms for evaluating candidates during pharmacy residency interviews. Our panelists explore this creative approach to interviewing as a way to evaluate candidates’ communication, collaboration, and clinical skills, while having fun.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode of educator essentials explores the use of escape rooms for evaluating candidates during pharmacy residency interviews. Our panelists explore this creative approach to interviewing as a way to evaluate candidates’ communication, collaboration, and clinical skills, while having fun.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5kw3bn/Breaking_Outside_the_Box-_Use_of_Escape_Rooms_for_Residency_Interviews8uqq2.m4a" length="42865043" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This episode of educator essentials explores the use of escape rooms for evaluating candidates during pharmacy residency interviews. Our panelists explore this creative approach to interviewing as a way to evaluate candidates’ communication, collaboration, and clinical skills, while having fun.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1795</itunes:duration>
                <itunes:episode>627</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Respiratory Syncytial Virus Vaccine Status Update</title>
        <itunes:title>Respiratory Syncytial Virus Vaccine Status Update</itunes:title>
        <link>https://ashpofficial.podbean.com/e/respiratory-syncytial-virus-vaccine-status-update/</link>
                    <comments>https://ashpofficial.podbean.com/e/respiratory-syncytial-virus-vaccine-status-update/#comments</comments>        <pubDate>Fri, 18 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6be307b5-2eff-326c-9e85-b28db7ee1224</guid>
                                    <description><![CDATA[<p>A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zvc6ry/Respiratory_Syncytial_Virus_Vaccine_Status_Updatebgdyw.m4a" length="18493377" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>774</itunes:duration>
                <itunes:episode>626</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Person-Centered Medication Safety: A National Quality Forum Action Team</title>
        <itunes:title>Person-Centered Medication Safety: A National Quality Forum Action Team</itunes:title>
        <link>https://ashpofficial.podbean.com/e/person-centered-medication-safety-a-national-quality-forum-action-team/</link>
                    <comments>https://ashpofficial.podbean.com/e/person-centered-medication-safety-a-national-quality-forum-action-team/#comments</comments>        <pubDate>Thu, 17 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fcce15de-4a26-3cc1-b4b5-c4680d0da856</guid>
                                    <description><![CDATA[<p>As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rcgg3q/Person_Centered_Medication_Saftey_mixdown9f9je.mp3" length="60755696" type="audio/mpeg"/>
        <itunes:summary><![CDATA[As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2526</itunes:duration>
                <itunes:episode>623</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Readjust and Refocus: Experiences with the Phase II Match</title>
        <itunes:title>Readjust and Refocus: Experiences with the Phase II Match</itunes:title>
        <link>https://ashpofficial.podbean.com/e/readjust-and-refocus-experiences-with-the-phase-ii-match/</link>
                    <comments>https://ashpofficial.podbean.com/e/readjust-and-refocus-experiences-with-the-phase-ii-match/#comments</comments>        <pubDate>Wed, 16 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0b9e76ac-fdbb-327c-b4e6-6fe0abdfb46d</guid>
                                    <description><![CDATA[<p>This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ephkzx/ASHP_Official_Readjust_and_Refocus_Mix.mp3" length="43983620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2748</itunes:duration>
                <itunes:episode>619</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Conversation with an Anesthesiologist: Key Issues on Neuromuscular Monitoring and Neuromuscular Blockade Reversal Strategies</title>
        <itunes:title>ASHP Advantage: Conversation with an Anesthesiologist: Key Issues on Neuromuscular Monitoring and Neuromuscular Blockade Reversal Strategies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/conversation-with-an-anesthesiologist-key-issues-on-neuromuscular-monitoring-and-neuromuscular-blockade-reversal-strategies/</link>
                    <comments>https://ashpofficial.podbean.com/e/conversation-with-an-anesthesiologist-key-issues-on-neuromuscular-monitoring-and-neuromuscular-blockade-reversal-strategies/#comments</comments>        <pubDate>Tue, 15 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c09a6f92-5f92-329a-a69c-ce848b8fe744</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cy7iup/ASHP_ADV_Conversations_with_an_Anesthesiologist_MIX.mp3" length="69918896" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1747</itunes:duration>
                <itunes:episode>624</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Strategies for Overcoming Site-of-Care Challenges for Infusion Services</title>
        <itunes:title>Strategies for Overcoming Site-of-Care Challenges for Infusion Services</itunes:title>
        <link>https://ashpofficial.podbean.com/e/strategies-for-overcoming-site-of-care-challenges-for-infusion-services/</link>
                    <comments>https://ashpofficial.podbean.com/e/strategies-for-overcoming-site-of-care-challenges-for-infusion-services/#comments</comments>        <pubDate>Mon, 14 Mar 2022 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3b1ea112-168e-3f1e-9273-bf78b0da4adf</guid>
                                    <description><![CDATA[<p>From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/e8n88h/Strategies_for_Overcoming_Site-of-Care_Challenges_for_Infusion_Servicesbql2u.m4a" length="48716533" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2040</itunes:duration>
                <itunes:episode>607</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ensuring Technician Voices in Department – Incorporating Technicians in Department Strategic Planning</title>
        <itunes:title>Ensuring Technician Voices in Department – Incorporating Technicians in Department Strategic Planning</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ensuring-technician-voices-in-department-%e2%80%93-incorporating-technicians-in-department-strategic-planning/</link>
                    <comments>https://ashpofficial.podbean.com/e/ensuring-technician-voices-in-department-%e2%80%93-incorporating-technicians-in-department-strategic-planning/#comments</comments>        <pubDate>Thu, 10 Mar 2022 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8c4711a6-e3c6-37a3-a7ae-8e5a853c6359</guid>
                                    <description><![CDATA[<p>In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/9ck5rh/Incorporating_tech_in_Dept_Strategic_planning_mixdown63vtj.mp3" length="33524156" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1392</itunes:duration>
                <itunes:episode>621</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Updates to HIV Prevention Pharmacotherapy</title>
        <itunes:title>Updates to HIV Prevention Pharmacotherapy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/updates-to-hiv-prevention-pharmacotherapy/</link>
                    <comments>https://ashpofficial.podbean.com/e/updates-to-hiv-prevention-pharmacotherapy/#comments</comments>        <pubDate>Thu, 10 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b3b626fd-1a3b-319d-97c6-c06d011eb6ad</guid>
                                    <description><![CDATA[<p>This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x79v2j/Updates_to_HIV_Prevention_Pharmacotherapy861im.m4a" length="21412960" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>897</itunes:duration>
                <itunes:episode>620</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>This Isn’t Exactly How I Pictured it Happening: Leadership During Unusual Times</title>
        <itunes:title>This Isn’t Exactly How I Pictured it Happening: Leadership During Unusual Times</itunes:title>
        <link>https://ashpofficial.podbean.com/e/this-isn-t-exactly-how-i-pictured-it-happening-leadership-during-unusual-times/</link>
                    <comments>https://ashpofficial.podbean.com/e/this-isn-t-exactly-how-i-pictured-it-happening-leadership-during-unusual-times/#comments</comments>        <pubDate>Wed, 09 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e946de20-5635-3b6d-aaff-50825de747b4</guid>
                                    <description><![CDATA[<p>A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bshqck/This_Isn_t_Exactly_How_I_Pictured_it_Happening-_Leadership_During_Unusual_Times9arj7.m4a" length="18713372" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>783</itunes:duration>
                <itunes:episode>622</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: Training Future Leaders</title>
        <itunes:title>Community Pharmacy: Training Future Leaders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-training-future-leaders/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-training-future-leaders/#comments</comments>        <pubDate>Tue, 08 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/64e5c340-b597-37da-86e6-28cc2f3b0896</guid>
                                    <description><![CDATA[<p>In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qha2xq/Comm_Pharmacy_training_future_leaders_mixdowna8jga.mp3" length="47559453" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1981</itunes:duration>
                <itunes:episode>618</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>MCM 2021 COVID-19 Coverage: A Pharmacy Leader’s Toolkit for Adjusting Operations During a Pandemic</title>
        <itunes:title>MCM 2021 COVID-19 Coverage: A Pharmacy Leader’s Toolkit for Adjusting Operations During a Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/mcm-2021-covid-19-coverage-a-pharmacy-leader-s-toolkit-for-adjusting-operations-during-a-pandemic/</link>
                    <comments>https://ashpofficial.podbean.com/e/mcm-2021-covid-19-coverage-a-pharmacy-leader-s-toolkit-for-adjusting-operations-during-a-pandemic/#comments</comments>        <pubDate>Mon, 07 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a0726308-fe9c-302b-8862-ed031cba3f4d</guid>
                                    <description><![CDATA[<p>During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i98rk7/A_Pharmacy_Leaders_Toolkit_for_Adjusting_Operations_mixdown7ukau.mp3" length="35024447" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1454</itunes:duration>
                <itunes:episode>617</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Big Data, Big Bias: Understanding Underlying Biases in AI and CDS</title>
        <itunes:title>Big Data, Big Bias: Understanding Underlying Biases in AI and CDS</itunes:title>
        <link>https://ashpofficial.podbean.com/e/big-data-big-bias-understanding-underlying-biases-in-ai-and-cds/</link>
                    <comments>https://ashpofficial.podbean.com/e/big-data-big-bias-understanding-underlying-biases-in-ai-and-cds/#comments</comments>        <pubDate>Fri, 04 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cd7746fb-a78a-3c62-96f9-e41f5ba5388b</guid>
                                    <description><![CDATA[<p>As technology advances and you continue to automate your pharmacy, have you ever asked yourself if your software solutions are the right fit for the patient population you serve? This podcast seeks to open your eyes to potential biases that could be present in your use of artificial intelligence, machine learning, and clinical decision support. Join our mixed clinical and industrial panel of experts as we discuss challenges associated with bias and potential mitigating strategies to overcome. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>As technology advances and you continue to automate your pharmacy, have you ever asked yourself if your software solutions are the right fit for the patient population you serve? This podcast seeks to open your eyes to potential biases that could be present in your use of artificial intelligence, machine learning, and clinical decision support. Join our mixed clinical and industrial panel of experts as we discuss challenges associated with bias and potential mitigating strategies to overcome. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kmyar5/Big_Data_Big_Bias-Understanding_Underlying_Biases_in_AI_and_CDS6kkn0.m4a" length="21419600" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[As technology advances and you continue to automate your pharmacy, have you ever asked yourself if your software solutions are the right fit for the patient population you serve? This podcast seeks to open your eyes to potential biases that could be present in your use of artificial intelligence, machine learning, and clinical decision support. Join our mixed clinical and industrial panel of experts as we discuss challenges associated with bias and potential mitigating strategies to overcome. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>897</itunes:duration>
                <itunes:episode>605</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacogenomic Testing in Children: Which Tests and What Comes After Testing?</title>
        <itunes:title>Pharmacogenomic Testing in Children: Which Tests and What Comes After Testing?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacogenomic-testing-in-children-which-tests-and-what-comes-after-testing/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacogenomic-testing-in-children-which-tests-and-what-comes-after-testing/#comments</comments>        <pubDate>Thu, 03 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5df2e982-2c96-3ae2-ace5-899727826baf</guid>
                                    <description><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wkt6ge/Pharmacogenomics_testing_in_children_MCM_clinical_feat_mixdowna2u2a.mp3" length="43549277" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1809</itunes:duration>
                <itunes:episode>616</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Practical Implementation of Remote Continuous Glucose Monitoring in Hospitalized Patients with Diabetes</title>
        <itunes:title>Practical Implementation of Remote Continuous Glucose Monitoring in Hospitalized Patients with Diabetes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/practical-implementation-of-remote-continuous-glucose-monitoring-in-hospitalized-patients-with-diabetes/</link>
                    <comments>https://ashpofficial.podbean.com/e/practical-implementation-of-remote-continuous-glucose-monitoring-in-hospitalized-patients-with-diabetes/#comments</comments>        <pubDate>Wed, 02 Mar 2022 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0db6b8db-a552-3e84-8dd6-1362204f8a2b</guid>
                                    <description><![CDATA[<p>In this podcast, Dr. Matt Baker, Dr. Megan Musselman, Rachel Rodgers, and Dr. Richard Hellman, discuss their cross-disciplinary effort to implement continuous glucose monitoring in the inpatient setting with host and AJHP Editor in Chief, Dr. Daniel Cobaugh.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast, Dr. Matt Baker, Dr. Megan Musselman, Rachel Rodgers, and Dr. Richard Hellman, discuss their cross-disciplinary effort to implement continuous glucose monitoring in the inpatient setting with host and AJHP Editor in Chief, Dr. Daniel Cobaugh.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ts3q2v/ASHP_Podcast_AJHP_Voices_Interview_Practical_Implementation_of_Remote_Continuous_Glucose_Monitoring_in_Hospitalized_Patients_REVISED.mp3" length="66587492" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast, Dr. Matt Baker, Dr. Megan Musselman, Rachel Rodgers, and Dr. Richard Hellman, discuss their cross-disciplinary effort to implement continuous glucose monitoring in the inpatient setting with host and AJHP Editor in Chief, Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1664</itunes:duration>
                <itunes:episode>615</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Incorporating Wellness into the PharmD Curriculum</title>
        <itunes:title>Incorporating Wellness into the PharmD Curriculum</itunes:title>
        <link>https://ashpofficial.podbean.com/e/incorporating-wellness-into-the-pharmd-curriculum/</link>
                    <comments>https://ashpofficial.podbean.com/e/incorporating-wellness-into-the-pharmd-curriculum/#comments</comments>        <pubDate>Wed, 02 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/114151db-208e-31a3-abcb-5f2b9fef6e09</guid>
                                    <description><![CDATA[<p>Maintaining wellness throughout the pursuit of a Doctorate of Pharmacy degree is challenging. Students must have open conversations about the difficulties of staying well so that we can normalize feeling unwell. In this episode, students from across the country share their experiences and tips to encourage others to maintain healthy lives and relationships throughout their pharmacy school careers. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Maintaining wellness throughout the pursuit of a Doctorate of Pharmacy degree is challenging. Students must have open conversations about the difficulties of staying well so that we can normalize feeling unwell. In this episode, students from across the country share their experiences and tips to encourage others to maintain healthy lives and relationships throughout their pharmacy school careers. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/r86wvj/ASHP_Podcast_Incorporating_Wellness_into_the_PharmD_Curriculum_MIX.mp3" length="83721620" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Maintaining wellness throughout the pursuit of a Doctorate of Pharmacy degree is challenging. Students must have open conversations about the difficulties of staying well so that we can normalize feeling unwell. In this episode, students from across the country share their experiences and tips to encourage others to maintain healthy lives and relationships throughout their pharmacy school careers. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2093</itunes:duration>
                <itunes:episode>614</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CMS Takes on DIR Fees</title>
        <itunes:title>CMS Takes on DIR Fees</itunes:title>
        <link>https://ashpofficial.podbean.com/e/cms-takes-on-dir-fees/</link>
                    <comments>https://ashpofficial.podbean.com/e/cms-takes-on-dir-fees/#comments</comments>        <pubDate>Tue, 01 Mar 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7899570a-9a30-38e4-bba1-c5f964364d20</guid>
                                    <description><![CDATA[<p>This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/cdnu3x/CMS_Rule_for_Medicare_Advantage_and_Part_D_Around_DIR_Feesbf95y.m4a" length="20237729" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>847</itunes:duration>
                <itunes:episode>613</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Pharmacist Education on Immunotherapy: An Investment into the Patient as a Team Member in irAE Management</title>
        <itunes:title>ASHP Advantage: Pharmacist Education on Immunotherapy: An Investment into the Patient as a Team Member in irAE Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacist-education-on-immunotherapy-an-investment-into-the-patient-as-a-team-member-in-irae-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacist-education-on-immunotherapy-an-investment-into-the-patient-as-a-team-member-in-irae-management/#comments</comments>        <pubDate>Fri, 25 Feb 2022 13:05:30 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/0f4df184-8088-3fdb-93a9-e1ee98c4691e</guid>
                                    <description><![CDATA[<p>This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4erhsx/IRAE_Edit_mixdowna6h2k.mp3" length="41632429" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1734</itunes:duration>
                <itunes:episode>612</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF</title>
        <itunes:title>Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF</itunes:title>
        <link>https://ashpofficial.podbean.com/e/refining-the-who-when-and-how-of-sglt2-inhibitors-of-patients-with-hfpef/</link>
                    <comments>https://ashpofficial.podbean.com/e/refining-the-who-when-and-how-of-sglt2-inhibitors-of-patients-with-hfpef/#comments</comments>        <pubDate>Thu, 24 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9dcd5951-c7e4-3ac2-bb2f-807bd90f12d9</guid>
                                    <description><![CDATA[<p>This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rx48rk/Part_1-_Refining_the_Who_When_and_How_of_SGLT2-Inhibitors_in_Patients_with_HFpEF6rgzo.m4a" length="19958380" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>836</itunes:duration>
                <itunes:episode>604</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Eosinophilic Esophagitis: The Role of Allergy Testing and Dietary Interventions</title>
        <itunes:title>ASHP Advantage: Eosinophilic Esophagitis: The Role of Allergy Testing and Dietary Interventions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/eosinophilic-esophagitis-the-role-of-allergy-testing-and-dietary-interventions/</link>
                    <comments>https://ashpofficial.podbean.com/e/eosinophilic-esophagitis-the-role-of-allergy-testing-and-dietary-interventions/#comments</comments>        <pubDate>Fri, 18 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/deaa0e29-9bf8-3632-b76b-25bb524d09b3</guid>
                                    <description><![CDATA[<p>Learn from the experts what suspected allergens factor in eosinophilic esophagitis (EoE) and the role of allergy testing. Dietary interventions used in EoE are discussed, including a review of efficacy and challenges with implementation. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from the experts what suspected allergens factor in eosinophilic esophagitis (EoE) and the role of allergy testing. Dietary interventions used in EoE are discussed, including a review of efficacy and challenges with implementation. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/3v4d7b/ASHP_ADV_Eosinophilic_Esophagitis_The_Role_of_Allergy_Testing_and_Dietary_Interventions_REVISED.mp3" length="34240196" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from the experts what suspected allergens factor in eosinophilic esophagitis (EoE) and the role of allergy testing. Dietary interventions used in EoE are discussed, including a review of efficacy and challenges with implementation. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>856</itunes:duration>
                <itunes:episode>608</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>PARP Inhibitors</title>
        <itunes:title>PARP Inhibitors</itunes:title>
        <link>https://ashpofficial.podbean.com/e/parp-inhibitors/</link>
                    <comments>https://ashpofficial.podbean.com/e/parp-inhibitors/#comments</comments>        <pubDate>Thu, 17 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/413f0cc7-8b64-3e1d-810a-8ce43dbd07ee</guid>
                                    <description><![CDATA[<p>In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/i4ticd/PARP_Inhibitors_mixdown7uxte.mp3" length="22076642" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>915</itunes:duration>
                <itunes:episode>600</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prepping Ahead: Skills Fair for IPPE Students</title>
        <itunes:title>Prepping Ahead: Skills Fair for IPPE Students</itunes:title>
        <link>https://ashpofficial.podbean.com/e/prepping-ahead-skills-fair-for-ippe-students/</link>
                    <comments>https://ashpofficial.podbean.com/e/prepping-ahead-skills-fair-for-ippe-students/#comments</comments>        <pubDate>Wed, 16 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/459c2dd6-bfe9-3699-991b-99c941c902ed</guid>
                                    <description><![CDATA[<p>Preparing students for introductory pharmacy practice experiences (IPPEs) can be difficult with only didactic classroom learning. An interactive skills fair can help bridge the gap between the classroom and practice, setting a foundation for successful IPPEs. In today’s episode of Educator Essentials, we’re speaking with Dr. Jacqueline Wasynczuk about how her institution helped revamp and improve IPPE-readiness for their students, and the impact of the program on both students and preceptors.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Preparing students for introductory pharmacy practice experiences (IPPEs) can be difficult with only didactic classroom learning. An interactive skills fair can help bridge the gap between the classroom and practice, setting a foundation for successful IPPEs. In today’s episode of Educator Essentials, we’re speaking with Dr. Jacqueline Wasynczuk about how her institution helped revamp and improve IPPE-readiness for their students, and the impact of the program on both students and preceptors.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/h6q2ki/Prepping_Ahead_Skills_fair_for_IPPE_mixdown6ejsp.mp3" length="42270904" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Preparing students for introductory pharmacy practice experiences (IPPEs) can be difficult with only didactic classroom learning. An interactive skills fair can help bridge the gap between the classroom and practice, setting a foundation for successful IPPEs. In today’s episode of Educator Essentials, we’re speaking with Dr. Jacqueline Wasynczuk about how her institution helped revamp and improve IPPE-readiness for their students, and the impact of the program on both students and preceptors.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1756</itunes:duration>
                <itunes:episode>599</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Reverse to Go Forward: Monitoring and Cost Considerations for Reversing Neuromuscular Blockade</title>
        <itunes:title>ASHP Advantage: Reverse to Go Forward: Monitoring and Cost Considerations for Reversing Neuromuscular Blockade</itunes:title>
        <link>https://ashpofficial.podbean.com/e/reverse-to-go-forward-monitoring-and-cost-considerations-for-reversing-neuromuscular-blockade/</link>
                    <comments>https://ashpofficial.podbean.com/e/reverse-to-go-forward-monitoring-and-cost-considerations-for-reversing-neuromuscular-blockade/#comments</comments>        <pubDate>Tue, 15 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/fafc5354-60d8-3a80-bb71-2875f382113b</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies.  Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies.  Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/s3pqe3/ASHP_ADV_Reverse_to_Go_Forward_Monitoring_and_Cost_Considerations_for_Reversing_Neuromuscular_Blockade_REVISED.mp3" length="80331752" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies.  Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2008</itunes:duration>
                <itunes:episode>606</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leadership Journeys: A Focus on State Affiliates</title>
        <itunes:title>Leadership Journeys: A Focus on State Affiliates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leadership-journeys-a-focus-on-state-affiliates/</link>
                    <comments>https://ashpofficial.podbean.com/e/leadership-journeys-a-focus-on-state-affiliates/#comments</comments>        <pubDate>Mon, 14 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/810d2348-cbfa-3cca-b612-f41084b7acd3</guid>
                                    <description><![CDATA[<p>This podcast episode focuses on leadership journeys of board members of state affiliate societies. Listen in to learn about the speakers’ experiences, tips, and pearls on how to become leaders in organizations. The goal is to support sharing of information with ASHP members to promote awareness of leadership opportunities and to learn how some members have chosen to be involved.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode focuses on leadership journeys of board members of state affiliate societies. Listen in to learn about the speakers’ experiences, tips, and pearls on how to become leaders in organizations. The goal is to support sharing of information with ASHP members to promote awareness of leadership opportunities and to learn how some members have chosen to be involved.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rv4356/Leadership_Journeys-_A_Focus_on_State_Affiliates75ayc.m4a" length="21094205" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This podcast episode focuses on leadership journeys of board members of state affiliate societies. Listen in to learn about the speakers’ experiences, tips, and pearls on how to become leaders in organizations. The goal is to support sharing of information with ASHP members to promote awareness of leadership opportunities and to learn how some members have chosen to be involved.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>883</itunes:duration>
                <itunes:episode>598</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Health Equity &amp; Pharmacy – Perspectives from Practice</title>
        <itunes:title>Health Equity &amp; Pharmacy – Perspectives from Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/health-equity-pharmacy-%e2%80%93-perspectives-from-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/health-equity-pharmacy-%e2%80%93-perspectives-from-practice/#comments</comments>        <pubDate>Fri, 11 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/42c0c22a-d13e-388d-acfb-fcc15cfcf936</guid>
                                    <description><![CDATA[<p>This podcast episode looks at the health equity research, the impact of the recent social justice movement on this field, and ways pharmacists can bridge gaps in access to medications, resources, and health information. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode looks at the health equity research, the impact of the recent social justice movement on this field, and ways pharmacists can bridge gaps in access to medications, resources, and health information. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x9gfqb/Health_Equity_Pharmacy_mixdownb3bej.mp3" length="73561369" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode looks at the health equity research, the impact of the recent social justice movement on this field, and ways pharmacists can bridge gaps in access to medications, resources, and health information. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3060</itunes:duration>
                <itunes:episode>603</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Impact of Systemic Racism on Pain Management: Quick Recap of the Literature</title>
        <itunes:title>Impact of Systemic Racism on Pain Management: Quick Recap of the Literature</itunes:title>
        <link>https://ashpofficial.podbean.com/e/impact-of-systemic-racism-on-pain-management-quick-recap-of-the-literature/</link>
                    <comments>https://ashpofficial.podbean.com/e/impact-of-systemic-racism-on-pain-management-quick-recap-of-the-literature/#comments</comments>        <pubDate>Thu, 10 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/247f3cc7-670c-3790-aa55-bb5a2b70f003</guid>
                                    <description><![CDATA[<p>This podcast episode discusses the impact of systemic racism on pain management. Speakers review current literature and how systemic racism may affect patient care.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses the impact of systemic racism on pain management. Speakers review current literature and how systemic racism may affect patient care.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kpiq6w/Impact_of_systemic_racism_on_Pain_Management_mixdown7xbwz.mp3" length="31795897" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses the impact of systemic racism on pain management. Speakers review current literature and how systemic racism may affect patient care.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1320</itunes:duration>
                <itunes:episode>602</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leadership in Pharmacy: Going All In to Pursue Leadership as a Passionate Professional and New Practitioner</title>
        <itunes:title>Leadership in Pharmacy: Going All In to Pursue Leadership as a Passionate Professional and New Practitioner</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leadership-in-pharmacy-going-all-in-to-pursue-leadership-as-a-professional-passion-and-new-practitioner/</link>
                    <comments>https://ashpofficial.podbean.com/e/leadership-in-pharmacy-going-all-in-to-pursue-leadership-as-a-professional-passion-and-new-practitioner/#comments</comments>        <pubDate>Wed, 09 Feb 2022 10:04:09 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8965f55e-a45b-37bd-ae4f-1d28433a58d5</guid>
                                    <description><![CDATA[<p>This podcast provides an engaging interview with two pharmacy leaders who have really leaned in to volunteering and serving in leadership roles, as well as pursuing Health-System Pharmacy Administration & Leadership Residency Training. Dr. Scott and Dr. Andoh will share their insights on their professional journeys as students, pharmacists and association leaders, as well as their perspectives on leadership opportunities to support the advancement of pharmacy practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast provides an engaging interview with two pharmacy leaders who have really leaned in to volunteering and serving in leadership roles, as well as pursuing Health-System Pharmacy Administration & Leadership Residency Training. Dr. Scott and Dr. Andoh will share their insights on their professional journeys as students, pharmacists and association leaders, as well as their perspectives on leadership opportunities to support the advancement of pharmacy practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/y3az3w/Leadership_in_Pharmacy_Going_All_In_to_pursue_Leadership_as_a_Professional_Passion_and_New_Practioner_NEW_mixdown96b5f.mp3" length="58962928" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast provides an engaging interview with two pharmacy leaders who have really leaned in to volunteering and serving in leadership roles, as well as pursuing Health-System Pharmacy Administration & Leadership Residency Training. Dr. Scott and Dr. Andoh will share their insights on their professional journeys as students, pharmacists and association leaders, as well as their perspectives on leadership opportunities to support the advancement of pharmacy practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2456</itunes:duration>
                <itunes:episode>601</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Speaking Clearly: Inclusive and Bias-Free Negotiations</title>
        <itunes:title>Speaking Clearly: Inclusive and Bias-Free Negotiations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/speaking-clearly-inclusive-and-bias-free-negotiations/</link>
                    <comments>https://ashpofficial.podbean.com/e/speaking-clearly-inclusive-and-bias-free-negotiations/#comments</comments>        <pubDate>Tue, 08 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ef70463e-a0be-35b3-9b72-48ac533e9406</guid>
                                    <description><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference: Speaking Clearly: Inclusive and Bias-Free Negotiations, our content matter expert outlines strategies to identify commonly used language that may cause a perception of bias in specialty pharmacy negotiations.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference: Speaking Clearly: Inclusive and Bias-Free Negotiations, our content matter expert outlines strategies to identify commonly used language that may cause a perception of bias in specialty pharmacy negotiations.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7c9x9b/Speaking_Clearly-_Inclusive_and_Bias_Free_Negotiations6us7d.m4a" length="23545689" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2021 Specialty Pharmacy Conference: Speaking Clearly: Inclusive and Bias-Free Negotiations, our content matter expert outlines strategies to identify commonly used language that may cause a perception of bias in specialty pharmacy negotiations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>986</itunes:duration>
                <itunes:episode>594</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leadership &amp; Lockdown: A Discussion on the Student Pharmacist Leader’s Transition in and Out of Remote Leadership Positions during the COVID-19 Pandemic</title>
        <itunes:title>Leadership &amp; Lockdown: A Discussion on the Student Pharmacist Leader’s Transition in and Out of Remote Leadership Positions during the COVID-19 Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/leadership-lockdown-a-discussion-on-the-student-pharmacist-leader-s-transition-in-and-out-of-remote-leadership-positions-during-the-covid-19-pandemic/</link>
                    <comments>https://ashpofficial.podbean.com/e/leadership-lockdown-a-discussion-on-the-student-pharmacist-leader-s-transition-in-and-out-of-remote-leadership-positions-during-the-covid-19-pandemic/#comments</comments>        <pubDate>Mon, 07 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9e65a51f-a4a3-3470-9f47-e1482c38d4a7</guid>
                                    <description><![CDATA[<p>For many student pharmacist leaders, the transition from in-person to remote leadership in March 2020 was a jarring experience. From re-planning an organization’s traditions to resolving conflicts through a screen, pharmacy students adapted to new leadership styles and ways to maintain their mental well-being. This podcast episode interviews second, third, and fourth year student pharmacists about their experiences navigating the pandemic as student leaders. Discussion topics include practical ways to organize remote leadership tasks and how to promote resiliency by relying on mentors around you. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For many student pharmacist leaders, the transition from in-person to remote leadership in March 2020 was a jarring experience. From re-planning an organization’s traditions to resolving conflicts through a screen, pharmacy students adapted to new leadership styles and ways to maintain their mental well-being. This podcast episode interviews second, third, and fourth year student pharmacists about their experiences navigating the pandemic as student leaders. Discussion topics include practical ways to organize remote leadership tasks and how to promote resiliency by relying on mentors around you. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hs6yde/Leadership_and_Lockdown89vrt.m4a" length="30126402" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[For many student pharmacist leaders, the transition from in-person to remote leadership in March 2020 was a jarring experience. From re-planning an organization’s traditions to resolving conflicts through a screen, pharmacy students adapted to new leadership styles and ways to maintain their mental well-being. This podcast episode interviews second, third, and fourth year student pharmacists about their experiences navigating the pandemic as student leaders. Discussion topics include practical ways to organize remote leadership tasks and how to promote resiliency by relying on mentors around you. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1262</itunes:duration>
                <itunes:episode>597</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Implementing Pharmacogenomics Services at Mayo Clinic</title>
        <itunes:title>Implementing Pharmacogenomics Services at Mayo Clinic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/implementing-pharmacogenomics-services-at-mayo-clinic/</link>
                    <comments>https://ashpofficial.podbean.com/e/implementing-pharmacogenomics-services-at-mayo-clinic/#comments</comments>        <pubDate>Fri, 04 Feb 2022 09:29:17 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9cbb6605-0432-353c-8c94-8a624b6b527a</guid>
                                    <description><![CDATA[<p>ASHP is committed to advancing the field of pharmacogenomics and educating members on patient specific pharmacogenomics testing, dosing and monitoring of medications to improve health outcomes. This podcast episode explores the important role pharmacists play in pharmacogenomics from a practice and research perspective and leading pharmacogenomics services implementation at Mayo Clinic. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>ASHP is committed to advancing the field of pharmacogenomics and educating members on patient specific pharmacogenomics testing, dosing and monitoring of medications to improve health outcomes. This podcast episode explores the important role pharmacists play in pharmacogenomics from a practice and research perspective and leading pharmacogenomics services implementation at Mayo Clinic. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ir7x7a/2_Implementing_pharmacogen_services_at_Mayo_Clinic_mixdown86x65.mp3" length="23771293" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ASHP is committed to advancing the field of pharmacogenomics and educating members on patient specific pharmacogenomics testing, dosing and monitoring of medications to improve health outcomes. This podcast episode explores the important role pharmacists play in pharmacogenomics from a practice and research perspective and leading pharmacogenomics services implementation at Mayo Clinic. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>986</itunes:duration>
                <itunes:episode>596</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Shortages That Don’t Dilute: Alternatives to Diluent Shortages</title>
        <itunes:title>Shortages That Don’t Dilute: Alternatives to Diluent Shortages</itunes:title>
        <link>https://ashpofficial.podbean.com/e/shortages-that-don-t-dilute-alternatives-to-diluent-shortages/</link>
                    <comments>https://ashpofficial.podbean.com/e/shortages-that-don-t-dilute-alternatives-to-diluent-shortages/#comments</comments>        <pubDate>Thu, 03 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/02f26d1f-4b07-3457-afa1-a043fedbe190</guid>
                                    <description><![CDATA[<p>Shortages in medications have become common place, however we are now dealing with a shortage of diluents such as sterile water, dextrose and normal saline. This podcast episode discusses alternatives and conservation methods needed to combat these shortages.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Shortages in medications have become common place, however we are now dealing with a shortage of diluents such as sterile water, dextrose and normal saline. This podcast episode discusses alternatives and conservation methods needed to combat these shortages.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/25y4z2/Diluent_shortages_mixdownbvtjl.mp3" length="20315288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Shortages in medications have become common place, however we are now dealing with a shortage of diluents such as sterile water, dextrose and normal saline. This podcast episode discusses alternatives and conservation methods needed to combat these shortages.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>842</itunes:duration>
                <itunes:episode>595</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Insight on Clinician Burnout from the Senior Advisor to the Office of the Surgeon General</title>
        <itunes:title>Insight on Clinician Burnout from the Senior Advisor to the Office of the Surgeon General</itunes:title>
        <link>https://ashpofficial.podbean.com/e/insight-on-clinician-burnout-from-the-senior-advisor-to-the-office-of-the-surgeon-general/</link>
                    <comments>https://ashpofficial.podbean.com/e/insight-on-clinician-burnout-from-the-senior-advisor-to-the-office-of-the-surgeon-general/#comments</comments>        <pubDate>Wed, 02 Feb 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8b3d268d-8cd0-3a10-8b1b-1e150cea373d</guid>
                                    <description><![CDATA[<p>This podcast episode offers insight on clinician burnout from a physician expert and senior advisor to the office of the Surgeon General. In an over-regulated industry and a work harder culture, how can we simplify our work lives to achieve well-being among leadership and staff. Well-being priorities from the office of the Surgeon General are discussed including components of an ideal healing healthcare system. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode offers insight on clinician burnout from a physician expert and senior advisor to the office of the Surgeon General. In an over-regulated industry and a work harder culture, how can we simplify our work lives to achieve well-being among leadership and staff. Well-being priorities from the office of the Surgeon General are discussed including components of an ideal healing healthcare system. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/x2gtzv/2_Insight_on_clinician_burnout_mixdown6x7z3.mp3" length="48586643" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode offers insight on clinician burnout from a physician expert and senior advisor to the office of the Surgeon General. In an over-regulated industry and a work harder culture, how can we simplify our work lives to achieve well-being among leadership and staff. Well-being priorities from the office of the Surgeon General are discussed including components of an ideal healing healthcare system. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2020</itunes:duration>
                <itunes:episode>593</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-Being Leaders in Academia</title>
        <itunes:title>Well-Being Leaders in Academia</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-leaders-in-academia/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-leaders-in-academia/#comments</comments>        <pubDate>Mon, 31 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a19a29dd-e084-3c6c-a784-9a241834077f</guid>
                                    <description><![CDATA[<p>In this educator essentials podcast episode, we speak with Dr. Kelly Gable and Dr. Suzanne Harris about their unique academic leadership roles as directors of well-being and resilience within their institutions. This episode explores their career journeys, role innovations, and the importance of prioritizing the well-being of the pharmacy workforce through formal leadership. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this educator essentials podcast episode, we speak with Dr. Kelly Gable and Dr. Suzanne Harris about their unique academic leadership roles as directors of well-being and resilience within their institutions. This episode explores their career journeys, role innovations, and the importance of prioritizing the well-being of the pharmacy workforce through formal leadership. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hhz6xm/ASHP_Well_Being_Leaders_in_Academia_2_REVISED.mp3" length="115905008" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this educator essentials podcast episode, we speak with Dr. Kelly Gable and Dr. Suzanne Harris about their unique academic leadership roles as directors of well-being and resilience within their institutions. This episode explores their career journeys, role innovations, and the importance of prioritizing the well-being of the pharmacy workforce through formal leadership. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2897</itunes:duration>
                <itunes:episode>588</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: irAE Potpourri: A Little Bit of This and That for Anyone and Everyone</title>
        <itunes:title>ASHP Advantage: irAE Potpourri: A Little Bit of This and That for Anyone and Everyone</itunes:title>
        <link>https://ashpofficial.podbean.com/e/irae-potpourri-a-little-bit-of-this-and-that-for-anyone-and-everyone/</link>
                    <comments>https://ashpofficial.podbean.com/e/irae-potpourri-a-little-bit-of-this-and-that-for-anyone-and-everyone/#comments</comments>        <pubDate>Fri, 28 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7ed7a8d4-7dbc-331d-b24c-3b210864fb7c</guid>
                                    <description><![CDATA[<p>This discussion is meant to be informative for pharmacists who are less familiar with immunotherapy-related adverse events, as well as to offer insight into decision making in challenging situations related to managing irAEs. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This discussion is meant to be informative for pharmacists who are less familiar with immunotherapy-related adverse events, as well as to offer insight into decision making in challenging situations related to managing irAEs. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2k5ech/ASHP_ADV_Pharmacist_Education_on_Immunotherapy_An_Investment_into_the_Patient_as_a_Team_Member_in_irAE_Management.mp3" length="68631644" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This discussion is meant to be informative for pharmacists who are less familiar with immunotherapy-related adverse events, as well as to offer insight into decision making in challenging situations related to managing irAEs. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1715</itunes:duration>
                <itunes:episode>592</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Expert Consensus Decision Pathway for Heart Failure with Reduced Ejection Fraction: Implications for Transitions of Care</title>
        <itunes:title>Expert Consensus Decision Pathway for Heart Failure with Reduced Ejection Fraction: Implications for Transitions of Care</itunes:title>
        <link>https://ashpofficial.podbean.com/e/expert-consensus-decision-pathway-for-heart-failure-with-reduced-ejection-fraction-implications-for-transitions-of-care/</link>
                    <comments>https://ashpofficial.podbean.com/e/expert-consensus-decision-pathway-for-heart-failure-with-reduced-ejection-fraction-implications-for-transitions-of-care/#comments</comments>        <pubDate>Thu, 27 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/28b67848-9349-34f0-8f32-5193541dc74f</guid>
                                    <description><![CDATA[<p>Management of heart failure (HF) has evolved over the past few years, prompting the American College of Cardiology (ACC) to release a 2021 Update to Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment to provide guidance and recommendations on clinical care of HF patients with a reduced ejection fraction (HFrEF). New therapies for HFrEF have emerged that expand the arsenal for this patient population, particularly angiotensin receptor-neprilysin inhibitors (ARNI) and sodium glucose cotransporter-2 (SGLT2) inhibitors. However, use of guideline directed medical therapy (GDMT) is still suboptimal, and there is a need for pharmacists to assist in improving medication adherence. This podcast episode provides general practitioners an update on new evidence for pharmacotherapy and provides guidance on how to initiate GDMT in patients with HFrEF successfully in both inpatient and outpatient settings.     </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Management of heart failure (HF) has evolved over the past few years, prompting the American College of Cardiology (ACC) to release a 2021 Update to Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment to provide guidance and recommendations on clinical care of HF patients with a reduced ejection fraction (HFrEF). New therapies for HFrEF have emerged that expand the arsenal for this patient population, particularly angiotensin receptor-neprilysin inhibitors (ARNI) and sodium glucose cotransporter-2 (SGLT2) inhibitors. However, use of guideline directed medical therapy (GDMT) is still suboptimal, and there is a need for pharmacists to assist in improving medication adherence. This podcast episode provides general practitioners an update on new evidence for pharmacotherapy and provides guidance on how to initiate GDMT in patients with HFrEF successfully in both inpatient and outpatient settings.     </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mwri35/ASHP_Podcast_Expert_Consensus_Decision_Pathway_for_Heart_Failure_with_Reduced_Ejection_Fraction_MIX.mp3" length="70737392" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Management of heart failure (HF) has evolved over the past few years, prompting the American College of Cardiology (ACC) to release a 2021 Update to Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment to provide guidance and recommendations on clinical care of HF patients with a reduced ejection fraction (HFrEF). New therapies for HFrEF have emerged that expand the arsenal for this patient population, particularly angiotensin receptor-neprilysin inhibitors (ARNI) and sodium glucose cotransporter-2 (SGLT2) inhibitors. However, use of guideline directed medical therapy (GDMT) is still suboptimal, and there is a need for pharmacists to assist in improving medication adherence. This podcast episode provides general practitioners an update on new evidence for pharmacotherapy and provides guidance on how to initiate GDMT in patients with HFrEF successfully in both inpatient and outpatient settings.     
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1768</itunes:duration>
                <itunes:episode>591</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Social Media Do’s and Don’ts for Students</title>
        <itunes:title>Social Media Do’s and Don’ts for Students</itunes:title>
        <link>https://ashpofficial.podbean.com/e/social-media-do-s-and-don-ts-for-students/</link>
                    <comments>https://ashpofficial.podbean.com/e/social-media-do-s-and-don-ts-for-students/#comments</comments>        <pubDate>Wed, 26 Jan 2022 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/9b259760-e719-3cca-8b5b-e7f85eb7261d</guid>
                                    <description><![CDATA[<p>During this podcast episode, we talk with two pharmacy-based social media influencers. We hope that through learning about their experiences, students may gain insight into how to leverage these platforms for their own professional development.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>During this podcast episode, we talk with two pharmacy-based social media influencers. We hope that through learning about their experiences, students may gain insight into how to leverage these platforms for their own professional development.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/duzhy3/Social_Media_dos_and_donts_for_students_mixdown6c9ew.mp3" length="52539708" type="audio/mpeg"/>
        <itunes:summary><![CDATA[During this podcast episode, we talk with two pharmacy-based social media influencers. We hope that through learning about their experiences, students may gain insight into how to leverage these platforms for their own professional development.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2185</itunes:duration>
                <itunes:episode>589</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: Controlled Substances Diversion: Creating a Value Proposition for All</title>
        <itunes:title>ASHP Advantage: Controlled Substances Diversion: Creating a Value Proposition for All</itunes:title>
        <link>https://ashpofficial.podbean.com/e/controlled-substances-diversion-creating-a-value-proposition-for-all/</link>
                    <comments>https://ashpofficial.podbean.com/e/controlled-substances-diversion-creating-a-value-proposition-for-all/#comments</comments>        <pubDate>Wed, 26 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/87294c0a-d177-3b0c-9404-342adfe0773c</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/fkyk2c/ASHP_ADV_Controlled_Substances_Diversion_Creating_a_Value_Proposition_for_All_MIX.mp3" length="55674560" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1391</itunes:duration>
                <itunes:episode>584</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversation with Katelyn Dervay</title>
        <itunes:title>Conversation with Katelyn Dervay</itunes:title>
        <link>https://ashpofficial.podbean.com/e/conversation-with-katelyn-dervay/</link>
                    <comments>https://ashpofficial.podbean.com/e/conversation-with-katelyn-dervay/#comments</comments>        <pubDate>Tue, 25 Jan 2022 11:27:25 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/805a4c6c-a595-316d-943d-7ca96b30bcc5</guid>
                                    <description><![CDATA[<p>In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nuxmh9/Conversation_with_K_Dervay_mixdownbvvjg.mp3" length="33302765" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1383</itunes:duration>
                <itunes:episode>590</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits</title>
        <itunes:title>It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits</itunes:title>
        <link>https://ashpofficial.podbean.com/e/it-s-complicated-financial-and-billing-considerations-for-managing-pharmacy-and-medical-benefits/</link>
                    <comments>https://ashpofficial.podbean.com/e/it-s-complicated-financial-and-billing-considerations-for-managing-pharmacy-and-medical-benefits/#comments</comments>        <pubDate>Mon, 24 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/20efc0cc-8ec6-3491-b31e-d762243bebf8</guid>
                                    <description><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nx3jv9/It_s_Complicated-_Financial_and_Billing_Considerations_for_Managing_Pharmacy_and_Medical_Benefits6oyua.m4a" length="37810033" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1583</itunes:duration>
                <itunes:episode>587</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Managing Biosimilars: A Specialty All Its Own</title>
        <itunes:title>Managing Biosimilars: A Specialty All Its Own</itunes:title>
        <link>https://ashpofficial.podbean.com/e/managing-biosimilars-a-specialty-all-its-own/</link>
                    <comments>https://ashpofficial.podbean.com/e/managing-biosimilars-a-specialty-all-its-own/#comments</comments>        <pubDate>Fri, 21 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/393292a1-d21b-34d3-a781-7774f0691c44</guid>
                                    <description><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qmfqw4/Managing_Biosimilars_A_Specialty_All_Its_Own_v2bmdzq.m4a" length="21991414" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>920</itunes:duration>
                <itunes:episode>585</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What you might have missed in 2021: Highlights from the New Clinical Practice Guideline for Management of Pediatric Patients with Acute Hematogenous Osteomyelitis</title>
        <itunes:title>What you might have missed in 2021: Highlights from the New Clinical Practice Guideline for Management of Pediatric Patients with Acute Hematogenous Osteomyelitis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/whatyou-mighthavemissed-in2021highlights-from-thenewclinical-practice-guideline-for-management-ofpediatricpatientswithacutehematogenous-osteomyelitis/</link>
                    <comments>https://ashpofficial.podbean.com/e/whatyou-mighthavemissed-in2021highlights-from-thenewclinical-practice-guideline-for-management-ofpediatricpatientswithacutehematogenous-osteomyelitis/#comments</comments>        <pubDate>Thu, 20 Jan 2022 12:55:24 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a068ed0d-3a90-3ffa-a5f8-7cb89607207c</guid>
                                    <description><![CDATA[<p>In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/weus4n/2_Guidline_for_management_of_pediatric_patients_mixdown9hqgx.mp3" length="27539268" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1143</itunes:duration>
                <itunes:episode>586</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>2022 ASHP/ASHP Foundation Pharmacy Forecast</title>
        <itunes:title>2022 ASHP/ASHP Foundation Pharmacy Forecast</itunes:title>
        <link>https://ashpofficial.podbean.com/e/2022-ashpashp-foundation-pharmacy-forecast/</link>
                    <comments>https://ashpofficial.podbean.com/e/2022-ashpashp-foundation-pharmacy-forecast/#comments</comments>        <pubDate>Fri, 14 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a403e496-34e0-3105-b355-a0df99bf733b</guid>
                                    <description><![CDATA[<p>Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pd9ch5/ASHPOfficial_AJHP_Voices_Interview_2022_ASHP_ASHP_Foundation_Pharmacy_Forecast_MIX_REV_1.mp3" length="85602908" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2140</itunes:duration>
                <itunes:episode>577</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Become a Wiz at Urine Drug Screens (UDS)</title>
        <itunes:title>Become a Wiz at Urine Drug Screens (UDS)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/become-a-wiz-at-urine-drug-screens-uds/</link>
                    <comments>https://ashpofficial.podbean.com/e/become-a-wiz-at-urine-drug-screens-uds/#comments</comments>        <pubDate>Thu, 13 Jan 2022 10:10:36 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/001ef3a2-e889-3db0-a79f-4cf19cfefc2a</guid>
                                    <description><![CDATA[<p>This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/rj5c3v/Become_a_urine_Drug_Screening_wiz_mixdown8hwa8.mp3" length="28828940" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1200</itunes:duration>
                <itunes:episode>583</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)</title>
        <itunes:title>ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ismp-targeted-medication-safety-best-practices-for-hospitals-7-neuromuscular-blocking-agents-nmb/</link>
                    <comments>https://ashpofficial.podbean.com/e/ismp-targeted-medication-safety-best-practices-for-hospitals-7-neuromuscular-blocking-agents-nmb/#comments</comments>        <pubDate>Wed, 12 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ade50310-1968-3e46-9e47-8d02fff8b755</guid>
                                    <description><![CDATA[<p>Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/nea6b5/ISMP_Best_Practice_7_mixdown7r2q0.mp3" length="19057689" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>793</itunes:duration>
                <itunes:episode>582</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Community Pharmacy: The Path to Leadership</title>
        <itunes:title>Community Pharmacy: The Path to Leadership</itunes:title>
        <link>https://ashpofficial.podbean.com/e/community-pharmacy-the-path-to-leadership/</link>
                    <comments>https://ashpofficial.podbean.com/e/community-pharmacy-the-path-to-leadership/#comments</comments>        <pubDate>Tue, 11 Jan 2022 16:11:21 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a18a7a9f-a1e3-307d-892c-d3dfcd2c56ec</guid>
                                    <description><![CDATA[<p>In this podcast we discuss with Dr. Andrea Luebchow, Program  Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast we discuss with Dr. Andrea Luebchow, Program  Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kjbrgu/Comm_Pharm_-Path_to_Leadership_Edit_mixdownbanad.mp3" length="42896996" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast we discuss with Dr. Andrea Luebchow, Program  Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
 ]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1787</itunes:duration>
                <itunes:episode>581</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>International Pharmacy Leadership</title>
        <itunes:title>International Pharmacy Leadership</itunes:title>
        <link>https://ashpofficial.podbean.com/e/international-pharmacy-leadership/</link>
                    <comments>https://ashpofficial.podbean.com/e/international-pharmacy-leadership/#comments</comments>        <pubDate>Mon, 10 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/82ee4645-2845-32aa-8a10-605a8e5703c0</guid>
                                    <description><![CDATA[<p>In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uggzeb/Leadership_with_International_Organizations6c1hb.m4a" length="24028454" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1006</itunes:duration>
                <itunes:episode>580</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pharmacy Informatics Women Leaders: Distinguished Service</title>
        <itunes:title>Pharmacy Informatics Women Leaders: Distinguished Service</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pharmacy-informatics-women-leaders-distinguished-service/</link>
                    <comments>https://ashpofficial.podbean.com/e/pharmacy-informatics-women-leaders-distinguished-service/#comments</comments>        <pubDate>Fri, 07 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dfc52314-4c65-3c31-87c5-652e4155a4eb</guid>
                                    <description><![CDATA[<p>Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/4hc52u/Pharmacy_Informatics_Women_Leaders_Distinguished_Service_-_Part_17m6av.m4a" length="39615604" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1658</itunes:duration>
                <itunes:episode>579</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Alcohol Withdrawal Management in the Emergency Department</title>
        <itunes:title>Alcohol Withdrawal Management in the Emergency Department</itunes:title>
        <link>https://ashpofficial.podbean.com/e/alcohol-withdrawal-management-in-the-emergency-department/</link>
                    <comments>https://ashpofficial.podbean.com/e/alcohol-withdrawal-management-in-the-emergency-department/#comments</comments>        <pubDate>Thu, 06 Jan 2022 10:08:46 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/7ee7b5a8-b0ea-3a49-9255-7cba726084fa</guid>
                                    <description><![CDATA[<p>EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/866riv/Management_of_Ethanol_Withdrawalbenr9.m4a" length="58137890" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2434</itunes:duration>
                <itunes:episode>578</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tools You Need to Flourish and Thrive in Your Career</title>
        <itunes:title>Tools You Need to Flourish and Thrive in Your Career</itunes:title>
        <link>https://ashpofficial.podbean.com/e/tools-you-need-to-flourish-and-thrive-in-your-career/</link>
                    <comments>https://ashpofficial.podbean.com/e/tools-you-need-to-flourish-and-thrive-in-your-career/#comments</comments>        <pubDate>Wed, 05 Jan 2022 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/93ae5648-f70c-33e5-8695-fa2e83bf554e</guid>
                                    <description><![CDATA[<p>In this podcast episode, we meet with Ashlee Klevens Hayes, pharmacist and executive career strategist to discuss self-trust, a key component to the value of wellbeing and resilience. Ashlee shares 10 tangible tools to help develop this skill through new habits, conquer imposter syndrome, and help you excel through transitionary phases in your career.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we meet with Ashlee Klevens Hayes, pharmacist and executive career strategist to discuss self-trust, a key component to the value of wellbeing and resilience. Ashlee shares 10 tangible tools to help develop this skill through new habits, conquer imposter syndrome, and help you excel through transitionary phases in your career.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/2at8ds/ASHPOfficial_Tools_You_Need_to_Flourish_and_Thrive_in_Your_Career_Revision.mp3" length="24616064" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, we meet with Ashlee Klevens Hayes, pharmacist and executive career strategist to discuss self-trust, a key component to the value of wellbeing and resilience. Ashlee shares 10 tangible tools to help develop this skill through new habits, conquer imposter syndrome, and help you excel through transitionary phases in your career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1538</itunes:duration>
                <itunes:episode>576</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP’s New Drug Supply Chain Recommendations</title>
        <itunes:title>ASHP’s New Drug Supply Chain Recommendations</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-s-new-drug-supply-chain-recommendations/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-s-new-drug-supply-chain-recommendations/#comments</comments>        <pubDate>Tue, 04 Jan 2022 11:32:56 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/2dca5fed-e79d-3b79-9e7f-b488ef4e86a4</guid>
                                    <description><![CDATA[<p>This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/quscue/Drug_Supply_Chain_recommendations_mixdown9tieo.mp3" length="31228880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1297</itunes:duration>
                <itunes:episode>575</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: Pharmacy Response: Perspectives from a Rural Healthcare Operation in Maryland and Delaware</title>
        <itunes:title>COVID-19: Pharmacy Response: Perspectives from a Rural Healthcare Operation in Maryland and Delaware</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-pharmacy-response-perspectives-from-a-rural-healthcare-operation-in-maryland-and-delaware/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-pharmacy-response-perspectives-from-a-rural-healthcare-operation-in-maryland-and-delaware/#comments</comments>        <pubDate>Wed, 22 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/79ff246a-4208-3c4e-a693-900e92982d68</guid>
                                    <description><![CDATA[<p>This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/detess/MCM_COVID-19_Presentation_COVID-19_Pharmacy_Response_Perspectives_from_a_Rural_Healthcare_Operation_in_Maryland_and_Delawareabo2n.m4a" length="45687979" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1913</itunes:duration>
                <itunes:episode>574</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>It‘s Alive! Managing Cell and Viral Vector Therapies in the Pharmacy</title>
        <itunes:title>It‘s Alive! Managing Cell and Viral Vector Therapies in the Pharmacy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/it-s-alive-managing-cell-and-viral-vector-therapies-in-the-pharmacy/</link>
                    <comments>https://ashpofficial.podbean.com/e/it-s-alive-managing-cell-and-viral-vector-therapies-in-the-pharmacy/#comments</comments>        <pubDate>Tue, 21 Dec 2021 11:04:33 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/35af7e47-ee40-35c5-9991-935faade252c</guid>
                                    <description><![CDATA[<p>Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ruix9u/Clinical_Highlights_from_the_2020_Midyear_It_s_Alive_Managing_Cell_and_Viral_Vector_Therapies_in_the_Pharmacy7xjwq.m4a" length="34189416" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1431</itunes:duration>
                <itunes:episode>573</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Using the KIDs List and Checking It Twice!</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Using the KIDs List and Checking It Twice!</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-using-the-kids-list-and-checking-it-twice/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-using-the-kids-list-and-checking-it-twice/#comments</comments>        <pubDate>Thu, 16 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/a0e50f59-73f1-361b-8ded-615a0b07162b</guid>
                                    <description><![CDATA[<p>Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pvm4xe/Using_the_KIDs_List_checking_it_twice_mixdown78h3i.mp3" length="38161835" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1583</itunes:duration>
                <itunes:episode>572</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP’s Statement on Pharmacist Payment for COVID-19 Oral Antivirals Explained</title>
        <itunes:title>ASHP’s Statement on Pharmacist Payment for COVID-19 Oral Antivirals Explained</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ashp-s-statement-on-pharmacist-payment-for-covid-19-oral-antivirals-explained/</link>
                    <comments>https://ashpofficial.podbean.com/e/ashp-s-statement-on-pharmacist-payment-for-covid-19-oral-antivirals-explained/#comments</comments>        <pubDate>Wed, 15 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4903af89-ecb8-3644-a8fd-0af289abcff9</guid>
                                    <description><![CDATA[<p>This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/dxrpi3/ASHPs_Statement_on_pharm_payment_ADV_mixdown63cjo.mp3" length="13571427" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>562</itunes:duration>
                <itunes:episode>571</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Weekly Preceptor Roadmap Tool and New Preceptor Success</title>
        <itunes:title>Weekly Preceptor Roadmap Tool and New Preceptor Success</itunes:title>
        <link>https://ashpofficial.podbean.com/e/weekly-preceptor-roadmap-tool-and-new-preceptor-success/</link>
                    <comments>https://ashpofficial.podbean.com/e/weekly-preceptor-roadmap-tool-and-new-preceptor-success/#comments</comments>        <pubDate>Tue, 14 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6b330e4d-0eeb-3633-89f4-8026c75cebdf</guid>
                                    <description><![CDATA[<p>For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qf4s9w/ASHP_Well_Being_Leaders_in_Academia_Weekly_Preceptor_Roadmap_MIX.mp3" length="38618732" type="audio/mpeg"/>
        <itunes:summary><![CDATA[For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>965</itunes:duration>
                <itunes:episode>570</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>(Management Case Study) Review of Multiple Process Adaptations in a Pharmacist-Run Anticoagulation Clinic During the COVID-19 Pandemic</title>
        <itunes:title>(Management Case Study) Review of Multiple Process Adaptations in a Pharmacist-Run Anticoagulation Clinic During the COVID-19 Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/management-case-study-review-of-multiple-process-adaptations-in-a-pharmacist-run-anticoagulation-clinic-during-the-covid-19-pandemic/</link>
                    <comments>https://ashpofficial.podbean.com/e/management-case-study-review-of-multiple-process-adaptations-in-a-pharmacist-run-anticoagulation-clinic-during-the-covid-19-pandemic/#comments</comments>        <pubDate>Mon, 13 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5ff51030-1cd4-3d29-8cec-b431b2fc62d2</guid>
                                    <description><![CDATA[<p>The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/683kke/COVID_19_-multiple_process_adaptation_-_Anticoagulation_121021_mixdownbutgv.mp3" length="37145725" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1543</itunes:duration>
                <itunes:episode>569</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Creating a High-Functioning Team Where Together Everyone Achieves More</title>
        <itunes:title>Creating a High-Functioning Team Where Together Everyone Achieves More</itunes:title>
        <link>https://ashpofficial.podbean.com/e/creating-a-high-functioning-team-where-together-everyone-achieves-more/</link>
                    <comments>https://ashpofficial.podbean.com/e/creating-a-high-functioning-team-where-together-everyone-achieves-more/#comments</comments>        <pubDate>Sun, 12 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/66cf0512-1b2d-3aca-a2ec-cad817130d1c</guid>
                                    <description><![CDATA[<p>Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/zvjfen/MIDYEAR_Creating_a_High-Functioning_Team_Where_Together_Everyone_Achieves_More8mlpa.m4a" length="42629854" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1785</itunes:duration>
                <itunes:episode>557</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Optimizing Diabetes Management Through Continuous Glucose Monitoring</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Optimizing Diabetes Management Through Continuous Glucose Monitoring</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-optimizing-diabetes-management-through-continuous-glucose-monitoring/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-optimizing-diabetes-management-through-continuous-glucose-monitoring/#comments</comments>        <pubDate>Sat, 11 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4544df22-8ac2-33a1-8373-c283f2c11248</guid>
                                    <description><![CDATA[<p>In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/z4pqhm/Clinical_Highlights_from_the_2020_Midyear_Optimizing_Diabetes_Management_Through_Continuous_Glucose_Monitoring69ia7.m4a" length="33343556" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1396</itunes:duration>
                <itunes:episode>556</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Enhancing pharmacy residency training program quality and efficiency through alignment of pharmacy residency programs within the multi-entity health system</title>
        <itunes:title>Enhancing pharmacy residency training program quality and efficiency through alignment of pharmacy residency programs within the multi-entity health system</itunes:title>
        <link>https://ashpofficial.podbean.com/e/enhancingpharmacy-residency-training-programquality-and-efficiency-through-alignment-ofpharmacy-residency-programs-withinthe-multientity-health-system/</link>
                    <comments>https://ashpofficial.podbean.com/e/enhancingpharmacy-residency-training-programquality-and-efficiency-through-alignment-ofpharmacy-residency-programs-withinthe-multientity-health-system/#comments</comments>        <pubDate>Fri, 10 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e3b518fe-285d-3058-b2d0-751d527f71b0</guid>
                                    <description><![CDATA[<p>Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/pbpjyv/ASHP_Podcast_AJHP_Voices_Enhancing_pharmacy_residency_training_program_quality_REVISED.mp3" length="87957128" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2198</itunes:duration>
                <itunes:episode>563</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog6070738/podbean-1400x1400.png" />    </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Take a Deep Breath: Updates in Asthma and COPD Management</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Take a Deep Breath: Updates in Asthma and COPD Management</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-take-a-deep-breath-updates-in-asthma-and-copd-management/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-take-a-deep-breath-updates-in-asthma-and-copd-management/#comments</comments>        <pubDate>Thu, 09 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/514dcdcf-2f61-3407-a2ef-41573fb1bd95</guid>
                                    <description><![CDATA[<p>This episode highlights the key takeaways from the ASHP Section of Clinical Specialists and Scientists’ 2020 Midyear Clinical Meeting presentation on how pharmacists can recommend therapy interventions for a patient with COPD to reduce exacerbation or hospital readmission.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode highlights the key takeaways from the ASHP Section of Clinical Specialists and Scientists’ 2020 Midyear Clinical Meeting presentation on how pharmacists can recommend therapy interventions for a patient with COPD to reduce exacerbation or hospital readmission.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/jngegk/Take_a_deep_breathe_mixdown987lu.mp3" length="51945662" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode highlights the key takeaways from the ASHP Section of Clinical Specialists and Scientists’ 2020 Midyear Clinical Meeting presentation on how pharmacists can recommend therapy interventions for a patient with COPD to reduce exacerbation or hospital readmission.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2157</itunes:duration>
                <itunes:episode>567</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Join Us For A Stretch: Yoga in the workplace</title>
        <itunes:title>Join Us For A Stretch: Yoga in the workplace</itunes:title>
        <link>https://ashpofficial.podbean.com/e/join-us-for-a-stretch-yoga-in-the-workplace/</link>
                    <comments>https://ashpofficial.podbean.com/e/join-us-for-a-stretch-yoga-in-the-workplace/#comments</comments>        <pubDate>Wed, 08 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3cbfd87c-28fd-37d4-ae6f-0b066ad36f22</guid>
                                    <description><![CDATA[<p>This podcast episode describes how ASHP incorporated yoga practice into the workplace, the benefits, and how you can bring the practice into your workplace and life.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode describes how ASHP incorporated yoga practice into the workplace, the benefits, and how you can bring the practice into your workplace and life.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/j3ab6g/Join_us_for_a_stretch_Yoga_in_the_workplace_mixdown6l40i.mp3" length="20044982" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode describes how ASHP incorporated yoga practice into the workplace, the benefits, and how you can bring the practice into your workplace and life.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>831</itunes:duration>
                <itunes:episode>565</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Implementing a Pharmacy Telemedicine Clinic and Residency Training Program During the COVID-19 Pandemic Within a Family Medicine Practice</title>
        <itunes:title>Implementing a Pharmacy Telemedicine Clinic and Residency Training Program During the COVID-19 Pandemic Within a Family Medicine Practice</itunes:title>
        <link>https://ashpofficial.podbean.com/e/implementing-a-pharmacy-telemedicine-clinic-and-residency-training-program-during-the-covid-19-pandemic-within-a-family-medicine-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/implementing-a-pharmacy-telemedicine-clinic-and-residency-training-program-during-the-covid-19-pandemic-within-a-family-medicine-practice/#comments</comments>        <pubDate>Tue, 07 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b45db911-de2c-382a-bc8c-91b69e6e68d8</guid>
                                    <description><![CDATA[<p>COVID-19 required the pharmacy referral service within the Family Medical Practice at Penn Presbyterian Medical Center to move to a virtual platform. This podcast episode, originally presented at the 2020 Midyear Clinical Meeting, describes the implementation of the pharmacy services as well as results of the transition for maintaining patient care visits and pharmacy residency training during a pandemic.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>COVID-19 required the pharmacy referral service within the Family Medical Practice at Penn Presbyterian Medical Center to move to a virtual platform. This podcast episode, originally presented at the 2020 Midyear Clinical Meeting, describes the implementation of the pharmacy services as well as results of the transition for maintaining patient care visits and pharmacy residency training during a pandemic.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/7z6avi/TELEMEDICINE_CLINIC_covid_19_mixdown69npv.mp3" length="32438617" type="audio/mpeg"/>
        <itunes:summary><![CDATA[COVID-19 required the pharmacy referral service within the Family Medical Practice at Penn Presbyterian Medical Center to move to a virtual platform. This podcast episode, originally presented at the 2020 Midyear Clinical Meeting, describes the implementation of the pharmacy services as well as results of the transition for maintaining patient care visits and pharmacy residency training during a pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1347</itunes:duration>
                <itunes:episode>568</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fast Facts for Ambulatory Care Pharmacist: 2022 Physician Fee Schedule Updates</title>
        <itunes:title>Fast Facts for Ambulatory Care Pharmacist: 2022 Physician Fee Schedule Updates</itunes:title>
        <link>https://ashpofficial.podbean.com/e/fast-facts-for-ambulatory-care-pharmacist-2022-physician-fee-schedule-updates/</link>
                    <comments>https://ashpofficial.podbean.com/e/fast-facts-for-ambulatory-care-pharmacist-2022-physician-fee-schedule-updates/#comments</comments>        <pubDate>Mon, 06 Dec 2021 11:45:44 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/4b4d2578-d3c8-3680-b967-b63f9d3ddea9</guid>
                                    <description><![CDATA[<p>This podcast episode reviews updates to the Physician Fee Schedule and their effect on ambulatory care pharmacy practice. Listeners will receive an overview of the Physician Fee Schedule and its impact on various scenarios pharmacists may encounter in practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode reviews updates to the Physician Fee Schedule and their effect on ambulatory care pharmacy practice. Listeners will receive an overview of the Physician Fee Schedule and its impact on various scenarios pharmacists may encounter in practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/v92cuu/ASHP_Podcast_Fast_Facts_for_Ambulatory_Care_Billing_2022_Updates_to_the_Physician_Fee_Schedule_MIX.mp3" length="85306412" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode reviews updates to the Physician Fee Schedule and their effect on ambulatory care pharmacy practice. Listeners will receive an overview of the Physician Fee Schedule and its impact on various scenarios pharmacists may encounter in practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2132</itunes:duration>
                <itunes:episode>566</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: The Effects of Augmented Renal Clearance on Antibiotics in Critically-ill Adult and Pediatric Patients: The Need for Exposure Guided Dosing</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: The Effects of Augmented Renal Clearance on Antibiotics in Critically-ill Adult and Pediatric Patients: The Need for Exposure Guided Dosing</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlightsfromthe-2020-midyear-the-effectsof-augmented-renal-clearance-on-antibiotics-in-critically-ill-adult-and-pediatric-patientstheneed/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlightsfromthe-2020-midyear-the-effectsof-augmented-renal-clearance-on-antibiotics-in-critically-ill-adult-and-pediatric-patientstheneed/#comments</comments>        <pubDate>Sun, 05 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/54169bc6-2afc-3091-b24d-cb369586678b</guid>
                                    <description><![CDATA[<p>In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tc5z2g/Clinical_Highlights_from_the_2020_Midyear_The_Effects_of_Augmented_Renal_Clearance_on_Antibiotics_in_Critically-ill_Adult_and_Pediatric_Patients_The_Need_for_Exposure_Guided_Dosing85yh5.m4a" length="18848701" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>789</itunes:duration>
                <itunes:episode>555</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Gastrointestinal and Nutrition Pharmacy Gems 2020</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Gastrointestinal and Nutrition Pharmacy Gems 2020</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-gastrointestinal-and-nutrition-pharmacy-gems-2020/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-gastrointestinal-and-nutrition-pharmacy-gems-2020/#comments</comments>        <pubDate>Sat, 04 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/bac913f7-5176-34b3-a52b-dfefe169cd5e</guid>
                                    <description><![CDATA[<p>In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/65rzh9/Clinical_Highlights_from_the_2020_Midyear_Gastrointestinal_and_Nutrition_Pharmacy_Gems_202066y3y.m4a" length="27471206" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1150</itunes:duration>
                <itunes:episode>554</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Opioid Stewardship: Strong Practice Successes</title>
        <itunes:title>Opioid Stewardship: Strong Practice Successes</itunes:title>
        <link>https://ashpofficial.podbean.com/e/opioid-stewardship-strong-practice-successes/</link>
                    <comments>https://ashpofficial.podbean.com/e/opioid-stewardship-strong-practice-successes/#comments</comments>        <pubDate>Fri, 03 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f12ed964-e694-3e7b-9a78-1733724c983b</guid>
                                    <description><![CDATA[<p>This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mf5q7s/ASHP_Podcast_Opioid_Stewardship_Strong_Practice_Successes_MIX.mp3" length="130034504" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3250</itunes:duration>
                <itunes:episode>564</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tips to Prepare for the 2021 Virtual Midyear Clinical Meeting</title>
        <itunes:title>Tips to Prepare for the 2021 Virtual Midyear Clinical Meeting</itunes:title>
        <link>https://ashpofficial.podbean.com/e/tips-to-prepare-for-the-2021-virtual-midyear-clinical-meeting/</link>
                    <comments>https://ashpofficial.podbean.com/e/tips-to-prepare-for-the-2021-virtual-midyear-clinical-meeting/#comments</comments>        <pubDate>Thu, 02 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c9f976ce-0f7a-3445-bb29-4b72103c5285</guid>
                                    <description><![CDATA[<p>The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/m8cecu/ASHP_Podcast_Tips_and_Tricks_to_Prepare_for_the_2021_Virtual_Midyear_Clinical_Meeting_MIX.mp3" length="53557328" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1338</itunes:duration>
                <itunes:episode>553</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Navigating Virtual Midyear 2021: Expert Advice and Must-Watch Sessions</title>
        <itunes:title>Navigating Virtual Midyear 2021: Expert Advice and Must-Watch Sessions</itunes:title>
        <link>https://ashpofficial.podbean.com/e/navigating-virtual-midyear-2021-expert-advice-and-must-watch-sessions/</link>
                    <comments>https://ashpofficial.podbean.com/e/navigating-virtual-midyear-2021-expert-advice-and-must-watch-sessions/#comments</comments>        <pubDate>Wed, 01 Dec 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/ceef6b56-8d51-3fb5-95bf-0a4a4106459e</guid>
                                    <description><![CDATA[<p>Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mc5ykd/Navigating_virtual_Midyear_112321_mixdown6mymz.mp3" length="47643854" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1978</itunes:duration>
                <itunes:episode>562</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Front Seat View to a Pharmacy Legend</title>
        <itunes:title>A Front Seat View to a Pharmacy Legend</itunes:title>
        <link>https://ashpofficial.podbean.com/e/a-front-seat-view-to-a-pharmacy-legend/</link>
                    <comments>https://ashpofficial.podbean.com/e/a-front-seat-view-to-a-pharmacy-legend/#comments</comments>        <pubDate>Tue, 30 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/6683cef2-5506-35ea-8f02-3af7b63e10f8</guid>
                                    <description><![CDATA[<p>In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of the <em>Life & Legacy of Joseph A. Oddis</em>, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/huj5yi/The_Life_and_Legacy_of_Dr_Joseph_A_Oddis_Episode_2_Dan_Cobaugh_William_Zellmer_REVISED_3_mixdown.mp3" length="39244397" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1634</itunes:duration>
                <itunes:episode>561</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Confidence, Humility, and Risk: Life Lessons from a Visionary Pharmacy Leader</title>
        <itunes:title>Confidence, Humility, and Risk: Life Lessons from a Visionary Pharmacy Leader</itunes:title>
        <link>https://ashpofficial.podbean.com/e/confidence-humility-and-risk-life-lessons-from-a-visionary-pharmacy-leader/</link>
                    <comments>https://ashpofficial.podbean.com/e/confidence-humility-and-risk-life-lessons-from-a-visionary-pharmacy-leader/#comments</comments>        <pubDate>Mon, 29 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d9430e2d-f6b5-3bb1-ae51-9c0157b63b3e</guid>
                                    <description><![CDATA[<p>In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of the <em>Life & Legacy of Joseph A. Oddis</em>, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hx92qk/The_Life_and_Legacy_of_Joseph_A_Oddis_Paul_Abramowitz_MIX.mp3" length="52514372" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1312</itunes:duration>
                <itunes:episode>560</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Controversies Surrounding Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Controversies Surrounding Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-controversies-surrounding-antithrombotic-therapy-following-transcatheter-aortic-valve-replacement/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-controversies-surrounding-antithrombotic-therapy-following-transcatheter-aortic-valve-replacement/#comments</comments>        <pubDate>Sun, 28 Nov 2021 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dab33eaa-a225-32f3-81be-ff24800d8416</guid>
                                    <description><![CDATA[<p>Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/bksaxa/Clinical_Highlights_from_the_2020_Midyear_Controversies_Surrounding_Antithrombotic_Therapy_Following_Transcatheter_Aortic_Valve_Replacement9gi8s.m4a" length="33143723" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1387</itunes:duration>
                <itunes:episode>559</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: On Your Mark, Ready, Set…Should We Go? An Update on Acute Kidney Injury Biomarkers</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: On Your Mark, Ready, Set…Should We Go? An Update on Acute Kidney Injury Biomarkers</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-on-your-mark-ready-set%e2%80%a6should-we-go-an-update-on-acute-kidney-injury-biomarkers/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-on-your-mark-ready-set%e2%80%a6should-we-go-an-update-on-acute-kidney-injury-biomarkers/#comments</comments>        <pubDate>Sun, 28 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/be3bd055-0e11-3d72-ae2c-7ff34c4ad231</guid>
                                    <description><![CDATA[<p>Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/atyihd/On_your_mark_ready_set_should_we_go_mixdown6jjwq.mp3" length="33216720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1377</itunes:duration>
                <itunes:episode>552</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Therapeutic Debates 2020: Anticoagulation in Patients with End Stage Renal Disease</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Therapeutic Debates 2020: Anticoagulation in Patients with End Stage Renal Disease</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-therapeutic-debates-2020-anticoagulation-in-patients-with-end-stage-renal-disease/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-therapeutic-debates-2020-anticoagulation-in-patients-with-end-stage-renal-disease/#comments</comments>        <pubDate>Sat, 27 Nov 2021 12:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/dcafd0a5-929b-38b6-a3f2-7165dc2195e6</guid>
                                    <description><![CDATA[<p>In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/xiwwjp/Clinical_Highlights_from_the_2020_Midyear_Therapeutic_Debates_2020_Anticoagulation_in_Patients_with_End_Stage_Renal_Diseaseb6m42.m4a" length="61620119" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2580</itunes:duration>
                <itunes:episode>558</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vancomycin Therapeutic Drug Monitoring — The Times They Are a Changin’</title>
        <itunes:title>Vancomycin Therapeutic Drug Monitoring — The Times They Are a Changin’</itunes:title>
        <link>https://ashpofficial.podbean.com/e/vancomycin-therapeutic-drug-monitoring-%e2%80%94-the-times-they-are-a-changin/</link>
                    <comments>https://ashpofficial.podbean.com/e/vancomycin-therapeutic-drug-monitoring-%e2%80%94-the-times-they-are-a-changin/#comments</comments>        <pubDate>Sat, 27 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3d5c2488-5ab8-3b8b-ba6e-a6ee17141675</guid>
                                    <description><![CDATA[<p>Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product <a href='https://elearning.ashp.org/products/8622/vancomycin-monitoring-the-abcs-of-aucs'>here</a>.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product <a href='https://elearning.ashp.org/products/8622/vancomycin-monitoring-the-abcs-of-aucs'>here</a>.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/etd9ej/Vancomycin_Therapeutic_Drug_Monitoring_The_Times_They_Are_a_Changin_mixdown9lnhp.mp3" length="39676881" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1649</itunes:duration>
                <itunes:episode>551</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exploring Residency Programs: A Focus on Pharmacogenomics</title>
        <itunes:title>Exploring Residency Programs: A Focus on Pharmacogenomics</itunes:title>
        <link>https://ashpofficial.podbean.com/e/exploring-residency-programs-a-focus-on-pharmacogenomics/</link>
                    <comments>https://ashpofficial.podbean.com/e/exploring-residency-programs-a-focus-on-pharmacogenomics/#comments</comments>        <pubDate>Tue, 23 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c2ee0b9f-e8f4-3656-a764-384e342e84b3</guid>
                                    <description><![CDATA[<p>Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.   </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.   </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5ubakv/Exploring_Residency_Programs_A_Focus_on_Pharmacogenomics__mixdown78qqq.mp3" length="13390283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.   
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>551</itunes:duration>
                <itunes:episode>549</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: Care of the Critically Ill Patient: Part Two: A Focus on the Management of Coagulopathy</title>
        <itunes:title>COVID-19: Care of the Critically Ill Patient: Part Two: A Focus on the Management of Coagulopathy</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-care-of-the-critically-ill-patient-part-two-a-focus-on-the-management-of-coagulopathy-1637261327/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-care-of-the-critically-ill-patient-part-two-a-focus-on-the-management-of-coagulopathy-1637261327/#comments</comments>        <pubDate>Mon, 22 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/5433415f-0f6b-3ba3-81f3-49244c977527</guid>
                                    <description><![CDATA[<p>In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gikk9p/COVID_19_-Covid_19_Critically_Ill_-_Coagulopathy_mixdownakz1h.mp3" length="34664712" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1440</itunes:duration>
                <itunes:episode>550</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ambulatory Care Residency Training: Identifying the Best Fit</title>
        <itunes:title>Ambulatory Care Residency Training: Identifying the Best Fit</itunes:title>
        <link>https://ashpofficial.podbean.com/e/ambulatory-care-residency-training-identifying-the-best-fit/</link>
                    <comments>https://ashpofficial.podbean.com/e/ambulatory-care-residency-training-identifying-the-best-fit/#comments</comments>        <pubDate>Fri, 19 Nov 2021 10:45:48 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1c0b5940-86d5-36cc-9a06-3fedff2a3b9d</guid>
                                    <description><![CDATA[<p>Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/swpif3/Diversity_of_Ambulatory_Care_Pharmacy_Residency_Programs_in_5_minutes_mixdown6ljk3.mp3" length="7088354" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>288</itunes:duration>
                <itunes:episode>548</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Impact of Disease Overestimation and Anchoring Bias in Antimicrobial Prescribing Behavior</title>
        <itunes:title>The Impact of Disease Overestimation and Anchoring Bias in Antimicrobial Prescribing Behavior</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-impact-of-disease-overestimation-and-anchoring-bias-in-antimicrobial-prescribing-behavior/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-impact-of-disease-overestimation-and-anchoring-bias-in-antimicrobial-prescribing-behavior/#comments</comments>        <pubDate>Thu, 18 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/81066cbd-9074-3d1d-a68a-a069ba7eadca</guid>
                                    <description><![CDATA[<p>Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/hn62gi/ASHP_Podcast_The_impact_of_disease_overestimation_and_anchoring_bias_in_antimicrobial_prescribing_behavior_MIX_1_6u011.mp3" length="78067316" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1951</itunes:duration>
                <itunes:episode>546</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASHP Advantage: C diff Infection: What you need to know!</title>
        <itunes:title>ASHP Advantage: C diff Infection: What you need to know!</itunes:title>
        <link>https://ashpofficial.podbean.com/e/c-diff-infection-what-you-need-to-know/</link>
                    <comments>https://ashpofficial.podbean.com/e/c-diff-infection-what-you-need-to-know/#comments</comments>        <pubDate>Wed, 17 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/441e5197-4ac3-3f47-a3d1-7ff1c650f7d9</guid>
                                    <description><![CDATA[<p>Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/kbf2ir/ASHP_ADV_C_diff_Infection_What_you_need_to_know_MIX.mp3" length="35547284" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>888</itunes:duration>
                <itunes:episode>547</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>(Management Case Study) Transitioning Specialty Pharmacy Services to Telemedicine for Embedded Clinical Pharmacists Within Various Specialty Clinics During the COVID-19 Pandemic</title>
        <itunes:title>(Management Case Study) Transitioning Specialty Pharmacy Services to Telemedicine for Embedded Clinical Pharmacists Within Various Specialty Clinics During the COVID-19 Pandemic</itunes:title>
        <link>https://ashpofficial.podbean.com/e/management-case-study-transitioning-specialty-pharmacy-servicesto-telemedicine-forembeddedclinical-pharmacistswithin-variousspecialtyclinics-duringthe/</link>
                    <comments>https://ashpofficial.podbean.com/e/management-case-study-transitioning-specialty-pharmacy-servicesto-telemedicine-forembeddedclinical-pharmacistswithin-variousspecialtyclinics-duringthe/#comments</comments>        <pubDate>Tue, 16 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c3a658a2-3842-3a95-9b09-8a760ae7e728</guid>
                                    <description><![CDATA[<p>Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/tuf2tn/MCM_COVID-19_Presentation_Transitioning_Specialty_Pharmacy_Services_to_Telemedicine_for_Embedded_Clinical_Pharmacists_Within_Various_Specialty_Clinics_During_the_COVID-19_Pandemic8xjdn.m4a" length="30083228" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1259</itunes:duration>
                <itunes:episode>542</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Adding It Up: Applying New Data to Management of Pediatric ADHD</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Adding It Up: Applying New Data to Management of Pediatric ADHD</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-adding-it-up-applying-new-data-to-management-of-pediatric-adhd/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-adding-it-up-applying-new-data-to-management-of-pediatric-adhd/#comments</comments>        <pubDate>Sun, 14 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/03957478-3171-36d7-8d35-f0c4345d90cf</guid>
                                    <description><![CDATA[<p>This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/asgm28/Clinical_Highlights_from_the_2020_Midyear_Adding_It_Up_Applying_New_Data_to_Management_of_Pediatric_ADHD94qe6.m4a" length="27020123" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1131</itunes:duration>
                <itunes:episode>541</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Progressive Models for Underserved Patients in Rural Health Settings</title>
        <itunes:title>Progressive Models for Underserved Patients in Rural Health Settings</itunes:title>
        <link>https://ashpofficial.podbean.com/e/progressive-models-for-underserved-patients-in-rural-health-settings/</link>
                    <comments>https://ashpofficial.podbean.com/e/progressive-models-for-underserved-patients-in-rural-health-settings/#comments</comments>        <pubDate>Sat, 13 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b2d83ef8-9008-38e5-9ead-3805c1991eec</guid>
                                    <description><![CDATA[<p>Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/ycwadm/Clinical_Highlights_from_the_2020_Midyear_Progressive_Models_for_Underserved_Patients_in_Rural_Health_Settings6qv8w.m4a" length="25838730" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1082</itunes:duration>
                <itunes:episode>540</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19: Care of the Critically Ill Patient: Part One: A Focus on the Management of Acute Respiratory Distress Syndrome</title>
        <itunes:title>COVID-19: Care of the Critically Ill Patient: Part One: A Focus on the Management of Acute Respiratory Distress Syndrome</itunes:title>
        <link>https://ashpofficial.podbean.com/e/covid-19-care-of-the-critically-ill-patient-part-one-a-focus-on-the-management-of-acute-respiratory-distress-syndrome/</link>
                    <comments>https://ashpofficial.podbean.com/e/covid-19-care-of-the-critically-ill-patient-part-one-a-focus-on-the-management-of-acute-respiratory-distress-syndrome/#comments</comments>        <pubDate>Fri, 12 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/c07f0794-d9ad-3e20-b11a-afa803e72ac7</guid>
                                    <description><![CDATA[<p>In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/84iich/MCM_COVID-19_Presentation_COVID-19_Care_of_the_Critically_Ill_Patient_Part_One_A_Focus_on_the_Management_of_Acute_Respiratory_Distress_Syndrome9ecsk.m4a" length="77743528" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3255</itunes:duration>
                <itunes:episode>539</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Opioid Tapering in Palliative Care — Stepping into the Mist of the Unknown</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Opioid Tapering in Palliative Care — Stepping into the Mist of the Unknown</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-opioid-tapering-in-palliative-care-%e2%80%94-stepping-into-the-mist-of-the-unknown/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-opioid-tapering-in-palliative-care-%e2%80%94-stepping-into-the-mist-of-the-unknown/#comments</comments>        <pubDate>Thu, 11 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/eb2432ae-9bf4-3b54-990b-db075751c805</guid>
                                    <description><![CDATA[<p>The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/43wgic/Opioid_tapering_in_Palliative_Care_mixdown7biku.mp3" length="26081290" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1079</itunes:duration>
                <itunes:episode>545</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>FDA’s New Draft Hospital/Health-System Compounding Guidance: What Does It Mean for Practice?</title>
        <itunes:title>FDA’s New Draft Hospital/Health-System Compounding Guidance: What Does It Mean for Practice?</itunes:title>
        <link>https://ashpofficial.podbean.com/e/fda-s-new-draft-hospital-health-compounding-guidance-what-does-it-mean-for-practice/</link>
                    <comments>https://ashpofficial.podbean.com/e/fda-s-new-draft-hospital-health-compounding-guidance-what-does-it-mean-for-practice/#comments</comments>        <pubDate>Wed, 10 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b8240e7d-cc38-348b-bfae-dd6b2a42bd17</guid>
                                    <description><![CDATA[<p>This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/wgp9sn/3_FDAs_New_Draft_11321_mixdown99fry.mp3" length="45725133" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1898</itunes:duration>
                <itunes:episode>544</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pay it forward - Mentoring student &amp; resident poster presenters</title>
        <itunes:title>Pay it forward - Mentoring student &amp; resident poster presenters</itunes:title>
        <link>https://ashpofficial.podbean.com/e/pay-it-forward-mentoring-student-resident-poster-presenters/</link>
                    <comments>https://ashpofficial.podbean.com/e/pay-it-forward-mentoring-student-resident-poster-presenters/#comments</comments>        <pubDate>Tue, 09 Nov 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/f841d834-7614-3bd0-bf86-4724823fac5e</guid>
                                    <description><![CDATA[<p>In this podcast episode, we explore the importance of paying it forward by serving as poster mentors for student pharmacists and residents. We discuss best practices in coaching learners through the research process and tips on how to effectively evaluate poster presentations to assist learner’s professional development.</p>
<p>For those interested in inspiring and motivating learners in the ASHP Midyear Clinical Meeting and Exhibition 2021 Poster Hall, <a href='https://midyear.ashp.org/posters/student-and-resident-poster-mentors'>sign up</a> to be a poster mentor by November 15. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this podcast episode, we explore the importance of paying it forward by serving as poster mentors for student pharmacists and residents. We discuss best practices in coaching learners through the research process and tips on how to effectively evaluate poster presentations to assist learner’s professional development.</p>
<p>For those interested in inspiring and motivating learners in the ASHP Midyear Clinical Meeting and Exhibition 2021 Poster Hall, <a href='https://midyear.ashp.org/posters/student-and-resident-poster-mentors'>sign up</a> to be a poster mentor by November 15. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/axxnus/Pay_it_forward_11421_mixdownaf8mu.mp3" length="33230091" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this podcast episode, we explore the importance of paying it forward by serving as poster mentors for student pharmacists and residents. We discuss best practices in coaching learners through the research process and tips on how to effectively evaluate poster presentations to assist learner’s professional development.
For those interested in inspiring and motivating learners in the ASHP Midyear Clinical Meeting and Exhibition 2021 Poster Hall, sign up to be a poster mentor by November 15. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1378</itunes:duration>
                <itunes:episode>543</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Veterans Day Tribute: Stories of Service to Country and the Profession</title>
        <itunes:title>Veterans Day Tribute: Stories of Service to Country and the Profession</itunes:title>
        <link>https://ashpofficial.podbean.com/e/veterans-day-tribute-stories-of-service-to-country-and-the-profession/</link>
                    <comments>https://ashpofficial.podbean.com/e/veterans-day-tribute-stories-of-service-to-country-and-the-profession/#comments</comments>        <pubDate>Mon, 08 Nov 2021 05:30:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/1bb4ef4d-471c-3f9a-a51f-7eb3091aa3b1</guid>
                                    <description><![CDATA[<p>In celebration of Veterans Day 2021, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our nation. In this episode, we speak with Carol Labadie, Tim Ekola, and Kelly Lunsford about their stories and the remarkable journeys they embarked on to become pharmacists that all began with their decision to enter the military. This special episode is part reflection, part inspirational, and all entertainment. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In celebration of Veterans Day 2021, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our nation. In this episode, we speak with Carol Labadie, Tim Ekola, and Kelly Lunsford about their stories and the remarkable journeys they embarked on to become pharmacists that all began with their decision to enter the military. This special episode is part reflection, part inspirational, and all entertainment. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/igtvc6/ASHP_Veterans_Day_Episode_MIX.mp3" length="116629544" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In celebration of Veterans Day 2021, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our nation. In this episode, we speak with Carol Labadie, Tim Ekola, and Kelly Lunsford about their stories and the remarkable journeys they embarked on to become pharmacists that all began with their decision to enter the military. This special episode is part reflection, part inspirational, and all entertainment. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2915</itunes:duration>
                <itunes:episode>533</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Speaking from the Heart: Great Debates in Cardiology: Anticoagulation in ECMO</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Speaking from the Heart: Great Debates in Cardiology: Anticoagulation in ECMO</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-speaking-from-the-heart-great-debates-in-cardiology-anticoagulation-in-ecmo/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-speaking-from-the-heart-great-debates-in-cardiology-anticoagulation-in-ecmo/#comments</comments>        <pubDate>Sun, 07 Nov 2021 23:13:00 -0500</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/3655d4d1-f876-3c68-836f-769f7ee99134</guid>
                                    <description><![CDATA[<p>In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best anticoagulation strategy for patients on ECMO.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best anticoagulation strategy for patients on ECMO.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/q9ji82/Clinical_Highlights_from_the_2020_Midyear_Speaking_from_the_Heart_Great_Debates_in_Cardiology_Anticoagulation_in_ECMObudpc.m4a" length="33014054" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best anticoagulation strategy for patients on ECMO.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1382</itunes:duration>
                <itunes:episode>538</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Don‘t Worry, Be ‘Appy‘: When Tech Meets Medicine</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Don‘t Worry, Be ‘Appy‘: When Tech Meets Medicine</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-don-t-worry-be-appy-when-tech-meets-medicine/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-don-t-worry-be-appy-when-tech-meets-medicine/#comments</comments>        <pubDate>Sat, 06 Nov 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/cc8273d3-3bae-3355-90fa-d9bb15b2e9c4</guid>
                                    <description><![CDATA[<p>Listen in as our content matter experts from Section of Clinical Specialists and Scientists present at the 2020 Midyear Clinical Meeting, where they summarized some of the available digital medicine technologies for cardiology, endocrinology, and oncology, and identify the barriers to implementing digital medicine technologies. Don’t Worry, Be ‘Appy!  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Listen in as our content matter experts from Section of Clinical Specialists and Scientists present at the 2020 Midyear Clinical Meeting, where they summarized some of the available digital medicine technologies for cardiology, endocrinology, and oncology, and identify the barriers to implementing digital medicine technologies. Don’t Worry, Be ‘Appy!  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/mkmayb/Clinical_Highlights_from_the_2020_Midyear_Don_t_Worry_Be_Appy_When_Tech_Meets_Medicine9zi9e.m4a" length="58949495" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[Listen in as our content matter experts from Section of Clinical Specialists and Scientists present at the 2020 Midyear Clinical Meeting, where they summarized some of the available digital medicine technologies for cardiology, endocrinology, and oncology, and identify the barriers to implementing digital medicine technologies. Don’t Worry, Be ‘Appy!  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2468</itunes:duration>
                <itunes:episode>537</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Larger Impact of Extern and Fellow Projects on ASHP Initiatives</title>
        <itunes:title>The Larger Impact of Extern and Fellow Projects on ASHP Initiatives</itunes:title>
        <link>https://ashpofficial.podbean.com/e/the-larger-impact-of-extern-and-fellow-projects-on-ashp-initiatives/</link>
                    <comments>https://ashpofficial.podbean.com/e/the-larger-impact-of-extern-and-fellow-projects-on-ashp-initiatives/#comments</comments>        <pubDate>Fri, 05 Nov 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/099e2b4b-835c-37fc-b399-2df309e97997</guid>
                                    <description><![CDATA[<p>A conversation between an ASHP fellow and extern describing their experiences and projects and how they relate to ASHP initiatives.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A conversation between an ASHP fellow and extern describing their experiences and projects and how they relate to ASHP initiatives.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/g4vy6f/ASHP_Experiences_mixdown75rkq.mp3" length="31495438" type="audio/mpeg"/>
        <itunes:summary><![CDATA[A conversation between an ASHP fellow and extern describing their experiences and projects and how they relate to ASHP initiatives.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1306</itunes:duration>
                <itunes:episode>535</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Operating Room Emergencies</title>
        <itunes:title>Operating Room Emergencies</itunes:title>
        <link>https://ashpofficial.podbean.com/e/operating-room-emergencies/</link>
                    <comments>https://ashpofficial.podbean.com/e/operating-room-emergencies/#comments</comments>        <pubDate>Thu, 04 Nov 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/b66f285c-7c7d-3bae-8a75-e25db41567a5</guid>
                                    <description><![CDATA[<p>Medication-related emergencies occurring in the operating room or peri-procedural areas include malignant hyperthermia and local anesthetic toxicity. In each instance, time is of the essence in recognizing and treating life-threatening drug reaction.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Medication-related emergencies occurring in the operating room or peri-procedural areas include malignant hyperthermia and local anesthetic toxicity. In each instance, time is of the essence in recognizing and treating life-threatening drug reaction.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qedk7z/Operating_room_emergencies_mixdownamqrc.mp3" length="35035586" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Medication-related emergencies occurring in the operating room or peri-procedural areas include malignant hyperthermia and local anesthetic toxicity. In each instance, time is of the essence in recognizing and treating life-threatening drug reaction.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1453</itunes:duration>
                <itunes:episode>532</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Harnessing the Power of Transformation: Pharmacists Today and Into the Future</title>
        <itunes:title>Harnessing the Power of Transformation: Pharmacists Today and Into the Future</itunes:title>
        <link>https://ashpofficial.podbean.com/e/harnessing-the-power-of-transformation-pharmacists-today-and-into-the-future/</link>
                    <comments>https://ashpofficial.podbean.com/e/harnessing-the-power-of-transformation-pharmacists-today-and-into-the-future/#comments</comments>        <pubDate>Wed, 03 Nov 2021 23:04:20 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/773cf0d5-1871-3154-94f8-ffc4f053615b</guid>
                                    <description><![CDATA[<p>In this feature from the 2020 Midyear Clinical Meeting, our content matter experts from the ASHP Section of Clinical Specialists and Scientists discuss the importance of emotional intelligence in daily life and why improving emotional intelligence can help pharmacy staff lead their industry’s transformation. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this feature from the 2020 Midyear Clinical Meeting, our content matter experts from the ASHP Section of Clinical Specialists and Scientists discuss the importance of emotional intelligence in daily life and why improving emotional intelligence can help pharmacy staff lead their industry’s transformation. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/qnkcjx/MCM_Presentation_Harnessing_the_Power_of_Transformation_Pharmacists_Today_and_Into_the_Future6t708.m4a" length="22184233" type="audio/x-m4a"/>
        <itunes:summary><![CDATA[In this feature from the 2020 Midyear Clinical Meeting, our content matter experts from the ASHP Section of Clinical Specialists and Scientists discuss the importance of emotional intelligence in daily life and why improving emotional intelligence can help pharmacy staff lead their industry’s transformation. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>928</itunes:duration>
                <itunes:episode>536</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Well-Being and Resilience: Real World Strategies for Leaders</title>
        <itunes:title>Well-Being and Resilience: Real World Strategies for Leaders</itunes:title>
        <link>https://ashpofficial.podbean.com/e/well-being-and-resilience-real-world-strategies-for-leaders/</link>
                    <comments>https://ashpofficial.podbean.com/e/well-being-and-resilience-real-world-strategies-for-leaders/#comments</comments>        <pubDate>Wed, 03 Nov 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/d3cf49a9-511e-3343-9303-63f843370269</guid>
                                    <description><![CDATA[<p>This podcast episode highlights real-world strategies to implement well-being and resilience as a value into your clinical practice from our friend and colleague who recently transitioned back into a leadership role in patient care. A great listen for those feeling burnt out, or who have recently transitioned roles during the pandemic.  </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast episode highlights real-world strategies to implement well-being and resilience as a value into your clinical practice from our friend and colleague who recently transitioned back into a leadership role in patient care. A great listen for those feeling burnt out, or who have recently transitioned roles during the pandemic.  </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/uxaxxt/ASHP_Well_Being_and_Resilience_Real_World_Strategies_for_Leaders_MIX_11121_mixdown9v6ue.mp3" length="40586670" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast episode highlights real-world strategies to implement well-being and resilience as a value into your clinical practice from our friend and colleague who recently transitioned back into a leadership role in patient care. A great listen for those feeling burnt out, or who have recently transitioned roles during the pandemic.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1690</itunes:duration>
                <itunes:episode>534</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Beyond the Basics — Mastering Common Labs</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Beyond the Basics — Mastering Common Labs</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-beyond-the-basics-%e2%80%94-mastering-common-labs/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-beyond-the-basics-%e2%80%94-mastering-common-labs/#comments</comments>        <pubDate>Sat, 30 Oct 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/86606270-4bde-3c01-831a-036013a9a15a</guid>
                                    <description><![CDATA[<p>In this excerpt from the 2020 Midyear Clinical Meeting, our content matter experts help you to evaluate a basic metabolic panel to determine the cause of common electrolyte derangements and interpret a basic metabolic panel to assess a patient’s volume status.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this excerpt from the 2020 Midyear Clinical Meeting, our content matter experts help you to evaluate a basic metabolic panel to determine the cause of common electrolyte derangements and interpret a basic metabolic panel to assess a patient’s volume status.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/sx6sek/Beyond_the_basics_-_Mastering_Common_labs_mixdowna5xu3.mp3" length="52002847" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this excerpt from the 2020 Midyear Clinical Meeting, our content matter experts help you to evaluate a basic metabolic panel to determine the cause of common electrolyte derangements and interpret a basic metabolic panel to assess a patient’s volume status.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2160</itunes:duration>
                <itunes:episode>531</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Dose, Selection, Volume, and Timing — Establishing the Therapeutic Index of Fluids in Sepsis</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Dose, Selection, Volume, and Timing — Establishing the Therapeutic Index of Fluids in Sepsis</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-dose-selection-volume-and-timing-%e2%80%94-establishing-the-therapeutic-index-of-fluids-in-sepsis/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlights-from-the-2020-midyear-dose-selection-volume-and-timing-%e2%80%94-establishing-the-therapeutic-index-of-fluids-in-sepsis/#comments</comments>        <pubDate>Fri, 29 Oct 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/e2573339-da8b-34f3-a00a-361931b8fd05</guid>
                                    <description><![CDATA[<p>This excerpt from the 2020 Midyear Clinical Meeting will describe the phases of fluid administration in critically ill patients, discuss approaches to passive de-resuscitation with fluid restriction and active de-resuscitation and help pharmacists determine an appropriate regimen for diuresing critically ill patients.</p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This excerpt from the 2020 Midyear Clinical Meeting will describe the phases of fluid administration in critically ill patients, discuss approaches to passive de-resuscitation with fluid restriction and active de-resuscitation and help pharmacists determine an appropriate regimen for diuresing critically ill patients.</p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/5bwipu/Dose_selection_Volume_timing_mixdown7r146.mp3" length="60425656" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This excerpt from the 2020 Midyear Clinical Meeting will describe the phases of fluid administration in critically ill patients, discuss approaches to passive de-resuscitation with fluid restriction and active de-resuscitation and help pharmacists determine an appropriate regimen for diuresing critically ill patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2511</itunes:duration>
                <itunes:episode>525</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clinical Highlights from the 2020 Midyear: Speaking from the Heart: Great Debates in Cardiology: The P2Y12 Carousel: Old School (Clopidogrel) vs New Kids on the Block (Ticagrelor/Prasugrel)</title>
        <itunes:title>Clinical Highlights from the 2020 Midyear: Speaking from the Heart: Great Debates in Cardiology: The P2Y12 Carousel: Old School (Clopidogrel) vs New Kids on the Block (Ticagrelor/Prasugrel)</itunes:title>
        <link>https://ashpofficial.podbean.com/e/clinical-highlightsfromthe-2020-midyear-speaking-from-theheart-great-debates-incardiologythep2y12-carouseloldschool-clopidogrelvsnew-kids-on-thebloc/</link>
                    <comments>https://ashpofficial.podbean.com/e/clinical-highlightsfromthe-2020-midyear-speaking-from-theheart-great-debates-incardiologythep2y12-carouseloldschool-clopidogrelvsnew-kids-on-thebloc/#comments</comments>        <pubDate>Thu, 28 Oct 2021 06:00:00 -0400</pubDate>
        <guid isPermaLink="false">ashpofficial.podbean.com/8fc14ee3-6b2c-3081-904d-c1a360b7707c</guid>
                                    <description><![CDATA[<p>In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best oral P2Y12 antiplatelet agents for your patients. </p>
<p>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best oral P2Y12 antiplatelet agents for your patients. </p>
<p><em>The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://cohst.app/pdcst/0Y7E2E/mcdn.podbean.com/mf/web/gh4aqp/Great_debates_in_Cardiology_mixdown7tmgg.mp3" length="48118907" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best oral P2Y12 antiplatelet agents for your patients. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.]]></itunes:summary>
        <itunes:author>American Society of Health-System Pharmacists©</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1998</itunes:duration>
                <itunes:episode>530</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
